Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6005820729806731,-2.5088478577883118,0.0,0.0,0.0,59/87,21.11%,RPL13;RPS8;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;RPL18A;RPS20;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;RPS14;RPL10;RPL32;RPL18;RPS28;RPSA;RPS5;RPL15;RPS24;RPS19;SRP68;RPL27;RPL39;RPL24;RPL12;RPS12;RPS4X;RPS27;RPL27A;RPS9;RPL30;RPL19;RPL28;RPL31;RPL13A;RPL36A;SEC61B;RPL29;RPLP2;RPLP0;RPL10A;RPS10;RPL35;RPS26
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.570030705884471,-2.4138244894849556,0.0,0.0008572298795605801,0.001,61/91,21.23%,RPL13;RPS8;RPS23;RPS29;RPL37A;RPS21;SIL1;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;RPL18A;RPS20;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;RPS14;RPL10;RPL32;RPL18;RPS28;RPSA;RPS5;RPL15;RPS24;RPS19;SRP68;RPL27;RPL39;RPL24;RPL12;RPS12;RPS4X;RPS27;RPL27A;RPS9;RPL30;RPL19;RPL28;RPL31;RPL13A;RPL36A;SEC62;RPL29;RPLP2;RPLP0;RPL10A;RPS10;RPL35;RPS26;SSR2
prerank,cytoplasmic translation (GO:0002181),-0.5616434918451281,-2.396366834915288,0.0,0.00057148658637372,0.001,60/91,22.11%,RPL13;RPS8;EIF3M;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;RPL18A;RPS20;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;RPS14;RPL10;RPL32;RPL18;RPS28;RPSA;RPS5;RPL15;RPS24;RPS19;RPL27;RPL39;RPL24;RPL12;RPS12;RWDD1;RPS4X;RPS27;RPL27A;RPS9;RPL30;RPL19;RPL28;RPL31;RPL13A;RPL36A;RPL29;RPLP0;RPL10A;RPS10;RPL35;RPS26;TMA7;RPS27A
prerank,protein targeting to ER (GO:0045047),-0.565953472784359,-2.357595652630768,0.0,0.00042861493978029006,0.001,65/99,22.11%,RPL13;RPS8;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;RPL18A;RPS20;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;EDEM1;RPS14;SPCS2;RPL10;RPL32;RPL18;RPS28;RPSA;RPS5;RPL15;RPS24;RPS19;SRP68;RPL27;RPL39;RPL24;RPL12;RPS12;SGTA;RPS4X;RPS27;RPL27A;RPS9;RPL30;RPL19;SGTB;RPL28;RPL31;RPL13A;RPL36A;SEC62;RPL29;RPLP2;RPLP0;RPL10A;RPS10;RPL35;RPS26;ZFAND2A;RPS27A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.4964784358189707,-2.2027506225833884,0.0,0.0027431356145938566,0.007,70/110,25.00%,RPL13;RPS8;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;EIF4G1;RPS7;RPL18A;RPS20;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;RPS14;RPL10;RPL32;RPL18;RPS28;RPSA;RPS5;RPL15;RPS24;RPS19;RPL27;RPL39;RPL24;RPL12;RPS12;RPS4X;RPS27;RPL27A;RPS9;RPL30;RPL19;RPL28;EIF4A3;RPL31;RBM8A;RPL13A;SMG1;RPL36A;RPL29;RPLP2;RPLP0;DCP1A;RPL10A;RPS10;RPL35;RPS26;NCBP1;RPS27A;CASC3;RPS3;RPL4;MAGOH;EIF3E;UPF1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.9075824217007714,2.1733089358398465,0.0,0.0,0.0,50/125,2.99%,KNL1;KIF11;CENPF;KIF4A;CENPE;NUF2;CDCA8;SPC25;NSL1;CENPM;KIF2C;NUSAP1;CENPH;CENPP;ZWILCH;CCNB1;KNTC1;NDC80;STIL;CENPK;CENPA;DLGAP5;INCENP;TTK;BUB1B;SGO1;PLK1;SKA1;BIRC5;BUB1;ESPL1;CENPI;SPDL1;KIF18A;CENPN;CDC20;WDR62;AURKB;CENPQ;CKAP5;CENPU;SKA2;XPO1;STMN1;DSN1;ITGB3BP;PMF1;GPSM2;AURKA;NUP160
prerank,mitotic sister chromatid segregation (GO:0000070),0.9081617364798685,2.16053146995625,0.0,0.0,0.0,41/98,2.82%,PRC1;KIF18B;CENPE;KIF14;CDCA8;NSL1;KIF23;CEP55;KIF2C;NUSAP1;NCAPG;CCNB1;NDC80;CDK1;CENPK;KIFC1;DLGAP5;SGO1;NCAPG2;PLK1;CDCA5;SPAG5;ESPL1;KNSTRN;SPDL1;NCAPH;SMC2;KIF18A;SMC4;KIF22;NCAPD3;NCAPD2;NCAPH2;PSRC1;HASPIN;PDS5A;DSN1;KMT5A;SMC1A;RB1;PDS5B
prerank,mitotic spindle organization (GO:0007052),0.9008474225410247,2.1482990938315565,0.0,0.0,0.0,56/153,3.24%,KNL1;KIF11;PRC1;CENPF;TPX2;KIF4A;CENPE;NUF2;CDCA8;SPC25;NSL1;CENPM;KIF23;KIF2C;CENPH;CENPP;ZWILCH;CCNB1;KNTC1;NDC80;STIL;CENPK;KIFC1;CENPA;DLGAP5;INCENP;TTK;BUB1B;SGO1;PLK1;SKA1;BIRC5;BUB1;CENPI;SPDL1;KIF18A;CENPN;CDC20;WDR62;AURKB;CEP192;CENPQ;CKAP5;CENPU;SKA2;XPO1;STMN1;DSN1;ITGB3BP;SMC1A;PMF1;GPSM2;CCDC61;AURKA;NUP160;RHOA
prerank,centromere complex assembly (GO:0034508),0.9363204707136767,2.125894291411567,0.0,0.0,0.0,18/36,2.07%,KNL1;CENPF;MIS18BP1;CENPE;CENPM;CENPH;CENPP;CENPK;CENPA;DLGAP5;CENPI;HJURP;CENPN;CENPQ;CENPU;HELLS;OIP5;ITGB3BP
prerank,chromosome condensation (GO:0030261),0.9240632295453151,2.0897753640615764,0.0,0.0,0.0,17/36,2.58%,TOP2A;NUSAP1;NCAPG;CCNB1;CDK1;INCENP;NCAPG2;PLK1;CDCA5;NCAPH;SMC2;SMC4;NCAPD3;NCAPD2;NCAPH2;KMT5A;RB1
prerank,mitotic nuclear division (GO:0140014),0.8927436479359308,2.0759336087738935,0.0,0.0,0.0,23/71,2.42%,KIF11;TPX2;KIF18B;CDCA8;NSL1;NUSAP1;NDC80;CENPK;KIFC1;SGO1;NCAPG2;PLK1;SPAG5;ESPL1;KNSTRN;KIF18A;SMC4;UBE2C;CEP192;UBE2S;DSN1;SMC1A;CCDC61
prerank,chromatin remodeling at centromere (GO:0031055),0.9295212740604271,2.0753606985103916,0.0,0.0,0.0,15/31,2.07%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;CENPI;HJURP;CENPN;CENPQ;CENPU;HELLS;OIP5;ITGB3BP
prerank,sister chromatid segregation (GO:0000819),0.9497425464673392,2.07339221204375,0.0,0.0,0.0,19/31,2.58%,TOP2A;KIF18B;CDCA8;NSL1;NUSAP1;NDC80;CENPK;KIFC1;SGO1;NCAPG2;PLK1;SPAG5;ESPL1;KNSTRN;KIF18A;SMC4;DSN1;SMC1A;RB1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.9136522976163436,2.0714663621980853,0.0,0.0,0.0,16/38,2.07%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;ASF1B;CENPI;HJURP;CENPN;ATRX;CENPQ;CENPU;OIP5;ITGB3BP
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.932541492202622,2.0628942426417827,0.0,0.0,0.0,14/29,2.07%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;CENPI;HJURP;CENPN;CENPQ;CENPU;OIP5;ITGB3BP
prerank,CENP-A containing chromatin organization (GO:0061641),0.932541492202622,2.0628942426417827,0.0,0.0,0.0,14/29,2.07%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;CENPI;HJURP;CENPN;CENPQ;CENPU;OIP5;ITGB3BP
prerank,mitotic metaphase plate congression (GO:0007080),0.8988123104592227,2.0544727751119884,0.0,0.0,0.0,14/51,1.69%,CENPE;KIF14;NUF2;CDCA8;CEP55;KIF2C;CCNB1;NDC80;KIFC1;CDCA5;SPDL1;KIF18A;KIF22;PSRC1
prerank,histone exchange (GO:0043486),0.90983963771968,2.0480136519682905,0.0,0.0,0.0,14/37,2.07%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;CENPI;HJURP;CENPN;CENPQ;CENPU;OIP5;ITGB3BP
prerank,mitotic spindle assembly (GO:0090307),0.8991293773106072,2.034524751913235,0.0,0.0,0.0,14/42,4.74%,KIF11;PRC1;TPX2;KIF4A;KIF23;KIFC1;RACGAP1;AURKB;CEP192;SMC1A;CCDC61;RHOA;CHEK2;SMC3
prerank,positive regulation of cell cycle process (GO:0090068),0.8539509252000381,2.0315329772074797,0.0,0.0,0.0,26/91,3.52%,KIF20B;KIF14;KIF23;ECT2;NUSAP1;E2F7;CCNB1;NDC80;E2F8;SPAG5;RACGAP1;CEP295;ATRX;AURKB;DBF4;GEN1;CIT;DDX11;PLK4;GPSM2;PHIP;AURKA;CSPP1;RHOA;RAD21;CDC6
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.8803262024889752,2.0238144545356764,0.0,0.0,0.0,18/56,3.24%,KIF4A;KIF23;CEP55;ECT2;NUSAP1;CKAP2;CENPA;INCENP;PLK1;RACGAP1;ESPL1;KIF20A;AURKB;ANLN;CIT;STMN1;ROCK2;RHOA
prerank,mitotic cytokinesis (GO:0000281),0.8864016121671241,2.022716406616801,0.0,0.0,0.0,16/47,3.07%,KIF4A;KIF23;CEP55;ECT2;NUSAP1;CKAP2;CENPA;INCENP;PLK1;RACGAP1;ESPL1;KIF20A;ANLN;CIT;STMN1;ROCK2
prerank,mitotic chromosome condensation (GO:0007076),0.9202147182212987,2.017799921428238,0.0,0.0,0.0,15/26,2.58%,NUSAP1;NCAPG;CCNB1;CDK1;NCAPG2;PLK1;CDCA5;NCAPH;SMC2;SMC4;NCAPD3;NCAPD2;NCAPH2;KMT5A;RB1
prerank,cellular response to cadmium ion (GO:0071276),-0.6222043687705882,-1.9949383384455721,0.0,0.08486575807649742,0.244,15/24,20.66%,MAPK8;MAPK9;JUN;MAPK3;MAPK1;CHUK;MT2A;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,positive regulation of cytokinesis (GO:0032467),0.8883663675835537,1.9911714310769308,0.0,8.728561554383074e-05,0.002,10/32,3.52%,KIF20B;KIF14;KIF23;ECT2;RACGAP1;AURKB;CIT;CSPP1;RHOA;CDC6
prerank,response to cadmium ion (GO:0046686),-0.6086147905863594,-1.9844898897025314,0.005917159763313609,0.08351868255147366,0.274,15/26,20.66%,MAPK8;MAPK9;JUN;MAPK3;MAPK1;CHUK;MT2A;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,regulation of cation channel activity (GO:2001257),-0.473302471091214,-1.983227464980132,0.0,0.07350746217231974,0.275,36/89,18.18%,CAMK2D;AHNAK;FGF14;LRRC7;MEF2C;GRIN2A;KCNAB1;CALM1;FKBP1A;GRIN2B;HOMER1;SHISA6;FGF13;CACNG7;NETO1;NEFL;MINK1;CACNG4;RELN;OPRM1;GRIA1;APP;SELENON;SHANK1;CACNB2;CACNG2;PRRT1;DLG4;GRIN1;CACNG3;CACNG8;GRIA2;STAC;CACNB1;NLGN1;PDE4D
prerank,positive regulation of cell division (GO:0051781),0.8715795656112313,1.973729534936611,0.0,0.0003316853390665568,0.008,11/38,3.54%,KIF20B;KIF14;KIF23;ECT2;RACGAP1;AURKB;CIT;CSPP1;RHOA;CDC6;FGFR2
prerank,DNA replication (GO:0006260),0.8310092645738764,1.9651917691309109,0.0,0.0007897269977775161,0.016,49/105,8.02%,BRCA1;EXO1;TICRR;CDK1;BRIP1;POLE;CLSPN;PIF1;BARD1;RMI2;DBF4;MCM5;POLA1;WDHD1;ORC1;PCLAF;TIPIN;POLA2;MCM8;CDC45;RFC4;NAP1L1;TIMELESS;FAM111A;MCM10;MCM6;MCM7;MCM2;RPAIN;TOPBP1;RBBP8;CDC6;RPA1;DNA2;RAD1;RFC2;BLM;MRE11;MCM3;POLD1;RPA2;MCM4;RFC1;ORC2;RFC3;CHEK1;RNASEH2A;ORC3;CDK2
prerank,negative regulation of protein transport (GO:0051224),-0.5978902273915397,-1.957067881354264,0.0,0.09200934040616893,0.357,12/25,23.46%,APOE;SNX3;SERGEF;CYP51A1;PPM1F;RHBDF1;PKDCC;WWP2;RHBDF2;DRD2;NDFIP1;DPH3
prerank,regulation of cytokinesis (GO:0032465),0.8296106402636468,1.954036564508717,0.0,0.0012815115373026058,0.027,17/78,3.52%,PRC1;KIF20B;KIF14;KIF23;ECT2;E2F7;E2F8;PLK1;RACGAP1;KIF20A;AURKB;CIT;PLK4;AURKA;CSPP1;RHOA;CDC6
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.8887067851253465,1.9523854474037672,0.0,0.001442110169854595,0.032,12/26,3.61%,CENPE;CCNB1;DLGAP5;PLK1;ESPL1;UBE2C;CDK5RAP2;FBXO5;ANAPC7;RB1;CDC6;CDC27
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.8372124749912718,1.9489954158479665,0.0,0.0014856739145689525,0.035,21/82,3.33%,CENPF;TPX2;HMMR;KIF14;NEK2;CDK1;PLK1;ATAD5;GTSE1;CEP192;CEP152;CDK5RAP2;CKAP5;HAUS8;PLK4;CEP57;HAUS4;HAUS6;AURKA;ACTR1A;CEP43
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.8595798236729072,1.9483332515936194,0.0,0.00145941549189285,0.036,20/40,7.35%,EME1;POLE;RAD51;ATRX;GEN1;DDX11;ZRANB3;TIPIN;MMS22L;TIMELESS;RFWD3;FAM111A;RTEL1;MSH3;PRIMPOL;TONSL;BLM;POLD1;ETAA1;NUCKS1
prerank,DNA replication initiation (GO:0006270),0.8693748719330042,1.938383381300279,0.0,0.0024238544008709922,0.063,23/37,8.02%,POLE;DBF4;MCM5;POLA1;ORC1;PRIM2;POLA2;MCM8;CDC45;PRIM1;MCM10;MCM6;MCM7;MCM2;TOPBP1;CDC6;RPA1;MCM3;RPA2;MCM4;ORC2;ORC3;CDK2
prerank,replication fork processing (GO:0031297),0.8592932478360005,1.9380635463978002,0.0,0.002395505226591799,0.065,19/38,7.35%,EME1;RAD51;ATRX;ZGRF1;GEN1;DDX11;BRCA2;ZRANB3;MMS22L;RFWD3;FAM111A;RTEL1;PRIMPOL;DNA2;TONSL;BLM;MRE11;ETAA1;NUCKS1
prerank,negative regulation of cell cycle process (GO:0010948),0.8278363439518058,1.9301771928011597,0.0,0.0034056976779155384,0.093,22/61,7.30%,BRCA1;NEK2;E2F7;E2F8;RRM2;EZH2;ESPL1;RAD51;AURKB;E2F1;CBX5;TERF1;FBXO5;SUZ12;RBBP8;TFDP1;EED;WAPL;YAF2;RBBP4;RBBP7;CHEK1
prerank,regulation of cell cycle process (GO:0010564),0.8176609251125072,1.9276033058539128,0.0,0.0035170083366540075,0.098,20/104,2.81%,KIF11;PRC1;KIF20B;MKI67;NEK2;ECT2;PLK1;SPAG5;RACGAP1;BUB1;KNSTRN;BORA;RMI2;KIF20A;AURKB;DBF4;TIPIN;PLK4;FBXO5;AURKA
prerank,kinetochore organization (GO:0051383),0.9684081749498278,1.9239848167025293,0.0,0.004007864513720895,0.116,7/13,0.53%,CENPF;CENPE;NUF2;CENPH;NDC80;CENPA;DLGAP5
prerank,monoacylglycerol metabolic process (GO:0046462),-0.7109668130213237,-1.9211727438841393,0.0,0.1357852129223959,0.509,4/13,4.75%,PLA2G4A;ABHD6;ABHD12;ABHD16A
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.929148049480265,1.9206590889812327,0.0,0.004493801367998511,0.131,11/17,3.45%,KNL1;ZWILCH;CDK1;CENPA;TTK;SPDL1;AURKB;HASPIN;MTBP;RB1;CTCF
prerank,protein depolymerization (GO:0051261),0.886166344740433,1.9182794668282628,0.0,0.004819802583310903,0.142,7/27,1.86%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.8455134349262442,1.9134183352689123,0.0,0.005779365756462732,0.175,17/42,6.63%,DTL;POLK;POLE;POLA1;PCLAF;USP43;RFC4;CDKN2D;POLH;RPA1;PRIMPOL;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,dendritic spine morphogenesis (GO:0060997),-0.6790358344414122,-1.9106231480472307,0.0035211267605633804,0.1404298402698332,0.55,8/15,14.13%,CTNND2;DOCK10;SHANK3;PAK3;DIP2A;EPHB2;SHANK1;DLG4
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.8205283515123307,1.9076115717416622,0.0,0.006799549450864415,0.209,11/78,2.89%,KIF11;KIF15;KIF4A;CENPE;KIF23;KIF2C;RACGAP1;KIF18A;KIF22;CTSE;ACTR1A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.8205283515123307,1.9076115717416622,0.0,0.006799549450864415,0.209,11/78,2.89%,KIF11;KIF15;KIF4A;CENPE;KIF23;KIF2C;RACGAP1;KIF18A;KIF22;CTSE;ACTR1A
prerank,microtubule depolymerization (GO:0007019),0.9290668565293771,1.906157330147214,0.0,0.006864043822349579,0.215,7/17,1.86%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.8198706486345634,1.9052557379883412,0.0,0.006880229668475199,0.221,11/79,2.89%,KIF11;KIF15;KIF4A;CENPE;KIF23;KIF2C;RACGAP1;KIF18A;KIF22;CTSE;ACTR1A
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.9017401476488274,1.9017111506357034,0.0012903225806451613,0.00717269545731429,0.242,8/20,0.95%,CENPF;KNTC1;TTK;BUB1B;PLK1;BUB1;TRIP13;CDC20
prerank,spindle assembly checkpoint signaling (GO:0071173),0.9017401476488274,1.9017111506357034,0.0012903225806451613,0.00717269545731429,0.242,8/20,0.95%,CENPF;KNTC1;TTK;BUB1B;PLK1;BUB1;TRIP13;CDC20
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.9017401476488274,1.9017111506357034,0.0012903225806451613,0.00717269545731429,0.242,8/20,0.95%,CENPF;KNTC1;TTK;BUB1B;PLK1;BUB1;TRIP13;CDC20
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.8277410068102101,1.9007008960340708,0.0,0.007139324676249668,0.246,21/57,8.22%,DTL;BRCA1;EME1;TICRR;CDK1;CLSPN;PLK1;FANCD2;TIPIN;RFWD3;TOPBP1;CHEK2;PRKDC;BLM;MRE11;RPA2;MDC1;CHEK1;UIMC1;CDK2;MRNIP
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.5922615105075852,-1.8978390311029523,0.0,0.14930087069013437,0.601,13/23,27.78%,ELOVL7;HACD2;ACSL4;HACD1;ACSL5;ACSL6;ELOVL6;ACOT7;ACSL1;ELOVL1;TECR;ACSBG1;FAR2
prerank,interstrand cross-link repair (GO:0036297),0.8199067573439538,1.895550672258153,0.0,0.008627767450719364,0.302,18/53,7.35%,NEIL3;EME1;RAD51AP1;FANCA;UBE2T;FANCD2;RAD51;RAD51AP2;MCM8;RFWD3;RNF168;USP1;FANCI;RPA1;ERCC4;RPA2;FANCL;NUCKS1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.8040820185955639,1.8951725531238754,0.0,0.008619962009462261,0.306,9/80,1.10%,KIF11;KIF15;KIF4A;CENPE;KIF23;KIF2C;RACGAP1;KIF18A;KIF22
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.49671714313975057,-1.8933290844331123,0.0,0.14401461976617747,0.618,22/46,18.07%,GRM7;GRIK1;MEF2C;CDH2;GRM3;SHANK3;OPHN1;SYT1;HOMER1;CACNG7;NRXN1;DGKI;TSHZ3;CACNG4;RELN;GRM5;CACNG2;ATP1A2;GRM1;CACNG3;CACNG8;NLGN1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.8913760474293987,1.8919751258902548,0.0012853470437017994,0.009554799256065017,0.339,9/21,2.23%,CENPF;KNTC1;TTK;BUB1B;PLK1;BUB1;TRIP13;CDC20;FBXO5
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.6409477803732575,-1.8917496259172293,0.003952569169960474,0.13629955085013223,0.622,11/18,27.51%,ELOVL7;HACD2;ACSL4;HACD1;ACSL5;ACSL6;ELOVL6;ACSL1;ELOVL1;TECR;ACSBG1
prerank,postreplication repair (GO:0006301),0.8190143220442792,1.8892020659517565,0.0,0.01041123425403359,0.362,17/45,6.93%,DTL;BRCA1;POLK;RAD18;PCLAF;USP43;RFC4;POLH;RPA1;PRIMPOL;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3;UBE2N
prerank,spindle assembly (GO:0051225),0.808069328486502,1.8891802780244125,0.0,0.010184903074598076,0.362,19/67,8.27%,KIF11;TPX2;NEK2;KIFC1;CEP192;HAUS8;SMC1A;CCDC61;HAUS4;HAUS6;RHOA;CHEK2;TUBGCP5;SMC3;NUMA1;HAUS7;STAG1;HAUS1;GOLGA8B
prerank,regulation of mitotic nuclear division (GO:0007088),0.8253467509683714,1.8855950740245186,0.0,0.011203201612088487,0.395,11/55,3.88%,KIF20B;MKI67;NEK2;NUSAP1;CCNB1;BORA;CDK5RAP2;FBXO5;PHIP;AURKA;OBSL1
prerank,DNA metabolic process (GO:0006259),0.7851747838498597,1.884036030624621,0.0,0.011660812701558639,0.414,94/270,9.01%,TOP2A;NEIL3;BRCA1;EXO1;TICRR;RAD51AP1;POLK;POLQ;UHRF1;CDK1;FANCA;POLE;RAD51B;BARD1;UBE2T;KPNA2;RMI2;RAD51;RAD54L;DBF4;MCM5;GEN1;POLA1;WDHD1;RAD18;ORC1;HMGB2;HELLS;PRIM2;TYMS;ZRANB3;POLA2;MCM8;TERF1;CDC45;RFC4;PDS5A;PRIM1;DMC1;SMC1A;TIMELESS;XRCC2;MCM10;MCM6;MCM7;MCM2;PDS5B;RPAIN;TOPBP1;EID3;RTEL1;POLH;RBBP8;RAD21;CDC6;RPA1;STN1;CHD1L;MSH3;PRIMPOL;DNA2;UHRF2;SMARCAD1;POLD3;RAD1;ERCC4;PRKDC;RFC2;BLM;MRE11;RECQL;MCM3;NSMCE4A;POLD1;RPA2;MCM4;RFC1;TCF7L2;ERCC3;FANCL;ORC2;RFC3;UBE2N;DNASE2;RIF1;CHEK1;RNASEH2A;ORC3;CDK2;TRIM28;HMGB3;RAD51C;AXIN2;MGMT
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.6849111279660767,-1.8824126441665443,0.0,0.1431002412279795,0.669,6/14,6.72%,PTK2;STAT3;STAT6;SOCS2;PIK3R1;LYN
prerank,embryonic heart tube development (GO:0035050),-0.6971784529722151,-1.8809954849126291,0.0036101083032490976,0.13747824193452804,0.676,7/14,18.05%,ACVR1;RYR2;MEGF8;SOX17;CITED2;NDRG4;TBX2
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.7101259092781443,-1.8757417370303924,0.006269592476489028,0.1373584818778247,0.695,7/12,17.56%,PARP8;PARP12;TIPARP;PARP6;PARP1;PARP16;PARP10
prerank,DNA replication checkpoint signaling (GO:0000076),0.9157229694594078,1.8714742745043942,0.0,0.018039620992089264,0.544,9/16,4.22%,TICRR;CLSPN;ORC1;TIPIN;CDC45;TIMELESS;TOPBP1;CDC6;DNA2
prerank,regulation of nuclear division (GO:0051783),0.8945868548229982,1.8704373634827072,0.0,0.018226109381707295,0.555,6/20,3.88%,KIF20B;MKI67;NEK2;BORA;FBXO5;OBSL1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.829565843522691,1.8667935911592988,0.0012048192771084338,0.020096229366973736,0.587,14/32,6.45%,E2F7;RRM2;POLA1;ORC1;E2F1;TYMS;CDC45;FBXO5;RB1;CDK14;CDC6;TFDP1;CCNA1;CCNE1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.8877133581935347,1.8660310764997945,0.0012254901960784314,0.020156262912506145,0.594,7/24,1.86%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.7388770102282225,-1.8649594753531686,0.009230769230769232,0.14696730046244166,0.733,5/10,13.19%,LYN;FAS;MAPK3;MAPK1;MAP2K1
prerank,dendrite morphogenesis (GO:0048813),-0.529836801852024,-1.8646038073574294,0.0,0.13959311828212814,0.734,17/35,15.65%,CTNND2;DOCK10;SHANK3;PAK3;KLF7;TAOK2;DIP2A;EPHB2;BTBD3;TMEM106B;MINK1;CTNNA2;CHRNA7;MEF2A;SHANK1;DLG4;DVL1
prerank,DNA recombination (GO:0006310),0.8395174189225523,1.864471067670654,0.0011641443538998836,0.02066775155221328,0.602,16/37,5.48%,EXO1;RAD51B;RAD54B;RAD51;RAD54L;GEN1;DMC1;XRCC2;RPAIN;RTEL1;RAD21;RPA1;MSH3;BLM;MRE11;RECQL
prerank,establishment of mitotic spindle localization (GO:0040001),0.8671200024848933,1.8617876302420433,0.0,0.021743816672140946,0.625,12/28,6.82%,NUSAP1;NDC80;CENPA;PLK1;ESPL1;SPDL1;SAPCD2;CDK5RAP2;GPSM2;NUMA1;ZW10;NDE1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.8853847440459847,1.8615152173264502,0.006666666666666667,0.021544470433004986,0.627,9/16,3.44%,SGO1;CDCA5;DSCC1;HASPIN;PDS5A;SMC1A;RB1;PDS5B;RAD21
prerank,regulation of DNA recombination (GO:0000018),0.8331232284978978,1.8600194040026734,0.0,0.022151842287659332,0.637,14/32,7.46%,RAD51AP1;FIGNL1;KPNA2;RAD51;ZRANB3;RTEL1;MSH3;SMARCAD1;BLM;MRE11;RPA2;SPIDR;CHEK1;SETD2
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.4251996798788495,-1.8587898439541108,0.0,0.14178582207931995,0.761,36/107,15.51%,NRG3;GRM7;GRIK1;DLGAP1;DLGAP4;SYN3;MCTP1;RIMS1;IQSEC2;MEF2C;CDH2;SLC8A3;GRM3;OPHN1;TMEM108;GRID2;CNTNAP4;SYT1;LGI1;HOMER1;GRIK4;BCR;CACNA1B;DGKI;RELN;CHRNA7;APP;GRM5;PSMC5;ATP1A2;GRM1;DLG4;LRP8;SLC12A2;SLC4A8;CPLX1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.7948681836300487,1.8573983922615456,0.0,0.023421640170927915,0.661,37/95,7.45%,BRCA1;RAD51AP1;POLQ;RAD51B;RAD54B;RAD51;RAD54L;MCM5;GEN1;RAD51AP2;BRCA2;MMS22L;MCM8;CDC45;AUNIP;XRCC2;RFWD3;SMC6;MCM6;MCM7;MCM2;RBBP8;RAD21;RPA1;SMC5;ERCC4;TONSL;BLM;MRE11;RECQL;MCM3;RPA2;MCM4;SPIDR;UBE2N;NUCKS1;NIPBL
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.6997561985441214,-1.8569124557132086,0.0,0.13797319013879814,0.768,8/13,13.91%,SHANK3;SQSTM1;EPHB2;LGMN;RELN;CHRNA7;APP;ADCY8
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.9104877556816607,1.8553565847079274,0.0013568521031207597,0.024304529155739076,0.676,4/16,4.60%,TOP2A;EME1;HFM1;ERCC4
prerank,glycerolipid catabolic process (GO:0046503),-0.6108542790310018,-1.8534781754078617,0.0,0.13622162086108128,0.786,9/19,14.51%,GPCPD1;PLA2G4A;ABHD6;ABHD12;PNPLA6;ENPP6;ABHD2;GDPD3;GDPD1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.8306344666873521,1.8532273706303892,0.0,0.025213707554466225,0.691,18/42,8.51%,RAD51AP1;POLQ;PARPBP;FIGNL1;RMI2;RAD51;TIMELESS;RTEL1;ARID2;KLHL15;RPA2;SPIDR;RIF1;CHEK1;SETD2;FUS;MRNIP;SMCHD1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.8369708509675069,1.8513191507832372,0.0,0.025954377781958072,0.707,12/32,8.22%,DTL;BRCA1;TICRR;CDK1;CLSPN;PLK1;TOPBP1;BLM;MRE11;CHEK1;UIMC1;MRNIP
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.466034825441274,-1.8486234227996337,0.0,0.13849853184552677,0.806,25/57,18.07%,DLGAP1;DLGAP4;LRRC7;MEF2C;GRIN2A;GRIN2B;SHISA6;CACNG7;NETO1;NEFL;MINK1;CACNG4;RELN;OPRM1;GRIA1;APP;SHANK1;CACNG2;PRRT1;DLG4;GRIN1;CACNG3;CACNG8;GRIA2;NLGN1
prerank,apoptotic nuclear changes (GO:0030262),0.859349434642199,1.8474597687381895,0.002577319587628866,0.02868262563239487,0.747,2/24,1.39%,TOP2A;HMGB2
prerank,protein localization to kinetochore (GO:0034501),0.9245937848808594,1.840796231171034,0.0,0.03398437284548875,0.806,7/14,2.49%,KNL1;ZWILCH;CDK1;TTK;SPDL1;AURKB;MTBP
prerank,regulation of DNA replication (GO:0006275),0.8019782636340629,1.8407055853644716,0.0,0.03356339740554443,0.807,19/49,7.74%,ESCO2;ATAD5;GLI2;DSCC1;TERF1;PDS5A;FBXO5;CDC6;STN1;DNA2;WAPL;CCNA2;SMC3;DHX9;BLM;FAF1;USP37;NUCKS1;ORC3
prerank,regulation of chromosome segregation (GO:0051983),0.904328371643906,1.8388882482611488,0.0,0.03476217830920203,0.823,10/16,4.92%,MKI67;KIF2C;BUB1;RMI2;AURKB;RAD18;SMC6;CDC6;SMC5;NUMA1
prerank,regulation of exit from mitosis (GO:0007096),0.8194146453216657,1.837225403315091,0.0,0.03579650236233686,0.831,12/38,6.61%,NEK2;KNTC1;BUB1B;CDCA5;CDC20;UBE2C;ANLN;UBE2S;ANAPC7;CDC27;ZW10;BUB3
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.7788841652798963,1.8341233865108892,0.0,0.03853329298928522,0.851,44/145,10.29%,CENPF;TPX2;HMMR;DTL;KIF14;NEK2;CCNB1;CDK1;RAD51B;PLK1;CEP192;CEP152;CDK5RAP2;CKAP5;HAUS8;PLK4;CEP57;FBXO5;HAUS4;HAUS6;AURKA;ACTR1A;CEP43;PSMC2;PSMD5;PCM1;FBXL7;HAUS7;NDE1;CDC25B;CNTRL;HAUS1;CDK2;PSMB1;CEP76;PSMD14;RAD51C;ALMS1;ODF2;CDC25C;PSMD1;SDCCAG8;CDC25A;NINL
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.9531406963689029,1.8339815481124764,0.0,0.038081932399544605,0.851,4/12,0.39%,CENPE;NUF2;KIF2C;NDC80
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.7684981239151971,1.8291989971909046,0.0,0.042180131905559554,0.878,48/184,8.94%,CENPF;TPX2;HMMR;CENPE;KIF14;NEK2;CCNB1;KNTC1;CDK1;BUB1B;PLK1;CDC20;UBE2C;CEP192;CEP152;CDK5RAP2;CKAP5;ANLN;E2F1;HAUS8;PLK4;CEP57;UBE2S;FBXO5;ANAPC7;HAUS4;HAUS6;AURKA;ACTR1A;CEP43;CDC6;PSMC2;CDC27;PSMD5;PCM1;ZW10;HAUS7;ERCC3;BUB3;NDE1;CNTRL;HAUS1;CDK2;PSMB1;CEP76;CUL3;PSMD14;ALMS1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.6792568208378804,-1.8289119964352767,0.0,0.1643023935824445,0.868,6/13,15.29%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2;SLC12A2
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.9708141979173964,1.8267964090511657,0.0,0.04409251844330424,0.894,6/10,0.78%,NEK2;ECT2;CCNB1;SPAG5;RACGAP1;KNSTRN
prerank,negative regulation of centrosome duplication (GO:0010826),0.9330308080008987,1.8222281543940384,0.0,0.04924342694641702,0.923,4/11,2.37%,BRCA1;CCNF;CDK5RAP2;TRIM37
prerank,protein localization to condensed chromosome (GO:1903083),0.9338608122430065,1.8213510638742982,0.0,0.049589294002697196,0.925,7/12,2.49%,KNL1;ZWILCH;CDK1;TTK;SPDL1;AURKB;MTBP
prerank,translesion synthesis (GO:0019985),0.7954788296961558,1.8201727554178282,0.0,0.05016740753381672,0.93,14/42,6.63%,DTL;POLK;PCLAF;USP43;RFC4;POLH;RPA1;PRIMPOL;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,recombinational repair (GO:0000725),0.7857784957278491,1.8153709996581333,0.0,0.05529603529369858,0.952,29/77,8.76%,BRCA1;RAD51AP1;POLQ;RAD51B;RAD54B;RAD51;GEN1;RAD51AP2;BRCA2;MMS22L;MCM8;AUNIP;XRCC2;RFWD3;SMC6;RBBP8;RPA1;SMC5;ERCC4;TONSL;BLM;MRE11;RECQL;RPA2;SPIDR;UBE2N;NUCKS1;PSMD14;RAD51C
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.5560942750220398,-1.8148152033353981,0.00966183574879227,0.1822127831993969,0.899,12/23,29.46%,GPX4;PTGS2;ASAH2;GSTM1;EPHX2;ELOVL6;ACOT7;HPGD;GSTM2;FADS1;ACSBG1;ALOX12
prerank,DNA repair (GO:0006281),0.7557150311506431,1.8094322272445764,0.0,0.06245993513368202,0.965,81/284,7.63%,NEIL3;BRCA1;EME1;EXO1;TICRR;RAD51AP1;POLK;POLQ;CDK1;FANCA;BRIP1;POLE;RAD51B;CDCA5;BARD1;TRIP13;UBE2T;FANCD2;KPNA2;RMI2;RAD51;RAD54L;POLA1;NSD2;WDHD1;RAD18;RAD51AP2;BRCA2;ZRANB3;RFC4;PDS5A;CDKN2D;SMC1A;TIMELESS;XRCC2;RFWD3;RNF168;FAM111A;BAZ1B;SETX;PDS5B;USP1;FANCI;RPAIN;TOPBP1;MGME1;EID3;POLH;RBBP8;RAD21;RPA1;FTO;APEX2;CHD1L;MSH3;PRIMPOL;DNA2;CHEK2;POLD3;RAD1;ERCC4;TDP2;PRKDC;RFC2;BLM;MRE11;RECQL;NSMCE4A;POLD1;RPA2;ERCC3;FANCL;MDC1;RFC3;TENT4A;UBE2N;MLH1;CHEK1;NUCKS1;SETD2;RNASEH2A
prerank,double-strand break repair (GO:0006302),0.7673000716270296,1.8081861159827126,0.0,0.06340718065155677,0.971,50/158,7.35%,BRCA1;EME1;RAD51AP1;POLQ;BRIP1;RAD51B;CDCA5;RAD54B;BARD1;TRIP13;KPNA2;RAD51;GEN1;POLA1;NSD2;HMGB2;RAD51AP2;BRCA2;MMS22L;MCM8;AUNIP;XRCC2;RFWD3;RNF168;SMC6;PAXIP1;BAZ1B;SETX;RBBP8;RAD21;RPA1;SMC5;DNA2;CHEK2;SMARCAD1;ERCC4;TDP2;PRKDC;TONSL;BLM;MRE11;RECQL;RPA2;SPIDR;MDC1;TENT4A;UBE2N;RIF1;PRPF19;NUCKS1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.8083229993812868,1.8064405994102235,0.0011325028312570782,0.06515871200346965,0.975,14/43,8.22%,DTL;BRCA1;TICRR;CDK1;CLSPN;PLK1;ORC1;TOPBP1;CDC6;BLM;MRE11;CHEK1;UIMC1;MRNIP
prerank,regulation of centriole replication (GO:0046599),0.8691216608213429,1.8055244313881493,0.005242463958060288,0.06542170242952379,0.975,6/17,2.37%,BRCA1;STIL;CEP295;CDK5RAP2;PLK4;TRIM37
prerank,DNA biosynthetic process (GO:0071897),0.8761868225343195,1.8024642673887772,0.0068212824010914054,0.06887786255808402,0.977,8/16,6.63%,POLE;POLA1;TYMS;CDKN2D;POLH;POLD3;POLD1;RFC3
prerank,sodium ion export across plasma membrane (GO:0036376),-0.6585633632468891,-1.801878212888488,0.003205128205128205,0.20191060701649974,0.924,5/13,12.55%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.8152313773214102,1.801106931897539,0.004705882352941176,0.07000030146312872,0.981,17/36,10.19%,BRCA1;RRM2;EZH2;RAD51;E2F1;CBX5;SUZ12;RBBP8;TFDP1;EED;YAF2;RBBP4;RBBP7;CHEK1;UXT;EPC1;APAF1
prerank,regulation of G0 to G1 transition (GO:0070316),0.8123782319555558,1.8006330423292998,0.004651162790697674,0.06986122454089352,0.983,17/38,10.19%,BRCA1;RRM2;EZH2;RAD51;E2F1;CBX5;SUZ12;RBBP8;TFDP1;EED;YAF2;RBBP4;RBBP7;CHEK1;UXT;EPC1;APAF1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.7649939895405332,1.7987959584328592,0.0,0.07183444519228485,0.985,33/94,11.85%,NEK2;CDK1;KIF24;PLK1;CEP192;CEP152;CDK5RAP2;CKAP5;HAUS8;PLK4;CEP57;CEP89;HAUS4;HAUS6;ACTR1A;SCLT1;CEP43;CEP97;PCM1;C2CD3;HAUS7;NDE1;CEP83;CNTRL;HAUS1;CEP76;ALMS1;ODF2;SDCCAG8;NINL;NPHP1;AKAP9;CC2D2A
prerank,regulation of sister chromatid cohesion (GO:0007063),0.8885340710869376,1.7979765025773657,0.004261363636363636,0.07232358368914678,0.988,8/12,4.51%,CDCA5;BUB1;ESPL1;DDX11;RB1;RAD21;CTCF;WAPL
prerank,mitotic cell cycle phase transition (GO:0044772),0.7515540467130437,1.797624351711532,0.0,0.07193176027949424,0.989,69/203,10.29%,CCNF;NEK2;MELK;CCNB1;CDKN3;CDK1;POLE;PLK1;CCNE2;MASTL;BORA;UBE2C;CCNB2;CEP192;CEP152;DBF4;CDK5RAP2;CKAP5;E2F1;WEE1;HAUS8;SPDYA;PLK4;CEP57;CDKN2D;UBE2S;ANAPC7;CDKN2C;HAUS4;HAUS6;RB1;CDK14;AURKA;ACTR1A;CEP43;E2F3;CDC27;TACC3;AJUBA;CHEK2;KHDRBS1;PCM1;FBXL7;CCNA2;EIF4E;HAUS7;CCNA1;CCNE1;USP37;NDE1;CDC25B;CUL5;CNTRL;FBXL8;CCDC57;HAUS1;CDK2;CEP76;CUL3;ALMS1;DNM2;CUL4B;ODF2;CDC25C;SKP2;SDCCAG8;FBXL17;CDC25A;NINL
prerank,chromosome organization (GO:0051276),0.7479976675289517,1.797398667829135,0.0,0.07137157742414302,0.989,24/99,11.17%,TOP2A;NUF2;CDCA8;CENPH;NDC80;PHF19;EZH2;HMGB2;NUP155;RFWD3;MSH3;TCF7L1;MTHFR;TCF7L2;HMGN2;NUCKS1;PHF1;SMARCA4;AXIN2;CUL4B;HDAC8;CENPW;XPA;HDAC1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.9160830158222252,1.7964258410529372,0.001445086705202312,0.0718391422613566,0.99,6/12,4.23%,TICRR;CLSPN;ORC1;TOPBP1;CDC6;CHEK2
prerank,keratan sulfate catabolic process (GO:0042340),-0.7056744183759347,-1.7925629902545246,0.002967359050445104,0.2150059534957129,0.934,8/11,17.29%,GNS;FMOD;HEXB;PRELP;HEXA;OGN;LUM;GALNS
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.7775886947738959,1.7925216518168245,0.0011037527593818985,0.07691435900389314,0.993,14/56,3.67%,DTL;CCNB1;CDK1;DLGAP5;RAD51B;CDCA5;ESPL1;UBE2C;FBXO5;ANAPC7;RB1;HYAL1;CDC27;TFDP1
prerank,regulation of NMDA receptor activity (GO:2000310),-0.5129025234848741,-1.792263135956464,0.0,0.20751086155934328,0.934,14/32,18.07%,LRRC7;MEF2C;GRIN2A;GRIN2B;EPHB2;NEFL;RELN;OPRM1;GRIA1;APP;DLG4;GRIN1;GRIA2;NLGN1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.7586639441329486,1.7871246688229192,0.0,0.08477991640796043,0.996,46/128,10.29%,NEK2;MELK;CCNB1;CDK1;PLK1;MASTL;BORA;CCNB2;CEP192;CEP152;CDK5RAP2;CKAP5;WEE1;HAUS8;PLK4;CEP57;HAUS4;HAUS6;CDK14;AURKA;ACTR1A;CEP43;AJUBA;CHEK2;KHDRBS1;PCM1;FBXL7;CCNA2;HAUS7;NDE1;CDC25B;CNTRL;FBXL8;CCDC57;HAUS1;CDK2;CEP76;ALMS1;DNM2;ODF2;CDC25C;SKP2;SDCCAG8;FBXL17;CDC25A;NINL
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.8768122474344843,1.7868416219185623,0.005494505494505495,0.08421226918289255,0.996,8/15,6.62%,CENPE;PLK1;UBE2C;ANAPC7;CDC6;CDC27;TACC3;TPR
prerank,regulation of spindle organization (GO:0090224),0.882445017467224,1.7865039769455588,0.0013736263736263737,0.08381576714165014,0.996,6/18,4.92%,TPX2;BORA;PSRC1;GPSM2;TACC3;NUMA1
prerank,chloride transmembrane transport (GO:1902476),-0.47464222144142687,-1.783287119864427,0.0,0.2197464456777018,0.946,20/48,15.48%,GABRB1;ANO3;GABRB3;GABRA2;SLC6A1;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;GABRA5;GABRB2;ANO4;GABRG2;SLC12A9;GABRG1;SLC12A2;SLC1A1;SLC4A8
prerank,meiosis I (GO:0007127),0.8401790949245583,1.7818193261839674,0.0,0.09035661445071452,0.996,3/23,0.99%,SGO1;MEIOC;MYBL1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.8546797239727791,1.7795499092532499,0.0037926675094816687,0.09357353700204593,0.997,10/23,6.82%,NDC80;CENPA;PLK1;SPDL1;SAPCD2;CDK5RAP2;GPSM2;NUMA1;ZW10;NDE1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.8953295649683956,1.7791587800870488,0.004261363636363636,0.0932955148010307,0.997,4/13,1.21%,CCNB1;NDC80;GEN1;CDK5RAP2
prerank,cell cycle G2/M phase transition (GO:0044839),0.7531408587909113,1.7778533806009211,0.0,0.09465514944974643,0.998,46/129,10.29%,NEK2;MELK;CCNB1;CDK1;PLK1;MASTL;BORA;CCNB2;CEP192;CEP152;CDK5RAP2;CKAP5;WEE1;HAUS8;PLK4;CEP57;HAUS4;HAUS6;CDK14;AURKA;ACTR1A;CEP43;AJUBA;CHEK2;KHDRBS1;PCM1;FBXL7;CCNA2;HAUS7;NDE1;CDC25B;CNTRL;FBXL8;CCDC57;HAUS1;CDK2;CEP76;ALMS1;DNM2;ODF2;CDC25C;SKP2;SDCCAG8;FBXL17;CDC25A;NINL
prerank,homologous chromosome segregation (GO:0045143),0.8194794027315357,1.7768122895429679,0.005208333333333333,0.09543010633037265,0.998,2/20,0.90%,SGO1;FANCD2
prerank,establishment of spindle orientation (GO:0051294),0.8220126246307178,1.7690723678955396,0.004796163069544364,0.10863567710585173,1.0,12/28,9.48%,NDC80;CENPA;PLK1;SPDL1;SAPCD2;CDK5RAP2;GPSM2;NUMA1;ZW10;NDE1;MAP4;LLGL2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.8174050899257357,1.7658865775525374,0.009937888198757764,0.1140254729431671,1.0,10/24,6.63%,POLK;POLE;RFC4;RPA1;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,positive regulation of synaptic transmission (GO:0050806),-0.42759494733429954,-1.758947548885348,0.0,0.2680843576679121,0.976,32/72,21.03%,RIMS1;SLC8A3;GRIN2A;SHANK3;SYT1;GRIN2B;LGI1;STX4;SLC24A2;SQSTM1;EPHB2;CACNG7;NRXN1;LGMN;TSHZ3;CACNG4;RELN;CHRNA7;APP;NFATC4;DTNBP1;CACNG2;ADRA1A;ADCY8;DLG4;CACNG3;CACNG8;PRKCZ;NLGN1;STX1B;GRIK2;KCTD13
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.8447709652054266,1.7560397960449414,0.005249343832020997,0.13426417359225107,1.0,6/21,2.23%,DTL;CCNB1;CDK1;RAD51B;ATAD5;FBXO5
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.902026161542037,1.756039343517633,0.007363770250368188,0.1329025923652655,1.0,2/10,1.00%,BRCA1;ATRX
prerank,DNA double-strand break processing (GO:0000729),0.8397959928215711,1.7552394861365348,0.013550135501355014,0.133226944525067,1.0,8/18,6.93%,BRCA1;BARD1;RBBP8;DNA2;SMARCAD1;BLM;MRE11;UBE2N
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.8554250821511443,1.7540604764916667,0.012465373961218837,0.13476375326274204,1.0,6/15,6.55%,EME1;FANCD2;TIPIN;CHEK2;MRE11;MDC1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5668496968160049,-1.7530295473038813,0.012345679012345678,0.2750878336086662,0.979,12/19,28.26%,MAPK8;SLCO1C1;MAP2K5;KLF4;CHRNA7;APP;KLF2;WFS1;PAX8;MAPK7;TMEM106A;EGF
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.8973516766649843,1.7520108272824721,0.0029154518950437317,0.13839652872883534,1.0,4/12,1.04%,CCNB1;CDK1;PLK1;CCNB2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.7409846186534139,1.7505649987616116,0.0010559662090813093,0.14042158974746655,1.0,37/83,14.08%,CDKN3;RRM2;POLE;CCNE2;DBF4;POLA1;ORC1;E2F1;TYMS;SPDYA;CDC45;CDKN2D;FBXO5;CDKN2C;RB1;CDK14;E2F3;CDC6;TFDP1;KHDRBS1;EIF4E;CCNA1;CCNE1;USP37;CUL5;CDK2;CUL3;KLF11;CUL4B;CDC25A;CRLF3;PCNA;NASP;BRD4;DHFR;PLK2;CDKN1B
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.7869507061731796,1.749860855031926,0.011890606420927468,0.1406120420421476,1.0,6/33,4.03%,KIF14;EZH2;FAM83D;E2F1;ATP2B4;DDRGK1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.8945316860283814,1.7489004747933516,0.017107309486780714,0.1417237236035588,1.0,6/10,6.98%,E2F7;E2F8;ATRX;DBF4;WIZ;STOML2
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.8515555056142329,1.7480664362677056,0.019973368841544607,0.14226931864961953,1.0,5/18,2.23%,DTL;CCNB1;CDK1;RAD51B;FBXO5
prerank,ganglion development (GO:0061548),-0.6801876847583439,-1.7472822121908296,0.006134969325153374,0.28170716917059563,0.986,6/11,21.19%,NRP2;SEMA3A;CTNNB1;UNC5C;TUBB3;NRP1
prerank,cellular response to radiation (GO:0071478),0.7837041574088282,1.746257419137514,0.004519774011299435,0.14522967735308084,1.0,9/40,6.39%,ECT2;RAD51AP1;FIGNL1;RAD51;INTS7;RAD1;BLM;NET1;SPIDR
prerank,protein localization to centrosome (GO:0071539),0.8431446448669293,1.7461927277606677,0.01634877384196185,0.14400413482557847,1.0,8/17,7.26%,STIL;SPAG5;CEP192;PCM1;CCDC14;C2CD3;CEP83;NUDCD3
prerank,neuron maturation (GO:0042551),-0.5811657436098112,-1.7428612266845,0.003952569169960474,0.2854835265566902,0.987,13/18,22.19%,B4GALT5;B4GALT6;APP;SCARF1;ADGRB3;CX3CL1;EPHA8;FARP2;MTCH1;PICK1;LGI4;ANKS1A;CLN5
prerank,base-excision repair (GO:0006284),0.7644507268110402,1.739648965245251,0.0011160714285714285,0.1588173897822159,1.0,13/48,6.63%,NEIL3;POLQ;POLE;RFC4;RPA1;APEX2;DNA2;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,regulation of centrosome duplication (GO:0010824),0.7746225721865622,1.7393928693677332,0.011933174224343675,0.15797655392330545,1.0,4/29,1.12%,CCNF;STIL;CEP295;GEN1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.7524508274208411,1.7386540191863615,0.0031746031746031746,0.15848528564852934,1.0,20/63,9.43%,E2F7;CCNB1;E2F8;CDK1;GTSE1;E2F1;RFWD3;AURKA;TFDP1;CNOT1;CHEK2;MDM4;PRKDC;CNOT6L;RPA2;PML;CDK2;CNOT6;CDC25C;PLAGL1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.7886859939617346,1.7369181938028193,0.006944444444444444,0.16116620506806073,1.0,14/36,7.35%,BRIP1;CLSPN;E2F1;TIPIN;CDC45;TIMELESS;CDC6;DNA2;CHEK2;INTS7;RAD1;MAP3K20;CHEK1;PRPF19
prerank,establishment of spindle localization (GO:0051293),0.8484701620396022,1.735995162299039,0.018258426966292134,0.16206678732515464,1.0,2/14,0.75%,NUSAP1;ESPL1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.753656998402477,1.7339452771427342,0.008602150537634409,0.16604080015617215,1.0,16/54,9.43%,E2F7;CCNB1;E2F8;CDK1;GTSE1;E2F1;AURKA;TFDP1;CNOT1;CHEK2;MDM4;CNOT6L;PML;CNOT6;CDC25C;PLAGL1
prerank,protein localization to microtubule organizing center (GO:1905508),0.8494804184100718,1.7334246163345288,0.0196078431372549,0.16595905035400352,1.0,7/15,6.99%,STIL;SPAG5;CEP192;PCM1;CCDC14;C2CD3;CEP83
prerank,regulation of double-strand break repair (GO:2000779),0.775195733280425,1.7331469445827643,0.004576659038901602,0.16526582546533655,1.0,16/39,9.01%,RAD51AP1;FIGNL1;RAD51;DDX11;TIMELESS;DEK;RTEL1;RPA2;SLF1;SPIDR;PML;CHEK1;SETD2;UBR5;MRNIP;MGMT
prerank,protein localization to chromosome (GO:0034502),0.7700266352355882,1.7305263629525243,0.0059031877213695395,0.1705892011095757,1.0,13/34,8.22%,CENPA;PLK1;ATRX;MCM8;HASPIN;RB1;RAD21;CTCF;RPA1;WAPL;RPA2;SLF1;MRNIP
prerank,regulation of chromosome organization (GO:0033044),0.8007682373714579,1.728855060090963,0.0076726342710997444,0.17357490681792825,1.0,12/22,13.75%,PIF1;BUB1;RMI2;RB1;HNRNPD;WAPL;MAPT;YLPM1;HDAC8;TERF2;CENPV;SMG6
prerank,regulation of cell division (GO:0051302),0.738645886873257,1.7269853368833143,0.0010471204188481676,0.17693164125037641,1.0,15/72,7.82%,PRC1;KIF18B;PLK1;KIF20A;AURKB;PLK4;AURKA;CSPP1;FGFR2;BLM;SFRP2;AHCTF1;PRPF40A;SETD2;SH3GLB1
prerank,DNA conformation change (GO:0071103),0.8380321212194297,1.726563422778763,0.019867549668874173,0.17647611128570626,1.0,6/17,9.77%,TOP2A;HMGB2;HAT1;ERCC3;HMGB3;HMGB1
prerank,regulation of mitotic spindle organization (GO:0060236),0.7726338423770875,1.724450803254786,0.009478672985781991,0.1806717682340457,1.0,12/35,10.88%,TPX2;PLK1;BORA;PSRC1;GPSM2;CEP97;TACC3;NUMA1;TPR;CCSAP;HNRNPU;DRG1
prerank,intracellular pH reduction (GO:0051452),-0.4966034395119795,-1.7243314789580224,0.013422818791946308,0.3274113887051086,0.991,18/33,32.02%,ATP6V0A1;DMXL2;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;GPR89B;GPR89A;ATP6V0C;ATP6V1H;TMEM9;RAB38;ATP6V1G2;ATP6V1B2;RAB39A;ATP6V1F;ATP6V0D2;ATP6V0E1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.7727677910786231,1.7224345413370572,0.010588235294117647,0.18471583944628042,1.0,8/34,3.61%,NUSAP1;DLGAP5;ESPL1;ANAPC7;RB1;PHIP;AURKA;CDC27
prerank,error-prone translesion synthesis (GO:0042276),0.7956053076753818,1.7194350610373998,0.01668806161745828,0.19130359740506778,1.0,9/21,6.63%,POLK;RFC4;POLH;RPA1;PRIMPOL;RFC2;RPA2;RFC1;RFC3
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.8256274109628244,1.7191796828075394,0.026134800550206328,0.19048311494564155,1.0,5/15,5.29%,EZH2;FAM83D;ATAD5;DDRGK1;DYRK3
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.7510359235665915,1.7184271745730253,0.0022497187851518562,0.19109355341060338,1.0,12/50,6.45%,CCNF;CCNB1;CDKN3;CCNE2;CCNB2;CDKN2D;CDKN2C;CDC6;CCNA2;BLM;CCNA1;CCNE1
prerank,nuclear membrane disassembly (GO:0051081),0.8711487563293521,1.715248602874112,0.008522727272727272,0.19835446646858232,1.0,4/14,1.04%,CCNB1;CDK1;PLK1;CCNB2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.8321589530284503,1.7134642782200993,0.016042780748663103,0.2015251677161925,1.0,11/18,11.52%,POLE;POLA1;RFC4;MCM7;GINS3;POLD3;MCM3;MCM4;RFC3;GINS1;PCNA
prerank,negative regulation of JNK cascade (GO:0046329),-0.48476523317582104,-1.7122230289064337,0.006024096385542169,0.35151323518438415,0.993,12/31,13.81%,MECOM;PRKN;ZMYND11;PDCD4;DUSP3;CYLD;DNAJA1;DACT1;PTPN22;HDAC3;PINK1;SH3RF2
prerank,intracellular protein transmembrane transport (GO:0065002),-0.465702822863825,-1.711910751640968,0.01639344262295082,0.3429395757064299,0.993,31/42,37.87%,PEX1;DNAJC19;AKT2;HSPD1;AIFM1;HSPA5;PEX5;TIMM44;PEX6;TOMM70;SEC62;SEC61B;DNAJC15;PAM16;TIMM17B;PEX26;TIMM17A;CHCHD4;SEC63;SEC61A2;C2CD5;ROMO1;PEX10;GRPEL1;ZFAND2B;SEC61A1;PEX16;DNLZ;TOMM40L;PEX2;PEX14
prerank,negative regulation of secretion by cell (GO:1903531),-0.4811544656376837,-1.709769322285666,0.0,0.3405751143119061,0.993,19/38,31.00%,GRM7;APOE;STXBP6;IL1RAPL1;SERGEF;CYP51A1;TNFRSF1B;SYT11;RHBDF1;SLC30A1;VAMP8;VAMP3;RHBDF2;DRD2;DPH3;TNFRSF1A;RSAD2;CHGA;HTR1B
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.8333659171107605,1.7095768609332085,0.01445466491458607,0.21148204984971997,1.0,6/16,8.51%,POLQ;PARPBP;RMI2;KLHL15;RIF1;SMCHD1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.7417490795883916,1.7094777643465073,0.004305705059203444,0.21011488842352935,1.0,20/58,10.44%,BRCA1;POLQ;BARD1;POLA1;NSD2;HMGB2;RNF168;PAXIP1;SMC5;ERCC4;PRKDC;MRE11;MDC1;UBE2N;RIF1;PRPF19;UIMC1;PSMD14;HMGB1;HERC2
prerank,placenta development (GO:0001890),0.859327545303227,1.7079244605539878,0.01744186046511628,0.21269000967120602,1.0,2/12,0.40%,E2F7;E2F8
prerank,cellular response to nitrogen compound (GO:1901699),0.81563260667865,1.705911348200639,0.012738853503184714,0.21712632580433835,1.0,9/20,9.08%,ATRX;DDX11;ATP2B4;TIMELESS;ROCK2;BLM;SPIDR;FMR1;RIOK3
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.8426344888106788,1.7046387547704476,0.009472259810554804,0.21920349793654317,1.0,8/16,6.08%,RAD51;MCM6;MCM7;MCM2;RPA1;BLM;RECQL;MCM4
prerank,male meiosis I (GO:0007141),0.8329240864868583,1.701921576597224,0.0163265306122449,0.22575333390217522,1.0,3/16,6.16%,MEIOC;MYBL1;CCNA1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.7108393715220287,1.7011754684033238,0.0,0.22645006015481972,1.0,94/336,11.13%,TOP2A;DTL;BRCA1;EXO1;TICRR;RAD51AP1;POLK;POLQ;CDK1;FANCA;RAD51B;BARD1;UBE2T;MASTL;RMI2;RAD51;RAD54L;POLA1;WDHD1;RAD18;WDR76;DDX11;E2F1;PCLAF;CBX5;ZRANB3;MCM8;SPDYA;RFC4;PDS5A;SMC1A;TIMELESS;XRCC2;RFWD3;RNF168;FAM111A;SMC6;MCM10;BAZ1B;SETX;MCM7;PDS5B;RPAIN;TOPBP1;EID3;RTEL1;POLH;RBBP8;RPA1;SMC5;CHD1L;MSH3;CHEK2;RAD1;ERCC4;PRKDC;RFC2;BLM;MRE11;RECQL;NSMCE4A;POLD1;NRDE2;SLF1;ERCC3;SPIDR;FANCL;RFC3;PML;FMR1;RIF1;ETAA1;CHEK1;NIPBL;PHF1;UBR5;MRNIP;TRIM28;HTRA2;RAD51C;YAP1;USP16;MGMT;CUL4B;SUSD6;IKBKG;CBX1;HERC2;MMS19;MBD4;FBXO45;BOK;USP28;XPA
prerank,response to ionizing radiation (GO:0010212),0.7383604407767311,1.7002688604344074,0.003134796238244514,0.227687133686845,1.0,18/70,8.22%,BRCA1;ECT2;TICRR;RAD51AP1;FIGNL1;FANCD2;RAD51;RFWD3;RNF168;PAXIP1;TOPBP1;INTS7;RAD1;BLM;NET1;SPIDR;UIMC1;MRNIP
prerank,proton transmembrane transport (GO:1902600),-0.4880647455745429,-1.6965577795291993,0.008547008547008548,0.37203776772929176,0.998,10/36,14.97%,ATP6V0D1;ATP6V0A4;ATP1A1;ATP1A3;ATP5MF;ATP5PO;ATP6V0C;ATP1A2;ATP6V1H;ATP5F1B
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.8010624801729336,1.6947311807861571,0.012706480304955527,0.24318063442563057,1.0,5/23,1.41%,ZWILCH;BUB1B;BUB1;AURKB;WEE1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.8659722259917495,1.6944230481466704,0.025787965616045846,0.24229492075672612,1.0,6/11,5.25%,ZRANB3;TIPIN;TIMELESS;FBXO5;MSH3;BLM
prerank,double-strand break repair via break-induced replication (GO:0000727),0.8740818512385682,1.6905448742930314,0.013313609467455622,0.25205059442971944,1.0,7/12,6.08%,MCM5;CDC45;MCM6;MCM7;MCM2;MCM3;MCM4
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.7881862146745943,1.6904827559424245,0.020202020202020204,0.25046449254187114,1.0,5/21,2.23%,PLK1;CDC20;UBE2C;UBE2S;FBXO5
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.780330378284761,1.6902900765284918,0.0199501246882793,0.24922931826479514,1.0,10/24,9.90%,PHF19;EZH2;PPM1D;SUZ12;MPHOSPH8;EED;RBBP4;RBBP7;PHF1;EPC1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.7607627113367585,1.6901520223029878,0.018137847642079808,0.24791109914231788,1.0,3/29,3.44%,TRIP13;FANCD2;RAD21
prerank,mitotic recombination (GO:0006312),0.843009288409977,1.6886158647524614,0.017857142857142856,0.2508282162504914,1.0,7/15,4.11%,RAD54B;RAD51;GEN1;DMC1;SMC6;SMC5;MSH3
prerank,negative regulation of DNA recombination (GO:0045910),0.7525309526926339,1.6872167046684523,0.006741573033707865,0.25370424720221174,1.0,13/43,8.51%,POLQ;PARPBP;RMI2;ATRX;ZRANB3;TERF1;RTEL1;MSH3;BLM;KLHL15;RIF1;POLR2A;SMCHD1
prerank,regulation of DNA repair (GO:0006282),0.7399574230187297,1.6870108584528696,0.011235955056179775,0.2525389545749583,1.0,17/44,12.38%,BRCA1;RNF168;DEK;EYA4;USP1;POLH;DHX9;PML;UBE2N;UBR5;UIMC1;TRIM28;SMCHD1;AXIN2;EYA2;PCNA;TRIP12
prerank,DNA geometric change (GO:0032392),0.7760488170897835,1.684924397207271,0.020910209102091022,0.25737285120798187,1.0,13/24,11.23%,PIF1;HMGB2;DDX11;ZRANB3;RTEL1;DNA2;DHX9;BLM;MRE11;RECQL;HMGB3;HMGB1;ANXA1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.7165910671298212,1.6845295697232956,0.0031512605042016808,0.25671873372477244,1.0,15/78,6.45%,CCNF;CCNB1;CDKN3;PLK1;CCNE2;CCNB2;SPDYA;PSRC1;CDKN2D;CDKN2C;CDC6;CCNA2;BLM;CCNA1;CCNE1
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.6111092611567226,-1.6845182362973103,0.011811023622047244,0.4023705173137431,1.0,3/15,6.91%,PLTP;APOE;ABCA5
prerank,dopamine metabolic process (GO:0042417),-0.5780063546088825,-1.684436577965917,0.008658008658008658,0.3927398693206798,1.0,9/18,24.48%,PRKN;TGFB2;MAOA;MAOB;MOXD1;GCH1;DRD2;ATP7A;COMT
prerank,cellular response to hydroxyurea (GO:0072711),0.8678797627155519,1.6826097670937175,0.029498525073746312,0.2609011887106236,1.0,6/10,6.86%,ATRX;DDX11;TIMELESS;BLM;SPIDR;FMR1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.6155054167274346,-1.6812118370141127,0.020477815699658702,0.3936148710392069,1.0,8/14,28.75%,ECE1;NOS3;ACE;ENPEP;AGTR1;EDN1;ACE2;EDN3
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.5401852616448678,-1.6810156899840238,0.013888888888888888,0.3845696521590583,1.0,15/22,24.18%,AEBP1;APOE;CAMSAP2;MAP1B;PRUNE1;MAP1A;CHRNA7;ABL1;CAMSAP1;GPX1;PIK3CA;ARL2;PARK7;GBA2;MAPRE3
prerank,negative regulation of cell division (GO:0051782),0.8770323437692683,1.6807907767000012,0.015691868758915834,0.2650154577327535,1.0,4/11,5.25%,E2F7;E2F8;AURKB;BLM
prerank,positive regulation of viral genome replication (GO:0045070),0.7750992042170364,1.6784618565483682,0.014285714285714285,0.27066532170551166,1.0,1/29,0.01%,TOP2A
prerank,smooth muscle tissue development (GO:0048745),-0.6747128019462157,-1.6765115738980731,0.026865671641791045,0.39089682507962453,1.0,6/10,15.89%,PROX1;MYLK;NF1;PTCH1;ENG;STRA6
prerank,negative regulation of histone methylation (GO:0031061),0.862634897891161,1.676317736596422,0.015337423312883436,0.2759944802068415,1.0,3/10,7.79%,BRCA1;BCOR;PHF1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.6085300139107203,-1.6730167185084823,0.02857142857142857,0.3851438601101291,1.0,3/14,7.97%,SLCO2B1;ABCG2;HMOX2
prerank,heme catabolic process (GO:0042167),-0.6085300139107203,-1.6730167185084823,0.02857142857142857,0.3851438601101291,1.0,3/14,7.97%,SLCO2B1;ABCG2;HMOX2
prerank,hyaluronan metabolic process (GO:0030212),0.7772614924887103,1.6702317763803798,0.023376623376623377,0.29466925522672904,1.0,4/23,3.31%,HMMR;HAS3;SPAM1;HYAL1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.7125666028805252,1.670123757100936,0.013215859030837005,0.2911302599445044,1.0,10/51,6.28%,CCNB1;CDK1;CCNB2;NDC1;NUP155;LBR;NUP205;NUP160;NUP85;AHCTF1
prerank,mitotic nuclear membrane organization (GO:0101024),0.7125666028805252,1.670123757100936,0.013215859030837005,0.2911302599445044,1.0,10/51,6.28%,CCNB1;CDK1;CCNB2;NDC1;NUP155;LBR;NUP205;NUP160;NUP85;AHCTF1
prerank,hyaluronan catabolic process (GO:0030214),0.7997597841828719,1.670042172371947,0.029649595687331536,0.2894875931519782,1.0,3/18,3.31%,HMMR;SPAM1;HYAL1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.49926363036656873,-1.66994517025759,0.023391812865497075,0.38668521741047907,1.0,20/29,36.63%,ELOVL7;ACLY;HACD2;ACSL4;HACD1;ACSL5;ACSL6;ELOVL6;PPT1;CBR4;ACSL1;SCD;ELOVL1;FASN;TECR;ACSBG1;HSD17B8;GCDH;SCD5;PPT2
prerank,DNA-dependent DNA replication (GO:0006261),0.7030578557376994,1.6688754263561798,0.0,0.2916461802792367,1.0,42/128,8.67%,POLE;RAD51;DBF4;MCM5;POLA1;WDHD1;ORC1;PRIM2;POLA2;MCM8;CDC45;RFC4;PRIM1;MCM10;MCM6;MCM7;MCM2;RPAIN;TOPBP1;MGME1;GINS3;CDC6;PSMC2;RPA1;PSMD5;PRIMPOL;DNA2;POLD3;RFC2;BLM;RECQL;MCM3;POLD1;RPA2;MCM4;RFC1;ORC2;RFC3;ORC3;CDK2;PSMB1;PSMD14
prerank,regulation of DNA metabolic process (GO:0051052),0.7311826731523647,1.6683958438019104,0.012359550561797753,0.29152466422183676,1.0,17/44,13.89%,TICRR;PIF1;KPNA2;USP1;POLH;HNRNPD;MPHOSPH8;SMARCAD1;YLPM1;GRHL2;UBE2N;NUCKS1;HDAC8;TERF2;STOX1;SMG6;WDR70
prerank,response to hydroxyurea (GO:0072710),0.8523316666459924,1.668315712873929,0.028985507246376812,0.2899057434725963,1.0,6/11,6.86%,ATRX;DDX11;TIMELESS;BLM;SPIDR;FMR1
prerank,protein monoubiquitination (GO:0006513),0.7381693072220427,1.6682853985542911,0.012658227848101266,0.2881384342798727,1.0,11/36,9.91%,DTL;UHRF1;UBE2T;RAD18;FANCL;RNF40;UBE2R2;CUL3;KLHL22;LEO1;OBI1
prerank,response to ethanol (GO:0045471),-0.6278449217019794,-1.666908089525743,0.015151515151515152,0.38790563996796634,1.0,5/14,4.65%,GRIN3A;GRIN2A;GLRA1;GRIN2B;GOT2
prerank,maintenance of blood-brain barrier (GO:0035633),-0.4727716449319721,-1.6643091255279123,0.006666666666666667,0.38807511005940426,1.0,16/30,24.68%,OCLN;JAM2;PECAM1;ACTB;CLDN5;ESAM;F11R;CDH5;TJP1;CLDN12;SLC12A2;SLC1A1;GJB6;CLDN1;MFSD2A;LAMA2
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.6469505205259851,-1.663503284601424,0.018072289156626505,0.3828143719294819,1.0,6/12,21.84%,PTK2;LYN;MAPK3;MAPK1;BST2;IL34
prerank,glycerophospholipid catabolic process (GO:0046475),-0.49886183165716524,-1.6630810814421557,0.014705882352941176,0.37663251988373647,1.0,10/27,16.77%,GPCPD1;PLA2G4A;ABHD12;PNPLA6;ABHD16A;PNPLA8;ENPP6;GDPD3;GDPD1;PLA2G7
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.543977649351278,-1.662927467939522,0.016666666666666666,0.369516503377643,1.0,8/21,23.61%,PTK2;MTUS1;MAPK3;MAPK1;THBS1;CMKLR1;IL34;PTK2B
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.8289709308217549,1.6626670974167241,0.031473533619456366,0.30092152386813364,1.0,5/12,3.61%,DLGAP5;ESPL1;ANAPC7;RB1;CDC27
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.8289709308217549,1.6626670974167241,0.031473533619456366,0.30092152386813364,1.0,5/12,3.61%,DLGAP5;ESPL1;ANAPC7;RB1;CDC27
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.8289709308217549,1.6626670974167241,0.031473533619456366,0.30092152386813364,1.0,5/12,3.61%,DLGAP5;ESPL1;ANAPC7;RB1;CDC27
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.7025183966201178,1.6622621639622917,0.003105590062111801,0.3004018491676397,1.0,22/84,9.73%,CCNB1;CDK1;BUB1B;PLK1;CDC20;UBE2C;AURKB;UBE2S;FBXO5;ANAPC7;RB1;AURKA;PSMC2;CDC27;PSMD5;BUB3;CDK2;PSMB1;CUL3;PSMD14;PSMD1;SKP2
prerank,cell cycle checkpoint signaling (GO:0000075),0.852488146486571,1.6619675359014592,0.029914529914529916,0.2996224229567896,1.0,4/12,1.41%,ZWILCH;BUB1B;BUB1;WEE1
prerank,positive regulation of DNA repair (GO:0045739),0.7239242469572011,1.6598734514403286,0.01901565995525727,0.3049521112016066,1.0,16/46,11.52%,BRCA1;DDX11;TIMELESS;RNF168;EYA4;DHX9;SLF1;SPIDR;UBE2N;UIMC1;TRIM28;SMCHD1;MGMT;HMGB1;EYA2;PCNA
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.7368367412261467,1.658875645136918,0.01722158438576349,0.30642972521537615,1.0,14/40,8.68%,ANKLE1;WDR76;KMT5A;RFWD3;FBXO5;USP1;POLH;MAPT;NSMCE4A;RPA2;FMR1;UBE2N;ETAA1;BCLAF1
prerank,phagosome acidification (GO:0090383),-0.502334820737068,-1.6583168551929535,0.015544041450777202,0.3759942133272637,1.0,14/26,32.02%,ATP6V0A1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP6V1H;RAB38;ATP6V1G2;ATP6V1B2;RAB39A;ATP6V1F;ATP6V0D2;ATP6V0E1
prerank,cell cycle G1/S phase transition (GO:0044843),0.7141106075767519,1.6574555990048476,0.00980392156862745,0.30906540404930566,1.0,21/61,10.88%,CDKN3;POLE;CCNE2;DBF4;E2F1;SPDYA;CDKN2D;CDKN2C;RB1;E2F3;KHDRBS1;CCNA2;EIF4E;CCNE1;USP37;CUL5;CDK2;CUL3;CUL4B;CDC25A;CRLF3
prerank,microtubule nucleation (GO:0007020),0.7923833291279339,1.6560174411040067,0.023225806451612905,0.311799204505955,1.0,5/19,9.14%,TPX2;TUBGCP5;NDE1;CCDC57;TPPP
prerank,cellular response to ionizing radiation (GO:0071479),0.7404271449250339,1.6522696170325089,0.011086474501108648,0.3224299278087715,1.0,13/47,8.83%,ECT2;RAD51AP1;FIGNL1;RAD51;INTS7;RAD1;BLM;NET1;SPIDR;MAP3K20;NUCKS1;NIPBL;YAP1
prerank,positive regulation of telomere capping (GO:1904355),0.79023852287192,1.6521927874162359,0.036734693877551024,0.32077723490975485,1.0,4/17,3.76%,NEK2;AURKB;RTEL1;HNRNPD
prerank,positive regulation of macrophage migration (GO:1905523),-0.5535092555022987,-1.6519521114574316,0.024096385542168676,0.3878560851294851,1.0,8/19,22.15%,PTK2;MAPK3;MAPK1;THBS1;CX3CL1;CMKLR1;IL34;P2RX4
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.6983730318075352,-1.6515786532738668,0.012012012012012012,0.3817847889524435,1.0,7/10,25.22%,WDFY1;IFI35;PTPN22;LBP;NR1H3;TIRAP;NINJ1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.8367980291004692,1.6486264301309883,0.026243093922651933,0.3316706193029888,1.0,3/12,5.25%,TICRR;TIPIN;BLM
prerank,nucleosome assembly (GO:0006334),0.7462919638553941,1.6470793490602866,0.026602176541717048,0.3351192578710106,1.0,9/31,6.93%,ASF1B;CHAF1B;ATRX;HMGB2;NAP1L1;ANP32B;HAT1;RBBP4;UBN1
prerank,negative regulation of double-strand break repair (GO:2000780),0.7574990058855798,1.6458181377080487,0.01542111506524318,0.3375286261071299,1.0,8/30,8.51%,POLQ;PARPBP;RMI2;AUNIP;KLHL15;RIF1;UBR5;SMCHD1
prerank,chloride transport (GO:0006821),-0.38659898800530224,-1.6456120909275953,0.0,0.3937334766810795,1.0,26/74,19.50%,GABRB1;ANO3;GABRB3;GABRA2;SLC6A1;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;ANO10;GABRA5;GABRB2;CLIC5;ANO4;GABRG2;SLC12A9;GABRG1;SLC12A2;SLC1A1;SLC4A8;TTYH3;CLCN2;FXYD1;LRRC8A
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.706702939137466,1.6444314430054097,0.013485477178423237,0.3404788573580888,1.0,19/72,9.43%,E2F7;CCNB1;E2F8;CDK1;GTSE1;ATRX;E2F1;PAXIP1;AURKA;TFDP1;CNOT1;CHEK2;MDM4;CNOT6L;PML;CNOT6;ING4;CDC25C;PLAGL1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.8460721218215344,1.643963171662636,0.03879310344827586,0.34013564618757325,1.0,4/12,2.01%,PLK1;CDC20;UBE2C;UBE2S
prerank,mitotic DNA replication (GO:1902969),0.8622103256488117,1.6428520143151788,0.029717682020802376,0.34207433388214725,1.0,8/10,10.69%,POLA1;CDC45;MCM6;MCM2;GINS3;MCM3;MCM4;GINS1
prerank,cellular response to zinc ion (GO:0071294),-0.5850331223391722,-1.6413558132328823,0.007326007326007326,0.40017327699058364,1.0,11/15,22.15%,GLRA1;MT2A;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;P2RX4
prerank,phosphatidylserine metabolic process (GO:0006658),-0.4802220041661124,-1.6405691805295097,0.024096385542168676,0.39540856128783813,1.0,8/32,10.21%,PLA2G4A;PLAAT3;ABHD12;ABHD16A;PLA1A;OSBPL10;SLC27A1;SERINC1
prerank,regulation of catecholamine secretion (GO:0050433),-0.4948493344833674,-1.6401846085613625,0.01818181818181818,0.38965531973681267,1.0,12/29,21.95%,PRKN;KCNB1;SYT1;SYT7;DTNBP1;KCNA2;SYT11;SYT12;SYT10;SYT6;SYT2;DRD2
prerank,nuclear membrane reassembly (GO:0031468),0.6995780053896757,1.6394854960552394,0.019736842105263157,0.35182337750988346,1.0,10/54,6.28%,CCNB1;CDK1;CCNB2;NDC1;NUP155;LBR;NUP205;NUP160;NUP85;AHCTF1
prerank,negative regulation of histone acetylation (GO:0035067),0.8462506157930908,1.639066862214738,0.02745664739884393,0.3512990616025522,1.0,2/11,5.17%,BRCA1;CTBP1
prerank,signal transduction in response to DNA damage (GO:0042770),0.7224515050597325,1.6377133821664493,0.022123893805309734,0.3541162628441087,1.0,13/49,7.35%,E2F7;BRIP1;CLSPN;ATRX;E2F1;PAXIP1;CHEK2;MDM4;INTS7;RAD1;MAP3K20;CHEK1;PRPF19
prerank,positive regulation of histone methylation (GO:0031062),0.7806367689394642,1.6376662781901197,0.020075282308657464,0.35230386871134023,1.0,7/24,9.74%,BRCA1;PHF19;PAXIP1;AUTS2;RIF1;PHF1;KMT2A
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5416302475342648,-1.633966106890244,0.02608695652173913,0.4024040465137259,1.0,8/20,12.76%,ANO6;PDCD4;PLCG1;SFRP4;GSN;THBS1;PIAS4;RGCC
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.5984985860887649,-1.6336335757006721,0.028662420382165606,0.3971831775297355,1.0,6/14,21.84%,PTK2;MAPK3;MAPK1;THBS1;CMKLR1;IL34
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.8262889696234612,1.6320220297694705,0.050073637702503684,0.3702599734018531,1.0,7/12,11.14%,BRCA1;RBM15;PCGF5;LRIF1;SMCHD1;HNRNPU;RBM15B
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.8063249143785849,1.630449508549472,0.0343878954607978,0.373777129942267,1.0,4/16,4.24%,BRCA1;PAXIP1;AUTS2;BCOR
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.7373423675279717,1.6296375636947356,0.028169014084507043,0.37474945767464574,1.0,13/29,15.37%,MEIOC;E2F1;THRAP3;EIF4ENIF1;FMR1;FUS;LARP1;AXIN2;HNRNPU;TAF15;TENT5D;PABPC1;GDNF
prerank,DNA damage checkpoint signaling (GO:0000077),0.7613913355466966,1.6289798156121527,0.027946537059538274,0.3750459073618373,1.0,9/28,7.35%,BRIP1;CLSPN;E2F1;CHEK2;INTS7;RAD1;MAP3K20;CHEK1;PRPF19
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.7167622642348007,1.6282816002554432,0.03103448275862069,0.37549770987850406,1.0,15/37,11.52%,POLK;RFC4;RPA1;CHD1L;POLD3;ERCC4;RFC2;POLD1;RPA2;RFC1;ERCC3;RFC3;CUL4B;XPA;PCNA
prerank,regulation of cell cycle phase transition (GO:1901987),0.6905277682756583,1.6267431176014597,0.0030959752321981426,0.3789279669121372,1.0,18/91,6.71%,CCNB1;CDK1;BUB1B;PLK1;GTSE1;CDC20;UBE2C;DBF4;UBE2S;ATP2B4;FBXO5;ANAPC7;PSMC2;CDC27;PSMD5;ERCC3;BUB3;FBXW7
prerank,glutamate receptor signaling pathway (GO:0007215),-0.44302103819072897,-1.6263833614330194,0.014705882352941176,0.414140402469677,1.0,15/37,14.42%,GRM7;GRIK1;GRIN3A;GRIN2A;GRM3;GRID2;KCNB1;CPEB4;GRIN2B;HOMER1;GRIK4;APP;GRM5;GRM1;GRIN1
prerank,regulation of mitotic cell cycle (GO:0007346),0.6784540961223136,1.6252606927615085,0.0,0.38247801828685707,1.0,35/171,9.80%,KIF20B;MKI67;NEK2;CCNB1;CDK1;DLGAP5;BUB1B;PLK1;CKS2;BORA;CDC20;UBE2C;UBE2S;FBXO5;ANAPC7;RB1;TTC28;PSMC2;CDC27;PSMD5;GBF1;OBSL1;EIF4E;ERCC3;BUB3;CDC25B;SCRIB;CCDC57;RNF40;PSMB1;BTG3;PSMD14;CDC25C;PSMD1;GAS1
prerank,negative regulation of protein secretion (GO:0050709),-0.4529003111409454,-1.62515803185108,0.039735099337748346,0.4115256473425985,1.0,15/38,23.46%,PRKN;APOE;KCNB1;SERGEF;NR1H3;OPRM1;CYP51A1;IRS1;RHBDF1;RAB11FIP1;MIDN;ADRA2A;RHBDF2;DRD2;DPH3
prerank,inorganic anion transmembrane transport (GO:0098661),-0.3978458499932917,-1.6243657244214835,0.0,0.4075787906723431,1.0,26/63,19.50%,GABRB1;ANO3;GABRB3;GABRA2;SLC6A1;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;SLC25A3;GABRA5;GABRB2;SLC5A6;ANO4;SLC5A5;GABRG2;SLC12A9;GABRG1;SLC12A2;SLC1A1;SLC4A8;SLC25A11;SLC26A2;LRRC8A
prerank,positive regulation of DNA replication (GO:0045740),0.8066809058214273,1.6232868569577694,0.04155124653739612,0.38747445644664946,1.0,6/16,5.75%,ATAD5;GLI2;STN1;DNA2;DHX9;FAF1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.8421312277122311,1.622480301241145,0.03268945022288262,0.38840885320211027,1.0,2/10,5.17%,BRCA1;CTBP1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.8187774946767364,1.6220026836692258,0.03829160530191458,0.38809831096364805,1.0,4/12,5.28%,EZH2;CYP26B1;CNOT1;ASXL1
prerank,microtubule polymerization (GO:0046785),0.7517683797914578,1.6184568586412091,0.02877697841726619,0.3987419359222877,1.0,7/28,9.14%,TPX2;CKAP5;TUBGCP5;MAPT;NDE1;CCDC57;TPPP
prerank,DNA strand elongation (GO:0022616),0.7942398257816942,1.6181657211120473,0.046419098143236075,0.39782164996411734,1.0,9/18,6.63%,POLA1;RFC4;MCM7;GINS3;POLD3;MRE11;MCM3;MCM4;RFC3
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.5990365568700674,-1.617441936210637,0.034482758620689655,0.4229893686956738,1.0,7/13,26.04%,GLUL;GLS;NOS3;PRODH;GLUD1;NOS1;GLS2
prerank,phagosome maturation (GO:0090382),-0.45156770177898703,-1.617017754298362,0.01935483870967742,0.41780065514583353,1.0,19/35,32.91%,ATP6V0A1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP6V1H;MCOLN1;RAB38;MREG;ATP6V1G2;ATP6V1B2;RAB14;RAB39A;RAB32;ATP6V1F;ATP6V0D2;ATP6V0E1;RAB31
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.812100181893518,1.614939945609543,0.056708160442600276,0.40752145821334496,1.0,6/14,10.47%,RAD51AP1;TIMELESS;ARID2;FUS;MRNIP;MMS19
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.7095845786530046,1.6145195093855227,0.027428571428571427,0.40700987029910657,1.0,15/39,11.52%,POLK;RFC4;RPA1;CHD1L;POLD3;ERCC4;RFC2;POLD1;RPA2;RFC1;ERCC3;RFC3;CUL4B;XPA;PCNA
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.8585649221980384,1.61134002268892,0.035493827160493825,0.41231039071658143,1.0,4/10,5.25%,EXO1;TERF1;DNA2;BLM
prerank,t-circle formation (GO:0090656),0.8585649221980384,1.61134002268892,0.035493827160493825,0.41231039071658143,1.0,4/10,5.25%,EXO1;TERF1;DNA2;BLM
prerank,telomere maintenance via telomere trimming (GO:0090737),0.8585649221980384,1.61134002268892,0.035493827160493825,0.41231039071658143,1.0,4/10,5.25%,EXO1;TERF1;DNA2;BLM
prerank,regulation of mitochondrial fusion (GO:0010635),-0.6407217885089176,-1.6110301577153578,0.025806451612903226,0.43183604599439646,1.0,5/11,18.24%,PRKN;ADCK1;OMA1;BNIP3;VAT1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.737733903149629,1.6105089834404354,0.03795966785290629,0.41338823789376783,1.0,5/28,5.53%,SKA3;SKA1;SKA2;STMN1;MAPT
prerank,actin filament polymerization (GO:0030041),0.7271810311735203,1.6089646551802355,0.03699284009546539,0.4171111506954371,1.0,1/29,0.03%,DIAPH3
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5726629280638721,-1.6087013198132678,0.036231884057971016,0.4332977179283374,1.0,8/16,29.39%,BMPR2;PLCB3;ACE;PRCP;GSK3A;DRD2;ADM;GPR37L1
prerank,midbody abscission (GO:0061952),0.7786817899064234,1.6077981651612738,0.06267029972752043,0.41925110616936795,1.0,2/17,1.02%,CEP55;KIF20A
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.8169184105845663,1.6056750051288056,0.05120481927710843,0.4250864304632512,1.0,5/11,6.93%,ASF1B;ATRX;HAT1;RBBP4;UBN1
prerank,insulin receptor signaling pathway (GO:0008286),-0.3891180401923209,-1.604092507962082,0.0,0.44129689946908335,1.0,26/69,14.67%,FOXO1;ATP6V0A1;GRB14;ATP6V0D1;GRB10;ATP6V1E1;INSR;ATP6V0B;PIK3R3;AKT2;PIK3R1;ATP6V0A4;FOXC2;IRS2;IGF2;NAMPT;GPLD1;BCAR3;CAV2;IRS1;ATP6V0C;GRB2;APC;ATP6V1H;SHC1;GSK3A
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.7737002305071942,1.6030352588147792,0.04827586206896552,0.43296131128379156,1.0,1/16,0.19%,BRCA1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.8071162806967427,1.6019851568114474,0.048034934497816595,0.43463568280294895,1.0,1/12,0.19%,BRCA1
prerank,regulation of integrin activation (GO:0033623),0.7955564424150559,1.6006130366615485,0.03918918918918919,0.43780001746841934,1.0,1/15,0.13%,KIF14
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.6138319906801368,-1.6002866456841052,0.023178807947019868,0.4472503719446505,1.0,4/12,8.20%,UNC13B;RIMS1;SYT1;SYT7
prerank,"base-excision repair, AP site formation (GO:0006285)",0.7702518635738448,1.5997739637288073,0.05874316939890711,0.4387764047600041,1.0,2/17,1.68%,NEIL3;TERF1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.7482788194632393,1.5989245361546498,0.060991105463786534,0.439767608255034,1.0,1/21,0.05%,TPX2
prerank,protein oxidation (GO:0018158),0.7991913856377171,1.5979060527359636,0.0578386605783866,0.4413397031733286,1.0,3/11,2.55%,LOXL3;LOXL2;LOX
prerank,negative regulation of histone modification (GO:0031057),0.8029162970112668,1.597804933815793,0.04481792717086835,0.4395756563359855,1.0,2/14,5.17%,BRCA1;CTBP1
prerank,mitotic cytokinetic process (GO:1902410),0.7587895742505518,1.597548508319373,0.06719367588932806,0.43843353852846023,1.0,3/20,3.24%,CEP55;KIF20A;RHOA
prerank,regulation of muscle contraction (GO:0006937),-0.49140786369536427,-1.5962445736502089,0.0223463687150838,0.4544542975784733,1.0,9/26,16.65%,CHRM2;CAV1;ANXA6;TPM1;ATP1A2;ENO1;MYL9;PLCE1;SRI
prerank,RNA biosynthetic process (GO:0032774),0.7245478169114254,1.5942572331839895,0.04457831325301205,0.44820974742685,1.0,11/31,11.73%,POLA1;PRIM2;TTF2;POLA2;PRIM1;NAT14;SETX;TAF12;POLR2A;TTF1;TAF4
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.5881714837832613,-1.592715525442922,0.03184713375796178,0.46005475113769495,1.0,10/13,28.52%,EDEM2;EDEM1;SAR1A;CD81;BCAP31;SAR1B;SORL1;SEC16B;TMEM30A;SEC16A
prerank,regulation of platelet activation (GO:0010543),-0.5040559751523923,-1.5907325908535421,0.0321285140562249,0.4596418990321633,1.0,8/21,8.01%,PLA2G4A;APOE;NOS3;TLR4;THBD;PLEK;LYN;PRKCQ
prerank,positive regulation of cellular respiration (GO:1901857),-0.6188306941577553,-1.5901054737109432,0.023880597014925373,0.4553886949227301,1.0,7/11,25.20%,IFNAR1;PINK1;NUPR1;IL10RB;PARK7;ISCU;PRELID1
prerank,potassium ion homeostasis (GO:0055075),-0.504673498170752,-1.5897759214023983,0.029411764705882353,0.4501383602697976,1.0,7/23,15.29%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;SLC12A9;ATP1A2;SLC12A2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.6704480912895631,1.5890462369178366,0.0041109969167523125,0.4656290836465444,1.0,18/104,7.22%,CCNF;CCNB1;CDKN3;EZH2;INCENP;CCNE2;CCNB2;CDKN2D;KSR1;CDKN2C;RB1;RHOA;CDC6;CCNA2;BLM;CCNA1;CCNE1;ETAA1
prerank,positive regulation of intracellular transport (GO:0032388),0.6975250077668776,1.5867550101561851,0.045300113250283124,0.47222515559104355,1.0,7/38,7.72%,KIF20B;SPAG5;PCM1;NEDD4;NUMA1;TPR;RAB29
prerank,regulation of protein export from nucleus (GO:0046825),0.7251762112037441,1.5851121534348505,0.06364749082007344,0.47612172848258955,1.0,9/23,10.03%,BARD1;GTSE1;GSK3B;XPO4;ANP32B;TCF7L2;TPR;EMD;RANGAP1
prerank,positive regulation of chromosome organization (GO:2001252),0.7766952305512257,1.5849063437532214,0.05364511691884457,0.47477940091102516,1.0,6/15,6.79%,ATRX;DDX11;RTEL1;RAD21;MRE11;PML
prerank,histone monoubiquitination (GO:0010390),0.7305549575070199,1.5836522098905153,0.0580964153275649,0.477097437479867,1.0,8/24,9.28%,UHRF1;RNF168;TRIM37;BCOR;RNF40;KDM2B;CUL4B;LEO1
prerank,protein export from nucleus (GO:0006611),0.7292506590085127,1.5824250159905404,0.05295566502463054,0.4794015598129969,1.0,10/27,13.03%,ANKLE1;CCHCR1;RANBP17;XPO1;XPO4;CSE1L;TPR;SMURF1;NUP214;STRADA
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.5832309217878532,-1.5821049724009355,0.023890784982935155,0.4698305523895628,1.0,6/15,8.52%,ACVR1;SMAD7;ACVR2A;FKBP1A;ACVR2B;DACT1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.6857496964442044,1.5813186679184346,0.02572347266881029,0.48121757489155076,1.0,21/61,15.27%,BRCA1;RAD51;ATRX;RNF168;EYA4;RTEL1;FGFR4;DHX9;MRE11;PML;UBE2N;UIMC1;TRIM28;SMCHD1;HMGB1;EYA2;PCNA;USP9X;BRCC3;GNL3;PRKD2
prerank,regulation of spindle assembly (GO:0090169),0.7213625020747758,1.5806713238802679,0.06607369758576874,0.4814274494326461,1.0,9/25,10.88%,PLK1;SPAG5;GPSM2;CEP97;NUMA1;TPR;CCSAP;HNRNPU;DRG1
prerank,negative regulation of chemokine production (GO:0032682),-0.5781195606483186,-1.580235340171414,0.03088803088803089,0.4696491805939926,1.0,5/14,17.81%,APOD;MAP2K5;KLF4;C1QTNF3;LGALS9
prerank,negative regulation of viral life cycle (GO:1903901),-0.5617745848302583,-1.5774159424391245,0.04516129032258064,0.4728791735612364,1.0,7/15,16.69%,MID2;LY6E;SNX3;IFITM3;GSN;BST2;IFITM2
prerank,protein prenylation (GO:0018342),0.8218558920600064,1.576564330481038,0.06046511627906977,0.4950709386341694,1.0,1/10,0.45%,AIPL1
prerank,ERAD pathway (GO:0036503),-0.37709698131383695,-1.5762685497439632,0.0,0.4703334605855716,1.0,39/83,24.83%,PRKN;UBE4A;ATXN3;HSP90B1;ERLEC1;OS9;TRIM25;ECPAS;RNF103;EDEM1;UFD1;DERL1;SELENOS;HSPA5;UBXN4;SGTA;RHBDD2;STUB1;YOD1;RCN3;SGTB;DNAJC18;POMT2;UBXN6;DNAJB9;ERLIN2;SEC61B;AUP1;DNAJB12;UBE2G2;SYVN1;UBXN8;GET4;SEL1L;TOR1A;UBE4B;WFS1;FAM8A1;RNF103-CHMP3
prerank,positive regulation of chromatin organization (GO:1905269),0.7768880773383252,1.574832643596181,0.06741573033707865,0.4995477897356648,1.0,9/12,18.18%,ATRX;TERF1;MIER1;UBE2N;TAL1;TERF2;TINF2;ACD;TERF2IP
prerank,regulation of DNA damage checkpoint (GO:2000001),0.8220029835588897,1.5741393335112084,0.0622154779969651,0.4998566214254737,1.0,5/10,7.22%,WDR76;RFWD3;RPA2;DDX39B;ETAA1
prerank,regulation of multicellular organismal development (GO:2000026),0.7285748322745358,1.5735944440041791,0.05236907730673317,0.4997367314258921,1.0,3/25,1.89%,CDK1;RACGAP1;HPSE
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5366057709559702,-1.5728346484354947,0.02880658436213992,0.4751440755215023,1.0,9/18,21.01%,CDH8;UNC13B;GRIK1;GRID2;GRIK4;SLC17A6;GRIA2;GRID1;GRIK2
prerank,positive regulation of double-strand break repair (GO:2000781),0.7082147833637757,1.5725313037834499,0.031425364758698095,0.5016027855028474,1.0,14/39,10.56%,RAD51AP1;DDX11;TIMELESS;ARID2;PRKDC;SLF1;SPIDR;RIF1;FUS;MRNIP;SMCHD1;MGMT;MMS19;PARP9
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.7311289161350406,1.572180394538542,0.03934010152284264,0.5006805133990714,1.0,7/24,14.06%,BRCA1;HPSE;SULF2;SULF1;EIF2AK3;RORA;ARNT
prerank,regulation of telomere maintenance (GO:0032204),0.7119027898611363,1.5720301194439306,0.061968408262454436,0.49901538680192736,1.0,15/26,18.83%,PIF1;ATRX;RTEL1;HNRNPD;ERCC4;MRE11;YLPM1;PML;HDAC8;TERF2;SMG6;GNL3;TINF2;TERF2IP;RAD50
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.729364546554507,1.5708208958704997,0.06064516129032258,0.5013372074156777,1.0,5/22,8.28%,SHCBP1;NAP1L1;SLC16A2;LRRK2;KDM2B
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.5082026137543607,-1.5694685913989392,0.015,0.48137743886724377,1.0,10/22,13.92%,CYRIB;TMSB4X;KANK3;KANK4;PFN1;SLIT2;SSH1;GSN;TMSB10;ARFGEF1
prerank,rRNA metabolic process (GO:0016072),-0.32770692926456857,-1.569437675803531,0.0,0.47560383688212926,1.0,78/160,26.80%,RPL13;RPL37A;RPL38;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;NVL;RPS7;RPL18A;RPS6;RPL14;RPLP1;RPL9;RPL37;RPL8;RPS14;NOL8;RPL10;RPL32;RPL18;SENP3;RPS28;RPL15;RPS24;RPS19;HEATR1;UTP20;KRR1;RPL27;RPL39;RPL24;RPL12;WDR75;EXOSC1;RPS27;RPL27A;RPS9;RPL30;RPL19;EXOSC9;RRP1;RRP1B;RPL28;RPL31;MPHOSPH10;LAS1L;DKC1;DDX49;SNU13;RPL13A;RPL36A;RPL29;MDN1;RPLP2;RPLP0;RPL10A;RPL35;NOB1;EMG1;NOLC1;PIH1D1;EXOSC2;EBNA1BP2;DDX54;RPL4;DEDD2;IMP3;BYSL;DDX47;BOP1;EXOSC3;NIFK;RPS25;EXOSC5;POP5
prerank,determination of bilateral symmetry (GO:0009855),0.7349583969518677,1.5692803074190818,0.056320400500625784,0.5049503894096135,1.0,5/24,8.91%,STIL;DNAH11;CFAP53;MKKS;NPHP3
prerank,synaptonemal complex organization (GO:0070193),0.7729896422988535,1.5681842098210672,0.05639614855570839,0.5048922998284495,1.0,2/15,3.44%,TRIP13;RAD21
prerank,synaptonemal complex assembly (GO:0007130),0.7729896422988535,1.5681842098210672,0.05639614855570839,0.5048922998284495,1.0,2/15,3.44%,TRIP13;RAD21
prerank,neuron remodeling (GO:0016322),-0.6372676032889496,-1.567280133509392,0.022988505747126436,0.476452548668939,1.0,8/10,26.67%,APP;SCARF1;ADGRB3;CX3CL1;EPHA8;FARP2;ANKS1A;C1QA
prerank,regulation of secretion (GO:0051046),-0.5803133768740327,-1.565736608030541,0.04240282685512368,0.47519453926002764,1.0,9/13,30.57%,MYO6;SGK1;GPLD1;KCNQ1;FGF10;POFUT2;EGF;ERBB3;OPRK1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.7757375689389026,1.5656888859688862,0.07758620689655173,0.5103065845994628,1.0,5/12,12.43%,ATP2B4;GSK3B;FHL2;PRNP;HOMER2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.7757375689389026,1.5656888859688862,0.07758620689655173,0.5103065845994628,1.0,5/12,12.43%,ATP2B4;GSK3B;FHL2;PRNP;HOMER2
prerank,cellular response to inorganic substance (GO:0071241),0.7307796786410737,1.5653865889155139,0.08538163001293661,0.509302838136698,1.0,8/21,8.02%,ATRX;DDX11;AQP1;TIMELESS;BLM;SPIDR;FMR1;CDK2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.42130609814052217,-1.5651558497704812,0.0,0.4716193054049124,1.0,14/41,19.35%,IGF1;GAS6;TLR4;CD34;PTPN22;LBP;SELENOS;CHRNA7;SYT11;CX3CL1;TRIM27;DICER1;LGALS9;ZC3H12A
prerank,protein autoubiquitination (GO:0051865),0.6652192672278084,1.564577920776486,0.04,0.5099769778193463,1.0,7/61,4.33%,BRCA1;UHRF1;UBE2T;RAD18;TRIM37;RNF220;UHRF2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.661987945444813,1.5634685140863178,0.0,0.5119212937336824,1.0,31/148,8.02%,TPX2;BRCA1;EXO1;CDK1;BRIP1;BARD1;RMI2;AURKB;RFC4;KMT5A;AURKA;TOPBP1;RBBP8;RPA1;DNA2;CHEK2;MDM4;TAF3;RAD1;RFC2;BLM;MRE11;RPA2;RBBP4;RFC3;RBBP7;PML;RRS1;CHEK1;TAF12;CDK2
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.7366869093048641,1.5631336377040144,0.07015306122448979,0.5110943660303258,1.0,4/22,8.26%,FANCA;CBFB;LAG3;IRF1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.7396181222353664,1.5629491118947008,0.06388526727509779,0.5095657767281375,1.0,2/21,1.19%,BRCA1;SLC18A2
prerank,tRNA modification (GO:0006400),-0.38341274198608427,-1.562943222548696,0.013888888888888888,0.4734934452396381,1.0,27/62,26.66%,TRMT9B;ANKRD16;DTWD2;MTO1;PUS10;AARS1;NSUN2;THUMPD3;TRMT61B;OSGEP;CDKAL1;QTRT2;TRMT1;TPRKB;TRUB1;METTL1;PUS3;QTRT1;THUMPD1;TRMT10A;LCMT2;TRMO;GTPBP3;WDR4;DTWD1;WDR6;ALKBH1
prerank,gas transport (GO:0015669),0.8225603963678645,1.5625799125395154,0.06018518518518518,0.5087559101839818,1.0,2/10,1.84%,RHAG;AQP1
prerank,negative regulation of protein depolymerization (GO:1901880),0.726060279859795,1.5617939807603547,0.06840796019900497,0.5096780923126758,1.0,1/24,0.05%,TPX2
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.757384343888714,1.5608161820494322,0.0814111261872456,0.5112362697650543,1.0,1/15,0.19%,BRCA1
prerank,microtubule bundle formation (GO:0001578),0.683873829500864,1.5602715180045834,0.05096262740656852,0.5110776334278797,1.0,7/42,4.92%,PLK1;KIF20A;CDK5RAP2;PSRC1;SPAG16;SPEF1;NUMA1
prerank,catecholamine metabolic process (GO:0006584),-0.5949982535714936,-1.5600345789813206,0.030927835051546393,0.47695871787178784,1.0,6/14,24.48%,PRKN;RNF180;DDC;DRD2;ATP7A;COMT
prerank,regulation of cell cycle (GO:0051726),0.6547542783533578,1.5581563947220132,0.0,0.5167837997276531,1.0,54/271,10.88%,CENPF;DTL;KIF20B;BRCA1;PRR11;CCNB1;CDKN3;DLGAP5;PLK1;BIRC5;BARD1;MASTL;CKS2;FIGNL1;CCNB2;TGM1;PCLAF;CDKN2D;DDIAS;FBXO5;CDKN2C;RB1;RASSF1;TTC28;FGFR2;LIN54;GBF1;UHRF2;CTBP1;LIN52;TCF7L2;RBBP4;PML;MAP3K20;MYBL2;CHEK1;FBXL8;LIN9;RNF40;IRF1;MFN2;HTRA2;LIN37;ING4;GRK5;PLAGL1;CSNK2A2;SKP2;FBXL17;CDC25A;TGFBR1;CDC123;HNRNPU;CRLF3
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.41683020760723655,-1.5569179043994426,0.00819672131147541,0.4820193759552136,1.0,13/36,14.64%,MECOM;PRKN;FOXO1;ZMYND11;IGBP1;DUSP3;CYLD;DACT1;PTPN22;HDAC3;PINK1;SH3RF2;DUSP1
prerank,positive regulation of telomere maintenance (GO:0032206),0.698977394699195,1.5558976009356003,0.04939759036144578,0.5228086505368144,1.0,7/31,6.79%,NEK2;ATRX;AURKB;RTEL1;HNRNPD;MRE11;PML
prerank,DNA modification (GO:0006304),0.7310955508527318,1.555851912680201,0.06306306306306306,0.5208079152816227,1.0,2/22,1.68%,NEIL3;TERF1
prerank,rRNA processing (GO:0006364),-0.3004248385681207,-1.554904707498025,0.0,0.483341274591328,1.0,82/172,26.80%,RPL13;RPL37A;RPL38;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;NVL;RPS7;RPL18A;RPS6;RPL14;RPLP1;RPL9;RPL37;RPL8;RPS14;NOL8;RPL10;RPL32;RPL18;SENP3;RPS28;RPL15;RPS24;RPS19;HEATR1;UTP20;KRR1;RSL1D1;NSA2;RPL27;RPL39;RPL24;RPL12;WDR75;EXOSC1;RPS27;RPL27A;RPS9;RPL30;RPL19;EXOSC9;RRP1;RRP1B;RPL28;RPL31;MPHOSPH10;LAS1L;DKC1;DDX49;SNU13;RPL13A;RPL36A;RPL29;MDN1;RPLP2;RIOK2;RPLP0;RPL10A;RPL35;NOB1;EMG1;THUMPD1;NOLC1;PIH1D1;NOP2;EXOSC2;RRP15;EBNA1BP2;DDX54;RPL4;IMP3;BYSL;DDX47;BOP1;EXOSC3;RPS25;EXOSC5;POP5
prerank,response to light stimulus (GO:0009416),0.6747819046073749,1.554766178734156,0.030335861321776816,0.522914957743886,1.0,9/55,6.30%,DTL;PCLAF;ZRANB3;CDKN2D;USP1;PRIMPOL;ERCC4;POLD1;ERCC3
prerank,acylglycerol metabolic process (GO:0006639),-0.42490042482958373,-1.554620123659594,0.0,0.47875807183638414,1.0,10/37,9.52%,CAV1;APOE;PLAAT3;DGKB;ABHD6;ABHD12;DGKG;LMF1;DGKI;ABHD2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.6948675498936774,1.5542107601592723,0.03968253968253968,0.522960630328879,1.0,10/37,9.80%,SKA3;SKA1;SKA2;STMN1;GSK3B;MAPT;BICD2;TPPP;ROCK1;MARK2
prerank,regulation of protein localization to nucleus (GO:1900180),0.6881995995928307,1.554119951875416,0.037486218302094816,0.5211503937622495,1.0,11/43,11.59%,CDK1;PLK1;GTSE1;GSK3B;CTNNA1;TPR;WWTR1;YAP1;PARP9;EIF2AK3;ILRUN
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.6150091328367553,-1.553872809868256,0.03459119496855346,0.47562923628596815,1.0,9/11,33.60%,UQCRC2;UQCRB;UQCR10;UQCRQ;UQCRC1;CYC1;UQCRFS1;CYCS;UQCC3
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.5095137289533496,-1.5534601690574654,0.0326530612244898,0.471759037015317,1.0,4/21,6.10%,PLA2G4A;PLAAT3;PLA1A;OSBPL10
prerank,mismatch repair (GO:0006298),0.7069162660801636,1.5533097239234372,0.06609547123623011,0.5220524164251032,1.0,14/27,17.19%,EXO1;RPA1;MSH3;POLD3;POLD1;RPA2;MLH1;SETD2;RNASEH2A;PCNA;MSH6;PMS1;MSH5;MCM9
prerank,positive regulation of B cell proliferation (GO:0030890),0.7139017841722788,1.5528854161757537,0.05776173285198556,0.5214841844610753,1.0,1/29,0.09%,TNFSF13B
prerank,dendritic spine organization (GO:0097061),-0.4721789738064932,-1.5518940966798545,0.02072538860103627,0.472091403019743,1.0,11/26,14.13%,CTNND2;DOCK10;SHANK3;PAK3;INSR;DIP2A;EPHB2;LGMN;CHRNA7;SHANK1;DLG4
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.745568440106444,1.5516864841489155,0.07397622192866579,0.523861407381597,1.0,8/19,9.30%,TYMS;ADK;ADA;POLD3;DCK;HPRT1;POLD1;CDA
prerank,response to steroid hormone (GO:0048545),-0.43886993933219,-1.5507801260103637,0.012121212121212121,0.4707021616090385,1.0,18/31,26.53%,CAV1;PAQR8;TGFB2;AR;ATP1A1;ABHD2;NR1H3;ATP1A3;CATSPER2;THBS1;ATP1A2;TGFB3;WBP2;URI1;ABCA2;PAQR7;UBE3A;CATSPER3
prerank,zinc ion homeostasis (GO:0055069),-0.45735476320676033,-1.5506738383598346,0.02197802197802198,0.4659682758088022,1.0,14/28,20.66%,PRKN;SLC39A10;SLC39A13;SLC39A7;SLC30A1;MT2A;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,DNA duplex unwinding (GO:0032508),0.6751597280523364,1.5489661166826467,0.026402640264026403,0.532348281997407,1.0,15/50,6.30%,PIF1;RAD51;DDX11;MCM6;MCM7;MCM2;RTEL1;RPA1;CHD1L;DHX9;BLM;MRE11;RECQL;MCM4;ERCC3
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.7098875335973174,1.5485572274883272,0.04579207920792079,0.5317721887365963,1.0,7/26,14.06%,BRCA1;HPSE;SULF2;SULF1;EIF2AK3;RORA;ARNT
prerank,positive regulation of protein export from nucleus (GO:0046827),0.7474567665988544,1.5475753301474526,0.07859078590785908,0.533243885910522,1.0,7/15,9.79%,GTSE1;GSK3B;XPO4;ANP32B;TCF7L2;TPR;EMD
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.7785395240049746,1.546442081085676,0.056657223796033995,0.5354603897070285,1.0,3/14,4.06%,BRCA1;PAXIP1;AUTS2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.6712773670209522,1.5456634384683585,0.046255506607929514,0.5363036041907112,1.0,14/46,9.79%,ECT2;GTSE1;GSK3B;XPO4;KHDRBS1;ANP32B;NEDD4;DHX9;NRDE2;TCF7L2;TPR;UBR5;TRIM28;EMD
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.7010312670452437,1.5456474414664105,0.06539833531510107,0.5342395449919746,1.0,4/32,4.80%,TPX2;STMN1;DYRK1A;SPEF1
prerank,peptidyl-arginine modification (GO:0018195),-0.5543000998716813,-1.5438983140422784,0.04247104247104247,0.4832430417893401,1.0,6/15,20.76%,ART3;KRTCAP2;PRMT8;PRMT1;PARK7;PADI2
prerank,positive regulation of protein kinase activity (GO:0045860),0.6489529741391789,1.5433827291113715,0.0020181634712411706,0.5407548351212946,1.0,23/148,9.85%,TPX2;CENPE;KIF14;ECT2;EZH2;INCENP;CLSPN;BORA;SPDYA;MAP4K4;RHOA;PRNP;STK3;NRK;EFNA1;ETAA1;CCN1;EPHA4;MRNIP;NOX4;AGT;MARK2;DDR2
prerank,Golgi inheritance (GO:0048313),0.7873049522642295,1.5427055826763356,0.07496251874062969,0.5412714515520246,1.0,2/11,3.78%,CDK1;GBF1
prerank,cellular response to fluid shear stress (GO:0071498),-0.588002979809055,-1.5418001675097823,0.03806228373702422,0.48522782974293666,1.0,9/12,25.09%,MEF2C;MAP2K5;KLF4;SREBF2;HDAC3;KLF2;MTSS1;ASS1;MAPK7
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.4257229111845714,-1.5410760133563715,0.0,0.48239948665663746,1.0,6/38,4.40%,CAMK2D;CTNNA3;CACNA2D1;CAV1;KCNJ3;BIN1
prerank,response to muramyl dipeptide (GO:0032495),-0.5947207871932281,-1.5401579032267274,0.050314465408805034,0.48043361127536016,1.0,6/12,17.04%,TRIM41;NOD1;PTPN22;ARHGEF2;CHMP5;ERBIN
prerank,protein heterooligomerization (GO:0051291),-0.53995262049645,-1.5398316695512761,0.04905660377358491,0.4764119997315467,1.0,7/17,14.42%,KCNC2;FARSB;CPSF6;GRIN2B;FARSA;CPSF7;GRIN1
prerank,positive regulation of DNA recombination (GO:0045911),0.7151847268772239,1.539282011611944,0.07701711491442542,0.5520908946992117,1.0,9/27,12.72%,RAD51AP1;TIMELESS;PAXIP1;ARID2;RIF1;FUS;MRNIP;MMS19;KMT5C
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.5928799482416487,-1.5381985784366456,0.05214723926380368,0.4764655116573617,1.0,6/12,21.77%,PODXL;JAG1;PROM1;PTPRO;KLF15;BASP1
prerank,ceramide catabolic process (GO:0046514),-0.5735392391201656,-1.5363639653887058,0.03717472118959108,0.47799477581279953,1.0,6/14,13.53%,HEXB;ACER2;ASAH1;ACER3;HEXA;ASAH2
prerank,cell proliferation in forebrain (GO:0021846),0.8033431723268669,1.5359686000696628,0.08169440242057488,0.5625615659366593,1.0,3/10,6.79%,KIF14;PCM1;AKNA
prerank,negative regulation of DNA replication (GO:0008156),0.7595708112871267,1.5358756608041781,0.07945205479452055,0.560692853257539,1.0,4/13,4.51%,TERF1;PDS5A;CDC6;WAPL
prerank,positive regulation of neuron migration (GO:2001224),0.8028847332018344,1.5351844331127453,0.07860262008733625,0.5612333645529853,1.0,1/11,0.10%,KIF20B
prerank,regulation of telomere capping (GO:1904353),0.711250942282551,1.534868607670694,0.07483870967741936,0.5603281625571388,1.0,4/23,3.76%,NEK2;AURKB;RTEL1;HNRNPD
prerank,regulation of dendritic spine development (GO:0060998),-0.5264838852745886,-1.5346910327667418,0.035856573705179286,0.4783846980818367,1.0,8/19,8.08%,GRIN3A;CPEB3;MEF2C;PSEN1;SHANK3;APOE;KIF1A;CAMK1
prerank,piRNA metabolic process (GO:0034587),0.7368137577883942,1.5319733178346253,0.08885941644562334,0.5688784812507618,1.0,3/19,6.44%,MYBL1;MAEL;EXD1
prerank,regulation of interleukin-4 production (GO:0032673),-0.492845008999124,-1.530931984879656,0.027777777777777776,0.4863572786578755,1.0,10/21,27.90%,LEF1;SLC7A5;PRKCQ;CEBPB;DDIT3;PRKCZ;LGALS9;CD86;SYK;FCER1G
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.5935751280973538,-1.5308723010926975,0.04452054794520548,0.4818785886429869,1.0,5/12,18.39%,APOD;IFT20;NDRG4;CBLB;CBL
prerank,nucleosome organization (GO:0034728),0.6602006852822391,1.5304565686197436,0.05257393209200438,0.5724642087246335,1.0,21/55,14.87%,CHAF1B;ATRX;HMGB2;NAP1L1;SMARCC1;CTCF;LIN54;NFE2;ARID2;ANP32B;ARID1A;SETD2;SRCAP;SMARCA4;ANP32E;NASP;SPTY2D1;SOX9;MCM3AP;CHAF1A;INO80
prerank,chromatin assembly (GO:0031497),0.6805462909607899,1.5301176157182588,0.06046511627906977,0.5716622042031807,1.0,8/38,6.50%,CHAF1B;ATRX;HMGB2;NAP1L1;CTCF;LIN54;ANP32B;RBBP4
prerank,glycerolipid metabolic process (GO:0046486),-0.5990156715913331,-1.52985293884129,0.032448377581120944,0.48079982921030173,1.0,7/11,23.64%,DGKB;DGKG;PIP5K1A;DGKQ;GAL3ST1;PLA2G15;PGP
prerank,epithelial cell-cell adhesion (GO:0090136),0.7860137762078467,1.5288864023268272,0.09104477611940298,0.5740543495185624,1.0,3/11,4.65%,SERPINB8;PLEKHA7;KIT
prerank,regulation of chromatin organization (GO:1902275),0.7739466443880275,1.5278425233040969,0.07604017216642754,0.5757588120149577,1.0,1/14,0.23%,MKI67
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.41272490718360605,-1.5273335255087157,0.0,0.4837849608969153,1.0,15/43,21.04%,IGF1;GAS6;TLR4;CD34;PTPN22;LBP;SELENOS;CHRNA7;SYT11;CX3CL1;TRIM27;DICER1;LGALS9;ZC3H12A;CD274
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.6212499996940435,-1.523938836266558,0.051515151515151514,0.49035151409705485,1.0,8/10,33.21%,MAP2K5;KLF4;TLE5;MAPK7;IRAK3;PTPRC;SH2B3;SIGIRR
prerank,neuromuscular process controlling balance (GO:0050885),-0.5839658425135766,-1.5235902598957476,0.05016722408026756,0.48684307308081237,1.0,4/12,12.14%,PCDH15;NRXN1;TPP1;SHANK1
prerank,regulation of microtubule depolymerization (GO:0031114),0.7090461069041238,1.5223297625886696,0.08125,0.5945490876202154,1.0,1/25,0.05%,TPX2
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.684580383941231,1.5223077835309615,0.0706713780918728,0.5923968480424018,1.0,9/33,8.02%,PIF1;RAD51;TERF1;RTEL1;RPA1;STN1;MRE11;RFC1;CDK2
prerank,histone H4-K5 acetylation (GO:0043981),0.7588154222471957,1.5220225217027155,0.08659217877094973,0.5891730376932249,1.0,2/15,2.62%,KANSL1;KANSL2
prerank,histone H4-K8 acetylation (GO:0043982),0.7588154222471957,1.5220225217027155,0.08659217877094973,0.5891730376932249,1.0,2/15,2.62%,KANSL1;KANSL2
prerank,positive regulation of nuclear division (GO:0051785),0.7044858479864621,1.5216186188061864,0.08333333333333333,0.5885387802470421,1.0,3/25,2.81%,NUSAP1;PHIP;AURKA
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.6736244393812889,1.5209465616677393,0.04157549234135667,0.5887414768431383,1.0,19/53,15.80%,BRCA1;ANKLE1;RNF168;EYA4;DHX9;NSMCE4A;FMR1;UBE2N;UIMC1;TRIM28;SMCHD1;BCLAF1;EYA2;PCNA;SPRED1;BRCC3;NSMCE1;FXR1;SPRED2
prerank,vascular transport (GO:0010232),-0.3740651811698115,-1.5205034115872702,0.0,0.49222296974254665,1.0,29/81,15.48%,SLC6A6;SLC16A12;SLC1A2;ATP8A1;SLC6A1;SLC13A3;SLC2A1;SLC44A1;SLC7A2;INSR;SLCO1C1;SLC22A8;SLCO2B1;SLC7A5;LRP1;ABCC4;SLC27A1;ABCG2;SLC5A6;SLC5A5;SLC15A2;SLC22A5;ATP1A2;SLC16A1;ABCC5;SLC2A3;SLC12A2;SLC1A1;SLC4A8
prerank,positive regulation of protein binding (GO:0032092),-0.38358365288378926,-1.520300631856519,0.024390243902439025,0.48835606938675735,1.0,20/56,11.18%,PRKN;MARK3;PSEN1;EPB41;TIAM1;CAV1;APOE;CLDN5;HIPK2;FKBP1A;VTN;RALB;LRP1;NVL;PPP2CB;DACT1;B2M;DERL1;APP;ABL1
prerank,mRNA stabilization (GO:0048255),0.6712507300941447,1.519753871992343,0.060090702947845805,0.5909608419795396,1.0,13/40,11.07%,MEIOC;E2F1;SYNCRIP;DHX9;THRAP3;EIF4ENIF1;YBX3;FUS;LARP1;AXIN2;HNRNPU;TAF15;TENT5D
prerank,retinoic acid metabolic process (GO:0042573),0.7619959615553227,1.5196050665145964,0.07112970711297072,0.5892973231531125,1.0,4/14,9.16%,ALDH8A1;CYP26B1;ALDH1A2;SCPEP1
prerank,positive regulation of cellular protein localization (GO:1903829),0.6639862277396308,1.5192703476715899,0.027225130890052355,0.5884448968866737,1.0,16/69,10.96%,NDC80;CDK1;PLK1;GTSE1;CENPQ;RANGRF;GSK3B;DDRGK1;NUMA1;PDZK1;MAPT;WWTR1;YAP1;SNX33;PARP9;EIF2AK3
prerank,transport across blood-brain barrier (GO:0150104),-0.36850524262221906,-1.5189993640321875,0.0,0.4881576638470655,1.0,29/83,15.48%,SLC6A6;SLC16A12;SLC1A2;ATP8A1;SLC6A1;SLC13A3;SLC2A1;SLC44A1;SLC7A2;INSR;SLCO1C1;SLC22A8;SLCO2B1;SLC7A5;LRP1;ABCC4;SLC27A1;ABCG2;SLC5A6;SLC5A5;SLC15A2;SLC22A5;ATP1A2;SLC16A1;ABCC5;SLC2A3;SLC12A2;SLC1A1;SLC4A8
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.44189025523757397,-1.5185722581019163,0.029411764705882353,0.48491657365571533,1.0,23/31,39.22%,PEX1;DNAJC19;HSPD1;AIFM1;PEX5;TIMM44;PEX6;TOMM70;DNAJC15;PAM16;TIMM17B;PEX26;TIMM17A;CHCHD4;ROMO1;PEX10;GRPEL1;PEX16;DNLZ;TOMM40L;PEX2;PEX14;TIMM50
prerank,lymphocyte mediated immunity (GO:0002449),-0.607017090937075,-1.518473822748001,0.040372670807453416,0.48089837632835664,1.0,3/12,12.80%,JAG1;MSH2;GNL1
prerank,positive regulation of endocytosis (GO:0045807),-0.40905158613309556,-1.5160789407941548,0.017391304347826087,0.4841844907447873,1.0,20/45,23.39%,SGIP1;APOE;VTN;ANO6;BICD1;LRP1;CLIP3;DAB2;B2M;HNRNPK;HIP1;LDLRAP1;CBLL1;NLGN1;PPT1;CBL;NCKAP1L;CD151;NEDD4L;TOR1A
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.5399236817801518,-1.5157840990779647,0.05776173285198556,0.48088359991488816,1.0,4/15,9.38%,ATP1B1;KCNJ3;ATP1A1;KCNN2
prerank,negative regulation of T cell differentiation (GO:0045581),0.7810670666418077,1.5148825118153282,0.09233176838810642,0.6027295521879542,1.0,3/10,8.26%,GLI3;LAG3;IRF1
prerank,telomere maintenance (GO:0000723),0.671665365436602,1.5120413498425038,0.040525739320920046,0.6114246680564763,1.0,27/50,19.32%,RAD51;TERF1;SMC6;RTEL1;RPA1;SMC5;STN1;DNA2;POLD3;ERCC4;PRKDC;BLM;MRE11;POLD1;RPA2;RIF1;PCNA;NSMCE2;TERF2;TEP1;TINF2;ATR;ACD;TERF2IP;SP100;RAD50;TERT
prerank,regulation of viral life cycle (GO:1903900),0.6991788594962252,1.5094366247402373,0.08997429305912596,0.6191768996074857,1.0,2/21,0.93%,TRIML2;KPNA2
prerank,aerobic electron transport chain (GO:0019646),-0.35371139645921407,-1.507740330044032,0.02040816326530612,0.5017750760531327,1.0,33/68,24.81%,COX4I1;COX6C;COX5A;COX7B;NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;COX7C;NDUFS3;UQCRC2;NDUFB3;NDUFS4;UQCRB;NDUFA5;NDUFA6;NDUFA4;NDUFB9;UQCR10;UQCRQ;COX8A;NDUFA11;NDUFAF1;NDUFB6;NDUFB11;NDUFB10;NDUFA10;COX5B;NDUFS6;UQCRC1;NDUFA1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.6426332725240925,1.5072106181979037,0.03970741901776385,0.6258562311057747,1.0,21/72,11.54%,POLK;ANKLE1;RFC4;RPA1;CHD1L;DNA2;POLD3;RNASE6;ERCC4;RFC2;MRE11;POLD1;RPA2;RFC1;ERCC3;RFC3;CUL4B;ENPP1;XPA;PCNA;RNASE1
prerank,regulation of osteoblast proliferation (GO:0033688),0.7285971294561489,1.506201520340754,0.08731241473396999,0.6275153740963848,1.0,8/17,15.25%,HPSE;RHOA;FGFR2;CCN1;NPR3;PLXNB1;BMP2;SFRP1
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.5282757766824953,-1.5047820473012439,0.04149377593360996,0.5075240492065075,1.0,7/17,16.52%,PCSK5;PCSK6;FURIN;LMF1;NR1H3;HDAC9;NR1H2
prerank,protein polymerization (GO:0051258),0.651463580991821,1.5040156497102295,0.05501618122977346,0.6335189976171235,1.0,7/55,5.53%,DIAPH3;UBE2C;CKAP5;UBE2S;UBE2K;DIAPH1;MAPT
prerank,response to UV (GO:0009411),0.6384384978425091,1.5022087971626508,0.026915113871635612,0.6382286933568941,1.0,27/95,14.87%,DTL;POLK;AURKB;PCLAF;ZRANB3;AQP1;CDKN2D;USP1;POLH;BMF;PRIMPOL;NEDD4;ERCC4;POLD1;ERCC3;FMR1;MAP3K4;CDC25A;USP28;XPA;PCNA;MSH6;USP47;YY1;SMPD1;RUVBL2;INO80
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.644784664860487,1.5018298481048287,0.04068522483940043,0.6373886599062334,1.0,10/66,3.67%,KIF14;E2F7;RBL1;E2F1;WEE1;CDKN2D;CDKN2C;RB1;HYAL1;TFDP1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.6619239890329099,1.5009773541056628,0.046052631578947366,0.6384356760531101,1.0,24/60,16.13%,CCNB1;CDK1;MED26;PPM1D;CBFB;PAXIP1;MOV10;MED14;SRF;TCF7L2;MED30;ATF7IP;TRIM28;MED24;MED15;SOX9;HEY2;MED1;CDK8;MED27;NFKB1;TNRC6C;TP53;PTEN
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.5728044767455346,-1.4988690211549325,0.08875739644970414,0.5215735290926391,1.0,6/12,16.69%,MID2;LY6E;SNX3;IFITM3;GSN;IFITM2
prerank,liver development (GO:0001889),0.6801569681604537,1.4984673109863507,0.08391608391608392,0.6462082976486663,1.0,6/32,8.91%,E2F7;E2F8;AURKA;TGFBR3;PHF2;NPHP3
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.6769573543693187,1.4977272011350067,0.0768321513002364,0.6467340398104595,1.0,6/31,2.58%,E2F7;RBL1;WEE1;CDKN2D;CDKN2C;RB1
prerank,metal ion transport (GO:0030001),-0.3437101915055877,-1.49772263391519,0.0,0.5208067717014354,1.0,27/86,16.75%,CACNA2D1;GRIN3A;RYR3;NIPA1;PSEN1;SLC8A3;TRPM7;CALCRL;TRPC5;CAV1;RYR2;NIPA2;SLC3A2;CACNG7;TPT1;RAMP1;RAMP2;CACNA1B;TRPC3;TRPC1;CHRNA7;SLC30A1;ATP2B2;NIPAL3;PANX1;CACNG3;CACNG8
prerank,renal absorption (GO:0070293),-0.6120545223211729,-1.4971903921479746,0.05660377358490566,0.5183954824996015,1.0,8/10,38.16%,SGK1;SLC15A2;GSN;KLHL3;KCNQ1;MAGED2;HYAL2;HAS2
prerank,smoothened signaling pathway (GO:0007224),0.6894037942530601,1.4962774298111918,0.07099879663056559,0.6502105404231214,1.0,3/32,1.25%,STIL;GLI2;GLI3
prerank,histone H4-K16 acetylation (GO:0043984),0.7264355104999177,1.4945981423661707,0.09234828496042216,0.6544140182802711,1.0,5/19,9.74%,KANSL1;KANSL2;ING4;MSL3;KMT2A
prerank,negative regulation of organelle assembly (GO:1902116),0.6640940335526401,1.494213907448828,0.08439306358381503,0.6536245420850209,1.0,11/35,12.64%,BRCA1;CDK5RAP2;TRIM37;CEP97;EVI5L;LRRK2;YAP1;TBC1D7;TMEM39A;SCFD1;SMAD4
prerank,error-free translesion synthesis (GO:0070987),0.7054361047822715,1.4932348478135253,0.08746736292428199,0.6550785446564497,1.0,8/22,6.63%,RFC4;POLH;RPA1;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,negative regulation of mRNA processing (GO:0050686),0.7455168601840513,1.4931709188614737,0.09537166900420757,0.6530798545529366,1.0,5/15,8.06%,BARD1;SRSF4;SRSF10;SRSF7;SAP18
prerank,glucose import (GO:0046323),-0.5673183420621798,-1.4926857000721399,0.06451612903225806,0.5295130219679081,1.0,6/13,21.55%,SLC2A1;SLC27A1;SLC2A3;ZDHHC7;SLC2A10;SLC27A4
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.5273367337299455,-1.4924011638590555,0.036231884057971016,0.5262829342548151,1.0,7/17,16.82%,PRKG1;MEF2C;PDCD4;SOD2;TPM1;TAFA5;TGFB3
prerank,regulation of chromatin binding (GO:0035561),0.7746834316134725,1.490820925443755,0.09327217125382263,0.6598914015094,1.0,4/10,10.56%,DDX11;BTAF1;WAPL;PARP9
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.34185510056994267,-1.4904554066503055,0.0,0.5279002801398025,1.0,39/87,24.98%,IMMP2L;TTC19;COX16;UQCC1;NDUFS5;OXA1L;NDUFS1;OMA1;NDUFA9;AIFM1;COX19;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;UQCC2;NDUFA6;NDUFB9;DMAC2;PET100;ACAD9;COX20;SMIM20;NDUFA11;COX17;NDUFAF1;NDUFB6;COX14;TIMMDC1;NDUFB11;NDUFB10;NDUFA10;COA8;NDUFS6;NDUFA1;CHCHD4
prerank,organophosphate catabolic process (GO:0046434),0.7607074745785299,1.4903464216330735,0.11209439528023599,0.6593211636338935,1.0,2/11,7.03%,PON1;ENPP2
prerank,chromatin assembly or disassembly (GO:0006333),0.757897066748945,1.4897149346217615,0.09131736526946108,0.6594085665742981,1.0,7/11,18.96%,CHAF1B;RBBP4;HDAC8;CHAF1A;TP53;SUV39H2;HIRIP3
prerank,RNA stabilization (GO:0043489),0.6674006344891227,1.488881872862461,0.07755581668625147,0.6604458677877733,1.0,12/33,11.07%,MEIOC;E2F1;TENT2;PHAX;THRAP3;EIF4ENIF1;FUS;LARP1;AXIN2;HNRNPU;TAF15;TENT5D
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.7072870996989248,1.4878803604663733,0.09324324324324325,0.6621591833777094,1.0,10/19,18.53%,PIF1;TERF1;STN1;HNRNPA1;HNRNPU;TERF2;SRC;TINF2;ACD;EXOSC10
prerank,protein acetylation (GO:0006473),0.6801669622912793,1.487237918782339,0.08383233532934131,0.6624182033418752,1.0,4/30,5.53%,ESCO2;DSCC1;HAT1;MAPT
prerank,protein heterotetramerization (GO:0051290),-0.5781108119569228,-1.4867713586676476,0.0462046204620462,0.5360313742045828,1.0,7/13,19.99%,FARSB;CPSF6;GRIN2B;FARSA;CPSF7;GRIN1;CBR4
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.5577867218764679,-1.4852138350110535,0.06802721088435375,0.5369825122348204,1.0,6/13,21.70%,TMSB4X;NOS3;PINK1;ENO1;PPARGC1A;NOS1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.4396010785482193,-1.4835453275027022,0.02717391304347826,0.5387213554216268,1.0,12/29,15.17%,CYRIB;PRKN;SHANK3;KANK3;KANK4;TJP1;PFN1;SLIT2;SSH1;SHANK1;ARFGEF1;FKBP4
prerank,protein neddylation (GO:0045116),-0.5486592586687509,-1.4815003990761442,0.07741935483870968,0.5412697956060072,1.0,5/13,15.16%,DCUN1D3;RBX1;DCUN1D5;DCUN1D4;DCUN1D2
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.6783171089983802,1.4809825217718815,0.10286458333333333,0.6846314850101493,1.0,11/24,18.53%,PIF1;TERF1;STN1;ERCC4;HNRNPA1;HNRNPU;TERF2;SRC;TINF2;ACD;EXOSC10
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.7681381323502451,1.4798268426022612,0.0998439937597504,0.6869448240439514,1.0,4/10,12.64%,BRCA1;CHEK1;KMT2A;SMAD4
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.6345875566258221,1.4792433712303426,0.044585987261146494,0.6868743006129554,1.0,12/66,10.96%,ECT2;CDK1;PLK1;GTSE1;TPR;NMD3;WWTR1;UBR5;TRIM28;YAP1;PARP9;EIF2AK3
prerank,hemidesmosome assembly (GO:0031581),-0.5889924967687046,-1.4771535076708648,0.06501547987616099,0.5507701976176728,1.0,6/11,26.76%,ITGA6;LAMA3;ITGB4;CD151;PLEC;LAMC2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.6031331627940822,-1.4770293793953224,0.07799442896935933,0.5469392439311093,1.0,5/10,16.20%,CCT5;TCP1;CCT7;CCT2;DKC1
prerank,protein localization to chromatin (GO:0071168),0.7189001155424006,1.4768136608267215,0.08616187989556136,0.694112380975599,1.0,7/18,8.22%,PLK1;MCM8;SGF29;RAD21;WAPL;NIPBL;MRNIP
prerank,pore complex assembly (GO:0046931),0.7191229767497533,1.476800154730147,0.11891891891891893,0.691869721593608,1.0,7/19,6.62%,PLEKHA7;NDC1;NUP205;TSPAN33;AFDN;AHCTF1;TPR
prerank,peroxisomal membrane transport (GO:0015919),-0.45501318137291036,-1.4763562178599163,0.03664921465968586,0.5448948759046844,1.0,12/27,22.04%,PEX1;FIS1;ABCD4;ALDH3A2;PEX3;PEX5;PEX6;ABCD2;GDAP1;PXMP4;PEX26;PXMP2
prerank,cellular response to light stimulus (GO:0071482),0.6295622050779277,1.4753534784113502,0.052127659574468084,0.6951635965193029,1.0,20/66,17.05%,POLK;AURKB;AQP1;BMF;NEDD4;ERCC4;POLD1;FMR1;CDC25A;USP28;PCNA;USP47;YY1;SMPD1;RUVBL2;INO80;TP53;METTL3;ATR;PTPRK
prerank,protein-DNA complex assembly (GO:0065004),0.6202020406880729,1.47415241768415,0.021384928716904276,0.6976858800023839,1.0,37/116,14.28%,CHAF1B;RAD51;ATRX;MCM5;ORC1;HMGB2;MCM8;DMC1;NAP1L1;MCM6;MCM7;MCM2;CDC6;PSMC2;RPA1;PSMD5;CHD1L;ANP32B;MCM3;RPA2;MCM4;ERCC3;ORC2;TCF4;ORC3;PSMB1;PSMD14;CUL4B;PSMD1;PSMB9;XPA;SPTY2D1;CENPV;SOX9;ORC6;CHAF1A;PSMC6
prerank,retrograde axonal transport (GO:0008090),-0.5112484410808487,-1.4737075504783896,0.052830188679245285,0.549268409393557,1.0,6/16,10.36%,TMEM108;KIF1A;MAP1A;KIF5B;NEFL;ACTR10
prerank,determination of left/right symmetry (GO:0007368),0.658265418026555,1.4728686934383004,0.08092485549132948,0.7002706721042681,1.0,5/36,8.91%,STIL;DNAH11;CFAP53;MKKS;NPHP3
prerank,cellular response to hydrogen peroxide (GO:0070301),0.6627590140184944,1.472597849721444,0.10011918951132301,0.6989779149015948,1.0,5/33,5.47%,ECT2;AQP1;SETX;FXN;NET1
prerank,myotube cell development (GO:0014904),-0.6055565149915982,-1.4721797244407004,0.06116207951070336,0.5500168743901801,1.0,4/10,11.49%,IGF1;CAV2;SIX1;SELENON
prerank,chordate embryonic development (GO:0043009),0.6409901473799289,1.4706132987381408,0.07759562841530054,0.7046389463409943,1.0,11/55,11.48%,BRCA1;STIL;FGFR2;ALDH1A2;SULF2;ZNF568;GRHL2;SULF1;LMX1B;TGFBR1;BMP2
prerank,nuclear migration (GO:0007097),0.7481849153242414,1.470466562121895,0.11265646731571627,0.7028839096087216,1.0,8/13,15.78%,SYNE3;SYNE2;PCM1;CLMN;CEP120;FBXW11;DOCK7;SUN2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5929895231480943,-1.4693036045471923,0.07180851063829788,0.5548146468614642,1.0,8/10,34.87%,HSP90AB1;LAPTM4B;FURIN;GATA6;CD24;TSKU;TYROBP;CDH3
prerank,protein targeting to peroxisome (GO:0006625),-0.4318539157600661,-1.468979772739467,0.046242774566473986,0.5516210302593261,1.0,19/29,37.87%,PEX1;FIS1;ALDH3A2;PEX3;LONP2;PEX5;PEX6;ABCD2;GDAP1;PXMP4;PEX26;PXMP2;HACL1;PEX11B;PEX10;ACBD5;PEX16;PEX2;PEX14
prerank,response to amyloid-beta (GO:1904645),-0.38418339702841114,-1.468859199627035,0.030303030303030304,0.5479540387170422,1.0,16/44,14.42%,CACNA2D1;PSEN1;GRIN2A;IGF1;TLR4;LRP1;VCAM1;CASP4;LGMN;CACNA1B;CHRNA7;ATP1A3;APP;GRM5;MMP2;GRIN1
prerank,positive regulation of histone modification (GO:0031058),0.6728460689120209,1.4673302091112304,0.08548009367681499,0.7128057933599002,1.0,8/33,7.78%,BRCA1;PAXIP1;CTBP1;ARRB1;FMR1;UBE2N;NIPBL;ZBTB7B
prerank,cilium assembly (GO:0060271),0.6182488768675517,1.4672159495940498,0.002,0.7109793318578692,1.0,66/296,10.81%,NEK2;CDK1;KIF24;PLK1;CEP192;CEP152;CDK5RAP2;CKAP5;HAUS8;PLK4;IFT80;CEP57;HYLS1;CEP89;BBS9;HAUS4;HAUS6;DZIP1L;ACTR1A;SCLT1;DNAAF3;ACTR3;CEP43;WDR35;PARVA;ASAP1;WDR90;GBF1;CEP97;SPAG16;IFT140;POC1B;FAM161A;EXOC4;KIF27;PCM1;TNPO1;C2CD3;OCRL;HAUS7;TXNDC15;MKKS;WDR11;NDE1;CEP83;NUDCD3;RILPL1;CNTRL;RFX2;SSX2IP;CCDC57;HAUS1;CFAP52;SPATA6;CEP76;WDPCP;NPHP3;ALMS1;ODF2;RAB1A;SDCCAG8;NINL;RSPH9;NPHP1;TTC39C;TRAPPC14
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.6768846214669879,1.4652743430475286,0.09035409035409035,0.7162637901871628,1.0,7/29,9.06%,BRCA1;CBFB;CNOT1;DDRGK1;VPS18;YAP1;KANK2
prerank,positive regulation of organelle assembly (GO:1902117),0.6490535305807729,1.465057534487887,0.07692307692307693,0.7148192336204793,1.0,15/44,11.42%,SPAG5;PLK4;GPSM2;ASAP1;CNOT1;NUMA1;CNOT6L;G3BP1;SH3GLB1;CNOT6;TAPT1;SDC1;ARHGAP35;CEP120;STX18
prerank,embryonic organ development (GO:0048568),0.6278579092179306,1.4648341183031326,0.06844919786096257,0.7132988895089496,1.0,22/61,17.04%,STIL;PBX4;GLI2;GLI3;FOXE1;PBX3;BMPR1A;TEAD1;FGFR2;KIT;ERCC3;KMT2A;TEAD3;TAL1;RBPJ;RARB;NES;HEY2;GDNF;SALL1;COBL;TEAD4
prerank,"base-excision repair, gap-filling (GO:0006287)",0.659938655308245,1.4641533355706875,0.09518213866039953,0.7138149316568062,1.0,11/35,11.52%,POLE;RFC4;RPA1;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3;MBD4;PCNA
prerank,telomere capping (GO:0016233),0.7247716143786926,1.463762850137343,0.11248285322359397,0.713036332367387,1.0,11/16,18.83%,TERF1;STN1;PRKDC;MRE11;TERF2;TINF2;ACD;TERF2IP;DCLRE1C;DCLRE1A;RAD50
prerank,indolalkylamine catabolic process (GO:0046218),0.7627912232911243,1.4616610073820078,0.11574074074074074,0.7189121778868063,1.0,3/10,13.32%,ACMSD;KMO;IL4I1
prerank,membrane repolarization (GO:0086009),-0.5279699456624736,-1.461581368010943,0.06597222222222222,0.5690997894541593,1.0,8/15,32.08%,ATP1B1;ATP1A1;ATP1B3;ATP1A2;KCNQ1;ATP1B2;KCNE4;KCNIP2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.5027752843414268,-1.4611250044024668,0.06593406593406594,0.566510064493838,1.0,5/17,12.80%,STAT3;JAG1;TLR4;MSH2;GNL1
prerank,negative regulation of viral transcription (GO:0032897),-0.5338957040955968,-1.4609688904984064,0.06134969325153374,0.5627403568779136,1.0,10/13,32.21%,MID2;IFITM3;TRIM14;TRIM27;TRIM11;TRIM21;TRIM32;ZFP36;HEXIM1;TRIM13
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.6716603576564244,1.4609668228793182,0.11166253101736973,0.719363571843574,1.0,1/26,0.19%,BRCA1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.4084263191153219,-1.4597418220569074,0.05555555555555555,0.562749831006496,1.0,10/33,17.43%,PRKG1;APOD;MEF2C;PDCD4;SOD2;TPM1;OGN;TAFA5;TGFB3;NDRG4
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.6428113894289457,1.4589687022304092,0.08169934640522876,0.7247010760807042,1.0,13/45,14.18%,ZWILCH;BUB1B;BUB1;WEE1;ZW10;CHEK1;SCRIB;BTG3;GAS1;TOM1L2;PLK2;CDKN1B;SMAD3
prerank,striated muscle tissue development (GO:0014706),-0.4389733701071488,-1.4584809205163618,0.040229885057471264,0.5628326466372038,1.0,7/29,11.36%,MEF2C;PGM5;CAV1;IGSF8;BMPR2;MYL6;SIX1
prerank,regulation of dopamine secretion (GO:0014059),-0.47186442630094616,-1.4573510216579006,0.045454545454545456,0.562427916015243,1.0,11/25,21.95%,PRKN;SYT1;SYT7;DTNBP1;KCNA2;SYT11;SYT12;SYT10;SYT6;SYT2;DRD2
prerank,water transport (GO:0006833),0.7328086410207124,1.4566679946767385,0.11911764705882352,0.7314704762075018,1.0,2/12,5.71%,AQP1;PDPN
prerank,female gamete generation (GO:0007292),0.6517567885198495,1.4566204210468536,0.1111111111111111,0.7293490266925756,1.0,10/29,19.65%,TRIP13;MCM8;DMC1;KMT2D;TOB2;USP9X;METTL3;MCM9;MARF1;FMN2
prerank,activation of protein kinase activity (GO:0032147),0.620828690757882,1.456488134632852,0.027607361963190184,0.7276476690358163,1.0,15/106,9.89%,TPX2;KIF14;ECT2;CLSPN;BORA;MAP4K4;STK3;NRK;IL18;TXN;TNFRSF10B;ANGPT1;MAPKAP1;MARK2;OSBPL8
prerank,DNA packaging (GO:0006323),0.7040746821174623,1.4552332088410354,0.12845303867403315,0.7304310473088753,1.0,6/16,16.00%,CHAF1B;HAT1;RBBP4;CHAF1A;KAT6A;TP53
prerank,regulation of intracellular protein transport (GO:0033157),0.654868300163596,1.4548397382523017,0.09328782707622298,0.7297154715366206,1.0,4/32,7.72%,KIF20B;PCM1;TPR;RAB29
prerank,linoleic acid metabolic process (GO:0043651),-0.49448592903571464,-1.453902191221534,0.06640625,0.5697801757214492,1.0,10/17,46.66%,PNPLA8;ACSL1;ELOVL1;GSTM2;FADS1;ALOX12;ELOVL2;ALOXE3;ALOX5;FADS2
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.38496553790831367,-1.453818561460198,0.030927835051546393,0.5660234943207628,1.0,26/46,31.04%,FIS1;DNAJC19;HSPD1;AIFM1;TIMM44;PINK1;TOMM70;HK1;BCAP31;GDAP1;AIP;FBXO7;DNAJC15;TOMM34;PAM16;TIMM17B;TIMM17A;TOMM7;TIMM9;CHCHD4;TIMM13;TOMM22;TIMM8B;ROMO1;TOMM5;GRPEL1
prerank,regulation of transposition (GO:0010528),0.7322776627010824,1.4532500750672537,0.11954992967651196,0.7334944013266352,1.0,1/13,0.99%,MYBL1
prerank,regulation of nervous system development (GO:0051960),0.6501118008805686,1.45320685634157,0.09953161592505855,0.7313866470454038,1.0,6/37,10.51%,KIF14;HMGB2;BHLHE41;YAP1;NPHP3;YTHDF2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6720478122570263,1.4523841613185249,0.08801955990220049,0.7324275657267707,1.0,8/26,15.25%,BRCA1;CNOT1;VPS18;SMARCA4;KANK2;HDAC1;PER1;SFRP1
prerank,T cell differentiation in thymus (GO:0033077),0.7242481272580228,1.4519391334730527,0.10773480662983426,0.7319028720784375,1.0,2/14,2.16%,GLI3;FADD
prerank,dopaminergic neuron differentiation (GO:0071542),0.7076917816441975,1.45162612534184,0.14082687338501293,0.7308970458242706,1.0,3/19,10.45%,EN1;LMX1B;NR4A2
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5917132444793192,-1.4509951051075969,0.09482758620689655,0.5715461162264673,1.0,5/10,12.24%,AKT2;CTTNBP2NL;IRS2;INPP5K;THBS1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.6549988291234133,1.4508676235409246,0.09305064782096584,0.73163162203659,1.0,6/33,2.58%,E2F7;RBL1;WEE1;CDKN2D;CDKN2C;RB1
prerank,diol metabolic process (GO:0034311),-0.48026034731102646,-1.4508521565790025,0.04247104247104247,0.5680773732894906,1.0,8/19,16.21%,CALM1;NOS3;PLPP3;DEGS2;ASAH2;GCH1;PRKG2;PTS
prerank,vacuolar acidification (GO:0007035),-0.48120796639155955,-1.4507660219568843,0.07048458149779736,0.5644447756279234,1.0,15/21,34.10%,ATP6V0A1;DMXL2;ATP6V0D1;ATP6V0A4;GRN;ATP6V1H;PPT1;ATP6AP2;TMEM9;CLN5;TMEM199;CLN3;ATP6V0D2;ATP6V0E1;CLN6
prerank,long-term synaptic potentiation (GO:0060291),-0.48334579850770265,-1.450410980113531,0.07555555555555556,0.5618762813293947,1.0,7/21,11.27%,SLC8A3;GRIN2A;GRIN2B;STX4;SLC24A2;TSHZ3;NFATC4
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.6361452057194815,1.450191035066558,0.06601731601731602,0.7320139168069562,1.0,23/59,16.13%,CCNB1;CDK1;MED26;PPM1D;CBFB;SETX;MOV10;MED14;TCF7L2;MED30;TRIM28;MED24;BCLAF1;MED15;SOX9;TWIST1;MED1;CDK8;MED27;NFKB1;TNRC6C;TP53;PTEN
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.6650048785900335,1.4499325703288013,0.10882708585247884,0.7308384914205154,1.0,8/27,14.82%,RRM2;TYMS;RRM1;CTPS1;GUK1;DTYMK;DUT;AK7
prerank,DNA methylation or demethylation (GO:0044728),0.6977193149951567,1.4494402556014452,0.12220762155059132,0.728239139174052,1.0,5/19,8.10%,ATRX;HELLS;PPM1D;GATAD2A;ATF7IP
prerank,DNA alkylation (GO:0006305),0.6977193149951567,1.4494402556014452,0.12220762155059132,0.728239139174052,1.0,5/19,8.10%,ATRX;HELLS;PPM1D;GATAD2A;ATF7IP
prerank,tryptophan catabolic process (GO:0006569),0.7419558428565779,1.4490389553577967,0.12443778110944528,0.7274865498319553,1.0,3/11,13.32%,ACMSD;KMO;IL4I1
prerank,nucleotide biosynthetic process (GO:0009165),0.6844067725276779,1.4483471698077703,0.12413793103448276,0.7279276681911053,1.0,6/18,11.46%,RRM2;RRM1;HPRT1;PRPS1L1;PRPS1;ADSL
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.7055379491400384,1.44805400051018,0.12280701754385964,0.7268611926633911,1.0,5/17,6.87%,DHDDS;ALG14;ALG13;SRD5A3;MPDU1
prerank,exit from mitosis (GO:0010458),0.7235744272824527,1.4478315266184225,0.1291248206599713,0.7255567434143569,1.0,2/12,2.01%,UBE2C;UBE2S
prerank,regulation of neuron migration (GO:2001222),0.6757956804215555,1.4477309788968415,0.1060419235511714,0.7238318958745338,1.0,6/26,10.64%,KIF20B;ULK4;NIPBL;PHACTR1;SRGAP2;PLXNB2
prerank,regulation of protein acetylation (GO:1901983),0.7248138223803802,1.4475582631347308,0.11159420289855072,0.7223773036895399,1.0,3/12,4.19%,CEP295;GSK3B;FAM161A
prerank,nuclear pore complex assembly (GO:0051292),0.771285822036212,1.4466791531454406,0.13505311077389984,0.7236513086342657,1.0,4/10,6.62%,NDC1;NUP205;AHCTF1;TPR
prerank,tRNA methylation (GO:0030488),-0.42039111194459966,-1.4458400819872679,0.0472972972972973,0.5733593633628501,1.0,21/34,36.22%,MTO1;NSUN2;THUMPD3;TRMT61B;DALRD3;TRMT1;METTL1;TRMT10A;LCMT2;TRMO;GTPBP3;WDR6;TRMT44;TRMT1L;TRMT10C;METTL6;TYW3;TRMT12;TRMT112;BCDIN3D;HSD17B10
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6542825213988418,1.4457642724354098,0.10801393728222997,0.7249544023740668,1.0,6/31,6.93%,PLK1;CDC20;UBE2C;UBE2S;FBXW7;UBE2N
prerank,peroxisome organization (GO:0007031),-0.44986855374064877,-1.4453314990086508,0.05128205128205128,0.5712833059101106,1.0,8/25,13.91%,PLAAT3;PEX1;FIS1;ABCD4;PEX3;LONP2;PEX6;ABCD2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.616623390576308,1.4448574657704873,0.06434599156118144,0.7262960558385777,1.0,18/73,9.90%,PHF19;EZH2;PPM1D;BAZ1B;DEK;SUZ12;CTCF;POLR1A;MPHOSPH8;EED;MYO1C;POLR1B;RBBP4;RBBP7;PHF1;PHF2;TAF1D;EPC1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.6532064649976043,1.444829017873562,0.11017964071856287,0.724279065579685,1.0,5/30,8.96%,BRCA1;FADD;GSK3B;SERPINE1;TNFRSF10B
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.6194691381788283,1.4447333159055429,0.08342602892102335,0.7225325120809036,1.0,6/51,5.09%,NEK2;PIF1;AURKB;TERF1;STN1;HNRNPA1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.37428164186818746,-1.4446323366569351,0.045454545454545456,0.5697492671511439,1.0,16/51,21.84%,PTK2;VEGFC;ANO6;GAS6;LGMN;MAPK3;MAPK1;THBS1;VEGFA;PLA2G7;CMKLR1;LGALS9;VEGFB;VEGFD;CREB3;IL34
prerank,modulation by symbiont of host process (GO:0044003),-0.603370769692584,-1.4436830847956241,0.09418282548476455,0.5690303294561271,1.0,8/10,32.09%,B2M;PGK1;ENO1;UBB;UBC;RPS27A;MRC1;UBA52
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.6068342784201692,1.4433667172963838,0.002,0.7254556170357171,1.0,58/306,8.63%,BRCA1;EXO1;TICRR;CDK1;MRPL36;BRIP1;POLE;CLSPN;PIF1;BARD1;RMI2;DBF4;MCM5;POLA1;ORC1;E2F1;PCLAF;TYMS;TIPIN;POLA2;MCM8;CDC45;RFC4;NAP1L1;TIMELESS;FAM111A;MCM10;MCM6;MCM7;MCM2;PABPC4;TOPBP1;RBBP8;CDC6;AGO2;RPA1;LARGE1;DNA2;POLD3;RAD1;RFC2;SRBD1;BLM;MRE11;MRPL18;MCM3;POLD1;RPA2;MCM4;ORC2;RFC3;CHEK1;POLR2A;RNASEH2A;ORC3;CDK2;DARS1;ING4
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.4952176486552952,-1.4429603048084227,0.0735930735930736,0.5679486332304459,1.0,9/18,18.35%,EPHA5;RPS6KA5;CRTC1;RELN;CRTC3;ADCY8;LRP8;VEGFA;CRTC2
prerank,telomere organization (GO:0032200),0.6439709570535945,1.4428564239273969,0.09933035714285714,0.7251963446317299,1.0,22/43,19.32%,TERF1;RTEL1;RPA1;STN1;DNA2;POLD3;ERCC4;PRKDC;BLM;MRE11;POLD1;RPA2;RIF1;PCNA;TERF2;TINF2;ATR;ACD;TERF2IP;SP100;RAD50;TERT
prerank,potassium ion import across plasma membrane (GO:1990573),-0.38641836381526,-1.4426807746507355,0.05357142857142857,0.5653010844976751,1.0,12/41,20.83%,ATP1B1;KCNJ3;KCNJ6;ATP1A1;ATP1B3;ATP1A3;KCNJ10;SLC12A9;ATP1A2;SLC12A2;KCNK9;KCNJ12
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.49100051656546073,-1.441652249847285,0.07058823529411765,0.564658434952112,1.0,10/18,18.07%,SHANK3;CACNG7;NRXN1;TSHZ3;CACNG4;RELN;CACNG2;CACNG3;CACNG8;NLGN1
prerank,response to nutrient levels (GO:0031667),-0.5023347171516948,-1.441016484830561,0.08,0.5631834393252452,1.0,5/17,10.84%,KCNB1;EIF4G1;PRKAA1;ULK1;MTOR
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.5790278198226525,-1.4408914351772275,0.07692307692307693,0.5600128941396016,1.0,6/11,16.21%,CALM1;NOS3;QDPR;GCH1;PRKG2;PTS
prerank,epiboly involved in wound healing (GO:0090505),0.6905790330241693,1.4406773035498606,0.13179347826086957,0.731222378419619,1.0,9/16,15.57%,RHOA;PDPN;CCN1;TMEFF2;ARHGAP35;MRTFA;CD44;LCP1;RHOC
prerank,receptor-mediated endocytosis (GO:0006898),-0.31079526694161,-1.4392029598101366,0.0,0.5613272292872931,1.0,45/132,19.52%,DNM3;SGIP1;CALCRL;LRP1B;MICALL1;CAV1;APOE;FNBP1L;TMEM108;INSR;HSP90B1;AP2A2;ACKR3;LRP1;RAMP1;RAMP2;DAB2;GPR107;DNM1;HSPH1;CD81;CAV2;VLDLR;AP2M1;SCARF1;ARHGAP27;PDLIM7;GRB2;LDLRAP1;IGF2R;AP2S1;CTSL;FCHO2;AP2A1;AP1S1;CLTB;LRP6;CUBN;LMBRD1;STAB1;SORL1;PPT1;GRK4;LRP3;FCHSD2
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.4268124232276299,-1.4390846238404116,0.049689440993788817,0.5581326086718733,1.0,16/29,30.81%,MCTP1;APOE;EPHB2;SHISA6;NETO1;RAB5A;APP;NSMF;DLG4;GRIK2;DRD2;SHISA9;SHISA7;CAMK2B;RAB3GAP1;CLN3
prerank,acidic amino acid transport (GO:0015800),-0.504349737483738,-1.4380845073545951,0.09157509157509157,0.55758760128248,1.0,8/17,15.47%,SLC6A6;SLC1A2;SLC6A1;SLC25A13;SLC25A12;GIPC1;LRRC8D;SLC1A1
prerank,regulation of myelination (GO:0031641),0.6713311055347881,1.4378110328689901,0.12192118226600986,0.7399474554413832,1.0,1/25,0.13%,KIF14
prerank,regulation of neurotransmitter transport (GO:0051588),-0.49823961506560777,-1.4367039896433182,0.08090614886731391,0.5584316896662455,1.0,3/16,0.99%,MCTP1;RIMS1;MEF2C
prerank,negative regulation of calcium ion transport (GO:0051926),-0.5206277084577242,-1.4356943423861022,0.07903780068728522,0.5581152200950256,1.0,12/15,44.12%,INPP5K;ATP1A2;TRIM27;SLC30A1;ADRA2A;PACSIN3;NOS1;PLN;CBARP;STC1;EPO;LILRB1
prerank,protein K11-linked ubiquitination (GO:0070979),0.6565846901650964,1.435149560659715,0.11585365853658537,0.7476573555670312,1.0,5/27,3.61%,UBE2T;UBE2C;UBE2S;ANAPC7;CDC27
prerank,regulation of multicellular organism growth (GO:0040014),-0.5150173898013727,-1.4344602793883747,0.07777777777777778,0.5585752227556471,1.0,5/15,16.43%,MBD5;IGF1;APP;PTCH1;PPIB
prerank,signal peptide processing (GO:0006465),-0.5595353470015787,-1.4327278616775496,0.10543130990415335,0.5602602057015198,1.0,7/11,26.42%,PCSK5;FURIN;SPCS2;PARL;CLN5;SPCS1;SEC11A
prerank,histone lysine methylation (GO:0034968),0.641772898634325,1.4323877889136514,0.12114014251781473,0.7560239838798145,1.0,5/33,5.85%,EZH2;SETD6;PAXIP1;SETDB2;SETD3
prerank,purine-containing compound salvage (GO:0043101),0.7247207905541098,1.4314422329261942,0.12850812407680945,0.7577327879165557,1.0,4/12,5.28%,ADK;ADA;DCK;HPRT1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5009452532171703,-1.4301150717834643,0.0756578947368421,0.5653640136160455,1.0,6/15,15.29%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2;SLC12A2
prerank,cardiac muscle cell contraction (GO:0086003),-0.473877416126418,-1.4298371441391862,0.07929515418502203,0.5628103809260463,1.0,7/19,17.97%,CAMK2D;CACNA2D1;SCN1A;ATP1A1;GSN;SCN1B;PIK3CA
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.48327818999493066,-1.429774501124317,0.07630522088353414,0.5596781587155161,1.0,11/18,18.78%,RIMS1;SHANK3;NRXN1;RELN;CHRNA7;SHANK1;DLG4;GRIN1;PRKCZ;NLGN1;STX1B
prerank,nuclear transport (GO:0051169),0.7109761922897363,1.4287146481336586,0.1103448275862069,0.7657702580607483,1.0,7/16,17.11%,XPO1;NUP205;PSIP1;RBM15B;NXT1;NUP98;NXT2
prerank,nuclear export (GO:0051168),0.5980628354865266,1.4285928136826813,0.07039337474120083,0.7639764009705812,1.0,22/80,13.03%,ANKLE1;CCHCR1;RANBP17;NUP155;XPO1;XPO4;SRSF4;PHAX;HNRNPA1;EIF4E;UPF3B;CSE1L;WASHC4;TPR;DDX39B;SRSF7;SMURF1;SRSF3;SRRM1;ATXN1;NUP214;STRADA
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5572009999828186,-1.4276452125663468,0.09393939393939393,0.5624967943832784,1.0,6/11,21.70%,CAMK2D;CACNA2D1;BIN1;CACNB2;CACNB1;NOS1
prerank,tRNA wobble uridine modification (GO:0002098),-0.5102621602653444,-1.427581556651787,0.09818181818181818,0.559311881060437,1.0,7/14,25.65%,ELP3;TRMT9B;MTO1;TRMU;DPH3;ELP4;GTPBP3
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.38261756855482365,-1.4275203977698099,0.050724637681159424,0.5561443695549179,1.0,18/39,21.43%,PIP4K2A;PIK3R3;PIP4K2B;SOCS2;PIK3C2B;PIK3R1;EFR3A;SOCS5;ITPKB;SMG1;PI4KA;PIK3CD;PIK3CA;TMEM150A;EFR3B;ITPKC;PIP4K2C;PIK3R2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.44743750296860474,-1.4275134476786866,0.06557377049180328,0.5529031872591676,1.0,10/25,24.73%,HSP90AB1;INSR;TLR4;KLF4;KLF2;PTGS2;DDAH2;P2RX4;ASS1;EDN1
prerank,fluid transport (GO:0042044),0.7167009943710099,1.4269562604038677,0.12645348837209303,0.7678703523095645,1.0,2/12,5.71%,AQP1;PDPN
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.335550871389858,-1.4262327769513024,0.043478260869565216,0.5535499284259554,1.0,33/69,24.81%,COX4I1;COX6C;COX5A;COX7B;NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;COX7C;NDUFS3;UQCRC2;NDUFB3;NDUFS4;UQCRB;NDUFA5;NDUFA6;NDUFA4;NDUFB9;UQCR10;UQCRQ;COX8A;NDUFA11;NDUFAF1;NDUFB6;NDUFB11;NDUFB10;NDUFA10;COX5B;NDUFS6;UQCRC1;NDUFA1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.47096175600896406,-1.4261726312124856,0.060240963855421686,0.5505509062531339,1.0,8/19,22.37%,MAOB;NOX1;PRDX2;PRDX1;PRDX3;GPX1;PARK7;PRDX5
prerank,catecholamine biosynthetic process (GO:0042423),-0.577650217484484,-1.4255506588594085,0.06472491909385113,0.5491721823797635,1.0,4/11,18.89%,TGFB2;MOXD1;GCH1;DDC
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.7418295658330286,1.4252469987120056,0.13304093567251463,0.7721100623855691,1.0,5/10,15.47%,CBFB;ZBTB7B;SH3RF1;HMGB1;RUNX1
prerank,cellular response to alcohol (GO:0097306),0.6329444027236795,1.425084257575172,0.1016949152542373,0.770614825827218,1.0,12/42,15.25%,BRCA1;RAD51;GRAMD1C;BLM;CTNNA1;SPIDR;LARP1;AHR;KLF9;GLRA2;ADCY6;SFRP1
prerank,renal system development (GO:0072001),0.6258652828072238,1.4248443263863741,0.09080841638981174,0.7693073417994484,1.0,9/52,11.24%,CENPF;GLI2;SULF2;SULF1;NPHP3;AGT;C1GALT1;TGFBR1;TBX18
prerank,telomere maintenance via recombination (GO:0000722),0.7451441868016953,1.4247667890190578,0.1426448736998514,0.767447405534334,1.0,4/11,4.60%,RAD51;SMC6;SMC5;ERCC4
prerank,clathrin-dependent endocytosis (GO:0072583),-0.42494876769207623,-1.4236224479349082,0.04522613065326633,0.5517801523608332,1.0,12/26,19.52%,SGIP1;ITSN2;FNBP1L;AP2A2;GPR107;AP2M1;AP2S1;FCHO2;AP2A1;CLTB;LMBRD1;FCHSD2
prerank,spermatid development (GO:0007286),0.6420722104570813,1.423517759035358,0.12956419316843346,0.7700033454138892,1.0,4/32,7.36%,MEIOC;CEP57;MKKS;RFX2
prerank,skeletal system morphogenesis (GO:0048705),0.6288748642045731,1.423409438823085,0.12265193370165746,0.7682650117196703,1.0,11/42,10.37%,RAB33B;CYP26B1;WWOX;FGFR2;HOXC4;PDGFRA;RFLNA;ANKRD11;HOXB3;DSCAML1;TGFBR1
prerank,neural tube development (GO:0021915),0.7134251915025333,1.4232272347969765,0.14344827586206896,0.766789706179984,1.0,3/15,6.70%,STIL;ALDH1A2;GRHL2
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.4951040390807114,-1.4231853528604503,0.09090909090909091,0.5499105185098848,1.0,9/15,22.15%,TMSB4X;FGF2;LGMN;FGF1;MET;THBS1;SMOC2;HSPB1;P2RX4
prerank,epithelial cell differentiation (GO:0030855),0.6006018886058625,1.4225202695164223,0.054865424430641824,0.7674013499220634,1.0,12/88,11.52%,E2F7;E2F8;CDK1;SCUBE1;FGFR2;RAB10;GRHL2;SCRIB;FN3K;HDAC1;ANXA1;PCNA
prerank,regulation of AMPA receptor activity (GO:2000311),-0.44231643803505616,-1.4219456660864074,0.06532663316582915,0.5501759814511591,1.0,13/25,18.07%,MEF2C;SHANK3;SHISA6;CACNG7;MINK1;CACNG4;RELN;SHANK1;CACNG2;PRRT1;CACNG3;CACNG8;NLGN1
prerank,positive regulation of tissue remodeling (GO:0034105),0.741296465467435,1.421242541966249,0.12859304084720122,0.7699085587959973,1.0,3/10,9.38%,ROCK2;IL18;ROCK1
prerank,odontogenesis (GO:0042476),0.6471440411494624,1.42115203250084,0.11124121779859485,0.768123395719719,1.0,12/35,12.79%,GLI2;AQP1;FGFR2;LAMB1;BCOR;ANKRD11;AXIN2;WNT6;EDA;HDAC1;BMP2;HDAC2
prerank,positive regulation of dephosphorylation (GO:0035306),0.6597500410350877,1.4206311846915665,0.1395631067961165,0.7681454295045981,1.0,11/27,16.15%,CDCA2;PPP1R7;MTMR9;CALM2;BMP2;SMPD1;CAMTA1;PTPA;PIN1;SRC;ANKLE2
prerank,negative regulation of secretion (GO:0051048),-0.5615825466461013,-1.4198711940420217,0.0935483870967742,0.553935167822717,1.0,7/10,28.49%,NR1H3;VAMP8;VAMP3;PTGER3;CD74;EGF;ERBB3
prerank,tryptophan metabolic process (GO:0006568),0.7356058556259916,1.4198265351554766,0.1398176291793313,0.7689806531823399,1.0,3/11,13.32%,ACMSD;KMO;IL4I1
prerank,spinal cord development (GO:0021510),0.7232656737130456,1.419550409799462,0.1463768115942029,0.7678968721438696,1.0,2/12,1.20%,GLI2;LOXL3
prerank,negative regulation of transposition (GO:0010529),0.6944678200723415,1.4194883503530848,0.14919354838709678,0.7660259349120642,1.0,4/16,13.59%,MYBL1;MOV10;TUT7;TUT4
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.48938229497972696,-1.418613320738217,0.0898876404494382,0.5548588951892847,1.0,8/17,27.90%,SLC7A5;PRKCQ;CEBPB;PRKCZ;LGALS9;CD86;SYK;FCER1G
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.3388937439645062,-1.417686850939315,0.022222222222222223,0.5543451814450021,1.0,32/69,24.83%,UBE4A;HSP90B1;OS9;TRIM25;ECPAS;RNF103;EDEM2;EDEM1;UFD1;DERL1;SELENOS;HSPA5;UBXN4;SGTA;RHBDD2;STUB1;YOD1;SGTB;DNAJC18;DNAJB9;ERLIN2;SEC61B;AUP1;DNAJB12;UBE2G2;SYVN1;UBXN8;SEL1L;UBE4B;WFS1;FAM8A1;RNF103-CHMP3
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.6246403926882849,1.4159405569592585,0.10409745293466224,0.7769571336834266,1.0,7/47,6.71%,BRCA1;ACMSD;ATP2B4;ROCK2;GCK;ERFE;FBXW7
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.43649107530173864,-1.4150256419197231,0.06111111111111111,0.5591710504373664,1.0,11/26,26.91%,HSP90AB1;INSR;TLR4;KLF4;KLF2;PTGS2;DDAH2;P2RX4;ASS1;EDN1;TMEM106A
prerank,protein sumoylation (GO:0016925),0.6090557170662276,1.4138522324788672,0.11328976034858387,0.78266504066487,1.0,30/49,25.66%,NDC1;NUP155;SAE1;NUP205;NUP160;NUP85;TPR;TRIM28;RANGAP1;NSMCE2;NUP214;SUMO2;TRPM4;RANBP2;NUP133;NUP42;NUP98;NUP210;EGR2;NUP188;NUP35;NUP43;PIAS1;UBA2;NUP93;UBE2I;NUP107;STX1A;SEH1L;EYA1
prerank,response to muscle stretch (GO:0035994),-0.5105525317165467,-1.4136732761682158,0.10507246376811594,0.5603062880181988,1.0,5/15,11.91%,PTK2;CDH2;RYR2;CTNNB1;GSN
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4274278631467346,-1.4131943324970313,0.06481481481481481,0.5586972189764664,1.0,12/27,26.46%,CAMK2D;AHNAK;CALM1;FKBP1A;SELENON;CACNB2;ADRA2A;CACNB1;PDE4D;NOS1;JPH2;JPH4
prerank,regulation of establishment of cell polarity (GO:2000114),0.6882105961157956,1.4131862759312541,0.14864864864864866,0.7829253139293605,1.0,2/16,3.07%,KIF20B;ROCK2
prerank,in utero embryonic development (GO:0001701),0.658269658533845,1.4125758871739964,0.13927227101631118,0.783018788449225,1.0,6/25,11.48%,STIL;FGFR2;ZNF568;LMX1B;TGFBR1;BMP2
prerank,cellular response to UV (GO:0034644),0.6002925379574453,1.4125075134739349,0.080797481636936,0.7811613257963801,1.0,26/76,17.05%,POLK;AURKB;AQP1;HYAL1;BMF;NEDD4;ERCC4;POLD1;FMR1;CHEK1;CUL4B;CDC25A;USP28;XPA;PCNA;PPID;USP47;YY1;SMPD1;RUVBL2;STK11;INO80;TP53;METTL3;ATR;PTPRK
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.622392572212149,1.4123723422957999,0.1336405529953917,0.7795917092394173,1.0,6/33,6.50%,EZH2;FAM83D;HYAL1;TFDP1;DDRGK1;LSM11
prerank,peptidyl-lysine monomethylation (GO:0018026),0.73474635427325,1.412066087414429,0.14069591527987896,0.778722236526267,1.0,5/10,7.46%,KMT5A;SETD6;SETD3;EEF1AKMT2;SETD2
prerank,regulation of protein neddylation (GO:2000434),-0.5730400291113076,-1.4119198618876878,0.11235955056179775,0.5592417836132209,1.0,7/10,29.92%,DCUN1D3;DCUN1D5;DCUN1D4;DCUN1D2;HIF1A;RPL11;COPS9
prerank,actin polymerization or depolymerization (GO:0008154),0.6136207027058834,1.4111430970545644,0.10831509846827134,0.7799934545845087,1.0,10/50,14.56%,DIAPH3;DIAPH1;MICAL3;ABI1;ARHGAP6;TWF1;RAC1;SVIL;DSTN;CAPG
prerank,positive regulation of histone acetylation (GO:0035066),0.6653626835337442,1.4103227720906268,0.13892365456821026,0.7809447504845454,1.0,3/23,6.67%,BRCA1;PAXIP1;ARRB1
prerank,histone H2A monoubiquitination (GO:0035518),0.6759873010143251,1.410028124993788,0.13474240422721268,0.7800038245169485,1.0,6/17,9.26%,RNF168;TRIM37;BCOR;PCGF5;KDM2B;CUL4B
prerank,response to organonitrogen compound (GO:0010243),-0.39209519522585884,-1.4097557738003448,0.10144927536231885,0.5627155096350278,1.0,14/38,23.03%,PRKN;GLRB;ERLEC1;GLRA1;GLRA3;DERL1;MTOR;RCN3;RRAGC;UBXN6;DNAJB12;SYVN1;DRD2;SEL1L
prerank,telomere maintenance via telomerase (GO:0007004),0.6474218826468353,1.4073227925241971,0.13664596273291926,0.7881848364457451,1.0,14/28,19.32%,PIF1;TERF1;RTEL1;RPA1;MRE11;RFC1;CDK2;TERF2;ANKRD28;TINF2;ACD;TERF2IP;RAD50;TERT
prerank,positive regulation of rRNA processing (GO:2000234),-0.59080187394118,-1.4070407708291448,0.1027190332326284,0.5673101006181672,1.0,9/10,38.77%,HEATR1;WDR75;BUD23;RIOK2;DIMT1;RIOK1;TRMT112;SIRT7;WDR43
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.401764314343454,-1.4069219286506107,0.059602649006622516,0.5645918772348888,1.0,9/34,6.81%,PTK2;FLT1;TEK;PIK3R3;PDGFRB;PIK3R1;FGF2;PIK3R4;PIK3IP1
prerank,vasoconstriction (GO:0042310),0.7354185061901725,1.4063924301185162,0.15574963609898107,0.7896802184342441,1.0,1/11,0.70%,KEL
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.4018806943416241,-1.405459758268513,0.05263157894736842,0.5661017769341987,1.0,15/33,22.24%,NRG3;GRIK1;IQSEC2;GRID2;GRIK4;BCR;CACNA1B;RELN;PSMC5;LRP8;SLC4A8;NLGN1;GRID1;GRIK2;BDNF
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.5629205685224798,-1.4048110160144738,0.10526315789473684,0.5651151189001068,1.0,3/11,7.70%,ATP1B1;KCNJ3;ATP1A1
prerank,axonogenesis (GO:0007409),-0.2673160934389033,-1.4046467021012596,0.0,0.5626149374614423,1.0,88/237,19.29%,PTK2;ENAH;SH3KBP1;EPHA5;TNR;UNC5D;NRP2;NRXN3;RPS6KA5;HSP90AB1;SHANK3;SPG11;DCC;OPHN1;SEMA6A;PAK3;BSG;GRB10;ACTB;B4GALT5;CNTN6;FEZ1;S100A6;KLF7;NRCAM;LGI1;SEMA6D;MAP1B;TAOK2;SEMA7A;BRSK1;EPHB2;PIK3R1;IRS2;PLCG1;B4GALT6;ULK1;NRXN1;SEMA4D;MAP1A;PRKCQ;KIF5B;PTPRO;SEMA3A;LAMA3;DAB1;RELN;SPTBN1;CTNNA2;MAPK3;NOTCH3;KIF5C;SIAH1;GFRA1;FEZ2;VLDLR;APP;GFRA2;SLIT2;MAPK1;UNC5C;PDLIM7;GRB2;SLITRK1;NTNG1;PTPN11;EPHA8;CNTN2;DOK5;SEMA3B;SHC1;SCN1B;UNC5B;SEMA3C;USP33;SHTN1;APBB1;PIK3CD;PIK3CA;ROBO2;NEXN;TUBB3;SLITRK4;ROBO4;SHC3;SEMA5B;EFNB3;CYFIP1
prerank,oogenesis (GO:0048477),0.6900711651512766,1.4041755363792392,0.14446002805049088,0.7959728031269127,1.0,5/15,19.65%,TRIP13;KMT2D;METTL3;MARF1;FMN2
prerank,histone modification (GO:0016570),0.5870814500355109,1.4024862067837551,0.046700507614213196,0.8003454058200744,1.0,21/109,11.17%,UHRF1;EZH2;INCENP;AURKB;SGF29;BAZ1B;EYA4;MIER1;CCNA2;TBL1XR1;UBE2N;MIDEAS;CDK2;RCOR1;MSL3;USP21;USP16;MIER3;MTA3;EYA2;HDAC1
prerank,somite development (GO:0061053),0.7163063791643824,1.4023539857182776,0.17585692995529062,0.7987430132130068,1.0,4/11,10.09%,LOXL3;PPP2R3A;SFRP2;MEOX2
prerank,tRNA transport (GO:0051031),0.625138161694038,1.402142273181236,0.13418903150525088,0.7973654929818681,1.0,23/35,26.65%,NDC1;NUP155;NUP205;NUP160;NUP85;TPR;NOL6;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;NUP188;NUP35;NUP43;TOMM20;NUP93;NUP107;SSB;SEH1L;NUP153;NUP37
prerank,regulation of telomerase activity (GO:0051972),0.6129552630882079,1.4019928568357498,0.11297539149888143,0.7957921628178692,1.0,6/45,6.70%,NEK2;PIF1;AURKB;TERF1;ERCC4;GRHL2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.41926644760738124,-1.4013605193482388,0.06787330316742081,0.5698142361525422,1.0,12/24,26.46%,CAMK2D;CALM1;FKBP1A;AKAP6;SELENON;SRI;PDE4D;CALM3;NOS1;GSTM2;JPH2;JPH4
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.7008661034054854,1.4011490134770124,0.14469914040114612,0.7968417200938572,1.0,5/13,15.84%,KPNA2;KPNA3;RANBP2;KPNA4;IPO5
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.6349139282209877,1.4010631487888379,0.13713592233009708,0.7930622169123162,1.0,15/32,19.95%,NDC1;NUP155;NUP205;NUP160;NUP85;TPR;NOL6;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;NUP188;NUP35
prerank,tRNA export from nucleus (GO:0006409),0.6349139282209877,1.4010631487888379,0.13713592233009708,0.7930622169123162,1.0,15/32,19.95%,NDC1;NUP155;NUP205;NUP160;NUP85;TPR;NOL6;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;NUP188;NUP35
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.5759868551556898,-1.4004048240029685,0.0967741935483871,0.5700444055641277,1.0,8/10,37.10%,OGT;SELENOS;ZNF692;DGKQ;PDK2;USP7;SIRT7;SDHAF3
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.7483851446962125,1.3996109759276973,0.1567732115677321,0.7962820371658986,1.0,7/10,18.22%,RTEL1;RIF1;TERF2;ACD;TERF2IP;DCLRE1C;DCLRE1A
prerank,nucleoside salvage (GO:0043174),0.7290185595819667,1.3994545787458088,0.17027863777089783,0.7948702724883631,1.0,4/10,9.30%,TK1;DCK;HPRT1;CDA
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.345835324080931,-1.3990065901376223,0.0625,0.5714151505504234,1.0,27/64,31.91%,PLA2G4A;SCP2;ACSL4;PNPLA8;GPX4;ACSL5;ACSL6;PTGS2;ASAH2;EPHX2;GPX1;ELOVL6;ACAD9;ACSL1;HPGD;SLC27A4;ELOVL1;AIG1;GSTM2;FADS1;HACL1;ACSBG1;ALOX12;PNPLA3;PLA2G4C;CPT1A;FAAH
prerank,positive regulation of chemotaxis (GO:0050921),-0.3750515563852799,-1.398792406517529,0.046296296296296294,0.5690318590156692,1.0,16/43,22.15%,TMSB4X;STX4;PDGFRB;STX3;NTRK3;FGF2;LGMN;MET;MEGF8;THBS1;PPM1F;VEGFA;SMOC2;NRP1;HSPB1;P2RX4
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.6153076089723282,1.3987750572296564,0.13567251461988303,0.7955260238704271,1.0,4/35,5.09%,NEK2;AURKB;RTEL1;HNRNPA1
prerank,ncRNA export from nucleus (GO:0097064),0.622316559285517,1.3985727439882465,0.12811387900355872,0.7942103647936712,1.0,16/36,19.95%,NDC1;NUP155;NUP205;NUP160;PHAX;NUP85;TPR;NOL6;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;NUP188;NUP35
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.4268936703493659,-1.3969270488509484,0.09090909090909091,0.5720728019958251,1.0,7/25,14.42%,PRKN;TMTC2;TRPM7;CAV1;FAM20A;SELENON;GRIN1
prerank,bicarbonate transport (GO:0015701),0.650351369175941,1.3963555683584143,0.16856780735107732,0.800436259958092,1.0,7/25,15.05%,RHAG;AQP1;SLC4A2;CYB5RL;SLC39A8;CA2;CYB5R1
prerank,negative regulation of cytokine production (GO:0001818),-0.28919616394665154,-1.3962363042422425,0.0,0.5711612786245536,1.0,47/163,19.54%,APOD;LEF1;RPS6KA5;TMSB4X;TRIB2;MAP2K5;GAS6;RNF135;TLR4;PIBF1;KLF4;TRIM25;PDCD4;CD34;IKBKE;TNFRSF21;CYLD;UFD1;PTPN22;SELENOS;SRGN;SARS1;CHID1;IRF3;THBS1;SYT11;RGCC;CX3CL1;RNF125;HDAC7;HDAC9;TRIM27;ABCD2;TBK1;C1QTNF3;IFIH1;PPP1R11;DDIT3;SSC5D;CMKLR1;LGALS9;NLRC5;UBA7;SLC2A10;NCKAP1L;ZC3H12A;INHBA
prerank,fatty acid biosynthetic process (GO:0006633),-0.35350418502655645,-1.3954930689403895,0.03571428571428571,0.5703990124108762,1.0,27/63,31.24%,ELOVL7;HACD3;ACLY;HACD2;GPX4;LIAS;HACD1;ABHD2;PTGS2;ASAH2;DEGS1;EPHX2;XBP1;ELOVL6;ACOT7;DECR2;CBR4;HPGD;SCD;ELOVL1;FADS1;TECR;ACSBG1;ALOX12;HSD17B8;OXSM;TECRL
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.6401084621749759,1.3952682220467714,0.1344019728729963,0.8022333194816335,1.0,14/29,19.32%,PIF1;TERF1;RTEL1;RPA1;MRE11;RFC1;CDK2;TERF2;ANKRD28;TINF2;ACD;TERF2IP;RAD50;TERT
prerank,nucleotide-excision repair (GO:0006289),0.5870705027816098,1.3949238079282953,0.04693877551020408,0.801478897170078,1.0,18/101,7.55%,POLK;BRIP1;POLE;POLA1;BRCA2;RFC4;RPA1;CHD1L;POLD3;ERCC4;RFC2;POLD1;RPA2;RFC1;ERCC3;RFC3;PRPF19;POLR2A
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.519172187877211,-1.394598746060556,0.11705685618729098,0.570192763949747,1.0,9/13,17.33%,INSR;IGF1;AKT2;IRS2;IGF2;EPM2AIP1;IRS1;DYRK2;SORBS1
prerank,transition metal ion homeostasis (GO:0055076),-0.41934120420610443,-1.3945154451351938,0.05263157894736842,0.567668016910223,1.0,9/28,18.43%,PRKN;FBXL5;FTL;HMOX2;NEO1;B2M;IREB2;CUTC;COMMD1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.5844089681448642,-1.394121304798793,0.09734513274336283,0.5659267972721144,1.0,6/10,32.40%,NR1H3;ABCD2;NR1H2;SLC45A3;MID1IP1;MLXIPL
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.6409624406854522,1.3938683597445396,0.1625487646293888,0.8033502883163922,1.0,1/20,0.19%,BRCA1
prerank,nuclear membrane organization (GO:0071763),0.6563261212153336,1.3937925199824277,0.16753926701570682,0.801598030421381,1.0,2/19,1.14%,PLK1;NEMP1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.37742118189599877,-1.3936395199032465,0.03968253968253968,0.56452873718462,1.0,21/38,24.81%,NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFA4;NDUFB9;NDUFA11;NDUFAF1;NDUFB6;NDUFB11;NDUFB10;NDUFA10;NDUFS6;NDUFA1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.4711622495770364,-1.3935100435231143,0.07264957264957266,0.5621722079808827,1.0,6/18,19.38%,TLR4;HSPD1;LBP;THBS1;NECTIN2;KARS1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.6179358874655039,1.3925235635698483,0.125,0.8042617540864859,1.0,15/46,16.95%,KIF14;RHOA;ATRNL1;PARVA;LAMB1;ITGB7;EFNA1;TMEFF2;SRGAP2;RAC1;ITGA8;ITGAV;NTN4;FERMT3;ANTXR1
prerank,embryonic axis specification (GO:0000578),0.6967730986775678,1.3921391030402652,0.16780354706684858,0.8036639926854047,1.0,1/15,0.42%,STIL
prerank,relaxation of muscle (GO:0090075),-0.5183190661071769,-1.391987884547247,0.09830508474576272,0.5639638990808107,1.0,8/13,25.05%,CAMK2D;ATP1B1;ATP1A1;GSN;ATP1A2;PIK3CA;P2RX4;GSTM2
prerank,covalent chromatin modification (GO:0016569),0.6954873725755741,1.3913792805754277,0.16643356643356644,0.8044657974307745,1.0,2/14,1.42%,AURKB;HELLS
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.5396540105138654,-1.391329158005113,0.09316770186335403,0.5629255483975502,1.0,6/12,29.99%,TLR4;GRIN1;RAB27A;ZNF205;SLC5A3;ADGRB1
prerank,mRNA methylation (GO:0080009),-0.49312040114748756,-1.3913128454076482,0.08679245283018867,0.5602165347218501,1.0,8/15,16.69%,METTL16;NSUN2;TRMT61B;METTL14;PCIF1;ZC3H13;CMTR1;CBLL1
prerank,histone H4 acetylation (GO:0043967),0.6107314800684871,1.3894215772984981,0.13215859030837004,0.809490508192147,1.0,21/47,19.07%,KANSL1;BRCA2;KANSL2;HAT1;ING4;MSL3;EP400;KMT2A;EPC1;ACTL6B;JADE1;RUVBL2;PER1;TRRAP;BRD8;PHF20;ZZZ3;KANSL3;NAA60;NAA40;JADE3
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5304035819991951,-1.3888975556397405,0.09731543624161074,0.5646008699427781,1.0,3/13,2.49%,PSEN1;TMSB4X;PER2
prerank,prostanoid metabolic process (GO:0006692),0.7024849506285659,1.388297632123852,0.15602836879432624,0.8116902705887734,1.0,4/13,7.55%,PTGR1;PTGR2;HPGDS;PTGS1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.6759739238376429,1.3881358849971173,0.16260162601626016,0.8102466393783512,1.0,5/18,9.48%,KIF20B;ROCK2;RIPOR2;ROCK1;LLGL2
prerank,cellular zinc ion homeostasis (GO:0006882),-0.4170748691126338,-1.3859817934650192,0.07142857142857142,0.5707153569027885,1.0,13/26,20.66%,SLC39A10;SLC39A13;SLC39A7;SLC30A1;MT2A;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,engulfment of apoptotic cell (GO:0043652),0.6548123041818164,1.3858990759093825,0.13773314203730272,0.8163780303891143,1.0,1/15,0.67%,XKR5
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5330297246582492,-1.3856002381997174,0.11326860841423948,0.5694325476284928,1.0,9/12,17.33%,INSR;IGF1;AKT2;IRS2;IGF2;EPM2AIP1;IRS1;DYRK2;SORBS1
prerank,transepithelial transport (GO:0070633),-0.5116809486145354,-1.3851157836308832,0.09505703422053231,0.5680054637538379,1.0,5/15,15.47%,SLC1A2;ABCG2;GPLD1;SLC12A2;SLC1A1
prerank,regulation of B cell proliferation (GO:0030888),0.6189913766036494,1.384252245646457,0.12276785714285714,0.8206359155379319,1.0,1/44,0.09%,TNFSF13B
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.4318338450189345,-1.3835454965047747,0.08292682926829269,0.5695533757681401,1.0,3/23,7.08%,PLA2G4A;PLAAT3;PNPLA8
prerank,regulation of coagulation (GO:0050818),-0.5540514389977413,-1.3825589631917974,0.11356466876971609,0.5699517366846021,1.0,2/11,5.38%,CAV1;EPHB2
prerank,neural tube closure (GO:0001843),0.624545235855827,1.3816324943996472,0.14976415094339623,0.8283800394379963,1.0,7/34,10.64%,STIL;MTHFD1L;MTHFR;GRHL2;SCRIB;KDM2B;PLXNB2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.6672946839393801,1.3814314102760366,0.1694915254237288,0.8270647455931284,1.0,3/20,6.67%,BRCA1;PAXIP1;ARRB1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5759508626924972,-1.3810925404252068,0.11676646706586827,0.5718251447779699,1.0,2/10,2.33%,KCNAB1;CAV1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.6322555200499229,1.3810117263823893,0.1536555142503098,0.8265443808716918,1.0,8/28,11.55%,CDK5RAP2;CKAP5;PSRC1;NUMA1;MAPT;DRG1;RAC1;AKAP9
prerank,fatty acid elongation (GO:0030497),-0.5125973258325958,-1.3807796070526281,0.10191082802547771,0.5700336086847794,1.0,7/13,26.99%,ELOVL7;HACD3;HACD2;HACD1;ELOVL6;ELOVL1;TECR
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.4966996422304827,-1.3804951603409854,0.11486486486486487,0.5681784034582328,1.0,5/14,13.19%,IGF1;GRN;TNFRSF1B;SYT11;CX3CL1
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.5121509993852834,-1.379936293358282,0.1059190031152648,0.566941398663402,1.0,5/13,18.84%,GOT2;DLST;ADHFE1;GOT1;GPT2
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.4164612504622806,-1.3799178191120367,0.06349206349206349,0.5643443330826216,1.0,8/30,21.04%,STAT3;TLR4;PIBF1;CD34;HSPD1;PRKCZ;LGALS9;CD274
prerank,sodium ion transport (GO:0006814),-0.32809649518995615,-1.3797171378875386,0.027777777777777776,0.5623269263643412,1.0,22/85,15.99%,SLC6A6;SLC8A3;ATP1B1;SLC6A1;HCN1;ANO6;SLC24A2;SGK1;SCN1A;FGF13;SCN9A;ATP1B3;NDUFA9;SLC5A6;SLC5A5;ATP1A2;SCN3A;SCN8A;SCN1B;SLC12A2;SLC4A8;SLC6A11
prerank,nuclear pore organization (GO:0006999),0.7008728826975335,1.3796867304063087,0.16852367688022285,0.8293474851196909,1.0,12/14,26.32%,NDC1;NUP205;AHCTF1;TPR;NUP133;NUP98;NUP35;NUP93;NUP107;SEH1L;RTN4;NUP153
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.6367682873806029,1.3795964212844787,0.15513126491646778,0.827619798298994,1.0,8/30,7.60%,CDKN2D;DDIAS;FBXO5;DYRK1A;RTEL1;SFRP2;DDX39B;YJU2
prerank,embryonic digestive tract development (GO:0048566),0.6644296820035283,1.3795409327931476,0.1628222523744912,0.8258034605830615,1.0,7/18,13.41%,GLI2;GLI3;FGFR2;PDGFRA;NIPBL;RBPMS2;RARB
prerank,histone methylation (GO:0016571),0.6384776201320925,1.379101376488392,0.15925925925925927,0.8255333351453615,1.0,2/26,2.26%,EZH2;SETD6
prerank,regulation of glucose metabolic process (GO:0010906),-0.39470533176483297,-1.3789256212677974,0.0379746835443038,0.5618608560824945,1.0,10/34,14.30%,PRKN;OGT;AKT2;IRS2;PDK1;GPLD1;SELENOS;IRS1;ZNF692;DGKQ
prerank,positive regulation of synapse assembly (GO:0051965),-0.41600169350336497,-1.3788715949966637,0.08854166666666667,0.5594329380978194,1.0,14/27,24.05%,PTPRD;SYNDIG1;GRID2;AGRN;EPHB2;IL1RAPL1;NRXN1;SEMA4D;LRRC4B;NLGN1;IL1RAP;BDNF;SRPX2;DLG5
prerank,tube closure (GO:0060606),0.6283945719099127,1.3783495250218825,0.1515513126491647,0.8262326074530574,1.0,6/31,10.64%,STIL;MTHFD1L;MTHFR;GRHL2;SCRIB;PLXNB2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.6052710500138888,1.3780476775421062,0.1265126512651265,0.8253041990273934,1.0,10/49,11.84%,KIF14;GSK3B;IAPP;PMEPA1;ANKRD27;SMAD6;RIOK3;HMGB1;PYDC1;AIDA
prerank,regulation of phospholipase C activity (GO:1900274),-0.4934990713885846,-1.3775456661927348,0.12152777777777778,0.5608553701504939,1.0,8/15,11.18%,FLT1;PDGFRB;BICD1;NTRK3;FGF2;PLCG1;ESR1;ABL1
prerank,regulation of glucose import (GO:0046324),-0.38899322460326496,-1.3771263187506602,0.08695652173913043,0.5595217353880957,1.0,14/30,17.33%,OCLN;GRB10;INSR;IGF1;CREBL2;AKT2;PIK3R1;IRS2;SELENOS;IRS1;PTPN11;GSK3A;PRKAG2;SORBS1
prerank,anterograde axonal transport (GO:0008089),0.6011856523109226,1.376473728635933,0.15074798619102417,0.8289309344247955,1.0,2/37,3.15%,KIF4A;TRAK1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.6430804464637242,1.3763683282781514,0.16843501326259946,0.827331133272412,1.0,10/21,15.66%,PNLDC1;CNOT1;CNOT6L;SAMD4A;TUT7;CNOT6;PAN3;TUT4;CNOT7;CNOT4
prerank,regulation of embryonic development (GO:0045995),0.6233516142762419,1.3760129209888223,0.13333333333333333,0.8266140827496685,1.0,6/34,9.06%,CDK1;RACGAP1;NIPBL;WDPCP;NPHP3;CCSAP
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.541046300388934,-1.3754906186006872,0.125,0.5615127231898132,1.0,6/12,22.32%,MAOA;HNMT;SMS;OAZ2;DDC;ATP7A
prerank,positive regulation of cartilage development (GO:0061036),0.6526870494637912,1.3752428491145106,0.1702127659574468,0.8275191275891455,1.0,6/17,12.75%,BMP1;LOXL2;SOX6;TAPT1;BMP2;SOX9
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.4882593372670217,-1.3746208786441299,0.13127413127413126,0.561516462279011,1.0,8/15,34.71%,NR1H3;NR1H2;PPARGC1A;SLC45A3;MID1IP1;MLXIPL;NR4A3;PPARG
prerank,aromatic amino acid family catabolic process (GO:0009074),0.6684344326908983,1.37300764654639,0.16477272727272727,0.833829566470267,1.0,3/15,13.32%,ACMSD;KMO;IL4I1
prerank,kidney development (GO:0001822),0.5958208683422735,1.3727959578521398,0.11158342189160468,0.8326627960315055,1.0,15/65,15.37%,CENPF;GLI2;SULF2;SULF1;NIPBL;NPHP3;KANK2;AGT;C1GALT1;TGFBR1;CTSH;IFT27;ITGA8;GREB1L;GDNF
prerank,sodium ion homeostasis (GO:0055078),-0.44426451378567855,-1.372621583337854,0.11842105263157894,0.5642648410804414,1.0,6/21,15.29%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2;SLC12A2
prerank,tRNA wobble base modification (GO:0002097),-0.4909891305604439,-1.372554139083624,0.10687022900763359,0.5619218398901706,1.0,7/14,26.66%,ELP3;TRMT9B;MTO1;DPH3;ELP4;GTPBP3;ALKBH1
prerank,primary neural tube formation (GO:0014020),0.6306775769046566,1.3718974637258017,0.16101694915254236,0.8339181462556515,1.0,6/30,10.64%,STIL;MTHFD1L;MTHFR;GRHL2;SCRIB;PLXNB2
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.6924956146910453,1.3702335402373294,0.1680327868852459,0.8380845517468896,1.0,7/15,12.79%,GLI2;ANKRD11;WNT6;EDA;HDAC1;BMP2;HDAC2
prerank,regulation of mitotic spindle assembly (GO:1901673),0.6419987864804614,1.3692358550205863,0.15384615384615385,0.8397376763159209,1.0,6/19,10.88%,PLK1;CEP97;TPR;CCSAP;HNRNPU;DRG1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.7185178778297306,1.3692217590313351,0.17739628040057226,0.8378269728428603,1.0,4/12,7.76%,GLI2;MYCBP2;NFIB;EPHA4
prerank,B cell homeostasis (GO:0001782),-0.5612666913443429,-1.3677579917490432,0.10919540229885058,0.5735591777269688,1.0,3/10,6.72%,DOCK10;MEF2C;LYN
prerank,pre-replicative complex assembly (GO:0036388),0.5868665565771599,1.3676105763234798,0.11169652265542676,0.8418197373811505,1.0,17/64,11.06%,MCM5;ORC1;MCM8;MCM6;MCM7;MCM2;CDC6;PSMC2;PSMD5;MCM3;MCM4;ORC2;ORC3;PSMB1;PSMD14;PSMD1;PSMB9
prerank,histone H2A ubiquitination (GO:0033522),0.6645558632022874,1.366703323413087,0.16124837451235371,0.8432650995014352,1.0,5/17,9.26%,RNF168;TRIM37;BCOR;KDM2B;CUL4B
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.5795345434334763,1.3658808752903657,0.11714589989350373,0.8442112088020013,1.0,11/72,9.18%,SHCBP1;CEP57;SETX;FGFR4;FGFR2;RBFOX2;HNRNPA1;FRS2;HNRNPH1;POLR2A;FGFRL1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.417241714236281,-1.3656957142073476,0.09195402298850575,0.5771432920981361,1.0,14/26,18.78%,RIMS1;SLC8A3;SHANK3;TMEM108;NRXN1;RELN;CHRNA7;APP;SHANK1;DLG4;GRIN1;PRKCZ;NLGN1;STX1B
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5719894376200994,-1.3653436661616665,0.12080536912751678,0.5757261608735145,1.0,4/10,23.42%,PFKP;HK1;PFKM;PFKL
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.7007461144360301,1.3650169953123636,0.1716867469879518,0.8453567915988294,1.0,5/11,8.31%,MPHOSPH8;SETDB2;TPR;ATF7IP;TRIM28
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.4112342398922838,-1.364748395147916,0.0875,0.5749455841333505,1.0,13/30,27.51%,ELOVL7;HACD3;HACD2;ABCD4;HACD1;ACSL6;ABCD2;ELOVL6;ACSL1;SLC27A4;ELOVL1;TECR;ACSBG1
prerank,regulation of interleukin-10 production (GO:0032653),-0.37748196803232753,-1.3646441183192544,0.07563025210084033,0.5727568338517298,1.0,7/44,8.78%,STAT3;TRIB2;TLR4;PIBF1;CD34;TNFRSF21;HSPD1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.6107244887483537,1.3635835050749232,0.15795868772782504,0.8485526178449107,1.0,3/32,5.09%,NEK2;AURKB;HNRNPA1
prerank,regulation of histone acetylation (GO:0035065),0.6167822655990859,1.3627011857798894,0.147024504084014,0.8499204865790961,1.0,6/33,9.74%,BRCA1;PAXIP1;CTBP1;ARRB1;CHEK1;KMT2A
prerank,acyl-CoA metabolic process (GO:0006637),-0.38404445686066346,-1.3621653133855718,0.044444444444444446,0.5772586008960946,1.0,14/35,27.43%,ACOT11;SUCLG2;ACBD6;DLST;ACACB;HMGCS2;ACSL6;DBI;ACSF2;ACOT7;ACOT13;MCEE;ACOT6;HMGCS1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.45719763640115607,-1.3617818518065898,0.11739130434782609,0.5758506657605739,1.0,8/20,13.22%,CAMK2D;PSEN1;FIS1;PACS2;TGM2;BCL2;TMCO1;BCAP31
prerank,regulation of anoikis (GO:2000209),-0.44694779021141173,-1.361657768235053,0.10756972111553785,0.5737306565469376,1.0,9/19,21.61%,PTK2;CAV1;SIK1;TLE1;BCL2;PIK3CA;TLE5;MYBBP1A;PTRH2
prerank,lipoprotein catabolic process (GO:0042159),-0.5398673478597819,-1.3614581757965192,0.13836477987421383,0.5718275161398401,1.0,8/11,27.05%,APOE;LYPLA1;ABHD17C;CTSD;PPT1;LYPLAL1;LYPLA2;ABHD17B
prerank,cellular response to interleukin-4 (GO:0071353),-0.5782131238006893,-1.3612992261218262,0.12244897959183673,0.5698820278812092,1.0,4/10,20.81%,LEF1;STAT6;XBP1;SHPK
prerank,tetrahydrofolate metabolic process (GO:0046653),0.703804656667109,1.3610768330079077,0.16248153618906944,0.8538660533328273,1.0,3/10,5.54%,TYMS;MTHFD1L;MTHFR
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.6506257298370556,1.3608394131253634,0.17866666666666667,0.8527353021642325,1.0,8/18,22.39%,AQP1;NR3C1;HNRNPU;ANXA1;KLF9;PCK2;UBE2L3;ZFP36L1
prerank,response to ATP (GO:0033198),-0.44554372779272977,-1.3607570678700671,0.125,0.5689598861046039,1.0,9/18,28.33%,RYR3;HSP90B1;TRPC3;SSH1;DGKQ;P2RX4;P2RX7;ABCC9;P2RY12
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.6735752906635968,1.3598465957951944,0.18129496402877698,0.8544333341825696,1.0,8/14,19.32%,ATRX;BRCA2;TERF2;TINF2;ATR;ACD;TERF2IP;TERT
prerank,mRNA modification (GO:0016556),-0.43298725216479195,-1.3592972857751995,0.08374384236453201,0.5703920442676145,1.0,10/22,16.69%,METTL16;NSUN2;TRMT61B;METTL14;PCIF1;ZC3H13;TRUB1;CMTR1;DKC1;CBLL1
prerank,"wound healing, spreading of cells (GO:0044319)",0.6255832443479862,1.359052586274121,0.1710691823899371,0.855476238774699,1.0,12/24,15.57%,RHOA;PDPN;CCN1;ARHGAP24;TMEFF2;ARHGAP35;MRTFA;ADAM17;ITGA5;CD44;LCP1;RHOC
prerank,cellular response to alkaloid (GO:0071312),0.6430020587634886,1.357797469965286,0.17177097203728361,0.8579817010668825,1.0,5/17,9.46%,RAD51;CASP7;BLM;SPIDR;SLC8A1
prerank,response to hydrogen peroxide (GO:0042542),0.6084087473203951,1.3568952835193095,0.14675767918088736,0.8593719324328978,1.0,6/45,5.80%,ECT2;AQP1;SETX;FXN;NET1;STK24
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.6248040021338191,1.3566081347535162,0.1822721598002497,0.8584773517502057,1.0,10/26,18.87%,RRM2;RRM1;LARGE1;TKT;ALG8;ST3GAL4;ST3GAL2;GK5;GK;GCNT1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.3726033171860453,-1.3555223912247403,0.08943089430894309,0.5784963395660762,1.0,11/39,12.76%,KRIT1;TEK;ANO6;GAS6;PDCD4;CDH5;PLCG1;RAMP2;THBS1;SCG2;RGCC
prerank,lipid transport (GO:0006869),-0.3017662932369015,-1.3544138004762145,0.0,0.5794225660710526,1.0,35/97,25.20%,CERT1;PLTP;ATP8A1;APOE;SLCO1C1;SLCO2B1;GOT2;SCP2;PEX3;ABCC4;ABCA5;SLC27A1;SLCO2A1;CHKA;ATP8B1;LBP;MTTP;SPNS2;GLTP;ABCD2;TNFAIP8L3;STARD5;OSBP;ACSL1;PRELID3B;OSBPL2;SLC27A4;PITPNC1;MFSD2A;PLEKHA8;ABCA2;NPC2;PRELID3A;ABCA3;PRELID1
prerank,histone ubiquitination (GO:0016574),0.6347326973212752,1.3536402399718148,0.16237113402061856,0.867469114948548,1.0,4/21,9.28%,UHRF1;UBE2N;RNF40;LEO1
prerank,regulation of T cell differentiation (GO:0045580),0.6110782312089255,1.3527653853117034,0.1658878504672897,0.8688338429631094,1.0,2/33,2.29%,FANCA;CBFB
prerank,central nervous system neuron differentiation (GO:0021953),-0.3896489808540969,-1.352746112421768,0.07432432432432433,0.581359674721574,1.0,13/33,22.32%,SPOCK1;NTRK2;OPHN1;GRID2;PROX1;MDGA2;CTNNB1;SOX4;LRP6;TOX;GBA2;ZC4H2;ATP7A
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.37456900853326697,-1.3520673356830593,0.061946902654867256,0.5808446792255898,1.0,19/39,23.92%,RPS15;RPS7;RPS6;RPS14;RPS28;RPSA;RPS5;RPS24;RPS19;RPS27;METTL17;SNU13;RIOK2;ERAL1;LTV1;NOB1;EMG1;SURF6;MRPS7
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.6776050039306285,1.3512755887731225,0.18651362984218078,0.8723456638257588,1.0,5/13,13.30%,ALG14;ALG13;SRD5A3;MPDU1;ALG8
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.33937166466852453,-1.3501698693402793,0.05194805194805195,0.5840545486466691,1.0,20/56,22.44%,HSP90B1;TAB2;TLR4;CTSB;SFTPA1;SFTPA2;TAB3;LGMN;NOD1;LBP;IRAK4;CTSL;CNPY3;UNC93B1;UBB;TIFA;CTSS;UBC;RPS27A;S100A1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.6787919726705544,1.3498777698575741,0.19568345323741007,0.8755399897398812,1.0,3/12,9.30%,TK1;DCK;CDA
prerank,epithelial to mesenchymal transition (GO:0001837),0.5882310192187485,1.3497835441825368,0.15548098434004473,0.8739344593691073,1.0,16/47,13.69%,FAM83D;LOXL3;LOXL2;TGFBR3L;ROCK2;GSK3B;TGFBR3;AKNA;TRIM28;ROCK1;TGFBR1;LIMS1;BMP2;RBPJ;SOX9;HEY2
prerank,inorganic ion transmembrane transport (GO:0098660),0.6883524499733625,1.3496900240014886,0.18039772727272727,0.8723268136001506,1.0,1/12,0.93%,RHAG
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4384940580316102,-1.348929896774975,0.10377358490566038,0.5827822656920452,1.0,12/23,21.65%,EP300;HSP90AB1;HIPK2;DAB2;GIPC1;THBS1;SDCBP;CITED2;SLC2A10;TGFB1I1;SNW1;CDKN1C
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4384940580316102,-1.348929896774975,0.10377358490566038,0.5827822656920452,1.0,12/23,21.65%,EP300;HSP90AB1;HIPK2;DAB2;GIPC1;THBS1;SDCBP;CITED2;SLC2A10;TGFB1I1;SNW1;CDKN1C
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.33712851099977187,-1.348914055264213,0.056338028169014086,0.5804219196811616,1.0,17/54,16.50%,DCUN1D3;SMAD7;OGT;PRMT3;CAV1;PER2;UFL1;SQSTM1;PINX1;DNAJA1;CTNNB1;SOX4;SPRY2;SH3RF2;PIAS3;UBXN1;PRKCG
prerank,regulation of catabolic process (GO:0009894),0.6546041603964973,1.3487830298571575,0.17615176151761516,0.8737288145607536,1.0,3/18,5.75%,FAM83D;CHEK2;FAF1
prerank,mesenchymal cell differentiation (GO:0048762),0.591976189435574,1.348534477310625,0.1322222222222222,0.8727227696496892,1.0,18/51,13.69%,FAM83D;LOXL3;LOXL2;TGFBR3L;ROCK2;GSK3B;FGFR2;TGFBR3;AKNA;TRIM28;ROCK1;FBXL17;TGFBR1;LIMS1;BMP2;RBPJ;SOX9;HEY2
prerank,relaxation of cardiac muscle (GO:0055119),-0.5026282056589831,-1.3484345592754272,0.12937062937062938,0.5796413500715263,1.0,8/13,25.05%,CAMK2D;ATP1B1;ATP1A1;GSN;ATP1A2;PIK3CA;P2RX4;GSTM2
prerank,sympathetic nervous system development (GO:0048485),-0.49759076113905476,-1.3482050734732784,0.09926470588235294,0.5780098966767176,1.0,5/15,12.69%,NRP2;SEMA3A;NF1;CTNNB1;SOX4
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.639591792857083,1.3476285780682262,0.1843137254901961,0.8740970822849097,1.0,9/21,13.71%,PAXIP1;SETX;MED14;SRF;MED30;MED24;BCLAF1;TWIST1;MED1
prerank,regulation of B cell apoptotic process (GO:0002902),0.6841399162263069,1.3473861289351208,0.19383259911894274,0.8730203541635121,1.0,2/12,2.97%,AURKB;FNIP1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5809151091006455,1.3470428149402454,0.14594594594594595,0.8722767898425164,1.0,23/59,16.16%,CDK1;CIT;DYRK1A;ROCK2;GSK3B;NLK;PRKDC;DYRK3;WNK1;CHEK1;CDC42BPA;LRRK2;ROCK1;CSNK2A2;MARK2;TGFBR1;CDC42BPG;PRKCA;PDPK1;PRKD1;PRKD2;STK39;HIPK3
prerank,inhibitory synapse assembly (GO:1904862),-0.5343092409783179,-1.346733017491658,0.11513157894736842,0.5796748091639088,1.0,5/11,11.17%,GABRB3;GABRA2;FGF13;GABRB2;GABRG2
prerank,axonal transport (GO:0098930),0.5949541668361834,1.346419442473804,0.16608996539792387,0.8726119310653515,1.0,1/36,0.11%,KIF4A
prerank,sprouting angiogenesis (GO:0002040),0.5739302500574599,1.3459479178017406,0.14933628318584072,0.8723435225470177,1.0,12/51,14.26%,E2F7;E2F8;LOXL2;PARVA;SRF;ADGRA2;ROBO1;ANGPT1;NR4A1;RSPO3;MIA3;EFNB2
prerank,membrane depolarization (GO:0051899),-0.392446009796242,-1.3450833270821085,0.10256410256410256,0.5819692173471638,1.0,20/32,37.61%,CAV1;SCN1A;CACNA1B;SCN9A;CACNG4;ABL1;CACNG2;SCN3A;SCN8A;SCN1B;P2RX4;P2RX7;CACNA1H;CACNB3;CACNA1I;YWHAH;SCN3B;CHRNA4;CACNA1A;KCNH2
prerank,neurotransmitter secretion (GO:0007269),-0.3558555568065219,-1.3445877211305897,0.07575757575757576,0.5809470992614006,1.0,13/44,17.82%,PCLO;SYN3;RIMS1;SYN2;SYT1;LIN7A;BRSK1;NRXN1;SNPH;CPLX1;DVL1;SNAP25;SYT10
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.541944713243827,-1.3444224365924824,0.1495601173020528,0.5790759282407631,1.0,2/11,8.01%,MALT1;PRKCQ
prerank,epithelial cell morphogenesis (GO:0003382),0.6631251330060117,1.3443626346980249,0.17938420348058903,0.8761836770708729,1.0,5/17,11.22%,COL22A1;COL18A1;GRHL2;RILPL1;COL15A1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.6134453450093633,1.341551756245919,0.18490566037735848,0.8844433692862385,1.0,7/26,11.87%,CCNB1;EIF4E;CDC25B;CCDC57;CUL3;TAL1;PRKCA
prerank,electron transport chain (GO:0022900),-0.4874967395069985,-1.341263672378669,0.12307692307692308,0.5854641009304861,1.0,9/15,29.97%,PDIA5;NDUFA5;PPARGC1A;ETFRF1;ETFDH;ETFB;NDOR1;CYB561;UQCRFS1
prerank,cardiac muscle contraction (GO:0060048),-0.382639809994823,-1.3408818198032517,0.07272727272727272,0.5843450345671287,1.0,9/34,19.13%,CAMK2D;ATP1B1;RYR2;TPM1;GSN;ATP1A2;SCN1B;PIK3CA;KCNQ1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.44575825047058937,-1.3406895730351196,0.11203319502074689,0.5825639390202684,1.0,13/20,29.94%,CDC73;MEIS2;CDK6;MEIS1;HOXA5;PRMT1;HOXA9;PTK2B;MAFB;HSPA9;ZFP36;HOXB8;CIB1
prerank,negative regulation of transferase activity (GO:0051348),0.6159496505441453,1.3400317742951142,0.1837968561064087,0.8881388625492339,1.0,12/28,16.00%,PIF1;TERF1;FBXO5;GSK3B;ERCC4;MAPT;HNRNPU;BAG5;CDKN1B;EIF4A2;SRC;TP53
prerank,DNA methylation (GO:0006306),0.6277648103273475,1.3391487038932692,0.19078104993597952,0.8895262628810939,1.0,7/23,14.25%,ATRX;HELLS;PPM1D;GATAD2A;ATF7IP;METTL4;DNMT3A
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.39807688491601156,-1.3391413829016445,0.09036144578313253,0.5850020191467394,1.0,15/29,24.51%,RASGRF1;IGF1;IRS2;LYN;TGM2;RELN;RASGEF1A;SHOC2;GRB2;SHC1;ERBIN;LRRC59;FGF10;MMD2;JAK2
prerank,sulfate transport (GO:0008272),0.6708533815206454,1.3388708837805534,0.19115549215406563,0.8885769869303856,1.0,1/14,0.74%,RACGAP1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.53884785213155,-1.3376586970561652,0.13031161473087818,0.586943617692228,1.0,5/10,14.13%,SHANK3;NETO1;RAB5A;APP;DLG4
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.5348193117611721,-1.3376478082331933,0.15028901734104047,0.5824093183280692,1.0,6/11,21.47%,CCT5;TCP1;CCT7;CCT2;DKC1;MEPCE
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.5348193117611721,-1.3376478082331933,0.15028901734104047,0.5824093183280692,1.0,6/11,21.47%,CCT5;TCP1;CCT7;CCT2;DKC1;MEPCE
prerank,natural killer cell mediated immunity (GO:0002228),0.656158684121648,1.3373743108030727,0.18424753867791843,0.8921588417654019,1.0,2/15,5.62%,ULBP1;RAET1E
prerank,chromatin organization (GO:0006325),0.5543398390026054,1.336910234056487,0.07142857142857142,0.8917807679584041,1.0,38/132,16.59%,PHF19;EZH2;ATRX;HMGB2;DDX11;LOXL2;SMARCC1;BAZ1B;RB1;CHD1L;SETDB2;SMARCAD1;TCF7L1;NUDT5;HMGN2;HP1BP3;RBBP4;ARID1A;NUCKS1;SETD2;PHF1;SMARCA4;HDAC8;HDAC1;SOX9;HDAC2;TADA2A;MCM3AP;ACTL6B;KDM5C;BAZ1A;RUVBL2;SOX1;INO80;DR1;CHD1;SUV39H2;LRWD1
prerank,negative regulation of translational initiation (GO:0045947),0.6685705268814589,1.336877427826763,0.1906779661016949,0.8899400704666083,1.0,6/13,17.74%,AGO2;TPR;FMR1;LARP1;RBM4;PAIP2B
prerank,termination of RNA polymerase II transcription (GO:0006369),0.5903521040567451,1.336869317381624,0.17432273262661954,0.8880295590469389,1.0,10/33,11.45%,TTF2;SETX;CSTF3;FIP1L1;SLBP;LSM11;WDR33;PCF11;SCAF8;CPSF4
prerank,regulation of synapse maturation (GO:0090128),0.6988119092178964,1.3367335025172462,0.19202363367799113,0.8865808201176911,1.0,2/10,4.57%,CDC20;ADGRL1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.343201532749214,-1.3365247890775105,0.028985507246376812,0.5833748364088664,1.0,15/57,18.00%,GRM7;CHRM2;GABBR1;GNAI1;PSAP;GNAL;GPR37;OPRM1;HTR4;ADCY3;ADCY8;ADCY4;CHRM3;ADRA2A;PDE2A
prerank,skeletal muscle tissue development (GO:0007519),-0.3924735052483616,-1.3362611214872497,0.09259259259259259,0.5818108556310275,1.0,7/32,11.49%,MEF2C;CAV1;IGSF8;MYL6;CAV2;SIX1;SELENON
prerank,endoderm development (GO:0007492),-0.49552137079243336,-1.3362494856125977,0.15140845070422534,0.5796324682548778,1.0,3/13,14.84%,KIF16B;DUSP1;SOX17
prerank,regulation of striated muscle contraction (GO:0006942),-0.4047972577150166,-1.335918796639792,0.1282051282051282,0.5782590308628155,1.0,9/27,22.15%,SMAD7;SLC8A3;CALM1;RYR2;ATP1A2;SRI;CALM3;NOS1;P2RX4
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.5673463573933758,1.3350000832069437,0.13755458515283842,0.890966307777278,1.0,9/60,6.70%,NEK2;AURKB;DSCC1;RFC4;FGFR4;RFC2;HNRNPA1;RFC3;GRHL2
prerank,iron ion transport (GO:0006826),-0.3426843407786217,-1.333993137810127,0.05154639175257732,0.5815355890585434,1.0,11/47,14.88%,ATP6V0A1;FTH1;ATP6V0D1;ATP6V1E1;SCARA5;ATP6V0B;ATP6V0A4;IREB2;ATP6V0C;ATP6V1H;MCOLN1
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.4869915039750016,-1.3331536737987537,0.14383561643835616,0.5818081121732455,1.0,6/15,13.84%,AKT2;PPM1K;IRS2;GPLD1;IRS1;LDLRAP1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.521678590977149,-1.332875589522134,0.13522012578616352,0.5804420409488265,1.0,3/12,8.24%,PRKG1;MEF2C;TPM1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.4953676081145999,-1.331914251571699,0.15017064846416384,0.5809883595796167,1.0,3/12,2.33%,CAMK2D;CALM1;CAV1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.6013427155000369,1.3316574353292716,0.18345323741007194,0.901372896187721,1.0,4/28,8.31%,ECT2;TPR;UBR5;TRIM28
prerank,V(D)J recombination (GO:0033151),0.6866978870449929,1.330959861815802,0.19377652050919378,0.9020136130228781,1.0,4/11,15.54%,HMGB2;PRKDC;HMGB1;DCAF1
prerank,positive regulation of telomerase activity (GO:0051973),0.5954573160489744,1.3308986266277392,0.18116805721096543,0.9002785434232007,1.0,2/33,1.03%,NEK2;AURKB
prerank,signal transduction by p53 class mediator (GO:0072331),0.6054519001010988,1.3304404002132577,0.20314389359129384,0.8999145081413443,1.0,7/30,10.91%,E2F7;ATRX;PAXIP1;MDM4;HINT1;NDRG1;BOK
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.3891829656975191,-1.3301106082711536,0.0851063829787234,0.5838702280423597,1.0,10/29,15.83%,PTK2;FLT1;TEK;PDGFRB;FGF2;PIK3R4;CD81;IRS1;EPHA8;TNFAIP8L3
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.6470920145914588,1.3297349487407617,0.19508867667121418,0.9005346118382573,1.0,4/20,9.30%,ACMSD;GCK;ERFE;CDA
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.47158741232167334,-1.3290500693161835,0.15637860082304528,0.5848940469619035,1.0,10/16,33.33%,PINK1;NUPR1;COX7A2;UQCC2;ATP7A;AK4;PDE12;MLXIPL;PPIF;VCP
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5660278014146112,1.3289929999472032,0.15806805708013172,0.9012819523741957,1.0,5/55,5.49%,HMMR;HPSE;SPAM1;HYAL1;GPC6
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.4950726713982409,-1.328649930165279,0.14760147601476015,0.583811931408198,1.0,11/15,32.82%,ENTPD1;CMPK1;ENTPD2;AK5;ENTPD5;AK4;CMPK2;AK1;NME2;ENTPD3;ENTPD6
prerank,UV-damage excision repair (GO:0070914),0.6747975385097051,1.3280808707232106,0.19596541786743515,0.9028073639848694,1.0,5/12,14.87%,POLA1;POLD3;CUL4B;XPA;INO80
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.5585606496557736,1.3277815619847064,0.005,0.9020069399217897,1.0,103/417,15.36%,DEPDC1;CENPF;BRCA1;EZH2;BIRC5;LOXL3;GLI3;HMGB2;E2F1;CBX5;RBM15;FOXE1;ATOH8;BTAF1;ILF3;KMT5A;SFMBT1;TIMELESS;LOXL2;RB1;SP3;TWIST2;ZEB1;CTCF;DAP;MPHOSPH8;RBFOX2;EED;BCOR;SETDB2;KHDRBS1;MBD1;NFIL3;BHLHE41;CTBP1;ZNF568;MAEL;IKZF1;SFRP2;YAF2;GZF1;TCF7L2;SCML2;HOXA7;SCMH1;GATAD2A;PML;PSPC1;MIDEAS;POU2F1;NIPBL;ZHX2;UIMC1;SAP18;ATF7IP;IRF1;TRIM28;RCOR1;ING4;BCLAF1;SMARCA4;NONO;LIMD1;ARID4A;EPC1;MTA3;NR3C1;RUNX1T1;LIMS1;SFPQ;DKK3;SMURF2;RBM15B;HDAC1;AHR;BMP2;ATXN1;L3MBTL2;NKX2-1;ZHX3;FBXW11;RBPJ;SMAD4;SOX9;HDAC2;ATF5;TWIST1;USP47;HEY2;BTRC;FOXK2;BCL7A;CDKN1B;KDM5C;PCGF6;EIF4A2;FOXM1;QARS1;YEATS2;PER1;RBAK;SFRP1;CNOT7
prerank,secretory granule organization (GO:0033363),-0.5458249908356463,-1.3275973098793077,0.11731843575418995,0.5847008858802054,1.0,5/10,14.63%,LYST;SRGN;DTNBP1;BLOC1S2;VPS33B
prerank,negative regulation of hemostasis (GO:1900047),-0.511359368444363,-1.32725601484301,0.1396103896103896,0.5833481079664545,1.0,4/12,5.91%,APOE;VTN;THBD;CD34
prerank,regulation of calcium ion transport (GO:0051924),-0.35318478131021463,-1.3272260795812874,0.04878048780487805,0.5812904282189283,1.0,19/54,23.79%,CACNA2D1;EPB41;SARAF;HOMER1;MYLK;INPP5K;CAMK2G;BCL2;CTNNB1;CACNB2;SRI;CRACR2A;ADRA2A;PLPP4;PACSIN3;NOS1;CD84;P2RX4;WFS1
prerank,protein localization to Golgi apparatus (GO:0034067),0.6229803491516679,1.3270814638045556,0.18932038834951456,0.9025925407755568,1.0,7/27,12.56%,RAB33B;GBF1;OBSL1;BICD2;VPS13A;GAK;ZDHHC15
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.6024186496105826,1.3269923385261528,0.18424242424242424,0.9009702950627483,1.0,13/30,18.77%,PIF1;TERF1;STN1;ERCC4;HNRNPA1;HNRNPU;TERF2;SRC;TP53;TINF2;ACD;EXOSC10;NIBAN2
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.49830439137043486,-1.3265253593422306,0.14233576642335766,0.581239677307348,1.0,8/13,18.61%,ERLEC1;OS9;EDEM2;EDEM1;YOD1;BCAP31;SVIP;UBE2G2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.4705684333070207,-1.3242686512509736,0.12915129151291513,0.5853655463285103,1.0,8/15,22.15%,TMSB4X;FGF2;LGMN;MET;VEGFA;SMOC2;HSPB1;P2RX4
prerank,cell differentiation in hindbrain (GO:0021533),-0.5428872841583483,-1.3238763251431858,0.14985590778097982,0.5843116630876326,1.0,3/11,4.80%,OPHN1;GRID2;PROX1
prerank,signal release from synapse (GO:0099643),-0.3597075901156048,-1.3237580358336218,0.06766917293233082,0.5824612069651368,1.0,13/43,17.82%,PCLO;SYN3;RIMS1;SYN2;SYT1;LIN7A;BRSK1;NRXN1;SNPH;CPLX1;DVL1;SNAP25;SYT10
prerank,positive regulation of transporter activity (GO:0032411),0.6697576653973069,1.3224853600498305,0.19635343618513323,0.9151293573892533,1.0,3/13,9.74%,PON1;PDZK1;KMT2A
prerank,organelle assembly (GO:0070925),0.5559195769122537,1.3216658561935786,0.01,0.9160787162582664,1.0,67/384,10.91%,CENPF;CENPE;NEK2;CENPA;DLGAP5;KIF24;ANLN;HAUS8;PLK4;IFT80;HYLS1;CEP89;BBS9;CCDC61;HAUS4;HAUS6;DZIP1L;SCLT1;ACTR3;VPS37B;WDR35;PARVA;ASAP1;WDR90;GBF1;SPAG16;IFT140;POC1B;FAM161A;EXOC4;KIF27;PATL1;PCM1;TUBGCP5;OCRL;MAPT;HAUS7;TXNDC15;LSM3;EIF4ENIF1;MKKS;G3BP1;WDR11;ATG7;CEP83;VPS37A;NUDCD3;RILPL1;RFX2;SSX2IP;STAM;CCDC57;HAUS1;CFAP52;GOLGA8B;ZFYVE1;WDPCP;ATP2A2;NPHP3;LIMD1;RAB1A;RB1CC1;YTHDF2;TTC39C;TRAPPC14;VTA1;CENPW
prerank,peptide biosynthetic process (GO:0043043),-0.2919727562977986,-1.3213184720914497,0.0,0.5870782312845683,1.0,79/153,21.11%,EEF1A1;RPL13;FARSB;RPS8;PCSK5;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;EIF4G1;RPS7;RPL18A;RPS20;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;GGT5;RPL8;MRRF;FURIN;RPS14;RPL10;RPL32;RPL18;RPS28;RPSA;RPS5;RPL15;RPS24;RPS19;SARS1;RPL27;RPL39;RPL24;RPL12;RPS12;MRPS5;RPS4X;RPS27;RPL27A;RPS9;WARS1;MRPS15;MRPS18A;RPL30;RPL19;MRPS21;MRPS6;RPL28;MRPL27;RPL31;RPL13A;RPL36A;RPL29;HBS1L;RPLP2;MRPL23;PCSK1;DHPS;MRPL9;RPLP0;RPL10A;RPS10;RPS6KB2;RPL35;TNIP1;RPS26
prerank,fibrinolysis (GO:0042730),0.6615229723439433,1.3212923220754895,0.19164265129682997,0.9155549683554352,1.0,4/13,18.00%,PLAU;SERPINE1;PLAUR;PLAT
prerank,innate immune response in mucosa (GO:0002227),-0.541203109001418,-1.3212857332278773,0.1498371335504886,0.5850516560683309,1.0,2/10,10.61%,DEFA6;RPL39
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.6963848214258873,1.321181479730143,0.19336219336219337,0.9140660147870897,1.0,3/11,3.18%,FADD;TICAM1;COLEC12
prerank,negative regulation of cilium assembly (GO:1902018),0.6635279990506642,1.3211088702006657,0.2094017094017094,0.9123843192934865,1.0,7/12,18.62%,CEP97;EVI5L;YAP1;TBC1D7;MAP4;ODF2L;LIMK2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4469651481828255,-1.32098648580932,0.12186379928315412,0.5838413863165477,1.0,2/17,2.92%,PLA2G4A;PLAAT3
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.36774332248393826,-1.3204045600050636,0.0847457627118644,0.5833341792611236,1.0,8/39,4.43%,MAML3;STAT3;EP300;MAML2;JAG1;TGFB2;NOS3;ZMIZ1
prerank,neuron migration (GO:0001764),-0.33418436047413214,-1.3203902155441758,0.05063291139240506,0.5813181966828709,1.0,13/48,9.35%,ASTN2;MEF2C;SPOCK1;DNER;NTRK2;CDKL5;ELP3;ADGRL3;NRCAM;MAP1B;FGF13;SEMA3A;RELN
prerank,positive regulation of B cell activation (GO:0050871),0.5838990510303124,1.3203576067829927,0.17980022197558268,0.9130527400679476,1.0,3/50,3.64%,TNFSF13B;PAXIP1;MMP14
prerank,cytoskeleton organization (GO:0007010),0.556298687283764,1.318891017038625,0.10050761421319797,0.9165745375482094,1.0,29/114,13.77%,DIAPH3;SYNE3;MAST2;PHIP;ARHGAP10;RHOA;OBSL1;PACSIN2;AJUBA;DIAPH1;FGD4;MICAL3;CNN2;ANK1;PRPF40A;PDZD8;FGD1;WDPCP;SH3D19;LIMD1;STRIP2;EPB41L3;FGD6;RAC1;RND2;DMTN;DES;PRKCI;LARP4
prerank,peptidyl-threonine modification (GO:0018210),0.5680269209602566,1.3174661858563477,0.14668094218415417,0.9197277092588384,1.0,24/66,16.16%,CDK1;CIT;DYRK1A;ROCK2;GSK3B;NLK;GALNT1;PRKDC;DYRK3;WNK1;CHEK1;CDC42BPA;LRRK2;ROCK1;CSNK2A2;MARK2;TGFBR1;CDC42BPG;PRKCA;PDPK1;PRKD1;PRKD2;STK39;HIPK3
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.4921664477076356,-1.3172811462645035,0.15151515151515152,0.5877180256827901,1.0,8/14,19.14%,ETNK1;SLC27A1;CHKA;ETNK2;PCYT2;SELENOI;CHKB;LPIN1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5896828376172937,1.3172213165050803,0.18118466898954705,0.9186904881691744,1.0,5/38,8.96%,BRCA1;FADD;GSK3B;SERPINE1;TNFRSF10B
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.5463580913940083,-1.317217271536812,0.13095238095238096,0.5858527864120295,1.0,6/10,14.92%,GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.5423320428427016,-1.3172061791867,0.14893617021276595,0.5837947515466806,1.0,9/10,45.58%,NAF1;DKC1;RPUSD4;GAR1;NOP10;RPUSD1;NHP2;RPUSD2;RPUSD3
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.41723381759296274,-1.3163504592953252,0.12558139534883722,0.5838942845835101,1.0,6/23,19.35%,CARD16;IGF1;GAS6;CX3CL1;GIT1;ZC3H12A
prerank,cellular response to amyloid-beta (GO:1904646),-0.3719622191666394,-1.3159047100901378,0.09302325581395349,0.582970458935693,1.0,13/35,14.42%,CACNA2D1;PSEN1;GRIN2A;IGF1;TLR4;LRP1;VCAM1;CASP4;LGMN;ATP1A3;APP;GRM5;GRIN1
prerank,defense response to protozoan (GO:0042832),-0.520051461296332,-1.315526906475793,0.16104868913857678,0.5820231205343797,1.0,10/12,42.85%,LYST;GBP4;GBP6;CD40;BATF;GBP7;MYD88;SLC11A1;GBP2;BATF2
prerank,regulation of Golgi organization (GO:1903358),0.6301539274857296,1.3151887055687503,0.2026315789473684,0.9239630653319308,1.0,5/17,11.55%,RAB33B;USP6NL;ARMH3;STX18;AKAP9
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.4763214744087265,-1.3145835205929592,0.1422924901185771,0.5825339995486378,1.0,5/15,9.17%,ABHD12;GOT2;ABHD16A;GGT5;PRODH
prerank,regulation of DNA recombination at telomere (GO:0072695),0.6179788692516412,1.3143157839114343,0.19295958279009126,0.9232396039251195,1.0,8/19,19.23%,ATRX;TERF1;POLR2A;TERF2;TINF2;ACD;TERF2IP;POLR2B
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.6179788692516412,1.3143157839114343,0.19295958279009126,0.9232396039251195,1.0,8/19,19.23%,ATRX;TERF1;POLR2A;TERF2;TINF2;ACD;TERF2IP;POLR2B
prerank,positive regulation of nervous system development (GO:0051962),-0.34769199872135215,-1.3139061536093164,0.09166666666666666,0.5822138658387768,1.0,22/42,27.17%,PTPRD;SYNDIG1;GRID2;EPHB2;IL1RAPL1;NUMBL;NUMB;NRXN1;TGM2;OPRM1;FAIM;LRRC4B;NLGN1;IL1RAP;SNW1;BDNF;SRPX2;DLG5;TRIM32;GPER1;SERPINF1;SOX11
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.4466063858219009,-1.3131147630024944,0.13076923076923078,0.5824002004574451,1.0,6/19,21.84%,PTK2;MAPK3;MAPK1;THBS1;CMKLR1;IL34
prerank,lipoxygenase pathway (GO:0019372),0.6637053183551359,1.313010992867908,0.20141843971631207,0.926009842424418,1.0,1/14,0.82%,PON1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.6337069541177357,1.3129048953114344,0.211340206185567,0.9245214851264775,1.0,9/20,15.63%,MOV10;AGO2;CNOT1;AJUBA;NRDE2;CNOT6;LIMD1;CNOT7;TNRC6C
prerank,retinal metabolic process (GO:0042574),0.6632494274460414,1.312655262197762,0.19062027231467474,0.9235470517024603,1.0,3/12,4.66%,ALDH8A1;ABCA4;RDH11
prerank,ncRNA processing (GO:0034470),-0.2549054559960284,-1.3113649903326716,0.2,0.5849559340215283,1.0,90/200,26.80%,RPL13;AGO1;AGO3;SRRT;RPL37A;RPL38;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;PUS10;NVL;RPS7;RPL18A;RPS6;RPL14;RPLP1;AARS1;RPL9;RPL37;RPL8;INTS3;RPS14;NOL8;RPL10;RPL32;RPL18;SENP3;RPS28;RPL15;RPS24;RPS19;HEATR1;UTP20;KRR1;SARS1;RPL27;RPL39;RPL24;RPL12;WDR75;EXOSC1;RPS27;RPL27A;RPS9;ADAR;RPL30;RPL19;EXOSC9;RRP1;RRP1B;RPL28;RPL31;DICER1;MPHOSPH10;LAS1L;DKC1;DDX49;SNU13;RPL13A;RPL36A;RPL29;AGO4;MDN1;RPLP2;INTS12;KARS1;RPLP0;RPL10A;RPL35;NOB1;EMG1;NOLC1;PIH1D1;EXOSC2;EBNA1BP2;DDX54;RPL4;IMP3;BYSL;INTS11;DDX47;INTS1;BOP1;EXOSC3;RPS25;EXOSC5;POP5
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.5352942897069797,-1.311359166824735,0.16358024691358025,0.582969342629827,1.0,2/10,8.32%,PRKN;OXA1L
prerank,neural crest cell migration (GO:0001755),-0.3677571662504176,-1.3113175501704404,0.072992700729927,0.5811079153415735,1.0,22/36,37.20%,SEMA6A;ANXA6;SEMA6D;SEMA7A;SEMA4D;ERBB4;SEMA3A;TBX1;SEMA3B;SEMA3C;SEMA5B;NRP1;SEMA6C;SEMA3G;SEMA4C;SOX10;SOX8;SEMA4A;HTR2B;SEMA4G;SEMA3E;SEMA3F
prerank,nucleus organization (GO:0006997),0.5748291149840027,1.3112653664123777,0.16852678571428573,0.9266936896257008,1.0,7/47,7.69%,CEP55;NDC1;NUP155;NUP205;NUMA1;TPR;LEMD3
prerank,positive regulation of ERAD pathway (GO:1904294),-0.47821742699403136,-1.3110168140444127,0.18411552346570398,0.579902847876118,1.0,4/13,13.22%,ATXN3;CAV1;SGTA;BCAP31
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5697735846558964,1.3103892568067408,0.1813304721030043,0.9278676009801308,1.0,10/51,10.99%,KIF20B;MAP4K4;SNX1;NRK;LRRK2;ANKRD27;DNM2;SRGAP2;EPB41L3;PLXNB1
prerank,positive regulation of protein processing (GO:0010954),-0.4407314656786013,-1.30936616065862,0.13765182186234817,0.5823098425401448,1.0,6/19,19.42%,GSN;CCBE1;PLGRKT;ENO1;NKD2;CLEC3B
prerank,maintenance of protein location in nucleus (GO:0051457),0.6157930168856782,1.308945808338865,0.21681997371879105,0.9311709060680856,1.0,9/20,19.08%,BARD1;TAF3;PML;RANGAP1;HNRNPU;MORC3;SUN2;SP100;SUN1
prerank,selective autophagy (GO:0061912),-0.3217932697716541,-1.3085739855757947,0.08045977011494253,0.5823874508534655,1.0,23/56,22.52%,PRKN;DYNC1LI2;UFL1;BECN1;SQSTM1;UBA5;DYNC1I2;ULK1;DYNC1LI1;ATM;DYNLL2;PEX5;KLHL3;WDFY3;USP30;ATG2B;AUP1;TEX264;UBB;PARK7;UBC;RPS27A;WDR81
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.49251055933374727,-1.308439733264197,0.16887417218543047,0.5807674513085123,1.0,5/13,24.73%,TLR4;NAMPT;SELENOS;JAK2;EDN1
prerank,regulation of lipid kinase activity (GO:0043550),0.6680078483468409,1.3067014154755583,0.20381231671554254,0.9373044446404183,1.0,2/11,2.58%,RBL1;RB1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.5495939027992744,1.3057883847825231,0.0973630831643002,0.9386170491220748,1.0,27/144,10.32%,KIF20B;ECT2;GTSE1;E2F1;SAE1;MIEF2;GSK3B;TFDP1;XPO4;PCM1;ANP32B;PRNP;PDZK1;LEPROT;MYO1C;TCF7L2;TPR;FBXW7;RAB29;RNF31;SH3GLB1;UBR5;TRIM28;HTRA2;CSNK2A2;EMD;MIEF1
prerank,photoreceptor cell development (GO:0042461),-0.47689961116786495,-1.3054416690919148,0.12781954887218044,0.5864895524139756,1.0,6/14,23.01%,RORB;VEGFA;DCX;AHI1;RP1;MFSD2A
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.6598227975225466,1.3046875222870697,0.19536903039073805,0.9406673901903096,1.0,3/13,7.78%,GLI3;CBFB;ZBTB7B
prerank,artery development (GO:0060840),-0.4214048481381618,-1.3025498631797572,0.14507772020725387,0.5925529627204158,1.0,13/23,21.19%,SMAD7;BMPR2;ACVRL1;ACVR2B;NF1;TBX1;ENG;VEGFA;STRA6;PDE2A;ROBO2;SLC2A10;NRP1
prerank,regulation of phosphate metabolic process (GO:0019220),0.6451779215345701,1.3025421739501672,0.20767195767195767,0.9464391712102707,1.0,2/16,2.69%,BARD1;MCM7
prerank,calcium ion transport (GO:0006816),-0.2832448558633225,-1.30240616436175,0.1,0.5909381549005606,1.0,33/113,16.96%,CACNA2D1;GRIN3A;RYR3;PSEN1;SLC8A3;TRPM7;CALCRL;TRPC5;CAV1;RYR2;FKBP1A;ANO6;GAS6;SLC24A2;TRPC4AP;SLC3A2;CACNG7;TPT1;RAMP1;RAMP2;CACNA1B;TRPC3;TRPM3;TRPC1;CHRNA7;CACNB2;TMCO1;ATP2B2;MCOLN1;PANX1;CACNG3;CACNG8;CRACR2A
prerank,positive regulation of immune effector process (GO:0002699),-0.3816085590285165,-1.3020156634819013,0.11398963730569948,0.5899398882477276,1.0,7/27,17.81%,DDX60;LBP;MYO18A;RPS19;CD81;XBP1;LGALS9
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.4678635891909202,-1.301047431075833,0.17491749174917492,0.5906171473182437,1.0,5/14,13.91%,AKT2;IRS2;LONP2;IRS1;ABCD2
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.6463421242167934,1.3009743123789685,0.20545977011494254,0.9501708500681789,1.0,6/13,16.12%,MOV10;ZC3HAV1;CNOT1;RC3H1;CNOT7;PNPT1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.560237349792167,1.300566945034077,0.15894736842105264,0.9496490328520518,1.0,23/70,17.55%,KIF14;RB1;RHOA;ATRNL1;PARVA;LAMB1;ITGB7;GRHL2;EFNA1;RILPL1;TMEFF2;SRGAP2;YTHDF2;RAC1;ITGA8;ITGAV;NTN4;TBCD;UNK;METTL3;FERMT3;ANTXR1;ABI2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.6372199958924459,1.3004493913359312,0.2127371273712737,0.9481627460052757,1.0,5/15,8.48%,RAB10;RTN3;LNPK;ATL2;ARL6IP1
prerank,regulation of membrane repolarization (GO:0060306),-0.48728911523432866,-1.3004492099598524,0.14057507987220447,0.5901999335679244,1.0,3/13,3.33%,CACNA2D1;CAV1;AKAP6
prerank,central nervous system myelination (GO:0022010),-0.5122766017460716,-1.300250560543135,0.15588235294117647,0.5888235655880673,1.0,6/11,30.05%,B4GALT5;B4GALT6;PLP1;TENM4;ABCA2;SOX10
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.5455930626397139,1.2990039143884415,0.003,0.9514119775743098,1.0,124/497,15.68%,DEPDC1;CENPF;BRCA1;EZH2;BIRC5;LOXL3;GLI3;HMGB2;E2F1;CBX5;TYMS;RBM15;FOXE1;ATOH8;TERF1;BTAF1;ILF3;PDS5A;SYNCRIP;KMT5A;SFMBT1;TIMELESS;LOXL2;RB1;SP3;TWIST2;ZEB1;CTCF;GSK3B;CDC6;CNOT1;DAP;MPHOSPH8;RBFOX2;EED;BCOR;SETDB2;KHDRBS1;MBD1;WAPL;NFIL3;BHLHE41;CTBP1;ZNF568;MAEL;IKZF1;SFRP2;EIF4ENIF1;YAF2;GZF1;TCF7L2;SCML2;SAMD4A;CAPRIN1;HOXA7;SCMH1;GATAD2A;PML;FMR1;PSPC1;MIDEAS;POU2F1;NIPBL;ZHX2;UIMC1;SAP18;ATF7IP;LARP1;IRF1;TRIM28;RCOR1;ING4;BCLAF1;SMARCA4;NONO;LIMD1;ARID4A;EPC1;MTA3;NR3C1;RUNX1T1;LIMS1;ENPP1;SFPQ;EIF2AK3;DKK3;SMURF2;MRPL13;RBM15B;HDAC1;AHR;BMP2;ATXN1;L3MBTL2;NKX2-1;ZHX3;FBXW11;RBPJ;SMAD4;SOX9;HDAC2;ATF5;TWIST1;USP47;RBM4;HEY2;DHFR;BTRC;FOXK2;BCL7A;CDKN1B;KDM5C;PCGF6;FOXM1;EPRS1;QARS1;YEATS2;PER1;RBAK;SFRP1;CNOT7;KAT6A;PASK;FXR1
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.424901587877478,-1.2989399386755431,0.14339622641509434,0.5904509175689112,1.0,3/18,4.40%,CAMK2D;CAV1;BIN1
prerank,cellular protein catabolic process (GO:0044257),-0.33113586794504024,-1.2989322037477558,0.08536585365853659,0.5885487399983729,1.0,27/59,26.53%,PRKN;UBE2G1;ADAMTS12;CTSC;CLPX;MALT1;AP2A2;CTSB;LGMN;CTSZ;BNIP3L;BNIP3;VLDLR;AP2M1;RAB12;AP2S1;CTSL;AP2A1;UBE2G2;CTSF;YME1L1;CTSS;MAGEC2;FAP;CTSO;CTSK;DENND3
prerank,positive regulation of viral life cycle (GO:1903902),0.6090837196302661,1.2985032530958789,0.21428571428571427,0.9513479647473234,1.0,3/22,6.86%,KPNA2;VPS37B;FMR1
prerank,L-amino acid transport (GO:0015807),-0.38567880190154435,-1.297684132174206,0.14450867052023122,0.5899198301891077,1.0,6/28,5.75%,SLC1A2;SLC7A2;SLC25A13;SLC25A12;SLC7A5;SLC3A2
prerank,cellular protein-containing complex assembly (GO:0034622),0.5480765934683747,1.296906642967492,0.07258064516129033,0.9554868886977744,1.0,20/159,9.53%,CENPF;CENPE;CENPA;DLGAP5;ANLN;NDC1;NUP205;DNAAF3;DHX9;MAPT;EIF4H;MKKS;AHCTF1;TCF4;TPR;NCK1;DNAI4;ANGPT1;PICALM;LONP1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.31095417486568133,-1.2966868479287021,0.037037037037037035,0.590740285927021,1.0,15/72,7.37%,PTK2;FLT1;TEK;NTRK2;INSR;IGF1;TGFB2;PDGFRB;BECN1;NTRK3;PIK3R1;FGF2;IRS2;LYN;SEMA4D
prerank,neurogenesis (GO:0022008),0.5761564551077728,1.296632188464563,0.17018909899888765,0.9545957234341769,1.0,7/43,6.03%,WDR62;CDK5RAP2;CIT;TRAK1;LPAR1;MAPT;CXCR4
prerank,negative regulation of cell aging (GO:0090344),0.6328596092934521,1.296490902127761,0.2070365358592693,0.953202302689557,1.0,7/16,15.09%,RBL1;FBXO5;MAP3K3;TERF2;TWIST1;FOXM1;SLC30A10
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.4100372397982632,-1.2958676175996866,0.1493212669683258,0.5909709391123903,1.0,14/22,31.71%,RPL23;RPS15;RPS7;RPS20;RPL37;ATM;DDX5;UBB;CDK5RAP3;HEXIM1;EEF1E1;CHD5;HIC1;SPRED3
prerank,presynapse assembly (GO:0099054),-0.43597669497075164,-1.2951189348295515,0.13147410358565736,0.5909837112719458,1.0,7/16,19.94%,PCLO;PTPRD;LRRTM3;IL1RAPL1;DVL1;NLGN1;FZD1
prerank,cardiolipin metabolic process (GO:0032048),-0.4873440859623517,-1.2945824464197717,0.16333333333333333,0.5904156969185116,1.0,4/13,7.08%,PLA2G4A;HADHB;SLC27A1;PNPLA8
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.46435310691278575,-1.2935617327399567,0.14189189189189189,0.591146827491445,1.0,6/15,19.04%,VEGFC;NTRK3;SCG2;VEGFA;VEGFB;VEGFD
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.48299666791523166,-1.293313118444026,0.16558441558441558,0.5897851472643402,1.0,8/13,31.24%,ELOVL7;HACD3;HACD2;HACD1;ELOVL6;ELOVL1;TECR;TECRL
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.45039700805926175,-1.2928929069719655,0.17537313432835822,0.5889744410839037,1.0,7/16,19.24%,PPP1R16B;FGF2;AGTR1;THBS1;VEGFA;GATA2;FGFBP1
prerank,negative regulation of coagulation (GO:0050819),-0.4730748459578832,-1.2927747558574456,0.15942028985507245,0.5873662693868116,1.0,4/14,5.91%,APOE;VTN;THBD;CD34
prerank,ribosome assembly (GO:0042255),-0.33377855791844674,-1.292591853880249,0.057692307692307696,0.5861438566318574,1.0,29/47,33.77%,RPL3;RPS15;RPS14;RPL10;BRIX1;RPS28;RPSA;RPS5;RPS19;RPL24;TRAF7;RPS27;DHX29;MDN1;MTERF3;RPLP0;ERAL1;NOP2;MRPS7;BOP1;RPL11;MRPL22;MRPS11;DDX3X;RSL24D1;NLE1;MPV17L2;C1QBP;PWP2
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.4218542937724809,-1.2925478577504679,0.1487603305785124,0.5843812046042409,1.0,12/20,29.51%,APOE;SREBF2;ARV1;FMO5;LDLRAP1;DGKQ;EPHX2;RAN;ABCA2;MBTPS1;MBTPS2;ACADVL
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.38313098933689455,-1.2922999524893604,0.1164021164021164,0.5832570466968557,1.0,16/31,33.78%,KCNB1;SYT1;SYT7;SYT11;SYT12;SCAMP5;ADRA2A;SYT10;SYT6;SYT2;CACNA1H;RAB3GAP1;CACNA1I;SYT13;SYT3;CBARP
prerank,respiratory electron transport chain (GO:0022904),-0.47780872977560657,-1.2919525021887486,0.1695501730103806,0.582350222897711,1.0,10/14,30.30%,SLC25A13;GPD2;SLC25A12;NDUFA5;PPARGC1A;ETFRF1;ETFDH;ETFB;UQCRFS1;SLC25A18
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.5100097552885706,-1.290896813937512,0.1476923076923077,0.5832441615034089,1.0,5/11,23.39%,UFD1;DERL1;POMT2;AUP1;TOR1A
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.6074477175566505,1.29086981443538,0.22208281053952322,0.9720035551112522,1.0,3/22,3.51%,MASTL;ROCK2;GSK3B
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.39972204159818525,-1.2908069165452958,0.12060301507537688,0.5816679770890845,1.0,9/27,21.26%,RIMS1;SYT1;SYT7;SYT11;SYT12;ARL8B;SYT10;SYT6;SYT2
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.666632113676571,1.2905205836282743,0.22173274596182085,0.9712929430571831,1.0,1/11,0.72%,BARD1
prerank,myelination (GO:0042552),-0.34408468473764775,-1.2903348807360056,0.09565217391304348,0.581132425392327,1.0,21/46,24.16%,SLC8A3;MAL;B4GALT5;TNFRSF21;B4GALT6;PLP1;ACER3;NF1;ARHGEF10;ABCD2;SCN8A;DEGS1;CMTM8;GAL3ST1;ADGRG6;LGI4;PLLP;EIF2B2;PMP22;MARVELD1;GPC1
prerank,genitalia development (GO:0048806),-0.4952864500118749,-1.2892561164411662,0.14150943396226415,0.5819792220837866,1.0,6/12,29.70%,DNAJC19;TBX3;PTPN11;STRA6;FOXF2;CHD7
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.6262658591367767,1.2887275618989509,0.21921515561569688,0.9759692733840015,1.0,2/16,5.62%,ULBP1;RAET1E
prerank,organelle transport along microtubule (GO:0072384),0.5886868712457185,1.2883974188337113,0.20941176470588235,0.9752371600846121,1.0,9/31,12.05%,ARHGAP21;TRAK1;MAPT;RHOT1;BICD2;NDE1;UXT;RAB1A;FBXW11
prerank,regulation of microtubule nucleation (GO:0010968),0.6729211647745259,1.2880021346793522,0.22897196261682243,0.9746688628934805,1.0,2/10,2.28%,CKAP5;RANGRF
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.47380918287558166,-1.2877759125826986,0.16911764705882354,0.583919515916903,1.0,9/14,35.31%,UQCC2;RPUSD4;FASTKD2;RMND1;COA3;MPV17L2;TRMT10C;C1QBP;FASTKD3
prerank,regulation of axon regeneration (GO:0048679),0.6551963639724039,1.2876748099787114,0.2223816355810617,0.9739143543572907,1.0,5/12,11.44%,RTN4R;STK24;EPHA4;PTPRS;CNTF
prerank,protein import into nucleus (GO:0006606),0.5540701920227905,1.2870726592876547,0.17590618336886993,0.974235729397317,1.0,22/66,17.22%,KPNA2;RANBP17;NUP155;KPNA3;RPAIN;E2F3;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;IPO7;APPL2;NUP214;RANBP2;IPO11;NXT1;NUP133;KPNA4;IPO5;NXT2;FAM53B
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5266398302463502,-1.2865226349210384,0.17647058823529413,0.5853028037535514,1.0,5/10,21.95%,SMARCD3;CTNNB1;CX3CL1;VEGFA;DRD2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5295522911919415,-1.285660390484411,0.17475728155339806,0.5856963805413694,1.0,3/10,6.72%,STAT3;STAT6;LYN
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.5368946143921995,1.2856193377466167,0.16614745586708204,0.9777845478460128,1.0,12/87,9.18%,SHCBP1;CEP57;SETX;FGFR4;HYAL1;FGFR2;RBFOX2;HNRNPA1;FRS2;HNRNPH1;POLR2A;FGFRL1
prerank,negative regulation of platelet activation (GO:0010544),-0.45116535578048306,-1.2849583140560024,0.1386861313868613,0.5858403660339287,1.0,4/16,5.24%,PRKG1;APOE;NOS3;THBD
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.5467152455088209,1.2849386597556605,0.14434060228452752,0.978194802762839,1.0,22/88,16.22%,KIF14;CCNF;PSMC2;PSMD5;FBXL7;FBXW7;CUL5;FBXL8;PSMB1;PSMD14;CUL4B;PSMD1;SKP2;FBXL17;PSMB9;FBXW11;BTRC;FBXO27;PSMC6;FBXO17;FBXL14;AMN1
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5113964406522309,-1.2834519846224646,0.1939799331103679,0.5877031736366001,1.0,6/11,17.56%,PARP8;PARP12;TIPARP;PARP6;PARP16;PARP10
prerank,regulation of macrophage activation (GO:0043030),-0.3874356033102802,-1.282781342317757,0.1377245508982036,0.5877356226679925,1.0,18/30,39.20%,TLR4;HSPD1;LBP;MYO18A;NR1H3;THBS1;ZC3H12A;KARS1;SHPK;SPHK1;LRFN5;MFHAS1;CD74;MIF;PJA2;TNIP2;CEBPA;FCGR2B
prerank,positive regulation of catabolic process (GO:0009896),0.5512355035491556,1.282687657037689,0.1849894291754757,0.9846404471895706,1.0,6/65,8.32%,DTL;BARD1;GSK3B;NEDD4;ATG7;SMURF1
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.41343349774991567,-1.2822898186386589,0.14644351464435146,0.5871738063176138,1.0,6/22,8.78%,CYRIB;STX7;MALT1;FBXO38;B2M;HSPD1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.4328783881011258,-1.2812441381974673,0.1422924901185771,0.5881012600393851,1.0,5/17,10.33%,TGFB2;TAOK2;LYN;MID1;STK25
prerank,synaptic vesicle localization (GO:0097479),-0.47586781683667306,-1.2811896647979342,0.17684887459807075,0.5865265249051445,1.0,7/13,18.07%,SPG11;SYNDIG1;KIF5B;KIF5C;SYNJ1;RAB27A;NLGN1
prerank,regulation of intracellular transport (GO:0032386),0.5745616528771161,1.2810986392168242,0.2004581901489118,0.9884823513065265,1.0,9/38,14.81%,SPAG5;ATPSCKMT;NUMA1;LRRK2;GAS1;NUP214;SCFD1;RBM4;LCP1
prerank,negative regulation of cellular senescence (GO:2000773),0.6414812698020556,1.2804307934150483,0.21927374301675978,0.9890053510534172,1.0,6/13,15.09%,RBL1;FBXO5;MAP3K3;TERF2;TWIST1;SLC30A10
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.2797374985827114,-1.2801580764147353,0.0,0.5874296850574351,1.0,77/168,21.18%,RPL13;AGO1;RPS8;NBDY;RPS23;RPS29;RPL37A;RPS21;RPL38;PARN;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;EIF4G1;RPS7;RPL18A;RPS20;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;CSDE1;RPS14;RPL10;RPL32;RPL18;RPS28;RPSA;RPS5;ATM;RPL15;RPS24;RPS19;RPL27;RPL39;RPL24;RPL12;RPS12;DDX5;RPS4X;DCP1B;RPS27;RPL27A;RPS9;RPL30;RPL19;EXOSC9;RPL28;EIF4A3;RPL31;RBM8A;DCPS;RPL13A;SMG1;MTPAP;RPL36A;RPL29;TENT4B;CNOT11;RPLP2;TNKS1BP1;ZC3H12A;RPLP0;DCP1A;RPL10A;RPS10;RPL35;RPS26;NCBP1
prerank,positive regulation of protein import (GO:1904591),0.5794737138491567,1.280034690971585,0.2222222222222222,0.9885225272361858,1.0,4/30,8.31%,ECT2;TPR;UBR5;TRIM28
prerank,natural killer cell activation (GO:0030101),0.6055377145272818,1.2785028788723676,0.23057324840764332,0.992160223504999,1.0,5/23,12.60%,ULBP1;NFIL3;ELF4;SNX27;CASP8
prerank,long-term memory (GO:0007616),-0.43619957478751537,-1.2779916258210504,0.18222222222222223,0.5910458435055558,1.0,7/19,12.14%,CPEB3;APOE;RASGRF1;SGK1;CAMK4;NFATC4;SHANK1
prerank,regulation of cellular metabolic process (GO:0031323),-0.3390681461260274,-1.2776377247734636,0.0625,0.5901488743904212,1.0,11/45,13.26%,PRKN;KIF16B;TBC1D16;ACLY;RNF34;ACACB;PARL;SSH1;PINK1;STUB1;MPV17
prerank,regulation of intracellular signal transduction (GO:1902531),0.5335073682662118,1.2774244601796347,0.014,0.994181720407859,1.0,108/420,16.48%,TPX2;BRCA1;ECT2;EXO1;CDK1;BRIP1;BARD1;FAM83D;RACGAP1;RMI2;AURKB;ARHGAP22;ARHGAP11A;ARHGAP21;RFC4;KMT5A;MAP4K4;ULK4;AURKA;DEPDC1B;ARHGAP10;ARHGAP28;TOPBP1;RHOA;RBBP8;RPA1;DNA2;CHEK2;MDM4;TAF3;RAD1;WDR54;RFC2;ARHGAP18;BLM;MRE11;OCRL;NET1;MAPT;RHOT1;VRK2;STK3;RPA2;NRK;FGD4;RBBP4;RFC3;RBBP7;VAV2;PML;RRS1;ARHGAP36;CHEK1;TAF12;GNA13;INPP5B;FGD1;CDK2;ARHGAP24;LRRK2;SYDE2;ARHGAP19;RHOQ;CSNK2A2;MAPKAP1;IKBKG;SRGAP2;SRGAP3;PPP2R5C;ARHGAP6;ARHGAP35;MYO9B;TAF15;ARHGAP23;HDAC1;ARHGEF18;RAC1;FAM13B;TAF4;EZR;RRAS;PDPK1;TRIM6;HDAC2;SSRP1;SPRED1;DLG1;XIAP;PAK1IP1;ITFG2;PIP5K1C;PTPN13;TAOK1;STK11;ITGAV;PIN1;SLC15A4;PRKD2;NF2;PRKAG1;RHOC;KAT6A;PPP2R5B;TP53;PTEN;TAF10;PHF20;PRKAR2B
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.46347033871549725,-1.2773108465811038,0.18596491228070175,0.589216317992174,1.0,6/15,16.20%,NAF1;CCT5;TCP1;CCT7;CCT2;DKC1
prerank,regulation of nervous system process (GO:0031644),-0.45304397582958306,-1.2771132057899472,0.16996047430830039,0.5879882615552612,1.0,8/18,10.99%,DLGAP1;DLGAP4;SLC8A3;TMEM108;NOS3;HTR2C;CHRNA7;APP
prerank,regulation of adaptive immune response (GO:0002819),0.6088417401825088,1.276921779369696,0.2070365358592693,0.9940725316012754,1.0,5/18,13.32%,FADD;IRF1;SAMSN1;AHR;IL4I1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.653133562123393,1.276742339526491,0.23478260869565218,0.9927512211056732,1.0,4/12,8.02%,RFWD3;PRKDC;RPA2;CDK2
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.4507711001693625,-1.2763928375461508,0.1568627450980392,0.5882784563389206,1.0,4/16,7.81%,KCNC2;APOE;NOS3;GUCY1A1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5363612999509957,-1.2763045336265582,0.19504643962848298,0.5850555997475315,1.0,5/10,15.62%,AP2A2;VLDLR;AP2M1;AP2S1;AP2A1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5363612999509957,-1.2763045336265582,0.19504643962848298,0.5850555997475315,1.0,5/10,15.62%,AP2A2;VLDLR;AP2M1;AP2S1;AP2A1
prerank,endochondral bone morphogenesis (GO:0060350),-0.5006840253190203,-1.2754917342655878,0.18849840255591055,0.5852661364769312,1.0,3/11,7.24%,MEF2C;BMPR2;FOXC1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.6085544480994755,1.2746545099379643,0.23316708229426433,0.9987362517291782,1.0,1/21,0.46%,CDK1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5916949866881472,1.272964787412277,0.2374839537869063,1.0,1.0,8/22,17.05%,TGM1;FGFR2;CASK;KLF9;NOTCH2;MED1;PRKD1;PTPRK
prerank,regulation of mitochondrial translation (GO:0070129),-0.4068739201346969,-1.272585385126058,0.15319148936170213,0.591051203409869,1.0,17/21,45.58%,UQCC2;MTG2;TSFM;RPUSD4;ALKBH1;FASTKD2;RMND1;COA3;MPV17L2;TRMT10C;C1QBP;FASTKD3;MTG1;SHMT2;NGRN;MALSU1;RPUSD3
prerank,sodium ion transmembrane transport (GO:0035725),-0.29308496924232763,-1.2723329327523243,0.09375,0.5900498743504033,1.0,19/84,15.99%,SLC6A6;SLC8A3;ATP1B1;SLC6A1;HCN1;ANO6;SLC24A2;SCN1A;ATP1A1;SCN9A;ATP1B3;ATP1A3;ATP1A2;SCN3A;SCN8A;SCN1B;SLC12A2;SLC4A8;SLC6A11
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.37358215822149277,-1.271490200257288,0.15894039735099338,0.5905389161555961,1.0,12/32,27.19%,CAV1;AKAP6;CEMIP;PLCG1;TRPC3;TRPC1;CX3CL1;GRIN1;P2RX4;P2RX7;GPER1;THY1
prerank,thyroid hormone generation (GO:0006590),0.6708209690686111,1.2710417240122247,0.20426829268292682,1.0,1.0,2/10,8.30%,FOXE1;CPQ
prerank,peptidyl-lysine methylation (GO:0018022),0.5698725730577654,1.2705605813610712,0.24452554744525548,1.0,1.0,6/26,7.46%,KMT5A;SETD6;ATPSCKMT;SETD3;EEF1AKMT2;SETD2
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.418338335835429,-1.2698161722538492,0.16091954022988506,0.5931681893933811,1.0,5/19,19.35%,CARD16;IGF1;CX3CL1;GIT1;ZC3H12A
prerank,regulation of microtubule-based movement (GO:0060632),-0.5121734054716683,-1.2690467920268582,0.20512820512820512,0.5934167629447394,1.0,9/11,44.82%,LAMP1;IGBP1;TTC21B;CFAP298;DYNLT2B;DRC1;HAP1;CCDC65;HDAC6
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.48059768416907367,-1.2688360763544195,0.18685121107266436,0.5922863857442526,1.0,8/14,30.56%,ANO6;PDCD4;PLCG1;THBS1;RGCC;ECSCR;GPER1;CD40
prerank,protein homooligomerization (GO:0051260),0.528358720386352,1.2686721453969858,0.1557128412537917,1.0,1.0,23/114,15.35%,ECT2;POLQ;TK1;UPB1;ALDH1A2;BLM;HPRT1;TRPA1;ATL2;ATL3;FUS;USP16;APIP;TRPM2;ACACA;APPL2;MICU1;TRPM4;EHD1;GSDMD;PKD2;VSTM5;SLC1A5
prerank,supramolecular fiber organization (GO:0097435),0.53198217228915,1.2684631413076033,0.045,1.0,1.0,67/333,15.59%,KIF18B;KIF14;KIF2C;KIF24;FIGNL1;KIF18A;BMP1;SPTA1;LOXL3;CKAP5;KATNAL2;COL22A1;SHROOM3;STMN1;LOXL2;LOX;TRIOBP;TSPAN33;RHOA;COL4A6;CGNL1;IAPP;COL4A4;PCM1;TUBGCP5;TPM4;COL18A1;SIAH2;MAPT;MYO1C;COL5A2;COL23A1;FAT1;CDC42EP2;TLL2;ADAMTS14;B4GALT7;FBLN5;CORO1B;ADAMTS2;TPPP;DDR2;SAMD14;FIGN;TGFBR1;COL15A1;RAC1;RND2;COL4A5;CALB1;COL12A1;P3H1;DES;USP9X;TSPAN5;DLG1;TMOD3;COL20A1;P3H4;MPRIP;TUBGCP3;PIN1;DBN1;HDGFL3;HSPG2;RHOC;PLOD2
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.3884289085805183,-1.2678729591066116,0.14594594594594595,0.5929461547323644,1.0,9/27,14.99%,PLAAT3;ETNK1;SLC27A1;PNPLA8;CHKA;ETNK2;PCYT2;SELENOI;CHKB
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.6293627100945275,1.267846885307911,0.22125181950509462,1.0,1.0,1/15,1.25%,GLI3
prerank,response to estrogen (GO:0043627),0.5845551577749013,1.2669335754305795,0.23297491039426524,1.0,1.0,1/31,0.19%,BRCA1
prerank,positive regulation of macrophage activation (GO:0043032),-0.4506231049312245,-1.2655760539058094,0.1576923076923077,0.5974005471006665,1.0,5/17,19.38%,TLR4;HSPD1;LBP;THBS1;KARS1
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.2750105209270623,-1.2642295696267505,0.0,0.5991815795981864,1.0,42/107,24.64%,PRKN;RASGRF1;RASGRF2;HSP90B1;ERLEC1;UFL1;ATF6;OS9;UBA5;PIK3R1;MAP3K5;CASP4;ATG10;DERL1;AIFM1;SELENOS;JUN;HSPA5;BCL2;PDIA4;THBS1;TMCO1;BCAP31;CEBPB;RCN3;TMTC3;NIBAN1;SCAMP5;UBXN6;DDIT3;DNAJB9;CREB3L1;DNAJB12;SYVN1;TMEM33;PIK3R2;ATP2A3;SEL1L;CDK5RAP3;WFS1;ERP44;MBTPS1
prerank,heart looping (GO:0001947),0.5559185276582078,1.2640573696051907,0.2319004524886878,1.0,1.0,5/39,8.91%,STIL;SETDB2;SRF;MKKS;NPHP3
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3620218287865653,-1.2637613141178095,0.12234042553191489,0.5987628247319285,1.0,10/28,13.91%,SHANK3;APOE;SQSTM1;EPHB2;LGMN;RELN;CHRNA7;APP;ABL1;ADCY8
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5594774111902865,1.2632165877672565,0.22085201793721973,1.0,1.0,9/48,12.45%,BRCA1;E2F1;CHEK2;PRKDC;PML;HTRA2;BOK;USP28;MSH6
prerank,protein autoprocessing (GO:0016540),0.6052492820829708,1.2631561736949743,0.24732620320855614,1.0,1.0,3/17,8.37%,FAM111A;FXN;HTRA2
prerank,negative regulation of insulin secretion (GO:0046676),-0.4363384681075883,-1.2629992102323815,0.16165413533834586,0.5990107480336851,1.0,6/17,16.99%,PRKN;KCNB1;KLF7;IRS1;MIDN;ADRA2A
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.42976152824784547,-1.2625321540887744,0.19421487603305784,0.5985364102815967,1.0,15/20,37.20%,SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;SEMA3B;SEMA3C;SEMA5B;SEMA6C;SEMA3G;SEMA4C;SEMA4A;SEMA4G;SEMA3E;SEMA3F
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.43728266883064965,-1.2615798601496007,0.1946564885496183,0.5992692529707722,1.0,3/16,12.67%,CLDN5;CLDN11;CLDN12
prerank,regulation of establishment of protein localization (GO:0070201),0.6398283913816829,1.2613095631626843,0.24606580829756797,1.0,1.0,4/13,12.06%,CEP295;SPIDR;CEP120;SCFD1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5422010019017595,1.2605060727650075,0.19313304721030042,1.0,1.0,6/63,12.17%,TNFSF13B;IL18;CD80;NCK1;ANXA1;NCK2
prerank,positive regulation of hemostasis (GO:1900048),0.6659592251251989,1.2592370346115807,0.2398753894080997,1.0,1.0,4/10,14.41%,HPSE;SERPINE1;DMTN;ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),0.6659592251251989,1.2592370346115807,0.2398753894080997,1.0,1.0,4/10,14.41%,HPSE;SERPINE1;DMTN;ST3GAL4
prerank,sulfur amino acid catabolic process (GO:0000098),-0.5072374132178444,-1.259035195916054,0.20285714285714285,0.6042937909169029,1.0,7/10,41.33%,TXN2;MTRR;CBS;CTH;ADO;MPST;BLMH
prerank,protein O-linked mannosylation (GO:0035269),0.5950434662265187,1.2590080913377857,0.23653088042049936,1.0,1.0,6/18,11.84%,POMT1;LARGE1;CRPPA;FKRP;RXYLT1;TMTC4
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.37495855311562715,-1.2589908535464132,0.1414141414141414,0.6027171209530163,1.0,9/27,15.83%,PTK2;FLT1;TEK;PDGFRB;FGF2;PIK3R4;IRS1;EPHA8;TNFAIP8L3
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.6017461889149653,1.258643157705059,0.2362002567394095,1.0,1.0,9/22,16.00%,PAXIP1;PSMC2;MED14;SRF;MED30;MED24;MED1;PSMC6;TP53
prerank,protein import into peroxisome matrix (GO:0016558),-0.4759742297379046,-1.2583074324937993,0.19701492537313434,0.6028830320374763,1.0,9/12,37.87%,PEX5L;PEX1;PEX5;PEX6;PEX26;PEX10;PEX16;PEX2;PEX14
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.5945447072913912,1.2580435126905918,0.24317295188556567,1.0,1.0,6/20,17.61%,PLK1;IPO7;CDKN1B;IPO5;PTEN;TFAP4
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.4327949522732226,-1.257158426746437,0.1821705426356589,0.6043062446197537,1.0,7/18,16.20%,PARN;NAF1;CCT5;TCP1;CCT7;CCT2;DKC1
prerank,thymus development (GO:0048538),0.6293749175303907,1.2570341748287626,0.23580786026200873,1.0,1.0,3/13,10.37%,FOXE1;FADD;TGFBR1
prerank,digestive tract development (GO:0048565),0.5648365502523287,1.2568747669648774,0.24029126213592233,1.0,1.0,6/32,7.45%,GLI2;GLI3;CLMP;FGFR2;KIT;NIPBL
prerank,chromatin disassembly (GO:0031498),0.6261436385633428,1.2563203385835173,0.23011363636363635,1.0,1.0,5/14,8.76%,SMARCC1;NFE2;ARID2;ARID1A;SMARCA4
prerank,nucleosome disassembly (GO:0006337),0.6261436385633428,1.2563203385835173,0.23011363636363635,1.0,1.0,5/14,8.76%,SMARCC1;NFE2;ARID2;ARID1A;SMARCA4
prerank,epithelium development (GO:0060429),0.5284183408778332,1.255737998157815,0.16122448979591836,1.0,1.0,14/107,11.52%,STIL;CDK1;LOXL3;TIMELESS;FGFR2;ALDH1A2;PPP2R3A;GRHL2;FN3K;KANK2;MEOX2;ERRFI1;BMP2;PCNA
prerank,neural crest cell development (GO:0014032),-0.3319494409346978,-1.2556894247484054,0.11926605504587157,0.6065308462359051,1.0,27/44,38.37%,CDH2;SEMA6A;ANXA6;SEMA6D;SEMA7A;SEMA4D;ERBB4;SEMA3A;TBX1;SEMA3B;SEMA3C;SEMA5B;NOLC1;KLHL12;SEMA6C;SOX11;SEMA3G;SEMA4C;SOX10;SOX8;SEMA4A;KBTBD8;HTR2B;SEMA4G;SEMA3E;SEMA3F;PDCD6
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.4996843515705396,-1.2549731396676767,0.19701492537313434,0.6067229529179605,1.0,4/11,4.15%,ACVR1;SMAD7;TGFBR2;TGFB2
prerank,regulation of protein dephosphorylation (GO:0035304),0.5656502932809577,1.2530722266544978,0.23208191126279865,1.0,1.0,11/37,17.50%,CDCA2;PPP1R7;PPP1R8;CALM2;ENSA;SMPD1;CAMTA1;PTPA;PIN1;ANKLE2;PPP6R2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.39582231992161565,-1.25284043291578,0.2,0.6107096157518365,1.0,14/24,28.42%,SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;MEGF8;SEMA3B;VEGFA;SEMA3C;SEMA5B;NRP1;SEMA6C;SEMA3G;SEMA4C
prerank,sphingoid biosynthetic process (GO:0046520),-0.5003585883012585,-1.2524258140708384,0.208955223880597,0.6083774663471486,1.0,6/11,23.59%,ACER2;ASAH1;ACER3;ASAH2;ABCA2;SPHK1
prerank,sphingosine biosynthetic process (GO:0046512),-0.5003585883012585,-1.2524258140708384,0.208955223880597,0.6083774663471486,1.0,6/11,23.59%,ACER2;ASAH1;ACER3;ASAH2;ABCA2;SPHK1
prerank,respiratory system development (GO:0060541),0.5739326652657203,1.2523659256064896,0.23962040332147094,1.0,1.0,7/32,11.68%,GLI2;LOXL3;FGFR2;PDPN;SMCHD1;NPHP3;NKX2-1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.48320270633426515,-1.2522698688365568,0.2175226586102719,0.6070037692624007,1.0,7/11,45.31%,AKAP6;LRRC38;KCNIP2;LRRC55;TREM2;RNF207;NOS1AP
prerank,nucleic acid metabolic process (GO:0090304),0.5406946313874534,1.2521231643095474,0.19703389830508475,1.0,1.0,23/69,19.51%,ANKLE1;KPNA2;TOPBP1;HNRNPD;RBFOX2;DNA2;HNRNPA1;DNASE2;HNRNPH1;POLR2A;MMS19;HNRNPU;ENPP1;HNRNPL;HNRNPH2;DXO;HNRNPA2B1;DDX1;METTL3;RAD50;XRN2;POLR2B;HNRNPR
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.6339220206995202,1.2520475738059875,0.24492753623188407,1.0,1.0,5/12,12.46%,DPYD;DPYSL4;CTPS1;CDA;DPYSL3
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.5398688233457433,1.2514853918904656,0.2326350606394708,1.0,1.0,19/50,19.95%,NDC1;NUP155;NUP205;NUP160;AGO2;NUP85;TPR;FMR1;POLR2A;PUM2;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;POLR2B;NUP188;NUP35
prerank,regulation of gene silencing by RNA (GO:0060966),0.5398688233457433,1.2514853918904656,0.2326350606394708,1.0,1.0,19/50,19.95%,NDC1;NUP155;NUP205;NUP160;AGO2;NUP85;TPR;FMR1;POLR2A;PUM2;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;POLR2B;NUP188;NUP35
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.5517389965209867,1.2510309103153021,0.23738532110091742,1.0,1.0,17/41,19.95%,NDC1;NUP155;NUP205;NUP160;GCK;NUP85;TPR;NUP214;RANBP2;NUP133;PRKAG1;NUP42;NUP98;LACC1;NUP210;NUP188;NUP35
prerank,modification-dependent protein catabolic process (GO:0019941),0.5320377663398634,1.2508429703697326,0.09719438877755511,1.0,1.0,31/193,8.67%,DTL;UHRF1;BUB1B;PLK1;CDC20;UBE2C;AURKB;UBE2S;RNF168;ANAPC7;AURKA;FEM1C;PSMC2;CDC27;UBE2K;NEDD4;FBXL7;UBR4;SIAH2;KLHL15;SPSB2;RNF43;BUB3;ARRB1;ELOC;RC3H2;RNF40;SMURF1;UBE2R2;CUL3;PSMD14
prerank,positive regulation of programmed cell death (GO:0043068),0.5197167085095385,1.2502298586290244,0.069,1.0,1.0,43/272,11.48%,TOP2A;ECT2;MELK;BARD1;E2F1;STPG1;ITGB3BP;FADD;STK17B;BMF;IAPP;AIFM2;FAM162A;CCAR1;NET1;FAF1;STK3;SFRP2;FGD4;ERCC3;VAV2;MAP3K20;ATG7;CALHM2;SCRIB;GNA13;FGD1;SAP18;FOXO3;LRRK2;HTRA2;ING4;BCLAF1;TNFRSF10B;KLF11;DNM2;HMGB1;APAF1;BOK;IP6K2;ARHGEF18;QRICH1;BMP2
prerank,negative regulation of protein processing (GO:0010955),0.630207542799538,1.2491621691782002,0.26331360946745563,1.0,1.0,4/12,9.80%,PRNP;SERPINE1;LRRK2;GAS1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.5310551310654743,1.2491409972059824,0.20229405630865485,1.0,1.0,16/72,11.52%,POLK;RFC4;RPA1;POLD3;ERCC4;RFC2;POLD1;RPA2;RFC1;ERCC3;RFC3;PRPF19;POLR2A;CUL4B;XPA;PCNA
prerank,aggrephagy (GO:0035973),-0.38605430253396744,-1.2490858690811097,0.15508021390374332,0.6137012328968425,1.0,12/27,22.52%,PRKN;DYNC1LI2;SQSTM1;DYNC1I2;DYNC1LI1;DYNLL2;WDFY3;UBB;PARK7;UBC;RPS27A;WDR81
prerank,polyamine metabolic process (GO:0006595),-0.47304213005692364,-1.2485036821428213,0.18506493506493507,0.6135840106143507,1.0,8/13,38.53%,SAT1;SMS;OAZ2;DHPS;PAOX;HDAC10;ODC1;SRM
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.37537570408627985,-1.247661357691173,0.18617021276595744,0.6140061252631812,1.0,10/26,13.68%,OCLN;INSR;IGF1;CREBL2;AKT2;PIK3R1;IRS2;CLIP3;IRS1;PTPN11
prerank,calcium import into the mitochondrion (GO:0036444),0.6472514861810592,1.247566322537512,0.25329428989751096,1.0,1.0,5/10,20.46%,MCU;MCUB;MICU1;MAIP1;MICU2
prerank,regulation of isotype switching (GO:0045191),0.6258125633835541,1.2471329870717418,0.2510176390773406,1.0,1.0,5/14,15.41%,PAXIP1;RIF1;KMT5C;SLC15A4;SHLD2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6233708261120438,1.2471045218115226,0.2510948905109489,1.0,1.0,5/12,15.47%,CBFB;ELF2;ELF1;RC3H1;RUNX1
prerank,early endosome to late endosome transport (GO:0045022),-0.417046528234819,-1.2467755942160328,0.14537444933920704,0.6144446257696106,1.0,5/20,12.77%,STX8;KIF16B;BECN1;RAB5A;HOOK1
prerank,peptidyl-lysine modification (GO:0018205),0.523620328092316,1.2463165049882363,0.18993839835728954,1.0,1.0,28/99,17.48%,LOXL3;NDC1;NUP155;SAE1;LOXL2;LOX;NUP205;ATPSCKMT;NUP160;SENP1;NUP85;NDUFAB1;TPR;EEF1AKMT2;TRIM28;RANGAP1;VIPAS39;NSMCE2;NUP214;SUMO2;TRPM4;RANBP2;P3H4;NUP133;PLOD2;NUP42;NUP98;NUP210
prerank,receptor metabolic process (GO:0043112),-0.31294446241548524,-1.2459139852421302,0.1111111111111111,0.6148574488309083,1.0,17/53,13.84%,DNM3;KIF16B;CALCRL;CAV1;BECN1;ACKR3;PIK3R4;LRP1;RAMP1;RAMP2;DNM1;LGMN;CD81;AP2M1;GRB2;ARFGEF2;LDLRAP1
prerank,apoptotic DNA fragmentation (GO:0006309),0.6124296054312761,1.2454554554392419,0.24753867791842477,1.0,1.0,3/16,9.77%,HMGB2;DNASE2;HMGB1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.5711352796054495,1.245405460677434,0.24725943970767356,1.0,1.0,10/26,17.91%,CDK5RAP2;PSRC1;NUMA1;MAPT;DRG1;RAC1;AKAP9;STMN2;TRPV4;CLASP1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5967373811353373,1.2453273812242134,0.23769338959212377,1.0,1.0,7/16,16.31%,TERF1;RTEL1;ERCC4;TERF2;SMG6;HNRNPA2B1;TINF2
prerank,cilium organization (GO:0044782),0.5204280124853787,1.2452949362477301,0.1111111111111111,1.0,1.0,40/209,10.81%,KIF24;MNS1;PLK4;IFT80;HYLS1;CEP89;BBS9;DZIP1L;SCLT1;ACTR3;WDR35;PARVA;ASAP1;WDR90;GBF1;SPAG16;IFT140;POC1B;FAM161A;EXOC4;KIF27;PCM1;OCRL;TXNDC15;MKKS;RTTN;WDR11;CEP83;NUDCD3;RILPL1;RFX2;SSX2IP;CCDC57;CFAP52;WDPCP;NPHP3;ODF2;RAB1A;TTC39C;TRAPPC14
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.49753986459902766,-1.2447267001319633,0.20689655172413793,0.6161879883859279,1.0,5/11,15.21%,GIGYF1;IGF1;PIK3R1;IRS1;GIGYF2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.3457203831861386,-1.2444487914859317,0.10810810810810811,0.6152825381483871,1.0,12/35,12.76%,FLT1;KRIT1;MEF2C;CAV1;APOE;NF1;ATP5F1A;CAV2;SYNJ2BP;THBS1;SCG2;RGCC
prerank,receptor recycling (GO:0001881),-0.5202561579399267,-1.2439128534094428,0.24169184290030213,0.6150289349910407,1.0,6/10,29.78%,ARFGEF2;SORL1;NSG1;PHETA1;PLEKHJ1;REP15
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.5456038755267586,1.243723247451262,0.23469387755102042,1.0,1.0,11/48,9.74%,ATAD2;BAZ1B;DEK;POLR1A;MYO1C;POLR1B;ELOF1;ARID1A;CHEK1;PHF2;TAF1D
prerank,vitamin D metabolic process (GO:0042359),-0.46609897488239227,-1.2427420319095208,0.21311475409836064,0.6164727199994772,1.0,4/13,26.31%,LGMN;PIAS4;CUBN;CYP2R1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6493116626498694,1.2420411746388755,0.2555391432791728,1.0,1.0,7/11,22.44%,PDPN;ENPP2;CORO1B;CD44;SRC;RREB1;ARPIN
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.6200170277097261,1.2418167203613768,0.2507462686567164,1.0,1.0,3/11,11.42%,ATL2;ARL6IP1;STX18
prerank,carboxylic acid catabolic process (GO:0046395),0.620749739005432,1.2418138681705582,0.2514124293785311,1.0,1.0,1/12,0.82%,PON1
prerank,phosphate ion homeostasis (GO:0055062),0.661170143018584,1.2396421359418037,0.24615384615384617,1.0,1.0,2/10,10.67%,FGFR4;ENPP1
prerank,regulation of protein catabolic process (GO:0042176),0.523459102978526,1.2385740512005912,0.18014329580348004,1.0,1.0,9/99,6.94%,DTL;BARD1;FAM83D;GSK3B;CHEK2;MDM4;NEDD4;FAF1;ATG7
prerank,protein targeting to mitochondrion (GO:0006626),-0.3126946692408093,-1.2383101334017623,0.1111111111111111,0.6265086407701089,1.0,27/52,31.04%,IMMP2L;FIS1;DNAJC19;HSPD1;AIFM1;IMMP1L;TIMM44;TOMM70;BCAP31;GDAP1;AIP;FBXO7;DNAJC15;TOMM34;PAM16;TIMM17B;TIMM17A;TOMM7;TIMM9;CHCHD4;TIMM13;TOMM22;TIMM8B;NDUFA13;ROMO1;TOMM5;GRPEL1
prerank,positive regulation of protein transport (GO:0051222),0.5281481547846053,1.238262357721243,0.2126984126984127,1.0,1.0,12/67,13.73%,KIF20B;FRMD4A;PCM1;MYH10;BMP6;TPR;RAB29;SYTL4;EZR;ACHE;PPID;ADAM9
prerank,regulation of organelle assembly (GO:1902115),0.5277240823430497,1.2365842648219687,0.2193074501573977,1.0,1.0,18/72,14.94%,STIL;CEP295;USP6NL;IFT140;TBC1D13;TBC1D2B;STAM;CEP76;ALMS1;SPICE1;SDCCAG8;NPRL3;TBC1D19;STX18;EZR;ATG3;PLK2;MTMR3
prerank,response to acidic pH (GO:0010447),-0.459745671315425,-1.235848479628007,0.22903225806451613,0.6312558318978058,1.0,7/13,37.04%,GPR4;LGMN;CTSS;PKD2L1;CHP1;SLC9A1;PKD1L3
prerank,motile cilium assembly (GO:0044458),0.6270009258959192,1.2353796433134459,0.26676176890156916,1.0,1.0,4/12,14.85%,DNAAF3;SPATA6;RSPH9;E2F4
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.3579852846201442,-1.2351406849305335,0.18243243243243243,0.631369236840304,1.0,12/31,27.12%,PRKN;ATXN3;HSPA5;PACRG;STUB1;DNAJC18;TM7SF3;HSPB8;DNAJB12;UBE2W;BAG3;HSPA9
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.33795775349349655,-1.2350679975571246,0.14935064935064934,0.6298542137405382,1.0,13/37,17.18%,FHIT;HSP90AB1;OGT;HIPK2;RPL23;RPS7;MAP1A;GIPC1;SGTA;CCAR2;SDCBP;UBXN1;RYBP
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.45557843056153385,-1.2349274625736877,0.2177121771217712,0.6285609669136588,1.0,6/14,35.75%,PIBF1;THBS1;CMKLR1;IRAK3;C1QBP;JAK3
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.5138630090393708,1.2344118869275618,0.160081053698075,1.0,1.0,33/140,11.59%,ECT2;RACGAP1;ARHGAP22;ARHGAP11A;ARHGAP21;DEPDC1B;ARHGAP10;ARHGAP28;RHOA;CGNL1;ARHGAP18;OCRL;NET1;RHOT1;FGD4;VAV2;ARHGAP36;GNA13;INPP5B;FGD1;ARHGAP24;SYDE2;ARHGAP19;RHOQ;SRGAP2;SRGAP3;ARHGAP6;ARHGAP35;MYO9B;ARHGAP23;ARHGEF18;RAC1;FAM13B
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.383823455187901,-1.234210649097124,0.1952662721893491,0.6286987435206891,1.0,6/26,9.79%,CAV1;WDFY1;IFI35;PTPN22;LBP;NR1H3
prerank,regulation of filopodium assembly (GO:0051489),-0.3268051821772346,-1.2338393666435055,0.16030534351145037,0.627931064969307,1.0,11/38,8.93%,PPP1R16B;ARAP1;FNBP1L;AGRN;GAP43;PALM;PIK3R1;MYO10;RAB5A;CAPZB;ARHGAP44
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.4344767066037685,-1.233770855533266,0.1906474820143885,0.6264726194552883,1.0,8/16,39.27%,TRIB2;TNFRSF21;CD274;TYROBP;JAK3;DLL1;FCGR2B;AGER
prerank,diol biosynthetic process (GO:0034312),-0.4564006089192827,-1.2329413916521945,0.199288256227758,0.6271007810272068,1.0,8/15,23.59%,ACER2;ASAH1;ACER3;QDPR;ASAH2;GCH1;ABCA2;SPHK1
prerank,negative regulation of vascular permeability (GO:0043116),-0.4640292319509714,-1.2317498710195882,0.20303030303030303,0.628627764820171,1.0,7/12,23.06%,PDE3A;CLDN5;RAMP2;SLIT2;VEGFA;PDE2A;SH3GL2
prerank,synapse assembly (GO:0007416),-0.2947172540024341,-1.2314853333354143,0.14285714285714285,0.6276758040840992,1.0,14/67,7.21%,DNM3;GABRB3;CDH2;DNER;GABRA2;SHANK3;SPOCK2;LRRTM3;GRID2;ADGRL3;NRCAM;SDK2;FGF13;NRXN1
prerank,protein homotetramerization (GO:0051289),0.5338047007079473,1.2314049884867944,0.23522975929978118,1.0,1.0,11/49,12.45%,TK1;UPB1;ALDH1A2;HPRT1;TRPA1;USP16;APIP;TRPM2;ACACA;APPL2;TRPM4
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.5763621252610451,1.2313998359706673,0.26153846153846155,1.0,1.0,6/22,17.61%,PLK1;IPO7;CDKN1B;IPO5;PTEN;TFAP4
prerank,peptidyl-serine phosphorylation (GO:0018105),0.5183085468200757,1.231252373563647,0.16012084592145015,1.0,1.0,51/153,19.06%,CDK1;TTK;CLSPN;PLK1;MASTL;MAST2;DYRK1A;AURKA;ROCK2;GSK3B;NLK;PRKDC;DYRK3;VRK2;WNK1;CDK2;LRRK2;ROCK1;CSNK2A2;MARK2;TGFBR1;CAMK1D;EIF2AK3;PRKCB;PRKCA;PDPK1;ULK2;CSNK1G2;MAPKAPK3;PRKCE;PRKCI;PLK2;CAB39;PRKD1;MORC3;VRK1;PRKD2;STK39;HIPK3;ATR;MAST4;CSNK1A1;PIKFYVE;SRPK2;CSNK1G1;MAST1;PKN2;MAPK14;RIPK1;HIPK1;CAMKV
prerank,positive regulation of glucose import (GO:0046326),-0.39777117330049405,-1.2302207086458592,0.2081447963800905,0.629331744288235,1.0,9/21,13.68%,OCLN;INSR;IGF1;CREBL2;AKT2;PIK3R1;IRS2;IRS1;PTPN11
prerank,protein methylation (GO:0006479),0.5516588733727689,1.2299507760790687,0.25720876585928487,1.0,1.0,4/40,7.07%,EZH2;ATPSCKMT;SETD3;EEF1AKMT2
prerank,positive regulation of protein metabolic process (GO:0051247),0.5238508847979012,1.2299385455590612,0.18292682926829268,1.0,1.0,14/110,9.83%,DTL;UHRF1;BARD1;ROCK2;GSK3B;NEDD4;IL18;SLC25A37;ATG7;CD80;SMURF1;AGT;ABCB10;RAB1A
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.5386276197680544,1.2298460271733018,0.2576617480136209,1.0,1.0,16/41,19.95%,NDC1;NUP155;NUP205;NUP160;GCK;NUP85;TPR;NUP214;RANBP2;NUP133;PRKAG1;NUP42;NUP98;NUP210;NUP188;NUP35
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.5680492842248361,1.229788476363322,0.2558139534883721,1.0,1.0,9/32,16.15%,CDCA2;PPP1R7;CALM2;SMPD1;PPP1R15B;CAMTA1;PTPA;PIN1;ANKLE2
prerank,translation (GO:0006412),-0.2544507787233897,-1.2295978628627635,0.0,0.6291265750372991,1.0,96/208,23.97%,EEF1A1;RPL13;FARSB;RPS8;RPS23;RPS29;RPL37A;RPS21;LARS2;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;EIF4G1;EEF2;RPS7;RPL18A;RPS20;RPS6;RPS18;RPL14;RPLP1;RPS13;AARS1;RARS1;RPL9;RPL37;RPL8;MRRF;FARSA;RPS14;RPL10;RPL32;RPL18;RPS28;RPSA;RPS5;RPL15;RPS24;RPS19;SARS1;RPL27;RPL39;RPL24;RPL12;RPS12;RWDD1;MRPS5;RPS4X;RPS27;RPL27A;N6AMT1;RPS9;WARS1;MRPS15;MRPS18A;RPL30;EEF1B2;RPL19;MRPS21;MRPS6;RPL28;MRPL27;RPL31;RPL13A;RPL36A;TARS1;RPL29;NARS1;HBS1L;RPLP2;MRPL23;DHPS;MRPL9;KARS1;RPLP0;RPL10A;RPS10;TSFM;RPS6KB2;RPL35;TNIP1;RPS26;MRPL51;TMA7;RPS27A;MRPL32;RPS3;MRPS14;MRPL47;MRPS7;RPL4
prerank,protein import into peroxisome membrane (GO:0045046),-0.3936670297584881,-1.2293788770058425,0.17061611374407584,0.628025264509574,1.0,9/22,22.04%,FIS1;ALDH3A2;PEX3;PEX5;ABCD2;GDAP1;PXMP4;PEX26;PXMP2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.5396156255476573,1.229159118216334,0.25688073394495414,1.0,1.0,3/46,6.39%,LMNB1;ANXA2;CNN2
prerank,positive regulation of protein deacetylation (GO:0090312),0.6245098245708198,1.2289917916358164,0.2649930264993027,1.0,1.0,4/14,7.78%,DYRK1A;CTBP1;NIPBL;ZBTB7B
prerank,respiratory tube development (GO:0030323),0.5672485851657436,1.2283531550093565,0.2583436341161928,1.0,1.0,6/28,11.68%,GLI2;LOXL3;FGFR2;PDPN;NPHP3;NKX2-1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.5248020885308166,1.2279778168186415,0.19631901840490798,1.0,1.0,12/98,9.83%,CCNB1;UHRF1;CDK1;ANXA2;XDH;ARRB1;FMR1;SCRIB;RAB29;ANGPT1;AGT;RAB1A
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.35411979088107165,-1.2274978583129872,0.14012738853503184,0.6308680298136684,1.0,14/36,20.27%,FHIT;HSP90AB1;OPHN1;OGT;MAP1A;GIPC1;CCAR2;SDCBP;UBXN1;PRKCG;AQP11;RYBP;GABARAPL2;PARK7
prerank,establishment of protein localization to organelle (GO:0072594),0.5291463671043177,1.2268597858463584,0.2160168598524763,1.0,1.0,20/72,17.22%,NEURL1B;RANBP17;NUP155;RPAIN;E2F3;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;IPO7;APPL2;NUP214;ZDHHC15;IPO11;NXT1;NUP133;IPO5;NXT2;FAM53B
prerank,granulocyte differentiation (GO:0030851),0.6029014494804891,1.224703585847738,0.261038961038961,1.0,1.0,6/18,10.75%,E2F1;LBR;DEK;PML;CDK2;TAL1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.45210077676528426,-1.2244449572182785,0.19708029197080293,0.6375006516177504,1.0,3/13,2.33%,CAMK2D;CALM1;CAV1
prerank,positive regulation of response to stimulus (GO:0048584),0.5554427945394205,1.2236991506002186,0.2530933633295838,1.0,1.0,7/40,8.68%,ANKLE1;ECHDC3;DHX9;NSMCE4A;FMR1;CD80;BCLAF1
prerank,L-serine metabolic process (GO:0006563),-0.4999795088667986,-1.2234602525594227,0.23415977961432508,0.6384489478310831,1.0,7/10,43.06%,SERINC3;PSAT1;CBS;PSPH;SHMT2;PHGDH;SHMT1
prerank,polarized epithelial cell differentiation (GO:0030859),0.6141766636233744,1.2234060990386602,0.2555391432791728,1.0,1.0,6/13,16.04%,RHOA;RAB10;RAP2A;SCRIB;EZR;MSN
prerank,response to progesterone (GO:0032570),-0.4242465474040701,-1.2223481562136123,0.1950207468879668,0.6397924215973729,1.0,10/18,26.53%,CAV1;TGFB2;ABHD2;NR1H3;CATSPER2;THBS1;TGFB3;WBP2;UBE3A;CATSPER3
prerank,regulation of gene silencing by miRNA (GO:0060964),0.5250484380126272,1.2223352655001087,0.23010752688172043,1.0,1.0,23/62,19.95%,NDC1;NUP155;NUP205;NUP160;AGO2;AJUBA;DHX9;NUP85;TPR;FMR1;POLR2A;LIMD1;PUM2;NUP214;RANBP2;NUP133;FXR1;NUP42;NUP98;NUP210;POLR2B;NUP188;NUP35
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.2993781833829793,-1.2222472818403207,0.13157894736842105,0.6368168335894832,1.0,24/56,24.81%,NDUFS5;OXA1L;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFB9;DMAC2;ACAD9;NDUFA11;NDUFAF1;NDUFB6;TIMMDC1;NDUFB11;NDUFB10;NDUFA10;NDUFS6;NDUFA1
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.2993781833829793,-1.2222472818403207,0.13157894736842105,0.6368168335894832,1.0,24/56,24.81%,NDUFS5;OXA1L;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFB9;DMAC2;ACAD9;NDUFA11;NDUFAF1;NDUFB6;TIMMDC1;NDUFB11;NDUFB10;NDUFA10;NDUFS6;NDUFA1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.5134035875620045,1.2215469357892514,0.009,1.0,1.0,179/807,15.59%,DEPDC1;CENPF;BRCA1;E2F7;E2F8;NR2E3;UHRF1;EZH2;EN1;PLK1;BIRC5;AURKB;GLI2;LOXL3;GLI3;TCFL5;HMGB2;E2F1;CBX5;RBM15;FOXE1;ATOH8;BTAF1;ILF3;KMT5A;SFMBT1;TIMELESS;CBFB;LOXL2;ZFP69;TRIM37;RB1;SP3;ETV6;TWIST2;FNIP1;MIER1;WWOX;SP2;ZEB1;CTCF;HDGF;FGFR2;JAZF1;CNOT1;DAP;MPHOSPH8;RBFOX2;EED;BCOR;SETDB2;MDM4;TAF3;KHDRBS1;MBD1;HIVEP1;CUX1;FHL2;NFIL3;BHLHE41;CTBP1;ZNF568;MAEL;TBL1XR1;MCPH1;IKZF1;SFRP2;BMP6;LCOR;YAF2;GZF1;TCF7L2;SCML2;ORC2;TPR;HOXA7;SCMH1;GATAD2A;PML;PSPC1;GLIS3;MIDEAS;EFNA1;RIF1;POU2F1;NIPBL;MXD1;ZBTB2;ZBTB7B;ZHX2;UIMC1;SAP18;FOXO3;ATF7IP;IRF1;KDM2B;TRIM28;RCOR1;LIN37;ING4;BCLAF1;SMARCA4;YAP1;ZFP90;KLF11;MIER3;NONO;KANK2;LIMD1;VHL;ARID4A;UXT;HMGB1;EPC1;HDAC8;MTA3;CXXC5;NR3C1;NR4A2;RUNX1T1;MYPOP;PARP9;LIMS1;HNRNPU;KCNIP3;SFPQ;DKK3;SMURF2;RBM15B;HDAC1;AHR;BMP2;ATXN1;L3MBTL2;NKX2-1;EZR;ZHX3;FBXW11;RBPJ;SMAD4;SOX9;HDAC2;SAP130;ATF5;ELK4;PPID;TWIST1;USP9X;IRF2BP1;RARB;USP47;DLG1;HEY2;MED1;BTRC;YY1;FOXK2;ZMYM5;BCL7A;CDKN1B;SMAD3;FOXP4;KDM5C;DNMT3A;PCGF6;FOXM1;QARS1;YEATS2;SOX1;PER1;RBAK;OTUD7B;SFRP1;CNOT7;RUNX1;DR1;NFKB1;DCAF1;KAT6A
prerank,positive regulation of cell population proliferation (GO:0008284),0.5115286379240777,1.2214431954328464,0.05805805805805806,1.0,1.0,71/423,13.08%,PRC1;KIF20B;KIF14;EZH2;TTK;BIRC5;SAPCD2;E2F1;TIPIN;SPDYA;MATK;AQP1;HPSE;NAP1L1;FBXO5;BMPR1A;PHIP;FGFR4;HYAL1;CEP43;FGFR2;FXN;GAREM1;DDRGK1;LAMB1;DHX9;CNOT6L;CCAR1;SFRP2;BMP6;TCF7L2;RTKN2;PDGFRA;IL18;TGFBR3;DERL2;CDC25B;SAAL1;CCN1;POU3F2;WWTR1;CDK2;CNOT6;CUL3;GRK5;YAP1;MAP3K3;S1PR2;PIM1;AGT;DDR2;TGFBR1;CDC123;HNRNPU;RBPMS2;HDAC1;CRKL;CNTF;BMP2;GLP2R;STOX1;RBPJ;KMT2D;TRPM4;ADAM17;GJA1;SOX9;HDAC2;IL31RA;CTSH;LRP5
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.6063441182041837,1.2214133011424417,0.2624821683309558,1.0,1.0,3/13,10.03%,BARD1;TPR;RANGAP1
prerank,determination of heart left/right asymmetry (GO:0061371),0.5379340225960128,1.221229839509942,0.2656072644721907,1.0,1.0,5/42,8.91%,STIL;SETDB2;SRF;MKKS;NPHP3
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.3230469421664777,-1.2209945133366507,0.1326530612244898,0.6383068920491878,1.0,19/48,27.19%,CAMK2D;CALM1;FKBP1A;AKAP6;CEMIP;PLCG1;TRPC1;SELENON;CX3CL1;SRI;PDE4D;CALM3;NOS1;PTK2B;GSTM2;JPH2;GPER1;JPH4;THY1
prerank,regulation of acrosome reaction (GO:0060046),-0.508294414670381,-1.2209315024532097,0.2521246458923513,0.6368565292028845,1.0,3/10,27.97%,GLRA1;CACNA1H;PLCB1
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.40794823815268033,-1.2206788280969245,0.20930232558139536,0.6358388696023699,1.0,12/18,31.61%,GOT2;SLC25A13;SLC25A12;MTHFD1;SMS;GOT1;NIT2;ASS1;ASPG;ADI1;NAT8L;ASNS
prerank,lung development (GO:0030324),0.5551469685121866,1.2203095555185557,0.2846975088967972,1.0,1.0,7/33,11.68%,GLI2;LOXL3;FGFR2;PDPN;NPHP3;ERRFI1;NKX2-1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.4679026961702786,-1.220078437675533,0.21203438395415472,0.6359087106558485,1.0,5/12,16.20%,CCT5;TCP1;CCT7;CCT2;DKC1
prerank,cellular response to interleukin-12 (GO:0071349),0.5319336417140467,1.2195804106524493,0.25617977528089886,1.0,1.0,11/48,19.89%,LMNB1;ANXA2;CNN2;CAPZA1;LCP1;HNRNPA2B1;MSN;SIRPA;CD47;TYK2;ARF1
prerank,response to interferon-alpha (GO:0035455),-0.41246194892847465,-1.2193920667008638,0.24363636363636362,0.6360300223264619,1.0,7/16,16.69%,IFNAR1;RO60;GAS6;IFITM3;ADAR;BST2;IFITM2
prerank,negative regulation of cellular metabolic process (GO:0031324),0.5523231193776792,1.2181381183130906,0.2530933633295838,1.0,1.0,2/37,4.81%,BRCA1;WDR54
prerank,negative regulation of cell development (GO:0010721),0.5556741880849007,1.2181019869898375,0.2591240875912409,1.0,1.0,6/25,11.99%,GSK3B;FBN1;PCM1;FBXW7;RFLNA;APPL2
prerank,positive regulation of protein ubiquitination (GO:0031398),0.5220861286303529,1.2178672961434551,0.22722513089005236,1.0,1.0,11/80,9.20%,BRCA1;PLK1;PAXIP1;FANCI;MYCBP2;FBXW7;UBE2N;LRRK2;CUL3;TBC1D7;ANGPT1
prerank,fatty acid oxidation (GO:0019395),-0.3048304069598192,-1.2178469642091898,0.17777777777777778,0.6383821066902499,1.0,15/57,16.73%,ADIPOR2;HADHB;ACADM;CROT;SCP2;ABCD4;MECR;ALDH3A2;HADH;ACAD10;ECHS1;ABCD2;DECR1;ECHDC2;ADH5
prerank,cellular response to reactive oxygen species (GO:0034614),0.5310998026997572,1.217811963205734,0.22234273318872017,1.0,1.0,10/59,11.23%,ECT2;AQP1;SETX;FXN;NET1;MAPT;PDGFRA;AGAP3;TRPM2;ANXA1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.4747223328104538,-1.21600120313581,0.2578616352201258,0.6415474043498367,1.0,7/11,29.02%,ATF6;HSPA5;CEBPB;DDIT3;CREB3L1;ATF6B;MBTPS2
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4845936756317042,-1.2155067550983276,0.21223021582733814,0.6411865191643249,1.0,4/12,4.40%,CTNNA3;CAV1;RYR2;BIN1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.4084242112624681,-1.2154214236787284,0.1952191235059761,0.6398141497081381,1.0,7/20,15.16%,PRKN;DCUN1D3;HSP90AB1;ZMIZ1;DCUN1D5;PINK1;DCUN1D2
prerank,regulation of microtubule-based process (GO:0032886),0.5452537685642168,1.214853467898666,0.2702394526795895,1.0,1.0,15/36,17.91%,MACF1;AURKA;GSK3B;MEMO1;DIAPH1;MAPT;BICD2;TPPP;ROCK1;MARK2;ATF5;TAOK1;MAP6;EPHA3;CLASP1
prerank,regulation of hydrolase activity (GO:0051336),-0.29477275103908074,-1.2147245775172844,0.09090909090909091,0.6400777712143808,1.0,17/71,12.28%,PRKG1;PTK2;EPHA5;CHN2;NTRK2;FGD5;CAV1;VAV3;RABGAP1;TDG;ARHGEF5;ARHGAP44;RASIP1;NF1;PLXNC1;ARHGAP27;RAB3GAP2
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.5064986675815937,1.2136872662776268,0.088,1.0,1.0,52/314,11.19%,KIF14;CCNF;CCNB1;CDK1;BUB1B;PLK1;CDC20;UBE2C;AURKB;UBE2S;FBXO5;ANAPC7;RB1;AURKA;FEM1C;PSMC2;CDC27;PSMD5;UBE2K;NEDD4;FBXL7;SPSB3;SIAH2;KLHL15;SPSB2;TBL1XR1;FAF1;BUB3;ARRB1;FBXW7;PML;DERL2;CUL5;FBXL8;CDK2;AGAP3;SMURF1;PSMB1;CUL3;PSMD14;KCTD2;KLHL22;CUL4B;PSMD1;SKP2;FBXL17;ARMC8;PPP2R5C;FBXO45;SMURF2;PSMB9;DCAF12
prerank,dendritic cell chemotaxis (GO:0002407),0.6063201351584487,1.2135668752989381,0.26975476839237056,1.0,1.0,4/14,12.45%,CXCR4;HMGB1;TRPM2;TRPM4
prerank,regulation of leukocyte activation (GO:0002694),-0.4427377670560232,-1.2132929656394433,0.23076923076923078,0.6424501887442255,1.0,8/14,33.43%,LYN;MYO18A;SHPK;MFHAS1;GPER1;CD74;MIF;PJA2
prerank,regulation of T cell cytokine production (GO:0002724),-0.42875212629982185,-1.2131924550120994,0.20284697508896798,0.6410424451325869,1.0,4/15,11.67%,SMAD7;MALT1;B2M;TNFRSF1B
prerank,striated muscle contraction (GO:0006941),-0.3130452393122565,-1.212856350980815,0.16483516483516483,0.6402173731615994,1.0,25/53,39.48%,ATP1B1;RCSD1;RYR2;TPM1;ATP1A2;SCN1B;DTNA;STAC;PIK3CA;KCNQ1;NOS1;ALDOA;SCN4B;MYH14;STAC3;SCN3B;MYL4;CASQ2;TNNI1;GAA;KCNH2;STAC2;TTN;DMD;SCN5A
prerank,proteoglycan biosynthetic process (GO:0030166),-0.35446586957234133,-1.2124295224105488,0.20670391061452514,0.6398102006988284,1.0,12/31,19.08%,IGF1;CSGALNACT1;BMPR2;CHST9;FAM20B;NDST3;HS3ST3B1;EXTL3;CANT1;BMPR1B;B3GAT2;XYLT2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5580807087644052,1.212033609589961,0.2876712328767123,1.0,1.0,8/26,15.82%,ATP2B4;GSK3B;FHL2;PRNP;HOMER2;CAMTA1;STIMATE;LMCD1
prerank,fatty acid transport (GO:0015908),-0.41169061506863475,-1.211527130697051,0.1934156378600823,0.6405128986576161,1.0,13/17,45.72%,APOE;GOT2;SLC27A1;ACSL1;SLC27A4;MFSD2A;FABP5;PPARG;SLC27A3;FABP3;SLC27A6;CD36;CPT1B
prerank,organelle disassembly (GO:1903008),0.541602026119505,1.211011692547061,0.269185360094451,1.0,1.0,12/33,17.43%,CDK1;GBF1;DDRGK1;DYRK3;RB1CC1;ULK2;ATG2A;VRK1;GFM2;MCTS1;DENR;MTIF3
prerank,amide biosynthetic process (GO:0043604),0.5398653016123066,1.2106610449022002,0.26948775055679286,1.0,1.0,10/47,15.04%,RHD;SLC25A15;CERS6;CERS5;PAM;SLC25A2;ASMT;AGK;SMPD1;SPTLC2
prerank,regulation of cellular component organization (GO:0051128),0.5103569585947668,1.210301223599918,0.19090909090909092,1.0,1.0,22/135,12.86%,KIF14;MKI67;HJURP;RAB33B;AURKA;ROCK2;STON1;PACSIN2;NEDD4;NET1;STON2;NCLN;ZFYVE16;ROCK1;PICALM;AGT;HNRNPU;BAG5;METTL4;ITCH;ATF5;SSRP1
prerank,intestinal lipid absorption (GO:0098856),0.620801574386328,1.2100075387445157,0.2687224669603524,1.0,1.0,3/11,19.65%,SOAT2;LDLR;UGCG
prerank,protein complex oligomerization (GO:0051259),0.5129146390821502,1.208503286535292,0.22269353128313893,1.0,1.0,19/85,16.80%,ECT2;POLQ;UPB1;BLM;ATL2;STOML2;ATL3;FUS;MCU;WDCP;BOK;MICU1;EHD1;GSDMD;PKD2;VSTM5;PNPT1;UGDH;LRRC8C
prerank,negative regulation of nuclear division (GO:0051784),0.6126046294183027,1.2084791895458336,0.2706222865412446,1.0,1.0,3/11,12.20%,FBXO5;CHEK1;TOM1L2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.2823058668384403,-1.2079176857283382,0.1111111111111111,0.64855743549637,1.0,18/76,17.38%,CHRM2;ANO1;HOMER1;HTR2C;GPR4;ESR1;TGM2;OPRM1;GNA14;GRM5;AGTR1;GRM1;ADRA1A;PLCE1;HTR2A;PTH1R;ADRA2A;CMKLR1
prerank,endocrine system development (GO:0035270),0.5813079811390409,1.2076056325198343,0.2892347600518807,1.0,1.0,5/21,11.68%,GLI2;FOXE1;TGFBR1;DKK3;NKX2-1
prerank,regulation of cellular respiration (GO:0043457),-0.4146351894577643,-1.206751235969704,0.22727272727272727,0.6502036238552601,1.0,7/17,26.33%,IFNAR1;TRAP1;CBFA2T3;PRDM16;IL10RB;PRELID1;NOA1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.46085767303407965,-1.2063477965849754,0.23178807947019867,0.6481742462561615,1.0,6/13,29.73%,STAT3;GRB2;SHC1;IL15;PLCB1;JAK1
prerank,cellular response to interleukin-15 (GO:0071350),-0.46085767303407965,-1.2063477965849754,0.23178807947019867,0.6481742462561615,1.0,6/13,29.73%,STAT3;GRB2;SHC1;IL15;PLCB1;JAK1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.46674804024939714,-1.2063435910484337,0.2537764350453172,0.6466134917246594,1.0,6/11,14.41%,MAP3K5;GSKIP;PRODH;PDK1;STK25;DIABLO
prerank,alpha-amino acid catabolic process (GO:1901606),0.5508813159445741,1.2058651132487823,0.27056019070321813,1.0,1.0,5/29,13.32%,ACMSD;ACAT1;KMO;HOGA1;IL4I1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.34221743530451687,-1.2048038348093912,0.1830065359477124,0.6490371777701578,1.0,20/33,35.08%,IGF1;PIK3C2B;PIK3R1;MYO16;NYAP2;NF1;IRS1;HTR2A;ERBB2;PIK3CD;PIK3CA;PIK3R2;EDN1;PIK3R5;ERBB3;PIK3C2A;C1QBP;AKT1;TYRO3;HTR2B
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.6311380066737244,1.2045871981425194,0.27180232558139533,1.0,1.0,3/11,10.24%,E2F2;ADAMTS9;PIK3CB
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5983516842888864,1.2045676197712472,0.2918918918918919,1.0,1.0,4/13,14.40%,DYRK1A;YJU2;TWIST1;CD44
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2987783703744554,-1.2044718550210187,0.13333333333333333,0.6483473910338378,1.0,30/75,23.01%,MEF2C;DCC;OPHN1;PAK3;ACTB;S100A6;KLF7;NRCAM;MAP1B;TAOK2;BRSK1;MAP1A;BTBD3;TMEM106B;MINK1;CTNNA2;APP;MEF2A;SLITRK1;NTNG1;DVL1;SHTN1;APBB1;SLITRK4;BAIAP2;S100B;PLPPR4;DRD2;ZDHHC17;MFSD2A
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.3502920112978207,-1.204444408266983,0.14450867052023122,0.6468346829038996,1.0,8/29,20.14%,PLA2G4A;PLAAT3;PNPLA8;NR1H3;LPCAT2;DBI;NR1H2;PLA2G12A
prerank,clathrin coat assembly (GO:0048268),-0.43174679895126244,-1.2038800380749128,0.21262458471760798,0.646660426501019,1.0,7/15,19.75%,SGIP1;NSG2;HIP1;AP2S1;FCHO2;CLTB;NSG1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.3959307248953748,-1.2037589752749231,0.2242152466367713,0.6454468180447765,1.0,13/20,36.63%,ACLY;ACSL4;PPT1;CBR4;SCD;FASN;FAR2;HSD17B8;DGAT2;FITM2;GCDH;SCD5;PPT2
prerank,pyroptosis (GO:0070269),0.5848783131431863,1.2033071976086445,0.2905027932960894,1.0,1.0,4/15,14.38%,DHX9;APIP;CASP8;GSDMD
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.3376312685942394,-1.2025806519950575,0.17763157894736842,0.6470773085603627,1.0,16/32,26.63%,PSEN1;TMSB4X;INSR;IGF1;PFKFB3;PRKAA1;APP;PINK1;NUPR1;ENO1;PPARGC1A;P2RX7;HIF1A;ENTPD5;BEND3;PRXL2C
prerank,cytoplasmic microtubule organization (GO:0031122),0.5243716181028952,1.2024073790660545,0.262987012987013,1.0,1.0,15/54,18.62%,FIGNL1;KATNAL2;RHOA;PCM1;TUBGCP5;NUMA1;MAPT;TPPP;FIGN;EZR;DLG1;TUBGCP3;TRPV4;CLASP1;LIMK2
prerank,keratan sulfate metabolic process (GO:0042339),-0.35491842223574716,-1.2020227092613425,0.1619718309859155,0.6469855565458701,1.0,14/31,17.39%,GNS;FMOD;B4GALT5;HEXB;B3GNT2;ST3GAL6;B4GALT6;PRELP;HEXA;OGN;B4GALT4;LUM;GALNS;CHST2
prerank,regulation of mast cell activation (GO:0033003),-0.48330181204371797,-1.2020170028083488,0.27647058823529413,0.645457360885707,1.0,9/10,49.71%,LYN;NECTIN2;CD84;CRLF2;CD300LF;MILR1;TSLP;PLSCR1;CD226
prerank,long-chain fatty acid import into cell (GO:0044539),-0.5071758742897918,-1.2015266282152326,0.2606060606060606,0.6453454584986467,1.0,4/10,21.55%,SLC2A1;SLC27A1;ACSL1;SLC27A4
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5133641668529209,1.2014899445481233,0.2526205450733753,1.0,1.0,17/74,15.37%,BRCA1;FADD;PHIP;EYA4;GSK3B;SIAH2;TCF7L2;SERPINE1;SH3RF1;TNFRSF10B;TGFBR1;EYA2;CASP8;BIRC6;ITGAV;SRC;GDNF
prerank,positive regulation of protein acetylation (GO:1901985),0.5992686119362907,1.2013308083850334,0.27403156384505023,1.0,1.0,2/12,4.19%,CEP295;FAM161A
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.32083936356924014,-1.2012025910152564,0.15,0.6445718662159403,1.0,9/41,6.28%,CACNA2D1;RYR3;SLC8A3;GRIN2A;RYR2;GRIN2B;SLC24A2;FGF2;HTR2C
prerank,positive regulation of neuron differentiation (GO:0045666),0.5298233181246174,1.2007935124518223,0.2876557191392978,1.0,1.0,4/40,6.59%,ECT2;RHOA;ZEB1;TCF4
prerank,protein modification by small protein conjugation (GO:0032446),0.5051297915430821,1.2002228616355526,0.07,1.0,1.0,71/361,14.31%,BRCA1;CCNF;UHRF1;PLK1;TRIML2;BARD1;UBE2T;UBE2C;RAD18;NDC1;NUP155;SAE1;UBE2S;RFWD3;RNF168;ANAPC7;NUP205;BRAP;NUP160;PDZRN3;CDC27;RNF220;UBE2K;DDRGK1;UHRF2;MYCBP2;NEDD4;FBXL7;PRKDC;SPSB2;NUP85;RNF43;TPR;ARRB1;FBXW7;UBE2N;ATG7;ELOC;CUL5;RNF40;VPS18;TRIM28;SMURF1;UBE2R2;CUL3;CUL4B;LEO1;VHL;FBXL17;RANGAP1;HERC2;FBXO45;SMURF2;TRIM63;ARRDC1;PCNA;NSMCE2;NUP214;FBXW11;SUMO2;TRPM4;TRIM6;ATG3;ITCH;RANBP2;USP9X;CRBN;BTRC;FBXO25;HLTF;TRIM5
prerank,regulation of viral transcription (GO:0046782),-0.3231615912902847,-1.1999242157668042,0.16129032258064516,0.6465256123320396,1.0,23/39,32.21%,MID2;NELFB;CCNT1;IFITM3;TRIM14;TRIM27;POLR2K;POLR2H;POLR2F;POLR2C;TRIM11;TRIM21;TRIM32;POLR2E;TARBP2;ZFP36;NELFCD;HEXIM1;POLR2J;NELFE;POLR2D;MDFIC;TRIM13
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.37510080750329355,-1.1996830513851082,0.19282511210762332,0.645599231275478,1.0,4/22,3.33%,ATP1B1;CALM1;RYR2;AKAP6
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.5828229296968124,1.1996290956363957,0.28783783783783784,1.0,1.0,6/18,11.48%,BHLHE41;FRS2;SOX6;HDAC1;CCN3;BMP2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5957351353414375,1.1993861461103474,0.2794759825327511,1.0,1.0,8/14,20.62%,ADK;LHPP;ADSL;PFAS;RFK;GART;PPAT;ADSS2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.3766701160706871,-1.1992336261643635,0.2100456621004566,0.6453629935628311,1.0,4/21,3.33%,CAMK2D;CALM1;RYR2;AKAP6
prerank,positive regulation of phosphatase activity (GO:0010922),-0.39497260769043774,-1.199217442355573,0.2096069868995633,0.6438802533856248,1.0,7/21,10.84%,MEF2C;HSP90AB1;CALM1;PDGFRB;PLEK;GPLD1;MTOR
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.41614980840837884,-1.1979261492772497,0.21653543307086615,0.6459257255950782,1.0,10/17,20.28%,SMAD7;CALM1;EIF4G1;INPP5K;SPRY2;CADM4;DGKQ;PPEF2;DDIT4;CALM3
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.42857301257906794,-1.197845408863567,0.23193916349809887,0.6445727774759442,1.0,9/15,23.03%,HSP90B1;OS9;UFD1;DERL1;SELENOS;SEC61B;AUP1;SYVN1;SEL1L
prerank,mitochondrion distribution (GO:0048311),0.6066144089486574,1.197664998860598,0.2849002849002849,1.0,1.0,3/12,8.10%,TRAK1;MAPT;LRRK2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.41662428241535254,-1.196887397661219,0.21551724137931033,0.6455760257078627,1.0,5/18,7.94%,FLT1;MEF2C;FGF2;PLCG1;IGF2
prerank,cellular response to hormone stimulus (GO:0032870),-0.2869187212770021,-1.1965441304200104,0.12280701754385964,0.6448880577198461,1.0,28/69,24.42%,THRB;STAT3;MEF2C;CAV1;AR;SOCS2;CTSB;RAMP1;RAMP2;ATP1A1;INPP5K;ATP1A3;SLC5A5;SFR1;SLIT2;ATP1A2;NSMF;SERPINB9;CTSL;ADRA2A;XBP1;ROBO2;SRA1;WBP2;CTSS;URI1;SLIT3;PAX8
prerank,cellular response to organic substance (GO:0071310),-0.26221207844435696,-1.1964506206227858,0.058823529411764705,0.6436185360227465,1.0,46/116,25.09%,STAT3;ACVR1;LEF1;ACVR2A;MAPK8;TGFBR2;AKAP6;BMPR2;MAP2K5;ACVRL1;NFAT5;SOCS2;KLF4;IL1RAPL1;RAMP1;TIPARP;RAMP2;ACVR2B;INPP5K;SLIT2;CTNNB1;PTPN14;ASAH2;PTPN11;LDLRAP1;SHC1;TBK1;SLC1A1;DCPS;ADRA2A;ERBB2;ROBO2;BMPR1B;PTPN9;PTPN12;CLEC3B;PARK7;CERS1;NOS1;RACK1;URI1;SLIT3;SPHK1;ARL6IP5;PLK5;MAPK7
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.5680289007333481,1.1960247780871711,0.2777777777777778,1.0,1.0,7/21,11.13%,RPA1;CHD1L;ERCC4;RPA2;ERCC3;CUL4B;XPA
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.5680289007333481,1.1960247780871711,0.2777777777777778,1.0,1.0,7/21,11.13%,RPA1;CHD1L;ERCC4;RPA2;ERCC3;CUL4B;XPA
prerank,regulation of cell population proliferation (GO:0042127),0.5022598553721919,1.1958355884629204,0.031,1.0,1.0,108/691,13.08%,PRC1;KIF20B;KIF14;SHCBP1;E2F7;CDKN3;UHRF1;EZH2;TTK;BIRC5;RAB33B;SAPCD2;TCFL5;HMGB2;TIPIN;SPDYA;MATK;CDKN2D;NAP1L1;TIMELESS;FBXO5;PPM1D;KSR1;CDKN2C;BMPR1A;PHIP;PDS5B;FGFR4;RHOA;CEP43;CTCF;CDC6;FGFR2;FXN;ALDH1A2;GAREM1;DDRGK1;RBFOX2;MDM4;ARID2;KIT;PRKDC;CNOT6L;COL18A1;CTBP1;CCAR1;PDPN;NMI;SFRP2;BMP6;PTPN2;TCF7L2;RTKN2;HP1BP3;PDGFRA;RBBP4;PML;DERL2;CDC25B;POU3F2;WWTR1;CLMN;CDK2;IRF1;SMAD6;CNOT6;BTG3;ING4;CUL3;CDCA7;GRK5;AXIN2;YAP1;KLF11;KANK2;ABI1;VHL;S1PR2;NOX4;ELN;AGT;NPR3;PPP2R5C;TGFBR1;CDC123;LIMS1;TRAPPC14;BOK;HDAC1;CRKL;CNTF;BMP2;GLP2R;STOX1;P3H1;NCK2;WNT9A;PLPP1;KMT2D;TRPM4;ADAM17;SOX9;TES;HDAC2;ATF5;IL31RA;CTSH;LRP5
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.35244034495336446,-1.1955136027595143,0.16483516483516483,0.6444384365870653,1.0,12/30,20.27%,FHIT;HSP90AB1;OGT;MAP1A;GIPC1;SGTA;CCAR2;SDCBP;UBXN1;RYBP;SVIP;PARK7
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.3950119427781885,-1.1954040036717082,0.24390243902439024,0.6432827233842457,1.0,5/18,16.99%,PRKN;KCNB1;IRS1;MIDN;ADRA2A
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.32957072829834627,-1.1948677308243534,0.20863309352517986,0.6431357295482981,1.0,11/37,13.84%,PRKG1;MEF2C;IGF1;PDCD4;FGF2;SOD2;TPM1;JUN;TAFA5;MMP2;LDLRAP1
prerank,regulation of protein kinase activity (GO:0045859),0.4983204364559455,1.1947978421276524,0.23741007194244604,1.0,1.0,12/106,10.21%,CENPE;ECT2;SPDYA;RB1;CEP43;TAB1;CCN1;WWTR1;MRNIP;GNAQ;DDR2;CEP85
prerank,cellular response to increased oxygen levels (GO:0036295),-0.4703595350126364,-1.194221281193844,0.26198083067092653,0.6431864758862078,1.0,4/11,7.91%,FOXO1;ATP6V0D1;CAV1;FAS
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.5061735352365029,1.194026764860471,0.2474120082815735,1.0,1.0,20/87,14.28%,E2F7;RBL1;WEE1;CDKN2D;FBXO5;CDKN2C;RB1;AURKA;PSMC2;PSMD5;FBXL7;PSMB1;PSMD14;KANK2;PSMD1;PSMB9;USP47;DLG1;JADE1;PSMC6
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.36535464831742614,-1.1938837086953873,0.19457013574660634,0.6424505400119614,1.0,8/24,25.19%,PLA2G4A;CDS2;SLC27A1;PNPLA8;SERAC1;PLA2G12A;PLA2G15;ABCA3
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.3531375016355756,-1.193688580209099,0.20958083832335328,0.6414590378394233,1.0,13/34,16.05%,MEF2C;GRIN2A;GABRA2;GRID2;GLRA1;GRIN2B;GABRA3;GABRA5;GABRG2;GRIN1;GSK3A;GABRG1;INSYN2A
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5470360479667772,1.1932931831260756,0.3025516403402187,1.0,1.0,6/27,9.85%,E2F1;AQP1;DHX9;PDGFRA;AGT;DDR2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3287662530728927,-1.1926369829555419,0.23870967741935484,0.6426836378774982,1.0,17/34,23.59%,FLT1;SEMA6A;VEGFC;RAMP2;FOXC1;SPRY2;VEGFA;ITGB1BP1;PIK3CA;VEGFB;VEGFD;MT1G;NRP1;HSPB1;NUS1;FLT4;SPHK1
prerank,regulation of oxidoreductase activity (GO:0051341),-0.4439474124106652,-1.192591980181494,0.24752475247524752,0.6413290165457848,1.0,6/13,34.00%,OXA1L;SZT2;ABL1;ATP7A;MT3;NOD2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.38554464645641523,-1.1925146758194656,0.23107569721115537,0.6400779650700749,1.0,4/20,3.00%,CAMK2D;ATP1B1;CALM1;RYR2
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.3738979746840183,-1.1923215937048388,0.215,0.6391280497500218,1.0,13/24,17.33%,INSR;IGF1;AKT2;IRS2;IGF2;EPM2AIP1;INPP5K;SELENOS;IRS1;PPP1R3B;GSK3A;DYRK2;SORBS1
prerank,negative regulation of wound healing (GO:0061045),-0.3559607634243699,-1.1923179526353394,0.21666666666666667,0.6376859375554722,1.0,6/28,5.91%,PHLDB2;APOE;VTN;THBD;FGF2;CD34
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.6182399355131548,1.192108325992449,0.3048780487804878,1.0,1.0,3/11,15.47%,CBFB;HMGB1;RUNX1
prerank,negative regulation of DNA metabolic process (GO:0051053),0.5698040000432797,1.1912932919778063,0.29987293519695046,1.0,1.0,8/24,12.45%,ZRANB3;RTEL1;MSH3;ERCC4;BLM;KMT2A;TERF2;MSH6
prerank,icosanoid biosynthetic process (GO:0046456),-0.4895610596974926,-1.1912905058453525,0.24057971014492754,0.6387426883615167,1.0,1/10,0.18%,PLA2G4A
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.5644227892832573,1.19128553396891,0.2819843342036554,1.0,1.0,3/20,9.53%,SAPCD2;RHOQ;PICALM
prerank,positive regulation of apoptotic process (GO:0043065),0.4966843872889033,1.1912543800876205,0.126,1.0,1.0,44/293,11.48%,TOP2A;ECT2;MELK;BARD1;E2F1;STPG1;ITGB3BP;FADD;STK17B;BMF;IAPP;AIFM2;FAM162A;PRNP;CCAR1;NET1;FAF1;STK3;SFRP2;FGD4;ERCC3;VAV2;MAP3K20;ATG7;CALHM2;SCRIB;GNA13;FGD1;SAP18;FOXO3;HTRA2;ING4;BCLAF1;TNFRSF10B;KLF11;DNM2;HMGB1;APAF1;TGFBR1;BOK;IP6K2;ARHGEF18;QRICH1;BMP2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.3657751048735561,-1.1903790034360375,0.21800947867298578,0.6396518073822017,1.0,9/23,12.77%,KIF1B;DYNC1I2;MYO10;KIF1A;KIF5B;KIF5C;TUBA1A;TUBA1B;HOOK1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.47025996205136417,-1.1902432853785945,0.2508250825082508,0.6385534268235961,1.0,5/10,20.28%,CACNA2D1;CALM1;CACNB2;SRI;CALM3
prerank,leukotriene biosynthetic process (GO:0019370),-0.4304855391790007,-1.1901034364005993,0.24666666666666667,0.6374753480590568,1.0,2/14,7.74%,PLA2G4A;GGT5
prerank,protein-containing complex subunit organization (GO:0043933),0.5066165680796734,1.189856860366546,0.24442190669371197,1.0,1.0,23/109,14.90%,KNTC1;FANCA;NDC1;KPNA3;NUP205;TEAD1;MDM4;ADD2;ZW10;TPR;PML;DARS1;YAP1;PICALM;KMT2A;IKBKG;CAPZA1;DMTN;SOX9;PPID;CAPG;EPRS1;NUP133
prerank,ribosomal small subunit assembly (GO:0000028),-0.41547843563705816,-1.1897931441268734,0.25390625,0.636793311918588,1.0,7/16,11.63%,RPS15;RPS14;RPS28;RPSA;RPS5;RPS19;RPS27
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6124944340451138,1.189206435668317,0.2898550724637681,1.0,1.0,4/12,8.31%,MPHOSPH8;SETDB2;ATF7IP;TRIM28
prerank,negative regulation of telomere maintenance (GO:0032205),0.5694274101314831,1.1891174115321739,0.28212290502793297,1.0,1.0,7/15,18.83%,TERF1;RTEL1;ERCC4;TERF2;SMG6;TERF2IP;RAD50
prerank,regulation of protein import into nucleus (GO:0042306),0.5221373154148217,1.1883648499919366,0.29296424452133796,1.0,1.0,4/36,8.31%,ECT2;TPR;UBR5;TRIM28
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.36319028954751154,-1.1874373540279448,0.21965317919075145,0.6413036228889435,1.0,9/27,19.35%,GAS6;TLR4;PTPN22;SELENOS;SYT11;CX3CL1;C1QTNF3;NCKAP1L;ZC3H12A
prerank,protein-DNA complex disassembly (GO:0032986),0.5790772888980911,1.1872049564489289,0.2847411444141689,1.0,1.0,5/16,8.76%,SMARCC1;NFE2;ARID2;ARID1A;SMARCA4
prerank,aortic valve morphogenesis (GO:0003180),0.5304187442600716,1.186769384339055,0.2860635696821516,1.0,1.0,10/30,13.69%,RB1;ROCK2;EFNA1;SMAD6;ROBO1;ROCK1;ELN;SOX9;TWIST1;HEY2
prerank,positive regulation of protein catabolic process (GO:0045732),0.5048660196134015,1.1863604646427905,0.24765868886576484,1.0,1.0,16/84,14.75%,DTL;BARD1;GSK3B;NEDD4;FAF1;ATG7;SMURF1;SH3D19;SNX33;SMURF2;EZR;ITCH;ADAM9;PLK2;CDKN1B;NKD1
prerank,response to interleukin-4 (GO:0070670),-0.4999076306047896,-1.1855791063341288,0.27405247813411077,0.6445910486787557,1.0,3/10,20.81%,LEF1;XBP1;SHPK
prerank,cognition (GO:0050890),-0.32213698051761397,-1.1855091355061844,0.1485148514851485,0.6433757890289583,1.0,19/42,29.95%,SHROOM4;PTCHD1;BBS4;NF1;CHRNA7;SOBP;CHMP2B;APP;GRM5;STRA6;CYFIP1;MFSD2A;CTNS;JAKMIP1;DOP1B;NSUN5;DGCR2;CHD7;LINS1
prerank,regulation of RNA export from nucleus (GO:0046831),0.6145574556668673,1.1854342228093113,0.30428360413589367,1.0,1.0,5/11,7.46%,KHDRBS1;DHX9;NRDE2;TPR;SETD2
prerank,protein mannosylation (GO:0035268),0.5525776746755556,1.1852814452273808,0.2770012706480305,1.0,1.0,6/22,11.84%,POMT1;LARGE1;CRPPA;FKRP;RXYLT1;TMTC4
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.38321823519672493,-1.1852206455586327,0.21176470588235294,0.6426563072687977,1.0,6/20,15.29%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2;SLC12A2
prerank,embryonic digit morphogenesis (GO:0042733),0.5750177992072018,1.1849509047284965,0.2897800776196636,1.0,1.0,8/18,18.35%,GLI3;MAP3K20;WDPCP;HDAC1;HDAC2;TWIST1;SALL1;OSR1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.6111765680198131,1.1841941719776703,0.3071528751753156,1.0,1.0,5/12,13.57%,KHDRBS1;NEDD4;TPR;NUP214;RBM4
prerank,pseudouridine synthesis (GO:0001522),-0.4455090814667586,-1.1841564127409043,0.26143790849673204,0.6439503269153949,1.0,11/13,42.62%,PUS10;TRUB1;DKC1;PUS3;GAR1;NOP10;PUS1;PUS7L;NHP2;PUSL1;RPUSD2
prerank,actin crosslink formation (GO:0051764),0.6050384750042914,1.1839014941007915,0.27941176470588236,1.0,1.0,4/12,14.81%,GAS2L3;DPYSL3;BAIAP2L1;LCP1
prerank,regulation of ERAD pathway (GO:1904292),-0.4772909832778285,-1.1838321272011378,0.2623456790123457,0.6432743848527712,1.0,6/11,27.73%,ATXN3;UBXN1;AQP11;TMEM259;USP19;RNFT1
prerank,positive regulation of hormone secretion (GO:0046887),-0.4026998458303035,-1.1829947407991435,0.23722627737226276,0.6438929298424486,1.0,11/17,46.29%,SNX4;C1QTNF3;VAMP8;EDN1;SOX11;EDN3;SPP1;GRP;VAMP7;RASL10B;NMB
prerank,regulation of heart contraction (GO:0008016),-0.26377972961792,-1.1826463833103915,0.16666666666666666,0.6433293583605122,1.0,30/90,22.44%,CAMK2D;RYR3;SMAD7;SLC8A3;ATP1B1;CALM1;RYR2;TGFB2;DMPK;ATP1A1;TPM1;ATP1B3;NPR1;TRPC1;ATP1A3;ATP1A2;ATP2B2;ATP2B3;GSK3A;SRI;TBX2;PDE4D;FXYD1;KCNQ1;CALM3;KCNJ12;ATP2A3;NOS1;P2RX4;S100A1
prerank,L-glutamate transmembrane transport (GO:0015813),-0.48191165976618844,-1.1809395290473959,0.26373626373626374,0.6461445412791342,1.0,8/10,33.19%,SLC1A2;SLC25A13;SLC25A12;SLC1A1;ARL6IP5;SLC25A18;SLC1A6;PRAF2
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.5891985601729799,1.1806765794439231,0.30491329479768786,1.0,1.0,4/14,13.86%,LOXL3;LIMS1;DMTN;PRKD1
prerank,negative regulation of heart contraction (GO:0045822),-0.4839011679179696,-1.1805836013812594,0.27241379310344827,0.6456272794435781,1.0,7/11,40.50%,ATP1A2;SRI;PDE4D;ZC3H12A;PLN;SPX;PIK3CG
prerank,histone H4 deacetylation (GO:0070933),0.6241310531596422,1.1803760742310982,0.3001464128843338,1.0,1.0,5/10,12.79%,SMARCAD1;RCOR1;HDAC8;HDAC1;HDAC2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.5677813962068224,1.1799949937290979,0.2813738441215324,1.0,1.0,7/18,17.91%,RB1;PDPN;DDR2;BMP2;SMAD3;RUNX1;CLASP1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.3500401886963119,-1.1794917051970695,0.2289156626506024,0.6470812847629757,1.0,12/29,25.47%,APOE;CREBL2;SLC27A1;GPLD1;NR1H3;MTOR;NR1H2;SORBS1;SLC45A3;MFSD2A;CTDNEP1;MID1IP1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.4930162257276466,-1.1787686890640627,0.29069767441860467,0.6474830967420843,1.0,5/10,26.13%,DIP2A;PRKAA1;KLF15;PARK7;MYOCD
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.5099673753207339,1.1781180370007838,0.27713382507903056,1.0,1.0,6/72,5.69%,TPX2;STMN1;DYRK1A;IAPP;SPEF1;SSH2
prerank,peptidyl-serine modification (GO:0018209),0.4954158363379258,1.1780234968715237,0.2050251256281407,1.0,1.0,49/166,19.06%,CDK1;TTK;CLSPN;PLK1;MASTL;MAST2;DYRK1A;AURKA;ROCK2;GSK3B;GALNT1;PRKDC;DYRK3;VRK2;WNK1;CDK2;LRRK2;ROCK1;CSNK2A2;MARK2;TGFBR1;CAMK1D;EIF2AK3;PRKCB;PRKCA;PDPK1;ULK2;CSNK1G2;MAPKAPK3;PRKCE;PRKCI;PLK2;CAB39;PRKD1;MORC3;VRK1;PRKD2;STK39;HIPK3;ATR;MAST4;CSNK1A1;SRPK2;CSNK1G1;MAST1;PKN2;MAPK14;HIPK1;CAMKV
prerank,neurotransmitter transport (GO:0006836),-0.277291708232862,-1.1779583342835158,0.16363636363636364,0.6480173368241712,1.0,21/73,16.08%,UNC13B;SYN3;RIMS1;GLUL;SLC1A2;GABRA2;GLS;APBA1;SYN2;SYT1;LIN7A;BRSK1;NRXN1;SNPH;SLC17A6;ATP1A2;SLC1A1;CPLX1;DVL1;SNAP25;SYNJ1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.5809483504672881,1.177750710431287,0.3112676056338028,1.0,1.0,3/15,7.43%,IQGAP2;ACTR3;ARPC5L
prerank,import into cell (GO:0098657),0.5217565720179074,1.1773237869874054,0.285385500575374,1.0,1.0,4/41,8.08%,NEURL1B;TSPO2;SLC19A1;SLC16A2
prerank,heart morphogenesis (GO:0003007),-0.3049880085509954,-1.1772373443588495,0.13,0.6484934741371671,1.0,15/50,14.84%,PTK2;ACVR1;INSR;RYR2;FKBP1A;ACVRL1;TGFB2;NOS3;TBX3;MEGF8;TBX1;HEYL;ENG;VEGFA;SOX17
prerank,modulation by symbiont of entry into host (GO:0052372),0.5632983512201912,1.1760241415151729,0.3074866310160428,1.0,1.0,1/16,0.69%,TRIML2
prerank,regulation of actomyosin structure organization (GO:0110020),0.606783480171857,1.1759820718539993,0.30737134909596664,1.0,1.0,5/13,16.01%,ROCK2;ALMS1;ROCK1;RAC1;FHOD1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5790218463810723,1.175892063655603,0.28530259365994237,1.0,1.0,5/14,16.04%,RHOA;RAP2A;SCRIB;EZR;MSN
prerank,barbed-end actin filament capping (GO:0051016),0.5756483504104473,1.1758291814610515,0.31136950904392763,1.0,1.0,8/18,15.75%,TRIOBP;ADD2;CAPZA1;TWF1;ADD3;SVIL;CAPG;ADD1
prerank,actin filament capping (GO:0051693),0.5756483504104473,1.1758291814610515,0.31136950904392763,1.0,1.0,8/18,15.75%,TRIOBP;ADD2;CAPZA1;TWF1;ADD3;SVIL;CAPG;ADD1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.49234036269343634,1.1754683436548075,0.2669404517453799,1.0,1.0,30/96,17.48%,NDC1;NUP155;NUP205;NUP160;SRSF4;FIP1L1;EIF4E;UPF3B;SLBP;NUP85;TPR;DDX39B;SRSF7;WDR33;SRSF3;SRRM1;RBM15B;CPSF4;NUP214;RANBP2;MCM3AP;SMG6;NXT1;NUP133;HNRNPA2B1;NUP42;UPF2;DHX38;NUP98;NUP210
prerank,RNA export from nucleus (GO:0006405),0.4933440544304913,1.1752625336427538,0.26212590299277605,1.0,1.0,31/100,17.48%,NDC1;NUP155;NUP205;NUP160;SRSF4;FIP1L1;HNRNPA1;EIF4E;UPF3B;SLBP;NUP85;TPR;DDX39B;SRSF7;WDR33;SRSF3;SRRM1;RBM15B;CPSF4;NUP214;RANBP2;MCM3AP;SMG6;NXT1;NUP133;HNRNPA2B1;NUP42;UPF2;DHX38;NUP98;NUP210
prerank,apical junction assembly (GO:0043297),0.5087679176887535,1.1751902410555504,0.2924944812362031,1.0,1.0,5/53,6.70%,ECT2;RHOA;AFDN;CTNNA1;GRHL2
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.4022352561014392,-1.1751322296579194,0.2450592885375494,0.6521738126563421,1.0,9/17,23.03%,HSP90B1;OS9;UFD1;DERL1;SELENOS;SEC61B;AUP1;SYVN1;SEL1L
prerank,negative regulation of response to wounding (GO:1903035),0.5646521137810602,1.1747057578112232,0.3023560209424084,1.0,1.0,5/19,11.40%,RTN4R;CASK;EPHA4;SERPINE1;PTPRS
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.3118625927728787,-1.174686574356353,0.1565217391304348,0.6518650021505163,1.0,14/39,20.04%,SH3KBP1;STAM2;DUSP3;EPN1;TSG101;LGMN;TGFA;GRB2;SPRY2;ARHGEF7;ERBB2;CBL;PTPN12;HBEGF
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.28767596790762984,-1.1742768276868425,0.09803921568627451,0.6515057933351731,1.0,23/71,22.11%,PRKN;CHFR;OTUD7A;ADAMTS12;CTSC;ATXN3;CLPX;MALT1;VPS4B;CTSB;LGMN;OMA1;CTSZ;STUB1;CTSL;NGLY1;CTSF;UBB;UBE2W;YME1L1;CTSS;UBC;RPS27A
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3842785266575408,-1.1737918654142458,0.23829787234042554,0.6512661138314914,1.0,8/20,14.46%,CPEB3;PSEN1;SHANK3;APOE;CAMK1;RELN;SHANK1;LRP8
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.3628182746198072,-1.173159991071679,0.18716577540106952,0.6515535740371695,1.0,11/26,23.59%,NOS3;ACER2;ASAH1;ACER3;CYB5R3;ASAH2;GCH1;DDAH2;NOS1;ABCA2;SPHK1
prerank,positive regulation of cell cycle (GO:0045787),0.50779675552537,1.1728026640415883,0.28987068965517243,1.0,1.0,12/62,12.47%,CCNB1;TGM1;SPDYA;PSRC1;FGFR2;EIF4E;CDC25B;CHEK1;CCDC57;TAL1;PRKCA;ADAM17
prerank,retina homeostasis (GO:0001895),-0.35565756820542466,-1.1723706165702157,0.2679425837320574,0.6520307065920188,1.0,6/23,13.20%,ACTB;POTEF;B2M;WHRN;BBS4;PRDX1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.513933121042439,1.1720038670728679,0.29227323628219487,1.0,1.0,17/48,19.95%,NDC1;NUP155;NUP205;NUP160;GCK;NUP85;TPR;NUP214;RANBP2;NUP133;PRKAG1;NUP42;PNPT1;NUP98;NUP210;NUP188;NUP35
prerank,cortical actin cytoskeleton organization (GO:0030866),0.5562393756669833,1.1715887519093493,0.2981132075471698,1.0,1.0,11/20,21.78%,ROCK2;RHOQ;ROCK1;LLGL2;DLG1;LCP1;FHOD1;NCKAP1;RAB13;FMNL2;IKBKB
prerank,positive regulation of vasculature development (GO:1904018),0.48799452756609096,1.170944949755647,0.2639751552795031,1.0,1.0,24/94,16.20%,BRCA1;VASH2;AQP1;ANGPT4;HYAL1;AGO2;ADAM12;ANXA3;SFRP2;HSPB6;SERPINE1;GAB1;PRKCB;PRKCA;RRAS;PDPK1;CTSH;TWIST1;PRKD1;ITGB1;PRKD2;RUNX1;ITGB8;STIM1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.493230269317943,1.1707022721059197,0.122,1.0,1.0,67/366,12.00%,ESCO2;PHF19;EZH2;MYBL1;ATRX;NSD2;TCFL5;E2F1;DSCC1;BRCA2;FBXO5;RB1;SP3;LIN54;HNRNPD;NLK;AJUBA;CHEK2;NFIA;CCNA2;SMC3;NFIL3;EIF4E;TCF7L1;SRSF10;CCAR1;YAF2;GZF1;SOX6;HP1BP3;USP37;GON4L;PML;PSPC1;MYBL2;NUCKS1;FUS;POLR2A;PRRX2;ORC3;WWTR1;PHF1;MYCBP;FOXO3;LMX1B;BNC2;MSL3;NONO;LIMD1;DNM2;VHL;NFYA;ZNHIT3;OBI1;ERC1;HINT1;TGFBR1;NR3C1;SFPQ;SLC39A8;POFUT1;AHR;NCOA2;BMP2;ATXN1;RORA;SPTY2D1
prerank,positive regulation of secretion (GO:0051047),0.5949616657028922,1.1706671594353846,0.3269230769230769,1.0,1.0,1/11,1.84%,AQP1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5898218114618713,1.170608307090884,0.310192023633678,1.0,1.0,7/11,24.04%,ACAT1;PPCDC;PANK4;PANK2;COASY;SLC25A16;DCAKD
prerank,coenzyme A biosynthetic process (GO:0015937),0.5898218114618713,1.170608307090884,0.310192023633678,1.0,1.0,7/11,24.04%,ACAT1;PPCDC;PANK4;PANK2;COASY;SLC25A16;DCAKD
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5898218114618713,1.170608307090884,0.310192023633678,1.0,1.0,7/11,24.04%,ACAT1;PPCDC;PANK4;PANK2;COASY;SLC25A16;DCAKD
prerank,positive regulation of innate immune response (GO:0045089),0.5324240256588456,1.170467658121508,0.30578512396694213,1.0,1.0,10/30,17.44%,FADD;UBE2K;DHX9;NMI;RIOK3;POLR3D;AKIRIN2;TRIM6;SLC15A4;MAVS
prerank,regulated exocytosis (GO:0045055),-0.2488091715160685,-1.1704206145052964,0.0,0.6555647187061767,1.0,50/173,19.42%,CYRIB;PCLO;RIMS1;VWF;TMSB4X;PECAM1;TIMP3;CALM1;VEGFC;IGF1;SYT1;APOOL;TGFB2;GAS6;RAB27B;PLEK;ISLR;PSAP;LYN;ABCC4;IGF2;SYT7;ENDOD1;LHFPL2;SRGN;SCG3;APP;TAGLN2;CHID1;THBS1;SYT11;SYT12;RAB11FIP2;RAB11FIP1;TMX3;VEGFA;HABP4;CPLX1;SCCPDH;SNAP25;LAMP2;STEAP2;TGFB3;SYT10;ACTN1;VEGFB;TEX264;SYT6;VEGFD;CLEC3B
prerank,cortical cytoskeleton organization (GO:0030865),0.5111964994654037,1.1700761151375318,0.29777777777777775,1.0,1.0,18/41,19.71%,ROCK2;RHOA;RHOQ;ROCK1;LLGL2;EPB41L3;RAC1;RND2;EZR;DLG1;LCP1;RHOC;FHOD1;NCKAP1;RAB13;TRPV4;FMNL2;RND3
prerank,membrane repolarization during action potential (GO:0086011),-0.434637528797996,-1.1700539288859315,0.28802588996763756,0.6551868286296066,1.0,6/13,37.61%,ATP1B1;ATP1A1;KCNQ1;KCNE4;KCNIP2;KCNH2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.556460594786882,1.1700178640315484,0.30614805520702637,1.0,1.0,8/23,14.65%,PLK1;UBE2K;S1PR2;CALM2;STOX1;TRIM6;CAB39;RPTOR
prerank,response to amino acid (GO:0043200),-0.3399416134533445,-1.1698164585102342,0.2057142857142857,0.6544567112839268,1.0,11/31,17.25%,CPEB3;GLRB;GLRA1;CPEB4;SH3BP4;GLRA3;MTOR;NSMF;GRIN1;RRAGC;XBP1
prerank,negative regulation of ossification (GO:0030279),0.5526133167168246,1.169714963737491,0.3173198482932996,1.0,1.0,8/23,15.25%,BCOR;CHSY1;SMAD6;ENPP1;RBPJ;TRPM4;SOX9;SFRP1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.498389355411712,1.1693732748056425,0.2805755395683453,1.0,1.0,17/85,13.86%,UHRF1;RAB33B;HYAL1;FGFR2;LAMB1;PRKDC;MCC;SFRP2;BMP6;TCF7L2;TGFBR3;YAP1;ANGPT1;LIMS1;NR4A1;SOX9;PRKD1
prerank,monocyte chemotaxis (GO:0002548),-0.3431114349827328,-1.1691728922085503,0.1917808219178082,0.6546870252574406,1.0,5/32,13.19%,FLT1;PTPRO;RPS19;TNFRSF11A;CX3CL1
prerank,positive regulation of T cell differentiation (GO:0045582),0.5183548762768878,1.1688841388845013,0.3079625292740047,1.0,1.0,2/36,1.25%,GLI2;GLI3
prerank,regulation of macrophage migration (GO:1905521),-0.48326730600313145,-1.1686905318264302,0.29461756373937675,0.6545386010044806,1.0,6/10,36.31%,MTUS1;CD81;PTK2B;P2RY12;CD200R1;CX3CR1
prerank,response to alcohol (GO:0097305),-0.362059562318385,-1.168491271600011,0.20855614973262032,0.653644126303586,1.0,6/27,4.65%,GRIN3A;GRIN2A;TGFBR2;GLRA1;GRIN2B;GOT2
prerank,replicative senescence (GO:0090399),0.5991104385622865,1.1683021936064237,0.2905109489051095,1.0,1.0,6/12,19.32%,CHEK2;CHEK1;SERPINE1;TP53;ATR;TERT
prerank,C4-dicarboxylate transport (GO:0015740),-0.43973652701164034,-1.168232365032564,0.2408026755852843,0.6529017229097077,1.0,6/14,18.09%,SLC1A2;SLC25A13;SLC25A12;LRRC8D;SLC1A1;SLC25A11
prerank,high-density lipoprotein particle assembly (GO:0034380),0.6024889880006237,1.168195245138867,0.3073394495412844,1.0,1.0,2/10,10.71%,BMP1;ABCA1
prerank,response to histamine (GO:0034776),-0.4741051333325192,-1.1679722903626244,0.26571428571428574,0.6521010858124248,1.0,4/10,11.17%,GABRB1;GABRB3;GABRB2;GABRG2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.4113438019106683,-1.1679699672434487,0.2751937984496124,0.650731125548113,1.0,2/17,3.33%,KCNAB1;AKAP6
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.5423018099076287,1.167179934914164,0.3105076741440378,1.0,1.0,8/28,15.41%,AUNIP;PRKDC;RIF1;MRNIP;SMCHD1;PARP9;KMT5C;SHLD2
prerank,endothelial cell differentiation (GO:0045446),-0.45059173733229396,-1.167019043158633,0.2783171521035599,0.65164926144223,1.0,6/12,8.25%,JAG1;BMPR2;ACVRL1;PROX1;TIE1;ACVR2B
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.4904127626206108,1.166495615077338,0.004,1.0,1.0,349/1646,16.00%,DEPDC1;CENPF;BRCA1;E2F7;E2F8;NR2E3;RRM2;MXD3;PHF19;ATAD2;EZH2;BRIP1;EN1;BIRC5;E2F2;MYBL1;ATRX;PBX4;POLA1;NSD2;GLI2;LOXL3;CDK5RAP2;ORC1;GLI3;TCFL5;HMGB2;E2F1;LCORL;BRCA2;CBX5;TYMS;RBM15;FOXE1;ATOH8;PSRC1;HAS3;CDC45;BTAF1;ZBTB8A;ILF3;NAT14;MED26;KMT5A;ATP2B4;SFMBT1;TIMELESS;FBXO5;DYRK1A;CBFB;LOXL2;ZFP69;BRD9;SMARCC1;ZNF32;PBX3;BAZ1B;RB1;SP3;CDK14;HOXC5;DEK;PHIP;ETV6;ZFP41;TWIST2;ELF2;TRAK1;TEAD1;ZSCAN29;SP2;RBBP8;ZEB1;RAD21;CTCF;E2F3;HDGF;CDC6;TFDP1;LIN54;HNRNPD;TFCP2L1;NFE2;DAP;NLK;MED14;MPHOSPH8;RBFOX2;EED;AJUBA;CHEK2;ZNF260;BCOR;SETDB2;MDM4;RFXAP;KHDRBS1;MBD1;HIVEP1;NFIA;CUX1;KIT;DHX9;WIZ;PCGF5;ZFP62;NFIL3;BHLHE41;KLF5;EPC2;TCF7L1;CTBP1;SRF;ELF4;BLM;SRSF10;TSHZ1;CCAR1;THRAP3;ZNF568;KLF13;NFIB;ZNF697;MAEL;TBL1XR1;SP8;SETD3;IKZF1;SFRP2;NUP85;LCOR;YAF2;PCBD2;CCNA1;GZF1;TCF7L2;PSIP1;HOXC4;SCML2;SOX6;ELF1;MED30;CCNE1;HP1BP3;GON4L;GMEB1;TCF4;HOXA7;ARRB1;SCMH1;GRHL2;GATAD2A;PML;PSPC1;ELOC;GLIS3;MIDEAS;ARID1A;MYBL2;TASP1;ELK1;NUCKS1;RFX2;POU2F1;NIPBL;FUS;POLR2A;PROX2;MXD1;PRRX2;ZBTB2;SRCAP;POU3F2;ZBTB7B;WWTR1;PHF1;PHF2;ZFX;MYCBP;ZHX2;MAMSTR;SIM1;LIN9;UIMC1;SAP18;FOXO3;OLIG2;ATF7IP;CD80;IRF1;KDM2B;TRIM28;ZNF23;RCOR1;LMX1B;SMAD6;BNC2;HMGB3;PLAGL2;MED24;ING4;BCLAF1;SMARCA4;YAP1;ZFP90;CREB5;MSL3;USP21;USP16;KLF11;HOXB3;NONO;LIMD1;ZBTB25;DNM2;VHL;ARID4A;NFYA;ZBTB20;PLAGL1;ZIC5;PICALM;AGT;UXT;KMT2A;HMGB1;ZNHIT3;EPC1;ERC1;HOXB6;TEAD3;MEOX2;MTA3;CARF;HINT1;TGFBR1;NR3C1;NR4A2;MMS19;RUNX1T1;MYPOP;PARP9;LIMS1;TADA1;SFPQ;TAL1;CRLF3;ZBTB24;TAF15;SLC39A8;DKK3;SMURF2;RBM15B;POFUT1;HDAC1;CHD2;TBX18;AHR;NCOA2;ZNF585B;ZNF585A;QRICH1;PRKCB;BMP2;PCNA;ATXN1;L3MBTL2;KLF9;NKX2-1;HTATSF1;RORA;SPTY2D1;ZHX3;FBXW11;ZIC4;RBPJ;KMT2D;ZNF496;NR4A1;METTL4;SMAD4;BRD4;SOX9;ZNF394;HDAC2;ATF5;ILF2;IL31RA;ELK4;LRP5;RAI1;TCF20;TADA2A;TWIST1;NCOA7;IRF2BP1;USP47;ACTL6B;HEY2;MED1;DHFR;BTRC;YY1;FOXK2;GPBP1L1;BCL7A;RLF;FOXL1;POU2F2;ARNT;CDKN1B;SMAD3;CAMTA1;FOXP4;KDM5C;PCGF6;BAZ1A;RUVBL2;FOXM1;JMJD1C;ZFP91;QARS1;YEATS2;E2F4;SOX1;ZNF445;PER1;RBAK;MED27;EFEMP1;SFRP1;PRDM8;CNOT7;ATF1;PKNOX2;RUNX1;HDGFL3;NFKB1;TRRAP;KAT6A;BICRA;HOXB7;MLF2;CHD1;ZNF112;ZNF25;ZBTB7C;DRAP1;TP53
prerank,dendritic cell differentiation (GO:0097028),-0.3717348560181249,-1.166433294826163,0.23684210526315788,0.6516883922045189,1.0,4/22,6.72%,TGFBR2;GAS6;CAMK4;LYN
prerank,gene silencing by miRNA (GO:0035195),0.5320898057504453,1.1662761484707314,0.2934272300469484,1.0,1.0,12/32,15.63%,ZC3H7A;MOV10;AGO2;CNOT1;AJUBA;CNOT6;LIMD1;PUM2;RBM4;CNOT7;ZC3H7B;TNRC6C
prerank,positive regulation of biosynthetic process (GO:0009891),-0.3117647442019483,-1.1653405762702873,0.1984732824427481,0.6529908341013492,1.0,11/40,18.02%,APOE;CREBL2;TLR4;LARP6;MTOR;RGCC;GRIN1;TGFB3;CREB3L1;SORBS1;RAB27A
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.2753925901049018,-1.1646035307051044,0.18181818181818182,0.6535270576388325,1.0,19/100,7.37%,PTK2;FLT1;TEK;NTRK2;PPP1R16B;PIP4K2A;INSR;IGF1;TGFB2;PDGFRB;BECN1;PIP4K2B;NTRK3;PIK3R1;FGF2;IRS2;LYN;PIK3IP1;SEMA4D
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.4791994712592551,-1.1645953612836049,0.3190883190883191,0.6521933240851422,1.0,6/10,21.47%,AKT2;IRS2;GPLD1;IRS1;PTH1R;SLC45A3
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.5888157682680822,1.164563420953156,0.2903225806451613,1.0,1.0,1/13,1.20%,GLI2
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5422320226142481,1.1643761773971255,0.32205513784461154,1.0,1.0,9/24,15.47%,CBFB;ROCK2;NUMA1;HOXA7;GRHL2;ROCK1;ERRFI1;MED1;RUNX1
prerank,protein polyubiquitination (GO:0000209),0.48867307234562996,1.1635064637622938,0.164,1.0,1.0,57/297,15.08%,DTL;BRCA1;CCNF;TRIML2;BARD1;UBE2T;UBE2C;UBE2S;RNF168;ANAPC7;CBFB;PSMC2;CDC27;PSMD5;UBE2K;NEDD4;FBXL7;SIAH2;FBXW7;FBXO30;UBE2N;PRPF19;RC3H2;FBXL8;RNF31;UBR5;SMURF1;PSMB1;UBE2R2;CUL3;PSMD14;TPP2;PSMD1;SKP2;FBXL17;SMURF2;UBOX5;PSMB9;FBXW11;TRIP12;TRIM6;ITCH;UBE2J1;IRF2BP1;SPOP;ZNRF2;BTRC;FBXO27;RC3H1;UBE2QL1;PSMC6;TRIM5;RNF114;ZNRF1;ZFP91;NPEPPS;FBXO17
prerank,regulation of cartilage development (GO:0061035),0.558672077027322,1.1632265914951638,0.3177083333333333,1.0,1.0,5/18,12.75%,BMP1;SOX6;TAPT1;BMP2;SOX9
prerank,bile acid and bile salt transport (GO:0015721),-0.3633048963034457,-1.1630833616290914,0.2372093023255814,0.6548240328115542,1.0,4/24,8.21%,SLCO1C1;SLCO2B1;ABCC4;ATP8B1
prerank,heterochromatin assembly (GO:0031507),0.5583452089491558,1.1626836009165642,0.29961089494163423,1.0,1.0,5/20,12.24%,HELLS;NRDE2;SMCHD1;HDAC1;CENPV
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.429279150523179,-1.1624850156357946,0.2640845070422535,0.6549591240455486,1.0,11/15,32.16%,PKM;KLF4;FGF2;TJP1;FGF1;VEGFA;S100A1;JAK1;JMJD8;SMAD1;BMPER
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.3720217451759538,-1.1623043008966172,0.2168141592920354,0.6527496223103462,1.0,8/20,18.47%,MCCC1;BCKDHA;HIBADH;ACAD8;BCAT1;ECHS1;BCKDK;MCCC2
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.3720217451759538,-1.1623043008966172,0.2168141592920354,0.6527496223103462,1.0,8/20,18.47%,MCCC1;BCKDHA;HIBADH;ACAD8;BCAT1;ECHS1;BCKDK;MCCC2
prerank,negative regulation of cellular protein localization (GO:1903828),0.5242159877079634,1.1622978466992506,0.31213872832369943,1.0,1.0,12/34,16.91%,ROCK2;GSK3B;MAPT;LEPROT;CTNNA1;RIPOR2;PICALM;SNX33;ILRUN;OTUD7B;LZTFL1;UBXN2B
prerank,nuclear envelope organization (GO:0006998),0.5511346781643669,1.16219842432508,0.31633986928104574,1.0,1.0,6/20,15.78%,NEMP1;NUP155;LEMD3;EMD;TOR1B;SUN2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3598928169834389,-1.1618664515629327,0.24545454545454545,0.6525424338743927,1.0,14/24,23.79%,PRKN;SELENOS;NR1H3;UBXN1;NR1H2;AQP11;CREB3L1;XBP1;SYVN1;CREB3;BCL2L1;PARK7;RACK1;WFS1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5979735438605506,1.1614642062080285,0.31790123456790126,1.0,1.0,4/10,18.35%,WNK1;ADAM17;STK39;OXSR1
prerank,gland development (GO:0048732),0.5018854971791695,1.1610097246537847,0.3041125541125541,1.0,1.0,21/59,19.08%,GLI2;FOXE1;FADD;FGFR2;TGFBR3;PHF2;ARHGAP35;TGFBR1;DKK3;ANXA1;NKX2-1;EZR;SOX9;GFER;PKD2;MSN;SALL1;COBL;IGSF3;ZBTB1;WNT4
prerank,atrial septum morphogenesis (GO:0060413),-0.4760193882118754,-1.1609074487209874,0.27492447129909364,0.6536457041802566,1.0,4/10,12.69%,ACVR1;BMPR2;TGFB2;SOX4
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.4602720211126817,-1.1607398003297213,0.2852941176470588,0.6527032620667329,1.0,3/10,19.94%,CTNNB1;LRP6;FZD1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.32447483278331624,-1.1601314730579686,0.23387096774193547,0.6529146598002823,1.0,17/40,19.58%,SGIP1;INSR;VTN;BICD1;DAB2;B2M;HNRNPK;SFRP4;HIP1;LDLRAP1;VEGFA;PICK1;AHI1;PPT1;CBL;TBC1D5;DGKD
prerank,eosinophil migration (GO:0072677),-0.42214967353088906,-1.1599094119951674,0.2757352941176471,0.6506741421862171,1.0,12/14,57.82%,SCG2;CX3CL1;CCL13;CCL2;CCL5;CCL4;CCL8;CCL7;CCL1;CCL3;CCL11;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),-0.42214967353088906,-1.1599094119951674,0.2757352941176471,0.6506741421862171,1.0,12/14,57.82%,SCG2;CX3CL1;CCL13;CCL2;CCL5;CCL4;CCL8;CCL7;CCL1;CCL3;CCL11;LGALS3
prerank,mRNA transport (GO:0051028),0.48571235372472477,1.1598198875499484,0.28307692307692306,1.0,1.0,31/101,17.48%,NDC1;NUP155;NUP205;NUP160;SRSF4;FIP1L1;EIF4E;UPF3B;SLBP;NUP85;TPR;FMR1;DDX39B;SRSF7;WDR33;SRSF3;SRRM1;RBM15B;CPSF4;NUP214;RANBP2;MCM3AP;SMG6;NXT1;NUP133;HNRNPA2B1;NUP42;UPF2;DHX38;NUP98;NUP210
prerank,epithelial tube morphogenesis (GO:0060562),-0.3414302184778941,-1.158853801842391,0.2733333333333333,0.6519233234058213,1.0,14/32,16.22%,ACVR1;MEF2C;PODXL;RYR2;ACVRL1;RHOB;PAK1;RASIP1;SLIT2;CTNNB1;MET;MEGF8;SOX17;MTSS1
prerank,mRNA export from nucleus (GO:0006406),0.4856616663299622,1.1587834189739392,0.28234086242299794,1.0,1.0,31/102,17.48%,NDC1;NUP155;NUP205;NUP160;SRSF4;FIP1L1;EIF4E;UPF3B;SLBP;NUP85;TPR;DDX39B;SRSF7;WDR33;SRSF3;SRRM1;RBM15B;CPSF4;NUP214;RANBP2;MCM3AP;SMG6;NXT1;NUP133;HNRNPA2B1;NUP42;IWS1;UPF2;DHX38;NUP98;NUP210
prerank,protein autophosphorylation (GO:0046777),0.49019123211471094,1.1586484038690448,0.2515151515151515,1.0,1.0,38/157,15.64%,NEK2;MELK;AURKB;DYRK1A;STK17B;AURKA;FGFR4;GSK3B;FGFR2;STK10;CHEK2;KIT;VRK2;STK24;MUSK;PDGFRA;EPHA4;LRRK2;GRK5;MAP3K3;PIM1;MARK2;DDR2;EIF2AK3;PDPK1;ULK2;AAK1;SIK2;MAPKAPK3;MEX3B;PRKD1;TAOK1;STK11;VRK1;PRKD2;SRC;STK39;PASK
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.3818163153566619,-1.1583888419951587,0.2631578947368421,0.6517798721582274,1.0,5/20,10.59%,IL1R1;MALT1;B2M;CD81;DENND1B
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.36460846116554674,-1.1583155728273071,0.24757281553398058,0.6506652431169924,1.0,13/24,39.16%,TAPBP;SEC24B;B2M;ACE;BCAP31;SAR1B;TAP2;FCER1G;ABCB9;CALR;SEC13;CANX;ERAP1
prerank,skeletal system development (GO:0001501),0.48583552099908195,1.1581247400855899,0.268958543983822,1.0,1.0,26/148,12.75%,EN1;RAB33B;BMP1;GLI2;MATN3;HYAL1;WWOX;FGFR2;MMP14;FBN1;DDRGK1;SULF2;BMP6;SOX6;SULF1;PAPSS2;SLC10A7;RFLNA;ANKRD11;NPR3;TGFBR1;EIF2AK3;BMP2;P3H1;GJA1;SOX9
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.27246589012460015,-1.1577241612176528,0.17307692307692307,0.6508920498840467,1.0,14/75,12.55%,CACNA2D1;SLC8A3;ATP1B1;SLC39A10;SLC6A1;KCNJ3;SLC24A2;KCNJ6;ATP1A1;ATP1B3;ATP1A3;KCNJ10;SLC12A9;ATP1A2
prerank,positive regulation of macrophage differentiation (GO:0045651),0.6056168431232211,1.1570114844526895,0.3058470764617691,1.0,1.0,4/11,18.70%,FADD;PRKCA;CASP8;RIPK1
prerank,regulation of macrophage differentiation (GO:0045649),0.5737352591046883,1.1559301823266783,0.3306122448979592,1.0,1.0,4/15,12.60%,FADD;PTPN2;PRKCA;CASP8
prerank,nuclear body organization (GO:0030575),0.5756367889967335,1.1556782890285033,0.30638297872340425,1.0,1.0,3/12,6.79%,DYRK3;SERBP1;PML
prerank,phospholipid catabolic process (GO:0009395),-0.36324358307734855,-1.1553663825165963,0.265,0.6553418732077785,1.0,7/24,14.51%,GPCPD1;PLA2G4A;ABHD12;PNPLA6;ENPP6;GDPD3;GDPD1
prerank,histone deacetylation (GO:0016575),0.5099010099654047,1.1550506998031018,0.31685393258426964,1.0,1.0,14/43,14.89%,MIER1;SMARCAD1;TBL1XR1;MIDEAS;RCOR1;MSL3;MIER3;HDAC8;MTA3;SFPQ;HDAC1;HDAC2;ELK4;PER1
prerank,carbohydrate transport (GO:0008643),0.5852989207631547,1.1545509447024682,0.32,1.0,1.0,1/11,1.84%,AQP1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.577715184523107,1.1545427962684238,0.3189033189033189,1.0,1.0,4/14,8.06%,SRSF4;SRSF10;SRSF7;SAP18
prerank,glycolipid metabolic process (GO:0006664),-0.2978190461670471,-1.1542568854942798,0.21495327102803738,0.6568519640111418,1.0,19/47,25.81%,HEXB;ST3GAL6;PSAP;ASAH1;ST6GALNAC3;ESYT1;B3GALNT1;HEXA;ST8SIA6;GBGT1;GLTP;CTSA;SCCPDH;GBA2;ST6GALNAC4;ESYT3;ABCA2;NEU1;SUMF1
prerank,regulation of glycogen metabolic process (GO:0070873),-0.4541408217026269,-1.1534133673248719,0.28102189781021897,0.6574884322424062,1.0,9/12,48.65%,INPP5K;PPP1R3B;PPP1R3C;AKT1;RUBCNL;PPP1R3E;KHK;PPP1R3D;GCGR
prerank,myeloid cell development (GO:0061515),0.5508928087022064,1.152173821241643,0.3288409703504043,1.0,1.0,8/18,17.35%,ANXA2;KIT;ABCB10;DMTN;MED1;SRC;ALAS2;FOXP1
prerank,embryonic organ morphogenesis (GO:0048562),0.5051828675551023,1.152095809635909,0.31363636363636366,1.0,1.0,12/42,15.24%,FOXE1;MFAP2;FGFR2;FBN1;HOXC4;PDGFRA;NIPBL;HOXB3;DSCAML1;RBPMS2;MFAP5;EFEMP1
prerank,nitrogen compound transport (GO:0071705),0.47919905155159104,1.1520507762597125,0.2694248234106963,1.0,1.0,11/141,7.92%,CENPF;RHAG;SLC18A2;NDC1;AQP1;ZG16;SLC6A2;PDPN;SLC38A4;SLC25A47;SLC16A10
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.4360124545725238,-1.1517968018855993,0.2847682119205298,0.6602731547276732,1.0,7/13,28.52%,SAR1A;CD81;SAR1B;SORL1;SEC16B;TMEM30A;SEC16A
prerank,epithelial cell migration (GO:0010631),0.5078553982090319,1.151731340901528,0.301909307875895,1.0,1.0,7/37,9.38%,ANLN;LOXL2;RHOA;KIT;ADGRA2;KANK2;ROCK1
prerank,embryonic eye morphogenesis (GO:0048048),0.5907289994809246,1.1514854689095164,0.31555555555555553,1.0,1.0,5/11,15.24%,MFAP2;FBN1;KDM2B;MFAP5;EFEMP1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.46026020685755575,-1.150973527898248,0.29878048780487804,0.6610648228414553,1.0,3/11,9.60%,MERTK;GAS6;SELENOS
prerank,cardiac conduction system development (GO:0003161),0.5378069390717196,1.150423717220605,0.32170542635658916,1.0,1.0,7/24,13.69%,BMPR1A;TBX18;GJA1;SMAD4;NOTCH2;MAML1;HEY2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.5710043653021609,1.149049789383268,0.32510288065843623,1.0,1.0,4/14,15.41%,PAXIP1;RIF1;KMT5C;SHLD2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5641320897282638,1.148906009839689,0.32920110192837465,1.0,1.0,6/15,13.22%,MTHFD1L;FGFR2;PDGFRA;NIPBL;TGFBR1;TWIST1
prerank,protein ubiquitination (GO:0016567),0.48128462682970524,1.1486705471068648,0.138,1.0,1.0,90/471,14.65%,DTL;BRCA1;CCNF;UHRF1;PLK1;TRIML2;BARD1;UBE2T;UBE2C;RAD18;UBE2S;RFWD3;RNF168;ANAPC7;CBFB;TRIM37;BRAP;PDZRN3;PSMC2;CDC27;RNF220;PSMD5;UBE2K;UHRF2;MYCBP2;NEDD4;FBXL7;PRKDC;SIAH2;SPSB2;RNF43;FANCL;ARRB1;FBXW7;FBXO30;UBE2N;ELOC;CUL5;PRPF19;RC3H2;FBXL8;RNF31;UBR5;RNF40;VPS18;SMURF1;PSMB1;UBE2R2;CUL3;PSMD14;SH3RF1;KLHL22;CUL4B;LEO1;VHL;TPP2;PSMD1;SKP2;OBI1;FBXL17;HERC2;FBXO45;SMURF2;UBOX5;PSMB9;TRIM63;ARRDC1;PCNA;FBXW11;TRIP12;TRIM6;ATG3;ITCH;USP9X;UBE2J1;IRF2BP1;SPOP;CRBN;ZNRF2;BTRC;FBXO25;FBXO27;HLTF;RC3H1;UBE2QL1;PSMC6;TRIM5;RNF114;BIRC6;ZNRF1
prerank,T cell differentiation (GO:0030217),0.5079218231203233,1.1483411689249905,0.3306636155606407,1.0,1.0,8/40,12.47%,GLI3;FADD;KIT;LEPR;PTPN2;ANXA1;LMBR1L;ADAM17
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.48300685516735564,1.148339050410577,0.29713114754098363,1.0,1.0,23/88,16.07%,HAS3;FNIP1;HYAL1;GSK3B;BMF;TRABD2B;AJUBA;FAF1;SLF1;SPIDR;TPR;CDC42EP2;SH3GLB1;STAM;TPPP;SDC1;TAL1;STX18;PRKCA;SYNPO2;SMAD3;RHOC;SMPD3
prerank,axonemal dynein complex assembly (GO:0070286),0.5285849973064894,1.1482789651181637,0.31801242236024846,1.0,1.0,8/27,19.24%,DNAAF3;DNAH1;DNAI4;DNAAF5;LRRC49;SPAG1;ODAD1;DNAH8
prerank,cobalamin metabolic process (GO:0009235),-0.4080394226919216,-1.147903207728733,0.28688524590163933,0.6675510860903853,1.0,9/17,36.01%,ABCD4;CUBN;LMBRD1;MTRR;MMAA;MTR;TCN2;MMADHC;CD320
prerank,organelle organization (GO:0006996),0.4820182708269264,1.1477287074787625,0.172,1.0,1.0,68/388,14.06%,DIAPH3;KIF4A;CDCA8;CEP55;MNS1;ARHGAP21;USP6NL;SYNE3;MAST2;MTFR2;MIEF2;PHIP;ARHGAP10;GBF1;OBSL1;PACSIN2;FAM161A;AJUBA;LNPK;DIAPH1;NUMA1;TSPO2;DYRK3;COG1;ZW10;RHOT1;FGD4;MICAL3;ATL2;CNN2;TMEM11;ANK1;PRPF40A;STOML2;ATL3;PDZD8;RAB29;FGD1;LRRK2;VPS18;GOLGA8B;GOLGA5;ZFYVE16;WDPCP;SH3D19;LIMD1;ODF2;LONP1;STRIP2;RAB1A;PITPNB;YTHDF2;FGD6;NIPSNAP2;CENPW;EIF2AK3;BAG5;GAK;FANCG;GORASP2;DMTN;DES;PPID;PPRC1;PRKCI;LARP4;PRKD1;MIA3
prerank,platelet degranulation (GO:0002576),-0.2563354843524515,-1.1476697332509362,0.09090909090909091,0.6668599563869294,1.0,39/118,20.58%,CYRIB;VWF;TMSB4X;PECAM1;TIMP3;CALM1;VEGFC;IGF1;APOOL;TGFB2;GAS6;RAB27B;PLEK;ISLR;PSAP;LYN;ABCC4;IGF2;ENDOD1;LHFPL2;SRGN;SCG3;APP;TAGLN2;CHID1;THBS1;TMX3;VEGFA;HABP4;SCCPDH;LAMP2;TGFB3;ACTN1;VEGFB;TEX264;VEGFD;CLEC3B;ITGB3;LGALS3BP
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.35279285347313033,-1.1469656370425472,0.24324324324324326,0.667245242356496,1.0,11/26,28.95%,EPHA5;KLF7;STX4;ANO1;GPLD1;ADCY8;ADRA2A;EFNA5;PIM3;BAIAP3;ADCY5
prerank,carnitine metabolic process (GO:0009437),-0.44180099592619115,-1.1467459021367308,0.2939297124600639,0.6664452057702819,1.0,4/12,11.10%,TMLHE;ACADM;CROT;BBOX1
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.31051698455612453,-1.1463691754857077,0.22950819672131148,0.666093078692221,1.0,10/39,14.73%,PTK2;PODXL;JAG1;MAP2K5;NEXMIF;KLF4;FXYD5;RGCC;PPM1F;VEGFA
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5391509621441454,1.146180646034321,0.3195187165775401,1.0,1.0,8/18,16.56%,SETD3;EEF1AKMT2;SETD2;KMT2A;KMT2D;ASH1L;SETD4;SUV39H2
prerank,cartilage development (GO:0051216),0.5043319807333929,1.1452236126947846,0.3303370786516854,1.0,1.0,17/49,19.79%,HYAL1;DDRGK1;WNT2B;SULF2;NFIB;SOX6;SULF1;CCN3;BMP2;SOX9;CD44;SNX19;RUNX1;ITGB8;TRPV4;OSR1;CREB3L2
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5567510005209907,1.1446314320020647,0.31761442441054094,1.0,1.0,8/15,19.16%,AGO2;CNOT1;EIF4ENIF1;TENT4A;PABPC1;CNOT7;TNRC6C;TNRC6B
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.4283603858004048,-1.1440917100976558,0.31511254019292606,0.6704283075450311,1.0,10/14,22.37%,VEGFC;FOXC1;VEGFA;PIK3CD;PIK3CA;VEGFB;VEGFD;NRP1;NUS1;FLT4
prerank,negative regulation of translation (GO:0017148),0.480520862183021,1.1440004250781808,0.304437564499484,1.0,1.0,26/87,16.45%,TYMS;ILF3;SYNCRIP;ROCK2;AGO2;FTO;CNOT1;EIF4ENIF1;SAMD4A;CAPRIN1;TPR;FMR1;LARP1;CPEB2;ROCK1;YTHDF2;EIF2AK3;MRPL13;MEX3D;RBM4;DHFR;EPRS1;CNOT7;FXR1;UNK;METTL3
prerank,diacylglycerol metabolic process (GO:0046339),-0.34831401882869506,-1.1437367967416614,0.2560386473429952,0.6699276870596691,1.0,13/23,36.44%,DGKB;DGKG;DGKI;DGKQ;PLCE1;DGKD;PLA2G15;DGKK;PNPLA2;LIPE;DGAT2;DGKA;ANG
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.44250611016536096,-1.1430558150851786,0.2996742671009772,0.67030989184616,1.0,5/12,14.73%,STAT3;SDK2;PROM1;RORB;VEGFA
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.506433892996261,1.1428939197920063,0.3228346456692913,1.0,1.0,16/44,16.45%,MOV10;ROCK2;AGO2;ZC3HAV1;FTO;CNOT1;EIF4ENIF1;ROCK1;YTHDF2;MEX3D;RC3H1;PABPC1;CNOT7;TNRC6C;PNPT1;METTL3
prerank,regulation of proteolysis (GO:0030162),0.5058071889866423,1.1424946569329764,0.3325892857142857,1.0,1.0,11/48,13.80%,PLK1;FADD;FGFR4;DNAJC1;FBXW11;CASP8;ITCH;HDAC2;PLAUR;SPOP;BTRC
prerank,synaptic vesicle exocytosis (GO:0016079),-0.3216695548396698,-1.1413297496215307,0.25190839694656486,0.6732841783712565,1.0,14/40,18.78%,UNC13B;PCLO;RIMS1;SNAP47;SYT1;STX4;STX3;SYT7;SNPH;SNAP29;CPLX1;SNAP25;SYT10;STX1B
prerank,fatty acid catabolic process (GO:0009062),-0.271260058227051,-1.1412561533722023,0.17142857142857143,0.672172437835363,1.0,23/67,23.82%,HADHB;ACADM;CROT;PCCB;SCP2;ABCD4;MECR;ALDH3A2;HADH;ABHD2;ACAD10;ECHS1;ABCD2;DECR1;ECHDC2;NUDT7;LPIN1;SLC27A4;PECR;MCEE;MMAA;PLA2G15;AIG1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.48165796427535135,1.14077182461546,0.2562814070351759,1.0,1.0,18/175,11.30%,TNFSF13B;BRCA1;MAP3K14;HYAL1;PSMC2;PSMD5;ACTN4;DHX9;NPNT;YBX3;FOXO3;PSMB1;PSMD14;PSMD1;EDA;LIMS1;PSMB9;PYDC1
prerank,regulation of actin filament-based process (GO:0032970),0.48332485480572124,1.1405327012885615,0.31309904153354634,1.0,1.0,13/70,12.63%,IQGAP3;IQGAP2;ROCK2;RHOA;ARHGAP18;CNN2;RHOQ;ROCK1;ARHGAP35;RAC1;RND2;EZR;DMTN
prerank,histone H2A acetylation (GO:0043968),0.5563334257665785,1.1401354161596347,0.31095890410958904,1.0,1.0,10/16,23.67%,MSL3;EP400;EPC1;RUVBL2;TRRAP;BRD8;NAA40;MEAF6;ACTL6A;MORF4L2
prerank,regulation of cell morphogenesis (GO:0022604),0.5165961170240726,1.1398004046519004,0.3317365269461078,1.0,1.0,8/30,14.40%,MACF1;MOV10;PHIP;PDPN;PDZD8;SH3D19;LARP4;CD44
prerank,positive regulation of calcium ion transport (GO:0051928),-0.3191619010087191,-1.1394001429348244,0.23376623376623376,0.6753864265574339,1.0,11/36,27.00%,CAV1;PDGFRB;MYLK;TRPC3;CACNB2;GRIN1;CRACR2A;P2RX4;WFS1;P2RX7;CXCL12
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.39522970746187974,-1.1393544839117897,0.28846153846153844,0.6741778147322259,1.0,4/18,9.04%,OCLN;SLC2A1;CLIP3;INPP5K
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.3822318162080723,-1.1389359697506845,0.2976190476190476,0.6739965750511535,1.0,9/19,19.08%,CSGALNACT1;HS6ST3;NDST3;NDST1;HS3ST3B1;NDST2;EXTL3;NDST4;XYLT2
prerank,intraciliary retrograde transport (GO:0035721),0.586355631227164,1.1382409314146342,0.33791208791208793,1.0,1.0,2/12,3.90%,WDR35;IFT140
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.47949066310027777,-1.1362722742569702,0.332378223495702,0.6794130512361656,1.0,2/10,0.95%,CPEB3;CDC73
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5004831458660982,1.1351940311121531,0.3370913190529876,1.0,1.0,5/43,8.91%,STIL;SETDB2;SRF;MKKS;NPHP3
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.587666683705012,1.13517080573028,0.34829721362229105,1.0,1.0,3/10,7.99%,PDE3B;WNK1;SERPINE1
prerank,negative regulation of phosphatase activity (GO:0010923),0.515326147282096,1.1346567838605353,0.3270440251572327,1.0,1.0,2/25,3.51%,MASTL;GSK3B
prerank,purine-containing compound catabolic process (GO:0072523),0.5752511774114404,1.1345253999023366,0.3262108262108262,1.0,1.0,3/13,9.23%,DPYD;XDH;ITPA
prerank,lysine metabolic process (GO:0006553),0.5764104454887817,1.1344322954824393,0.3347763347763348,1.0,1.0,1/12,1.44%,SLC25A21
prerank,lysine catabolic process (GO:0006554),0.5764104454887817,1.1344322954824393,0.3347763347763348,1.0,1.0,1/12,1.44%,SLC25A21
prerank,artery morphogenesis (GO:0048844),-0.33128134192486003,-1.1337499099250854,0.2857142857142857,0.6841360248508621,1.0,14/30,21.19%,SMAD7;JAG1;BMPR2;TGFB2;PDGFRB;LRP1;NF1;TBX1;ENG;VEGFA;STRA6;TBX2;HPGD;NRP1
prerank,regulation of monooxygenase activity (GO:0032768),-0.35374377777872373,-1.1335990040096213,0.2594594594594595,0.6832155366062147,1.0,5/23,5.39%,CALM1;CAV1;NOS3;LYPLA1;NOSTRIN
prerank,regulation of lamellipodium organization (GO:1902743),0.5577089664180677,1.1335901863024003,0.35269709543568467,1.0,1.0,5/14,14.40%,PDPN;TWF1;RAC1;DMTN;CD44
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.4797258656183832,1.1328018218498876,0.30318602261048305,1.0,1.0,28/101,17.16%,UHRF1;PLK1;FADD;FGFR4;LARP4B;HNRNPD;PRKDC;UPF3B;FAF1;SAMD4A;FMR1;ATG7;AGT;PLXNB2;METTL5;EZR;FBXW11;EIF3C;CASP8;HDAC2;LARP4;BTRC;PASK;FXR1;MSN;METTL3;AMER1;PYM1
prerank,digestive tract morphogenesis (GO:0048546),0.5614313767139498,1.1323209282825533,0.3389830508474576,1.0,1.0,4/14,10.83%,FGFR2;PDGFRA;NIPBL;RBPMS2
prerank,regulation of mononuclear cell migration (GO:0071675),-0.35635545292937987,-1.1322649795130981,0.2694063926940639,0.6852466841494745,1.0,6/23,12.24%,PTK2;LYN;MAPK3;SLIT2;MAPK1;THBS1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5130353869474639,1.1322472207201693,0.3115151515151515,1.0,1.0,8/26,16.56%,ATPSCKMT;SETD3;SETD2;KMT2A;KMT2D;KMT5C;SETD4;SUV39H2
prerank,endodermal cell fate commitment (GO:0001711),-0.4722115830422128,-1.1313759435580624,0.32407407407407407,0.6861910050970584,1.0,4/10,17.68%,CDC73;RTF1;SOX17;SOX2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.4764694308582137,1.1309053541122638,0.204,1.0,1.0,67/341,14.65%,DTL;KIF14;UHRF1;BUB1B;PLK1;CDC20;UBE2C;AURKB;UBE2S;RNF168;ANAPC7;AURKA;FEM1C;VPS37B;PSMC2;CDC27;PSMD5;UBE2K;NEDD4;FBXL7;UBR4;SPSB3;SIAH2;KLHL15;SPSB2;TBL1XR1;FAF1;RNF43;BUB3;ARRB1;FBXW7;PML;ELOC;VPS37A;RC3H2;RNF40;AGAP3;SMURF1;PSMB1;UBE2R2;CUL3;PSMD14;KCTD2;KLHL22;PSMD1;SKP2;FBXL17;ARMC8;PPP2R5C;FBXO45;SMURF2;PSMB9;ARRDC1;ADRM1;FBXW11;TRIP12;ITCH;COPS3;USP9X;SPOP;CRBN;BTRC;RC3H1;PSMC6;RNF114;BIRC6;ZNRF1
prerank,negative regulation of anoikis (GO:2000811),-0.4106672325253936,-1.1307666275392378,0.2636986301369863,0.6863884241415645,1.0,6/14,21.61%,PTK2;CAV1;TLE1;BCL2;PIK3CA;PTRH2
prerank,protein localization to nucleus (GO:0034504),0.47155614861252204,1.130672515292851,0.3258655804480652,1.0,1.0,32/102,20.76%,PLK1;RANBP17;NUP155;RPAIN;E2F3;TAF3;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;PML;RRS1;HNRNPU;XPA;IPO7;APPL2;NUP214;IPO11;NXT1;MORC3;NUP133;TOR1B;IPO5;NXT2;FAM53B;PIKFYVE;IPO9;NUP188;COL1A1;IPO4;INTS13
prerank,cellular response to interferon-beta (GO:0035458),0.5597613881232972,1.1299360138950982,0.34065934065934067,1.0,1.0,5/14,16.12%,UBE2K;IRF1;HTRA2;TRIM6;PNPT1
prerank,connective tissue development (GO:0061448),0.5165162910996176,1.1298843138694854,0.37394451145958985,1.0,1.0,12/35,16.74%,HYAL1;DDRGK1;SULF2;SOX6;SULF1;PGRMC2;SOX9;LRP5;CD44;SPTLC2;ITGB8;SH3PXD2B
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.554802284713653,1.1294318755740753,0.32,1.0,1.0,6/16,15.41%,PRKDC;RIF1;SMCHD1;PARP9;KMT5C;SHLD2
prerank,substrate-dependent cell migration (GO:0006929),-0.41691925519706335,-1.1286105235916049,0.2828282828282828,0.690495370948049,1.0,11/14,31.49%,OPHN1;VEGFC;EPHA8;SDCBP;ITGB1BP1;SHTN1;NRP1;ANKS1A;P2RY12;PTPRC;ITGA2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.36868749176433735,-1.1282826631927565,0.3231441048034934,0.689989430658362,1.0,5/19,10.84%,CHD8;AR;ICE1;ZNF76;MTOR
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.3581161758539667,-1.127435727597894,0.25949367088607594,0.6908878700578018,1.0,16/24,36.40%,ATF6;GCN1;HSPA5;KLF2;CEBPB;VEGFA;DDIT3;CREB3L1;MAPK7;HIF1A;ATF6B;MBTPS2;MT3;CHD6;ATF3;NFE2L2
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.4731759293237409,1.127131622363556,0.152,1.0,1.0,121/572,15.54%,E2F7;E2F8;NR2E3;UHRF1;EZH2;EN1;PLK1;ATRX;AURKB;GLI2;GLI3;TCFL5;E2F1;CBX5;FOXE1;KMT5A;CBFB;LOXL2;ZFP69;TRIM37;RB1;ETV6;FNIP1;MIER1;WWOX;SP2;ZEB1;CTCF;HDGF;FGFR2;JAZF1;CNOT1;EED;BCOR;MDM4;TAF3;HIVEP1;NEDD4;CUX1;FHL2;NFIL3;BHLHE41;CTBP1;SRF;ZNF568;NFIB;TBL1XR1;MCPH1;BMP6;LCOR;GZF1;TCF7L2;ORC2;TPR;HOXA7;GATAD2A;GLIS3;EFNA1;RIF1;NIPBL;MXD1;ZBTB2;ZBTB7B;ZHX2;FOXO3;KDM2B;LIN37;SMARCA4;YAP1;ZFP90;KLF11;MIER3;KANK2;VHL;UXT;HMGB1;EPC1;HDAC8;MTA3;CXXC5;NR3C1;NR4A2;MYPOP;PARP9;HNRNPU;KCNIP3;SFPQ;SMURF2;HDAC1;BMP2;ATXN1;NKX2-1;EZR;RBPJ;SMAD4;SOX9;HDAC2;SAP130;ELK4;PPID;TWIST1;USP9X;IRF2BP1;RARB;DLG1;HEY2;MED1;YY1;ZMYM5;SMAD3;FOXP4;DNMT3A;FOXM1;YEATS2;SOX1;PER1;OTUD7B;RUNX1;DR1;NFKB1;DCAF1
prerank,bicellular tight junction assembly (GO:0070830),0.49064861702167,1.1270020384039838,0.3617021276595745,1.0,1.0,3/46,6.70%,ECT2;AFDN;GRHL2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.503538893720341,1.1263553143326814,0.34837962962962965,1.0,1.0,11/40,14.18%,EZH2;LOXL2;PDPN;TCF7L2;WWTR1;AXIN2;TGFBR1;BMP2;SMAD4;TWIST1;SMAD3
prerank,positive regulation of cellular process (GO:0048522),0.4736736316270613,1.1263024039857026,0.139,1.0,1.0,82/565,13.08%,PRC1;KIF20B;KIF14;EZH2;TTK;BIRC5;SPAG5;ANKLE1;SAPCD2;TGM1;RAD18;TIPIN;SPDYA;MATK;NAP1L1;FBXO5;SMC6;ECHDC3;PHIP;COLEC12;FGFR4;CSPP1;HYAL1;CEP43;CDC6;FGFR2;MMP14;SMC5;FXN;GAREM1;DDRGK1;ACTN4;NUMA1;CNOT6L;SRF;CCAR1;MAPT;PDPN;FAF1;NSMCE4A;SFRP2;BMP6;RTKN2;PDGFRA;FMR1;DERL2;CDC25B;CHEK1;PPP3CA;EPHA4;POU3F2;WWTR1;CDK2;CNOT6;CUL3;BCLAF1;GRK5;AXIN2;KLHL22;TPPP;VHL;S1PR2;TGFBR1;CAMK1D;CDC123;TAL1;HDAC1;CRKL;CNTF;RAC1;GLP2R;ACACA;PRKCA;STOX1;KMT2D;TRPM4;ADAM17;SOX9;HDAC2;IL31RA;CTSH;LRP5
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.4180193221144007,-1.1261545759719827,0.3090277777777778,0.6926679676908244,1.0,2/13,3.94%,LAMP1;STX4
prerank,positive regulation of hydrolase activity (GO:0051345),0.47544387070581906,1.1261214319626482,0.32661290322580644,1.0,1.0,24/137,12.97%,ECT2;EZH2;HMGB2;ARHGAP11A;USP6NL;MAP4K4;RHOA;GSK3B;RTN4R;EVI5L;NET1;AFDN;RSU1;TBC1D7;MTMR9;PICALM;SRGAP2;LIMS1;CALM2;PLXNB1;BMP2;SNX18;DOCK11;CTSH
prerank,axoneme assembly (GO:0035082),0.5084134410585044,1.1256623788547337,0.33816425120772947,1.0,1.0,7/30,16.63%,DNAAF3;SPAG16;SPEF1;DNAI4;RSPH9;TTLL3;SPAG1
prerank,mRNA polyadenylation (GO:0006378),0.5119220679587921,1.125503335539981,0.3450363196125908,1.0,1.0,11/26,16.12%,TENT2;CSTF3;FIP1L1;TUT1;WDR33;LEO1;PAPOLB;PCF11;SCAF8;PABPC1;PNPT1
prerank,RNA polyadenylation (GO:0043631),0.5119220679587921,1.125503335539981,0.3450363196125908,1.0,1.0,11/26,16.12%,TENT2;CSTF3;FIP1L1;TUT1;WDR33;LEO1;PAPOLB;PCF11;SCAF8;PABPC1;PNPT1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.5520171677677682,1.125501442931598,0.3444592790387183,1.0,1.0,2/18,3.64%,PLK1;MMP14
prerank,P-body assembly (GO:0033962),0.5707974560085403,1.1253835241194106,0.34184397163120567,1.0,1.0,7/12,17.53%,PATL1;LSM3;EIF4ENIF1;LIMD1;RC3H1;LSM4;EDC3
prerank,negative regulation of bone mineralization (GO:0030502),0.5728075651382745,1.1253179807967828,0.36530324400564174,1.0,1.0,4/13,12.45%,BCOR;RFLNA;ENPP1;TRPM4
prerank,cellular response to insulin stimulus (GO:0032869),-0.2625460519861099,-1.1249691192956333,0.14285714285714285,0.6945099803232276,1.0,38/124,14.75%,TBC1D4;FOXO1;ATP6V0A1;GRB14;ATP6V0D1;GRB10;ATP6V1E1;INSR;ATP6V0B;PIK3R3;PKM;AKT2;PIK3R1;ATP6V0A4;FOXC2;IRS2;SLC27A1;IGF2;NAMPT;INPP5K;GPLD1;SELENOS;BCAR3;CAV2;HDAC5;IRS1;PARP1;ATP6V0C;KAT2B;GRB2;HDAC9;RAB12;GOT1;APC;ATP6V1H;SHC1;GSK3A;ZDHHC7
prerank,regulation of synapse assembly (GO:0051963),-0.29397912456425096,-1.124928484708725,0.2184873949579832,0.693294870212233,1.0,19/46,24.55%,PTPRD;MEF2C;SYNDIG1;GRID2;EPHB2;IL1RAPL1;EIF4G1;NRXN1;APP;SLITRK1;LRRC4B;ROBO2;NLGN1;IL1RAP;BDNF;SLIT1;SRPX2;DLG5;LRFN5
prerank,lipid phosphorylation (GO:0046834),-0.45181679499602934,-1.1248636641415974,0.32653061224489793,0.6921267528713725,1.0,6/10,24.53%,DGKB;DGKG;DGKI;DGKQ;DGKD;DGKK
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.5304524607066998,1.1248452129566815,0.34566326530612246,1.0,1.0,5/21,14.63%,MASTL;GSK3B;PPP1R8;ENSA;PTPA
prerank,purine nucleotide biosynthetic process (GO:0006164),0.5576958000801405,1.124611289613469,0.3597014925373134,1.0,1.0,7/12,18.97%,ADA;HPRT1;PRPS1L1;PRPS1;ADSL;GART;PPAT
prerank,response to zinc ion (GO:0010043),-0.34516675466346874,-1.1243723908780763,0.2978723404255319,0.6921602625248919,1.0,12/25,22.15%,GLRA1;SLC30A4;MT2A;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;P2RX4
prerank,positive regulation of heart contraction (GO:0045823),-0.36388590376509705,-1.1242537057465025,0.2909090909090909,0.6911545787272262,1.0,11/19,32.32%,RYR2;TGFB2;ATP1A2;ADRA1A;GSK3A;KCNQ1;EDN1;ADM;EDN3;CHGA;SCN3B
prerank,blood vessel diameter maintenance (GO:0097746),0.5126387976399596,1.1240882828259788,0.3623529411764706,1.0,1.0,7/34,9.76%,KEL;ROCK2;SCPEP1;ROCK1;BDKRB2;AGT;KCNMB2
prerank,positive regulation of cell communication (GO:0010647),-0.33791321207559183,-1.1235905762468086,0.2768361581920904,0.6914134246344631,1.0,12/28,28.75%,RIMS1;SYT1;LGI1;HOMER1;DLG4;GRIK2;KCTD13;CDKN2AIP;EDN1;NMU;SOX11;EDN3
prerank,cellular senescence (GO:0090398),0.5201283149368132,1.122926168575627,0.345,1.0,1.0,9/27,19.56%,SMC6;SMC5;SRF;PML;NSMCE2;TERF2;KAT6A;MAPK14;PRKCD
prerank,nucleoside phosphate catabolic process (GO:1901292),0.5663650797349654,1.122384130972828,0.35413642960812775,1.0,1.0,4/13,10.67%,SMPDL3A;ENPP3;ITPA;ENPP1
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.4462760618385961,-1.1222038539507937,0.3288590604026846,0.6935086770537119,1.0,5/12,18.85%,AKT2;IRS2;IRS1;ABCD2;PPARGC1A
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.44759884444387416,-1.1221806220725257,0.3217665615141956,0.6922736665784707,1.0,5/11,22.37%,PRDX2;PRDX1;PRDX3;GPX1;PRDX5
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5561923203930825,1.1205381539405719,0.35260115606936415,1.0,1.0,7/13,19.16%,AGO2;CNOT1;EIF4ENIF1;PABPC1;CNOT7;TNRC6C;TNRC6B
prerank,contractile actin filament bundle assembly (GO:0030038),0.5527717595072439,1.1204224389804647,0.36049723756906077,1.0,1.0,6/15,15.30%,RHOA;ARRB1;PHACTR1;CUL3;ITGB1;SRC
prerank,stress fiber assembly (GO:0043149),0.5527717595072439,1.1204224389804647,0.36049723756906077,1.0,1.0,6/15,15.30%,RHOA;ARRB1;PHACTR1;CUL3;ITGB1;SRC
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.25321067417803494,-1.1203503863823947,0.1,0.6955775938890078,1.0,37/109,21.43%,PLA2G4A;PIP4K2A;INPP4B;PLAAT3;MTMR10;PIK3R3;PDGFRB;PIP4K2B;PLEK;PIK3C2B;PLCB3;PIK3R1;FGF2;PIK3R4;PLCG1;SLC27A1;RAB5A;MTMR4;INPP5K;RUFY1;PIP5K1A;BMX;INPP5D;SYNJ2;CDS1;PIK3R6;SYNJ1;PI4KA;PIK3CD;IMPA1;PIK3CA;INPP4A;PIP4P1;CDIPT;PLA2G12A;PIP4K2C;PIK3R2
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.4299937436694201,-1.1202489422660542,0.33223684210526316,0.6945749327698114,1.0,7/12,29.02%,SREBF2;DGKQ;CLCN2;RAN;ABCA2;MBTPS1;MBTPS2
prerank,protein phosphorylation (GO:0006468),0.4733499041791902,1.1199475387565363,0.176,1.0,1.0,106/478,15.64%,NEK2;MELK;CDK1;INCENP;TTK;CLSPN;PLK1;BIRC5;MASTL;AURKB;NEK3;CIT;PLK4;MATK;HUNK;MAST2;HASPIN;ILF3;MAP4K4;DYRK1A;STK17B;BAZ1B;CDK14;BMPR1A;AURKA;ROCK2;FGFR4;MAP4K2;GSK3B;FGFR2;STK10;NLK;CHEK2;MYLK3;KIT;CCNA2;PRKDC;CTBP1;DYRK3;VRK2;STK24;STK3;MUSK;NRK;MAP3K1;CCNE1;PDGFRA;TGFBR3;WNK1;MAP3K20;CDC25B;CHEK1;CDC42BPA;EPHA4;CDK2;LRRK2;GRK5;ABI1;MAP3K3;ROCK1;CSNK2A2;PIM1;MARK2;DDR2;PXK;ERC1;TGFBR1;CAMK1D;CDC42BPG;EIF2AK3;SRPK1;LMTK3;PRKCB;BMP2;PRKCA;PDPK1;GRK3;ULK2;CSNK1G2;AAK1;SIK2;MAPKAPK3;MEX3B;STRADA;BTK;PRKCE;CDK19;MAML1;PRKCI;PLK2;CAB39;PRKD1;MORC3;NRBP1;PRDX4;TAOK1;STK11;BIRC6;VRK1;CDK8;EFEMP1;PRKD2;SRC;PRKAG1;STK39;PASK
prerank,response to copper ion (GO:0046688),0.5296991628515193,1.1198836350244807,0.3412384716732543,1.0,1.0,3/20,5.19%,AQP1;LOXL2;PRNP
prerank,ubiquinone biosynthetic process (GO:0006744),-0.413072484187466,-1.1195929144663654,0.305019305019305,0.694940531425643,1.0,6/15,11.99%,COQ8B;COQ5;NDUFA9;COQ10A;COQ3;PDSS2
prerank,import into nucleus (GO:0051170),0.47449894443774643,1.1195549285904745,0.3550420168067227,1.0,1.0,24/73,20.62%,RANBP17;NUP155;RPAIN;E2F3;TNPO1;HNRNPA1;NUP85;EIF4ENIF1;CSE1L;TPR;IPO7;APPL2;NUP214;IPO11;NXT1;NUP133;IPO5;NXT2;FAM53B;GEMIN7;IPO9;NUP188;SNRPB;IPO4
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.30612317464071254,-1.1190871576066,0.23636363636363636,0.6949522576126616,1.0,13/41,14.72%,SMAD7;MEF2C;JAG1;TGFBR2;FKBP1A;CPE;TGFB2;PROX1;TPM1;SOX4;HEYL;GSK3A;ENG
prerank,mitochondrial transport (GO:0006839),-0.2912747744904941,-1.1188654548741612,0.2676056338028169,0.6941802784016227,1.0,28/53,31.28%,FIS1;DNAJC19;SLC25A13;MTX2;OXA1L;SLC25A24;BNIP3;TIMM44;BCL2;TOMM70;BCAP31;GDAP1;SLC25A4;AIP;FBXO7;TOMM34;BCL2L1;TIMM17B;TIMM17A;TOMM7;TIMM9;TMEM14C;TMEM14A;TIMM13;TOMM22;TIMM8B;TOMM5;BAK1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5145055237312073,1.1179493953034363,0.354916067146283,1.0,1.0,12/29,21.10%,FADD;UBE2K;USP18;PTPN2;YTHDF2;TRIM6;CNOT7;IFNAR2;METTL3;MAVS;PTPN1;ISG15
prerank,peptidyl-lysine acetylation (GO:0018394),-0.45968549386123236,-1.1176486407759132,0.35443037974683544,0.6959716896658861,1.0,5/10,32.29%,EP300;KAT2B;KAT7;CREBBP;ESCO1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.33332429229648264,-1.1175695674572446,0.3048780487804878,0.6949011329623036,1.0,8/30,13.29%,EP300;SAFB2;AR;PRMT2;KDM4C;DAB2;DDX5;HEYL
prerank,regulation of neuroblast proliferation (GO:1902692),-0.4052226622566618,-1.117533179183512,0.30714285714285716,0.6936977735569863,1.0,7/15,21.95%,NF1;SMARCD3;CTNNB1;CX3CL1;VEGFA;TAFA1;DRD2
prerank,fatty acid transmembrane transport (GO:1902001),-0.3681032736430858,-1.1174511492171917,0.31092436974789917,0.6926734919397474,1.0,6/19,17.33%,SLC2A1;ABCD4;SLC27A1;ACACB;ABCD2;PRKAG2
prerank,regulation of microtubule polymerization (GO:0031113),0.4917826593514041,1.1171727577057817,0.3413793103448276,1.0,1.0,9/40,11.55%,CDK5RAP2;PSRC1;STMN1;DYRK1A;NUMA1;MAPT;DRG1;RAC1;AKAP9
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.4583007370404578,-1.1170959190932903,0.34911242603550297,0.6922931464307837,1.0,2/10,8.02%,TLR4;NAMPT
prerank,regulation of T cell chemotaxis (GO:0010819),0.5654425915610704,1.1166634979461445,0.3535660091047041,1.0,1.0,4/11,18.35%,WNK1;ADAM17;STK39;OXSR1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.510739347293397,1.1163341900137655,0.344578313253012,1.0,1.0,9/26,14.65%,MTBP;HYAL1;CDC6;TFDP1;LSM11;ANXA1;ADAM17;ADAMTS1;RPTOR
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.31530893120563824,-1.1158436201175648,0.24324324324324326,0.6939797804674364,1.0,15/32,25.60%,EP300;FHIT;PPP1R13B;CDIP1;HIPK2;MSH2;DDX5;DYRK2;DDIT4;RRP8;MYBBP1A;SNW1;BCL3;PDK2;AEN
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.5225393003963669,1.1153128987981422,0.3325062034739454,1.0,1.0,7/22,16.15%,CDKN2D;CDKN2C;CDA;ROCK1;CDKN1B;TP53;ANKLE2
prerank,actin nucleation (GO:0045010),0.518844063066112,1.1152823874792568,0.3554140127388535,1.0,1.0,3/21,7.43%,IQGAP2;ACTR3;ARPC5L
prerank,purine-containing compound biosynthetic process (GO:0072522),0.5115517797435338,1.115233194296689,0.36086404066073696,1.0,1.0,7/25,11.46%,ADK;ADA;DCK;HPRT1;PRPS1L1;PRPS1;ADSL
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.56855230200067,1.1148014425967423,0.3480825958702065,1.0,1.0,2/12,8.13%,IL18;CD80
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4802040047400662,1.1147590131466945,0.35662148070907196,1.0,1.0,10/76,9.20%,BRCA1;SAE1;PAXIP1;FANCI;MYCBP2;FBXW7;LRRK2;CUL3;TBC1D7;ANGPT1
prerank,intracellular lipid transport (GO:0032365),-0.3594010105531572,-1.1141909933038725,0.2925764192139738,0.6969989332329913,1.0,9/21,25.47%,CERT1;ABCD4;ACACB;ARV1;ABCD2;PRKAG2;PLEKHA8;NPC2;MID1IP1
prerank,smooth muscle contraction (GO:0006939),0.5581535144058205,1.114023432120448,0.34893617021276596,1.0,1.0,6/14,16.20%,ROCK2;ROCK1;BDKRB2;SLC8A1;SMTN;TPCN2
prerank,regulation of peptidase activity (GO:0052547),-0.3764385491428731,-1.1139417876929822,0.31092436974789917,0.6963606076036306,1.0,6/19,13.74%,CST3;CAV1;PSMA3;FURIN;PINK1;RCN3
prerank,cellular macromolecule catabolic process (GO:0044265),0.4893469467054242,1.1138782643897551,0.35832414553472985,1.0,1.0,16/49,18.84%,PABPC4;HNRNPD;CHEK2;RNASE6;SIAH2;RNASEH2A;ADAMTS9;HTRA2;PPP1R8;EXOSC7;STT3B;FBXO27;FBXO17;PNPT1;RIPK1;XRN2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5156500728387269,1.113192511278619,0.35515151515151516,1.0,1.0,8/27,16.96%,KMT5A;DYRK1A;YJU2;TWIST1;SPRED1;CD44;SPRED2;ATR
prerank,collagen fibril organization (GO:0030199),0.4733260592987401,1.112994407714333,0.3471502590673575,1.0,1.0,19/88,12.16%,BMP1;LOXL3;COL22A1;LOXL2;LOX;COL4A6;COL4A4;COL18A1;COL5A2;COL23A1;TLL2;ADAMTS14;ADAMTS2;DDR2;TGFBR1;COL15A1;COL4A5;COL12A1;P3H1
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.40145313459144316,-1.1129083253213556,0.31208053691275167,0.6977064770192332,1.0,7/14,21.47%,AKT2;IRS2;GPLD1;IRS1;PPARGC1A;NNMT;SLC45A3
prerank,glutamate metabolic process (GO:0006536),-0.3772112357869256,-1.1127810191835645,0.3442622950819672,0.6967646102009306,1.0,9/19,26.04%,GLUL;GLS;GOT2;PRODH;GOT1;ALDH5A1;GLUD1;OAT;GLS2
prerank,mitochondrial fusion (GO:0008053),0.5458845117447849,1.112564974687636,0.3581890812250333,1.0,1.0,8/18,20.39%,MIEF2;STOML2;MFN2;MIEF1;CHCHD3;MFN1;MIGA2;SPG7
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5351025682860696,1.1125497950119503,0.35013262599469497,1.0,1.0,6/18,14.15%,ITGB7;ADD2;PODXL2;ROCK1;SLC39A8;ITGB1
prerank,dendritic cell migration (GO:0036336),0.5548647574744944,1.1122672245718543,0.3572395128552097,1.0,1.0,4/16,12.45%,CXCR4;HMGB1;TRPM2;TRPM4
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.4167714906235694,-1.1120946504940499,0.31329113924050633,0.6972240830283402,1.0,8/13,29.02%,NR1H3;NUPR1;NR1H2;AQP11;MANF;WFS1;USP19;MBTPS2
prerank,inner dynein arm assembly (GO:0036159),0.5652259068290741,1.1120851158181086,0.3545878693623639,1.0,1.0,2/10,10.82%,DNAH1;DNAAF5
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.4880315125551099,1.1118891332669112,0.3630434782608696,1.0,1.0,14/52,11.14%,RBM15;TRA2B;RBFOX2;KHDRBS1;HNRNPA1;THRAP3;MBNL3;RBM25;FMR1;SAP18;CELF2;HNRNPU;HNRNPL;RBM15B
prerank,amino acid import (GO:0043090),-0.3545476538486152,-1.111585068683004,0.2753623188405797,0.6973033212270847,1.0,5/21,5.70%,SLC6A6;SLC6A1;SH3BP4;SFXN2;SLC7A5
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.2654095667650142,-1.1113484527961808,0.21052631578947367,0.6966140428918743,1.0,27/78,18.29%,STX8;PRKCH;ACTB;STX7;STX4;AR;SQSTM1;EPHB2;STX3;PIK3R1;LRP1;ZDHHC5;CLIP3;NUMB;DAB2;KIF5B;SPTBN1;AP2M1;LDLRAP1;ZDHHC7;ZDHHC8;VAMP8;NKD2;STAC;SORBS1;DPP10;PTPN9
prerank,tyrosine metabolic process (GO:0006570),0.5594909635435406,1.1111497472407212,0.3557833089311859,1.0,1.0,4/11,22.35%,TYR;IL4I1;THAP4;GSTZ1
prerank,neuron projection organization (GO:0106027),-0.3985298418552679,-1.1106070886182906,0.3333333333333333,0.6973019560301963,1.0,10/15,19.48%,PSEN1;INSR;LGMN;MAP1A;CHRNA7;ATP1A3;APP;ABCD2;PICK1;DCTN1
prerank,regulation of transport (GO:0051049),-0.3120159834206979,-1.1105535697127067,0.26717557251908397,0.696176454638418,1.0,8/36,12.19%,PRKN;MYO6;EPB41;ACTB;ICA1;DNAJA1;WWC1;PINK1
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.3265205459428463,-1.110128114339316,0.3105590062111801,0.6960489208656659,1.0,20/32,41.06%,ADIPOR2;APOE;CREBL2;ASAH1;ASXL3;MTOR;PRKAG2;SORBS1;AVIL;MID1IP1;GPER1;MLXIPL;FITM2;AKT1;STAR;PDK4;C3;CREB1;PPARA;PRKAB2
prerank,regulation of mRNA stability (GO:0043488),0.4692325626338824,1.1100744520033223,0.3289738430583501,1.0,1.0,38/145,15.68%,MEIOC;E2F1;XPO1;ROCK2;PSMC2;PSMD5;HNRNPD;FTO;TNPO1;SERBP1;THRAP3;EIF4ENIF1;SAMD4A;FMR1;FUS;RC3H2;LARP1;PSMB1;PSMD14;AXIN2;ROCK1;PUM2;PSMD1;YTHDF2;HNRNPU;TAF15;PSMB9;TENT5D;PRKCA;EXOSC7;NUP214;MEX3D;RC3H1;PSMC6;PABPC1;ZC3H14;GDNF;FXR1
prerank,regulation of cell killing (GO:0031341),-0.3853309458356642,-1.10951637767561,0.3359375,0.6962783815591785,1.0,3/16,10.02%,MAPK8;TGFB2;NOX1
prerank,regulation of blood circulation (GO:1903522),-0.31480341023888825,-1.1093944515911256,0.24550898203592814,0.6953031784121043,1.0,13/34,22.44%,CAMK2D;ECE1;PER2;DMPK;TPM1;ACE;AGTR1;SRI;TBX2;FXYD1;KCNQ1;KCNJ12;S100A1
prerank,positive regulation of transferase activity (GO:0051347),0.4650384311163234,1.1084712397781158,0.3407258064516129,1.0,1.0,18/142,7.76%,NEK2;PLK1;AURKB;DSCC1;RFC4;FGFR4;FGFR2;HNRNPD;KIT;RFC2;MRE11;MUSK;PDGFRA;RFC3;GRHL2;FBXW7;UBE2N;EPHA4
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5699450334824314,1.1080552986771368,0.36123348017621143,1.0,1.0,3/11,9.84%,DDX11;SMARCA4;NOL11
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.46262438088158275,1.1070535627796407,0.283,1.0,1.0,60/259,15.33%,KIF24;PLK4;IFT80;HYLS1;CEP89;MAP4K4;BBS9;DZIP1L;SCLT1;ACTR3;WDR35;PARVA;ASAP1;WDR90;GBF1;SPAG16;IFT140;POC1B;FAM161A;EXOC4;KIF27;PCM1;KIT;SPEF1;OCRL;NTN1;RAP2A;TXNDC15;MKKS;FGD4;WDR11;CEP83;NUDCD3;RILPL1;RFX2;SSX2IP;FGD1;CCDC57;CFAP52;WDPCP;NPHP3;S1PR2;RAB1A;SRGAP2;FGD6;TTC39C;TRAPPC14;RAC1;EZR;CC2D2A;DMTN;EHD1;TTLL3;EXOC8;ARF4;ITGB1;CEP162;EMP1;LZTFL1;VSTM5
prerank,cellular response to peptide (GO:1901653),-0.2814144364612471,-1.106927758959607,0.15625,0.7001946329751312,1.0,20/56,14.42%,CACNA2D1;PSEN1;GRIN2A;CAV1;IGF1;TLR4;RPL23;LRP1;TRIM41;VCAM1;CASP4;LGMN;NOD1;PTPN22;ATP1A3;APP;ARHGEF2;GRM5;CHMP5;GRIN1
prerank,regulation of stem cell population maintenance (GO:2000036),0.5282068360608267,1.106297640762807,0.3620457604306864,1.0,1.0,2/18,3.91%,LOXL2;CNOT1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.5469101766526813,1.1055048168499717,0.35825105782792666,1.0,1.0,6/15,19.93%,ADGRV1;KIT;MKKS;LHFPL5;KCNA1;PIEZO2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.4353053064508029,-1.1053848407078224,0.3538961038961039,0.7027928245680906,1.0,6/11,24.36%,SLC27A1;GPLD1;NR1H3;NR1H2;MFSD2A;CTDNEP1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.3038461525461622,-1.1048737255120251,0.2847222222222222,0.7027869121033747,1.0,9/37,14.48%,PTPRD;FAT4;GRID2;IL1RAPL1;VCAM1;NECTIN3;CADM3;HMCN1;TENM4
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.3545493498798179,-1.1047483612224824,0.31862745098039214,0.7018316156948616,1.0,6/25,13.19%,AKAP6;CEMIP;PLCG1;TRPC1;CACNB2;CX3CL1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5212287436082679,1.1047247343840876,0.3505674653215637,1.0,1.0,7/21,13.69%,ROCK2;BCOR;ROCK1;ENPP1;TRPM4;SOX9;HEY2
prerank,sphingolipid metabolic process (GO:0006665),-0.24372105382177203,-1.1042388191126618,0.23333333333333334,0.7018857171285823,1.0,42/108,25.95%,CERT1;ELOVL7;HEXB;SGMS2;HACD3;ACER2;PLPP3;HACD2;PSAP;ASAH1;ALDH3A2;ST6GALNAC3;ACER3;ESYT1;HACD1;B3GALNT1;HEXA;SERINC1;DEGS2;SPNS2;ARV1;GLTP;ASAH2;CTSA;DEGS1;GAL3ST1;ELOVL6;VAPB;PPT1;CERS1;GBA2;SPTSSA;ESYT3;SGPL1;ABCA2;PLA2G15;ELOVL1;SPHK1;NEU1;KDSR;SUMF1;SPTSSB
prerank,regulation of centrosome cycle (GO:0046605),0.5159716013932129,1.103620375727688,0.36096938775510207,1.0,1.0,2/21,2.81%,GEN1;AURKA
prerank,regulation of cell projection organization (GO:0031344),0.5514539067797568,1.1035811985805248,0.37280701754385964,1.0,1.0,2/13,2.73%,MACF1;MOV10
prerank,negative regulation of gene expression (GO:0010629),0.4612664689632325,1.1031762854218305,0.259,1.0,1.0,71/302,15.68%,PHF19;EZH2;RBL1;HELLS;TYMS;ATOH8;ILF3;SYNCRIP;ATP2B4;PPM1D;RB1;BMPR1A;MOV10;AURKA;ROCK2;SUZ12;AGO2;CNOT1;DDRGK1;MPHOSPH8;EED;SETDB2;MAPT;XDH;SFRP2;EIF4ENIF1;SAMD4A;CAPRIN1;RBBP4;RBBP7;FBXW7;FMR1;PHF1;LARP1;YAP1;ROBO1;VHL;SLC24A3;PICALM;EPC1;FLOT2;LSM2;YTHDF2;ATP2B1;PARP9;EIF2AK3;RBMS3;MRPL13;HDAC1;CRKL;BMP2;TERF2;STOX1;CENPV;TRIM6;NOTCH2;DXO;PTBP2;RBM4;HEY2;DHFR;YY1;DNMT3A;EPRS1;SFRP1;CNOT7;RUNX1;NFKB1;ITGB8;TNRC6C;FXR1
prerank,basement membrane organization (GO:0071711),0.558530419996629,1.103091462311895,0.3583208395802099,1.0,1.0,5/14,18.30%,NID2;LAMB1;NID1;NTN4;COL4A1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.5541319629861945,1.1028316040151473,0.3593519882179676,1.0,1.0,4/13,13.09%,XPO1;NMD3;RRS1;SDAD1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3396631710418131,-1.1024381481729977,0.27167630057803466,0.7050317759798833,1.0,6/25,5.88%,CAMK2D;CTNNA3;CALM1;CAV1;RYR2;FGF13
prerank,"DNA-templated transcription, termination (GO:0006353)",0.4652742910757269,1.1016572667972553,0.35306553911205074,1.0,1.0,17/68,13.17%,TTF2;SETX;POLR1A;CSTF3;FIP1L1;SLBP;POLR1B;ERCC3;LSM11;POLR2A;WDR33;TAF1D;PCF11;SCAF8;CPSF4;TTF1;POLR1G
prerank,aortic valve development (GO:0003176),0.49045509494048506,1.1011241683885327,0.3896260554885404,1.0,1.0,11/34,13.69%,RB1;ROCK2;EFNA1;SMAD6;ROBO1;ROCK1;ELN;BMP2;SOX9;TWIST1;HEY2
prerank,nucleocytoplasmic transport (GO:0006913),0.47905631144691146,1.1007494389084,0.3555045871559633,1.0,1.0,10/40,17.31%,XPO1;NUP205;PHAX;HNRNPA1;RBM15B;ATXN1;NXT1;NUP98;NXT2;GEMIN7
prerank,chondrocyte differentiation (GO:0002062),0.49491756366785317,1.1006415481015674,0.3847058823529412,1.0,1.0,13/32,19.79%,WNT2B;SULF2;NFIB;SOX6;SULF1;EIF2AK3;CCN3;BMP2;SOX9;SNX19;RUNX1;OSR1;CREB3L2
prerank,regulation of apoptotic process (GO:0042981),0.46021406469386883,1.1002969484207106,0.172,1.0,1.0,105/676,14.15%,TOP2A;KIF14;ECT2;MELK;STIL;CDK1;PLK1;BIRC5;BARD1;FIGNL1;E2F1;STPG1;AQP1;ITGB3BP;FADD;MAP4K4;STK17B;SETX;PHIP;ARHGAP10;STEAP3;ANGPT4;GSK3B;FXN;BMF;IAPP;DDRGK1;ACTN4;ANP32B;AIFM2;FHL2;PRKDC;FAM162A;SIAH2;MRE11;CCAR1;NET1;PDPN;FAF1;STK3;SFRP2;FGD4;ANXA5;ERCC3;RBM25;VAV2;TMEM219;MAP3K20;ATG7;CALHM2;SCRIB;GNA13;FGD1;SAP18;FOXO3;HTRA2;SMAD6;ARL6IP1;ING4;BCLAF1;GRK5;SH3RF1;TNFRSF10B;KLF11;MGMT;DNM2;ANGPT1;VHL;PIM1;AGT;SKP2;HMGB1;GAS1;ERC1;APIP;APAF1;NDRG1;BOK;IP6K2;ANP32E;HDAC1;ANXA1;ARHGEF18;QRICH1;BMP2;CHM;TXNDC5;CASP8;ITCH;SOX9;NOTCH2;HDAC2;ATF5;IL31RA;PPID;CTSH;PLAUR;USP47;PRKCI;MED1;PLK2;ARF4;XIAP;SMPD1;ITGB1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5389868678968673,1.0999379590074503,0.3788487282463186,1.0,1.0,7/16,16.32%,GBF1;DDRGK1;LRRK2;TAPT1;MIA3;VAPA;BCAP29
prerank,inositol lipid-mediated signaling (GO:0048017),-0.2865223250360702,-1.099865750479546,0.27450980392156865,0.7103242100045121,1.0,18/50,21.43%,OGT;ADAP2;IGF1;PDGFRB;PIK3C2B;KCNH1;PLCB3;PIK3R1;IRS2;IRS1;PLCE1;TNFAIP8L3;PI4KA;PIK3CD;PIK3CA;EXOC1;PLCH1;PIK3R2
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.4175271625988626,-1.0992662291218096,0.33223684210526316,0.7106313675951578,1.0,2/12,8.12%,STAT3;ESR1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.33561768037772827,-1.098706114577678,0.31840796019900497,0.7107912634031763,1.0,5/24,6.99%,KRIT1;TEK;GAS6;CDH5;RAMP2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.5023967140438312,1.0983041705108019,0.37667071688942894,1.0,1.0,4/29,6.93%,PLK1;FBXO5;FBXW7;UBE2N
prerank,RNA transport (GO:0050658),0.4616644196204064,1.0982559443339621,0.3620146904512067,1.0,1.0,18/71,16.60%,CKAP5;NUP155;SRSF4;HNRNPA1;EIF4E;UPF3B;SLBP;TPR;FMR1;DDX39B;SRSF7;SRSF3;SRRM1;NUP214;SIDT1;HNRNPA2B1;PNPT1;DHX38
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5663271977949625,1.0981023624962305,0.3620689655172414,1.0,1.0,4/10,16.04%,RHOA;RAP2A;EZR;MSN
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4944403045858544,1.0979610284806771,0.37247924080664296,1.0,1.0,10/35,15.67%,NLK;KIT;LEPROT;VHL;OCIAD2;CRLF3;PIGU;ADIPOR1;NF2;OCIAD1
prerank,pulmonary valve development (GO:0003177),-0.37822961986086917,-1.097610211418819,0.3203125,0.7122820343581434,1.0,9/18,18.03%,JAG1;BMPR2;TGFB2;NOS3;SLIT2;TNFRSF1B;HEYL;STRA6;ROBO2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.38000770638457726,-1.0975537928378243,0.28346456692913385,0.7111912869460242,1.0,13/18,35.31%,COX16;OXA1L;COX19;PET100;COX20;SMIM20;COX17;COX14;COA8;COA5;COA3;SURF1;FASTKD3
prerank,secretion (GO:0046903),-0.39910169616993496,-1.0973723122929755,0.34098360655737703,0.7103891273646146,1.0,4/14,10.44%,RIMS1;SLC22A6;NPR1;TPD52
prerank,negative regulation of immune system process (GO:0002683),0.5349600532258518,1.0972322089762467,0.3544827586206897,1.0,1.0,3/16,12.75%,FADD;HOXA7;SOX9
prerank,cellular response to mechanical stimulus (GO:0071260),0.48493293932882603,1.0970835252123723,0.37299771167048057,1.0,1.0,12/46,12.75%,AQP1;FADD;MAP3K14;CASP8AP2;MAP3K1;CNN2;CHEK1;IRF1;TNFRSF10B;PIEZO1;CASP8;SOX9
prerank,defense response to Gram-negative bacterium (GO:0050829),0.48648632580674767,1.097054917082038,0.37037037037037035,1.0,1.0,4/42,7.99%,HMGB2;AQP1;RNASE6;SERPINE1
prerank,organic hydroxy compound transport (GO:0015850),-0.3140351483172181,-1.0967034454233857,0.2987012987012987,0.710844648769445,1.0,9/36,23.98%,SLCO1C1;SLCO2B1;ABCC4;ATP8B1;SLC16A1;STRA6;STARD5;OSBP;NPC2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4643622781278142,1.0967003639092658,0.3575076608784474,1.0,1.0,31/114,22.56%,TNFSF13B;MAP3K14;PSMC2;PSMD5;ACTN4;FOXO3;PSMB1;PSMD14;PSMD1;EDA;LIMS1;PSMB9;PYDC1;ADAM17;PLVAP;PSMC6;TP53;TNFRSF25;PSMB2;PSME4;RIPK1;PSMB7;PSMD11;TRAF6;PSME3;TRAF2;IKBKB;PSMD13;BIRC2;PSMB8;PSMD4
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.5195331622224015,1.0965795738544888,0.3716129032258065,1.0,1.0,3/23,9.77%,HMGB2;DNASE2;HMGB1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5629915140590614,1.0965563870547037,0.3706395348837209,1.0,1.0,4/12,10.29%,NIN;PCM1;BICD2;NINL
prerank,B cell receptor signaling pathway (GO:0050853),-0.3137873963308313,-1.0964512376478,0.29559748427672955,0.710230047291285,1.0,9/32,19.09%,MEF2C;VAV3;BCL2;BMX;PIK3CD;CD38;RFTN1;BCAR1;NCKAP1L
prerank,positive regulation of organelle organization (GO:0010638),0.496474109864818,1.0960661164204253,0.37922705314009664,1.0,1.0,10/32,15.19%,GSK3B;ANXA2;LNPK;ATL3;SORBS3;HTRA2;ANXA1;STX18;ADRB2;UVRAG
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.31085106541238383,-1.094777468637153,0.3546099290780142,0.7131429451472693,1.0,12/34,22.15%,SMAD7;ATP1B1;CALM1;RYR2;ADRA1A;SRI;PDE4D;KCNQ1;ZC3H12A;CALM3;NOS1;P2RX4
prerank,positive regulation of behavior (GO:0048520),-0.45851324934665105,-1.094733531524383,0.3786127167630058,0.7119730284250746,1.0,5/10,18.07%,SGIP1;MEF2C;CFAP20;STRA6;NLGN1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.36810302262089845,-1.0942781229755547,0.3231939163498099,0.7119451783966648,1.0,8/17,23.70%,COX4I1;COX6C;COX5A;COX7B;COX7C;NDUFA4;COX8A;COX5B
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.4218229626015958,-1.094254011794903,0.36451612903225805,0.7107574678320261,1.0,6/13,31.05%,KCNB1;SYT1;SCAMP5;SYT10;CACNA1H;CACNA1I
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4863970974155832,1.0939953571562429,0.371900826446281,1.0,1.0,9/34,14.18%,E2F1;ASXL1;ANKRD26;WWTR1;YAP1;RUNX1T1;ENPP1;RORA;SMAD3
prerank,regulation of phosphorylation (GO:0042325),0.46206608409320843,1.0939547824218698,0.3488843813387424,1.0,1.0,29/120,16.76%,BARD1;NDC1;NUP155;CDKN2D;CDKN2C;MCM7;NUP205;PHIP;FNIP1;NUP160;GCK;NUP85;TPR;PML;ROCK1;PLXNB2;DSCAM;NUP214;KCTD20;RANBP2;CDKN1B;BTBD10;NUP133;PIN1;PRKAG1;NUP42;ANKLE2;SESN2;NUP98
prerank,regulation of aerobic respiration (GO:1903715),-0.39117274853045014,-1.0930697764466997,0.3246268656716418,0.7125899158333968,1.0,6/15,26.36%,CBFA2T3;PINK1;COX7A2;UQCC2;ATP7A;AK4
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.46523265378282075,1.0926938046505594,0.3802672147995889,1.0,1.0,17/94,12.45%,BRCA1;E2F1;ITPR1;CHEK2;PRKDC;STK24;PML;CUL5;HTRA2;CUL3;TNFRSF10B;APAF1;HINT1;BOK;LGALS12;QRICH1;MSH6
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.3262402412599269,-1.0923664251730316,0.31901840490797545,0.7119182337157631,1.0,10/29,24.99%,CROT;ACOT11;ACLY;ACBD6;ACSL6;DBI;ACSF2;ACOT7;ACOT13;ACOT6
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.3262402412599269,-1.0923664251730316,0.31901840490797545,0.7119182337157631,1.0,10/29,24.99%,CROT;ACOT11;ACLY;ACBD6;ACSL6;DBI;ACSF2;ACOT7;ACOT13;ACOT6
prerank,receptor internalization (GO:0031623),-0.28210206199396554,-1.092058525031874,0.30392156862745096,0.7115156824984683,1.0,13/44,13.84%,DNM3;CALCRL;CAV1;ACKR3;LRP1;RAMP1;RAMP2;DNM1;RAB5A;CD81;AP2M1;GRB2;LDLRAP1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5470719804101815,1.0920381090908398,0.36281859070464767,1.0,1.0,5/13,15.78%,EFL1;LRRK2;RHOQ;GNAI3;MFN1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.3976069595899659,-1.091970725165871,0.36538461538461536,0.7105262024599058,1.0,5/15,13.14%,GRM7;GRM3;HOMER1;GRM5;GRM1
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3306963620674833,-1.091648864959921,0.3435897435897436,0.710017703357841,1.0,9/27,12.76%,DACH1;BMPR2;ACVRL1;PDGFRB;FGF2;PINX1;ATM;NABP2;RGCC
prerank,icosanoid metabolic process (GO:0006690),0.48687304950233495,1.0915555996418587,0.3836405529953917,1.0,1.0,12/40,20.66%,PON1;PTGR1;ABCC10;PTGS1;DAGLB;PON2;DPEP1;PTGIS;DPEP2;PON3;DAGLA;MAPKAPK2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.3640608127400985,-1.0911491262830737,0.32806324110671936,0.7100054594854435,1.0,11/17,38.84%,TEK;NTRK3;ABL1;BAIAP2;NRP1;FES;BCAS3;HRAS;NTF3;HCK;HCLS1
prerank,regulation of cell-cell adhesion (GO:0022407),-0.30302848543194094,-1.0907855600622363,0.2833333333333333,0.7096621897418791,1.0,7/39,9.10%,PTK2;PTPRG;SMAD7;PODXL;JAG1;FUT9;MINK1
prerank,plasma membrane invagination (GO:0099024),0.5014682819633739,1.0905536081615224,0.3747044917257683,1.0,1.0,5/29,13.32%,AURKB;RHOA;SNX33;SNX18;DOCK1
prerank,anterior/posterior axis specification (GO:0009948),-0.3870049884591001,-1.0905136475635624,0.336996336996337,0.7090397682984364,1.0,3/15,16.72%,TASOR;TBX3;DDIT3
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.39233621506941396,-1.090405793820935,0.3238434163701068,0.7081101760099405,1.0,2/15,4.15%,SMAD7;TGFB2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.30625274922114964,-1.0904051888733652,0.3067484662576687,0.7068955787955152,1.0,15/34,28.43%,PTPRB;PTPRZ1;DUSP3;DUSP22;PTPN22;PTPRO;PTPN11;DUSP1;PTPN9;PTPRT;PTPN12;PGP;PTPRF;DUSP8;DUSP6
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.40847979462313333,-1.0899128412476211,0.3680555555555556,0.7069152073233854,1.0,3/14,6.50%,PUM1;DDX60;ZDHHC5
prerank,positive regulation of angiogenesis (GO:0045766),0.4515646437505713,1.0897128885150213,0.37551440329218105,1.0,1.0,25/108,16.20%,BRCA1;VASH2;AQP1;ANGPT4;HYAL1;AGO2;ADAM12;ANXA3;SFRP2;HSPB6;SERPINE1;GAB1;PRKCB;PRKCA;RRAS;PDPK1;CTSH;TWIST1;PRKD1;ITGA5;ITGB1;PRKD2;RUNX1;ITGB8;STIM1
prerank,regulation of DNA binding (GO:0051101),0.48143816817766244,1.0896377020113868,0.3885778275475924,1.0,1.0,3/44,1.40%,HJURP;HMGB2;E2F1
prerank,peptide cross-linking (GO:0018149),0.5006960222050696,1.0891433781496318,0.3813038130381304,1.0,1.0,1/25,1.17%,TGM1
prerank,positive regulation of protein maturation (GO:1903319),-0.43148880045716775,-1.0890287472899878,0.34375,0.7079018998913486,1.0,3/11,16.57%,SOX4;CCBE1;NKD2
prerank,response to growth factor (GO:0070848),-0.2947822497478681,-1.0889537676922256,0.2868217054263566,0.706863566727761,1.0,20/41,25.09%,ACVR1;ACVR2A;TGFBR2;BMPR2;MAP2K5;ACVRL1;KLF4;ACVR2B;CTNNB1;SHC1;ERBB2;SOX2;BMPR1B;NOS1;RACK1;URI1;SPHK1;GATA6;PLK5;MAPK7
prerank,cellular component assembly (GO:0022607),0.45904691868801784,1.0889376765181016,0.322,1.0,1.0,54/253,16.51%,KNTC1;FANCA;TRIP13;CHAF1B;HAS3;KPNA3;TEAD1;RHOA;RAD21;PARVA;SPAG16;RTN3;MDM4;ADD2;SPEF1;ZW10;NLGN3;RBBP4;GRHL2;PML;QSOX1;ARL6IP1;DARS1;YAP1;CORO1B;RHOQ;PICALM;KMT2A;IKBKG;HAS1;RSPH9;YTHDF2;LIMS1;CAPZA1;RAC1;EZR;GORASP2;DPYSL3;DMTN;SOX9;PPID;BAIAP2L1;TTLL3;CHAF1A;CAPG;P3H4;EPRS1;LCP1;ADD1;TP53;TINF2;SYCP2;NLGN2;NCKAP1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.4545134741061888,-1.0882811438228757,0.3764367816091954,0.7072423974308545,1.0,5/10,19.09%,TGFBR2;PRKCQ;CD81;LGALS9;NCKAP1L
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.48924949235108,1.088154015500825,0.39038031319910516,1.0,1.0,6/37,7.80%,IFT80;WDR35;IFT140;PCM1;TNPO1;SSX2IP
prerank,organic substance transport (GO:0071702),0.4574211170421919,1.0881239638886355,0.38351983723296035,1.0,1.0,8/121,7.02%,CENPF;SLC18A2;NDC1;ZG16;ABCA4;SLC6A2;SLC19A1;ABCA9
prerank,regulation of metal ion transport (GO:0010959),-0.3770621148415437,-1.0879408054745776,0.3177966101694915,0.7069259915964021,1.0,5/16,16.65%,CACNA2D1;EPB41;CAMK2G;BCL2;SRI
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.42635858730032883,-1.0877819112409168,0.37650602409638556,0.7060343222294589,1.0,2/11,4.15%,MEF2C;TGFB2
prerank,regulation of stem cell proliferation (GO:0072091),0.5396348163827152,1.087553108706027,0.38409703504043125,1.0,1.0,9/17,24.23%,HMGB2;YAP1;HNRNPU;GJA1;TERT;FBLN1;EIF2AK2;ZFP36L1;KDM1A
prerank,heart contraction (GO:0060047),-0.28701813875961835,-1.087214392574369,0.30158730158730157,0.7061946923740015,1.0,19/41,39.48%,ATP1B1;RYR2;TPM1;ACE;ATP1A2;SCN1B;GPX1;PIK3CA;KCNQ1;SCN4B;SCN3B;MYL4;CASQ2;TNNI1;GAA;KCNH2;TTN;DMD;SCN5A
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.4585010974704313,1.0872042659831018,0.3663265306122449,1.0,1.0,30/113,16.00%,TERF1;FNIP1;GSK3B;ASAP1;PSMC2;RPA1;BMF;TRABD2B;CHD1L;AJUBA;ERCC4;FAF1;RPA2;SLF1;ERCC3;SPIDR;CDC42EP2;SH3GLB1;TPPP;CUL4B;ABCA1;TAL1;XPA;PIEZO1;PSMC6;CAPG;LCP1;SRC;RHOC;TP53
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.4628646502239716,1.0871794144695759,0.3785488958990536,1.0,1.0,16/87,12.77%,IQGAP3;IQGAP2;ROCK2;RHOA;ARHGAP18;PDGFRA;RHOQ;ROCK1;ARHGAP35;TRPM2;TWF1;RAC1;RND2;EZR;DMTN;NOTCH2
prerank,negative regulation of chemotaxis (GO:0050922),-0.3192911801570466,-1.0868274599304573,0.28717948717948716,0.7059106748985192,1.0,13/31,18.98%,SEMA6A;SEMA6D;SEMA7A;DUSP3;SEMA4D;SEMA3A;SLIT2;ANGPT2;THBS1;SEMA3B;SEMA3C;ROBO2;SEMA5B
prerank,regulation of protein kinase C signaling (GO:0090036),0.5318564176348479,1.0864531285456107,0.36684782608695654,1.0,1.0,2/14,2.64%,ADGRV1;ULK4
prerank,positive regulation of ATPase activity (GO:0032781),0.48621229273972405,1.0861819366306302,0.391304347826087,1.0,1.0,3/41,4.78%,UHRF1;MSH3;DHX9
prerank,Golgi organization (GO:0007030),0.4635291618470878,1.0856989423933783,0.3910386965376782,1.0,1.0,28/112,18.46%,CDK1;ARHGAP21;USP6NL;GBF1;OBSL1;COG1;ZW10;ATL2;ATL3;RAB29;LRRK2;GOLGA8B;GOLGA5;RAB1A;BAG5;GAK;GORASP2;VTI1A;PRKD1;VRK1;BET1;TMED3;UBXN2B;CSNK1A1;COG4;CLASP1;PI4K2B;TMED10
prerank,tight junction assembly (GO:0120192),0.4743506689692571,1.0851655413748051,0.4088888888888889,1.0,1.0,3/49,6.70%,ECT2;AFDN;GRHL2
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.3817275103732237,-1.0850211876119058,0.3383458646616541,0.7092708439296678,1.0,9/17,31.05%,KCNB1;SLC4A8;SCAMP5;SYT10;RAB27A;NLGN1;RAB3D;CACNA1H;CACNA1I
prerank,protein import into mitochondrial matrix (GO:0030150),-0.3642514626752923,-1.0847095046491633,0.35714285714285715,0.7088582768989632,1.0,12/18,39.22%,DNAJC19;TIMM44;TOMM70;DNAJC15;PAM16;TIMM17B;TIMM17A;ROMO1;GRPEL1;DNLZ;TOMM40L;TIMM50
prerank,regulation of protein localization (GO:0032880),0.46684620302031,1.084620509985835,0.4120819848975189,1.0,1.0,12/58,14.31%,TRIML2;BORA;DZIP1L;AFDN;TPR;FBXW7;WDPCP;PICALM;AAK1;TRIM6;DLG1;TRIM5
prerank,monocarboxylic acid transport (GO:0015718),-0.28026218476275333,-1.0842144739369737,0.34782608695652173,0.7089117926212551,1.0,13/51,17.76%,SLC16A12;SLCO1C1;SLCO2B1;ABCC4;SLC27A1;ABCG2;SLCO2A1;ATP8B1;SLC5A6;SLC16A1;SLC16A4;SLC6A11;STARD5
prerank,ether lipid biosynthetic process (GO:0008611),-0.45517249350198724,-1.0829527453185466,0.3775811209439528,0.7109850213850585,1.0,4/10,11.19%,PLA2G4A;CHPT1;DHRS7B;LPCAT2
prerank,tetrapyrrole metabolic process (GO:0033013),-0.3844679910653135,-1.082927937504463,0.3670886075949367,0.7098438724828422,1.0,7/18,25.90%,ABCD4;CUBN;LMBRD1;MTRR;MMAA;MTR;TCN2
prerank,cristae formation (GO:0042407),-0.3381832372708746,-1.0819348831327886,0.3254437869822485,0.711072903043474,1.0,14/27,25.38%,APOOL;ATP5PF;ATP5F1A;ATP5MF;ATP5MC3;ATP5PO;DNAJC11;ATP5PD;ATP5F1B;ATP5F1D;ATP5F1E;ATP5MG;MICOS13;ATP5ME
prerank,histone mRNA catabolic process (GO:0071044),0.5298624388193386,1.0819209551175646,0.3770491803278688,1.0,1.0,5/15,13.59%,TENT2;ERI1;TUT7;TUT1;TUT4
prerank,positive regulation of response to wounding (GO:1903036),-0.34191190434884144,-1.0818505402034297,0.3217821782178218,0.7100787732116626,1.0,10/24,22.36%,PTK2;OCLN;VTN;MYLK;GRN;SCARF1;ARFGEF1;ADRA2A;HBEGF;CLDN1
prerank,positive regulation of cellular component organization (GO:0051130),0.46074423708613277,1.0809008708045826,0.37525562372188137,1.0,1.0,20/107,10.75%,CDC20;HAS3;RB1;FNIP1;HYAL1;GSK3B;ASAP1;BMF;TRABD2B;AJUBA;ADGRL1;ABCB4;FAF1;SLF1;SPIDR;CDC42EP2;SH3GLB1;TPPP;TGFBR1;TAL1
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.2811002404693292,-1.0797908823816251,0.3,0.7138735665466528,1.0,16/50,16.50%,SMAD7;OGT;PRMT3;CAV1;PER2;UFL1;SQSTM1;PINX1;DNAJA1;LIMK1;ABL1;SOX4;SPRY2;SH3RF2;UBXN1;PRKCG
prerank,microtubule anchoring at centrosome (GO:0034454),0.5676580815314396,1.0797272223305672,0.37116564417177916,1.0,1.0,3/10,10.29%,NIN;PCM1;NINL
prerank,positive regulation of ruffle assembly (GO:1900029),-0.4166023631890528,-1.079536321334737,0.34146341463414637,0.7133438442763367,1.0,9/13,32.11%,FAM98A;PFN1;PLEKHM1;EPS8L2;NLGN1;P2RY12;DEF8;EPS8;HRAS
prerank,purine nucleotide catabolic process (GO:0006195),0.5463022948565522,1.0793380069207155,0.37392550143266473,1.0,1.0,6/13,23.98%,XDH;ITPA;HINT1;PNP;NT5E;GDA
prerank,cellular response to organic cyclic compound (GO:0071407),0.4531271803626642,1.0793268777414071,0.3637284701114488,1.0,1.0,29/141,15.27%,BRCA1;RAD51;AQP1;ROCK2;CASP7;ABCB4;DIAPH1;BLM;LCOR;CTNNA1;SPIDR;IL18;LRRK2;LARP1;RIOK3;P2RY1;NR3C1;TRPM2;AHR;AKAP9;EZR;RORA;DMTN;MED1;RUVBL2;RAMP3;ADCY6;SFRP1;PKD2
prerank,response to laminar fluid shear stress (GO:0034616),-0.44450708516157456,-1.0791125825237888,0.3742138364779874,0.7132352285436769,1.0,5/10,11.35%,SMAD7;MAP2K5;KLF4;SREBF2;KLF2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.38314737162806045,-1.0780003769518676,0.3386454183266932,0.7148158019615556,1.0,11/16,25.38%,ATP5PF;ATP5F1A;ATP5MF;ATP5MC3;ATP5PO;ATP5PD;ATP5F1B;ATP5F1D;ATP5F1E;ATP5MG;ATP5ME
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.490982325111256,1.0776172576280865,0.3761904761904762,1.0,1.0,8/29,13.49%,RAB33B;COG1;GOLGA5;COPB2;COPZ1;VTI1A;GOSR1;TRAPPC10
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3209145352302408,-1.0773244813863254,0.3055555555555556,0.7153078673942588,1.0,6/27,5.75%,SLC1A2;SLC7A2;SLC25A13;SLC25A12;SLC7A5;SLC3A2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.29743333297745134,-1.077287187536918,0.31543624161073824,0.7142172536602467,1.0,10/33,13.35%,EP300;SAFB2;UFL1;AR;UBA5;PRMT2;KDM4C;ESR1;DDX5;KCTD6
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.5652260742598719,1.077140354364364,0.39296187683284456,1.0,1.0,3/10,14.16%,PRNP;SCRIB;RC3H1
prerank,cilium movement (GO:0003341),0.4669880656223027,1.0768477694737897,0.40022421524663676,1.0,1.0,7/47,10.82%,DNAH11;CFAP53;SPEF1;DNAH1;DNAI4;RSPH9;DNAAF5
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.36272103031654046,-1.0766538532848084,0.36220472440944884,0.7146208334151036,1.0,5/19,13.91%,ABHD5;AKT2;IRS2;IRS1;ABCD2
prerank,lipid oxidation (GO:0034440),-0.4105736358313028,-1.0764348868364813,0.3746130030959752,0.7139762988623953,1.0,3/12,18.85%,ADIPOR2;PLA2G7;PPARGC1A
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.516075663121935,1.076076206974708,0.3876478318002628,1.0,1.0,4/18,10.36%,STMN1;CUL3;RIPOR2;ARHGAP35
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.3799257695726254,-1.0758992815302775,0.3613138686131387,0.7141558118533603,1.0,3/16,3.00%,CAMK2D;CALM1;RYR2
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.46806905283533806,1.0756317937150441,0.3908174692049272,1.0,1.0,18/52,15.91%,PNLDC1;CNOT1;PATL1;CNOT6L;LSM3;SAMD4A;RC3H2;TUT7;CNOT6;LSM2;PAN3;EXOSC7;LSM7;TUT4;RC3H1;CNOT7;CNOT4;LSM4
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5561527223849579,1.0749849645621192,0.3930131004366812,1.0,1.0,5/11,9.39%,AJUBA;DHX9;FMR1;LIMD1;PUM2
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4624947810132446,1.0746094250853018,0.39052631578947367,1.0,1.0,22/74,17.91%,EZH2;LOXL2;USF3;PDPN;SFRP2;EFNA1;WWTR1;AXIN2;TGFBR1;BMP2;NKX2-1;SMAD4;ADIPOR1;TWIST1;SPRED1;SMAD3;SFRP1;SPRED2;PTEN;EPHA3;SMAD2;CLASP1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5055755214386277,1.074604516809797,0.38491547464239273,1.0,1.0,4/21,11.92%,CYP26B1;LPIN2;AGXT;HOGA1
prerank,ribosomal large subunit assembly (GO:0000027),-0.3296687600162622,-1.0745167633467974,0.3155339805825243,0.7164214123373644,1.0,14/24,31.42%,DHX30;RPL3;RPL10;BRIX1;RPL24;TRAF7;MDN1;RPLP0;NOP2;BOP1;RPL11;FASTKD2;RSL24D1;NLE1
prerank,neurotransmitter uptake (GO:0001504),-0.40857630738111983,-1.0743633285948095,0.3786407766990291,0.7156166295391159,1.0,9/12,45.32%,GLUL;ATP1A2;SNAP25;SLC22A2;SLC1A6;SLC22A3;SLC38A1;SLC29A2;SLC29A4
prerank,regulation of protein kinase A signaling (GO:0010738),0.517164623576823,1.0742941767771483,0.3968462549277267,1.0,1.0,7/20,17.54%,ADGRV1;IAPP;LRRK2;ADRB2;RAMP3;PRKAR2B;PRKAR2A
prerank,histone H3 deacetylation (GO:0070932),0.5318066024766761,1.0740698900177148,0.3801324503311258,1.0,1.0,7/15,14.89%,SMARCAD1;HDAC8;SFPQ;HDAC1;HDAC2;ELK4;PER1
prerank,mitochondrion disassembly (GO:0061726),-0.3015024002125495,-1.073924096383329,0.3669064748201439,0.7155733446106366,1.0,14/34,19.87%,PRKN;FIS1;WDR45B;BECN1;SQSTM1;ULK1;BNIP3;PINK1;ATG9A;USP30;ATG2B;FBXO7;FUNDC1;GABARAPL2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.5197488535250432,1.0738031103134131,0.38675496688741723,1.0,1.0,10/22,18.53%,ERI2;ERI1;RRS1;RPP40;EXOSC7;ERI3;WDR12;NOL9;ABT1;EXOSC10
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5349688950193814,1.0731643112089417,0.3876177658142665,1.0,1.0,3/16,5.98%,CDKN2D;DDIAS;SFRP2
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.3454064521496303,-1.0729702490731678,0.3624454148471616,0.7167002991083609,1.0,5/22,16.99%,APOD;PRKAA1;ASXL3;CCDC3;ADRA2A
prerank,positive regulation of RNA splicing (GO:0033120),0.48847574675507865,1.072861019283372,0.40803897685749085,1.0,1.0,11/29,21.16%,DYRK1A;SETX;TRA2B;THRAP3;POLR2A;DAZAP1;NUP98;HNRNPLL;SLC38A2;TRA2A;RBMX
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.32849386274239367,-1.0720987479935344,0.30092592592592593,0.7175630400985791,1.0,18/25,34.68%,LYST;VPS4B;LAPTM4B;CHMP2B;CHMP5;CHMP1A;LEPROTL1;UBXN6;CHMP2A;CHMP3;MVB12A;TMEM50B;DENND10;CHMP7;TMEM50A;CHMP4C;VCP;CHMP1B
prerank,positive regulation of cellular component movement (GO:0051272),0.5048778084113906,1.0720756125067092,0.39564660691421255,1.0,1.0,8/24,14.61%,CCDC25;ACTN4;NTN1;PDPN;TGFBR1;ADAM17;TWIST1;STK11
prerank,apoptotic cell clearance (GO:0043277),0.4787161847139661,1.0716692889364692,0.3842424242424242,1.0,1.0,6/30,15.01%,XKR5;HMGB1;ANXA1;RAC1;TXNDC5;ITGAV
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.5480230961701491,1.0716558657135848,0.4005722460658083,1.0,1.0,5/12,10.26%,ROCK2;PRNP;ROCK1;PICALM;FLOT2
prerank,autonomic nervous system development (GO:0048483),-0.37509000491739386,-1.0713407142345324,0.3682008368200837,0.7181572669630276,1.0,9/17,32.98%,SEMA3A;NF1;SOX4;NRP1;KIF26A;EDNRB;SOX11;SOX10;SOX8
prerank,regulation of cellular component biogenesis (GO:0044087),0.48081414906914355,1.071327762462221,0.42660550458715596,1.0,1.0,8/39,12.00%,HJURP;ROCK2;NCLN;ROCK1;AGT;BAG5;EZR;SPTY2D1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.43067737833457004,-1.0711536479259027,0.38153846153846155,0.717406471681114,1.0,1/11,0.29%,STAT3
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.2876208327774473,-1.0702640071942855,0.3516483516483517,0.7183028842828516,1.0,17/45,20.04%,PTK2;KIF16B;RPS6KA5;PIK3R1;PLCG1;TGFA;GRB2;PTPN11;SHC1;PLCE1;ERBIN;PIK3CA;CBL;BCAR1;SHC3;DGKD;HBEGF
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.26205790149481745,-1.0702447210778865,0.29411764705882354,0.717195255663791,1.0,26/70,19.89%,PTK2;HSP90AB1;ELMO1;ACTB;WIPF1;VAV3;PIK3R1;PLCG1;PLD2;LYN;MYO10;PAK1;MAPK3;WIPF2;LIMK1;ABL1;WIPF3;MAPK1;GRB2;ELMO2;PLPP4;PIK3CA;ARPC5;NCKAP1L;CYFIP1;BAIAP2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.4510836232276187,1.070054550425331,0.319,1.0,1.0,92/476,14.18%,BRCA1;ATAD2;MYBL1;PBX4;GLI2;CDK5RAP2;GLI3;HMGB2;E2F1;BRCA2;FOXE1;ATOH8;PSRC1;HAS3;ILF3;NAT14;DYRK1A;SMARCC1;SP3;PHIP;ELF2;TEAD1;CTCF;HNRNPD;NFE2;MED14;CHEK2;NFIL3;ELF4;BLM;THRAP3;NFIB;TBL1XR1;SETD3;NUP85;YAF2;PCBD2;ELF1;MED30;TCF4;PML;ARID1A;TASP1;ELK1;FOXO3;ATF7IP;CD80;IRF1;TRIM28;MED24;SMARCA4;YAP1;ZFP90;CREB5;USP21;USP16;DNM2;VHL;NFYA;PICALM;AGT;KMT2A;EPC1;TGFBR1;MMS19;PARP9;TAL1;CRLF3;TAF15;HDAC1;AHR;QRICH1;BMP2;NKX2-1;RORA;FBXW11;ZNF496;SMAD4;BRD4;SOX9;HDAC2;ATF5;ILF2;IL31RA;LRP5;RAI1;HEY2;MED1;BTRC;FOXK2;RLF;SMAD3
prerank,negative regulation of programmed cell death (GO:0043069),0.44878056190629406,1.0697878915733636,0.334,1.0,1.0,61/355,16.16%,KIF14;STIL;CDK1;PLK1;BIRC5;BARD1;FIGNL1;AQP1;MAP4K4;SETX;PHIP;ARHGAP10;ANGPT4;GSK3B;FXN;DDRGK1;AIFM2;FHL2;PRKDC;SIAH2;MRE11;PDPN;ANXA5;SMAD6;ARL6IP1;GRK5;SH3RF1;MGMT;KANK2;ANGPT1;VHL;PIM1;ERC1;APIP;HDAC1;ANXA1;TXNDC5;ITCH;SOX9;NOTCH2;HDAC2;ATF5;IL31RA;CTSH;PLAUR;USP47;PRKCI;MED1;PLK2;ARF4;XIAP;CD44;BIRC6;SFRP1;SRC;GDNF;TNFAIP8;NFKB1;TP53;ANKLE2;HIPK3
prerank,protein localization to vacuole (GO:0072665),-0.3898470535439981,-1.06932074573878,0.38513513513513514,0.7182613844663055,1.0,7/13,23.03%,SH3BP4;SZT2;CD81;KPTN;MFSD1;LMBRD1;GLMP
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.4481634181540326,1.0687637294368624,0.16,1.0,1.0,340/1668,16.02%,BRCA1;CKAP2;E2F7;CCNB1;E2F8;NR2E3;UHRF1;CDK1;MXD3;ATAD2;EZH2;BRIP1;EN1;PLK1;E2F2;MYBL1;ATRX;AURKB;PBX4;GLI2;GLI3;TCFL5;RBL1;HMGB2;E2F1;LCORL;CBX5;FOXE1;ATOH8;ZBTB8A;MED26;KMT5A;ATP2B4;FADD;PPM1D;CBFB;LOXL2;ZFP69;TRIM37;BRD9;SMARCC1;ZNF32;PBX3;BAZ1B;RB1;SP3;SETX;BMPR1A;MOV10;HOXC5;DEK;PHIP;ETV6;ZFP41;TWIST2;FNIP1;ELF2;MIER1;TRAK1;ACTR3;TEAD1;WWOX;ZSCAN29;SP2;RBBP8;ZEB1;RAD21;CTCF;E2F3;HDGF;AGO2;FGFR2;SENP1;TFDP1;JAZF1;TFCP2L1;BCL2L12;NFE2;CNOT1;GALR1;DDRGK1;AUTS2;MED14;EED;ZNF260;BCOR;MDM4;RFXAP;TAF3;HIVEP1;RGMA;NFIA;CUX1;KIT;FHL2;DHX9;SSBP3;WIZ;PCGF5;PRKDC;ZFP62;NFIL3;BHLHE41;KLF5;EPC2;TCF7L1;CTBP1;SRF;ELF4;ASXL1;TSHZ1;THRAP3;ZNF568;KLF13;NFIB;ZNF697;TBL1XR1;SP8;LPIN2;MCPH1;SETD3;MLLT10;IKZF1;SFRP2;BMP6;LCOR;GZF1;TCF7L2;PSIP1;HOXC4;SOX6;ELF1;MED30;IL18;ORC2;GMEB1;TCF4;TPR;HOXA7;ARRB1;GRHL2;GATAD2A;AKNA;ELOC;GLIS3;MIDEAS;ARID1A;EFNA1;RIF1;MYBL2;ELK1;NUCKS1;RFX2;POU2F1;NIPBL;FUS;PPP3CA;CCN1;PROX2;MXD1;PRRX2;ZBTB2;SRCAP;POU3F2;ZBTB7B;WWTR1;PHF2;ZFX;ZHX2;MAMSTR;FHL5;SIM1;LIN9;SERPINE1;SAP18;FOXO3;OLIG2;IRF1;KDM2B;TRIM28;ZNF23;RCOR1;LMX1B;SMAD6;LIN37;PELP1;HMGB3;PLAGL2;MED24;BCLAF1;ZFP64;SMARCA4;NCK1;YAP1;ZFP90;CREB5;RHOQ;USP16;KLF11;HOXB3;MIER3;KANK2;ZBTB25;VHL;ARID4A;MED15;NFYA;ZBTB20;PLAGL1;ZIC5;UXT;KMT2A;HMGB1;EPC1;HDAC8;IKBKG;HOXB6;TEAD3;MEOX2;MTA3;CARF;CXXC5;NR3C1;NR4A2;MYPOP;PARP9;HNRNPU;KCNIP3;TADA1;SFPQ;TAL1;CRLF3;ZBTB24;SMURF2;HDAC1;CHD2;TBX18;MRTFA;AHR;NCOA2;ZNF585B;ZNF585A;PRKCB;BMP2;ATXN1;KLF9;NKX2-1;HTATSF1;NFATC2IP;EZR;RORA;ZHX3;NCK2;ZIC4;SLC30A9;RBPJ;KMT2D;AKIRIN2;ZNF496;NR4A1;SMAD4;BRD4;SOX9;ZNF394;HDAC2;SAP130;ATF5;RPRD1A;ELK4;PPID;LRP5;RAI1;TCF20;TADA2A;TWIST1;USP9X;NCOA7;PPRC1;IL4I1;IRF2BP1;MAML1;RARB;ACTL6B;DLG1;HEY2;MED1;YY1;PRKD1;FOXK2;ZMYM5;ARF4;RLF;FOXL1;POU2F2;ARNT;SMAD3;CAMTA1;FOXP4;DNMT3A;PCGF6;BAZ1A;RUVBL2;FOXM1;CDK8;JMJD1C;ZFP91;YEATS2;E2F4;SOX1;INO80;ZNF445;PER1;RBAK;PIN1;MED27;OTUD7B;PRKD2;PKD2;GDNF;ATF1;PKNOX2;RUNX1;DR1;HDGFL3;NFKB1;DCAF1;KAT6A;ZNF507;TNRC6C;HOXB7;CHD1;ZNF112;ZNF25;PPIL4;CSRP3;ZBTB7C;DRAP1;TP53;FHOD1;BRD8
prerank,regulation of ATP metabolic process (GO:1903578),0.4601918647986402,1.0686952313317934,0.40563991323210413,1.0,1.0,15/54,17.48%,NDC1;NUP155;NUP205;NUP160;GCK;NUP85;TPR;NUP214;RANBP2;ATP5IF1;NUP133;PRKAG1;NUP42;NUP98;NUP210
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.45509285437899766,1.0684976057028315,0.3820803295571576,1.0,1.0,17/101,15.30%,EZH2;INCENP;SPDYA;PSRC1;ATP2B4;RHOA;KIT;ETAA1;LRRK2;ROBO1;CALM2;ADAM17;ADRB2;CAB39;RPTOR;PKD2;SRC
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.4891002224953798,1.068476938193817,0.40442890442890445,1.0,1.0,10/33,16.00%,ATOH8;TEAD1;KLF5;SRF;FOXO3;SMARCA4;NR3C1;SMAD3;GNL3;TP53
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2175725904271725,-1.0684080940850857,0.2777777777777778,0.7194405796964543,1.0,43/119,21.43%,PIP4K2A;INPP4B;PIK3R3;PIP4K2B;SOCS2;PIK3C2B;PIK3R1;FGF2;PIK3R4;SLC27A1;RAB5A;EFR3A;DPM1;SOCS5;MTMR4;INPP5K;RUFY1;PIGV;PIP5K1A;ITPKB;PIGQ;BMX;INPP5D;SYNJ2;PIGB;CDS1;PIK3R6;PGAP2;SYNJ1;PIGP;SMG1;PI4KA;PIK3CD;IMPA1;PIK3CA;INPP4A;TMEM150A;EFR3B;PIGF;CDIPT;ITPKC;PIP4K2C;PIK3R2
prerank,embryonic limb morphogenesis (GO:0030326),0.48434056360148686,1.067967233616349,0.40159271899886234,1.0,1.0,14/34,20.43%,GLI3;CYP26B1;AFF3;MAP3K20;NIPBL;WDPCP;CACNA1C;HDAC1;HDAC2;TWIST1;SALL1;OSR1;SKI;FBXW4
prerank,filopodium assembly (GO:0046847),0.508491445390326,1.0678498020491594,0.3851540616246499,1.0,1.0,8/16,15.33%,SPEF1;FGD4;FGD1;S1PR2;SRGAP2;FGD6;EZR;VSTM5
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.5301808575870034,1.067350148845303,0.41081081081081083,1.0,1.0,6/15,21.10%,USP18;PTPN2;YTHDF2;CNOT7;METTL3;ISG15
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4830398827532286,1.0672673025227302,0.4096244131455399,1.0,1.0,7/37,11.88%,PABPC4;HNRNPD;RNASE6;NUDT5;RNASEH2A;PPP1R8;EXOSC7
prerank,regulation of dendrite extension (GO:1903859),-0.3632022956562664,-1.067049611824596,0.35714285714285715,0.7216186053665733,1.0,3/18,3.34%,RIMS1;ITSN2;SYT1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3390890344659934,-1.0669523902604572,0.3348623853211009,0.7206897512926357,1.0,6/22,9.79%,WDFY1;IFI35;LYN;PTPN22;LBP;NR1H3
prerank,dorsal/ventral pattern formation (GO:0009953),0.5182246796215537,1.0660108406177269,0.3938223938223938,1.0,1.0,6/20,15.25%,GLI2;BMPR1A;LMX1B;DSCAML1;AIDA;SFRP1
prerank,gluconeogenesis (GO:0006094),-0.2907363483215929,-1.0658059725107187,0.3125,0.7223590451763822,1.0,16/39,22.09%,PER2;GOT2;SLC25A13;SLC25A12;MDH1;MDH2;PGK1;GOT1;ENO1;PGAM1;SLC25A11;CRTC2;PPARGC1A;GAPDH;ALDOC;TPI1
prerank,regulation of kinase activity (GO:0043549),0.45405488761593576,1.0656356725256215,0.4105480868665977,1.0,1.0,14/89,11.86%,ECT2;RBL1;RB1;FGFR4;FGFR2;KIT;MRE11;MAPT;MUSK;PDGFRA;EPHA4;DDR2;HNRNPU;ROR1
prerank,cyclooxygenase pathway (GO:0019371),0.5566515886944526,1.0655289775449996,0.40667678300455234,1.0,1.0,3/10,7.55%,PTGES2;HPGDS;PTGS1
prerank,negative regulation of microtubule polymerization (GO:0031115),0.5337188748723669,1.0648578925726144,0.38461538461538464,1.0,1.0,2/12,2.23%,STMN1;DYRK1A
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5561048314323798,1.064731596936931,0.38552437223042835,1.0,1.0,3/10,7.76%,ANXA2;EFNA1;EPHA4
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.44765206091139015,1.0647078584812815,0.359,1.0,1.0,71/327,16.00%,PHF19;EZH2;MYBL1;ATRX;NSD2;TCFL5;E2F1;BRCA2;RB1;SP3;LIN54;HNRNPD;NLK;AJUBA;CHEK2;ACTN4;NFIA;NFIL3;TCF7L1;SRSF10;CCAR1;YAF2;GZF1;SOX6;HP1BP3;GON4L;PML;PSPC1;MYBL2;FUS;POLR2A;PRRX2;WWTR1;PHF1;MYCBP;LMX1B;BNC2;MSL3;NONO;LIMD1;DNM2;VHL;NFYA;ZNHIT3;ERC1;HINT1;TGFBR1;NR3C1;SFPQ;SLC39A8;POFUT1;AHR;NCOA2;BMP2;ATXN1;RORA;SPTY2D1;KMT2D;ATF5;FOXK2;GPBP1L1;JMJD1C;SOX1;RBAK;EFEMP1;PRDM8;TRRAP;HOXB7;MLF2;DRAP1;TP53
prerank,anion transport (GO:0006820),-0.3035880777736369,-1.0645720627409918,0.3617021276595745,0.7243812991580679,1.0,8/33,13.61%,SLC13A3;SLCO2B1;SLC13A4;ABCG2;SLC22A6;SLC17A6;LRRC8B;LRRC8D
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.3708633022736646,-1.0643352138939275,0.3726235741444867,0.7237964761247732,1.0,8/16,27.21%,ABHD5;SLC27A1;GPLD1;NR1H3;NR1H2;MFSD2A;CTDNEP1;PNPLA2
prerank,lipid modification (GO:0030258),-0.2880058320177609,-1.0643080410456252,0.2894736842105263,0.7227217193561963,1.0,11/37,20.92%,PLPPR1;DGKB;PLPP3;DGKG;DGKI;DGKQ;PLA2G7;EPHX2;PLPP4;DGKD;PLPPR4
prerank,response to estradiol (GO:0032355),-0.3051204188716502,-1.0642853659259137,0.3575757575757576,0.7216174841819036,1.0,7/31,11.79%,STAT3;SOCS2;CCDC62;STRN3;GGT5;ESR1;CTNNB1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.5464493434498077,1.0641789611956674,0.39361702127659576,1.0,1.0,5/11,17.86%,DCK;ENPP3;ERH;SLC19A2;SLC25A19
prerank,regulation of potassium ion transport (GO:0043266),-0.299063643908636,-1.064169381611723,0.3763440860215054,0.7207632647403099,1.0,13/31,33.26%,KCNIP4;KCNAB1;KIF5B;KCNN2;ADRA2A;DPP10;NOS1;DRD2;PTK2B;KCNIP1;KCNIP2;CASQ2;CACNA1D
prerank,cellular response to misfolded protein (GO:0071218),-0.340905778584863,-1.0636348039867254,0.35267857142857145,0.7209016176618501,1.0,10/20,23.39%,ATXN3;UFD1;DERL1;STUB1;DNAJC18;POMT2;AUP1;DNAJB12;UBE2W;TOR1A
prerank,regulation of ion transport (GO:0043269),-0.2612210558697503,-1.0634391361677193,0.3076923076923077,0.7202396307501651,1.0,28/76,23.39%,PRKN;NKAIN2;SYT1;KCNJ3;KCNJ6;SIK1;ATP1A1;NKAIN4;SYT7;B2M;DTNBP1;KCNJ10;KCNA2;SYT11;SYT12;WWP2;VAMP3;NKAIN3;SYT10;SYT6;ITGB3;KCNJ12;SYT2;NOS1;DRD2;P2RX4;NEDD4L;TOR1A
prerank,protein modification process (GO:0036211),0.4503778874349784,1.063343313281202,0.40445859872611467,1.0,1.0,33/76,25.12%,TGM1;UBE2S;LOXL2;LOX;GGCX;PRKDC;ST8SIA2;PHKA2;B4GALT7;DUSP12;RPN2;NAGPA;SEPHS1;ATG3;ST3GAL1;UBL5;PLOD2;NTAQ1;PLAT;YES1;UBE2D3;ICMT;UBE2L3;NEDD8;PIGH;FBXO22;PARP4;USP25;UBE2I;RABGGTB;FBXW2;UBL4A;ADPRH
prerank,regulation of feeding behavior (GO:0060259),-0.4221502390508352,-1.0631991280044177,0.38823529411764707,0.7196669708434326,1.0,3/11,5.06%,SGIP1;STAT3;CFAP20
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.38972038263922687,-1.062659958468467,0.362962962962963,0.7188015185341065,1.0,6/16,15.69%,APOD;PHLDB2;ACVRL1;DUSP22;THBS1;ITGB1BP1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.38972038263922687,-1.062659958468467,0.362962962962963,0.7188015185341065,1.0,6/16,15.69%,APOD;PHLDB2;ACVRL1;DUSP22;THBS1;ITGB1BP1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.2969197274007456,-1.0626102142368206,0.33098591549295775,0.717802524751165,1.0,14/32,19.24%,RHOJ;MAP2K5;KLF4;FGF2;FOXC2;HDAC5;THBS1;PTGS2;HDAC7;HDAC9;VEGFA;ITGB1BP1;GATA2;FGFBP1
prerank,eye morphogenesis (GO:0048592),0.5083771775957769,1.0616146423594177,0.40981432360742703,1.0,1.0,11/19,19.75%,MFAP2;FBN1;COL5A2;NIPBL;MFAP5;NKD1;EFEMP1;AGTPBP1;SHROOM2;SKI;ALDH1A3
prerank,regulation of cytoskeleton organization (GO:0051493),0.44605427994947044,1.061597079748217,0.4024640657084189,1.0,1.0,22/108,12.81%,IQGAP3;IQGAP2;ROCK2;RHOA;GSK3B;SPEF1;DIAPH1;ARHGAP18;MAPT;BICD2;SORBS3;RHOQ;TPPP;ROCK1;MARK2;ARHGAP35;PLXNB1;RAC1;RND2;EZR;DMTN;CLIC4
prerank,negative regulation of B cell proliferation (GO:0030889),-0.42226080606050653,-1.061502271746883,0.36996336996337,0.7192361824555817,1.0,3/11,9.54%,LYN;TNFRSF21;ATM
prerank,negative regulation of hippo signaling (GO:0035331),0.5456865638020494,1.0613902952068655,0.4170337738619677,1.0,1.0,7/12,22.94%,CIT;AJUBA;LIMD1;SHANK2;MAPK14;WWC2;VGLL4
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.2582849339605231,-1.0610246074941123,0.37777777777777777,0.719261840269789,1.0,26/71,19.89%,PTK2;HSP90AB1;ELMO1;ACTB;WIPF1;VAV3;PIK3R1;PLCG1;PLD2;LYN;MYO10;PAK1;MAPK3;WIPF2;LIMK1;ABL1;WIPF3;MAPK1;GRB2;ELMO2;PLPP4;PIK3CA;ARPC5;NCKAP1L;CYFIP1;BAIAP2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.5305763293678023,1.0609938573058944,0.3991537376586742,1.0,1.0,4/13,10.41%,SRSF10;PRPF19;PRPF3;LSM2
prerank,autophagy of peroxisome (GO:0030242),-0.4083992755262086,-1.0608885953482956,0.36824324324324326,0.7185233352061069,1.0,5/12,17.43%,SQSTM1;PIK3R4;ATM;PEX5;USP30
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.5062635388475049,1.0607047400728615,0.3930942895086321,1.0,1.0,1/17,0.53%,DLGAP5
prerank,phospholipid transport (GO:0015914),-0.259125157720976,-1.060702138871285,0.37362637362637363,0.7178437620057407,1.0,21/52,25.20%,PLTP;ATP8A1;APOE;SCP2;ATP8B1;ATP8A2;ATP9B;MTTP;ATP9A;TNFAIP8L3;PRELID3B;OSBPL2;PITPNC1;MFSD2A;TMEM30A;NPC2;SCARB2;PRELID3A;ATP10B;ABCA3;PRELID1
prerank,cellular response to ATP (GO:0071318),-0.3863003239835304,-1.0606570885017437,0.3882783882783883,0.7168245071052055,1.0,6/14,28.33%,RYR3;HSP90B1;SSH1;P2RX4;P2RX7;P2RY12
prerank,regulation of activated T cell proliferation (GO:0046006),0.4912978576560258,1.0606124388714455,0.41155234657039713,1.0,1.0,6/30,14.16%,FADD;PRNP;IL18;SCRIB;HMGB1;RC3H1
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.4030159047490891,-1.0602759733909706,0.3761755485893417,0.7165823727696046,1.0,4/12,25.22%,SCP2;ACSL1;ELOVL1;FADS1
prerank,positive regulation of dendrite extension (GO:1903861),-0.3658387191804108,-1.0596056407659658,0.3971119133574007,0.7170815141181798,1.0,3/17,3.34%,RIMS1;ITSN2;SYT1
prerank,blood vessel morphogenesis (GO:0048514),-0.26962064016877496,-1.0592448373349888,0.3333333333333333,0.7167808003246999,1.0,17/54,15.89%,FLT1;SMAD7;CDH2;CAV1;TGFBR2;PROX1;RAMP2;RASIP1;NF1;CUL7;CCBE1;TBX1;ENG;VEGFA;SOX17;SLC1A1;STRA6
prerank,protein deubiquitination (GO:0016579),0.4432269742108452,1.0591509736950173,0.3973973973973974,1.0,1.0,50/242,16.33%,BRCA1;CDK1;CLSPN;BARD1;CDC20;USP1;RHOA;PSMC2;PSMD5;MDM4;USP18;CCNA2;ASXL1;SIAH2;TAB1;RHOT1;CCNA1;USP37;STAM;UIMC1;PSMB1;PSMD14;USP21;USP16;PSMD1;SKP2;IKBKG;CDC25A;TGFBR1;USP28;SMURF2;PSMB9;ADRM1;SMAD4;USP9X;USP47;ADRB2;YY1;FOXK2;SMAD3;PSMC6;BRCC3;OTUD1;INO80;OTUD7B;TRRAP;TP53;PTEN;RAD23B;TAF10
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5458130903689576,1.0585646625184817,0.3900481540930979,1.0,1.0,3/10,12.75%,LOXL2;SOX6;SOX9
prerank,lymphocyte proliferation (GO:0046651),0.5043831473933496,1.0584576696660912,0.4025641025641026,1.0,1.0,5/22,16.04%,HELLS;ELF4;CTPS1;LMBR1L;MSN
prerank,positive regulation of isotype switching (GO:0045830),0.5284860604023799,1.0583370173131805,0.3975409836065574,1.0,1.0,4/15,15.41%,PAXIP1;RIF1;KMT5C;SHLD2
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.3245958166304128,-1.0577868383029205,0.3446601941747573,0.7190700997518382,1.0,9/25,21.19%,PSEN1;ITGA6;AR;APP;THBS1;SDCBP;PTH1R;NCKAP1L;NRP1
prerank,post-translational protein modification (GO:0043687),0.44222955278639603,1.057568444017941,0.368,1.0,1.0,50/332,14.28%,DTL;ESCO2;CCNF;MATN3;DSCC1;F5;FEM1C;ASB15;PSMC2;FBN1;PSMD5;OBSL1;LAMB1;FBXL7;SPSB3;SPSB2;RBBP7;FBXW7;FBXO30;ELOC;CUL5;CCN1;QSOX1;FBXL8;KLHL5;PSMB1;FN3K;SUMF2;CUL3;PSMD14;KLHL22;CUL4B;DCAF10;VHL;PSMD1;SKP2;RAB1A;WSB2;PSMB9;STT3A;APLP2;FBXW11;CHM;STT3B;DCAF7;COPS3;BTRC;FBXO27;MIA3;PSMC6
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.27724887039643314,-1.05695465124666,0.34210526315789475,0.7200677578347531,1.0,12/45,14.09%,CAMK2D;TRIM25;VCAM1;MID1;TRIM8;B2M;IRF2;CAMK2G;IFNGR2;IRF3;IRF9;IFNGR1
prerank,regulation of biomineral tissue development (GO:0070167),0.4959980110795839,1.0567310900465503,0.41967621419676215,1.0,1.0,9/26,16.24%,FBXO5;ROCK2;ROCK1;DDR2;ENPP1;SOX9;TWIST1;HEY2;NOTUM
prerank,myoblast differentiation (GO:0045445),-0.3899298331721599,-1.0563897844979315,0.35,0.7203477323537325,1.0,7/14,11.33%,DDX17;JAG1;IGF1;PLEKHM3;HINFP;MBNL1;DDX5
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.36446489520026804,-1.0558592038360295,0.3684210526315789,0.7204511318833643,1.0,5/17,16.63%,CAV1;KLF7;MAFG;CEBPB;AJAP1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.52218186673918,1.0553266895775233,0.4,1.0,1.0,3/15,9.19%,GSTO2;HNRNPA1;CPEB2
prerank,transferrin transport (GO:0033572),-0.2990009072309717,-1.0552393986667685,0.3716216216216216,0.720889128514686,1.0,16/33,32.02%,ATP6V0A1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP6V1H;MCOLN1;ARHGAP1;ATP6V1G2;ATP6V1B2;ATP6AP1;REP15;ATP6V1F;ATP6V0D2;ATP6V0E1
prerank,protein modification by small protein removal (GO:0070646),0.4427752843941554,1.05517037071867,0.40681362725450904,1.0,1.0,52/252,16.33%,BRCA1;CDK1;CLSPN;BARD1;CDC20;USP1;RHOA;PSMC2;SENP1;PSMD5;MDM4;USP18;CCNA2;ASXL1;SIAH2;TAB1;RHOT1;CCNA1;USP37;STAM;UIMC1;PSMB1;PSMD14;USP21;USP16;PSMD1;SKP2;IKBKG;CDC25A;TGFBR1;USP28;SMURF2;PSMB9;ADRM1;SMAD4;COPS3;USP9X;USP47;ADRB2;YY1;FOXK2;SMAD3;PSMC6;BRCC3;OTUD1;INO80;OTUD7B;TRRAP;TP53;PTEN;RAD23B;TAF10
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5344469496542105,1.0551366253606327,0.4045584045584046,1.0,1.0,4/13,19.31%,SRF;NFIB;SOX9;NFATC3
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.43872485147022244,-1.0548551874679184,0.3972222222222222,0.7206569705754796,1.0,2/10,0.69%,DLGAP1;DLGAP4
prerank,regulation of hemopoiesis (GO:1903706),0.5635711494881919,1.0540741336542243,0.4203125,1.0,1.0,3/10,15.47%,CBFB;PRKCB;RUNX1
prerank,retinoid metabolic process (GO:0001523),0.4452675691300918,1.0539831557533856,0.4299363057324841,1.0,1.0,10/71,10.24%,ALDH8A1;CYP26B1;ALDH1A2;ABCA4;RDH11;RDH12;GPC6;ALDH1A1;SCPEP1;SDC1
prerank,response to prostaglandin E (GO:0034695),0.5475159295529156,1.053837496827468,0.4195488721804511,1.0,1.0,4/10,21.97%,TGFBR3;ADCY6;SFRP1;GNB1
prerank,actomyosin structure organization (GO:0031032),0.44724235845567933,1.0535737496891462,0.4163135593220339,1.0,1.0,20/75,16.68%,CIT;ROCK2;RHOA;MYLK3;CSRP2;MYH10;ARRB1;EPB41L2;CDC42BPA;PHACTR1;CUL3;ROCK1;CDC42BPG;EPB41L3;TMOD3;ITGB1;FRMD6;SRC;CSRP3;TNNT3
prerank,ganglioside metabolic process (GO:0001573),-0.344661921456419,-1.0534837388621308,0.34710743801652894,0.723048892199501,1.0,6/20,10.68%,ST8SIA4;HEXB;ST6GALNAC3;ST6GALNAC5;HEXA;ST8SIA6
prerank,positive regulation of proteolysis (GO:0045862),0.4572378739845236,1.0531695471292002,0.4281009879253567,1.0,1.0,12/55,13.80%,PLK1;FADD;FGFR4;SH3D19;SNX33;FBXW11;CASP8;HDAC2;ATP5IF1;CTSH;ADAM9;BTRC
prerank,cell-substrate junction assembly (GO:0007044),-0.3011083675701972,-1.053120693848057,0.3586206896551724,0.7228352839983603,1.0,12/33,20.03%,ITGA6;THSD1;TAOK2;BCR;LAMA3;ITGB4;PIP5K1A;ARHGEF7;SORBS1;ACTN1;CD151;PLEC
prerank,mesenchyme development (GO:0060485),0.5147560941787291,1.0529174883117973,0.39231824417009603,1.0,1.0,5/15,15.27%,FGFR2;SFRP2;TGFBR1;BMP2;PKD2
prerank,regulation of cellular senescence (GO:2000772),0.48421896721345364,1.052854924127794,0.41767554479418884,1.0,1.0,9/28,19.32%,RBL1;FBXO5;MAP3K3;TERF2;TWIST1;SLC30A10;PNPT1;YPEL3;TERT
prerank,estrogen metabolic process (GO:0008210),-0.3674747290654969,-1.0528397041526507,0.3691275167785235,0.7223951483351516,1.0,8/15,48.91%,HSD17B11;HSD17B7;HSD17B8;HSD17B10;HSD17B2;SULT1A1;HSD17B14;HSD17B1
prerank,RNA destabilization (GO:0050779),0.519303237204399,1.052718898867054,0.4152431011826544,1.0,1.0,8/18,16.45%,ROCK2;FTO;ROCK1;YTHDF2;DXO;MEX3D;ZC3H18;METTL3
prerank,positive regulation of protein sumoylation (GO:0033235),0.5570892118842513,1.0526290530650257,0.42358078602620086,1.0,1.0,5/10,23.15%,SAE1;GNL3;HDAC4;PIAS1;UBA2
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5089335513715967,1.0525520713658096,0.3904109589041096,1.0,1.0,1/18,0.98%,CEP295
prerank,regulation of neuron differentiation (GO:0045664),0.4479234658045551,1.052140176978326,0.42077649527806926,1.0,1.0,7/76,9.38%,ECT2;CDK5RAP2;RHOA;ZEB1;TCF4;LRRK2;ROCK1
prerank,regulation of cation transmembrane transport (GO:1904062),0.4853202026667796,1.051490610612441,0.4209891435464415,1.0,1.0,9/29,17.79%,ATP2B4;RANGRF;PDZK1;WNK1;SNTA1;KCNIP3;DLG1;DPP6;WNK3
prerank,sphingosine metabolic process (GO:0006670),-0.36169279844316704,-1.0506743441756101,0.379182156133829,0.7267463037394666,1.0,7/17,23.59%,ACER2;PLPP3;ASAH1;ACER3;ASAH2;ABCA2;SPHK1
prerank,response to organophosphorus (GO:0046683),0.5113933271194547,1.050213116231887,0.41168289290681503,1.0,1.0,2/16,6.63%,TYMS;RFC3
prerank,extracellular matrix organization (GO:0030198),0.44116223509198,1.0497503163331834,0.39579158316633267,1.0,1.0,64/276,15.61%,BMP1;LOXL3;MATN3;COL22A1;HAS3;NID2;LOXL2;SCUBE1;MMP25;MMP24;MMP28;MFAP2;LOX;COL4A6;MMP14;FBN1;ADAM12;LAMB1;COL4A4;ITGB7;COL18A1;COL5A2;COL23A1;ADAMTS10;NPNT;ADAMTS5;TLL2;ADAMTS14;QSOX1;ADAMTS9;SERPINE1;ADAMTSL2;FBLN5;ADAMTS2;ADAMTS16;ELN;DDR2;HAS1;TGFBR1;SLC39A8;NID1;COL15A1;POSTN;COL4A5;COL12A1;P3H1;BGN;ADAM19;ADAMTSL3;EXOC8;ADAMTS1;ITGA5;ITGB1;ITGA8;COL20A1;CD44;MFAP5;CAPG;P3H4;LCP1;ITGAV;HSPG2;PLOD2;ITGB8
prerank,external encapsulating structure organization (GO:0045229),0.4393153922170625,1.0495614126140302,0.4292878635907723,1.0,1.0,48/205,15.61%,TGM1;MATN3;COL22A1;NID2;MMP25;MMP24;MMP28;MFAP2;LOX;COL4A6;MMP14;FBN1;ADAM12;LAMB1;COL4A4;ITGB7;COL18A1;COL5A2;COL23A1;ADAMTS10;NPNT;ADAMTS5;ADAMTS14;ADAMTS9;SERPINE1;ADAMTSL2;FBLN5;ADAMTS2;ADAMTS16;ELN;DDR2;SLC39A8;NID1;COL15A1;POSTN;COL4A5;BGN;ADAM19;ADAMTSL3;ADAMTS1;ITGA5;ITGB1;ITGA8;CD44;MFAP5;ITGAV;HSPG2;ITGB8
prerank,negative regulation of proteolysis (GO:0045861),0.4696889443314916,1.0495378993580327,0.41550925925925924,1.0,1.0,7/34,9.80%,DNAJC1;PRNP;EFNA1;EPHA4;LRRK2;ROCK1;GAS1
prerank,regulation of transmembrane transport (GO:0034762),-0.31523278607695815,-1.0494142583408181,0.35443037974683544,0.7287296721461426,1.0,8/31,11.83%,OCLN;SLC2A1;ACTB;KCNJ3;CTTNBP2NL;KCNJ6;BCL2;KCNJ10
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.4225217961177282,-1.048592857515983,0.39090909090909093,0.7295920318493208,1.0,2/10,1.81%,APOD;LRCH1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.49621062523351533,1.0485446183211486,0.40977443609022557,1.0,1.0,2/22,2.25%,PPM1G;PPM1D
prerank,negative regulation of intracellular protein transport (GO:0090317),0.4934536141565765,1.0484711742302968,0.4005102040816326,1.0,1.0,4/22,12.63%,BARD1;LRRK2;RANGAP1;DMTN
prerank,macrophage chemotaxis (GO:0048246),0.5408632069975495,1.0482663149671567,0.4187779433681073,1.0,1.0,1/10,5.09%,CKLF
prerank,protein K63-linked ubiquitination (GO:0070534),0.4659732816927061,1.0481462020221417,0.4360135900339751,1.0,1.0,6/41,7.35%,UBE2T;UBE2S;RNF168;NEDD4;UBE2N;PRPF19
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.45756552379920457,1.0478875319373895,0.4423913043478261,1.0,1.0,1/55,0.19%,BRCA1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5403102705547952,1.0478807125745877,0.40358744394618834,1.0,1.0,4/11,14.26%,FRS2;SOX6;BMP2;EFNB2
prerank,phosphorylation (GO:0016310),0.4421324453735895,1.0478265434392566,0.38,1.0,1.0,81/384,14.67%,NEK2;MELK;CDK1;PLK1;BIRC5;AURKB;NEK3;PLK4;MATK;HUNK;MAST2;HASPIN;ILF3;MAP4K4;DYRK1A;STK17B;CDK14;BMPR1A;AURKA;ROCK2;MAP4K2;GSK3B;STK10;NLK;CHEK2;MYLK3;PRKDC;CTBP1;DYRK3;VRK2;STK24;STK3;NRK;MAP3K1;CCNE1;WNK1;MAP3K20;CDC25B;CHEK1;CDC42BPA;CDK2;LRRK2;GRK5;LIMD1;ROCK1;PIM1;MARK2;PXK;PIK3CB;TGFBR1;CDC42BPG;EIF2AK3;SRPK1;LMTK3;PRKCB;BMP2;DGKE;PRKCA;PDPK1;GRK3;CSNK1G2;AAK1;SIK2;MEX3B;STRADA;AGK;BTK;PRKCE;CDK19;MAML1;PANK2;PRKCI;PLK2;PRKD1;MORC3;NRBP1;TAOK1;STK11;BIRC6;VRK1;CDK8
prerank,maturation of 5.8S rRNA (GO:0000460),0.500446917433357,1.0475921041687841,0.40554821664464996,1.0,1.0,7/17,21.38%,PRKDC;MPHOSPH6;MAK16;WDR12;NOL9;EXOSC10;URB1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.4385754459341582,1.0472244179987285,0.334,1.0,1.0,166/834,16.02%,BRCA1;CKAP2;E2F7;E2F8;NR2E3;UHRF1;ATAD2;DLGAP5;E2F2;MYBL1;ATRX;GLI2;GLI3;RBL1;HMGB2;E2F1;ATOH8;FADD;PAXIP1;SP3;SETX;BMPR1A;PHIP;ACTR3;TEAD1;WWOX;E2F3;AGO2;FGFR2;SENP1;TFDP1;BCL2L12;GALR1;DDRGK1;AUTS2;MED14;RFXAP;HIVEP1;RGMA;NFIA;DHX9;SSBP3;PCGF5;PRKDC;KLF5;SRF;ELF4;ASXL1;THRAP3;NFIB;TBL1XR1;LPIN2;SETD3;MLLT10;SFRP2;BMP6;TCF7L2;HOXC4;ELF1;MED30;IL18;TCF4;HOXA7;ARRB1;GRHL2;AKNA;GLIS3;MYBL2;ELK1;POU2F1;PPP3CA;CCN1;POU3F2;WWTR1;FHL5;SERPINE1;FOXO3;IRF1;LMX1B;PELP1;MED24;BCLAF1;ZFP64;SMARCA4;NCK1;YAP1;RHOQ;USP16;HOXB3;LEO1;PLAGL1;KMT2A;HMGB1;EPC1;HDAC8;IKBKG;MEOX2;NR3C1;NR4A2;HNRNPU;SFPQ;TAL1;CRLF3;HDAC1;MRTFA;AHR;NCOA2;BMP2;NKX2-1;NFATC2IP;RORA;NCK2;SLC30A9;RBPJ;KMT2D;AKIRIN2;NR4A1;SMAD4;BRD4;SOX9;HDAC2;ATF5;ELK4;LRP5;PLXND1;TCF20;TWIST1;NCOA7;PPRC1;IL4I1;MAML1;RARB;HEY2;MED1;YY1;PRKD1;FOXK2;ARF4;RLF;POU2F2;ARNT;SMAD3;RUVBL2;FOXM1;CDK8;E2F4;SOX1;INO80;PER1;PIN1;GNL3;PRKD2;PKD2;GDNF;ATF1;RUNX1;DR1;NFKB1;KAT6A;ZNF507;HOXB7;CSRP3;DRAP1;TP53;FHOD1;BRD8
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.36400193139132675,-1.0471924761326454,0.4048582995951417,0.7320401854803118,1.0,11/17,25.38%,ATP5PF;ATP5F1A;ATP5MF;ATP5MC3;ATP5PO;ATP5PD;ATP5F1B;ATP5F1D;ATP5F1E;ATP5MG;ATP5ME
prerank,mitochondrial fission (GO:0000266),-0.36325495253736323,-1.0471599277704409,0.36666666666666664,0.7309916384283486,1.0,4/16,7.25%,DNM3;PRKN;FIS1;DNM1
prerank,macromolecule catabolic process (GO:0009057),-0.31601337272423824,-1.0471016625414866,0.3693181818181818,0.7300274354170517,1.0,8/26,10.84%,KIF16B;CLPX;BECN1;PIK3R4;LGMN;TPP1;SIAH1;MTOR
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.38584073009407155,-1.0469992707027294,0.4271523178807947,0.7291863933126792,1.0,4/13,15.03%,UPP2;NT5M;TDG;SMUG1
prerank,neuropeptide signaling pathway (GO:0007218),-0.2613968785920932,-1.0466573572001572,0.35135135135135137,0.7289115694612425,1.0,9/58,10.66%,SORCS3;SORCS1;GLRB;GLRA1;CPE;GLRA3;GPR37;OPRM1;HCRTR2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.3994850061930863,-1.0466278727957405,0.39672131147540984,0.7278897846627466,1.0,6/13,16.21%,CALM1;NOS3;QDPR;GCH1;PRKG2;PTS
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4691481215476258,1.0464717971635467,0.4280898876404494,1.0,1.0,12/43,16.00%,ATOH8;TEAD1;KLF5;SRF;NFIB;FOXO3;SMARCA4;NR3C1;SOX9;SMAD3;GNL3;TP53
prerank,regulation of protein-containing complex assembly (GO:0043254),0.43581462018999206,1.0463356451014427,0.4177732379979571,1.0,1.0,20/110,11.84%,HJURP;RB1;FNIP1;GSK3B;BMF;IAPP;TRABD2B;AJUBA;FAF1;SLF1;SPIDR;CDC42EP2;SH3GLB1;NCLN;ATF7IP;RIOK3;TPPP;ABCA1;TAL1;AIDA
prerank,heme biosynthetic process (GO:0006783),0.49416758676353534,1.0457614308773255,0.4178525226390686,1.0,1.0,7/22,16.97%,HMBS;FXN;COX10;ABCB10;CPOX;ATP5IF1;ALAS2
prerank,cellular component disassembly (GO:0022411),0.45354722865648267,1.0456195603800849,0.41025641025641024,1.0,1.0,11/53,16.74%,BMP1;SCUBE1;MMP14;DYRK3;ADAMTS5;TLL2;EXOC8;CD44;CAPG;LCP1;SH3PXD2B
prerank,synapse organization (GO:0050808),-0.22441970262789604,-1.0456054726714852,0.375,0.7292359626725029,1.0,17/125,5.05%,DNM3;UNC13B;CTNND2;PTPRD;PSEN1;CDH2;SLC8A3;DNER;SLC6A1;SHANK3;ARHGAP39;PAK3;SPOCK2;ADGRL3;NRCAM;AGRN;SDK2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5098899641562533,1.0454740522898638,0.421957671957672,1.0,1.0,6/20,15.73%,PPIL1;FKBP5;PPIG;PPID;PIN1;PPWD1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5013266601021574,1.0453903699034175,0.41644562334217505,1.0,1.0,3/18,9.77%,FADD;IL18;HMGB1
prerank,cellular response to ketone (GO:1901655),0.47036340979913116,1.0451995635592795,0.42790152403282533,1.0,1.0,12/35,17.46%,AQP1;ROCK2;LARP1;NR3C1;AHR;KLF9;ADCY6;SFRP1;SRC;MSN;PCK2;ADCY2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.41835610827666414,-1.045095355560619,0.40683229813664595,0.729292216535616,1.0,8/11,45.89%,LYN;TIRAP;MFHAS1;TNFAIP3;PJA2;TREM2;TLR6;TLR1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.47490347018457146,1.0448109678729172,0.4059040590405904,1.0,1.0,7/25,14.06%,HMGB2;PRKDC;FOXO3;ABCB10;TAL1;MED1;ARNT
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.541199317645709,1.0447021776361602,0.43157894736842106,1.0,1.0,1/11,1.19%,SLC18A2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5391263796649971,1.0444519148847697,0.423728813559322,1.0,1.0,5/10,20.96%,ADA;WNK1;PIEZO1;FERMT3;DPP4
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.49156727398465055,1.044366973404459,0.39641943734015345,1.0,1.0,2/22,4.00%,VKORC1L1;ALDH1A2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.2543247377595998,-1.0440691456860829,0.3333333333333333,0.7305543876154692,1.0,26/73,19.89%,PTK2;HSP90AB1;ELMO1;ACTB;WIPF1;VAV3;PIK3R1;PLCG1;PLD2;LYN;MYO10;PAK1;MAPK3;WIPF2;LIMK1;ABL1;WIPF3;MAPK1;GRB2;ELMO2;PLPP4;PIK3CA;ARPC5;NCKAP1L;CYFIP1;BAIAP2
prerank,hemopoiesis (GO:0030097),0.446504014614976,1.0439201609386446,0.42916235780765255,1.0,1.0,19/87,16.00%,MELK;ETV6;FGFR2;FUT10;KIT;WNT2B;SFRP2;RTKN2;TGFBR3;KMT2A;YTHDF2;TAL1;RRAS;NOTCH2;MFAP5;SFRP1;RUNX1;KAT6A;TP53
prerank,negative regulation of blood pressure (GO:0045776),-0.3936493071488119,-1.0436856173841116,0.38079470198675497,0.7303753962958177,1.0,5/13,21.95%,BMPR2;NOS3;PRCP;NOS1;DRD2
prerank,positive regulation of DNA binding (GO:0043388),0.4778304718926621,1.0432377452791164,0.4105392156862745,1.0,1.0,12/31,21.76%,HMGB2;RB1;TXN;HMGB1;TRIM6;PLAUR;TWIST1;NGF;NIBAN2;SKI;TRAF6;SIRT2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.3883664203233958,-1.0432337986028017,0.40955631399317405,0.7303624432977699,1.0,4/14,21.14%,CROT;SCP2;DECR2;AMACR
prerank,response to X-ray (GO:0010165),0.5263993209788609,1.0426446256586575,0.40585774058577406,1.0,1.0,5/14,14.29%,BLM;NUCKS1;NIPBL;ANXA1;BRCC3
prerank,regulation of cilium movement (GO:0003352),0.5527447936892393,1.0425898919829122,0.4098124098124098,1.0,1.0,1/10,3.34%,DNAH11
prerank,stress granule assembly (GO:0034063),-0.34383084883642345,-1.0422737985624597,0.41203703703703703,0.7316069719393123,1.0,5/20,8.22%,DDX6;RPS23;UBAP2L;BICD1;CSDE1
prerank,leukocyte tethering or rolling (GO:0050901),0.5046494871787756,1.0420267462328687,0.4092140921409214,1.0,1.0,5/17,14.15%,ITGB7;ADD2;PODXL2;ROCK1;ITGB1
prerank,cellular response to acid chemical (GO:0071229),-0.313668273433359,-1.0415423364067589,0.358974358974359,0.7322625209979923,1.0,10/27,17.25%,CPEB3;GLRA1;CPEB4;SH3BP4;MTOR;KLF2;NSMF;VEGFA;RRAGC;XBP1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.345144315717977,-1.0411864774332005,0.39147286821705424,0.7320562972974174,1.0,8/18,23.03%,OS9;RNF103;EDEM2;SYVN1;UBB;UBC;RPS27A;SEL1L
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.3535805527216892,-1.0407147875044158,0.38545454545454544,0.7322028373665586,1.0,4/18,18.91%,LYN;GPLD1;CMKLR1;BCAR1
prerank,negative regulation of metabolic process (GO:0009892),-0.2610544775771852,-1.0403454276972333,0.32558139534883723,0.7319716548837103,1.0,15/54,16.72%,LNPEP;MAP2K6;FIS1;NOVA2;ZNF423;ABHD6;TLR4;ACOT11;FOXC2;ACVR2B;NR1H3;ZDHHC7;CCDC3;NR1H2;DDIT3
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.27212021328022395,-1.040248006638543,0.33,0.7311235479808581,1.0,20/44,31.20%,APOE;PDCD4;LYN;DNAJA1;PTPN22;STK38;INPP5K;NF1;SPRY2;DUSP1;SORL1;UCHL1;CDK5RAP3;BMP7;CD300A;MAPK8IP1;IRAK3;SPRY4;DUSP19;SH2B3
prerank,vesicle organization (GO:0016050),-0.27587406272262305,-1.04020604060428,0.35714285714285715,0.7301397924016078,1.0,15/46,14.63%,CAV1;FNBP1L;SQSTM1;CD34;LAPTM4B;DNM1;USP8;SAR1A;VPS11;CHMP2B;SRGN;CAV2;ARFGEF2;HOOK1;VPS33B
prerank,cardiac muscle cell differentiation (GO:0055007),-0.34707677125221215,-1.0401549317180327,0.4345991561181435,0.7291794096826129,1.0,8/21,26.13%,ACVR1;MEF2C;SIK1;VEGFA;MYH11;KDM6B;CBY1;MYOCD
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.4716326063682825,1.0396374490554707,0.4583333333333333,1.0,1.0,10/31,16.04%,RHOA;PARD3B;RAP2A;ANK1;SCRIB;MARK2;EZR;PRKCI;DLG1;MSN
prerank,cellular glucose homeostasis (GO:0001678),-0.2800038967881944,-1.0395489473376012,0.3559322033898305,0.729594473564578,1.0,15/41,21.91%,UNC13B;FOXO1;KCNB1;GAS6;PIK3R1;PRKAA1;SOX4;HK1;LRRC8D;ADCY8;XBP1;PPARGC1A;LRRC8A;PIK3R2;RACK1
prerank,"phagocytosis, engulfment (GO:0006911)",0.4560988233943605,1.0394346328454247,0.42491268917345754,1.0,1.0,1/36,0.67%,XKR5
prerank,positive regulation of mitochondrial fission (GO:0090141),0.501731487115143,1.0393912424827765,0.41492146596858637,1.0,1.0,5/18,10.54%,MIEF2;AURKA;MCU;MIEF1;DDHD1
prerank,vesicle transport along microtubule (GO:0047496),0.4876226688604996,1.0393654192253527,0.4283950617283951,1.0,1.0,13/23,25.55%,TRAK1;NDE1;RAB1A;FBXW11;KIFAP3;FYCO1;DYNC1I1;DYNC1H1;KIF5A;HTT;KIF13A;KIF1C;PAFAH1B1
prerank,glucose metabolic process (GO:0006006),-0.2619176653565408,-1.0392384803690644,0.39473684210526316,0.7293230295669481,1.0,22/58,24.78%,APOD;PER2;GOT2;SLC25A13;SLC25A12;IRS2;MDH1;OMA1;MDH2;PGK1;GOT1;ENO1;PGAM1;SLC25A11;CRTC2;PPARGC1A;GAPDH;ALDOC;TPI1;GALM;BRAT1;ALDOA
prerank,transcription by RNA polymerase II (GO:0006366),0.4331565719885771,1.0389768352433384,0.4044044044044044,1.0,1.0,63/305,14.10%,NR2E3;E2F2;TRIP13;TCFL5;TTF2;MED26;PMF1;CBFB;SETX;DEK;TEAD1;E2F3;TFDP1;CSTF3;FIP1L1;TAF3;MBD1;INTS7;PHAX;KLF13;TBL1XR1;SLBP;ERCC3;ELOF1;LSM11;ELOC;GLIS3;POU2F1;SETD2;TAF12;POLR2A;ZBTB7B;WWTR1;NR2C2AP;YAP1;WDR33;LEO1;NFYA;PCF11;TEAD3;NR3C1;NR4A2;SCAF8;INTS8;TAF15;HDAC1;GTF2A1;CPSF4;TAF4;ADRM1;RORA;RBPJ;NR4A1;RNGTT;NOTCH2;SSRP1;RPRD1A;MAML1;RARB;DDX21;MED1;POU2F2;NRBP1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.4053647778316931,-1.0383145208841793,0.3925233644859813,0.7305124799160998,1.0,7/12,27.30%,HSPA5;SGTA;SGTB;SEC62;SEC61B;SEC63;SEC61A2
prerank,hematopoietic stem cell proliferation (GO:0071425),0.522161479427543,1.0382780383674912,0.4281609195402299,1.0,1.0,5/11,15.47%,ETV6;WNT2B;SFRP2;YTHDF2;RUNX1
prerank,regulation of neuron death (GO:1901214),0.4411943501660233,1.0380882955182518,0.4528301886792453,1.0,1.0,10/82,10.01%,KIF14;GSK3B;PRNP;MAPT;RILPL1;RAB29;LRRK2;HTRA2;PICALM;IKBKG
prerank,central nervous system neuron development (GO:0021954),-0.3616665092381275,-1.0378815979157106,0.39245283018867927,0.7305071739278794,1.0,4/15,6.87%,HSP90AB1;NTRK2;B4GALT5;B4GALT6
prerank,cellular response to amino acid starvation (GO:0034198),-0.2441317722545572,-1.037763788384386,0.37777777777777777,0.7297283477997841,1.0,21/71,15.63%,ATP6V0D1;MAPK8;ATP6V1E1;ATP6V0B;MIOS;SESN3;WDR59;MAP3K5;FAS;RNF152;GCN1;MAPK3;SZT2;MTOR;MAPK1;ATP6V0C;KPTN;CEBPB;ATP6V1H;DAPL1;RRAGC
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.25860623319109716,-1.0375778395899642,0.358974358974359,0.729045522651517,1.0,21/54,23.07%,HEATR3;RPL35A;RPL3;NVL;RPL14;RPL10;BRIX1;RSL1D1;NSA2;RPL24;TRAF7;LAS1L;SNU13;MDN1;LTO1;RPLP0;RPL10A;SURF6;NOP2;RRP15;EBNA1BP2
prerank,ion homeostasis (GO:0050801),0.4774993527291158,1.0373910590481819,0.4369645042839657,1.0,1.0,4/30,8.29%,RHAG;RANGRF;WNK1;SLC4A2
prerank,sterol transport (GO:0015918),-0.34771511440833447,-1.0371605345086692,0.39826839826839827,0.729070219513709,1.0,6/19,23.98%,CAV1;ARV1;LDLRAP1;OSBP;OSBPL2;NPC2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.4702926102074571,1.0368815721106615,0.42168674698795183,1.0,1.0,12/29,19.14%,ZC3H7A;DGCR8;AGO2;TUT7;PUM2;TUT4;SMAD3;HNRNPA2B1;ZC3H7B;METTL3;SMAD2;SPOUT1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.32829384148622576,-1.0368693798020443,0.38222222222222224,0.7287413467735425,1.0,10/22,23.03%,OS9;RNF103;EDEM2;EDEM1;MAN1A2;SYVN1;UBB;UBC;RPS27A;SEL1L
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.43310575234604726,-1.036640003737613,0.3994252873563218,0.728143666020515,1.0,1/10,0.01%,PRKG1
prerank,RNA processing (GO:0006396),0.43686283733243086,1.0364960265277166,0.448692152917505,1.0,1.0,53/176,17.04%,SYNCRIP;SETX;PABPC4;SNRNP25;TENT2;SRSF4;HNRNPD;CSTF3;LSM3;NRDE2;TENT4A;DDX39B;HNRNPH1;RBMS2;FUS;SRSF7;YJU2;DHX8;PPIG;TUT7;CELF2;TUT1;HNRNPUL1;TSEN34;PRPF3;NONO;SF3A2;HNRNPU;FASTKD5;SFPQ;SNRNP48;IVNS1ABP;HNRNPL;SRRM1;SRPK1;SNRNP35;ATXN1;RNGTT;SF3B3;RBMS1;RBM4;TUT4;TSEN2;WBP4;LUC7L3;KIN;HNRNPA2B1;ZCCHC8;LSM4;METTL3;NOL9;PRPF4;PRPF18
prerank,receptor signaling pathway via STAT (GO:0097696),-0.3158416813589857,-1.036474634426843,0.38190954773869346,0.7274873190814185,1.0,4/25,5.18%,STAT3;IFNAR1;STAT6;SOCS2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.34387335897588595,-1.0360588063487923,0.425531914893617,0.7275041003674887,1.0,9/18,19.24%,RHOJ;FGF2;FOXC2;PTGS2;HDAC7;HDAC9;VEGFA;GATA2;FGFBP1
prerank,regulation of protein localization to membrane (GO:1905475),-0.31493135156468505,-1.0359791802325051,0.4022346368715084,0.7266472863991718,1.0,10/28,16.07%,PRKN;STX8;ACTB;STX7;AR;SPTBN1;GSN;LDLRAP1;ZDHHC7;VAMP8
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.42484944502453226,-1.0358381188848866,0.4171779141104294,0.7259057711400613,1.0,6/11,25.94%,PRKN;PINK1;FBXO7;PARK7;RACK1;HIF1A
prerank,reverse cholesterol transport (GO:0043691),-0.39256145652774466,-1.0355250403205962,0.3614864864864865,0.725581895808735,1.0,2/13,6.91%,APOE;ABCA5
prerank,regulation of cellular catabolic process (GO:0031329),-0.25453690031144255,-1.0354604260655642,0.390625,0.7246891442756347,1.0,27/62,25.17%,PRKN;EP300;PIP4K2A;DRAM2;ACER2;PIP4K2B;PSAP;LONP2;MTMR4;ATM;DAPK2;ABL1;OSBPL7;NUPR1;FBXL2;RRAGC;DDIT3;USP33;USP10;RMC1;PIP4K2C;PIK3R2;HSPB1;RAB39B;SCARB2;SMCR8;RRAGD
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.5280349794279213,1.035357270372889,0.43043478260869567,1.0,1.0,5/13,12.27%,BMPR1A;FGFR2;TGFBR3;PIM1;RBPJ
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.38343733998754204,-1.0352117802414322,0.3961038961038961,0.7242007792407656,1.0,4/14,26.28%,PTGS2;OSMR;PARK7;PTGER3
prerank,regulation of presynapse assembly (GO:1905606),-0.34954299139295086,-1.0350531900892186,0.35864978902953587,0.722514151114919,1.0,6/18,15.46%,PTPRD;IL1RAPL1;EIF4G1;APP;SLITRK1;LRRC4B
prerank,regulation of presynapse organization (GO:0099174),-0.34954299139295086,-1.0350531900892186,0.35864978902953587,0.722514151114919,1.0,6/18,15.46%,PTPRD;IL1RAPL1;EIF4G1;APP;SLITRK1;LRRC4B
prerank,autophagy of mitochondrion (GO:0000422),-0.27634497450397,-1.035044032710892,0.3904109589041096,0.7214968458482445,1.0,14/38,19.87%,PRKN;FIS1;WDR45B;BECN1;SQSTM1;ULK1;BNIP3;PINK1;ATG9A;USP30;ATG2B;FBXO7;FUNDC1;GABARAPL2
prerank,activin receptor signaling pathway (GO:0032924),-0.3743530546642924,-1.0348792940329268,0.40584415584415584,0.720859616549616,1.0,3/15,8.25%,ACVR1;ACVR2A;ACVR2B
prerank,establishment of epithelial cell polarity (GO:0090162),0.4844128549870849,1.0348495667708957,0.4073107049608355,1.0,1.0,10/19,25.79%,RHOA;RAP2A;CYTH3;EZR;MSN;CLASP1;SIPA1L3;GOLPH3;CYTH1;CDC42
prerank,glycerophospholipid metabolic process (GO:0006650),-0.24887098360367407,-1.034076015704249,0.358974358974359,0.721693411955837,1.0,26/75,19.22%,GPCPD1;PLA2G4A;ABHD6;ABHD12;PDGFRB;PNPLA6;PLA1A;PLEK;PLCB3;PLCG1;ENPP6;GPLD1;SERINC1;PIGV;PIGX;GDPD3;PIP5K1A;PIGQ;GDPD1;PIGB;SYNJ1;PIGP;PLA2G7;HDHD5;ACP6;PIGF
prerank,transition metal ion transport (GO:0000041),-0.29810536859089165,-1.0336405993920426,0.4016393442622951,0.7216960217774723,1.0,11/35,22.32%,FTH1;TRPC5;TRPC3;TRPC1;IREB2;SLC31A2;SLC30A1;ATOX1;CUTC;COX17;ATP7A
prerank,regulation of humoral immune response (GO:0002920),-0.2791643443620372,-1.0335886794914744,0.38095238095238093,0.7207895157331137,1.0,18/44,40.03%,VTN;CD81;C4B;C1QB;C2;GATA6;CR1L;C1QC;C1QA;CFHR2;PHB2;CR2;C1QBP;C3AR1;C3;SERPING1;FCGR2B;C7
prerank,organophosphate ester transport (GO:0015748),-0.3141915230581906,-1.0335746702187767,0.38235294117647056,0.7197770770019742,1.0,11/24,25.20%,PLTP;SCP2;MTTP;TNFAIP8L3;PRELID3B;OSBPL2;PITPNC1;NPC2;PRELID3A;ABCA3;PRELID1
prerank,cellular response to interleukin-7 (GO:0098761),-0.36585818467584014,-1.03351431001334,0.41568627450980394,0.7178470068911388,1.0,4/17,11.06%,STAT3;SOCS2;IRS2;IRS1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.36585818467584014,-1.03351431001334,0.41568627450980394,0.7178470068911388,1.0,4/17,11.06%,STAT3;SOCS2;IRS2;IRS1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.5085205942750725,1.0335118071612073,0.41643454038997213,1.0,1.0,4/14,15.27%,KCNN4;RAB29;IKBKG;PRKD2
prerank,negative regulation of biosynthetic process (GO:0009890),0.49522073723947263,1.0334760143655228,0.4046639231824417,1.0,1.0,1/16,1.19%,SLC18A2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.48624829928215535,1.032269920937017,0.4335483870967742,1.0,1.0,7/21,16.93%,BMPR1A;BMP6;WWTR1;TGFBR1;CCN3;SMAD4;VEPH1
prerank,motor neuron axon guidance (GO:0008045),0.5035269589799121,1.0320419614527159,0.42178770949720673,1.0,1.0,4/15,11.54%,NTN1;NTN3;EPHA4;RAC1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.470368248250673,1.0318224378864735,0.4462616822429907,1.0,1.0,6/30,11.54%,LPAR1;RTN4R;NET1;ARRB1;ROBO1;RAC1
prerank,RNA catabolic process (GO:0006401),0.45310819113470785,1.031332608843996,0.4492099322799097,1.0,1.0,12/46,16.45%,PABPC4;HNRNPD;DNA2;RNASE6;RNASEH2A;PPP1R8;LSM2;YTHDF2;EXOSC7;DXO;PNPT1;METTL3
prerank,regulation of response to oxidative stress (GO:1902882),-0.40710584212658363,-1.0313084075889303,0.4119496855345912,0.7221068705795297,1.0,4/11,12.19%,PRKN;MCTP1;SELENON;PINK1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.501548848480728,1.0312590805620365,0.4334705075445816,1.0,1.0,6/19,13.65%,PARD3B;SCRIB;MARK2;CLIC4;PRKCI;DLG1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5023677707185392,1.0306716843160546,0.43593130779392336,1.0,1.0,7/19,15.47%,BMPR1A;FGFR2;TGFBR3;PIM1;TGFBR1;RBPJ;RUNX1
prerank,histone mRNA metabolic process (GO:0008334),0.4739618405458116,1.0306518308661108,0.45588235294117646,1.0,1.0,6/27,8.37%,TENT2;SLBP;LSM11;ERI1;TUT7;TUT1
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5217003866070231,1.0301201848277688,0.4320809248554913,1.0,1.0,2/13,6.94%,SAE1;ATG7
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4737913735530473,1.0295340991150226,0.4429771908763505,1.0,1.0,9/29,16.13%,USF3;SFRP2;EFNA1;NKX2-1;ADIPOR1;SPRED1;SFRP1;SPRED2;PTEN
prerank,ganglioside biosynthetic process (GO:0001574),-0.36651595812946236,-1.0290671751975875,0.391304347826087,0.7265409534586448,1.0,6/15,10.68%,ST8SIA4;B4GALT5;ST6GALNAC3;B4GALT6;ST6GALNAC5;ST8SIA6
prerank,positive regulation of kinase activity (GO:0033674),0.43559317300243366,1.0290257077126255,0.4588477366255144,1.0,1.0,12/107,8.22%,CENPE;SPDYA;FGFR4;FGFR2;KIT;MRE11;MAPT;MUSK;PDGFRA;CCN1;EPHA4;MRNIP
prerank,regulation of cellular component movement (GO:0051270),0.44824524919444303,1.0290172511652502,0.44694533762057875,1.0,1.0,12/49,12.47%,ROCK2;RHOA;ACTN4;MYCBP2;MEMO1;DIAPH1;ARHGAP18;PDPN;TGFBR3;ROCK1;TGFBR1;ADAM17
prerank,positive regulation of JNK cascade (GO:0046330),-0.25041860483814804,-1.0286679646756218,0.4444444444444444,0.7265023229275915,1.0,38/70,39.27%,TNFRSF19;SH3RF3;HIPK2;TPD52L1;TAOK2;ANKRD6;MAP3K5;DUSP22;SEMA3A;MINK1;APP;SH3RF2;SDCBP;TIRAP;GADD45B;FLT4;MAP3K11;PTK2B;WNT16;MFHAS1;MAPK8IP1;EDA2R;PLCB1;GADD45G;MBIP;DUSP19;TRAF1;HRAS;PJA2;CCL19;NOD2;EDAR;DUSP15;PYCARD;UNC5CL;GADD45A;FCGR2B;AGER
prerank,calcium ion import (GO:0070509),0.47583380433161226,1.0285793112758845,0.44865525672371637,1.0,1.0,10/28,20.46%,MCU;ATP2A2;SLC8A1;MCUB;CACNA1C;MICU1;MAIP1;TRPV4;CACNA1G;MICU2
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4485108000647376,1.0282624110317977,0.4531422271223815,1.0,1.0,16/52,18.50%,E2F1;SAE1;TFDP1;LEPROT;FBXW7;RNF31;SH3GLB1;HTRA2;CSNK2A2;CASP8;NPEPPS;UBL5;TP53;PPP3R1;YWHAQ;BAD
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.29765737099554906,-1.0281011671045337,0.45054945054945056,0.7268110968856359,1.0,5/27,5.88%,CAMK2D;CTNNA3;CAV1;RYR2;FGF13
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.2654861017299338,-1.0280463075928388,0.36538461538461536,0.7258905392101274,1.0,8/46,8.23%,PLA2G4A;PLD1;DGKB;ABHD5;PLD2;SLC27A1;AGPAT5;DGKG
prerank,retinol metabolic process (GO:0042572),0.5124441040490038,1.027788121284409,0.4161931818181818,1.0,1.0,2/14,5.42%,RDH11;RDH12
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.3390498691143414,-1.0272990564197906,0.38961038961038963,0.7266065806156463,1.0,7/20,18.32%,OGT;ASAH1;CYLD;STUB1;NUPR1;SDCBP;BIRC3
prerank,detection of visible light (GO:0009584),0.4978793605764358,1.027166119010356,0.43391188251001334,1.0,1.0,3/16,18.06%,ABCA4;GNAQ;CEP250
prerank,brain development (GO:0007420),0.43725695697413913,1.0270559180963914,0.4612286002014099,1.0,1.0,31/136,18.74%,CENPF;PBX4;CDK5RAP2;PBX3;NFIB;CXCR4;MKKS;SOX6;GRHL2;NIPBL;UTP3;DSCAML1;PLXNB2;DHX37;ATXN1;NKX2-1;FBXW11;TMX2;NES;QARS1;HSPG2;PTEN;ARNT2;SLC6A17;GRIN2D;SHROOM2;MAST1;AMIGO1;COL4A1;ZIC1;EGR2
prerank,regulation of lipid storage (GO:0010883),0.4952137923858393,1.026810760282785,0.44472361809045224,1.0,1.0,6/22,15.53%,FTO;PTPN2;FBXW7;LPL;ITGAV;NFKB1
prerank,synaptic vesicle cycle (GO:0099504),-0.30205066364332434,-1.0263546917501112,0.37777777777777777,0.7278928861697197,1.0,12/30,18.07%,PCLO;RIMS1;SYNDIG1;BRSK1;PLD2;RAB5A;SYT7;SLC17A6;CPLX1;SNAP25;SYT10;NLGN1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4634334288579296,1.0262099331925023,0.4563986409966025,1.0,1.0,22/42,23.77%,SMARCC1;SMARCAD1;RBBP4;ARID1A;SRCAP;SMARCA4;ANP32E;HDAC1;NASP;SPTY2D1;HDAC2;ACTL6B;INO80;MBD3;MBD2;ZNHIT1;ARID1B;CHD4;SMARCC2;ACTL6A;CECR2;SMARCB1
prerank,positive regulation of cholesterol efflux (GO:0010875),0.4985393878217763,1.026153379816418,0.45663265306122447,1.0,1.0,1/21,0.82%,PON1
prerank,response to tumor necrosis factor (GO:0034612),0.4376606124064969,1.0260872885894583,0.4569672131147541,1.0,1.0,6/91,7.40%,BRCA1;HYAL1;DHX9;AFF3;NPNT;YBX3
prerank,positive regulation of developmental growth (GO:0048639),-0.2679864165796205,-1.0243797652722173,0.4019607843137255,0.7318019490695274,1.0,8/49,4.66%,RUFY3;RIMS1;ITSN2;CDKL5;INSR;SYT1;AGRN;SEMA7A
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.45113278271882995,1.024170438116776,0.4487917146144994,1.0,1.0,8/33,14.06%,HMGB2;RAB7B;PRKDC;FOXO3;ABCB10;TAL1;MED1;ARNT
prerank,establishment of endothelial barrier (GO:0061028),-0.3090134576501445,-1.0236427593279223,0.4,0.7324628632657827,1.0,11/29,19.81%,PPP1R16B;PECAM1;RAP1A;F11R;TJP1;RAP2C;PDE2A;PDE4D;RAB1B;ROBO4;RAPGEF3
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4780964448841647,1.0233509994718473,0.43742098609355246,1.0,1.0,7/24,12.85%,STMN1;ARHGAP28;CGNL1;TMEFF2;ARHGAP6;ARHGEF18;WASF2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.46551306385287905,1.023176571831895,0.4662857142857143,1.0,1.0,15/44,19.16%,AQP1;CDKN2D;FNIP1;SIAH2;ARL6IP1;SH3RF1;CAST;USP47;XIAP;CD44;SRC;NGF;LAMTOR5;DPEP1;DNAJB6
prerank,primary miRNA processing (GO:0031053),0.5257050866709952,1.0229557528348234,0.4410828025477707,1.0,1.0,5/10,17.44%,DGCR8;SMAD3;HNRNPA2B1;METTL3;SMAD2
prerank,regulation of cell adhesion (GO:0030155),0.43236293392159814,1.0223993859020455,0.4654471544715447,1.0,1.0,24/129,15.30%,KIF14;ROCK2;HYAL1;PDE3B;CXCR4;IL18;EFNA1;PLAU;PPP3CA;EPHA4;RSU1;RIPOR2;ANGPT1;ROCK1;YTHDF2;PLXNB2;PLXNB1;DSCAM;PRKCA;PLXND1;MIA3;ITGAV;PRKD2;SRC
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5387500194574147,1.0214764003278112,0.4406015037593985,1.0,1.0,3/10,8.10%,TXN;PYCR1;LRRK2
prerank,mitochondrion localization (GO:0051646),0.4867867043716084,1.0213886803455412,0.4412532637075718,1.0,1.0,5/19,15.78%,TRAK1;LRRK2;MFN2;MARK2;MFN1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4838366911002149,1.0212013064611407,0.45136186770428016,1.0,1.0,6/19,19.36%,MTHFD1L;MTHFR;SLC19A1;DHFR;GGH;MTHFS
prerank,actin cytoskeleton reorganization (GO:0031532),0.4313826637646644,1.021114632638639,0.44314558979808716,1.0,1.0,27/63,22.98%,RHOA;PARVA;AUTS2;KIT;PDLIM4;RAP2A;NRK;CDC42BPA;PHACTR1;MCU;S1PR2;CDC42BPG;GAB1;ANXA1;EZR;DMTN;MKLN1;ANTXR1;SIPA1L1;TRPV4;SYDE1;PTPN1;WHAMM;FER;FLNA;MYH9;CXADR
prerank,fatty acid beta-oxidation (GO:0006635),-0.2563328302645434,-1.0206887577729893,0.4,0.7384835351692859,1.0,12/51,16.04%,HADHB;ACADM;CROT;SCP2;ABCD4;MECR;HADH;ACAD10;ECHS1;ABCD2;DECR1;ECHDC2
prerank,positive regulation of histone deacetylation (GO:0031065),0.5219508654018158,1.0205523741779479,0.4418938307030129,1.0,1.0,5/12,15.27%,CTBP1;NIPBL;ZBTB7B;PRKD1;PRKD2
prerank,RNA splicing (GO:0008380),0.43150428660874,1.0201930450826087,0.47564766839378236,1.0,1.0,28/95,18.15%,SYNCRIP;SNRNP25;SRSF4;TRA2B;SRSF10;NRDE2;DDX39B;FUS;SRSF7;YJU2;DHX8;PPIG;PRPF3;NONO;SFPQ;SNRNP48;IVNS1ABP;SRRM1;SRPK1;SNRNP35;SF3B3;WBP4;LUC7L3;LSM4;PRPF4;PRPF18;SRPK2;PDCD7
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.4272910816670355,1.0200706440455458,0.418,1.0,1.0,214/1082,16.02%,BRCA1;CKAP2;E2F7;E2F8;NR2E3;UHRF1;ATAD2;E2F2;MYBL1;ATRX;PBX4;GLI2;CDK5RAP2;GLI3;RBL1;HMGB2;E2F1;BRCA2;FOXE1;ATOH8;PSRC1;HAS3;ILF3;NAT14;FADD;DYRK1A;SMARCC1;SP3;SETX;BMPR1A;PHIP;ELF2;ACTR3;TEAD1;WWOX;CTCF;E2F3;AGO2;FGFR2;SENP1;TFDP1;HNRNPD;BCL2L12;NFE2;GALR1;DDRGK1;AUTS2;MED14;CHEK2;RFXAP;HIVEP1;RGMA;NFIA;DHX9;SSBP3;PCGF5;PRKDC;NFIL3;KLF5;SRF;ELF4;BLM;ASXL1;THRAP3;NFIB;TBL1XR1;LPIN2;SETD3;MLLT10;SFRP2;NUP85;BMP6;YAF2;PCBD2;TCF7L2;HOXC4;ELOF1;ELF1;MED30;IL18;TCF4;HOXA7;ARRB1;GRHL2;PML;AKNA;DDX39B;GLIS3;ARID1A;MYBL2;CHEK1;TASP1;ELK1;POU2F1;PPP3CA;CCN1;POU3F2;WWTR1;FHL5;SERPINE1;FOXO3;ATF7IP;CD80;IRF1;TRIM28;LMX1B;PELP1;MED24;BCLAF1;ZFP64;SMARCA4;NCK1;YAP1;ZFP90;CREB5;RHOQ;USP21;USP16;HOXB3;DNM2;VHL;NFYA;PLAGL1;PICALM;AGT;KMT2A;HMGB1;EPC1;HDAC8;IKBKG;MEOX2;TGFBR1;NR3C1;NR4A2;MMS19;SCAF8;PARP9;HNRNPU;SFPQ;TAL1;CRLF3;TAF15;EIF2AK3;HDAC1;MRTFA;AHR;NCOA2;QRICH1;BMP2;NKX2-1;NFATC2IP;RORA;FBXW11;NCK2;SLC30A9;RBPJ;KMT2D;AKIRIN2;ZNF496;NR4A1;SMAD4;BRD4;SOX9;HDAC2;ATF5;ILF2;IL31RA;ELK4;LRP5;RAI1;TCF20;TWIST1;NCOA7;PPRC1;IL4I1;MAML1;RARB;HEY2;MED1;BTRC;YY1;PRKD1;FOXK2;ARF4;RLF;POU2F2;ARNT;SMAD3;RUVBL2;FOXM1;RPTOR;CDK8;E2F4;SOX1;INO80;PER1;PIN1;SFRP1;PRKD2;PKD2;GDNF;ATF1;RUNX1;DR1;NFKB1;KAT6A;ZNF507;BICRA;HOXB7;CSRP3;DRAP1;TP53;FHOD1;BRD8
prerank,"phototransduction, visible light (GO:0007603)",0.5019266257445691,1.0198146180167644,0.436241610738255,1.0,1.0,2/14,8.77%,ABCA4;GNAQ
prerank,negative regulation of binding (GO:0051100),0.4383034156113009,1.019715158156975,0.47286012526096033,1.0,1.0,22/81,19.92%,AURKB;DDX11;E2F1;BTAF1;AURKA;ARHGAP28;GSK3B;WAPL;LRRK2;ROCK1;PSME3IP1;ILRUN;MITD1;NES;PIN1;TFAP4;DNAJB2;SP100;STYX;PRKCD;ZFPM1;IFIT2
prerank,protein-containing complex assembly (GO:0065003),0.42863106788806116,1.0195427648133701,0.481,1.0,1.0,69/259,18.70%,KNTC1;FANCA;PLEKHA7;F5;KPNA3;FADD;TSPAN33;TEAD1;GSK3B;MDM4;FBXL7;ADD2;DHX9;TCF7L1;BLM;ZW10;AFDN;TCF7L2;PML;STOML2;LRRK2;DARS1;MCU;CUL3;SMARCA4;AXIN2;YAP1;TRAPPC6B;LEO1;PICALM;KMT2A;RAB1A;IKBKG;WDCP;RSPH9;CDC123;BOK;CAPZA1;HDAC1;F8;SCFD1;KMT2D;SEC24D;CASP8;DMTN;SOX9;PPID;TRAPPC10;TLE4;GSDMD;CAPG;EPRS1;ANKRD28;TLE3;TRRAP;TP53;BET1;FERMT3;SH3PXD2B;AMER1;TRAPPC9;CSNK1A1;USO1;TFAP4;FANCC;TMED10;BAD;KIFAP3;RIPK1
prerank,heart development (GO:0007507),-0.22565616582668893,-1.0194134968062456,0.5714285714285714,0.740484371867091,1.0,43/150,18.25%,PTK2;ACVR1;TEK;ECE1;MEF2C;TCF25;ADAP2;TGFBR2;INSR;PCSK5;TAB2;FKBP1A;BMPR2;ACVRL1;TGFB2;RBM20;NTRK3;POU6F1;FOXC2;MTHFD1;RAMP2;FOXC1;ERBB4;NF1;PDLIM2;MEF2A;MEGF8;PDLIM7;KAT2B;SOX4;TBX1;HDAC9;CACYBP;PTPN11;VEGFA;SOX17;PLCE1;STRA6;CRELD1;CITED2;NDRG4;TBX2;PDLIM1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4641438256125231,1.0192800496997363,0.43498273878020716,1.0,1.0,8/33,15.27%,KCNN4;PRNP;PTPN2;RAB29;IKBKG;EZR;RC3H1;PRKD2
prerank,positive regulation of phagocytosis (GO:0050766),-0.2686061016680624,-1.0189322887891321,0.41964285714285715,0.7405668173901988,1.0,27/47,43.69%,MERTK;ANO6;GAS6;MYO18A;C4B;GATA2;RAB27A;NCKAP1L;C2;IL15;FCER1G;TUB;PTPRC;ABCA7;CALR;RAB31;LYAR;PYCARD;C3;SLC11A1;LMAN2;FCGR2B;CD300LF;CCL2;IL2RG;TREM2;AHSG
prerank,oligosaccharide biosynthetic process (GO:0009312),0.4865286989622707,1.0187730315295631,0.46254927726675427,1.0,1.0,6/20,16.99%,B4GALT1;MPDU1;ST3GAL3;ST3GAL4;ST3GAL2;B3GALT2
prerank,regulation of defense response to virus (GO:0050688),0.5076624525763099,1.0185418444109597,0.4427792915531335,1.0,1.0,6/14,23.21%,DHX9;ILRUN;ITCH;RNF216;ELMOD2;PCBP2
prerank,mRNA destabilization (GO:0061157),0.45832455933776023,1.0175847495574597,0.44839449541284404,1.0,1.0,11/38,14.16%,MOV10;ROCK2;FTO;CNOT1;RC3H2;TUT7;ROCK1;YTHDF2;MEX3D;TUT4;RC3H1
prerank,cell-matrix adhesion (GO:0007160),0.42707431237771476,1.0170114892102304,0.4825102880658436,1.0,1.0,21/95,17.05%,OTOA;NID2;HPSE;TRIP6;ITGB7;NPNT;ADAMTS9;SGCE;FBLN5;RAC1;MKLN1;ADAM9;ITGB1;ITGA8;CD44;ITGAV;SRC;ITGB8;RCC2;FERMT3;PTPRK
prerank,regulation of amyloid fibril formation (GO:1905906),-0.3688928233079166,-1.0170112354095546,0.42379182156133827,0.7441841984010631,1.0,6/15,13.05%,PSEN1;APOE;CHRNA7;APP;CRYAB;PFDN5
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.49310997153452274,1.0166828550426217,0.45265888456549935,1.0,1.0,4/18,14.06%,FGL1;WNK1;IL4I1;MIA3
prerank,mRNA splice site selection (GO:0006376),0.4570862705739537,1.016230698573278,0.45476477683956573,1.0,1.0,10/30,19.95%,SETX;SRSF10;PSIP1;CELF2;SF3A2;LUC7L3;PRPF39;SFSWAP;LUC7L2;SF3A3
prerank,synaptic vesicle transport (GO:0048489),-0.3991780009406017,-1.0159543209841326,0.4350453172205438,0.7456838964421754,1.0,6/11,23.39%,SPG11;KIF5B;KIF5C;SYNJ1;RAB27A;TOR1A
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.43558843146946463,1.0159520673229974,0.4755463059313215,1.0,1.0,23/73,20.93%,FADD;SENP1;DAP;CASP8AP2;ANP32B;FAM162A;MAPT;XDH;ROBO1;TNFRSF10B;APAF1;BOK;EIF2AK3;CASP8;SMAD3;BCL2L13;NGF;TNFSF10;BAD;RIPK1;COL4A3;SNCA;TRAF2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4248350479758877,1.015343787819125,0.48133198789101916,1.0,1.0,33/138,17.09%,NR2E3;E2F2;MED26;TEAD1;E2F3;TAF3;TBL1XR1;ERCC3;TAF12;POLR2A;WWTR1;NR2C2AP;YAP1;TEAD3;NR3C1;NR4A2;TAF15;HDAC1;GTF2A1;TAF4;RORA;RBPJ;NR4A1;NOTCH2;MAML1;RARB;MED1;NRBP1;MED27;DR1;TAF10;TEAD4;CCN2
prerank,regulation of extracellular matrix organization (GO:1903053),0.49084539502636176,1.0153095373554042,0.43829787234042555,1.0,1.0,6/15,17.66%,RB1;FGFR4;AGT;DDR2;RUNX1;RIC1
prerank,extracellular structure organization (GO:0043062),0.42538184008848523,1.0151763193042724,0.48694779116465864,1.0,1.0,48/204,15.61%,MATN3;COL22A1;NID2;MMP25;MMP24;MMP28;MFAP2;LOX;COL4A6;MMP14;FBN1;ADAM12;LAMB1;COL4A4;ITGB7;COL18A1;COL5A2;COL23A1;ADAMTS10;NPNT;ADAMTS5;ADAMTS14;ADAMTS9;SERPINE1;ADAMTSL2;FBLN5;ADAMTS2;ADAMTS16;ELN;DDR2;TGFBR1;SLC39A8;NID1;COL15A1;POSTN;COL4A5;BGN;ADAM19;ADAMTSL3;ADAMTS1;ITGA5;ITGB1;ITGA8;CD44;MFAP5;ITGAV;HSPG2;ITGB8
prerank,heterochromatin organization (GO:0070828),0.5054364209227529,1.0150581958195657,0.4520547945205479,1.0,1.0,4/14,8.51%,LOXL2;SETDB2;HP1BP3;SMCHD1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.4689109108833078,1.014512980628919,0.4642857142857143,1.0,1.0,9/30,15.07%,SAE1;LEPROT;FBXW7;RNF31;SH3GLB1;HTRA2;CSNK2A2;NPEPPS;UBL5
prerank,phosphatidic acid metabolic process (GO:0046473),-0.26042537295016344,-1.0144637255150801,0.40816326530612246,0.7481642330301954,1.0,8/48,8.23%,PLA2G4A;PLD1;DGKB;ABHD5;PLD2;SLC27A1;AGPAT5;DGKG
prerank,serine family amino acid metabolic process (GO:0009069),-0.3617227045677745,-1.0144516380837754,0.41843971631205673,0.7471389600492152,1.0,12/16,49.08%,MTHFD1;SARS1;CBS;THNSL2;SEPHS2;CTH;SEPSECS;PSPH;SHMT2;SHMT1;GLYAT;DAO
prerank,alanine transport (GO:0032328),-0.4028891171195945,-1.014308875431887,0.42592592592592593,0.7464023022745336,1.0,1/10,0.32%,SLC6A6
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.48814869007297845,1.0132152691035643,0.4395750332005312,1.0,1.0,2/17,1.69%,SPDYA;PSRC1
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5369037912979888,1.01305742630621,0.4456035767511177,1.0,1.0,2/10,5.53%,TERF1;MAPT
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.439929564908829,1.0130395514787711,0.4693446088794926,1.0,1.0,13/76,13.54%,SPAG5;PLK4;GPSM2;MYLK3;NUMA1;CDC42EP2;SORBS3;NCK1;NCK2;SYNPO2;BAIAP2L1;PRKCE;NES
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.47106481838520486,1.0124781018988243,0.45591939546599497,1.0,1.0,7/24,16.97%,HMBS;FXN;COX10;ABCB10;CPOX;ATP5IF1;ALAS2
prerank,ephrin receptor signaling pathway (GO:0048013),-0.22938973121623935,-1.0119690973445286,0.4444444444444444,0.7510196969444785,1.0,27/82,19.23%,PTK2;EPHA5;PSEN1;PAK3;ACTB;TIAM1;GRIN2B;VAV3;AP2A2;EPHB2;NCSTN;LYN;DNM1;PAK1;AP2M1;MMP2;PTPN11;EPHA8;AP2S1;SDCBP;GRIN1;AP2A1;ARHGEF7;PSEN2;ARPC5;GIT1;EFNB3
prerank,histone acetylation (GO:0016573),0.43710741655149593,1.0117137393642495,0.48886532343584305,1.0,1.0,25/69,19.07%,BRCA2;SGF29;HAT1;TAF12;ING4;MSL3;EP400;EPC1;TADA1;TADA2A;ACTL6B;JADE1;RUVBL2;YEATS2;PER1;DR1;TRRAP;KAT6A;BRD8;TAF10;PHF20;ZZZ3;NAA60;NAA40;JADE3
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.43876186650700205,1.0116723031543282,0.4994731296101159,1.0,1.0,19/66,17.05%,BRCA2;ATOH8;FGFR2;CASK;MCC;NFIB;XDH;SFRP2;TGFBR3;FBXW7;SULF1;ROBO1;KLF9;SOX9;ATP5IF1;MED1;SFRP1;TINF2;PTPRK
prerank,positive regulation of protein polymerization (GO:0032273),0.4334735730539262,1.011577300970244,0.4643237486687966,1.0,1.0,13/65,13.29%,CDK5RAP2;PSRC1;NUMA1;MAPT;CDC42EP2;NCK1;TPPP;DRG1;RAC1;AKAP9;NCK2;BAIAP2L1;PRKCE
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.47607428780129246,1.010520178963462,0.4644243208279431,1.0,1.0,8/23,16.13%,OCRL;INPP5B;MTMR1;MTMR2;MTMR9;PIP4P2;MTMR3;PTEN
prerank,protein ADP-ribosylation (GO:0006471),-0.3160939237890796,-1.010209028347842,0.41916167664670656,0.7540845323763579,1.0,8/28,12.90%,PARP8;PARP12;TIPARP;ART3;PARP6;PARP1;SIRT5;PARP16
prerank,axonal transport of mitochondrion (GO:0019896),0.5185771171868143,1.0100364675441942,0.45918367346938777,1.0,1.0,2/11,5.53%,TRAK1;MAPT
prerank,toxin transport (GO:1901998),0.5232678780609155,1.0100269359306675,0.4661764705882353,1.0,1.0,3/10,16.95%,ANTXR2;RAB29;ANTXR1
prerank,protein N-linked glycosylation (GO:0006487),0.4407097454738436,1.009815380761226,0.4814422057264051,1.0,1.0,15/66,14.43%,ALG14;B4GALT1;ALG13;SRD5A3;MPDU1;B4GALT7;MAGT1;RPN2;SLC39A8;STT3A;MAN1C1;STT3B;UBE2J1;ALG8;ST3GAL1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5041080299144012,1.009064891953777,0.45734265734265733,1.0,1.0,2/14,8.13%,IL18;CD80
prerank,cardiac muscle cell development (GO:0055013),0.4842730929256999,1.008906363553871,0.45369127516778524,1.0,1.0,7/20,15.93%,OBSL1;MYLK3;PDGFRA;SLC8A1;PDLIM5;HEY2;CSRP3
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.43902012690467335,1.0085246459325425,0.47150837988826816,1.0,1.0,6/45,12.64%,TTK;BMPR1A;BMP6;TGFBR1;BMP2;SMAD4
prerank,RNA 3'-end processing (GO:0031123),0.42445611199064515,1.0072684608330749,0.48366701791359323,1.0,1.0,17/69,13.59%,TENT2;SRSF4;CSTF3;FIP1L1;UPF3B;TENT4A;DDX39B;SRSF7;TUT7;TUT1;WDR33;PCF11;SRSF3;SRRM1;CPSF4;RPRD1A;TUT4
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.3115885192180662,-1.0069537258929275,0.4,0.7612010037916739,1.0,7/24,18.18%,PDE3A;PEX5L;GNAI1;UBE2B;PRKAR1B;PDE2A;PDE4D
prerank,negative regulation by host of viral process (GO:0044793),-0.43050421082412305,-1.0065496631733253,0.4722222222222222,0.7610792512590038,1.0,1/10,0.21%,PRKN
prerank,cellular response to oxygen levels (GO:0071453),-0.4148315372903946,-1.0064101932689455,0.4406779661016949,0.7603545573995016,1.0,5/10,27.52%,ATP6V0D1;CPEB4;PICK1;ATP6AP1;TMEM199
prerank,response to gamma radiation (GO:0010332),0.47471942198465766,1.005793239223799,0.44374209860935526,1.0,1.0,3/24,8.83%,FANCD2;MAP3K20;YAP1
prerank,cardiac muscle cell action potential (GO:0086001),-0.28919727267327866,-1.0051737775074634,0.3870967741935484,0.7623535814461031,1.0,6/30,15.12%,CACNA2D1;ATP1B1;SCN1A;ATP1A1;ATP1A2;SCN1B
prerank,cell junction organization (GO:0034330),-0.23734499277739649,-1.0046978005008815,0.4222222222222222,0.76245901451235,1.0,17/71,12.21%,CTNND2;PSEN1;SLC8A3;OCLN;SLC6A1;OPHN1;PAK3;ACTB;TGFB2;AGRN;SDK2;TJP1;CHRNA7;APP;LIMS2;GRM5;APBB2
prerank,myelination in peripheral nervous system (GO:0022011),-0.3786326327488846,-1.0045984358221032,0.46534653465346537,0.7616689320726122,1.0,6/13,25.25%,NF1;ARHGEF10;DICER1;ADGRG6;LGI4;PRX
prerank,regulation of mitochondrial fission (GO:0090140),0.4697598192429044,1.0045439691245794,0.4766009852216749,1.0,1.0,7/24,10.54%,MIEF2;AURKA;MAPT;LRRK2;MCU;MIEF1;DDHD1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.434223902828799,1.0041073685735988,0.4883474576271186,1.0,1.0,15/72,11.54%,STMN1;LPAR1;RTN4R;NET1;ARRB1;CUL3;RIPOR2;ROBO1;KANK2;EPS8L1;ARHGAP35;MYO9B;ABCA1;ARHGEF18;RAC1
prerank,response to exogenous dsRNA (GO:0043330),0.4911018291552539,1.0039914173570048,0.4671814671814672,1.0,1.0,3/18,4.78%,TICAM1;COLEC12;DHX9
prerank,sulfur compound catabolic process (GO:0044273),-0.2726349249675889,-1.0032403385398863,0.45454545454545453,0.7637526960134762,1.0,12/38,17.29%,GNS;FMOD;HEXB;GGT5;PRELP;TXN2;HEXA;OGN;IDS;LUM;NUDT7;GALNS
prerank,excitatory postsynaptic potential (GO:0060079),-0.3373475423829625,-1.0032015382359725,0.4318181818181818,0.7627735662017061,1.0,4/19,3.66%,MEF2C;GRIN2A;GRID2;GRIN2B
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.2961056394500081,-1.0030953465045789,0.4371584699453552,0.7619839544321346,1.0,9/27,14.67%,PSEN1;BRSK1;HOMER1;IL1RAPL1;CAMK2G;CTNNA2;NCS1;NTNG1;GSK3A
prerank,regulation of autophagosome maturation (GO:1901096),0.4968657729529577,1.0025262358361693,0.4724186704384724,1.0,1.0,6/13,20.32%,TBC1D25;TMEM39A;ADRB2;UVRAG;CLEC16A;FYCO1
prerank,positive regulation of cyclase activity (GO:0031281),-0.37090730087242874,-1.0021392654445547,0.46308724832214765,0.76324631276512,1.0,4/14,9.90%,MAPK8;NOS3;NF1;MAPK3
prerank,rRNA 3'-end processing (GO:0031125),0.5303193917528922,1.0018095071189401,0.47129909365558914,1.0,1.0,5/10,18.53%,ERI2;ERI1;EXOSC7;ERI3;EXOSC10
prerank,negative regulation of MAPK cascade (GO:0043409),-0.23421945803430008,-1.001733924348675,0.46153846153846156,0.7631633446612337,1.0,38/87,31.71%,FOXO1;SEMA6A;TIMP3;CAV1;APOE;TLR4;WNK2;EPHB2;IGBP1;DUSP3;LYN;STK38;INPP5K;NF1;LMO3;SYNJ2BP;SPRY2;DUSP1;ITGB1BP1;SORL1;PPEF2;UCHL1;TNIP1;PIK3R2;RPS6KA6;CDK5RAP3;BMP7;CD300A;P2RX7;GPER1;DAG1;DUSP6;IRAK3;PTPRC;SPRY4;ABCA7;SH2B3;SPRED3
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.30159324713801056,-1.0006292362492608,0.45454545454545453,0.7647479637079867,1.0,11/27,21.55%,GRB14;PIP4K2A;GRB10;PIP4K2B;PRKCQ;INPP5K;IRS1;GSK3A;PRKCZ;PIP4K2C;SLC27A4
prerank,positive regulation of cell migration (GO:0030335),0.4191551591994564,1.0005209570599518,0.4984984984984985,1.0,1.0,49/253,15.78%,KIF20B;ARHGEF39;GTSE1;MAP4K4;FBXO5;SYNE2;TWIST2;TRIP6;ROCK2;HYAL1;CEP43;AGO2;MMP14;DDRGK1;LAMB1;ACTN4;KIT;SPAG9;CCAR1;PDPN;MYO1C;PDGFRA;ENPP2;PLAU;NIPBL;PPP3CA;CCN1;DDR2;TGFBR1;SMURF2;GAB1;CRKL;BMP2;PRKCA;ADAM17;DMTN;SOX9;CTSH;PRKCE;DOCK1;ADAM9;INSL3;MIA3;ITGB1;SRC;ELP6;SEMA3D;RHOC;SUN2
prerank,carboxylic acid transport (GO:0046942),-0.2525330981800445,-1.0003578766612866,0.4375,0.7642939312736241,1.0,16/55,24.06%,SLC6A6;SLC16A12;SLC13A3;SLC7A5;SLC3A2;PSAP;SLC7A6;SLC16A1;SLC16A4;SLC1A1;SLC6A11;SLC38A5;SLC6A15;SLC36A1;SLC6A7;SLC16A13
prerank,regulation of insulin secretion (GO:0050796),-0.23053158366747292,-1.0002546322832517,0.45454545454545453,0.7634794622118151,1.0,27/101,21.15%,PRKN;EPHA5;MYRIP;SLC2A1;KCNC2;PER2;RAP1A;KCNB1;IRS2;ACSL4;SYT7;HADH;KCNS3;IRS1;SOX4;SNAP25;MIDN;UQCC2;ADRA2A;PICK1;TM7SF3;CACNA2D2;LRRC8A;RAPGEF3;GLUD1;NNAT;EFNA5
prerank,glycosphingolipid metabolic process (GO:0006687),-0.26129890683231194,-1.000217945513864,0.45132743362831856,0.7625687163076538,1.0,12/42,13.67%,HEXB;PSAP;ASAH1;ST6GALNAC3;B4GALT6;ST8SIA1;ESYT1;B3GALNT1;ST6GALNAC5;HEXA;GLTP;CTSA
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.3423130904369554,-1.0,1.0,0.7600031936294925,1.0,70/224,18.32%,GRM7;UNC13B;GRIK1;DLGAP1;GABRB1;GABRB3;CHRM2;SLC1A2;GRIN2A;GABRA2;SLC6A1;GRM3;SPG11;ATXN3;CALM1;AMPH;APBA1;GLRB;SYN2;GLRA1;SYT1;GRIN2B;PTCHD1;KCNQ3;HOMER1;GRIK4;RPS6KA2;CAMK4;HTR2C;GABRA3;PLP1;GLRA3;NRXN1;CACNA1B;CAMK1;PRKACB;MINK1;GABRA5;GABRB2;CHRNA7;CHRFAM7A;GRIA1;GIPC1;HCRTR2;PRKAR1B;SYNJ2BP;GABRG2;HTR4;MAPK1;CAMKK2;GRM5;CACNB2;GRM1;DLG4;SDCBP;GRIN1;GABRG1;DTNA;CHRM3;SLC1A1;CPLX1;SNAP25;HTR2A;LRP6;GRIA2;SYPL1;CACNB1;SYT10;NLGN1;APBA2
prerank,chemical synaptic transmission (GO:0007268),-0.31172297879575156,-1.0,1.0,0.7600031936294925,1.0,84/284,18.32%,CDH8;GRM7;UNC13B;GRIK1;DLGAP1;GABRB1;SYN3;RIMS1;GABRB3;CHRM2;SLC1A2;GRIN2A;GABRA2;SLC6A1;GRM3;SPG11;KIF1B;ATXN3;CALM1;AMPH;APOE;APBA1;GRID2;GLRB;SYN2;GLRA1;SYT1;LIN7A;GRIN2B;PTCHD1;KCNQ3;BRSK1;HOMER1;SHISA6;GRIK4;RPS6KA2;CAMK4;HTR2C;GABRA3;PLP1;RIC3;GLRA3;NRXN1;CACNA1B;CAMK1;PRKACB;MINK1;GABRA5;SNPH;GABRB2;CHRNA7;CHRFAM7A;GRIA1;GIPC1;HCRTR2;PRKAR1B;SYNJ2BP;GABRG2;SLC17A6;HTR4;MAPK1;CAMKK2;GRM5;CACNB2;GRM1;DLG4;SDCBP;TBC1D24;GRIN1;GABRG1;DTNA;CHRM3;SLC1A1;CPLX1;DVL1;SNAP25;HTR2A;LRP6;GRIA2;SYPL1;CACNB1;SYT10;NLGN1;APBA2
prerank,ribosome biogenesis (GO:0042254),-0.23448165281005368,-1.0,1.0,0.7600031936294925,1.0,89/187,26.80%,GLUL;RPL13;HEATR3;RPL37A;RPL38;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;NVL;RPS7;RPL18A;RPS6;RPL14;RPLP1;RPL9;RPL37;RPL8;RPS14;NAF1;NOL8;RPL10;RPL32;RPL18;SENP3;RPS28;RPL15;RPS24;RPS19;HEATR1;UTP20;KRR1;RPL27;RPL39;RPL24;RPL12;WDR75;EXOSC1;RPS27;RPL27A;RPS9;RPL30;DHX29;RPL19;EXOSC9;RRP1;RRP1B;METTL17;RPL28;RPL31;RBIS;MPHOSPH10;LAS1L;DKC1;DDX49;SNU13;RPL13A;RPL36A;RPL29;MDN1;RPLP2;LTO1;RIOK2;LSG1;RPLP0;LTV1;RPL10A;RPL35;NOB1;EMG1;NOLC1;SURF6;PIH1D1;EXOSC2;RAN;EBNA1BP2;TSC1;DDX54;RPL4;IMP3;BYSL;DDX47;BOP1;EXOSC3;RPS25;EXOSC5;POP5
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5275665236591259,0.9996519653281111,0.4646017699115044,1.0,1.0,5/10,16.00%,PSMC2;ATF7IP;HMGB1;PSMC6;TP53
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.44747975359776954,0.9991954500974708,0.5,1.0,1.0,12/49,15.66%,HMGB2;RBM15;CBFB;MOV10;NFE2;RAB7B;KMT2A;HDAC1;KMT2D;RUNX1;TNRC6C;CNOT4
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.5198581831169417,0.999049639336401,0.46021840873634945,1.0,1.0,1/10,2.45%,ADGRV1
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.2510871388337157,-0.9989766073919379,0.35185185185185186,0.7615513620100607,1.0,13/66,19.37%,STAT3;CARD16;IGF1;MALT1;TLR4;APP;CX3CL1;PANX1;LGALS9;TRIM16;GIT1;ZC3H12A;EGR1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5013907103276396,0.9987837705460602,0.47230320699708456,1.0,1.0,6/12,20.62%,LHPP;ADSL;PFAS;GART;PPAT;ADSS2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.49396253115656347,0.9987199721559255,0.44871794871794873,1.0,1.0,4/14,18.35%,WNK1;ADAM17;STK39;OXSR1
prerank,organonitrogen compound catabolic process (GO:1901565),-0.2502066321753694,-0.9984050841557334,0.43333333333333335,0.7618770320335888,1.0,20/57,23.57%,PLA2G4A;LNPEP;CLPX;RENBP;PNPLA8;TPP1;TXN2;SIAH1;ACE;MTOR;ENPEP;RIDA;PLA2G7;BCKDK;PPT1;NAGK;CLN5;SGPL1;PLA2G15;USE1
prerank,regulation of stem cell differentiation (GO:2000736),0.42393050828056084,0.998027166135965,0.49326424870466323,1.0,1.0,32/89,22.56%,CBFB;BMPR1A;PSMC2;PSMD5;PRKDC;PDGFRA;PSMB1;PSMD14;YAP1;PSMD1;KMT2A;YTHDF2;HNRNPU;TAL1;PSMB9;ITCH;PSMC6;GDNF;RUNX1;OCIAD1;METTL3;PSMB2;PUS7;PSME4;PSMB7;PSMD11;PSME3;EIF2AK2;LDB1;PSMD13;PSMB8;PSMD4
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.4035544114605255,-0.9979299121687055,0.46394984326018807,0.7619645389153565,1.0,7/11,30.45%,PARN;DKC1;TENT4B;EXOSC2;EXOSC3;EXOSC5;FBL
prerank,stabilization of membrane potential (GO:0030322),0.49176928872177306,0.997274838345971,0.45892351274787535,1.0,1.0,4/16,12.70%,KCNN4;KCNK2;KCNK12;KCNK6
prerank,regulation of cell motility (GO:2000145),0.41940902567767524,0.9972247553090289,0.5055837563451777,1.0,1.0,17/121,13.22%,KIF14;CCDC25;MACF1;ROCK2;RHOA;MEMO1;DIAPH1;ARHGAP18;NTN1;ENPP2;ROCK1;PLXNB2;PLXNB1;RAC1;TBCCD1;PLXND1;TWIST1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.3146996435113788,-0.9972050702849735,0.4375,0.7627231892342822,1.0,5/25,3.66%,MEF2C;GRIN2A;GRID2;GLRA1;GRIN2B
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4528872903526515,0.9967093565270272,0.49339735894357745,1.0,1.0,9/31,18.50%,E2F1;GSK3B;TFDP1;BOK;CASP8;TP53;PPP3R1;YWHAQ;BAD
prerank,positive regulation of T cell migration (GO:2000406),0.46747248725761364,0.996401090271638,0.4423076923076923,1.0,1.0,5/20,18.35%,RHOA;WNK1;ADAM17;STK39;OXSR1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.3819597012114745,-0.9963331446723837,0.4607142857142857,0.7638301022365492,1.0,10/11,61.83%,PKD2L1;PKD1L3;LPO;RTP4;RTP3;TAS1R2;GNAT3;GNAT2;PIGR;TAS1R3
prerank,cardiac myofibril assembly (GO:0055003),0.4887823920745741,0.995815060550856,0.4625668449197861,1.0,1.0,3/15,6.49%,OBSL1;MYLK3;PDGFRA
prerank,activation of GTPase activity (GO:0090630),0.42376620232346934,0.9957940062721472,0.4948453608247423,1.0,1.0,12/89,10.03%,ECT2;ARHGAP22;USP6NL;EVI5L;TBC1D25;TBC1D13;TBC1D2B;SCRIB;ARHGAP24;SYDE2;TBC1D7;RANGAP1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.5049797588184389,0.9957893142971808,0.4829059829059829,1.0,1.0,4/13,13.00%,ECHDC3;ERFE;ZBTB7B;GKAP1
prerank,regulation of developmental growth (GO:0048638),-0.2862356199089299,-0.995639198808997,0.4292929292929293,0.7644845571046622,1.0,8/29,11.36%,MBD5;APOE;INSR;IGF1;NRCAM;APP;ABL1;SIX1
prerank,negative regulation of cation channel activity (GO:2001258),-0.30163269844404994,-0.9953943023871653,0.41450777202072536,0.7640636837164076,1.0,5/26,7.78%,KCNAB1;CALM1;FKBP1A;EPHB2;GNB5
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.4677956529096229,0.9953284215188745,0.46503067484662575,1.0,1.0,5/26,13.71%,KNSTRN;GAREM1;PDPK1;SOX9;MED1
prerank,GTP metabolic process (GO:0046039),0.4869025043169262,0.9951256260940866,0.47801418439716314,1.0,1.0,5/15,15.78%,EFL1;LRRK2;RHOQ;GNAI3;MFN1
prerank,regulation of wound healing (GO:0061041),-0.2715776595258277,-0.9951181528972246,0.4262295081967213,0.7637594743911349,1.0,7/42,5.88%,PTK2;OCLN;CAV1;VTN;EPHB2;MYLK;FGF2
prerank,neuron cell-cell adhesion (GO:0007158),-0.37066938216125295,-0.9950953433131112,0.4600760456273764,0.762786913906381,1.0,4/14,7.21%,ASTN2;NRXN3;NCAM2;NRXN1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.4963631777812955,0.9948197901843085,0.44367176634214184,1.0,1.0,4/13,12.64%,BMPR1A;BMP6;TGFBR1;SMAD4
prerank,inorganic anion transport (GO:0015698),0.4290121265923045,0.9947826929187049,0.4760348583877996,1.0,1.0,8/53,13.24%,RACGAP1;ANO9;ENPP3;ENPP1;CLCN1;CLIC4;CLIC1;SLC25A30
prerank,B cell proliferation (GO:0042100),-0.34076643897966574,-0.9945708542393994,0.432,0.7631419871346165,1.0,7/17,32.60%,MEF2C;HSPD1;BCL2;CD180;PTPRC;CD40;CR2
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.4146401347717466,0.9945177414519636,0.5145728643216081,1.0,1.0,35/166,15.16%,NR2E3;E2F2;NAT14;MED26;TEAD1;E2F3;POLR1A;TAF3;TBL1XR1;POLR1B;ERCC3;TAF12;POLR2A;WWTR1;NR2C2AP;YAP1;TAF1D;TEAD3;NR3C1;NR4A2;TAF15;HDAC1;GTF2A1;TAF4;RORA;RBPJ;NR4A1;NOTCH2;POLR1G;MAML1;RARB;MED1;NRBP1;TFB1M;MED27
prerank,ncRNA metabolic process (GO:0034660),0.45011924518470087,0.9944204300348926,0.4953161592505855,1.0,1.0,6/37,8.21%,DGCR8;AGO2;MAPT;MAEL;EXD1;TUT7
prerank,positive regulation of transport (GO:0051050),0.42360914451025783,0.9940962681199078,0.518324607329843,1.0,1.0,10/85,11.23%,SPAG5;PON1;GSK3B;ANXA2;NUMA1;FMR1;KMT2A;CAMK1D;BOK;ANXA1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.5032606419522013,0.9937035596953724,0.4692202462380301,1.0,1.0,5/14,17.54%,ATP2B4;PKIG;ADRB2;PRKAR2B;PRKAR2A
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4409841778540058,0.9935497148581035,0.4955456570155902,1.0,1.0,16/50,19.16%,AQP1;CDKN2D;FNIP1;BCL2L12;SIAH2;ARL6IP1;SH3RF1;PLAUR;USP47;XIAP;CD44;SRC;NGF;LAMTOR5;DPEP1;DNAJB6
prerank,axon development (GO:0061564),-0.2399963706519673,-0.9931914895767003,0.4666666666666667,0.7655304459744046,1.0,21/78,13.99%,GRM7;DCC;PAK3;ACTB;S100A6;CAMSAP2;KLF7;NRCAM;MAP1B;TAOK2;BRSK1;GAP43;EPHB2;PLP1;MAP1A;CTNNA2;APP;RTN4RL1;SLITRK1;NTNG1;NREP
prerank,amide transport (GO:0042886),-0.30623409053760275,-0.9930656719323012,0.4467005076142132,0.7648443998596264,1.0,10/26,19.60%,CERT1;PLTP;SLC27A1;ABCG2;SLC5A6;GLTP;AQP11;SLC38A5;TAP2;DISP1
prerank,regulation of fat cell differentiation (GO:0045598),0.4261529226015859,0.9927412715205841,0.4957627118644068,1.0,1.0,24/74,19.67%,E2F1;FTO;ASXL1;ANKRD26;SFRP2;WWTR1;YAP1;TMEM64;RUNX1T1;ENPP1;BMP2;RORA;TRPM4;LRP5;SMAD3;WDFY2;MEDAG;LPL;SFRP1;AAMDC;FRZB;ZFPM2;SYAP1;ZFPM1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4988738792642514,0.9925807888648289,0.47307132459970885,1.0,1.0,3/11,6.22%,AGO2;NECAB1;SOAT1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.49787589255714587,0.9920847100375103,0.46695402298850575,1.0,1.0,5/14,18.35%,ZEB1;XDH;SPRED1;SPRED2;OSR1
prerank,sensory perception of chemical stimulus (GO:0007606),-0.3573020092171252,-0.9920313646866404,0.47962382445141066,0.7664438417670103,1.0,6/15,21.95%,GNAL;BBS4;ADCY3;SYT10;SLC24A4;DRD2
prerank,regulation of cellular protein metabolic process (GO:0032268),0.4451484877865546,0.9917766693560356,0.4923580786026201,1.0,1.0,4/47,9.66%,UHRF1;EIF4E;FOXO3;AGT
prerank,megakaryocyte differentiation (GO:0030219),0.514611210730115,0.9917737602473021,0.46889226100151743,1.0,1.0,4/11,19.67%,KIT;TAL1;MED1;ZFPM1
prerank,positive regulation of binding (GO:0051099),0.4207156926151136,0.9915922820286983,0.5191313340227508,1.0,1.0,15/84,11.48%,PON1;HMGB2;DDX11;STMN1;GSK3B;ADD2;DHX9;STK3;TCF7L2;NMD3;TXN;LRRK2;HMGB1;PARP9;BMP2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4225662820680685,0.9915524323538961,0.5061855670103093,1.0,1.0,11/85,12.77%,KIF14;DENND4C;MFN2;KANK2;EPS8L1;MAPKAP1;MYO9B;ARHGEF18;CRKL;DENND1A;NOTCH2
prerank,steroid catabolic process (GO:0006706),-0.40801866611135423,-0.9909648178951169,0.4722222222222222,0.7679404485761899,1.0,4/10,35.20%,HSD17B11;YWHAH;SPP1;HSD11B1
prerank,cellular response to hexose stimulus (GO:0071331),-0.3108023643144394,-0.9907660874396078,0.42592592592592593,0.7674118735683835,1.0,7/23,17.25%,UNC13B;KCNB1;GAS6;PRKAA1;SOX4;ADCY8;XBP1
prerank,cellular response to sterol (GO:0036315),0.48509107372783383,0.9905848672827389,0.46453407510431155,1.0,1.0,5/13,20.99%,GRAMD1C;RORA;INSIG2;GRAMD1B;INSIG1
prerank,secondary palate development (GO:0062009),-0.3695297891757844,-0.9900479133554781,0.4602076124567474,0.7681625521010631,1.0,3/14,4.15%,LEF1;TGFBR2;TGFB2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.45904988138371217,0.9890932532069833,0.4850374064837905,1.0,1.0,9/25,19.83%,CEP97;EVI5L;ARHGAP24;YAP1;TBC1D7;ODF2L;LIMK2;PRKCD;PLXNB3
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.40347861522334616,-0.9888619539583903,0.4462025316455696,0.7699773469459187,1.0,2/10,8.04%,SLC44A1;HNMT
prerank,cAMP metabolic process (GO:0046058),-0.36464992600874413,-0.9887162259644517,0.47572815533980584,0.7693045403713957,1.0,7/13,28.95%,ADCY3;ADCY8;ADCY4;PDE4D;PTHLH;EPHA2;ADCY5
prerank,morphogenesis of an epithelium (GO:0002009),0.4614714934770642,0.9886312868965704,0.4718826405867971,1.0,1.0,5/25,12.75%,TIMELESS;FGFR2;KDM2B;TBX18;SOX9
prerank,anion transmembrane transport (GO:0098656),-0.24203260618225553,-0.9885902894144086,0.45614035087719296,0.7685788766639778,1.0,22/67,19.50%,SLC16A12;SLC1A2;SLC13A3;SLC7A2;SLC13A4;SLC25A13;SFXN2;SLC25A12;SLC7A5;SLC3A2;SLC27A1;SLC5A6;LRRC8B;LRRC8D;ABCC5;SLC25A4;SLC1A1;SLC35A2;SLC38A5;SLC25A11;SLC25A38;LRRC8A
prerank,actin filament bundle organization (GO:0061572),0.4475927958179084,0.9881877475526202,0.46871310507674147,1.0,1.0,13/33,22.60%,ADD2;RFLNA;CORO1B;EZR;DPYSL3;DMTN;BAIAP2L1;LCP1;ADD1;SHROOM2;SHROOM1;MYO1B;PLS1
prerank,sensory perception of taste (GO:0050909),-0.39536548594511356,-0.9881303708863317,0.4937106918238994,0.7685236406708789,1.0,8/10,56.10%,PKD2L1;PKD1L3;ASIC1;CD36;ASIC3;TAS1R1;TAS1R2;GNAT3
prerank,cardiocyte differentiation (GO:0035051),-0.40835354713652977,-0.9874454614896374,0.47181008902077154,0.769061231789193,1.0,6/10,26.13%,TGFB2;SIK1;KDM6B;CBY1;GATA6;MYOCD
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.4539564269478027,0.9874387541777924,0.48104265402843605,1.0,1.0,9/31,13.22%,TWIST2;CRIM1;SMAD6;TMEM64;LIMD1;TRPM4;SOX9;LRP5;TWIST1
prerank,regulation of steroid metabolic process (GO:0019218),-0.31519961665652574,-0.9873742394577525,0.41037735849056606,0.7682049691054739,1.0,7/23,17.05%,APOE;ASAH1;STUB1;ARV1;FMO5;DGKQ;EPHX2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.3246031938636594,-0.9865372632137153,0.48582995951417,0.7691379022940323,1.0,8/19,21.68%,EP300;CDIP1;HIPK2;MSH2;DYRK2;DDIT4;SNW1;BCL3
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.40501572442786526,-0.9864696056974865,0.4952681388012618,0.7682883213707101,1.0,5/10,17.85%,NEXMIF;RGCC;PPM1F;VEGFA;NOTCH4
prerank,regulation of establishment of planar polarity (GO:0090175),0.4220242682592969,0.9863872523006252,0.5088082901554404,1.0,1.0,15/88,11.54%,SAPCD2;VANGL1;RHOA;PSMC2;PSMD5;SPEF1;DAAM1;SMURF1;PSMB1;PSMD14;NPHP3;PSMD1;SMURF2;PSMB9;RAC1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.3955801535548704,-0.98596636866915,0.46788990825688076,0.7684800456529776,1.0,3/10,9.22%,RAP1A;CD34;TMEM100
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.3502665050982791,-0.9857996497707054,0.450199203187251,0.7679403641319292,1.0,4/17,9.05%,CPEB3;CPSF6;CCNT1;CPSF7
prerank,quinone biosynthetic process (GO:1901663),-0.36931313691542433,-0.9856312260886876,0.4666666666666667,0.7673367667502076,1.0,5/14,11.99%,COQ8B;COQ5;COQ10A;COQ3;PDSS2
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4252303609986318,0.9853457931599694,0.5163329820864068,1.0,1.0,27/70,22.56%,CBFB;PSMC2;PSMD5;PRKDC;PSMB1;PSMD14;YAP1;PSMD1;KMT2A;YTHDF2;TAL1;PSMB9;ITCH;PSMC6;RUNX1;METTL3;PSMB2;PUS7;PSME4;PSMB7;PSMD11;PSME3;EIF2AK2;LDB1;PSMD13;PSMB8;PSMD4
prerank,negative regulation of cellular component organization (GO:0051129),0.42248795925011545,0.9851568288114466,0.5252631578947369,1.0,1.0,12/74,11.84%,PON1;RTEL1;GSK3B;IAPP;BMP6;TMEFF2;RIOK3;DNM2;MTMR2;SNX33;TERF2;AIDA
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.3434882496236689,-0.9850567274526099,0.46387832699619774,0.7677157305886176,1.0,10/17,39.48%,RYR2;KCNQ1;NEDD4L;KCNJ8;PKP2;GPD1L;KCNE4;SCN3B;KCNH2;SCN5A
prerank,regulation of trophoblast cell migration (GO:1901163),0.4939548149959111,0.9849194214754129,0.4828060522696011,1.0,1.0,4/14,19.45%,AGO2;SMURF2;GJA1;SYDE1
prerank,extracellular matrix disassembly (GO:0022617),0.42816364865392237,0.9848223165616213,0.4955357142857143,1.0,1.0,10/53,16.74%,BMP1;SCUBE1;MMP14;ADAMTS5;TLL2;EXOC8;CD44;CAPG;LCP1;SH3PXD2B
prerank,long-chain fatty acid transport (GO:0015909),-0.28867297427322053,-0.9845003783842291,0.43023255813953487,0.7680307851204323,1.0,12/30,30.54%,APOE;ABCD4;SLC27A1;ACACB;ABCD2;PRKAG2;ACSL1;SLC27A4;MFSD2A;MID1IP1;FABP5;CPT1A
prerank,regulation of cilium assembly (GO:1902017),0.42630688138218203,0.9843706308456441,0.5075921908893709,1.0,1.0,14/62,12.57%,USP6NL;CEP97;IFT140;EVI5L;TBC1D13;TBC1D2B;YAP1;TBC1D7;TAPT1;SDCCAG8;ARHGAP35;CEP120;TBC1D19;ATG3
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.33759915534978024,-0.9843103783125186,0.46530612244897956,0.767485540965327,1.0,2/17,2.33%,ADIPOR2;CAV1
prerank,response to amino acid starvation (GO:1990928),-0.23109477672756235,-0.9837968684473319,0.5227272727272727,0.7677014632764335,1.0,21/72,15.63%,ATP6V0D1;MAPK8;ATP6V1E1;ATP6V0B;MIOS;SESN3;WDR59;MAP3K5;FAS;RNF152;GCN1;MAPK3;SZT2;MTOR;MAPK1;ATP6V0C;KPTN;CEBPB;ATP6V1H;DAPL1;RRAGC
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3354197245770274,-0.9834656206941734,0.4777327935222672,0.7674288946317823,1.0,4/17,10.84%,HSP90AB1;CALM1;PDGFRB;MTOR
prerank,metallo-sulfur cluster assembly (GO:0031163),0.4568775342322364,0.9834001188904041,0.48875,1.0,1.0,9/22,22.77%,FXN;NUBP2;CIAO3;MMS19;ISCA2;NUBP1;LYRM4;CIAO2A;NFS1
prerank,immunoglobulin mediated immune response (GO:0016064),-0.39745027765816354,-0.9833058105533063,0.486404833836858,0.7667837449669431,1.0,3/10,27.90%,CD81;CD74;FCER1G
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.40148064938503525,-0.9828401797438588,0.48732394366197185,0.7669483931304004,1.0,4/10,24.80%,CST3;TNFRSF1B;TNFRSF1A;FAP
prerank,ceramide transport (GO:0035627),-0.38950398381021845,-0.9825303574224077,0.4808259587020649,0.7666466545760642,1.0,4/12,12.66%,CERT1;PLTP;PSAP;GLTP
prerank,regulation of smoothened signaling pathway (GO:0008589),0.42629254835459324,0.982505480508102,0.48379888268156424,1.0,1.0,11/50,15.25%,GLI3;FGFR2;TXNDC15;WDR11;TUBD1;GAS1;FBXL17;TEDC1;RORA;BTRC;SFRP1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.43717300243724,0.9824943596983078,0.4851598173515982,1.0,1.0,11/37,15.80%,PLK1;UBE2K;S1PR2;CALM2;STOX1;TRIM6;DMTN;SPRED1;CAB39;RPTOR;SPRED2
prerank,membrane lipid biosynthetic process (GO:0046467),-0.25388134848404414,-0.9824227201878829,0.4625,0.7658914792506213,1.0,23/58,23.59%,CERT1;ELOVL7;SGMS2;HACD3;ACER2;PLPP3;HACD2;ALDH3A2;ACER3;HACD1;ST8SIA6;DEGS2;SPNS2;GBGT1;DEGS1;SCCPDH;ELOVL6;VAPB;CERS1;SPTSSA;SGPL1;ELOVL1;SPHK1
prerank,bone development (GO:0060348),0.4402646624876036,0.9822154995264206,0.4908256880733945,1.0,1.0,11/39,16.74%,CYP26B1;FGFR2;SULF2;SULF1;SLC10A7;P3H1;GJA1;LRP5;TP53;NOTUM;SH3PXD2B
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.289729189120882,-0.9820319716759046,0.4943181818181818,0.765792025740785,1.0,9/29,11.64%,RPS8;RPS21;NOL10;RPS14;KRI1;RPS19;HEATR1;UTP20;NGDN
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.3379358467515087,-0.9815847090817056,0.4828767123287671,0.7657838827971967,1.0,6/16,11.48%,CAMK2D;IGF1;AKAP6;TRPC3;MEF2A;PARP1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.26238088359601813,-0.981551082913674,0.5121951219512195,0.7648952427792438,1.0,10/40,11.12%,PTK2;NUB1;HIPK2;UFL1;GNA12;RPL23;RPS7;ARAF;UBQLN4;SGTA
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.49671397114565985,0.9812384869925521,0.4904109589041096,1.0,1.0,5/14,14.82%,SMPDL3A;ENPP3;ITPA;ENPP1;AK7
prerank,B cell mediated immunity (GO:0019724),-0.4024254691810483,-0.9812096811876346,0.48417721518987344,0.7647797413610453,1.0,3/10,27.90%,MSH2;CD74;FCER1G
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.47170835628861363,0.9810883637547048,0.4931506849315068,1.0,1.0,3/24,5.98%,CDKN2D;DDIAS;SFRP2
prerank,extracellular matrix assembly (GO:0085029),0.45897867668075754,0.9809163898923777,0.45806451612903226,1.0,1.0,5/23,10.28%,HAS3;LAMB1;QSOX1;FBLN5;HAS1
prerank,base conversion or substitution editing (GO:0016553),-0.3803385409575427,-0.9808407065352721,0.47678018575851394,0.7647021455154166,1.0,3/11,19.40%,ADAR;ADARB1;ADARB2
prerank,embryonic skeletal system development (GO:0048706),0.44088269704887856,0.9806784401337166,0.48333333333333334,1.0,1.0,12/35,20.11%,SULF2;HOXC4;PDGFRA;SULF1;HOXB3;DSCAML1;WNT9A;XYLT1;OSR1;HOXA3;DYNC2I1;COL1A1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.4254511217433638,0.9801344351537565,0.5307443365695793,1.0,1.0,8/59,14.80%,ACMSD;CYP39A1;ALDH1A2;NDUFAB1;ACACA;HOGA1;ELOVL4;LPL
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.38013664175364414,-0.9801173920960479,0.44904458598726116,0.7653715117706568,1.0,4/12,13.91%,STX4;ANO1;GPLD1;ADCY8
prerank,prostanoid biosynthetic process (GO:0046457),-0.3532803167083476,-0.9799287041145175,0.46153846153846156,0.7648763232954371,1.0,4/15,12.39%,PLA2G4A;PTGDS;PNPLA8;PTGS2
prerank,nerve growth factor signaling pathway (GO:0038180),-0.3989478540720033,-0.9798485639811466,0.5042016806722689,0.7640760968644752,1.0,2/10,9.40%,RAP1A;KIDINS220
prerank,regulation of blood coagulation (GO:0030193),-0.2904777645670309,-0.9796995493587047,0.42786069651741293,0.7634451892968702,1.0,6/27,5.91%,CAV1;APOE;VTN;THBD;EPHB2;CD34
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.47980328052914567,0.9792638018037982,0.47651933701657456,1.0,1.0,5/15,22.39%,NR3C1;HNRNPU;ANXA1;UBE2L3;ZFP36L1
prerank,inner mitochondrial membrane organization (GO:0007007),-0.24920863166999388,-0.978669695335378,0.48214285714285715,0.7647765380373055,1.0,24/47,30.37%,APOOL;MTX2;ATP5PF;ATP5F1A;GHITM;ATP5MF;ATP5MC3;ATP5PO;TOMM70;DNAJC11;ATP5PD;ATP5F1B;MTX3;ATP5F1D;ATP5F1E;ATP5MG;TIMM9;MICOS13;ATP5ME;HSPA9;TIMM13;TIMM8B;NDUFA13;ROMO1
prerank,organic acid transport (GO:0015849),-0.23190919036622862,-0.9786656232170935,0.5333333333333333,0.7638060915597116,1.0,26/94,23.01%,SLC6A6;SLC13A3;SLC7A2;SLCO1C1;SFXN5;SLCO2B1;GOT2;SLC3A2;ABCC4;SLC27A1;ABCG2;SLC22A6;ATP8B1;SLC5A6;SLC7A6;SLC16A1;LRRC8D;SLC38A5;STARD5;SLC25A11;SLC6A15;ACSL1;SLC27A4;SLC36A1;SLC7A14;MFSD2A
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.2996693834859701,-0.9785919417282526,0.4413145539906103,0.763024481364062,1.0,5/24,6.28%,RYR3;RYR2;ANXA6;FGF2;HTR2C
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.30927754369997307,-0.9783334538650376,0.4558139534883721,0.7625908250155804,1.0,2/23,0.30%,CAMK2D;CACNA2D1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.34366091330307247,-0.9782981334847661,0.48638132295719844,0.7617099786952584,1.0,6/17,21.19%,IGF1;VTN;PDGFRB;S100A11;CCN4;NRP1
prerank,regulation of immune effector process (GO:0002697),-0.2690025443859445,-0.9782866479164368,0.46564885496183206,0.76077240788977,1.0,17/41,40.03%,VTN;CD81;C4B;C1QB;C2;CR1L;C1QC;C1QA;CFHR2;PHB2;CR2;C1QBP;C3AR1;C3;SERPING1;FCGR2B;C7
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.3212883403147807,-0.9782435014997873,0.48727272727272725,0.7599070226490433,1.0,10/18,30.81%,PSEN1;APOE;NCSTN;LDLRAP1;PSEN2;NSG1;BACE1;PSENEN;ADAM10;CLN3
prerank,folic acid metabolic process (GO:0046655),0.46731856070896716,0.9773227877479974,0.47320261437908495,1.0,1.0,3/18,6.13%,MTHFD1L;MTHFR;SLC19A1
prerank,cellular component maintenance (GO:0043954),0.5003383644688485,0.9770925616037476,0.48857142857142855,1.0,1.0,3/12,9.29%,LNPK;PRNP;MTMR2
prerank,regulation of rRNA processing (GO:2000232),-0.3561191671750088,-0.9768112192075131,0.4797047970479705,0.762363832380848,1.0,11/16,38.77%,USP36;HEATR1;WDR75;KAT2B;BUD23;RIOK2;DIMT1;RIOK1;TRMT112;SIRT7;WDR43
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.4018583255741385,-0.9757464529669488,0.4878048780487805,0.7639811094892935,1.0,4/10,23.30%,PLA2G4A;PNPLA8;PLA2G7;PLA2G15
prerank,inositol phosphate metabolic process (GO:0043647),-0.2585744447839534,-0.9756181292612809,0.49504950495049505,0.7633278972656982,1.0,17/46,20.91%,INPP4B;CALM1;IPPK;PPIP5K2;PLCB3;FGF2;PLCG1;NUDT3;ITPKB;INPP5D;INPP1;PLCE1;SYNJ1;IMPA1;INPP4A;ITPKC;PLCH1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4508695796467893,0.9753541807731145,0.4793491864831039,1.0,1.0,4/22,10.96%,DDX11;SMARCA4;NOL11;EIF2AK3
prerank,cellular protein modification process (GO:0006464),0.4084528388311317,0.9753257091720938,0.617,1.0,1.0,241/982,19.87%,DTL;CCNF;NEK2;MELK;CDK1;PLK1;BIRC5;AURKB;TGM1;MATN3;NEK3;F5;PLK4;MATK;HUNK;MAST2;HASPIN;ILF3;UBE2S;PPM1G;MAP4K4;DYRK1A;PPM1D;LOXL2;STK17B;LOX;CDK14;TRIOBP;BMPR1A;AURKA;ROCK2;FEM1C;ASB15;MAP4K2;GSK3B;PSMC2;ZC3HAV1;GGCX;LARGE1;FBN1;PSMD5;STK10;OBSL1;NLK;LAMB1;CHEK2;FUT10;MYLK3;FBXL7;PRKDC;SPSB3;LHPP;ST8SIA2;CTBP1;B3GNT8;DYRK3;TAB1;PPP2R3A;SPSB2;VRK2;SSH2;STK24;STK3;SETD3;NRK;MAP3K1;CCNE1;RBBP7;FBXW7;FBXO30;WNK1;MAP3K20;ATG7;ELOC;CDC25B;CUL5;CHEK1;CDC42BPA;ST3GAL3;PHKA2;PPP3CA;CCN1;QSOX1;FBXL8;KLHL5;B4GALT7;CDK2;PORCN;LRRK2;PSMB1;FN3K;SUMF2;CUL3;PSMD14;GRK5;KLHL22;DUSP12;CUL4B;MTMR2;DCAF10;VHL;ROCK1;PIM1;PSMD1;RPN2;SKP2;MARK2;RAB1A;ST3GAL5;PXK;WSB2;PPP2R5C;TGFBR1;UST;CDC42BPG;PARP9;PTPN21;EIF2AK3;PSMB9;SRPK1;PIGU;ANXA1;LMTK3;PTPRS;PRKCB;BMP2;STT3A;PRKCA;APLP2;FBXW11;CHM;P3H1;PDPK1;NAGPA;SEPHS1;GRK3;CSNK1G2;AAK1;ATG3;PPP1CC;STT3B;DCAF7;SIK2;MEX3B;STRADA;COPS3;BTK;PRKCE;CDK19;MAML1;PRKCI;BTRC;PLK2;PRKD1;ARF4;FBXO27;MORC3;MIA3;NRBP1;PSMC6;PIGT;ST3GAL4;ST3GAL1;MACROD2;PTPN13;TAOK1;STK11;BIRC6;PTPRA;VRK1;CDK8;MTMR3;UBL5;FBXO17;PTPRU;CKAP4;PRKD2;ST3GAL2;PRKAG1;PLOD2;STK39;PASK;PRSS23;DAPP1;ASB2;FBXW10;PPP2R5B;FBXL14;PTEN;HIPK3;NOTUM;PPP2R1B;UBLCP1;NTAQ1;GLRX;B3GALT2;PTPRK;GOLM1;RAB13;CSNK1A1;PTPRE;CDKL4;METAP1;WNK3;SRPK2;PSMB2;PLAT;MAST1;PKN2;LTBP1;OXSR1;FNTB;LIMK2;IGFBP3;PSME4;FBXO4;PSMB7;BRAF;HIPK1;OGFOD1;ASB3;CLK3;DUSP7;STRADB;CAND1;PPM1A;PTPN1;PARP14;YES1;PRKCD;TESK2;DCAF8;DAPK1;UGCG;TYK2;RAB3A;PSMD11;TRIB1;PTPN5;PRKAB1;UBE2D3
prerank,T cell activation (GO:0042110),0.4176910205028764,0.9744054159372525,0.517799352750809,1.0,1.0,15/69,16.04%,ADA;KIT;LEPR;PTPN2;SCRIB;PPP3CA;RAB29;CTPS1;NCK1;NCK2;LMBR1L;CASP8;CD44;LCP1;MSN
prerank,regulation of viral entry into host cell (GO:0046596),0.4412594048942122,0.974367156700882,0.49879227053140096,1.0,1.0,1/30,0.69%,TRIML2
prerank,regulation of organelle organization (GO:0033043),0.4152971973801632,0.9741506347070045,0.5213319458896982,1.0,1.0,21/80,16.04%,RAB33B;USP6NL;MIEF2;TBC1D25;SPEF1;DIAPH1;MAPT;RHOT1;ARMH3;ARL6IP1;MARK2;PLXNB1;STX18;AKAP9;EZR;STOX1;CENPV;CLIC4;TAOK1;CLEC16A;MSN
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.4933901822030733,0.9740898056187168,0.49127906976744184,1.0,1.0,5/12,20.13%,GSS;GCLM;BDH2;GCLC;HAGH
prerank,response to axon injury (GO:0048678),-0.3222629481399284,-0.9740506328979274,0.4921875,0.7660553436109622,1.0,10/18,29.34%,APOD;GAP43;RTN4RL1;NREP;P2RX4;MTR;FLRT3;MORN4;P2RY12;SARM1
prerank,regulation of stress fiber assembly (GO:0051492),0.4199559723171702,0.973838093853144,0.5067920585161965,1.0,1.0,23/74,17.91%,STMN1;ARHGAP28;ROCK2;RHOA;CGNL1;LPAR1;SORBS3;TMEFF2;ALMS1;ROCK1;ARHGAP6;TGFBR1;ARHGEF18;RAC1;WASF2;ARHGEF10L;SFRP1;NF2;RHOC;FHOD1;CCN2;CD47;CLASP1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.3591781247333268,-0.97358380424868,0.4850498338870432,0.766224794976231,1.0,7/13,36.67%,PIK3R4;IRAK4;UNC93B1;PIK3AP1;EPG5;TNIP2;MYD88
prerank,actin filament-based transport (GO:0099515),0.46075516884164514,0.973417960627726,0.504424778761062,1.0,1.0,3/21,5.87%,SYNE2;ACTN4;MYO1C
prerank,regulation of translational initiation (GO:0006446),0.42162034615698024,0.9733250645774313,0.5063559322033898,1.0,1.0,18/63,17.74%,CTIF;AGO2;KHDRBS1;EIF4H;TPR;FMR1;LARP1;NCK1;CDC123;YTHDF2;EIF2AK3;NCK2;RBM4;PPP1R15B;EIF4A2;DDX1;EIF3H;PAIP2B
prerank,regulation of water loss via skin (GO:0033561),0.4840701819063449,0.9729241273696786,0.4931693989071038,1.0,1.0,1/15,1.86%,STMN1
prerank,establishment of skin barrier (GO:0061436),0.4840701819063449,0.9729241273696786,0.4931693989071038,1.0,1.0,1/15,1.86%,STMN1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.5057391800430188,0.9723159682535375,0.48480463096960924,1.0,1.0,3/11,13.70%,ARRB1;GRK3;ADRB2
prerank,protein tetramerization (GO:0051262),0.4138313897377194,0.9717137126612932,0.5194123819517313,1.0,1.0,11/67,12.45%,TK1;UPB1;ALDH1A2;HPRT1;TRPA1;USP16;APIP;TRPM2;ACACA;APPL2;TRPM4
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.42767779735950306,0.9712794621430011,0.4983127109111361,1.0,1.0,12/43,13.86%,FBXO5;BMPR1A;BMP6;NPNT;CCN1;WWTR1;YAP1;DDR2;BMP2;ZHX3;LRP5;PRKD1
prerank,positive regulation of cholesterol transport (GO:0032376),0.4585076537317283,0.9712335808695778,0.5152625152625152,1.0,1.0,2/27,4.62%,PON1;ABCB4
prerank,purine nucleotide metabolic process (GO:0006163),0.44661999510702743,0.9711643245432232,0.48214285714285715,1.0,1.0,12/24,23.98%,HPRT1;XDH;GUK1;ITPA;PRPS1L1;PRPS1;ADSL;GART;PPAT;PNP;NT5E;GDA
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4344283693657386,0.9711419989600009,0.5099183197199533,1.0,1.0,15/38,21.07%,SAE1;LEPROT;FBXW7;RNF31;SH3GLB1;LRRK2;HTRA2;CSNK2A2;ATP5IF1;NPEPPS;UBL5;SIAH3;SREBF1;UBE2D3;UBE2L3
prerank,positive regulation of glycolytic process (GO:0045821),-0.31343582286863103,-0.9705249911989036,0.44495412844036697,0.7716582310536249,1.0,6/20,10.99%,PSEN1;INSR;IGF1;PFKFB3;PRKAA1;APP
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.31343582286863103,-0.9705249911989036,0.44495412844036697,0.7716582310536249,1.0,6/20,10.99%,PSEN1;INSR;IGF1;PFKFB3;PRKAA1;APP
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.3784165778627721,-0.9703682604289046,0.4782608695652174,0.7711095860684034,1.0,4/12,6.87%,HSP90AB1;B4GALT5;EPHB2;B4GALT6
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.41313169559425106,0.9696491819258913,0.5052742616033755,1.0,1.0,1/69,0.13%,KIF14
prerank,cellular response to drug (GO:0035690),-0.2902739199184599,-0.9691024527099152,0.5168539325842697,0.7730358877922163,1.0,7/25,20.52%,MEF2C;GAS6;ACER2;GPLD1;PPM1F;KCNQ1;CERS1
prerank,protein targeting to lysosome (GO:0006622),0.4616932791825,0.9690821633324183,0.49477806788511747,1.0,1.0,4/20,12.29%,AP4M1;NEDD4;ZFYVE16;NAGPA
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.45282120666177195,0.9686508756126856,0.5012562814070352,1.0,1.0,7/23,18.50%,E2F1;TFDP1;CASP8;TP53;PPP3R1;YWHAQ;BAD
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.45282120666177195,0.9686508756126856,0.5012562814070352,1.0,1.0,7/23,18.50%,E2F1;TFDP1;CASP8;TP53;PPP3R1;YWHAQ;BAD
prerank,regulation of dendrite development (GO:0050773),-0.2662163030490302,-0.9683033508021165,0.49624060150375937,0.7739687352033605,1.0,12/37,14.85%,HECW1;DCC;CDKL5;TNIK;CAMSAP2;SEMA4D;VLDLR;NSMF;ADGRB3;RTN4IP1;LRP8;CSMD3
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.488388682866067,0.9682352353936042,0.5171467764060357,1.0,1.0,5/13,17.44%,DHX9;AGPAT2;AGPAT1;AXL;MAVS
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.30954709777881706,-0.9681135676246545,0.4716981132075472,0.7734644303508211,1.0,8/24,20.02%,NBL1;ANO6;LYN;LGMN;SLIT2;DUSP1;PLA2G7;CREB3
prerank,glucose transmembrane transport (GO:1904659),-0.3248347805529813,-0.9681019647609304,0.4728682170542636,0.7725102157993962,1.0,6/18,32.57%,SLC2A1;SLC2A3;SLC2A10;SLC2A9;SLC5A3;SLC45A1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4178974489195357,0.9678786976025079,0.5184782608695652,1.0,1.0,8/56,12.64%,TTK;BMPR1A;BMP6;PMEPA1;SMAD6;TGFBR1;BMP2;SMAD4
prerank,sulfur compound transport (GO:0072348),0.4471282608571483,0.9677807700542103,0.5,1.0,1.0,1/27,0.74%,RACGAP1
prerank,response to iron ion (GO:0010039),0.49418652119920914,0.9676741685364446,0.4957983193277311,1.0,1.0,5/12,22.24%,FXN;BMP6;ACO1;SNCA;SLC11A2
prerank,tRNA processing (GO:0008033),-0.23965861148209702,-0.9675931353800203,0.5072463768115942,0.7727964914984293,1.0,28/61,29.38%,TRMT9B;ANKRD16;DTWD2;CSTF2;AARS1;NSUN2;RTRAF;SARS1;CDKAL1;QTRT2;TRMT10B;TRMT1;TRUB1;TSEN15;METTL1;KARS1;PUS3;QTRT1;THUMPD1;TRMT10A;RTCB;LCMT2;WDR4;DTWD1;POP5;ELAC2;CLP1;PTCD1
prerank,positive regulation of lipid localization (GO:1905954),-0.3914900492531478,-0.9668012834668053,0.4884488448844885,0.7737142585443906,1.0,3/11,8.25%,LRP1;IKBKE;VSTM2A
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.43973170231345526,0.9666900965873569,0.4934445768772348,1.0,1.0,10/31,20.00%,FGFR2;HOXC4;PDGFRA;HOXB3;DSCAML1;TGFBR1;TWIST1;OSR1;HOXA3;DYNC2I1
prerank,regulation of small molecule metabolic process (GO:0062012),-0.28701069960322445,-0.9665233387760693,0.4946808510638298,0.7734097064932346,1.0,8/28,18.07%,PRKN;APOE;PDK1;ARV1;FMO5;DGKQ;EPHX2;BCKDK
prerank,T cell homeostasis (GO:0043029),0.5091177434564871,0.9658281038056299,0.4924924924924925,1.0,1.0,1/10,2.16%,FADD
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.35303973345433814,-0.9657485621602733,0.4673202614379085,0.7743286956968412,1.0,4/13,9.52%,NR3C2;AR;ESR1;ABHD2
prerank,N-glycan processing (GO:0006491),-0.3216801859087427,-0.9656503797509945,0.49382716049382713,0.7735907181610628,1.0,12/18,27.71%,ST8SIA4;MAN2A1;ST8SIA1;ST8SIA6;MAN1A2;MGAT4B;PRKCSH;GNPTAB;GANC;ST8SIA5;ST8SIA3;MAN2A2
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3524889739372587,-0.9654299821990691,0.5036496350364964,0.7732064244751933,1.0,7/15,20.36%,LEF1;EP300;CCNT1;JUN;RRP1B;TAF11;SNW1
prerank,negative regulation of RNA splicing (GO:0033119),0.4651553993433492,0.9651496731365783,0.4946949602122016,1.0,1.0,6/19,17.65%,SRSF4;SRSF10;SRSF7;SAP18;PTBP2;SFSWAP
prerank,limb morphogenesis (GO:0035108),0.4701756778872618,0.9651026268063181,0.5071895424836601,1.0,1.0,3/20,7.45%,GLI3;CYP26B1;NIPBL
prerank,regulation of myoblast fusion (GO:1901739),0.49176649956487617,0.9640556133084561,0.5087209302325582,1.0,1.0,4/11,24.16%,RIPOR2;EHD1;MAPK14;EHD2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.4117953520677638,0.9639760882963674,0.5421436004162331,1.0,1.0,29/84,19.92%,RBM15;SRSF4;TRA2B;RBFOX2;KHDRBS1;HNRNPA1;SRSF10;THRAP3;MBNL3;RBM25;FMR1;SRSF7;SAP18;CELF2;SRSF3;HNRNPU;HNRNPL;RBM15B;SRPK1;RBM4;DAZAP1;FXR1;NUP98;SFSWAP;SRPK2;CWC22;LARP7;KHDRBS3;TRA2A
prerank,positive regulation of locomotion (GO:0040017),-0.29836386149958066,-0.9638131395452939,0.4972375690607735,0.7759879143786723,1.0,6/27,5.41%,SPOCK2;STX4;PDGFRB;AKT2;CFAP20;STX3
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.2876088016671344,-0.9637104816553937,0.47058823529411764,0.7752548793161492,1.0,4/29,5.18%,STAT3;IFNAR1;STAT6;SOCS2
prerank,cardiac ventricle development (GO:0003231),0.455750450248887,0.9632954652156044,0.5033288948069241,1.0,1.0,6/20,16.45%,MDM4;MATR3;HEY2;TMEM65;HECTD1;SALL1
prerank,histone H3 acetylation (GO:0043966),0.42731024352848807,0.963131652050779,0.5207166853303471,1.0,1.0,14/40,19.07%,BRCA2;SGF29;TAF12;ING4;TADA1;TADA2A;JADE1;YEATS2;PER1;DR1;KAT6A;TAF10;NAA60;JADE3
prerank,organic anion transport (GO:0015711),0.4087342790235612,0.9631201205541441,0.5415352260778128,1.0,1.0,15/76,17.86%,RHAG;AQP1;SLCO4A1;SLC19A1;SLC16A2;SLC4A2;CYB5RL;SLC39A8;SLCO3A1;CA2;CYB5R1;SLC25A42;LRRC8C;SLC25A17;SLC25A19
prerank,membrane lipid catabolic process (GO:0046466),0.5036741701410625,0.9628581798400517,0.48847926267281105,1.0,1.0,5/10,21.21%,ENPP2;SMPD2;NAGA;PDXDC1;SMPDL3B
prerank,response to nitric oxide (GO:0071731),0.4825577779707335,0.9628507336681914,0.5065312046444121,1.0,1.0,3/13,8.02%,AQP1;TXN;CDK2
prerank,negative regulation of multicellular organismal process (GO:0051241),0.4052596744657816,0.9628044150854791,0.579,1.0,1.0,40/199,16.13%,PON1;BRCA2;ATP2B4;SFMBT1;LOXL2;RB1;ROCK2;USF3;GSK3B;SRF;MCC;NFIB;SFRP2;CHSY1;HOXA7;GRHL2;EFNA1;ADAMTS5;SMAD6;ALDH1A1;ROBO1;ROCK1;NPR3;ATP2B1;TBX18;BMP2;NKX2-1;RBPJ;ADAM17;GJA1;SOX9;ADIPOR1;SPRED1;HEY2;DOCK7;STK11;SFRP1;TLE3;SPRED2;PTEN
prerank,phospholipid metabolic process (GO:0006644),-0.22160114622681595,-0.9627663263923203,0.5084745762711864,0.7765164282984597,1.0,20/71,23.64%,PLA2G4A;PLPPR1;PIP4K2A;PLAAT3;ABHD12;PIP4K2B;PLPP3;GPX4;AGPAT5;PCYT2;PIP5K1A;TNFAIP8L3;ACP6;PIP4P1;PLBD2;PLPPR4;AGPAT4;ABCA2;PLA2G15;PGP
prerank,response to cholesterol (GO:0070723),0.46652663176163056,0.9622558446216649,0.474034620505992,1.0,1.0,3/17,10.37%,GRAMD1C;PMVK;TGFBR1
prerank,ether lipid metabolic process (GO:0046485),0.4821624443368205,0.9622235706731862,0.5041322314049587,1.0,1.0,4/14,11.94%,AGMO;AGPS;PEDS1;TMEM86B
prerank,regulation of epidermal cell differentiation (GO:0045604),0.4556620159534278,0.9621989945729671,0.496790757381258,1.0,1.0,4/21,10.20%,CBFB;ROCK2;ROCK1;ERRFI1
prerank,negative regulation of apoptotic process (GO:0043066),0.4036253004976814,0.9621264080592293,0.614,1.0,1.0,70/444,15.53%,KIF14;STIL;CDK1;PLK1;BIRC5;BARD1;FIGNL1;AQP1;CDKN2D;MAP4K4;RB1;SETX;PHIP;ARHGAP10;FNIP1;ANGPT4;GSK3B;FXN;DDRGK1;FHL2;PRKDC;SIAH2;MRE11;PDPN;ANXA5;KDM2B;SMAD6;ARL6IP1;GRK5;SH3RF1;YAP1;MGMT;ANGPT1;VHL;CSNK2A2;PIM1;ERC1;APIP;NR4A2;SFPQ;HDAC1;ANXA1;CNTF;PRKCA;TXNDC5;ITCH;SOX9;NOTCH2;HDAC2;ATF5;IL31RA;CTSH;PLAUR;USP47;PRKCI;MED1;PLK2;ARF4;XIAP;ITGA5;ITGB1;CD44;BIRC6;QARS1;SLC30A10;SFRP1;SRC;GDNF;TNFAIP8;NFKB1
prerank,negative regulation of synaptic transmission (GO:0050805),0.4443943480915482,0.9620426369296112,0.49806451612903224,1.0,1.0,9/23,19.89%,LRRK2;GRIK3;MTMR2;ACHE;PLK2;PTEN;STXBP1;SHANK2;ARF1
prerank,regulation of leukocyte migration (GO:0002685),0.46583493597183917,0.9619114024978757,0.4905405405405405,1.0,1.0,4/16,14.06%,HOXA7;ANXA1;RAC1;MIA3
prerank,mRNA 3'-end processing (GO:0031124),0.40291873235187564,0.9617221990342277,0.549266247379455,1.0,1.0,19/78,12.87%,TENT2;SRSF4;CSTF3;FIP1L1;UPF3B;SLBP;LSM11;DDX39B;SRSF7;TUT1;WDR33;LEO1;PAPOLB;PCF11;SRSF3;SCAF8;SRRM1;CPSF4;RPRD1A
prerank,cellular response to osmotic stress (GO:0071470),0.4529741131921708,0.9617086245573198,0.4910025706940874,1.0,1.0,8/21,18.35%,AQP1;YBX3;CAB39;PKD2;STK39;WNK3;TRPV4;OXSR1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.43267202128042753,0.9616507950716232,0.5018050541516246,1.0,1.0,12/29,23.74%,FADD;WWOX;PML;HTRA2;AGT;SFRP1;PPP2R1B;TNFSF10;RIPK1;TRAF2;BID;BCL10
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.4034286786567354,0.9613341798934197,0.5451713395638629,1.0,1.0,20/84,15.68%,TYMS;ILF3;SYNCRIP;CNOT1;RTN3;PRNP;EIF4ENIF1;SAMD4A;CAPRIN1;FMR1;LARP1;ROCK1;EIF2AK3;MRPL13;RBM4;DHFR;EPRS1;PIN1;CNOT7;FXR1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4522294388895358,0.9610711915459176,0.4980289093298292,1.0,1.0,8/20,20.28%,RB1;DDRGK1;TRIM6;TWIST1;LAMTOR5;NIBAN2;GTF2B;TRAF6
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.3314412952924301,-0.9610221077199284,0.5086206896551724,0.7796102601937347,1.0,7/18,27.97%,CHRM2;AGRN;OPRM1;CHRM3;CDK5R1;RGS10;PLCB1
prerank,histone deubiquitination (GO:0016578),0.4607366905684677,0.9610061473187385,0.49525101763907736,1.0,1.0,6/18,16.33%,UIMC1;USP21;USP16;BRCC3;TRRAP;TAF10
prerank,regulation of Wnt signaling pathway (GO:0030111),0.40379396117802246,0.9607957670981145,0.5734840698869476,1.0,1.0,30/108,17.22%,CBFB;CDK14;MACF1;DEPDC1B;WWOX;FGFR2;TRABD2B;NLK;SULF2;TCF7L1;SFRP2;RNF43;HMGXB4;SULF1;LRRK2;SMARCA4;GNAQ;EMD;BMP2;RSPO3;BTRC;FOXL1;NKD1;SFRP1;RUNX1;NOTUM;SALL1;TMEM237;AMER1;FAM53B
prerank,ESCRT complex disassembly (GO:1904896),-0.4032318506363891,-0.9606368950183718,0.5148809523809523,0.7785382932339054,1.0,6/10,27.77%,VPS4B;CHMP2B;CHMP5;CHMP1A;CHMP2A;CHMP7
prerank,ESCRT III complex disassembly (GO:1904903),-0.4032318506363891,-0.9606368950183718,0.5148809523809523,0.7785382932339054,1.0,6/10,27.77%,VPS4B;CHMP2B;CHMP5;CHMP1A;CHMP2A;CHMP7
prerank,RNA metabolic process (GO:0016070),0.4072715957490291,0.9604215242128604,0.562753036437247,1.0,1.0,34/127,16.81%,SYNCRIP;SETX;PABPC4;TENT2;AGO2;HNRNPD;FTO;RBFOX2;RNASE6;DHX9;HNRNPA1;DDX39B;HNRNPH1;RBMS2;POLR2A;RNASEH2A;DHX8;CELF2;HNRNPUL1;PPP1R8;HNRNPU;HNRNPL;ATXN1;RNASE1;EXOSC7;HNRNPH2;RNGTT;RBMS1;RBM4;HNRNPA2B1;PNPT1;METTL3;NOL9;PRPF4
prerank,cellular response to glucose stimulus (GO:0071333),-0.2892485660851234,-0.9599015172877883,0.4797687861271676,0.7792462716022317,1.0,8/30,17.25%,UNC13B;KCNB1;GAS6;PRKAA1;SOX4;RAB11FIP2;ADCY8;XBP1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.2608988882494349,-0.9596161651855132,0.5333333333333333,0.778945366643172,1.0,7/39,7.55%,CAMK2D;FGF14;HECW1;WNK2;FGF13;NETO1;FXYD5
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.27072477924963423,-0.9594972970800769,0.5067567567567568,0.7782382022454996,1.0,7/33,12.24%,PTPRG;KRIT1;APOE;ACVRL1;SYNJ2BP;SLIT2;THBS1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.24856162765755316,-0.9594338261760439,0.5428571428571428,0.7774632702271199,1.0,14/43,20.04%,SH3KBP1;STAM2;DUSP3;EPN1;TSG101;SOCS5;TGFA;ZGPAT;GRB2;SPRY2;ARHGEF7;CBLB;CBL;HBEGF
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.4003605201597866,0.9592899957538823,0.5905905905905906,1.0,1.0,72/241,19.95%,RBM15;SYNCRIP;PPIL1;SNRNP25;SRSF4;HNRNPD;TRA2B;CSTF3;FIP1L1;DHX9;HNRNPA1;SRSF10;CCAR1;UPF3B;RAVER2;LSM3;DDX39B;PRPF40A;PSPC1;HNRNPH1;PRPF19;FUS;SRSF7;POLR2A;DHX8;HNRNPUL1;PRPF3;WDR33;NONO;SF3A2;PCF11;SRSF3;LSM2;HNRNPU;SFPQ;SNRNP48;HNRNPL;SRRM1;RBM15B;SNRNP35;CPSF4;HNRNPH2;SF3B3;LSM7;SNRNP27;RBM4;WBP4;PABPC1;AQR;UBL5;HNRNPA2B1;RBM19;ZCCHC8;PPWD1;LSM4;METTL3;RALY;RBM10;DHX38;PRPF4;GEMIN7;CWC25;BUD13;PDCD7;CWC22;CDC5L;POLR2B;DNAJC8;HNRNPR;SNRPB;TRA2A;SF3A3
prerank,response to unfolded protein (GO:0006986),-0.25270812690911754,-0.9592848292234697,0.5339805825242718,0.7768795667269706,1.0,12/48,18.08%,PRKN;HSP90AB1;DNAJA1;HSPH1;HSPD1;HSPA4L;DERL1;HSPA5;PACRG;DDIT3;TM7SF3;HSPB8
prerank,regulation of complement activation (GO:0030449),-0.26341363686512187,-0.9591669665965006,0.5531914893617021,0.7762321612102372,1.0,16/40,40.03%,VTN;CD81;C4B;C1QB;C2;CR1L;C1QC;C1QA;CFHR2;PHB2;CR2;C1QBP;C3AR1;C3;SERPING1;C7
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.3317085557597144,-0.9590572454921967,0.47843137254901963,0.7755212875888534,1.0,4/17,8.57%,TMSB4X;MAP2K5;KLF4;PTPN22
prerank,protein localization to cilium (GO:0061512),0.4374184152689562,0.9588965293872671,0.512280701754386,1.0,1.0,4/32,7.72%,BBS9;WDR35;IFT140;RAB29
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.5063458005838899,0.9587092113495964,0.5007363770250368,1.0,1.0,5/10,18.81%,ING4;FOXM1;TP53;TFAP4;SP100
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4291068340896032,0.9585618976189234,0.5173611111111112,1.0,1.0,9/32,17.55%,ACTR3;AUTS2;ENPP2;CORO1B;RAC1;WASF2;SRC;NCKAP1;ABI2
prerank,amino acid import across plasma membrane (GO:0089718),-0.29114693306640743,-0.958493290067182,0.518324607329843,0.7758768776653627,1.0,5/24,5.75%,SLC6A6;SLC1A2;SLC7A2;SLC7A5;SLC3A2
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.21298797241983047,-0.9581252113103376,0.5714285714285714,0.7757438471020327,1.0,22/112,16.03%,STAT3;PSEN1;IGF1;GAS6;TLR4;EPHB2;CD34;PTPN22;LBP;SELENOS;CHRNA7;APP;ARHGEF2;THBS1;SYT11;ARFGEF2;CX3CL1;TRIM27;PTPN11;IFNGR1;DICER1;IFIH1
prerank,positive regulation of cell junction assembly (GO:1901890),-0.24450289608311865,-0.9577633850460203,0.5125,0.7756592295089302,1.0,27/56,29.59%,PTPRD;TEK;SYNDIG1;CAV1;GRID2;CLDN5;EPHB2;IL1RAPL1;CNTNAP2;NRXN1;ABL1;PPM1F;VEGFA;LRRC4B;NLGN1;IL1RAP;NRP1;BDNF;TSC1;SRPX2;DLG5;EPHA2;THY1;ACE2;COL16A1;EPHB3;NPHP4
prerank,organelle fission (GO:0048285),-0.2908416126746655,-0.9574490003071281,0.5240641711229946,0.7755038172792575,1.0,4/24,7.25%,DNM3;PRKN;FIS1;DNM1
prerank,endoplasmic reticulum organization (GO:0007029),0.4020870792539517,0.9570663022177912,0.5359749739311783,1.0,1.0,21/72,19.56%,RAB10;RTN3;LNPK;PRNP;ATL2;ATL3;LRRK2;TRAM2;EMD;EIF2AK3;STX18;GAK;MIA3;TOR1B;VAPA;TMCC1;CYB5A;REEP2;TRAM1;CCDC47;DNM1L
prerank,carbohydrate biosynthetic process (GO:0016051),0.45026882383303707,0.956190239940851,0.5231958762886598,1.0,1.0,6/21,16.99%,B4GALT1;MPDU1;ST3GAL3;ST3GAL4;ST3GAL2;B3GALT2
prerank,myeloid dendritic cell activation (GO:0001773),-0.37202190745806835,-0.9561299037984297,0.5112540192926045,0.7776076151999352,1.0,2/12,6.12%,TGFBR2;CAMK4
prerank,regulation of cytoplasmic translation (GO:2000765),0.4761056892569848,0.9559974262876701,0.5084745762711864,1.0,1.0,4/14,9.19%,DHX9;FMR1;YBX3;CPEB2
prerank,organelle fusion (GO:0048284),0.4522188859992309,0.9555365918761779,0.499359795134443,1.0,1.0,9/22,21.09%,MIEF2;VPS18;MFN2;MIEF1;CHCHD3;MFN1;MIGA2;SPG7;EEA1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.4605604723106861,0.9554553992012347,0.49473684210526314,1.0,1.0,6/19,17.44%,CBFB;DHX9;ELF1;PARP9;RUNX1;MAVS
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3972909902447608,0.9549635138647901,0.5919597989949749,1.0,1.0,34/158,18.70%,ECT2;TRIML2;FADD;MAP3K14;TICAM1;MIER1;RHOA;LPAR1;UBE2N;RNF31;TNFRSF10B;MAP3K3;IKBKG;CXXC5;PRKCB;ROR1;TRIM6;GJA1;CASP8;BRD4;DDX21;PLK2;PRKD1;TRIM5;VAPA;RHOC;DDX1;MAVS;TNFSF10;LAMTOR5;PLEKHG5;TERF2IP;ANKRD17;RIPK1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4773393003780817,0.9542824941663519,0.5213204951856947,1.0,1.0,4/18,9.53%,ROCK2;EFNA1;EPHA4;PICALM
prerank,regulation of neuron projection arborization (GO:0150011),0.47880979273792673,0.9540850121801026,0.5105189340813464,1.0,1.0,3/15,11.33%,MACF1;MOV10;GRIP1
prerank,neuron differentiation (GO:0030182),0.4000545521760267,0.9538370997558195,0.5771543086172345,1.0,1.0,17/165,10.45%,EN1;PBX4;GLI2;ATOH8;PBX3;MYEF2;TDP2;WNT2B;SRF;ERCC3;WNK1;POU3F2;OLIG2;LMX1B;WNT6;TGFBR1;NR4A2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.40366031234810595,0.9535930553654312,0.5903614457831325,1.0,1.0,62/152,24.72%,MACF1;DEPDC1B;FGFR2;PSMC2;RNF220;PSMD5;SULF2;TBL1XR1;ADGRA2;SFRP2;WNK1;SULF1;UBR5;LRRK2;PSMB1;PSMD14;SMARCA4;AXIN2;LRRK1;PSMD1;SMURF2;PSMB9;BMP2;TRPM4;CSNK1G2;RSPO3;USP47;XIAP;PSMC6;PIN1;SFRP1;NFKB1;SALL1;AMER1;FAM53B;CSNK1G1;PSMB2;PSME4;PSMB7;ZEB2;CAPRIN2;TERT;PPM1A;SKI;PSMD11;LGR4;COL1A1;SEMA5A;PSME3;CSNK1E;ZRANB1;PSMD13;PSMB8;GPRC5B;PSMD4;DISC1;WLS;PSMF1;GPC3;AXIN1;PSMA5;TGFB1
prerank,regulation of sensory perception of pain (GO:0051930),0.4897840123148549,0.95333997813006,0.5195936139332366,1.0,1.0,2/11,11.43%,ATPSCKMT;CCN3
prerank,tRNA 5'-leader removal (GO:0001682),0.4811561684289821,0.9531499661325515,0.5246132208157525,1.0,1.0,5/13,19.87%,RPP40;POP1;RPP30;PRORP;RPP21
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.2876748494969972,-0.9529781763117742,0.47468354430379744,0.7839851588671416,1.0,5/28,8.96%,CYRIB;SH3KBP1;PRKCQ;HSPD1;XRCC6
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.45644707905700377,0.9528192018890428,0.4935400516795866,1.0,1.0,5/19,10.24%,XDH;MYO1C;JCAD;ROBO1;PIK3CB
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.28950362280802394,-0.9521056573199417,0.5304878048780488,0.7850623592388356,1.0,7/29,20.02%,JAM2;ANO6;GAS6;LGMN;PLA2G7;LGALS9;CREB3
prerank,receptor catabolic process (GO:0032801),-0.29778941093281885,-0.9520701604607154,0.4845360824742268,0.7841814250237706,1.0,10/24,15.62%,KIF16B;GPRASP1;BECN1;AP2A2;PIK3R4;LGMN;VLDLR;AP2M1;AP2S1;AP2A1
prerank,calcium ion homeostasis (GO:0055074),-0.22154221650204298,-0.9519706958978188,0.631578947368421,0.7834769756612432,1.0,21/95,16.91%,TMTC2;SLC8A3;ATP1B1;CAV1;RYR2;SLC24A2;DMPK;CDH5;HTR2C;TPT1;FAM20A;CHRNA7;SELENON;TMCO1;SLC30A1;ATP2B2;GRIN1;ATP2B3;RMDN3;HTR2A;PTH1R
prerank,activation of protein kinase B activity (GO:0032148),-0.27602146847546627,-0.9515241715372721,0.5316455696202531,0.7835703031381691,1.0,10/29,16.99%,INSR;IGF1;GAS6;RICTOR;NTRK3;FGF1;MTOR;PINK1;ITGB1BP1;ADRA2A
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.22046232314453434,-0.9515149721103556,1.0,0.7826550212459573,1.0,57/172,23.05%,PLA2G4A;PLD1;PIP4K2A;INPP4B;SLC44A1;CHPT1;DGKB;ETNK1;PIK3R3;ABHD5;PIP4K2B;CDS2;PIK3C2B;PIK3R1;FGF2;PIK3R4;PLD2;SLC27A1;AGPAT5;CHKA;RAB5A;DGKG;ETNK2;MTMR4;INPP5K;PCYT2;RUFY1;STARD7;LPCAT2;SELENOI;PIP5K1A;BMX;INPP5D;DGKQ;CHKB;SYNJ2;SLC44A5;CDS1;PIK3R6;SYNJ1;PI4KA;PIK3CD;IMPA1;PIK3CA;INPP4A;HDHD5;ACP6;LPIN1;DGKD;CDIPT;PLA2G12A;PIP4K2C;PIK3R2;GPAT3;AGPAT4;MFSD2A;PLEKHA8
prerank,outer dynein arm assembly (GO:0036158),0.47498783251080295,0.9515043620382715,0.5084269662921348,1.0,1.0,4/14,19.24%,DNAAF5;LRRC49;ODAD1;DNAH8
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.4995363818011126,0.9509330065764665,0.514792899408284,1.0,1.0,2/11,11.54%,STMN1;RAC1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.3398236916366236,-0.950932530648715,0.5185185185185185,0.7830965568519468,1.0,5/16,19.35%,APOD;PDCD4;CHID1;ABCD2;ZC3H12A
prerank,negative regulation of angiogenesis (GO:0016525),0.40566232842257954,0.9507558047428515,0.5451745379876797,1.0,1.0,12/84,10.24%,E2F2;ATP2B4;THBS2;ROCK2;ANGPT4;PDE3B;PML;SULF1;ADAMTS9;SERPINE1;ROCK1;PIK3CB
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.45692710309097145,0.9505542743053477,0.5,1.0,1.0,3/15,9.85%,FGFR4;PDPN;DDR2
prerank,regulation of cellular component size (GO:0032535),0.4371109235446774,0.9503379784026148,0.5171990171990172,1.0,1.0,11/30,17.52%,HP1BP3;VAV2;RAB22A;PICALM;RAC1;EZR;RPTOR;MSN;PTEN;LARS1;LAMTOR5
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.37643543656639256,-0.9502681881874475,0.5348101265822784,0.7836444404534328,1.0,8/11,49.89%,P2RX4;CDH13;TREM2;P2RX3;P2RX5;TRAT1;CCL4;NEUROD2
prerank,positive regulation of blood coagulation (GO:0030194),0.4612405838226765,0.9498859163562724,0.5156462585034014,1.0,1.0,4/17,14.41%,HPSE;SERPINE1;DMTN;ST3GAL4
prerank,vasodilation (GO:0042311),-0.35359688157142644,-0.9498550422817496,0.5279503105590062,0.783638087012022,1.0,5/13,25.75%,NOS3;SOD2;KLF2;NOS1;GPER1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.25175199223697653,-0.9497773487820774,0.504424778761062,0.7828899152936871,1.0,10/44,11.83%,ATP1B1;GABBR1;AKAP6;KCNJ3;ANO6;WNK2;KCNJ6;ATP1B3;KCNN2;KCNJ10
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.3951832612687112,-0.9488097011430112,0.5126582278481012,0.7842222966367556,1.0,4/10,19.28%,APOD;LRP1;NDRG4;PTPN12
prerank,muscle tissue development (GO:0060537),-0.35525635940866085,-0.9484579965394966,0.5226480836236934,0.7840754850904534,1.0,5/13,15.89%,PGM5;NF1;PTCH1;ENG;STRA6
prerank,regulation of glycolytic process (GO:0006110),0.41097797499917266,0.9483795752041903,0.5550802139037433,1.0,1.0,17/68,17.48%,NDC1;NUP155;NUP205;NUP160;PFKFB1;GCK;NUP85;TPR;ZBTB20;NUP214;RANBP2;ARNT;NUP133;PRKAG1;NUP42;NUP98;NUP210
prerank,protein deacetylation (GO:0006476),0.41724319491614176,0.9481605293487513,0.5307262569832403,1.0,1.0,9/41,12.79%,MIER1;TBL1XR1;MIDEAS;RCOR1;MSL3;MIER3;MTA3;HDAC1;HDAC2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.42776905549048216,0.9471759291078442,0.5190751445086705,1.0,1.0,7/35,10.36%,STMN1;ARHGAP24;MFN2;CUL3;RIPOR2;MAPKAP1;ARHGAP35
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.45726964127155023,0.9470346364933843,0.5013698630136987,1.0,1.0,7/16,23.75%,TRA2B;THRAP3;DAZAP1;NUP98;TRA2A;RBMX;NCL
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.23037307331673165,-0.9469106221879255,0.603448275862069,0.7865530725803782,1.0,21/69,21.43%,OGT;IGF1;PDGFRB;PIK3C2B;KCNH1;PLCB3;PIK3R1;IRS2;MYO16;NYAP2;NF1;IRS1;PLCE1;HTR2A;PI4KA;ERBB2;PIK3CD;PIK3CA;EXOC1;PLCH1;PIK3R2
prerank,positive regulation of heart rate (GO:0010460),-0.33382274631133985,-0.9465267114065165,0.5236220472440944,0.7863648592538437,1.0,10/17,32.32%,RYR2;TPM1;ADRA1A;PDE4D;KCNQ1;ADRA1B;EDN1;ADM;EDN3;SCN3B
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.4522226665618629,0.946061426341607,0.5032851511169514,1.0,1.0,5/18,15.24%,GSK3B;POLR1A;CTNNA1;ILRUN;OTUD7B
prerank,regulation of cell development (GO:0060284),0.41818522957143794,0.9459835485142778,0.5426267281105991,1.0,1.0,8/36,14.57%,HMGB2;BHLHE41;ADGRA2;YAP1;YTHDF2;NOTCH2;HEY2;DOCK7
prerank,regulation of cell growth (GO:0001558),0.3961724341746032,0.945779574077619,0.613682092555332,1.0,1.0,37/204,15.25%,KIF14;RAB33B;PSRC1;CDKN2D;CDKN2C;RB1;HYAL1;CEP43;MMP14;FXN;NET1;SFRP2;RBBP7;PML;DERL2;SMARCA4;KLHL22;CDA;AGT;TGFBR1;ENPP1;CRLF3;IP6K2;CCN3;NDRG3;ADAM17;GJA1;SMAD4;ITCH;USP47;JADE1;CDKN1B;SMAD3;STK11;RPTOR;INO80;SFRP1
prerank,mitochondrion transport along microtubule (GO:0047497),0.474852789826288,0.9455201462412368,0.5286532951289399,1.0,1.0,3/13,9.72%,MAPT;RHOT1;UXT
prerank,regulation of osteoblast differentiation (GO:0045667),0.40141128206862636,0.9453960386477922,0.5641821946169773,1.0,1.0,21/82,13.86%,FBXO5;BMPR1A;TWIST2;FGFR2;BMP6;NPNT;CCN1;CRIM1;WWTR1;SMAD6;YAP1;TMEM64;LIMD1;DDR2;BMP2;ZHX3;TRPM4;SOX9;LRP5;TWIST1;PRKD1
prerank,mammary gland development (GO:0030879),0.45201842122684377,0.9452373470448132,0.5445420326223338,1.0,1.0,3/21,10.36%,GLI2;ZBTB7B;ARHGAP35
prerank,regulation of lymphocyte migration (GO:2000401),0.499586423482822,0.9444342802399719,0.5258493353028065,1.0,1.0,3/10,16.04%,STK10;MIA3;MSN
prerank,potassium ion transmembrane transport (GO:0071805),-0.20888622745090696,-0.9444071513295806,0.5714285714285714,0.7902328069186029,1.0,23/135,12.55%,ATP1B1;KCNAB1;KCNC2;HCN1;KCNB1;KCNJ3;SLC24A2;KCNQ3;KCNK13;KCNH1;KCNK10;KCNJ6;ATP1A1;ATP1B3;KCNN2;KCNH7;KCNS3;ATP1A3;KCNJ10;SLC12A9;KCNA2;KCNA6;ATP1A2
prerank,regulation of gene expression (GO:0010468),0.39709576900137744,0.9441026631976449,0.734,1.0,1.0,172/903,16.04%,BRCA1;PHF19;EZH2;TCF19;TRIML2;MYBL1;ATRX;NSD2;ERMAP;TCFL5;RBL1;E2F1;BRCA2;ATOH8;ZC3H7A;MED26;ATP2B4;RB1;SP3;BMPR1A;MOV10;AURKA;TICAM1;ROCK2;FGFR4;CTCF;GSK3B;AGO2;LIN54;HNRNPD;TRA2B;DDRGK1;NLK;AJUBA;CHEK2;SETDB2;NFIA;UBAP2;NFIL3;TCF7L1;SRSF10;CCAR1;MAPT;XDH;AFF3;MUSK;SFRP2;MBNL3;BMP6;AFDN;YAF2;GZF1;SOX6;HP1BP3;GON4L;FBXW7;PML;PSPC1;HNRNPH1;MYBL2;YBX3;FUS;POLR2A;CIAO3;PRRX2;ZBTB7B;WWTR1;PHF1;MATR3;MYCBP;UBR5;CDK2;LARP1;LMX1B;BNC2;ZFP64;YAP1;ROBO1;MSL3;NONO;LIMD1;DNM2;ANGPT1;VHL;NFYA;ROCK1;PUM2;SLC24A3;SLC8A1;PICALM;WNT6;ZNHIT3;ERC1;PIK3CB;FLOT2;HINT1;TGFBR1;NR3C1;YTHDF2;PARP9;LIMS1;SFPQ;EIF2AK3;SLC39A8;RBMS3;HNRNPL;POFUT1;HDAC1;AHR;NCOA2;CRKL;CNTF;CPSF4;BMP2;ATXN1;NKX2-1;TERF2;EZR;RORA;ZUP1;SPTY2D1;STOX1;HNRNPH2;FUBP1;RBPJ;KMT2D;TRIM6;GJA1;CASP8;METTL4;C1QTNF1;TOB2;SOX9;NOTCH2;ATF5;CTSH;TWIST1;ADAM19;PTBP2;HEY2;MED1;LARP4;YY1;FOXK2;GPBP1L1;RC3H1;SMAD3;TRIM5;RAMP3;JMJD1C;SOX1;PER1;RBAK;PIN1;EFEMP1;SFRP1;PRDM8;CNOT7;GDNF;PRKAG1;ZC3H7B;RUNX1;NFKB1;TRRAP;ITGB8;ZNF507;TNRC6C;HOXB7;MLF2;DRAP1;TP53;MSN
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.4306883689296998,0.9438133534682618,0.5375722543352601,1.0,1.0,12/36,19.53%,FADD;UBE2K;CXCR4;AGPAT2;PARP9;ADAM17;TRIM6;AGPAT1;AXL;MAVS;RIPK1;PARP14
prerank,proteasomal protein catabolic process (GO:0010498),0.3913819383865268,0.943665514025413,0.6138415245737212,1.0,1.0,64/201,22.80%,KIF14;FEM1C;PSMC2;PSMD5;UBE2K;NEDD4;SPSB3;SIAH2;SPSB2;TBL1XR1;FAF1;ARRB1;FBXW7;PML;PRPF19;AGAP3;SMURF1;PSMB1;CUL3;PSMD14;KCTD2;KLHL22;CUL4B;PSMD1;SKP2;FBXL17;ARMC8;PPP2R5C;FBXO45;SMURF2;PSMB9;FBXW11;ITCH;SPOP;CRBN;BTRC;PSMC6;ZNRF1;RAD23B;SIAH3;UBXN2B;WWP1;PSMB2;PLAA;PSME4;HECTD3;PSMB7;CCDC47;PSMD11;ZSWIM8;UBE2D3;HECW2;PSME3;CLOCK;FEM1B;PCNP;SIRT2;PSMD13;GID4;BIRC2;PSMB8;RNF216;PSMD4;DDB1
prerank,endocytic recycling (GO:0032456),-0.2482505424310577,-0.9431565281383044,0.5865384615384616,0.7920824546086765,1.0,11/50,10.59%,VPS35L;MICALL1;VPS53;STX6;SNX4;ANKRD50;SNX3;EHD4;CCDC93;ENTR1;DENND1B
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.21972865430380453,-0.9425433776306819,0.68,0.7925013606929736,1.0,31/107,20.66%,SLC8A3;ATP1B1;SLC39A10;CAV1;RYR2;SLC39A13;SLC24A2;DMPK;CDH5;HTR2C;TPT1;CHRNA7;TMCO1;SLC39A7;SLC30A1;ATP2B2;ATP2B3;RMDN3;HTR2A;MT2A;PTH1R;VAPB;SLC24A4;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,positive regulation of developmental process (GO:0051094),0.39843206478709836,0.9425179915093814,0.6016016016016016,1.0,1.0,29/164,12.75%,CDC20;BMP1;FBXO5;PAXIP1;BMPR1A;MIEF2;AURKA;AGO2;ADGRL1;NUMA1;SRF;SOX6;FMR1;ENPP2;RIF1;MCU;CORO1B;VHL;TAPT1;MIEF1;DDHD1;SMURF2;GRIP1;BMP2;TRPM4;ZDHHC15;GJA1;KMT5C;SOX9
prerank,atrioventricular valve morphogenesis (GO:0003181),0.44730203530595564,0.9423437639755851,0.5141700404858299,1.0,1.0,7/19,13.69%,BMPR1A;MDM4;EFNA1;SMAD6;BMP2;SMAD4;HEY2
prerank,neuron projection development (GO:0031175),0.3968574035522884,0.9421099298916014,0.5997993981945837,1.0,1.0,39/168,17.45%,KIF20B;VASH2;STMN1;MAP4K4;ADGRV1;RB1;GSK3B;LAMB1;NEDD4;MAPT;NRK;EPHA4;LRRK2;ANKRD27;DNM2;MAP4;ROCK1;SVBP;HMGB1;MARK2;SAMD14;SRGAP2;EPB41L3;PLXNB1;MAPK8IP3;FRYL;EHD1;BLOC1S5;TAOK1;DOCK7;VAPA;GDNF;DBN1;HDGFL3;PTEN;NCKAP1;STMN2;NGF;RAB13
prerank,aspartate family amino acid catabolic process (GO:0009068),0.449368414063431,0.9420800530752134,0.5019354838709678,1.0,1.0,1/19,1.44%,SLC25A21
prerank,regulation of ruffle assembly (GO:1900027),-0.2990618950879823,-0.9420164495592841,0.5252525252525253,0.7927212901001237,1.0,12/23,32.11%,CAV1;FAM98A;PFN1;PLEKHM1;EPS8L2;NLGN1;P2RX4;ABI3;P2RY12;DEF8;EPS8;HRAS
prerank,negative regulation of transport (GO:0051051),-0.24129553764657952,-0.941886333382406,0.5333333333333333,0.7920987560835743,1.0,17/51,23.99%,PRKN;MCTP1;SNX3;CTTNBP2NL;NR1H3;CRYAB;SYT11;PPM1F;WWP2;SCAMP5;BST2;NR1H2;ITGB3;PACSIN3;RACK1;NDFIP1;ARL6IP5
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.429554367725186,0.9412916352176776,0.53437876960193,1.0,1.0,6/28,11.32%,MMP14;DLK1;ARRB1;FBXW7;YTHDF2;ARRDC1
prerank,chromatin remodeling (GO:0006338),0.3964175673592868,0.9406663298276564,0.5752302968270215,1.0,1.0,38/100,23.77%,ATRX;SMARCC1;BAZ1B;RB1;CHD1L;SMARCAD1;NUDT5;RBBP4;ARID1A;SRCAP;SMARCA4;HDAC1;SOX9;HDAC2;TADA2A;ACTL6B;KDM5C;BAZ1A;RUVBL2;INO80;DR1;SUV39H2;MBD3;ZBTB1;KDM4B;MBD2;ARID1B;NPM3;HDAC4;CHD4;CBX3;DAXX;MYSM1;KAT2A;SMARCC2;ACTL6A;CECR2;SMARCB1
prerank,regulation of muscle cell differentiation (GO:0051147),0.43065863066727583,0.9406490543359662,0.5266990291262136,1.0,1.0,5/31,6.12%,CDH15;FGFR2;SPAG9;SRF;CTNNA1
prerank,regulation of protein processing (GO:0070613),0.4350320174622202,0.9403734899100511,0.5187165775401069,1.0,1.0,4/21,15.47%,PRNP;LRRK2;GAS1;RUNX1
prerank,protein trimerization (GO:0070206),-0.3449452480154458,-0.9398216478172605,0.5306122448979592,0.7949602130068771,1.0,2/14,3.02%,SLC1A2;SCARA5
prerank,protein homotrimerization (GO:0070207),-0.3449452480154458,-0.9398216478172605,0.5306122448979592,0.7949602130068771,1.0,2/14,3.02%,SLC1A2;SCARA5
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.26935549517960666,-0.9397264376564631,0.553030303030303,0.7942275461137285,1.0,11/35,18.39%,SGIP1;VTN;BICD1;B2M;HNRNPK;SMAP1;BMP2K;HIP1;LDLRAP1;PPT1;CBL
prerank,regulation of JUN kinase activity (GO:0043506),-0.2742294980592311,-0.9396189822156176,0.58,0.7935615396301399,1.0,12/33,25.01%,PDCD4;MAP3K5;DNAJA1;PAK1;PTPN22;ARHGEF5;TNFRSF11A;PPEF2;MAP3K11;RPS3;EDN1;MAPK8IP1
prerank,protein deneddylation (GO:0000338),-0.37862165099120126,-0.9395821223095773,0.5364431486880467,0.7927066121011728,1.0,7/10,30.49%,COPS8;COPS7A;COPS2;COPS4;TOR1A;COPS6;GPS1
prerank,glucose homeostasis (GO:0042593),-0.22838535637270654,-0.9395640208583976,0.6190476190476191,0.7918192926467663,1.0,17/83,13.91%,MBD5;STAT3;FOXO1;ADIPOR2;INSR;KCNB1;KLF7;PIK3R1;RPS6;PRKAA1;CRY2;INPP5K;IRS1;SOX4;HK1;LRRC8D;ADCY8
prerank,Rac protein signal transduction (GO:0016601),-0.3212363040593002,-0.9394892927040589,0.5372549019607843,0.791075589727793,1.0,3/18,3.61%,ELMO1;TIAM1;HACD3
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.44622604667194365,0.9393909579925238,0.5233766233766234,1.0,1.0,8/20,20.46%,STOML2;MCU;MCUB;MICU1;PMPCA;MAIP1;SPG7;MICU2
prerank,neurotrophin signaling pathway (GO:0038179),-0.3074202044742202,-0.9393499902456884,0.5550847457627118,0.790466918316405,1.0,9/21,29.25%,NTRK2;RAP1A;KIDINS220;GRB2;DDIT4;BCAR1;BDNF;ZFYVE27;SOS1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.4828151006320566,0.9393241969949776,0.5321100917431193,1.0,1.0,1/11,1.68%,TERF1
prerank,regulation of interleukin-13 production (GO:0032656),-0.364268905800453,-0.9391808517817467,0.528052805280528,0.7899766657389603,1.0,4/13,17.81%,LEF1;TNFRSF21;PRKCZ;LGALS9
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.39156055626641234,0.938680290640869,0.64,1.0,1.0,77/264,19.95%,RBM15;COIL;SYNCRIP;PPIL1;SNRNP25;SRSF4;HNRNPD;TRA2B;CSTF3;FIP1L1;DHX9;HNRNPA1;SRSF10;CCAR1;UPF3B;RAVER2;LSM3;DDX39B;PRPF40A;PSPC1;HNRNPH1;PRPF19;FUS;SRSF7;POLR2A;DHX8;HNRNPUL1;PRPF3;WDR33;NONO;SF3A2;PCF11;SRSF3;LSM2;HNRNPU;SFPQ;SNRNP48;HNRNPL;SRRM1;RBM15B;SRPK1;SNRNP35;CPSF4;HNRNPH2;SF3B3;LSM7;SNRNP27;RBM4;WBP4;PABPC1;AQR;UBL5;HNRNPA2B1;RBM19;ZCCHC8;PPWD1;DDX1;LSM4;METTL3;RALY;RBM10;DHX38;PRPF4;GEMIN7;CWC25;BUD13;SRPK2;PDCD7;CWC22;CDC5L;POLR2B;DNAJC8;HNRNPR;TGS1;SNRPB;TRA2A;SF3A3
prerank,epidermal cell differentiation (GO:0009913),0.41211652963237333,0.9385882843910094,0.5425055928411633,1.0,1.0,8/41,13.73%,TGM1;ERCC3;HDAC1;ANXA1;HDAC2;CLIC4;MED1;ADAM9
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.35824057841866086,-0.938140795231094,0.5480769230769231,0.7914659431128809,1.0,4/12,13.12%,OS9;RER1;HSPA5;KDELR3
prerank,regulation of hippo signaling (GO:0035330),0.4511966736097726,0.9380875400730065,0.5332446808510638,1.0,1.0,6/17,18.50%,CIT;AJUBA;LIMD1;NF2;SHANK2;MAPK14
prerank,regulation of platelet aggregation (GO:0090330),-0.3248888932299211,-0.9380375567985,0.5381679389312977,0.7907543183603835,1.0,4/17,8.01%,PRKG1;F11R;LYN;PRKCQ
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.35644147296976925,-0.9379028886560385,0.5194805194805194,0.7901327985069556,1.0,4/13,16.61%,BPNT2;TPST1;TPST2;ABHD14B
prerank,regulation of exocytosis (GO:0017157),-0.24432369425816813,-0.9375566372458138,0.5697674418604651,0.789986519336033,1.0,8/46,7.83%,STXBP5L;CADPS;SYT1;STXBP6;STX4;RAB27B;IL1RAPL1;RAB5A
prerank,positive regulation of biomineral tissue development (GO:0070169),0.42072086409460185,0.9373719581329264,0.5600907029478458,1.0,1.0,9/40,11.48%,FBXO5;ADGRV1;BMPR1A;BMP6;CCN1;SLC8A1;WNT6;ATP2B1;BMP2
prerank,cell chemotaxis (GO:0060326),0.4005343332887785,0.9372551554385803,0.5590465872156013,1.0,1.0,9/60,12.61%,HMGB2;PARVA;LPAR1;KIT;CXCR4;PDGFRA;CORO1B;CCN3;NR4A1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.4446564788349777,0.9371375367118383,0.5207547169811321,1.0,1.0,4/22,7.84%,VPS37B;NEDD4;VPS37A;STAM
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.45942411875508854,0.936941175218414,0.5414201183431953,1.0,1.0,4/13,18.50%,BMF;RHOT1;VDAC2;BAD
prerank,regulation of protein ubiquitination (GO:0031396),0.39596598578138903,0.9368011083632594,0.5932721712538226,1.0,1.0,16/108,11.51%,BRCA1;PAXIP1;FANCI;MYCBP2;ARRB1;FBXW7;UBE2N;LRRK2;CUL3;TBC1D7;ANGPT1;SVBP;HDAC8;TGFBR1;IVNS1ABP;BAG5
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.34526169958680386,-0.936546082077737,0.5171232876712328,0.7913825935137724,1.0,5/13,7.68%,HSP90AB1;STX4;STX3;RIC3;MAP1A
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.3627392920802165,-0.9359760551484052,0.5229885057471264,0.7917739690607686,1.0,9/12,41.80%,SERINC3;MTHFD1;PSAT1;CBS;SEPHS2;CTH;PSPH;GGT1;PHGDH
prerank,response to reactive oxygen species (GO:0000302),-0.23984442297402597,-0.9357821707524115,0.5897435897435898,0.79130220002518,1.0,22/54,24.14%,APOD;MAPK8;APOE;MAPK9;SOD2;TPM1;JUN;MAPK3;STK25;MAPK1;CAMKK2;MPV17;TXNRD2;CHUK;GLRX2;PRDX3;GPX1;ERCC6L2;PRDX5;RPS3;PDK2;COA8
prerank,regulation of mRNA catabolic process (GO:0061013),0.3940369485676002,0.935747367190833,0.6036400404448938,1.0,1.0,43/121,23.62%,XPO1;MOV10;PSMC2;ZC3HAV1;PSMD5;HNRNPD;CNOT1;TNPO1;SERBP1;SAMD4A;FMR1;RC3H2;PSMB1;PSMD14;PUM2;PSMD1;YTHDF2;PSMB9;PRKCA;EXOSC7;NUP214;RC3H1;PSMC6;PABPC1;ZC3H14;CNOT7;FXR1;PNPT1;PSMB2;PSME4;PSMB7;PRKCD;PSMD11;PSME3;MAPKAPK2;DIS3;PSMD13;PSMB8;ZFP36L1;PSMD4;YTHDF1;HSPA8;PSMF1
prerank,response to sterol (GO:0036314),0.4829050327138602,0.9355286742667505,0.5255474452554745,1.0,1.0,5/11,20.99%,PMVK;TGFBR1;RORA;SMAD2;INSIG1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.43220021107264783,0.9352911760647918,0.522867737948084,1.0,1.0,11/27,19.16%,AGO2;AJUBA;DHX9;EIF4ENIF1;FMR1;LIMD1;PUM2;FXR1;TP53;RIPK1;TNRC6B
prerank,positive regulation of vasoconstriction (GO:0045907),-0.35982809005641114,-0.9351329890279027,0.5311475409836065,0.7918466187468232,1.0,4/13,24.07%,CAV1;ADRA1A;ADRA1B;TBXA2R
prerank,regulation of sodium ion transport (GO:0002028),0.41818515269092715,0.9351160797502811,0.5382830626450116,1.0,1.0,10/34,17.79%,ATP2B4;RANGRF;NEDD4;WNK1;SNTA1;DLG1;NKAIN1;PER1;CNKSR3;WNK3
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.46249932390976345,0.9350797388187961,0.5226960110041265,1.0,1.0,2/14,4.65%,TICAM1;KIT
prerank,regulation of GTPase activity (GO:0043087),0.39352486819127347,0.9347222651670656,0.614070351758794,1.0,1.0,26/177,10.99%,ECT2;EZH2;ARHGAP11A;USP6NL;MAP4K4;GSK3B;RTN4R;EVI5L;OCRL;NET1;AFDN;FGD4;VAV2;WNK1;EPHA4;FGD1;LRRK2;RSU1;TBC1D7;CPEB2;PICALM;SRGAP2;LIMS1;FGD6;PLXNB2;PLXNB1
prerank,T cell proliferation (GO:0042098),0.47053305364278386,0.9346851936222056,0.5246575342465754,1.0,1.0,3/13,16.04%,CTPS1;LMBR1L;MSN
prerank,miRNA metabolic process (GO:0010586),0.43684144576068895,0.9336314811597335,0.5319426336375489,1.0,1.0,4/20,13.59%,DGCR8;AGO2;TUT7;TUT4
prerank,cellular response to copper ion (GO:0071280),0.4558910521317532,0.933081868841116,0.5336134453781513,1.0,1.0,2/16,5.19%,AQP1;PRNP
prerank,Golgi localization (GO:0051645),0.48949854910798657,0.9328752121273023,0.53125,1.0,1.0,3/11,15.19%,ARHGAP21;TBCCD1;UVRAG
prerank,regulation of cellular response to heat (GO:1900034),0.39727055972309344,0.9320886980967369,0.5783385909568874,1.0,1.0,23/77,20.66%,NDC1;NUP155;NUP205;NUP160;GSK3B;RPA1;MAPT;NUP85;RPA2;TPR;BAG5;NUP214;RANBP2;RPTOR;NUP133;NUP42;NUP98;ATR;NUP210;DNAJB6;NUP188;NUP35;MAPKAPK2
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4818277557564439,0.9320804852272343,0.5486725663716814,1.0,1.0,3/12,10.24%,ATP2B4;XDH;PIK3CB
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.28008506210504924,-0.9319084679456718,0.5112781954887218,0.7981239292618443,1.0,14/32,32.47%,CALM1;AKAP6;CEMIP;PLCG1;TRPC1;CX3CL1;CALM3;GSTM2;JPH2;GPER1;THY1;P2RY6;GSTO1;APLNR
prerank,protein destabilization (GO:0031648),0.42607304856818523,0.9314516240527942,0.5190751445086705,1.0,1.0,6/32,13.80%,PLK1;PRNP;CUL3;FBXW11;CTSH;BTRC
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.4197189899641799,0.9313047201051016,0.557285873192436,1.0,1.0,14/45,19.14%,ZC3H7A;EIF4E;MATR3;FOXO3;LARP1;PUM2;PARP9;MEX3D;LARP4;RC3H1;PER1;ZC3H7B;METAP1;SPOUT1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.3990878423227809,0.9311627561555322,0.5738219895287958,1.0,1.0,27/73,22.56%,CBFB;PSMC2;PSMD5;PRKDC;PSMB1;PSMD14;YAP1;PSMD1;KMT2A;YTHDF2;TAL1;PSMB9;ITCH;PSMC6;RUNX1;METTL3;PSMB2;PUS7;PSME4;PSMB7;PSMD11;PSME3;EIF2AK2;LDB1;PSMD13;PSMB8;PSMD4
prerank,melanocyte differentiation (GO:0030318),0.4759173158880055,0.9303265791885292,0.5246153846153846,1.0,1.0,3/11,10.67%,LRMDA;KIT;ENPP1
prerank,cellular response to virus (GO:0098586),0.4149571366147813,0.9298389933931591,0.5152998776009792,1.0,1.0,4/30,9.08%,VWCE;GBF1;FMR1;RIOK3
prerank,negative regulation of locomotion (GO:0040013),-0.35855450087905993,-0.9295984501345118,0.535483870967742,0.8022914120700441,1.0,4/12,14.01%,FRMD5;DUSP3;SPOCK3;CCDC125
prerank,response to leucine (GO:0043201),0.4928969800997747,0.9285086339004734,0.5477996965098634,1.0,1.0,5/10,16.38%,KLHL22;SESN1;RPTOR;SESN2;LARS1
prerank,cellular response to leucine (GO:0071233),0.4928969800997747,0.9285086339004734,0.5477996965098634,1.0,1.0,5/10,16.38%,KLHL22;SESN1;RPTOR;SESN2;LARS1
prerank,bile acid metabolic process (GO:0008206),-0.28082722818490563,-0.9283062240951218,0.5869565217391305,0.8043862871243926,1.0,8/27,21.23%,OSBPL6;CYP7B1;SCP2;OSBPL7;OSBP;AMACR;GBA2;OSBPL2
prerank,actin filament depolymerization (GO:0030042),0.4795388848921619,0.9282588964683621,0.5451936872309899,1.0,1.0,5/11,23.29%,MICAL3;TWF1;DSTN;CFL2;MICAL2
prerank,bone morphogenesis (GO:0060349),0.46007494679637073,0.9280434507104721,0.5217983651226158,1.0,1.0,2/14,3.54%,CYP26B1;FGFR2
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.2687943804833556,-0.9278705347797982,0.5804195804195804,0.8043899115552763,1.0,13/33,26.04%,GLUL;GLS;GOT2;PRODH;KYAT1;GOT1;ALDH5A1;DDAH2;GLUD1;NIT2;RIMKLA;OAT;GLS2
prerank,angiogenesis involved in wound healing (GO:0060055),0.4730758356885811,0.9278190942337594,0.548480463096961,1.0,1.0,2/11,5.18%,HPSE;SRF
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.45652893963080665,0.9273286309313652,0.5308641975308642,1.0,1.0,6/15,19.16%,AGO2;CNOT1;PABPC1;CNOT7;TNRC6C;TNRC6B
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.45652893963080665,0.9273286309313652,0.5308641975308642,1.0,1.0,6/15,19.16%,AGO2;CNOT1;PABPC1;CNOT7;TNRC6C;TNRC6B
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.26886117092300404,-0.9272888536402382,0.5686274509803921,0.8047630403503949,1.0,13/35,21.19%,NRP2;SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;MET;SEMA3B;FARP2;SEMA3C;PLXNA4;SEMA5B;NRP1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.3921022808030127,0.9272160513881109,0.6026970954356846,1.0,1.0,22/88,18.64%,TYMS;ILF3;SYNCRIP;CNOT1;DNAJC1;EIF4ENIF1;SAMD4A;CAPRIN1;FMR1;LARP1;EIF2AK3;MRPL13;RBM4;DHFR;EPRS1;CNOT7;NFKB1;FXR1;RIC1;PAIP2B;PLAT;PUS7
prerank,positive regulation of GTPase activity (GO:0043547),0.3923104208857952,0.9269354188030147,0.6395582329317269,1.0,1.0,24/188,10.99%,ECT2;EZH2;ARHGAP22;ARHGAP11A;USP6NL;MAP4K4;GSK3B;RTN4R;EVI5L;TBC1D25;NET1;TBC1D13;AFDN;TBC1D2B;SCRIB;ARHGAP24;SYDE2;RSU1;TBC1D7;PICALM;RANGAP1;SRGAP2;LIMS1;PLXNB1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.3497132505172639,-0.926802309163218,0.5249169435215947,0.8049626688484836,1.0,8/13,26.97%,NAMPT;PTGS2;PARP16;PARP10;NAXD;NNMT;NUDT12;NAXE
prerank,ncRNA 3'-end processing (GO:0043628),0.4775898390300743,0.9263717342041927,0.5420827389443652,1.0,1.0,3/14,10.64%,INTS7;ERI1;INTS8
prerank,neurotransmitter biosynthetic process (GO:0042136),0.4622500661178137,0.9261941817406782,0.5288184438040345,1.0,1.0,4/14,19.50%,CHAT;ACHE;DAGLB;DAGLA
prerank,isotype switching (GO:0045190),0.4965674007491787,0.9260841837720168,0.5562310030395137,1.0,1.0,2/10,12.45%,RNF168;MSH6
prerank,negative regulation of interferon-beta production (GO:0032688),0.4883669782448571,0.9260555485141211,0.5406203840472673,1.0,1.0,5/10,23.38%,PTPRS;YY1;SIRPA;RELB;REL
prerank,lipoprotein localization (GO:0044872),0.4726202164709067,0.9260083589433339,0.5358711566617862,1.0,1.0,5/11,19.54%,PRKCB;MIA3;UNC119;ZDHHC3;UNC119B
prerank,regulation of angiogenesis (GO:0045765),0.3866020020452896,0.9259313266282077,0.6549648946840522,1.0,1.0,36/192,15.61%,BRCA1;VASH2;AQP1;ATP2B4;THBS2;ROCK2;ANGPT4;HYAL1;AGO2;ADAM12;PDE3B;ADGRA2;ANXA3;SFRP2;PML;SULF1;HSPB6;SERPINE1;ROCK1;GAB1;PRKCB;PRKCA;RRAS;PDPK1;CTSH;PLXND1;TWIST1;SPRED1;ADAMTS1;PRKD1;ITGB1;SFRP1;PRKD2;RUNX1;HSPG2;ITGB8
prerank,regulation of microglial cell activation (GO:1903978),-0.3268565296287014,-0.9256706455365248,0.5296167247386759,0.8066166490300392,1.0,5/15,29.87%,GRN;SYT11;CX3CL1;SPHK1;PTPRC
prerank,generation of neurons (GO:0048699),0.38796616906780856,0.9255966401147744,0.6446446446446447,1.0,1.0,22/190,10.64%,EN1;RACGAP1;CIT;HMGB2;ATOH8;ARTN;MYEF2;AUTS2;WNT2B;BHLHE41;MAPT;POU3F2;OLIG2;LMX1B;SH3RF1;YAP1;WNT6;MARK2;SDCCAG8;NR4A2;YTHDF2;PLXNB2
prerank,regulation of cholesterol transport (GO:0032374),-0.3063943293594632,-0.9254542570555327,0.5069124423963134,0.8061841169402799,1.0,8/20,23.28%,OSBPL6;LRP1;ABCA5;NR1H3;ARV1;NR1H2;NUS1;ABCA2
prerank,actin filament organization (GO:0007015),0.3845934507542232,0.925286512914575,0.6351758793969849,1.0,1.0,34/151,17.85%,SPTA1;GAS2L3;SHROOM3;TRIOBP;RHOA;CGNL1;TPM4;MYO1C;FAT1;CDC42EP2;RFLNA;MCU;CORO1B;ABI1;SAMD14;RAC1;RND2;DPYSL3;SVIL;DMTN;BAIAP2L1;DLG1;TMOD3;DSTN;CAPG;MPRIP;LCP1;DBN1;RHOC;FHOD1;COBL;ABI2;SHROOM2;TRPV4
prerank,anterior/posterior pattern specification (GO:0009952),0.40363266666804004,0.9249422856696818,0.5731441048034934,1.0,1.0,15/53,20.68%,HOXC5;BHLHE41;HOXC4;HOXA7;HOXB3;HOXB6;TGFBR1;BMP2;LRP5;HEY2;HOXB7;SMAD2;HOXA3;SKI;HOXA6
prerank,response to ketone (GO:1901654),-0.2917559667168579,-0.9246702787179563,0.529126213592233,0.8071526258812441,1.0,12/24,26.53%,CAV1;TGFB2;ABHD2;NR1H3;CATSPER2;SLIT2;THBS1;TGFB3;WBP2;SLIT3;UBE3A;CATSPER3
prerank,negative regulation of cell population proliferation (GO:0008285),0.3869384596042481,0.924572945952339,0.7,1.0,1.0,65/351,16.31%,E2F7;CDKN3;E2F1;CDKN2D;PPM1D;CDKN2C;PDS5B;CTCF;E2F3;CDC6;TFDP1;ALDH1A2;MDM4;ARID2;COL18A1;CTBP1;MCC;PDPN;NMI;SFRP2;PTPN2;RBBP4;TGFBR3;PML;CLMN;B4GALT7;SLC16A2;IRF1;KDM2B;MFN2;SMAD6;BTG3;ING4;AXIN2;KLF11;KANK2;ABI1;VHL;NOX4;EMD;PPP2R5C;PLXNB1;CCN3;BMP2;APPL2;P3H1;NCK2;WNT9A;PLPP1;SOX9;TES;ATF5;ADAMTS1;MORC3;CDKN1B;STK11;PTPRU;SFRP1;PKD2;NF2;CNOT7;ZBTB7C;TP53;PTEN;TINF2
prerank,aorta morphogenesis (GO:0035909),-0.3212026397961784,-0.9244177848818483,0.5051903114186851,0.8068429343357173,1.0,6/17,6.13%,JAG1;ACVRL1;PDGFRB;PROX1;MYLK;LRP1
prerank,regulation of synapse organization (GO:0050807),0.4291810032993752,0.9243617592436579,0.5476477683956574,1.0,1.0,3/26,7.76%,ARHGAP22;NEDD4;EPHA4
prerank,regulation of interleukin-1 production (GO:0032652),0.4505350117577391,0.9243387969300167,0.531628532974428,1.0,1.0,6/15,20.66%,HMGB1;ANXA1;SIRPA;FOXP1;TMED10;CEACAM1
prerank,protein acylation (GO:0043543),-0.2539143822193169,-0.9243097885753888,0.6524822695035462,0.8061867231877577,1.0,15/38,23.59%,FOXO1;EP300;GLUL;ZDHHC5;ZDHHC1;ZDHHC13;KAT2B;ING5;ZDHHC7;NAA80;ZDHHC8;ZDHHC16;ZDHHC20;ZDHHC17;SPHK1
prerank,alpha-amino acid metabolic process (GO:1901605),-0.2386145678425597,-0.9242772899154273,0.5729166666666666,0.8053290443008398,1.0,16/45,23.67%,GLUL;GLS;GOT2;SLC25A13;SLC25A12;MTHFD1;KYAT1;GOT1;MTRR;GPT2;DDAH2;GLUD1;ATP7A;ASS1;RIMKLA;OAT
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.3693093570437127,-0.9240408906608275,0.5377643504531722,0.8049614932876715,1.0,2/11,4.40%,CAV1;BIN1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.39791739563249395,0.9240246377406343,0.5669882100750268,1.0,1.0,11/57,13.02%,MIEF2;AURKA;GSK3B;BMF;FAM162A;HTRA2;MCU;MIEF1;DDHD1;BOK;PLAUR
prerank,mesonephros development (GO:0001823),-0.36414215035239017,-0.9238106649277689,0.5850144092219021,0.804618378764338,1.0,4/11,24.42%,FGF1;FGF10;BMP7;PAX8
prerank,RNA modification (GO:0009451),-0.2377938546253675,-0.9236764246125502,0.5978260869565217,0.8040305663706223,1.0,24/54,26.66%,TRMT9B;ANKRD16;DTWD2;PARN;AARS1;NSUN2;CDKAL1;QTRT2;ADAR;TRMT1;TRUB1;METTL1;ADARB1;MEPCE;PUS3;QTRT1;THUMPD1;NOP2;JMJD6;LCMT2;NSUN5;WDR4;DTWD1;ALKBH1
prerank,cellular calcium ion homeostasis (GO:0006874),-0.20720931592395914,-0.9235977841380248,0.625,0.8032479366415238,1.0,29/133,16.91%,CAMK2D;PSEN1;SLC8A3;ATP1B1;TRPC5;CAV1;RYR2;ANXA6;SLC24A2;PACS2;DMPK;CDH5;HTR2C;TPT1;TRPC3;TRPC1;CHRNA7;HCRTR2;CAV2;BCL2;TMCO1;ADCY8;SLC30A1;ATP2B2;ATP2B3;SMDT1;RMDN3;HTR2A;PTH1R
prerank,negative regulation of leukocyte activation (GO:0002695),-0.33549188448007206,-0.9232954961064722,0.5361216730038023,0.8029608601910043,1.0,7/15,25.75%,NR1H3;GRN;ZC3H12A;CD84;CD300A;LRFN5;GPER1
prerank,negative regulation of cell communication (GO:0010648),-0.2992337213500418,-0.923095518629929,0.5714285714285714,0.8025080817694527,1.0,5/21,13.39%,ACVR1;GLRA1;SOCS5;OPRM1;HHIP
prerank,cellular defense response (GO:0006968),-0.2539956597446882,-0.9230355596903036,0.5714285714285714,0.8017083611811046,1.0,8/40,23.61%,BECN1;LSP1;RAB23;LBP;CCR9;LGALS3BP;NCF2;PTK2B
prerank,protein import (GO:0017038),0.39455347469455976,0.922801871737597,0.5989637305699482,1.0,1.0,28/84,22.17%,RANBP17;NUP155;RPAIN;E2F3;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;SNX33;IPO7;APPL2;NUP214;IPO11;NXT1;NUP133;IPO5;NXT2;FAM53B;SLC25A17;IPO9;NUP188;PEX12;IPO4;HSPA4;RAB8B;PEX13;APPL1
prerank,positive regulation of cell differentiation (GO:0045597),0.38644968060048024,0.9220738559682448,0.6556556556556556,1.0,1.0,47/237,15.53%,ECT2;EZH2;CDH15;FBXO5;LOXL2;BMPR1A;RHOA;ZEB1;SPAG9;SRF;PDPN;SFRP2;BMP6;CTNNA1;SOX6;IL18;TCF4;NPNT;CCN1;WWTR1;AXIN2;YAP1;RIPOR2;TMEM64;VHL;AGT;DDR2;TGFBR1;BMP2;ZHX3;RRAS;TRPM4;GJA1;SMAD4;SOX9;LRP5;TWIST1;RBM4;PRKD1;BLOC1S5;SMAD3;WDFY2;MEDAG;LPL;SFRP1;GDNF;NFKB1
prerank,neutrophil activation (GO:0042119),-0.3631947223034944,-0.9220183048402723,0.5732484076433121,0.8031599584557225,1.0,5/12,32.65%,KMT2E;IL15;SYK;FCER1G;TYROBP
prerank,neuromuscular process (GO:0050905),-0.31713168264344355,-0.9219818114126612,0.5757575757575758,0.802306702817585,1.0,7/16,19.48%,UBA5;NRXN1;TPP1;SHANK1;GCH1;STRA6;DCTN1
prerank,"transcription, DNA-templated (GO:0006351)",0.3871671454038963,0.921929517481003,0.6566566566566566,1.0,1.0,34/207,12.86%,TRIP13;TCFL5;E2F1;TTF2;NAT14;PMF1;CBFB;SETX;DEK;TFDP1;TAF3;MBD1;KLF13;ERCC3;ELOC;GLIS3;TAF12;POLR2A;ZBTB7B;FOXO3;GTF3C4;LEO1;NFYA;EPC1;NR4A2;MMS19;DRG1;IVNS1ABP;TAF15;GTF2A1;TTF1;TAF4;RNGTT;SSRP1
prerank,regulation of neurogenesis (GO:0050767),0.400127795716059,0.9216908879254887,0.5672451193058569,1.0,1.0,9/55,14.57%,HMGB2;NAP1L1;PCM1;BHLHE41;YAP1;YTHDF2;APPL2;HEY2;DOCK7
prerank,primary alcohol metabolic process (GO:0034308),-0.285388087189387,-0.9216336798257793,0.5857142857142857,0.8021762387955281,1.0,7/25,14.51%,IGF1;RDH10;GPD2;ALDH3A2;GDPD3;DHRS3;GDPD1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.27271672138013525,-0.921330958071823,0.5714285714285714,0.8019059561870779,1.0,11/28,21.55%,GRB14;PIP4K2A;GRB10;PIP4K2B;PRKCQ;INPP5K;IRS1;GSK3A;PRKCZ;PIP4K2C;SLC27A4
prerank,positive regulation of natural killer cell activation (GO:0032816),0.4576931907821491,0.9212494467490603,0.5325936199722607,1.0,1.0,4/13,18.79%,TICAM1;IL18;AXL;ZBTB1
prerank,glycogen catabolic process (GO:0005980),0.45876191903194935,0.9211886663407894,0.5365168539325843,1.0,1.0,4/15,10.18%,AGL;PYGB;PHKA2;RB1CC1
prerank,positive regulation of autophagy (GO:0010508),0.3891915273260866,0.9211297531852151,0.6052356020942409,1.0,1.0,19/81,14.61%,TRIML2;TICAM1;GSK3B;TPCN1;SH3GLB1;FOXO3;LRRK2;LARP1;ROCK1;HMGB1;SESN1;IKBKG;PIK3CB;TRIM6;GNAI3;PLK2;PRKD1;TRIM5;STK11
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.304566950447272,-0.920554466084983,0.5884615384615385,0.8027753719732555,1.0,6/18,13.19%,SNX3;DAB2;VPS11;MAPK3;MAPK1;MAP2K1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.38551940920422145,0.9203384168209054,0.6107723577235772,1.0,1.0,36/132,16.77%,TRIML2;MOV10;TICAM1;PFKFB1;GSK3B;ZC3HAV1;CNOT1;FAF1;TPCN1;SH3GLB1;FOXO3;LRRK2;SH3D19;ROCK1;ZBTB20;HMGB1;SNX33;PIK3CB;EZR;TRIM6;DAGLB;ITCH;DXO;TWIST1;ADAM9;PLK2;PRKD1;ARNT;RC3H1;TRIM5;STK11;CNOT7;MSN;ZC3H18;PNPT1;AMER1
prerank,atrial septum development (GO:0003283),0.46336086162184303,0.9200718892093742,0.5555555555555556,1.0,1.0,4/13,13.69%,MDM4;NPHP3;NOTCH2;HEY2
prerank,T cell mediated immunity (GO:0002456),-0.35268012289858464,-0.9196401592397984,0.5751633986928104,0.8038991137578837,1.0,2/13,12.80%,JAG1;GNL1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.32829431262239184,-0.919616205609885,0.5274725274725275,0.8030265748683649,1.0,10/15,36.04%,PRKN;IGF1;GHITM;GPX1;BCL2L1;PRELID1;HGF;PPIF;AKT1;PSMD10
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.38370272744359046,0.9193338176841576,0.6109979633401222,1.0,1.0,26/122,15.68%,ATAD5;GLI2;FGFR4;LARP4B;GCK;HNRNPD;STN1;DNA2;DHX9;PRKDC;UPF3B;FAF1;SAMD4A;SLC25A37;NMD3;FMR1;ABCB10;PLXNB2;METTL5;PCNA;EIF3C;LARP4;PRKD2;NFKB1;PASK;FXR1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.20828118424432518,-0.9192774364891391,0.7105263157894737,0.8028999090017631,1.0,30/91,23.18%,FTH1;SLC39A10;ATP6V0D1;SCARA5;SLC39A13;CUL1;FBXL5;FTL;ABCG2;HMOX2;APP;COX19;IREB2;GLRX3;SLC31A2;SLC39A7;SLC30A1;MT2A;ATOX1;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;ATP7A;NDFIP1;ISCU
prerank,camera-type eye development (GO:0043010),0.4253784353816123,0.9191309662640819,0.5576441102756893,1.0,1.0,8/25,22.74%,FBN1;CACNA1C;NES;EFEMP1;SHROOM2;SKI;ALDH1A3;CEP290
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.42113858708366614,0.9185029728509496,0.554467564259486,1.0,1.0,12/27,25.77%,CSTF3;RNASE6;PCF11;POP1;RPP30;RNASE1;KHNYN;LACTB2;TRIR;RNASEH1;TOE1;NUDT16
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.40738391336329105,0.9183957936709682,0.5594563986409966,1.0,1.0,13/42,16.38%,CARS2;SARS2;VARS1;DARS2;IARS2;DARS1;PPA1;TARS2;PARS2;RARS2;EPRS1;QARS1;LARS1
prerank,cellular response to organonitrogen compound (GO:0071417),0.3831205271023149,0.9181906700547857,0.5957011258955988,1.0,1.0,22/99,17.52%,BRCA1;AQP1;DIAPH1;CTNNA1;LARP1;P2RY1;TRPM2;AHR;AKAP9;EZR;DMTN;SOX9;SLC38A9;GLRA2;RPTOR;SFRP1;PKD2;IPO5;SESN2;LARS1;LAMTOR3;LAMTOR5
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.46475821620625957,0.9171232440652679,0.5552486187845304,1.0,1.0,3/13,8.10%,TXN;PYCR1;LRRK2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.3929560114268699,0.9169149497509747,0.591304347826087,1.0,1.0,10/57,14.08%,MRPL36;XPO1;RRS1;CUL4B;MRTO4;DHX37;NOM1;RPS17;SDAD1;PAK1IP1
prerank,blood circulation (GO:0008015),0.4045217015667044,0.9166193584856931,0.5861297539149888,1.0,1.0,8/49,10.09%,F5;ROCK2;MYOF;SCPEP1;ROCK1;BDKRB2;ELN;MEOX2
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.39455758708575406,0.9166147733959533,0.5871657754010695,1.0,1.0,21/63,21.45%,FADD;PHIP;WWOX;BCL2L12;SIAH2;TCF7L2;PML;SH3RF1;TNFRSF10B;AGT;TGFBR1;CASP8;BIRC6;ITGAV;SRC;TNFSF10;RIPK1;SP100;PSME3;TRAF2;FEM1B
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.4428683276728351,0.916608349779317,0.5656050955414013,1.0,1.0,5/19,10.60%,CBFB;ROCK2;MYO1C;ROCK1;NPHP1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.335911028967057,-0.9158148775900294,0.5833333333333334,0.8096507186607256,1.0,2/14,8.41%,ATP1B1;ATP1B3
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.37545014246128033,-0.9154858121022996,0.5565476190476191,0.8095033402457891,1.0,6/10,24.61%,ATP5F1A;ATP5MC3;ATP5PO;ATP5PD;ATP5F1D;ATP5MG
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.3159696175627584,-0.9153694255212447,0.5887096774193549,0.808836936021873,1.0,8/17,24.64%,APOE;PRKAA1;FGF1;SREBF2;ERLIN2;RAN;ABCA2;MBTPS1
prerank,positive regulation of cell development (GO:0010720),-0.26382995820804,-0.9152027437740627,0.6198830409356725,0.8083398127962601,1.0,13/31,27.81%,PDE3A;NUMBL;NUMB;TGM2;OPRM1;FAIM;SNW1;ATP6AP1;TRIM32;GPER1;SERPINF1;SOX11;NKX6-1
prerank,macrophage activation (GO:0042116),-0.2535284207266504,-0.9147825765493774,0.6054421768707483,0.8084082299705052,1.0,9/34,15.37%,TLR4;IFI35;CD93;LBP;APP;CRTC3;CX3CL1;IFNGR1;SBNO2
prerank,negative regulation of signal transduction (GO:0009968),0.3815348368124937,0.9146033183358747,0.709,1.0,1.0,39/249,11.48%,EZH2;GLI3;RB1;BRAP;CYP26B1;WWOX;MMP14;CNOT1;TRABD2B;NLK;DLK1;NEDD4;SULF2;ASXL1;SIAH2;NTN1;LEPROT;XDH;SFRP2;RNF43;PTPN2;HMGXB4;ARRB1;FBXW7;SULF1;LRRK2;NCK1;KANK2;MTMR2;CSNK2A2;AGT;PIK3CB;NR4A2;YTHDF2;ENPP1;DKK3;ARRDC1;PRKCB;BMP2
prerank,cilium-dependent cell motility (GO:0060285),0.42334571679296473,0.9142213189309716,0.5376884422110553,1.0,1.0,3/22,10.41%,DNAH2;DNAH1;RSPH9
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.2792651479226777,-0.9141793761024892,0.5645161290322581,0.8088536362339076,1.0,6/23,10.99%,PSEN1;INSR;IGF1;PFKFB3;PRKAA1;APP
prerank,B cell activation involved in immune response (GO:0002312),0.4689739676345225,0.9139541140561164,0.5693848354792561,1.0,1.0,2/13,12.45%,RNF168;MSH6
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.33855608782137336,-0.9136505931736963,0.5493421052631579,0.8090539447372932,1.0,7/14,15.79%,PPP2R2B;PPTC7;PPP2CB;PPM1F;PPP2R2C;DUSP1;PPP5C
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4299686146354368,0.9131778492723537,0.5597402597402598,1.0,1.0,5/21,10.96%,TXNDC12;LRRK2;NCK1;BOK;EIF2AK3
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.36538127485881755,-0.913175022456511,0.5789473684210527,0.809140531244268,1.0,3/11,20.27%,PRKN;PINK1;PARK7
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.2557860604286089,-0.9126959287347808,0.59375,0.8092767852912014,1.0,8/37,15.33%,STAT3;APOD;TLR4;PDCD4;PLD3;CHID1;ABCD2;IL17D
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.2955504957817092,-0.9120707580969128,0.5686274509803921,0.8097632892016269,1.0,14/22,39.15%,AHNAK;GNB5;CACNB2;SRI;STAC;CACNB1;DRD2;CACNB3;STAC3;CBARP;HPCA;STAC2;DMD;GPR35
prerank,negative regulation of gluconeogenesis (GO:0045721),0.4755372784915993,0.9120252193932245,0.5494672754946728,1.0,1.0,2/11,4.90%,GCK;ERFE
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.28020008459191365,-0.9119597261147269,0.5798816568047337,0.8091312467871106,1.0,9/26,13.86%,FMOD;B4GALT5;B3GNT2;ST3GAL6;B4GALT6;PRELP;OGN;B4GALT4;LUM
prerank,positive regulation of protein modification process (GO:0031401),0.38072874108125315,0.9116182810496459,0.6720160481444333,1.0,1.0,37/203,15.07%,CDCA2;CEP295;DYRK1A;FNIP1;ROCK2;TRABD2B;FAM161A;RAP2A;LEPR;MUSK;ARRB1;FMR1;UBE2N;ATG7;EFNA1;TXN;CCN1;LRRK2;PPP1R7;AXIN2;ANGPT1;RB1CC1;P2RY1;CALM2;CRKL;BMP2;RAC1;ADAM17;SOX9;PLAUR;SLCO3A1;SMPD1;CAMTA1;TAOK1;WDFY2;PTPA;PIN1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.4361458396815954,0.9115121245000246,0.5391527599486521,1.0,1.0,3/21,9.86%,GCK;GPI;TKT
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.31104964649543887,-0.9111693120538686,0.5896414342629482,0.8100315860357887,1.0,6/17,10.43%,NTRK2;APOE;IGF1;BIN1;RTN1;CHRNA7
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.3604022296376014,-0.9110566969147066,0.5680473372781065,0.8093758329432394,1.0,2/10,1.54%,CAMK2D;HECW1
prerank,spliceosomal snRNP assembly (GO:0000387),0.3966320102716857,0.9108144553108851,0.5782857142857143,1.0,1.0,9/38,19.75%,COIL;SRSF10;PRPF19;PRPF3;LSM2;LSM4;GEMIN7;TGS1;SNRPB
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.3741730968140365,-0.9106511856897184,0.5875370919881305,0.8093680368746359,1.0,6/10,33.25%,ACADM;ETFDH;ETFB;ACADS;ACADVL;GCDH
prerank,cellular response to dsRNA (GO:0071359),0.4508396517642637,0.9103821118274427,0.5738786279683378,1.0,1.0,3/15,9.08%,COLEC12;DHX9;RIOK3
prerank,regulation of brown fat cell differentiation (GO:0090335),0.45033378957963177,0.9102933462745908,0.5513654096228868,1.0,1.0,4/16,10.63%,FTO;ZBTB7B;PIM1;HNRNPU
prerank,positive regulation of catalytic activity (GO:0043085),-0.2536252823298917,-0.909854940269517,0.6307692307692307,0.8102441573842208,1.0,10/37,11.18%,PSEN1;CAV1;MAPK8;STX4;NCSTN;MSH2;IGF2;NHEJ1;MAPK3;ABL1
prerank,Golgi to endosome transport (GO:0006895),0.438700939766498,0.9088795788030684,0.5381471389645777,1.0,1.0,3/16,8.31%,AP4M1;GBF1;VPS13A
prerank,pulmonary valve morphogenesis (GO:0003184),-0.311330421835908,-0.9086957524181415,0.5593869731800766,0.8119974456714912,1.0,7/17,18.03%,JAG1;TGFB2;NOS3;SLIT2;HEYL;STRA6;ROBO2
prerank,carboxylic acid metabolic process (GO:0019752),0.4100810190262467,0.9085629336443092,0.5760095011876485,1.0,1.0,2/33,3.61%,PON1;GSTO2
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.315051502681405,-0.9084366876668571,0.594306049822064,0.8116484388915285,1.0,5/16,11.33%,DDX17;AR;SAFB;ESR1;DDX5
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.3047145905667757,-0.9082883838776512,0.5662650602409639,0.811081863054269,1.0,3/18,5.98%,POLDIP3;THOC2;DDX19B
prerank,negative regulation of cell projection organization (GO:0031345),0.4045323433083077,0.9078695642171862,0.5853391684901532,1.0,1.0,17/48,17.85%,LPAR1;RTN4R;PRNP;RAB29;EPHA4;DENND5A;PTPRS;BAG5;GAK;DPYSL3;HDAC2;EFNB2;ADCY6;PTEN;STMN2;TRPV4;MYLIP
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.3533712973193533,-0.9073658246099625,0.6047297297297297,0.8122423796201895,1.0,3/12,5.26%,MAP2K5;TLR4;KLF4
prerank,microtubule anchoring (GO:0034453),0.46159624133564425,0.9073159740676435,0.5595408895265424,1.0,1.0,2/12,6.76%,PCM1;BICD2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.46231450150828746,0.907050297685175,0.5972027972027972,1.0,1.0,2/12,4.78%,COLEC12;DHX9
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.3375946512713121,-0.9065568276517996,0.549645390070922,0.8131502666597722,1.0,5/14,11.54%,PRKG1;MEF2C;LRP1;TPM1;SLIT2
prerank,negative regulation of myotube differentiation (GO:0010832),0.4591825805834249,0.906512741200014,0.5803698435277382,1.0,1.0,3/12,11.43%,BHLHE41;HDAC1;CCN3
prerank,regulation of cholesterol efflux (GO:0010874),0.4241690266484318,0.9061733320586307,0.5834319526627219,1.0,1.0,1/30,0.82%,PON1
prerank,membrane fusion (GO:0061025),-0.26418848148152174,-0.9060719112157978,0.6089743589743589,0.8133105676958526,1.0,10/33,16.62%,DNM3;RIMS1;NAPG;DNM1;RABIF;SNAP29;NSFL1C;GCA;VPS33B;VAMP3
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.43539373637090106,0.9060266876893823,0.5304964539007092,1.0,1.0,4/17,11.54%,MCU;RIPOR2;CAMK1D;RAC1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.40574336654812626,0.9053138815122478,0.5796610169491525,1.0,1.0,9/38,15.17%,DHX9;NMI;BMP6;RIOK3;PUM2;POLR3D;PRKCA;AKIRIN2;SLC15A4
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.36981696322221436,-0.9052248487640208,0.5647382920110193,0.8141321039178431,1.0,4/10,16.99%,FKBP1A;BIN1;ATP1A2;ADRA2A
prerank,proteasome assembly (GO:0043248),0.46000948990294854,0.904971389896001,0.5630630630630631,1.0,1.0,5/11,22.56%,PSMD5;ADRM1;PSMD11;PSMD13;PSMD4
prerank,myelin maintenance (GO:0043217),0.47890961711299296,0.904944389410631,0.5787037037037037,1.0,1.0,4/10,21.93%,CXCR4;EPB41L3;PTEN;SOD1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.4692891590622386,0.9049168002870814,0.5447976878612717,1.0,1.0,5/11,18.81%,ING4;FOXM1;TP53;TFAP4;SP100
prerank,regulation of regulated secretory pathway (GO:1903305),-0.2581674968704135,-0.9046751628753733,0.6118421052631579,0.8144401361011047,1.0,11/34,18.44%,RIMS1;SYT1;RAB5A;SYT7;DTNBP1;SYT11;SYT12;PREPL;SYT10;RAB27A;SYT6
prerank,negative regulation of cell differentiation (GO:0045596),0.38324441314211216,0.9046717754097602,0.6880641925777332,1.0,1.0,43/181,16.13%,E2F1;ADGRV1;RB1;TWIST2;SUZ12;USF3;ANP32B;ASXL1;XDH;ANKRD26;SFRP2;COL5A2;EFNA1;CRIM1;WWTR1;SMAD6;YAP1;NPHP3;TMEM64;LIMD1;LEO1;TGFBR1;RUNX1T1;YTHDF2;HNRNPU;ENPP1;ABCA1;NKX2-1;RORA;WNT9A;TRPM4;SOX9;ADIPOR1;LRP5;TWIST1;SPRED1;MED1;SMAD3;ITGAV;EFEMP1;SFRP1;SPRED2;PTEN
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.37872726190656947,-0.9046586864302372,0.5955678670360111,0.8135818842409082,1.0,5/10,33.92%,GAS6;LYN;LGALS9;CXCL12;CCL19
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.4433143187630178,0.9046362750565808,0.5662337662337662,1.0,1.0,3/17,11.81%,PRNP;PTPN2;EZR
prerank,stem cell differentiation (GO:0048863),0.409478091741639,0.9045413262785145,0.584971098265896,1.0,1.0,13/39,20.80%,SETD6;FGFR2;KIT;SETD2;FBXL17;METTL5;LMBR1L;SFRP1;TP53;MLLT3;OSR1;PSMD11;EEF1AKMT4-ECE2
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4447453438596805,0.904376311915544,0.5649794801641587,1.0,1.0,3/15,12.08%,LARGE1;CHST3;GNPDA2
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.46390447029574,0.903605745977751,0.56998556998557,1.0,1.0,4/12,19.81%,ACTN4;DMTN;RCC2;FBLN1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.46390447029574,0.903605745977751,0.56998556998557,1.0,1.0,4/12,19.81%,ACTN4;DMTN;RCC2;FBLN1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.3114213152378798,-0.9033661661423212,0.6153846153846154,0.8156005357830622,1.0,7/17,20.10%,EMC2;EMC3;SGTA;EMC1;EMC9;GET4;MMGT1
prerank,myofibril assembly (GO:0030239),0.3984595528332965,0.9032777947329943,0.5771889400921659,1.0,1.0,10/42,22.31%,OBSL1;MYLK3;CSRP2;PDGFRA;TMOD3;CSRP3;TNNT3;TMOD1;LMOD1;TMOD2
prerank,proteolysis (GO:0006508),0.3774331034373019,0.9028249232729578,0.717,1.0,1.0,33/252,13.64%,KEL;BMP1;VASH2;CTSE;FAM111A;MMP25;MMP24;ADGRV1;SENP1;MMP14;CASP7;TRABD2B;LVRN;NLN;CPXM1;CAPN15;TASP1;PLAU;TMPRSS5;SPPL2B;ADAMTS9;CPQ;HTRA2;VHL;LONP1;SVBP;TRHDE;ADAM17;CASP8;CTSH;ADAM19;CAPN5;HTRA3
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.4727790669954568,0.9027810438057992,0.5548872180451128,1.0,1.0,2/10,14.25%,PCGF5;DNMT3A
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.26109790666926475,-0.9025380376828938,0.6397058823529411,0.8165232224916552,1.0,15/34,34.00%,STX4;EPHB2;SLC7A5;PTPN22;VAMP3;DNAJB9;XBP1;CD86;PHB2;LAPTM5;PTPRC;RBP4;SPHK2;CLCF1;NOD2
prerank,sarcomere organization (GO:0045214),0.41435407613670694,0.9023780157655492,0.5610062893081761,1.0,1.0,4/27,16.68%,MYLK3;CSRP2;CSRP3;TNNT3
prerank,protein alkylation (GO:0008213),-0.28163803262189285,-0.902376355661536,0.5953488372093023,0.8159662921562933,1.0,8/22,26.97%,PRMT3;FAM98A;PRMT2;METTL21A;PRMT8;PRMT1;METTL22;GSPT1
prerank,type I interferon signaling pathway (GO:0060337),-0.24603617282271986,-0.9020199013138901,0.6339285714285714,0.8149686340758977,1.0,17/41,29.73%,IFNAR1;IFI35;IFITM3;IRF2;IRF3;IRF9;ADAR;IFIT1;BST2;IFI27;IFITM2;EGR1;RNASEL;STAT2;SAMHD1;RSAD2;JAK1
prerank,cellular response to type I interferon (GO:0071357),-0.24603617282271986,-0.9020199013138901,0.6339285714285714,0.8149686340758977,1.0,17/41,29.73%,IFNAR1;IFI35;IFITM3;IRF2;IRF3;IRF9;ADAR;IFIT1;BST2;IFI27;IFITM2;EGR1;RNASEL;STAT2;SAMHD1;RSAD2;JAK1
prerank,apoptotic process (GO:0006915),0.37685779395220337,0.901961947371368,0.7001003009027081,1.0,1.0,36/203,16.55%,MELK;ESPL1;CIT;FADD;MCM2;CASP7;BMF;DAP;IAPP;MAGI3;AIFM2;FAM162A;STK3;CXCR4;ERCC3;CHEK1;IRF1;ING4;BCLAF1;TNFRSF10B;PLAGL1;IKBKG;APAF1;BOK;AHR;CASP8;NOTCH2;PRKCE;JADE1;STK11;FXR1;BCL2L13;AKAP1;RFK;NCKAP1;TNFRSF25
prerank,positive regulation of translational initiation (GO:0045948),0.443253981566638,0.9017961179682216,0.5528455284552846,1.0,1.0,4/18,10.51%,KHDRBS1;LARP1;CDC123;YTHDF2
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.4523193312542178,0.901771972993922,0.5768115942028985,1.0,1.0,2/13,8.11%,LARGE1;CHST3
prerank,negative regulation of viral genome replication (GO:0045071),0.3997367302977046,0.9016674877306516,0.564625850340136,1.0,1.0,4/40,4.08%,ILF3;FAM111A;ZC3HAV1;MPHOSPH8
prerank,regulation of JNK cascade (GO:0046328),-0.2043949395215348,-0.900937256069805,0.6363636363636364,0.8163564094125265,1.0,21/101,14.18%,MECOM;PRKN;TNFRSF19;SH3RF3;HIPK2;TPD52L1;TAOK2;ZMYND11;ANKRD6;MAP3K5;DUSP3;CYLD;DUSP22;DACT1;SEMA3A;MINK1;APP;HDAC3;PINK1;SH3RF2;SDCBP
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.33908876396509957,-0.9008787717994543,0.5765472312703583,0.8155980799730999,1.0,1/13,0.29%,STAT3
prerank,triglyceride biosynthetic process (GO:0019432),0.43581832789725145,0.9008571487945619,0.5718015665796344,1.0,1.0,8/18,27.37%,LPIN2;AGMO;PCK2;GK;LPIN3;GPAM;LPGAT1;DGAT1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.36509229839588386,-0.9003168712065119,0.593939393939394,0.8159987115476041,1.0,2/10,1.54%,CAMK2D;HECW1
prerank,cellular metal ion homeostasis (GO:0006875),-0.2088517182795127,-0.8995942723087937,0.88,0.8167010220086321,1.0,22/102,16.91%,SLC8A3;ATP1B1;CAV1;RYR2;SLC24A2;DMPK;CDH5;HTR2C;TPT1;ATP1A1;ATP1B3;CHRNA7;ATP1A3;TMCO1;ATP1A2;SLC30A1;ATP2B2;ATP2B3;SLC12A2;RMDN3;HTR2A;PTH1R
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.3093598182544515,-0.8995381370798364,0.5968992248062015,0.8159224062347252,1.0,8/18,21.84%,PTPRZ1;TNFRSF21;NF1;TNFRSF1B;DAAM2;TENM4;SLC45A3;IL34
prerank,ureteric bud morphogenesis (GO:0060675),0.44188020830448566,0.8992339487908799,0.5842391304347826,1.0,1.0,5/16,16.45%,NPNT;BMP2;PKD2;GDNF;SALL1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.3533177095773564,-0.8988646155809511,0.5791139240506329,0.816569230121162,1.0,5/10,18.61%,ERLEC1;OS9;YOD1;SVIP;UBE2G2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.43639283944823093,0.8984817030701924,0.563249001331558,1.0,1.0,6/17,24.23%,CCNE1;HNRNPU;GJA1;TERT;FERMT2;KDM1A
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.4272907630804417,0.8981445697786713,0.5484764542936288,1.0,1.0,4/19,11.54%,MCU;RIPOR2;CAMK1D;RAC1
prerank,RNA interference (GO:0016246),0.4388957172090856,0.8981049774733414,0.5735099337748344,1.0,1.0,3/17,6.18%,AGO2;DHX9;NRDE2
prerank,regulation of dendrite morphogenesis (GO:0048814),0.41490017852425637,0.8979643429855898,0.562137049941928,1.0,1.0,6/32,6.46%,GSK3B;OBSL1;NEDD4;CUX1;RAP2A;CAPRIN1
prerank,protein palmitoylation (GO:0018345),-0.2570980339566452,-0.8975344135626971,0.639344262295082,0.818599620145507,1.0,12/30,23.01%,GLUL;ZDHHC5;CLIP3;ZDHHC1;ZDHHC13;ZDHHC7;ZDHHC8;GOLGA7;ZDHHC16;ZDHHC20;ZDHHC4;ZDHHC17
prerank,mitochondrion organization (GO:0007005),-0.2011138930568584,-0.8971189815843617,0.8333333333333334,0.8185206509210733,1.0,61/165,23.15%,DNM3;PRKN;IMMP2L;SLC25A36;FIS1;DNAJC19;NOS3;ADCK1;MTX2;ESRRA;ALAS1;DNM1;OXA1L;NDUFS1;HSPD1;OMA1;CHCHD2;AIFM1;TFB2M;BNIP3L;BNIP3;TIMM44;CAV2;MEF2A;PARP1;SIRT5;PINK1;SUPV3L1;TOMM70;BCAP31;MPV17;GDAP1;COX7A2;SSBP1;SLC25A4;ATP5F1B;TFAM;MTX3;HIGD1A;USP30;PRDX3;ATP5F1D;AIP;PPARGC1A;FBXO7;TOMM34;BCL2L1;PARK7;ATCAY;POLG2;YME1L1;VPS13D;GABPA;TIMM17B;TIMM17A;TOMM7;ATP7A;FMC1;WDR81;SLIRP;RAB38
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.4285325867957707,0.8968896165976765,0.5643693107932379,1.0,1.0,5/20,15.27%,SPDYA;PSRC1;STOX1;ADAM17;PKD2
prerank,glutathione biosynthetic process (GO:0006750),0.4620249608425016,0.8967728046878207,0.5693215339233039,1.0,1.0,4/11,20.13%,GSS;GCLM;GCLC;HAGH
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.44716948289465963,0.8967397015799181,0.5561643835616439,1.0,1.0,7/13,21.93%,SCAP;DKK3;BMP2;NFKB1;ERLIN1;BMP5;SOD1
prerank,acetyl-CoA metabolic process (GO:0006084),0.4430771515043965,0.8965729210347442,0.5704514363885089,1.0,1.0,5/15,13.44%,PMVK;ACAT1;ACSS1;ACACA;MVK
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.4323889992743953,0.8957144453248099,0.5578947368421052,1.0,1.0,2/18,8.91%,CFAP53;NPHP3
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.35242442159769927,-0.8956501097431679,0.5830903790087464,0.8208064327386875,1.0,3/11,13.81%,NOVA2;PCBP1;IGF2BP2
prerank,regulation of macrophage cytokine production (GO:0010935),-0.33789190746000675,-0.895537389119044,0.6063829787234043,0.8201519040556903,1.0,6/13,29.26%,TGFB2;SEMA7A;TGFB3;CD74;LAPTM5;IRAK3
prerank,regulation of calcium-mediated signaling (GO:0050848),0.4111241388492949,0.8954933925845024,0.5806060606060606,1.0,1.0,3/25,8.10%,ITPR1;MAPT;LRRK2
prerank,polyol metabolic process (GO:0019751),-0.23647963443274148,-0.8953197978405707,0.69,0.8197323277910881,1.0,22/46,29.16%,INPP4B;CALM1;IPPK;PPIP5K2;PLCB3;PLCG1;NUDT3;ITPKB;INPP5D;INPP1;PLCE1;SYNJ1;IMPA1;INPP4A;ITPKC;PLCH1;PLCB1;IMPA2;PLCD1;IP6K1;PLCD3;SLC5A3
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.46073134998080056,0.8951430351879648,0.6049204052098408,1.0,1.0,5/11,21.25%,RSPO3;NKD1;SFRP1;MLLT3;CSNK1E
prerank,maintenance of protein localization in organelle (GO:0072595),0.42852864077723607,0.8951281743695529,0.5683930942895087,1.0,1.0,5/19,14.05%,TAF3;PML;TAPT1;HNRNPU;MORC3
prerank,regulation of T cell mediated immunity (GO:0002709),0.46983972495508797,0.8950749745952867,0.5736994219653179,1.0,1.0,3/10,18.79%,HMGB1;TRPM4;ZBTB1
prerank,positive regulation of ion transport (GO:0043270),-0.24304032119052982,-0.8950224040690516,0.6601941747572816,0.8195321310125607,1.0,19/48,33.26%,ANO6;SNX4;MYLK;KIF5B;CACNB2;SCN1B;VAMP8;CRACR2A;ADRA2A;DRD2;P2RX4;WFS1;P2RX7;SCN4B;RAB3B;PKP2;GPD1L;SCN3B;CACNA1D
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4394293683574584,0.8946306025424018,0.5728155339805825,1.0,1.0,6/16,19.53%,LEPROT;PTPN2;VHL;ADIPOR1;NF2;PARP14
prerank,purine ribonucleotide catabolic process (GO:0009154),0.42669757642360523,0.89436222166548,0.5810635538261998,1.0,1.0,5/21,13.46%,HPRT1;XDH;ACAT1;HINT1;NUDT4
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.4729412423566817,0.894358279114572,0.5695266272189349,1.0,1.0,3/10,19.33%,TICAM1;MIA3;CD68
prerank,positive regulation of cell motility (GO:2000147),0.3741797997444137,0.8942421033026519,0.7057057057057057,1.0,1.0,23/205,7.62%,ARHGEF39;GTSE1;CCDC25;MAP4K4;SYNE2;TWIST2;TRIP6;ROCK2;CEP43;MMP14;DDRGK1;LAMB1;ACTN4;KIT;SPAG9;CCAR1;NTN1;PDPN;MYO1C;PDGFRA;PLAU;PPP3CA;CCN1
prerank,regulation of receptor binding (GO:1900120),-0.3700753465672302,-0.8939649306112931,0.579250720461095,0.8209931912537183,1.0,5/10,25.89%,ADAM15;B2M;ATP2A3;BDNF;PTPRF
prerank,regulation of protein metabolic process (GO:0051246),0.3982908111015211,0.893952462959012,0.6058558558558559,1.0,1.0,4/44,5.75%,FAM83D;ROCK2;CHEK2;FAF1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.4588174156099937,0.8936008786531688,0.5781487101669196,1.0,1.0,2/10,5.31%,UPB1;DPYD
prerank,protein K48-linked ubiquitination (GO:0070936),0.39319965404940826,0.8934053551661912,0.6183783783783784,1.0,1.0,7/54,9.73%,UBE2T;UBE2C;UBE2K;UBR5;UBE2R2;CUL3;SKP2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.37459222989029634,0.8932115078324446,0.6993987975951904,1.0,1.0,49/182,19.53%,RBL1;ATOH8;ATP2B4;RB1;BMPR1A;MOV10;AURKA;ROCK2;AGO2;DDRGK1;SETDB2;WDR54;MAPT;XDH;SFRP2;FBXW7;YAP1;ROBO1;MTMR2;VHL;SLC24A3;PICALM;FLOT2;PARP9;RBMS3;HDAC1;CRKL;BMP2;TERF2;STOX1;TRIM6;NOTCH2;HEY2;YY1;SFRP1;CNOT7;RUNX1;NFKB1;ITGB8;TNRC6C;LDLR;FOXP1;ANKRD13D;RBL2;WNT4;TNRC6B;TERT;HAVCR2;PARP14
prerank,visual perception (GO:0007601),0.37759724437218206,0.892903383942061,0.6377870563674322,1.0,1.0,7/84,8.51%,GPR179;ADGRV1;EYA4;CRYBA1;COL18A1;RDH12;TYR
prerank,positive regulation of vacuole organization (GO:0044090),-0.35573068080998355,-0.8927193901750917,0.5828220858895705,0.82275039412472,1.0,5/10,12.28%,PIP4K2A;PIP4K2B;RALB;GRN;RAB3GAP2
prerank,cellular response to superoxide (GO:0071451),-0.3703173744845454,-0.8926619986912053,0.6028169014084507,0.8219884117885912,1.0,6/10,22.32%,NOS3;SOD2;PRDX2;PRDX1;ADPRS;ATP7A
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.4508543340759754,0.8924683252553938,0.5905172413793104,1.0,1.0,4/12,17.35%,SMARCA4;HDAC1;SFRP1;FOXP1
prerank,ventricular septum morphogenesis (GO:0060412),-0.2735610878090791,-0.8918452446982965,0.6,0.8227932039687702,1.0,11/27,18.03%,ACVR1;SMAD7;TGFBR2;BMPR2;TGFB2;PROX1;SLIT2;SOX4;HEYL;CITED2;ROBO2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.44663948139080345,0.8916049319601475,0.5664739884393064,1.0,1.0,3/11,13.08%,FGFR2;SOX9;LRP5
prerank,regulation of fibroblast proliferation (GO:0048145),0.3973226242107501,0.8915515239499097,0.5984513274336283,1.0,1.0,11/45,16.00%,E2F1;AQP1;DHX9;PDGFRA;B4GALT7;AGT;EMD;DDR2;MORC3;SFRP1;TP53
prerank,gastrulation (GO:0007369),0.45018360009636316,0.8912814345905617,0.5821727019498607,1.0,1.0,5/15,17.44%,MKKS;NPHP3;LRP5;UGDH;SMAD2
prerank,positive regulation of stress fiber assembly (GO:0051496),0.39528529658422673,0.8902789601970101,0.6148723640399556,1.0,1.0,13/44,17.51%,ROCK2;RHOA;LPAR1;SORBS3;TGFBR1;RAC1;ARHGEF10L;SFRP1;NF2;RHOC;FHOD1;CCN2;CD47
prerank,sterol metabolic process (GO:0016125),0.38622198128121765,0.8901785289233421,0.6087888531618435,1.0,1.0,13/60,17.83%,LBR;CYP39A1;CYP26B1;PMVK;SOAT1;ABCA1;SCAP;TM7SF2;SOAT2;FDXR;STARD3;DHCR7;INSIG2
prerank,ureteric bud development (GO:0001657),0.43296943664001464,0.8900404886937995,0.5697050938337802,1.0,1.0,6/17,18.35%,FGFR2;NPNT;BMP2;PKD2;SALL1;OSR1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.19836020768297113,-0.8899261277999502,0.8214285714285714,0.8258171464015159,1.0,29/93,25.01%,TNFRSF19;SH3RF3;HIPK2;TPD52L1;TGFB2;TAOK2;ANKRD6;MAP3K5;DUSP22;MID1;SEMA3A;MINK1;STK25;APP;SH3RF2;SDCBP;VEGFA;ZC3H12A;PRMT1;TIRAP;GADD45B;FLT4;MAP3K11;SPHK1;PTK2B;WNT16;ARL6IP5;MFHAS1;MAPK8IP1
prerank,aorta development (GO:0035904),-0.32042227391470385,-0.8899241647138935,0.6138613861386139,0.8249365951492368,1.0,7/14,18.05%,JAG1;PDGFRB;LRP1;TBX1;PDE2A;ROBO2;TBX2
prerank,iron-sulfur cluster assembly (GO:0016226),0.41201055374326334,0.8896069914993405,0.5819774718397998,1.0,1.0,9/24,22.77%,FXN;NUBP2;CIAO3;MMS19;ISCA2;NUBP1;LYRM4;CIAO2A;NFS1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3633106324750956,-0.8895568647166057,0.5918918918918918,0.8247948000233372,1.0,3/10,8.57%,PDCD4;DNAJA1;PTPN22
prerank,negative regulation of cell activation (GO:0050866),-0.3228152083859474,-0.8894317566531607,0.6079734219269103,0.8241797211419756,1.0,3/14,5.24%,APOE;NOS3;THBD
prerank,negative regulation of protein catabolic process (GO:0042177),-0.23227076963639293,-0.8891941722962692,0.6851851851851852,0.8238483395447505,1.0,5/40,4.91%,SNRNP70;CST3;TIMP3;BANP;SNX3
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4204956888564884,0.8890991853059959,0.5949868073878628,1.0,1.0,4/22,15.67%,KIT;OCIAD2;CRLF3;OCIAD1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.46309791957962587,0.8886436837324576,0.5497702909647779,1.0,1.0,1/10,2.58%,RB1
prerank,regulation of MAPK cascade (GO:0043408),0.37299247050952394,0.8884748633763481,0.6871846619576185,1.0,1.0,26/157,14.55%,FAM83D;MAP4K4;KSR1;ULK4;ROCK2;FGFR2;LPAR1;IAPP;KIT;WDR54;VRK2;STK3;NRK;TGFBR3;JCAD;CCN1;ROCK1;HMGB1;APIP;BMP2;ROR1;RRAS;SPRED1;ADRB2;TRIM5;TAOK1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.40922179522225177,0.8884632703739377,0.6057347670250897,1.0,1.0,15/31,22.36%,CAPRIN1;EFNA1;EPHA4;LRRK2;LZTS3;PDLIM5;ZDHHC15;DBN1;PTEN;SIPA1L1;ABI2;TANC2;CAPRIN2;CDK5;NGEF
prerank,protein localization to organelle (GO:0033365),0.3768649835404318,0.8883923385005458,0.6828282828282828,1.0,1.0,25/133,16.43%,RAB33B;CNTLN;BBS9;WDR35;RPA1;GBF1;OBSL1;IFT140;DDRGK1;PACSIN2;DHX9;PRNP;RPA2;BICD2;LRRK2;TRAM2;EMD;XPA;GAK;EHD1;TOR1B;VAPA;DDX1;CSRP3;CYB5A
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.4245085130218497,0.8880031383708566,0.5847568988173456,1.0,1.0,5/17,13.69%,BMPR1A;BMP2;RBPJ;NOTCH2;HEY2
prerank,dicarboxylic acid transport (GO:0006835),-0.2644180035680035,-0.8880023975091085,0.6523809523809524,0.8254629184468639,1.0,6/28,10.54%,SLC1A2;SLC13A3;SLC25A13;SLC25A12;SLC22A6;GIPC1
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.3199106941983823,-0.8873271330402065,0.6474576271186441,0.8251029507907799,1.0,8/15,28.99%,AP3D1;DTNBP1;BLOC1S2;AP3M1;AP3B2;AP3M2;AP3S1;BLOC1S6
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.3199106941983823,-0.8873271330402065,0.6474576271186441,0.8251029507907799,1.0,8/15,28.99%,AP3D1;DTNBP1;BLOC1S2;AP3M1;AP3B2;AP3M2;AP3S1;BLOC1S6
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.23684116132597025,-0.8872744035738129,0.6436781609195402,0.8243210161970022,1.0,10/46,12.86%,SEMA6A;TIMP3;TLR4;WNK2;EPHB2;DUSP3;LYN;LMO3;SYNJ2BP;SPRY2
prerank,limb development (GO:0060173),0.4051475912698192,0.8869799349040747,0.5819070904645477,1.0,1.0,3/28,6.89%,GLI3;LNPK;MAP3K20
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.34249771747797314,-0.8869246016312329,0.59375,0.8233524462331637,1.0,7/11,42.97%,SHC1;PTK2B;SYK;JAK1;JAK3;IL2RA;IL2RG
prerank,cellular response to interleukin-2 (GO:0071352),-0.34249771747797314,-0.8869246016312329,0.59375,0.8233524462331637,1.0,7/11,42.97%,SHC1;PTK2B;SYK;JAK1;JAK3;IL2RA;IL2RG
prerank,neutral amino acid transport (GO:0015804),-0.2671428398417033,-0.8865696227040146,0.6265060240963856,0.8232446278811009,1.0,9/28,23.76%,SLC6A6;SLC7A5;SLC3A2;SLC1A1;SLC38A5;SLC6A15;SLC36A1;SLC6A7;CTNS
prerank,carbohydrate derivative transport (GO:1901264),-0.29519861945665105,-0.8865130676673707,0.6033057851239669,0.8224752530967836,1.0,4/18,10.95%,PLTP;LBP;SLC15A2;VLDLR
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.45456392765030207,0.8865036733291916,0.5865671641791045,1.0,1.0,3/10,13.08%,FGFR2;SOX9;LRP5
prerank,positive regulation of epithelial cell migration (GO:0010634),0.3755284243677572,0.8849223083012019,0.6494845360824743,1.0,1.0,24/92,15.30%,ATOH8;MAP4K4;ROCK2;ANGPT4;HYAL1;GPI;ANXA3;ENPP2;ANGPT1;AGT;PIK3CB;RAC1;PRKCA;RRAS;SOX9;CTSH;PRKCE;DOCK1;ADAM9;PRKD1;INSL3;AAMP;PRKD2;SRC
prerank,cardiac atrium morphogenesis (GO:0003209),-0.31160877514571705,-0.8847866309640456,0.635036496350365,0.8253543676619197,1.0,3/16,4.80%,BMPR2;TGFB2;PROX1
prerank,vascular process in circulatory system (GO:0003018),0.44933920115289216,0.8838447954851888,0.5934844192634561,1.0,1.0,6/13,19.38%,ROCK2;SCPEP1;ROCK1;ADCY6;GCLM;GCLC
prerank,regulation of tube diameter (GO:0035296),0.44933920115289216,0.8838447954851888,0.5934844192634561,1.0,1.0,6/13,19.38%,ROCK2;SCPEP1;ROCK1;ADCY6;GCLM;GCLC
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3787684547770502,0.8837557833604985,0.6118769883351007,1.0,1.0,23/65,19.48%,FBN1;PEG10;PMEPA1;LEMD3;ADAMTSL2;SMURF1;SMAD6;TGFBR1;SMURF2;NKX2-1;PDPK1;ADAM17;SPRED1;HTRA3;SMAD3;PIN1;SPRED2;VEPH1;SMAD2;LTBP1;SKIL;PPM1A;SKI
prerank,endothelial cell migration (GO:0043542),0.38842275088786804,0.8832603389423476,0.5817535545023697,1.0,1.0,10/37,17.90%,LOXL2;RHOA;ADGRA2;CORO1B;LGALS12;CCN3;NR4A1;PLXND1;RAB13;PLEKHG5
prerank,positive regulation of reproductive process (GO:2000243),-0.2650347909529937,-0.8830713715053773,0.6467391304347826,0.8280078654440038,1.0,11/31,27.97%,PDE3A;GLRA1;CFAP69;LHFPL2;VEGFA;PGAM4;INHBA;TACR3;PRDM9;CACNA1H;PLCB1
prerank,metal ion homeostasis (GO:0055065),-0.24790977721084556,-0.8829257947239552,0.6915887850467289,0.8274479374658253,1.0,7/40,15.29%,TMTC2;CAV1;FAM20A;SELENON;SLC12A9;GRIN1;SLC12A2
prerank,cardiac muscle tissue development (GO:0048738),0.38059148707745905,0.8828082002002806,0.5926748057713651,1.0,1.0,14/50,20.90%,BMPR1A;ADAMTS9;TBX18;BMP2;GJA1;SMAD4;NOTCH2;MAML1;HEY2;CSRP3;ZFPM1;CACNA1G;NDUFV2;BMP5
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.33345708837066623,-0.8825979421644103,0.6101694915254238,0.827278430505775,1.0,1/12,0.80%,IL1R1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3875022116797961,0.8825139296715342,0.5963923337091319,1.0,1.0,4/47,9.66%,SERPINB8;SERPINA9;SERPINE1;AGT
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.32971654213851065,-0.8824825543209969,0.60431654676259,0.8266065176394845,1.0,4/13,20.69%,GLUL;GOT2;GOT1;GLUD1
prerank,eye photoreceptor cell development (GO:0042462),-0.31003572001324137,-0.8823564133463918,0.6094890510948905,0.8259793791250924,1.0,4/15,18.92%,BBS4;RORB;VEGFA;RP1
prerank,cellular response to calcium ion (GO:0071277),0.3738260278651312,0.8822643952929313,0.624332977588047,1.0,1.0,2/67,2.45%,ECT2;ADGRV1
prerank,regulation of immunoglobulin production (GO:0002637),-0.2789072899329827,-0.882063305605338,0.627906976744186,0.8257975157451977,1.0,10/23,33.68%,STX4;EPHB2;VAMP3;DNAJB9;XBP1;CD86;PHB2;PTPRC;RBP4;CLCF1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.3871670111884392,0.8817451975496621,0.5888501742160279,1.0,1.0,4/35,8.16%,PCDHGB4;CDH18;CDH24;PCDHGC3
prerank,regulation of actin nucleation (GO:0051125),0.45237814190558767,0.881575338597062,0.5949008498583569,1.0,1.0,5/12,22.44%,ARFIP1;CORO1B;ARF1;WHAMM;ARPIN
prerank,neuron projection extension (GO:1990138),-0.2551308411025179,-0.8812317966317902,0.6575342465753424,0.8265715171382726,1.0,14/32,24.75%,NRP2;HSP90AB1;SPG11;TMEM108;MAP1B;ULK1;SEMA3A;CTNNB1;CDKL3;SEMA5B;CYFIP1;NRP1;SH3GL2;FLRT3
prerank,glycolytic process (GO:0006096),0.4084852016250087,0.8807593972980016,0.5915151515151515,1.0,1.0,4/28,8.41%,PFKFB1;GCK;GPI;PGM1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.38235916035687034,0.8806069831956492,0.6207264957264957,1.0,1.0,5/66,9.25%,EZH2;KIT;LRRK2;ROBO1;MAP3K4
prerank,regulation of phospholipase activity (GO:0010517),0.4493039944685224,0.880370676305584,0.5874233128834356,1.0,1.0,2/10,12.28%,FGFR2;PDPK1
prerank,response to interferon-beta (GO:0035456),0.42045793189987485,0.8801934297254357,0.5747126436781609,1.0,1.0,6/22,16.19%,UBE2K;IRF1;HTRA2;TRIM6;PNPT1;IFNAR2
prerank,homocysteine metabolic process (GO:0050667),0.46292422615706985,0.8801895299601012,0.6014285714285714,1.0,1.0,3/11,18.03%,MTHFR;NOX4;DPEP1
prerank,skeletal muscle organ development (GO:0060538),-0.27392384063614134,-0.8798654838207584,0.6353591160220995,0.8285234840139506,1.0,8/26,21.77%,MEF2C;CAV1;IGSF8;MYL6;SIX1;STRA6;DISP1;BASP1
prerank,protein-containing complex disassembly (GO:0032984),-0.22277241425219266,-0.8792753802509384,0.7738095238095238,0.8289260019212799,1.0,16/54,19.94%,CAV1;TECPR1;SNX14;RPL23;TSG101;FZD2;SNAP29;CTNNB1;APC;VPS33B;DVL1;VAMP8;LAMP2;LRP6;GABARAPL2;FZD1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3668571205112178,0.8792535573241422,0.787,1.0,1.0,61/348,15.68%,CENPE;TTK;PLK1;SPDYA;ATP2B4;BMPR1A;FNIP1;ROCK2;ANGPT4;UBE2K;DDRGK1;PRNP;SH2D3C;MRE11;RAP2A;LEPR;MUSK;SFRP2;BMP6;ARRB1;FMR1;ENPP2;EFNA1;TXN;CCN1;LRRK2;CD80;MRNIP;AXIN2;ANGPT1;S1PR2;AGT;DDR2;RB1CC1;TGFBR1;P2RY1;CALM2;CRKL;BMP2;RAC1;AKAP9;STOX1;ADAM17;TRIM6;SMAD4;SOX9;PLAUR;SLCO3A1;CAB39;PRKD1;ITGA5;CD44;RAMP3;DOCK7;WDFY2;RPTOR;PIN1;PRKD2;SRC;PRKAG1;FXR1
prerank,negative regulation of macrophage activation (GO:0043031),-0.3137608875247871,-0.8791491823196258,0.5992217898832685,0.8282907333329825,1.0,7/16,29.87%,NR1H3;GRN;SYT11;CX3CL1;ZC3H12A;LRFN5;PTPRC
prerank,protein K48-linked deubiquitination (GO:0071108),-0.28665354723892245,-0.8791143276810653,0.6113744075829384,0.8275041992553149,1.0,8/23,21.13%,OTUD7A;ATXN3;USP8;MINDY1;YOD1;USP33;MINDY2;OTUB1
prerank,vasculature development (GO:0001944),-0.3013834796330584,-0.8789967290001167,0.6338028169014085,0.826887887233623,1.0,8/16,17.97%,BMPR2;ACVRL1;PDGFRB;CDH5;ACVR2B;STRA6;NOTCH4;PIK3CA
prerank,wound healing (GO:0042060),0.37337691040279086,0.8789256617332667,0.6385927505330491,1.0,1.0,13/62,14.18%,HPSE;MACF1;FUT10;SRF;PDGFRA;MYOF;PPP3CA;CORO1B;TGFBR1;SYTL4;SMPD1;MIA3;SMAD3
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.27653478784724456,-0.8783735566334065,0.6889952153110048,0.8273208872110213,1.0,10/23,18.68%,HSP90B1;OS9;UFD1;DERL1;SURF4;SELENOS;PREB;SEC61B;AUP1;SYVN1
prerank,regulation of vasoconstriction (GO:0019229),-0.27150485823117276,-0.8778484340941032,0.6363636363636364,0.8276187614244437,1.0,8/27,15.41%,ECE1;CAV1;PER2;BMPR2;ACE;AGTR1;ADRA1A;CHRM3
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.2821152951408148,-0.8770936560469755,0.6320754716981132,0.8283611661191949,1.0,11/22,41.69%,APOE;CREBL2;MTOR;SORBS1;MLXIPL;ANGPTL3;AKT1;PPARG;CREB1;PPARA;EEF1A2
prerank,negative regulation of cellular process (GO:0048523),0.36654551609727,0.8768912778603453,0.814,1.0,1.0,112/521,18.86%,E2F7;CDKN3;MYBL1;RAD18;PSRC1;CDKN2D;FBXO5;PPM1D;TXNDC12;CDKN2C;RB1;PDS5B;HYAL1;SUZ12;CTCF;CDC6;ALDH1A2;MDM4;ARID2;ANP32B;CASK;SPEF1;PDE3B;COL18A1;CTBP1;BLM;PDPN;NMI;SFRP2;PTPN2;RBBP4;RBBP7;TGFBR3;PML;CCN1;CLMN;IRF1;HTRA2;SMAD6;BTG3;ING4;SMARCA4;NCK1;AXIN2;RIPOR2;KLF11;KANK2;ANGPT1;ABI1;CDA;VHL;NOX4;PIP4P2;SRGAP2;PPP2R5C;PLXNB2;ENPP1;TMEM98;CRLF3;EIF2AK3;PLXNB1;IP6K2;DSCAM;CCN3;BMP2;NDRG3;APPL2;P3H1;NCK2;WNT9A;PLPP1;GJA1;NR4A1;SMAD4;TES;ATF5;PLXND1;ORC6;ADAMTS1;JADE1;PRKD1;MIA3;CDKN1B;SMAD3;FOXM1;STK11;PTPRU;SFRP1;PKD2;NF2;CNOT7;ZBTB7C;TP53;DYSF;PTEN;SESN2;PTPRK;SIRPA;NGF;CCN2;SLURP1;TFAP4;CHMP4B;FRZB;IGFBP3;DNAJB2;SIPA1;PLXNA2;DCBLD2;NIBAN2;SP100;ADNP2
prerank,positive regulation of neutrophil migration (GO:1902624),0.41895980113444903,0.8764786240354409,0.5622377622377622,1.0,1.0,4/18,11.54%,MCU;RIPOR2;CAMK1D;RAC1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.2859242971243946,-0.876453942044556,0.6347826086956522,0.8288109231575645,1.0,5/20,10.99%,HSP90AB1;TXNIP;ANO6;ENTPD1;APP
prerank,hexose transmembrane transport (GO:0008645),-0.2882934414991246,-0.8764399524928401,0.6163793103448276,0.8279805894973217,1.0,7/21,32.57%,SLC2A1;SLC2A3;SLC2A10;SLC45A3;SLC2A9;SLC5A3;SLC45A1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.30787160261603086,-0.8762044541551038,0.6302816901408451,0.8276509932589855,1.0,5/15,30.65%,PRKN;BCL2;TAF9B;CD74;MIF
prerank,neuron apoptotic process (GO:0051402),0.41605729126623814,0.8759573134974413,0.58777633289987,1.0,1.0,2/19,5.12%,CIT;FAM162A
prerank,nucleoside catabolic process (GO:0009164),0.44605519806792837,0.8759230884912984,0.5896296296296296,1.0,1.0,2/11,5.31%,UPB1;DPYD
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.33070657729793324,-0.875828350377644,0.6095890410958904,0.8275553050382214,1.0,6/13,21.19%,TGFBR2;CTNNB1;ENG;VEGFA;NOTCH4;NRP1
prerank,establishment of protein localization to membrane (GO:0090150),0.3754951305275472,0.8757454201396557,0.6169312169312169,1.0,1.0,22/66,23.49%,SYNE3;VPS37B;RAB10;MYO1C;AFDN;VPS37A;ZDHHC18;GORASP2;CHM;ZDHHC15;ATG3;PRKCI;ZDHHC3;ZDHHC21;PIKFYVE;BRAF;ZDHHC24;ICMT;VPS37C;ZDHHC2;ZDHHC14;BID
prerank,regulation of myotube differentiation (GO:0010830),0.4073870614888359,0.8754296439148692,0.5997474747474747,1.0,1.0,6/24,13.39%,MMP14;BHLHE41;HDAC1;CCN3;PIEZO1;MAML1
prerank,protein deacylation (GO:0035601),-0.28469339785969616,-0.8752984517320609,0.625,0.8278279617827885,1.0,10/23,27.05%,LYPLA1;ABHD17C;HDAC5;HDAC3;SIRT5;HDAC7;PPT1;LYPLAL1;LYPLA2;ABHD17B
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.4248750638369599,0.8749406167848998,0.6066225165562914,1.0,1.0,2/18,6.71%,FBN1;FBXW7
prerank,glycogen metabolic process (GO:0005977),0.39879655001096465,0.874846443419889,0.5952380952380952,1.0,1.0,6/27,12.55%,GSK3B;AGL;PYGB;PHKA2;PGM1;GYG1
prerank,tRNA 5'-end processing (GO:0099116),0.4286628869094864,0.8738274268919259,0.5953991880920162,1.0,1.0,5/15,19.87%,RPP40;POP1;RPP30;PRORP;RPP21
prerank,negative regulation of axon extension (GO:0030517),-0.2569449238558823,-0.8734035415254893,0.6424581005586593,0.8308662853993377,1.0,10/30,18.98%,SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;SEMA3B;SEMA3C;CDKL3;MAG;SEMA5B
prerank,neural crest cell differentiation (GO:0014033),-0.29823104048048,-0.8731518477780996,0.6395348837209303,0.8304818225940014,1.0,2/18,1.10%,MEF2C;CDH2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.3772902585312057,0.8729288983452589,0.6315228966986155,1.0,1.0,11/61,12.77%,MAP4K4;LPAR1;RTN4R;AUTS2;NET1;ARRB1;ROBO1;PIK3CB;CRKL;RAC1;NOTCH2
prerank,apoptotic mitochondrial changes (GO:0008637),-0.25083229017093794,-0.8726492447081154,0.6132596685082873,0.8306832342934435,1.0,8/32,13.33%,FIS1;SOD2;ERBB4;NDUFS1;HSPD1;BNIP3;BCL2;CCAR2
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.26093999893554526,-0.8725896362566968,0.6889952153110048,0.829933129759366,1.0,13/26,33.78%,CALM1;FKBP1A;GNB5;ATP1A2;SRI;ADRA2A;CALM3;DRD2;GSTM2;GSTO1;CASQ2;PLN;CBARP
prerank,negative regulation of cell cycle (GO:0045786),0.3705442581592653,0.8724403117612616,0.6504751847940866,1.0,1.0,17/73,18.66%,PLK1;RB1;SCRIB;HTRA2;BTG3;GAS1;BMP2;IPO7;NR4A1;CDKN1B;SMAD3;IPO5;PTEN;PTPRK;ANGEL2;TFAP4;SIPA1
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.2895239139639755,-0.871985194413072,0.6437768240343348,0.8303647020760643,1.0,5/18,18.32%,PUM1;DDX60;UFD1;RNF125;BIRC3
prerank,Rho protein signal transduction (GO:0007266),0.38013523542088257,0.871495191143163,0.625945945945946,1.0,1.0,10/53,10.40%,ROCK2;RHOA;NTN1;PDPN;CDC42EP2;GNA13;ROCK1;EPS8L1;ARHGAP6;MYO9B
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.37094469944576386,0.8702341350377994,0.7106339468302658,1.0,1.0,19/113,15.27%,TGM1;HMGB2;VASH2;HYAL1;FGFR2;LAMB1;BMP6;TCF7L2;YAP1;TGFBR1;BMP2;PRKCA;NR4A1;SOX9;NOTCH2;PRKD1;ARNT;SFRP1;PRKD2
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.3549230574358374,-0.8700640532525968,0.6442307692307693,0.8334731232488817,1.0,4/11,17.81%,MEF2C;LYN;PIK3CD;LGALS9
prerank,leukotriene metabolic process (GO:0006691),0.4148570993584394,0.869695346424168,0.5994623655913979,1.0,1.0,6/19,20.66%,PTGR1;ABCC10;MGST3;DPEP1;DPEP2;MAPKAPK2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.37365545972769376,0.8695475213516903,0.6585623678646935,1.0,1.0,12/65,14.28%,AURKB;AURKA;PSMC2;PSMD5;FBXL7;CHEK1;PSMB1;PSMD14;PSMD1;PSMB9;USP47;PSMC6
prerank,establishment of vesicle localization (GO:0051650),-0.2891279818629017,-0.8695094267167476,0.6482213438735178,0.8337182975292131,1.0,7/18,18.34%,SPG11;KIF5B;KIF5C;SYT11;SYNJ1;RAB27A;RAB11A
prerank,keratinocyte differentiation (GO:0030216),0.3922875961567348,0.8694243423539202,0.6185935637663885,1.0,1.0,5/29,13.73%,TGM1;ANXA1;CLIC4;MED1;ADAM9
prerank,positive regulation of viral process (GO:0048524),0.37376830811777895,0.8693084784065175,0.6429341963322546,1.0,1.0,13/60,19.23%,KPNA2;DHX9;POLR2A;LARP1;TMEM39A;SRPK1;PPID;PABPC1;CNOT7;AXL;SRPK2;PKN2;POLR2B
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3694496901806142,0.8690227313945122,0.695959595959596,1.0,1.0,51/129,25.03%,FGFR2;PSMC2;RNF220;PSMD5;TBL1XR1;ADGRA2;SFRP2;WNK1;UBR5;LRRK2;PSMB1;PSMD14;AXIN2;LRRK1;PSMD1;SMURF2;PSMB9;TRPM4;CSNK1G2;USP47;XIAP;PSMC6;PIN1;SFRP1;NFKB1;AMER1;FAM53B;CSNK1G1;PSMB2;PSME4;PSMB7;ZEB2;CAPRIN2;PPM1A;PSMD11;LGR4;COL1A1;SEMA5A;PSME3;CSNK1E;PSMD13;PSMB8;GPRC5B;PSMD4;WLS;PSMF1;GPC3;AXIN1;PSMA5;TGFB1;PSMC3
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.294249298085854,-0.8688703208170391,0.6278195488721805,0.8342875152736574,1.0,8/17,25.75%,AR;ATP1A1;ABHD2;ATP1A3;ATP1A2;URI1;BMP7;GPER1
prerank,vasculogenesis (GO:0001570),-0.2580975693842795,-0.8684207294496185,0.6377952755905512,0.8342776156116466,1.0,9/32,14.84%,CAV1;TGFBR2;PDGFRB;RAMP2;RASIP1;CUL7;ENG;VEGFA;SOX17
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.2653945786683207,-0.8683904529532228,0.69377990430622,0.8334668336179357,1.0,8/23,18.39%,CAV1;TSG101;DUSP22;SOCS5;ZGPAT;SRCIN1;CBLB;CBL
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.2076917182757007,-0.8683790345245979,0.8103448275862069,0.8326401305641182,1.0,32/65,34.77%,SH3KBP1;ARAP1;STAM2;DUSP3;EPN1;TSG101;TGFA;BCAR3;GRB2;SPRY2;HIP1;RHBDF1;ARHGEF7;AFAP1L2;CBL;PTPN12;DGKD;HBEGF;RHBDF2;SH3GL2;MVB12A;GPER1;SHKBP1;ZFYVE28;EGF;NEU3;RNF126;AKT1;MVB12B;PDE6H;DOK1;CDH13
prerank,regulation of mitochondrion organization (GO:0010821),0.3767958669697274,0.8675475796935281,0.617877094972067,1.0,1.0,10/47,12.03%,MIEF2;GSK3B;IAPP;MAPT;RHOT1;FBXW7;LRRK2;HTRA2;CSNK2A2;STOX1
prerank,response to retinoic acid (GO:0032526),0.37229033616411283,0.8673237234595117,0.6327193932827736,1.0,1.0,9/59,12.97%,AQP1;CDKN2D;SETX;ASXL1;HTRA2;WNT6;WNT9A;SOX9;CTSH
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.43137137132058734,0.8672887534559696,0.5977653631284916,1.0,1.0,5/16,12.27%,BMPR1A;FGFR2;TGFBR3;PIM1;RBPJ
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.3499651829997188,-0.8667397018447861,0.6276923076923077,0.834278580492468,1.0,2/10,5.26%,MAP2K5;KLF4
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.3499651829997188,-0.8667397018447861,0.6276923076923077,0.834278580492468,1.0,2/10,5.26%,MAP2K5;KLF4
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.4106362841309317,0.8666610787382156,0.6005188067444877,1.0,1.0,6/21,17.35%,CBFB;ELF2;ELF1;PRKCB;RUNX1;FOXP1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.292467175172133,-0.8664128716860862,0.6741071428571429,0.8341162272865386,1.0,7/19,19.95%,BPNT2;TPST1;SLC35B3;TPST2;ABHD14B;SLC26A2;PAPSS1
prerank,protein dephosphorylation (GO:0006470),0.3633073404435316,0.8661451850488034,0.698685540950455,1.0,1.0,39/135,19.78%,PPM1G;PPM1D;EYA4;LHPP;TAB1;PPP2R3A;SSH2;PTPN2;PPP3CA;NCK1;DUSP12;MTMR2;PPP2R5C;EYA2;PTPN21;PTPRS;FBXW11;PPP1CC;RPRD1A;PPP2R2D;BTRC;PPP1R15B;PTPN13;STK11;PTPRA;MTMR3;PTPRU;DAPP1;PPP2R5B;PTEN;PPP2R1B;UBLCP1;PTPRK;PTPRE;RPRD1B;DUSP7;PPM1A;PTPN1;PTPN5
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4163407725296694,0.8661320804735221,0.6290726817042607,1.0,1.0,10/21,22.93%,MACF1;ROCK2;RHOA;ROCK1;PTPRA;EPHA3;CLASP1;LDB1;VCL;SLK
prerank,cytosolic calcium ion transport (GO:0060401),0.3977012574434369,0.8655616307781904,0.6022304832713755,1.0,1.0,11/28,20.46%,MCU;ATP2A2;SLC8A1;MCUB;CACNA1C;ATP2B1;MICU1;ITPR3;MAIP1;JPH1;MICU2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4450776172468839,0.8650623553469096,0.6118518518518519,1.0,1.0,4/11,15.32%,LEPROT;VHL;ADIPOR1;NF2
prerank,negative regulation of potassium ion transport (GO:0043267),-0.3339011015372728,-0.8648713141034948,0.6419354838709678,0.8363901746233566,1.0,5/13,23.61%,CAV1;BIN1;NOS1;NEDD4L;PTK2B
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.37185973464856475,0.8643491882513415,0.6819603753910324,1.0,1.0,15/86,13.29%,CDK5RAP2;PSRC1;RB1;MYLK3;NUMA1;MAPT;CDC42EP2;NCK1;DRG1;RAC1;AKAP9;NCK2;SYNPO2;BAIAP2L1;PRKCE
prerank,regulation of TOR signaling (GO:0032006),0.3721922171789953,0.8642315016949514,0.6755888650963597,1.0,1.0,13/67,17.52%,FAM83D;FNIP1;TNFAIP8L1;DEPDC5;DYRK3;TBC1D7;NPRL3;SLC38A9;ITFG2;RPTOR;LARS1;LAMTOR3;LAMTOR5
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.2935545309160267,-0.864139311992371,0.6818181818181818,0.8370377422750939,1.0,4/19,10.44%,APOE;RIC3;CHRNA7;CHRFAM7A
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.32946441621323097,-0.863720048941157,0.6143790849673203,0.8361535473690215,1.0,7/11,32.97%,CALM1;FKBP1A;SRI;CALM3;GSTM2;GSTO1;CASQ2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.32946441621323097,-0.863720048941157,0.6143790849673203,0.8361535473690215,1.0,7/11,32.97%,CALM1;FKBP1A;SRI;CALM3;GSTM2;GSTO1;CASQ2
prerank,sensory perception (GO:0007600),-0.22742706639353036,-0.8636051976600984,0.7,0.835519202977121,1.0,9/45,14.02%,PCDH15;GNAL;SCN9A;WHRN;BBS4;OPRM1;CHRNA7;KCNA2;TMEM150C
prerank,negative regulation of cell growth (GO:0030308),0.36510775757631786,0.8629677174706141,0.6971544715447154,1.0,1.0,32/121,19.09%,PSRC1;CDKN2D;CDKN2C;RB1;HYAL1;RTN4R;SFRP2;RBBP7;PML;SMARCA4;CDA;ENPP1;CRLF3;IP6K2;PTPRS;CCN3;NDRG3;ULK2;GJA1;SMAD4;JADE1;CDKN1B;SMAD3;STK11;SFRP1;TP53;SESN2;FRZB;DNAJB2;SIPA1;DCBLD2;CAPRIN2
prerank,sensory perception of sound (GO:0007605),0.3671631824385754,0.8616893927407692,0.6639344262295082,1.0,1.0,9/88,12.43%,BIRC5;ADGRV1;KIT;MKKS;NIPBL;RIPOR2;ROR1;LHFPL5;HOMER2
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.2878973845755509,-0.861686069173676,0.6565217391304348,0.8385537676113731,1.0,8/19,20.27%,PRKN;USP36;SREBF2;CAMKK2;PINK1;GSK3A;FBXO7;PARK7
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4144835155891249,0.8614137193205252,0.6056701030927835,1.0,1.0,4/22,9.53%,ROCK2;EFNA1;EPHA4;PICALM
prerank,positive regulation of cell killing (GO:0031343),-0.31061449329306073,-0.8612027634851072,0.6470588235294118,0.8386005772236523,1.0,2/13,10.02%,MAPK8;NOX1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.36061674380976205,0.8610461107227906,0.7497497497497497,1.0,1.0,50/186,18.82%,GLI3;WWOX;GSK3B;PSMC2;PSMD5;BICC1;TRABD2B;NLK;SIAH2;MCC;STK3;SFRP2;RNF43;TCF7L2;HMGXB4;WWTR1;PSMB1;CUL3;PSMD14;AXIN2;NPHP3;TMEM64;LIMD1;PSMD1;EMD;DKK3;PSMB9;RBMS3;HDAC1;BMP2;LMBR1L;LZTS2;SOX9;JADE1;PSMC6;TLE4;RUVBL2;STK11;NKD1;PTPRU;SFRP1;TLE3;NOTUM;AMER1;MLLT3;CSNK1A1;PSMB2;FRZB;PSME4;PSMB7
prerank,regulation of phospholipid metabolic process (GO:1903725),0.44900638786868285,0.860960161760278,0.6032689450222882,1.0,1.0,4/10,14.94%,MTMR1;MTMR2;MTMR9;MTMR3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.23466489627551979,-0.8609375728626736,0.7619047619047619,0.8382473671971666,1.0,21/45,39.87%,STAT3;MALT1;TLR4;APP;PANX1;LGALS9;TRIM16;EGR1;HSPB1;JAK2;P2RX7;TMEM106A;TYROBP;CCL19;NOD2;USP50;PYCARD;MYD88;FZD5;AGER;CASP1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.42386348868385465,0.8609057211045346,0.592032967032967,1.0,1.0,5/14,15.24%,RFLNA;TGFBR1;WNT9A;SOX9;EFEMP1
prerank,phospholipid biosynthetic process (GO:0008654),0.38021323874981133,0.8606523260720338,0.6020524515393386,1.0,1.0,5/36,13.28%,DHDDS;LPCAT1;SRD5A3;AGK;AGPAT3
prerank,negative regulation of signaling (GO:0023057),-0.26285546052878556,-0.86059992899828,0.6932515337423313,0.8380963696854843,1.0,5/25,13.39%,ACVR1;GLRA1;SOCS5;OPRM1;HHIP
prerank,xenobiotic transport (GO:0042908),-0.2894460154231774,-0.8605125912354962,0.6758893280632411,0.8374181517570516,1.0,4/17,13.99%,SLC7A5;ABCG2;SLC15A2;ABCC5
prerank,sphingoid metabolic process (GO:0046519),-0.3277286692636511,-0.8603537080265653,0.6445086705202312,0.8368782541085251,1.0,8/12,38.31%,PLPP3;DEGS2;ASAH2;SPHK1;KDSR;SPHK2;SGPP1;PLPP2
prerank,regulation of B cell differentiation (GO:0045577),0.4194238783116296,0.8602746451077713,0.6057692307692307,1.0,1.0,4/17,15.25%,MMP14;BTK;IL4I1;SFRP1
prerank,negative regulation of T cell proliferation (GO:0042130),0.40091763502342903,0.8600435764997062,0.6081730769230769,1.0,1.0,5/28,14.16%,PRNP;SCRIB;CD80;IL4I1;RC3H1
prerank,negative regulation of peptidase activity (GO:0010466),0.3713206651213792,0.8598390000368922,0.6308040770101925,1.0,1.0,4/47,9.66%,SERPINB8;SERPINA9;SERPINE1;AGT
prerank,regulation of postsynapse organization (GO:0099175),0.398330423753671,0.8597044685709213,0.6251497005988024,1.0,1.0,9/28,18.82%,ARHGAP22;EPHA4;LRRK2;LZTS3;PDLIM5;ZDHHC15;SIPA1L1;ABI2;TANC2
prerank,intracellular protein transport (GO:0006886),0.36225562869905986,0.8596270082892189,0.8108108108108109,1.0,1.0,78/304,19.61%,ANKLE1;CCHCR1;RANBP17;USP6NL;NUP155;XPO1;RANGRF;STX11;RPAIN;TRAK1;E2F3;AP4M1;XPO4;ARFIP1;FUT10;EVI5L;TBC1D25;SNX1;TNPO1;MYO1C;TBC1D13;NUP85;EIF4ENIF1;CSE1L;WDR11;TPR;VPS26C;TBC1D2B;RAB22A;RAB29;STAM;STXBP2;SMURF1;STX2;SRPRA;RAB1A;COPB2;SNX27;VIPAS39;COPZ1;HERC2;AP3B1;IPO7;APPL2;NUP214;SCFD1;EHD1;STRADA;IPO11;IFT27;ARF4;NXT1;NUP133;MAIP1;ARL4A;IPO5;STX12;NUP42;ARF3;STXBP1;TBC1D9;VPS26A;TMED3;NXT2;FAM53B;USO1;RIC1;ACD;ARL5A;TMED10;EGR2;TBC1D12;STRADB;IPO9;TBC1D10A;BCS1L;NUP188;KIF13B
prerank,actin filament bundle assembly (GO:0051017),0.38806004132360294,0.859611953688455,0.6269185360094451,1.0,1.0,12/33,22.60%,ADD2;CORO1B;EZR;DPYSL3;DMTN;BAIAP2L1;LCP1;ADD1;SHROOM2;SHROOM1;MYO1B;PLS1
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.3073685765239292,-0.8591529980216165,0.650375939849624,0.8384452886442293,1.0,8/16,32.95%,EP300;NAA25;KAT2B;NAA80;NAA30;CREBBP;NAA10;NAA16
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.3587223831885329,-0.8588696388592585,0.6705539358600583,0.838135538126251,1.0,2/10,3.88%,SMAD7;MALT1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.39221762248097625,0.8586959904375951,0.6026894865525673,1.0,1.0,6/24,17.55%,ACTR3;AUTS2;RAC1;WASF2;NCKAP1;ABI2
prerank,neuron projection morphogenesis (GO:0048812),0.3598804774349349,0.8584423517633796,0.7176113360323887,1.0,1.0,15/137,10.99%,KIF20B;MAP4K4;ALCAM;FGFR2;RAB10;NRK;LRRK2;ANKRD27;FARP1;DSCAML1;DNM2;ROCK1;SRGAP2;EPB41L3;PLXNB1
prerank,mesoderm development (GO:0007498),-0.2906455855229944,-0.858399266534029,0.6885245901639344,0.8381928087473548,1.0,6/18,14.73%,FOXC2;TBX3;TIE1;TBX1;BMX;VEGFA
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.2623863271788744,-0.8582893884394216,0.6963350785340314,0.8375904236089153,1.0,11/27,22.11%,MAPK8;CUL1;TAOK2;MAP3K5;MAPK3;MAPK1;CHUK;MAP2K7;UBB;UBC;RPS27A
prerank,chondroitin sulfate metabolic process (GO:0030204),0.38353245400720537,0.8581318546594388,0.6057347670250897,1.0,1.0,8/30,17.28%,CHST15;HYAL1;CHSY1;CHST3;DSE;BGN;UGDH;ARSB
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.40499919496416814,0.8578537009678874,0.6085319949811794,1.0,1.0,5/24,10.32%,MIEF2;PRNP;PDZK1;MYO1C;MIEF1
prerank,negative regulation of protein binding (GO:0032091),0.37035084547621433,0.8577061940207684,0.6642027455121436,1.0,1.0,17/71,19.92%,AURKB;DDX11;AURKA;GSK3B;LRRK2;ATP2A2;ROCK1;PSME3IP1;MITD1;NES;ADRB2;PIN1;DNAJB2;STYX;PRKCD;ZFPM1;IFIT2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.37491056833798553,0.8575271906956715,0.6353467561521253,1.0,1.0,12/45,18.95%,DYRK1A;SETX;NMD3;POLR2A;DXO;NFKB1;TP53;ZC3H18;PNPT1;HNRNPLL;RIPK1;SLC38A2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.4373487590040433,0.8570548354298887,0.5913669064748202,1.0,1.0,2/12,12.24%,SOAT1;SOAT2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.38950543279480826,0.8565472476240248,0.636150234741784,1.0,1.0,10/35,15.30%,RBFOX2;NEDD4;PMEPA1;ARID1A;UBR5;YAP1;NR3C1;PLPP1;MED1;SRC
prerank,regulation of macromolecule metabolic process (GO:0060255),0.357374284868066,0.8564591454648204,0.75,1.0,1.0,32/170,17.35%,TCF19;TRIML2;ROCK2;CTCF;HNRNPD;UBAP2;AFF3;YBX3;CIAO3;CDK2;ZFP64;MTMR1;MTMR2;SLC8A1;MTMR9;AHR;ZUP1;STOX1;FUBP1;TRIM6;TOB2;MKLN1;TRIM5;ZNF445;MTMR3;PIN1;GDNF;ZNF507;PRDM10;SIRPA;LDLR;FOXP1
prerank,bile acid biosynthetic process (GO:0006699),-0.26418134860528586,-0.8561588385448627,0.6273584905660378,0.8410287522794684,1.0,7/24,21.23%,OSBPL6;CYP7B1;SCP2;OSBPL7;OSBP;AMACR;OSBPL2
prerank,positive regulation of T cell proliferation (GO:0042102),0.36797639453407993,0.8545569528602032,0.661925601750547,1.0,1.0,7/55,12.17%,FADD;IL18;CD80;NCK1;HMGB1;ANXA1;NCK2
prerank,regulation of endopeptidase activity (GO:0052548),0.37086505537034126,0.8543490775993505,0.6582969432314411,1.0,1.0,7/59,11.17%,SERPINB8;SERPINA9;SERPINE1;PICALM;AGT;PSMB9;HDAC1
prerank,negative regulation of growth (GO:0045926),0.35988313751506823,0.8542406313500486,0.7155870445344129,1.0,1.0,32/121,19.09%,PSRC1;CDKN2D;CDKN2C;RB1;HYAL1;SFRP2;RBBP7;PML;ING4;SMARCA4;CDA;ENPP1;CRLF3;IP6K2;CCN3;NDRG3;GJA1;SMAD4;NOTCH2;JADE1;CDKN1B;SMAD3;STK11;SFRP1;TP53;PNPT1;SESN2;FRZB;DNAJB2;SIPA1;DCBLD2;CAPRIN2
prerank,negative regulation of neuron death (GO:1901215),0.3595989065371523,0.8540415053038616,0.6783867631851086,1.0,1.0,12/93,15.37%,KIF14;GSK3B;LRRK2;KDM2B;HTRA2;IKBKG;CNTF;NENF;PRKCI;BTBD10;SLC30A10;GDNF
prerank,mRNA processing (GO:0006397),0.35684219988360055,0.8538437013632227,0.817,1.0,1.0,79/287,19.95%,RBM15;SYNCRIP;PPIL1;SNRNP25;SRSF4;HNRNPD;TRA2B;CSTF3;FIP1L1;DHX9;HNRNPA1;SRSF10;CCAR1;UPF3B;RAVER2;LSM3;ERCC3;DDX39B;PRPF40A;PSPC1;HNRNPH1;PRPF19;FUS;SRSF7;POLR2A;DHX8;HNRNPUL1;PRPF3;WDR33;NONO;SF3A2;PCF11;SRSF3;LSM2;HNRNPU;SFPQ;SNRNP48;HNRNPL;SRRM1;RBM15B;SNRNP35;CPSF4;HNRNPH2;RNGTT;SF3B3;RPRD1A;LSM7;SNRNP27;RBM4;WBP4;PABPC1;AQR;UBL5;KIN;HNRNPA2B1;RBM19;ZCCHC8;PPWD1;LSM4;METTL3;RALY;RBM10;DHX38;PRPF4;PRPF18;GEMIN7;CWC25;BUD13;PDCD7;CWC22;RPRD1B;CDC5L;POLR2B;DNAJC8;HNRNPR;SNRPB;TRA2A;ERCC2;SF3A3
prerank,erythrocyte development (GO:0048821),0.43602726902899086,0.8534582202968369,0.6126543209876543,1.0,1.0,4/10,16.97%,ABCB10;DMTN;MED1;ALAS2
prerank,ketone body metabolic process (GO:1902224),0.4438252212234858,0.8531789831988477,0.6352395672333848,1.0,1.0,3/10,18.94%,ACAT1;AACS;BDH2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3826506858533408,0.8531513221466932,0.6168446026097272,1.0,1.0,15/34,25.79%,TRIOBP;LIMS1;CRKL;RAC1;DMTN;DOCK1;DOCK5;RREB1;FERMT2;FLNA;S100A10;CRK;MYADM;P4HB;CDC42
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.27072867551822855,-0.8531462985143423,0.6854460093896714,0.8459661374044244,1.0,6/21,20.20%,GUCY1A1;NPR1;ADCY3;ADCY8;ADCY4;AMPD2
prerank,regulation of peptide hormone secretion (GO:0090276),-0.19986596808611062,-0.8530019769534749,0.8,0.8453853036544429,1.0,15/67,19.81%,SLC2A1;KCNC2;PER2;RAP1A;KCNB1;HTR2C;SYT7;HADH;KCNS3;SNAP25;UQCC2;ADRA2A;PICK1;CACNA2D2;RAPGEF3
prerank,positive regulation of inflammatory response (GO:0050729),-0.20013870614588247,-0.8529437060809631,0.7674418604651163,0.8446611871037932,1.0,20/86,19.38%,SNX4;TLR4;PDCD4;GPR4;IFI35;LBP;RPS19;GRN;CD81;APP;AGTR1;CX3CL1;NUPR1;OSMR;VAMP8;PLA2G7;FEM1A;PDE2A;CCN4;KARS1
prerank,regulation of exosomal secretion (GO:1903541),-0.29142554918153274,-0.8524808152914851,0.696,0.8448129305235784,1.0,5/19,15.27%,PRKN;VPS4B;TSG101;SDCBP;ATP9A
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.3388888836367966,-0.8524023457655111,0.6298701298701299,0.8441251601204908,1.0,4/11,20.76%,NBL1;SLIT2;DUSP1;PADI2
prerank,muscle cell differentiation (GO:0042692),-0.2478323798219779,-0.8523872900433017,0.718562874251497,0.8433204675348303,1.0,6/32,13.14%,MEF2C;SYNE1;SPEG;NEBL;MRTFB;TBX1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4083255564911683,0.8523062080859036,0.6040609137055838,1.0,1.0,3/23,4.90%,PFKFB1;GCK;ERFE
prerank,cell projection organization (GO:0030030),0.3848148045381329,0.8521590299890296,0.6111771700356718,1.0,1.0,8/30,16.51%,PARVA;PACSIN2;RHOQ;NPHP1;RAC1;ITGB1;CAPG;NCKAP1
prerank,response to purine-containing compound (GO:0014074),-0.2903969931799646,-0.8515313996664652,0.6666666666666666,0.8441256521709337,1.0,9/17,32.64%,RYR2;TRPC3;DGKQ;NDUFS4;P2RX4;P2RX7;ABCC9;P2RY6;VGF
prerank,entry into host (GO:0044409),-0.31242468174429405,-0.8508041340393566,0.6725352112676056,0.8446931064517171,1.0,6/13,18.39%,CTNND1;CTNNB1;MET;GRB2;CBLL1;CBL
prerank,carboxylic acid transmembrane transport (GO:1905039),0.37773201270242635,0.8507419199604587,0.6554054054054054,1.0,1.0,6/40,13.24%,SLC25A21;SLC38A7;SLC38A4;SLC19A1;SLC38A9;SLC25A30
prerank,response to peptide (GO:1901652),-0.23912052283237928,-0.8505863113560693,0.7044025157232704,0.8443261340754299,1.0,7/33,13.44%,STAT3;GNAI1;STAT6;CACNA1B;CHRNA7;IRS1;MMP2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3540091467646594,0.8505032145344293,0.773,1.0,1.0,40/208,18.70%,ECT2;TRIML2;FADD;MAP3K14;TICAM1;MIER1;RHOA;LPAR1;TRIM59;UBE2N;RNF31;TNFRSF10B;RIOK3;MAP3K3;IKBKG;CXXC5;PRKCB;RORA;ROR1;PDPK1;TRIM6;GJA1;CASP8;BRD4;DDX21;PLK2;PRKD1;TRIM5;PER1;VAPA;OTUD7B;RHOC;DDX1;MAVS;TNFSF10;LAMTOR5;PLEKHG5;TERF2IP;ANKRD17;RIPK1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.39680169215855704,0.850120452425434,0.6254681647940075,1.0,1.0,6/25,12.83%,SRSF4;TRA2B;SRSF10;PRPF3;SRRM1;SF3B3
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.4128178763867931,0.8498879750284112,0.6267029972752044,1.0,1.0,4/16,12.46%,UPB1;DPYD;DPYSL4;DPYSL3
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.39208085942424187,0.8493564527858988,0.6119951040391677,1.0,1.0,7/27,12.85%,STMN1;ARHGAP28;CGNL1;TMEFF2;ARHGAP6;ARHGEF18;WASF2
prerank,positive regulation of phospholipase activity (GO:0010518),0.38893277709544516,0.849296941747593,0.6017925736235595,1.0,1.0,6/22,13.94%,FGFR2;KIT;PDGFRA;GNA13;PDPK1;ARF4
prerank,chemical homeostasis (GO:0048878),-0.20676063810109716,-0.8491523825529002,0.8307692307692308,0.846236162499602,1.0,27/61,33.18%,ABHD5;ADCK1;WNK2;SLC4A7;TLCD2;IRS2;PNPLA8;NR1D2;NR1H3;KLHL3;SLC4A8;TLCD3A;AQP11;TENT4B;USF2;USF1;NEDD4L;EIF5A2;ABHD8;PNPLA2;CLN8;DDX3X;PNPLA3;VGF;TLCD1;ANGPTL3;FITM2
prerank,lipid homeostasis (GO:0055088),-0.20939291508825508,-0.8489777108812661,0.8115942028985508,0.8457114394674596,1.0,26/57,33.18%,APOE;ABHD5;ADCK1;TLCD2;IRS2;PRKAA1;PNPLA8;NR1D2;NR1H3;RCN3;TLCD3A;XBP1;USF2;USF1;ABCA2;ABHD8;PNPLA2;CLN8;ORMDL1;DDX3X;PNPLA3;DGAT2;MLXIPL;TLCD1;ANGPTL3;FITM2
prerank,nucleotide-sugar metabolic process (GO:0009225),0.42712024976494045,0.848672217622968,0.5994152046783626,1.0,1.0,1/12,2.52%,GMDS
prerank,sensory perception of light stimulus (GO:0050953),0.3580956979010393,0.8485309741522947,0.6860706860706861,1.0,1.0,7/87,8.51%,GPR179;ADGRV1;EYA4;CRYBA1;COL18A1;RDH12;TYR
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.29571836274906604,-0.8483241583991943,0.6717557251908397,0.8461199758133526,1.0,3/18,11.54%,MTUS1;LYN;SLIT2
prerank,positive regulation of translation (GO:0045727),0.35683901710589444,0.848322975412354,0.7128205128205128,1.0,1.0,22/94,17.16%,LARP4B;AGO2;HNRNPD;KHDRBS1;DHX9;PRKDC;UPF3B;SAMD4A;FMR1;YBX3;LARP1;USP16;CDC123;YTHDF2;PLXNB2;METTL5;EIF3C;LARP4;PASK;FXR1;METTL3;PYM1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3564281630862819,0.8482952457924129,0.7530120481927711,1.0,1.0,48/161,19.72%,GLI3;GSK3B;PSMC2;PSMD5;BICC1;SIAH2;MCC;STK3;SFRP2;TCF7L2;WWTR1;PSMB1;CUL3;PSMD14;AXIN2;NPHP3;TMEM64;LIMD1;PSMD1;EMD;DKK3;PSMB9;RBMS3;HDAC1;TBX18;BMP2;LMBR1L;LZTS2;SOX9;JADE1;PSMC6;TLE4;RUVBL2;STK11;NKD1;PTPRU;SFRP1;TLE3;NOTUM;AMER1;MLLT3;CSNK1A1;PSMB2;FRZB;PSME4;PSMB7;TMEM131L;PSMD11
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4130010616284773,0.8482335846231909,0.6188679245283019,1.0,1.0,2/20,3.95%,STMN1;ADA
prerank,negative regulation of neuron projection development (GO:0010977),0.37629358366365045,0.8480721852872818,0.6724700761697497,1.0,1.0,18/56,17.85%,RHOA;LPAR1;RTN4R;EFNA1;RAB29;EPHA4;DENND5A;PTPRS;BAG5;GAK;DPYSL3;HDAC2;EFNB2;ADCY6;PTEN;STMN2;TRPV4;MYLIP
prerank,mucosal immune response (GO:0002385),-0.3068836627649736,-0.8475685183533427,0.622568093385214,0.8467439235959057,1.0,2/15,10.61%,DEFA6;RPL39
prerank,regulation of T cell activation (GO:0050863),-0.22494391420113008,-0.8473471788415149,0.7560975609756098,0.8463342156548954,1.0,7/42,11.67%,CYRIB;DUSP3;PRKCQ;PTPN22;HSPD1;ABL1;TNFRSF1B
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.36176541826487124,0.8473139905351733,0.6496272630457934,1.0,1.0,24/67,18.50%,ROCK2;RHOA;VAV2;SULF1;NCK1;ABI1;ROCK1;CYBB;PIK3CB;SH2D2A;RAC1;NCK2;WASF2;MAPKAPK3;DOCK1;PRKD1;ITGAV;AAMP;PRKD2;SRC;NCKAP1;AXL;SHB;MAPK14
prerank,activation of protein kinase A activity (GO:0034199),-0.29854255203062846,-0.8472471079812925,0.68,0.8456925339070295,1.0,5/16,14.63%,PRKACB;PRKAR1B;ADCY3;ADCY8;ADCY4
prerank,triglyceride catabolic process (GO:0019433),0.41245768616463613,0.8471756391914133,0.6047430830039525,1.0,1.0,2/19,14.80%,FABP12;LPL
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.3914073528335916,0.8470004895263055,0.61003861003861,1.0,1.0,5/21,16.52%,CHST15;CHSY1;CHST3;BGN;UGDH
prerank,cellular response to nutrient levels (GO:0031669),-0.21041208531678757,-0.8469799239918646,0.7857142857142857,0.8453950147679141,1.0,23/62,25.22%,FOXO1;KCNB1;BMPR2;WDR45B;RALB;EIF4G1;PRKAA1;ULK1;VPS41;MTOR;SREBF2;KLF10;RRAGC;LAMP2;USP33;XBP1;TFEB;MFSD2A;TSC1;PDK2;MAP1LC3A;RRAGD;FADS1
prerank,sensory perception of smell (GO:0007608),-0.34618901633239,-0.8468717713863483,0.6705539358600583,0.8447674020434867,1.0,5/11,21.95%,BBS4;ADCY3;SYT10;SLC24A4;DRD2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.3818465086949048,0.8465262457755394,0.6319526627218935,1.0,1.0,6/29,11.13%,RPA1;CHD1L;RPA2;ERCC3;CUL4B;XPA
prerank,regulation of cell migration (GO:0030334),0.3559457035260167,0.8462229875354912,0.85,1.0,1.0,71/382,16.28%,KIF14;ARHGEF39;GTSE1;MAP4K4;SYNE2;ULK4;MACF1;TWIST2;TRIP6;ROCK2;RHOA;CEP43;MMP14;DDRGK1;LAMB1;ACTN4;ARID2;KIT;SPAG9;CCAR1;PDPN;RAP2A;STK24;MYO1C;SFRP2;AFDN;PDGFRA;ENPP2;SULF1;PLAU;PPP3CA;CCN1;PHACTR1;EPHA4;SERPINE1;FOXO3;TMEFF2;ROBO1;ROCK1;SRGAP2;SRGAP3;TGFBR1;PLXNB2;PLXNB1;ANXA1;BMP2;RAC1;NKX2-1;TBCCD1;PRKCA;APPL2;DPYSL3;ADAM17;CLIC4;CTSH;PLXND1;ADAM9;MIA3;ITGB1;NKD1;PTPRU;SFRP1;SRC;NF2;ELP6;SEMA3D;RHOC;SUN2;LMO4;PTEN;RCC2
prerank,regulation of vasculature development (GO:1901342),0.39609054969464974,0.8459454181149326,0.6381909547738693,1.0,1.0,6/26,20.42%,VASH2;ADGRA2;PLXND1;SFRP1;SP100;EGLN1
prerank,regulation of cellular response to stress (GO:0080135),0.35885085484894597,0.8458619987221034,0.7209775967413442,1.0,1.0,14/115,6.62%,NDC1;NUP155;NUP205;NUP160;ROCK2;GSK3B;RPA1;AJUBA;AIFM2;DYRK3;MAPT;NUP85;RPA2;TPR
prerank,response to organic cyclic compound (GO:0014070),0.363529124919497,0.8454193280399179,0.6428571428571429,1.0,1.0,9/52,15.25%,CDKN2D;FGFR4;ABCB4;IL18;LRRK2;TRPM2;ANXA1;DHFR;SFRP1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.39358201138367765,0.8453222962344178,0.6316455696202532,1.0,1.0,9/25,21.58%,STOML2;CD80;ANXA1;PRKD2;RUNX1;PDE4B;TRAF6;TRAF2;PNP
prerank,synaptic vesicle recycling (GO:0036465),-0.25104341341028596,-0.8452641437805316,0.6942675159235668,0.8469346503548694,1.0,11/31,18.07%,OPHN1;AMPH;SYT1;PLD2;RAB5A;SYT7;TBC1D24;SYNJ2;FCHO2;SYNJ1;NLGN1
prerank,endomembrane system organization (GO:0010256),0.3561879160269271,0.8451431969621244,0.7677677677677678,1.0,1.0,47/178,20.51%,ARHGAP21;USP6NL;NUP155;GBF1;OBSL1;LNPK;COG1;ZW10;WASHC4;ATL2;MYOF;ATL3;RAB22A;LEMD3;RAB29;LRRK2;VPS18;GOLGA8B;GOLGA5;RAB1A;SNX33;EIF2AK3;BAG5;GAK;GORASP2;EXOC8;PRKD1;MIA3;TOR1B;VAPA;TMCC1;SYP;SUN2;DYSF;TMED3;UBXN2B;CSNK1A1;COG4;CLASP1;PI4K2B;TMED10;SUN1;LYSMD3;DNM1L;TRAPPC8;ATP8B2;ANK3
prerank,glycogen biosynthetic process (GO:0005978),-0.32963849791732514,-0.8448472198082051,0.6507462686567164,0.8460030424791556,1.0,2/12,2.86%,PER2;GBE1
prerank,glucan biosynthetic process (GO:0009250),-0.32963849791732514,-0.8448472198082051,0.6507462686567164,0.8460030424791556,1.0,2/12,2.86%,PER2;GBE1
prerank,lymphocyte chemotaxis (GO:0048247),-0.2429315809958849,-0.8447901333940967,0.7748344370860927,0.8452708893196167,1.0,16/34,42.12%,CYP7B1;GAS6;CX3CL1;SLC12A2;PIK3CD;CCL13;CXCL16;GPR183;CCL19;ADAM8;CH25H;CCL15;HSD3B7;PIK3CG;CXCL10;CCL2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3893581220594406,0.8447737400280583,0.6511919698870765,1.0,1.0,1/26,1.19%,SLC18A2
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.4352439220807133,0.8446945409242997,0.634703196347032,1.0,1.0,3/12,13.34%,UST;DSE;BGN
prerank,response to glucocorticoid (GO:0051384),0.3890496413593175,0.8444134643279496,0.6295843520782396,1.0,1.0,7/26,22.39%,NR3C1;HNRNPU;ANXA1;ADAM9;PDCD7;UBE2L3;ZFP36L1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3706717536226703,0.844215066464346,0.65625,1.0,1.0,10/48,13.32%,TRIOBP;OBSL1;CUX1;PRKDC;CAPRIN1;LIMS1;CRKL;RAC1;DMTN;DOCK1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.4167020464033399,0.8437929499504432,0.6333333333333333,1.0,1.0,5/14,20.51%,ACTN4;WNK1;GLRX;WNK3;ANK3
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.36058394591296294,0.8437006878528232,0.6833333333333333,1.0,1.0,15/80,12.85%,ANLN;ACTR3;AUTS2;FMR1;CDC42EP2;RHOQ;RIPOR2;EPS8L1;TAPT1;ARHGAP35;CEP120;RAC1;DPYSL3;DOCK11;WASF2
prerank,autophagy of nucleus (GO:0044804),0.40813135337467793,0.8434995977739782,0.6273972602739726,1.0,1.0,5/16,14.48%,ATG7;RB1CC1;ULK2;ATG3;ATG2A
prerank,lung epithelium development (GO:0060428),0.44147276808194885,0.8431274740186572,0.6147919876733436,1.0,1.0,2/10,10.20%,GRHL2;ERRFI1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.3457344078331218,-0.8430462872636938,0.6470588235294118,0.8478037258061992,1.0,2/10,5.10%,SARAF;HOMER1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.43702651017953553,0.8424024663637676,0.6468797564687976,1.0,1.0,3/11,7.30%,ELOF1;ARID1A;CHEK1
prerank,regulation of cell size (GO:0008361),0.3995841381111713,0.8414105310473707,0.631917631917632,1.0,1.0,9/23,17.52%,RHOA;VAV2;RAC1;EZR;RPTOR;MSN;PTEN;LARS1;LAMTOR5
prerank,positive regulation of immunoglobulin production (GO:0002639),0.3826424163468774,0.8411257246105333,0.638196915776987,1.0,1.0,5/31,15.41%,PAXIP1;GPI;RIF1;KMT5C;SHLD2
prerank,regulation of protein binding (GO:0043393),0.3531802225206059,0.8409199696866133,0.7261663286004056,1.0,1.0,13/114,9.80%,PLK1;AURKB;DDX11;AURKA;GSK3B;ADD2;STK3;TCF7L2;NMD3;LRRK2;ROCK1;PSME3IP1;MARK2
prerank,mesonephric tubule development (GO:0072164),0.41568222156553475,0.8407749496266855,0.6337448559670782,1.0,1.0,5/15,18.35%,FGFR2;NPNT;PKD2;SALL1;OSR1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3775301734987931,0.8405165136945478,0.6452353616532721,1.0,1.0,9/39,16.28%,MAP4K4;RHOA;ACTN4;CASK;HOXA7;DMTN;NF2;TBCD;RCC2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.3799330482349444,0.8403243864973169,0.6593533487297921,1.0,1.0,2/35,3.51%,MASTL;GSK3B
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3825022990553086,0.8399582152986774,0.6338535414165666,1.0,1.0,10/32,16.28%,MAP4K4;CASK;HOXA7;SERPINE1;ARHGAP6;DMTN;SRC;NF2;PTEN;RCC2
prerank,negative regulation of immune effector process (GO:0002698),0.4187182679266313,0.8396813079544009,0.63,1.0,1.0,6/13,22.17%,ENPP3;RC3H1;CD47;HAVCR2;FER;APPL1
prerank,regulation of p38MAPK cascade (GO:1900744),0.37588802673595656,0.8394923871811365,0.6478711162255466,1.0,1.0,8/35,14.89%,ULK4;XDH;MAP3K4;RELL1;BMP2;EZR;DLG1;PER1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.401330983185912,0.8389215191556347,0.6276881720430108,1.0,1.0,5/19,15.25%,MAP4K4;ROCK1;LIMS1;RAC1;SFRP1
prerank,glucan catabolic process (GO:0009251),0.42273193861718605,0.8384327918573916,0.6441631504922645,1.0,1.0,3/15,7.60%,AGL;PYGB;PHKA2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.24976285720135763,-0.8383954305778084,0.7251461988304093,0.8558374078191504,1.0,4/27,8.78%,CYRIB;NFAT5;PRKCQ;HSPD1
prerank,outflow tract septum morphogenesis (GO:0003148),0.3859809785923818,0.8382310664197067,0.6292134831460674,1.0,1.0,6/24,12.64%,BMPR1A;FGFR2;PARVA;SMAD6;ROBO1;SMAD4
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.35268042974153463,0.8378493735258483,0.7017364657814096,1.0,1.0,23/95,16.52%,HAS3;CHST15;HYAL1;B4GALT1;GPC6;CHSY1;SLC10A7;ST3GAL3;SLC35D2;B4GALT7;CHST3;ANGPT1;SDC1;HAS1;UST;HS2ST1;DSE;BGN;ST3GAL4;ST3GAL1;ST3GAL2;HSPG2;UGDH
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.2717510510795225,-0.8376608316265085,0.7523809523809524,0.8563457033586758,1.0,7/21,19.94%,CAV1;FZD2;CTNNB1;APC;DVL1;LRP6;FZD1
prerank,endothelial cell proliferation (GO:0001935),0.40827940904298543,0.8376263431635266,0.6258596973865199,1.0,1.0,2/17,3.08%,LOXL2;ANGPT4
prerank,Notch signaling pathway (GO:0007219),0.35589455381720414,0.8375823330216662,0.6631130063965884,1.0,1.0,11/59,13.69%,DLGAP5;GMDS;POFUT1;BMP2;RBPJ;ADAM17;ITCH;NOTCH2;PLXND1;MAML1;HEY2
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.3870901928966638,0.837558473230337,0.6419753086419753,1.0,1.0,7/25,19.56%,BMF;FAM162A;PLAUR;TP53;TNFSF10;BAD;DNM1L
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.4148698516195143,0.8375275300759951,0.6400541271989174,1.0,1.0,1/15,2.23%,DYRK1A
prerank,positive regulation of transmembrane transport (GO:0034764),-0.30497743668203575,-0.8371187173340331,0.7040816326530612,0.8565434226599703,1.0,9/13,36.37%,ANO6;CLIP3;ACSL5;ACSL1;P2RX7;SLC26A6;C2CD5;NR4A3;C3
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3672953092435792,0.8370589761103362,0.6773127753303965,1.0,1.0,10/62,13.02%,CDKN2D;DDIAS;TXNDC12;SFRP2;RTKN2;YBX3;LRRK2;HTRA2;BAG5;PLAUR
prerank,positive regulation of cellular senescence (GO:2000774),-0.3374330644731982,-0.8369055497837634,0.6614420062695925,0.8561255657745579,1.0,4/10,29.81%,B2M;HMGA2;ABI3;EEF1E1
prerank,phasic smooth muscle contraction (GO:0014821),-0.34640599723174104,-0.8366921301561977,0.6677018633540373,0.8556950938408576,1.0,6/10,35.08%,DRD2;EDNRB;EDN1;PTGER3;EDN3;HTR2B
prerank,calcium ion import across plasma membrane (GO:0098703),0.4116339748590395,0.8364554497304824,0.6306818181818182,1.0,1.0,3/14,10.76%,ATP2B4;SLC8A1;TRPM2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3650704883798123,0.8364140859537578,0.6832627118644068,1.0,1.0,10/64,10.24%,MAP4K4;MACF1;ROCK2;RHOA;GSK3B;CASK;HOXA7;PLAU;ROCK1;PIK3CB
prerank,regulation of steroid biosynthetic process (GO:0050810),0.42622459219655434,0.8361703410146986,0.6383928571428571,1.0,1.0,4/11,20.90%,FGFR4;BMP2;WNT4;BMP5
prerank,regulation of dephosphorylation (GO:0035303),0.417128752179659,0.8354228186023288,0.6385041551246537,1.0,1.0,6/15,15.30%,MTMR1;MTMR2;MTMR9;SMG6;MTMR3;SRC
prerank,calcium ion import into cytosol (GO:1902656),0.4049917884541055,0.8354214180443612,0.634453781512605,1.0,1.0,3/15,10.76%,ATP2B4;SLC8A1;TRPM2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3612817282032946,0.8351283898883595,0.6838709677419355,1.0,1.0,19/55,22.56%,AURKA;PSMC2;PSMD5;FBXL7;PSMB1;PSMD14;PSMD1;PSMB9;ATF5;USP47;PSMC6;PSMB2;PSME4;PSMB7;PSMD11;PSME3;PSMD13;PSMB8;PSMD4
prerank,autophagosome maturation (GO:0097352),-0.23529519989894673,-0.8350641990049303,0.7792207792207793,0.8579344520643286,1.0,18/32,33.87%,CALM1;TECPR1;SNX14;TSG101;SNAP29;VPS33B;VAMP8;LAMP2;GABARAPL2;CHMP3;MAP1LC3A;VPS33A;MAP1LC3B;CLN3;EPG5;ATG14;VCP;GABARAP
prerank,negative regulation of glycolytic process (GO:0045820),0.44443902424825354,0.834682763403999,0.631578947368421,1.0,1.0,1/10,3.00%,PFKFB1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.44443902424825354,0.834682763403999,0.631578947368421,1.0,1.0,1/10,3.00%,PFKFB1
prerank,erythrocyte differentiation (GO:0030218),0.3673067102203391,0.8345167726452538,0.656599552572707,1.0,1.0,11/44,13.71%,KIT;TSPO2;DYRK3;IKZF1;PTPN2;TGFBR3;ABCB10;TAL1;DMTN;ATP5IF1;MED1
prerank,stem cell development (GO:0048864),-0.2944951433872862,-0.8340958555165855,0.7158671586715867,0.8589292560960139,1.0,14/16,50.45%,CDH2;NOLC1;KLHL12;SOX11;PTPRC;SOX8;KBTBD8;PDCD6;NRG1;SNAI2;WNT7A;SHH;CYP26C1;PEF1
prerank,sodium-independent organic anion transport (GO:0043252),0.43200909381702923,0.8335263085196187,0.6342525399129173,1.0,1.0,3/10,13.57%,SLCO4A1;SLC16A2;SLCO3A1
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.32694280865103253,-0.8334236486768759,0.7111801242236024,0.859260777693211,1.0,3/11,8.89%,PRKN;DAB2;VPS11
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.356460256395247,0.8331784411801085,0.7060063224446786,1.0,1.0,23/72,22.49%,FADD;CBFB;USP18;VRK2;PTPN2;ELF1;RNF31;SPPL2B;AGPAT2;IKBKG;CASP8;AGPAT1;RUNX1;IFNAR2;AXL;RIPK1;HIPK1;PTPN1;TRAF2;TAX1BP1;IKBKB;BIRC2;PIAS1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.41270321272334376,0.8330214723992235,0.6512890094979648,1.0,1.0,5/16,16.45%,NPNT;BMP2;PKD2;GDNF;SALL1
prerank,nucleotide metabolic process (GO:0009117),0.3950895577787853,0.8329610092051847,0.6400506970849176,1.0,1.0,12/23,26.30%,DCK;NUDT5;ENPP3;GUK1;AK7;NMNAT1;NMNAT2;PNP;NMNAT3;ME1;AK8;CTPS2
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.36585483636383614,0.8328948289374235,0.685807150595883,1.0,1.0,22/59,23.79%,MAP3K14;TICAM1;ROCK2;TAB1;RNF31;ROCK1;ERC1;IKBKG;PRDX4;RIPK1;RELB;TRAF6;TANK;TRAF2;IKBKB;BIRC2;TLR7;DAB2IP;NFKBIL1;REL;BCL10;RIPK2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.4033573375966623,0.8327876743177363,0.6302864938608458,1.0,1.0,4/18,8.18%,GSK3B;FMR1;LRRK2;VPS18
prerank,non-motile cilium assembly (GO:1905515),0.38136829098704483,0.8327369656706491,0.6418439716312057,1.0,1.0,3/30,5.29%,CEP89;PCM1;C2CD3
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3521399768914511,0.8326012517766366,0.8318318318318318,1.0,1.0,73/248,20.27%,GLI3;CDK14;GSK3B;FGFR2;PSMC2;RNF220;PSMD5;BICC1;SIAH2;MCC;TBL1XR1;ADGRA2;STK3;SFRP2;TCF7L2;WNK1;WWTR1;UBR5;LRRK2;PSMB1;CUL3;PSMD14;GNAQ;AXIN2;NPHP3;TMEM64;LIMD1;LRRK1;PSMD1;EMD;DKK3;SMURF2;PSMB9;RBMS3;HDAC1;BMP2;LMBR1L;LZTS2;TRPM4;CSNK1G2;SOX9;USP47;BTRC;JADE1;XIAP;PSMC6;TLE4;RUVBL2;STK11;NKD1;PIN1;PTPRU;SFRP1;TLE3;NFKB1;NOTUM;AMER1;FAM53B;MLLT3;CSNK1A1;CSNK1G1;PSMB2;FRZB;PSME4;PSMB7;ZEB2;CAPRIN2;TMEM131L;PPM1A;PSMD11;LGR4;COL1A1;SEMA5A
prerank,mitochondrial gene expression (GO:0140053),-0.21587731357863882,-0.832446463116281,0.7751937984496124,0.8602439834492985,1.0,26/42,34.20%,LARS2;TFB2M;MRPS15;MRPS18A;MRPS21;MRPS6;TFAM;MRPL23;MRPL51;MRPS14;MRPL47;MRPS7;NOA1;MRPL16;MRPS11;MRPS16;FASTKD2;MRPL12;QRSL1;TEFM;GATC;POLRMT;MRPS12;TWNK;MRPL57;MRPS34
prerank,positive regulation of bone resorption (GO:0045780),-0.32696635524396317,-0.8322588597297614,0.672566371681416,0.8597263735957917,1.0,7/11,36.26%,TNFRSF11A;PLEKHM1;ATP6AP1;SYK;DEF8;SPP1;ADAM8
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4063120166711589,0.8319550243821069,0.637203166226913,1.0,1.0,4/17,14.40%,DYRK1A;YJU2;TWIST1;CD44
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.425806352436524,0.8312912054189913,0.6339285714285714,1.0,1.0,5/13,17.94%,RRS1;RPP40;TSR1;NOL9;ABT1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.4073752296056238,0.8309500643845522,0.6362359550561798,1.0,1.0,7/15,25.77%,RPP40;POP1;RPP30;KHNYN;LACTB2;RNASEH1;NUDT16
prerank,copper ion homeostasis (GO:0055070),-0.28652610599923717,-0.8307032508917677,0.7387755102040816,0.8618407245992292,1.0,8/17,22.32%,APP;COX19;SLC31A2;MT2A;ATOX1;CUTC;COMMD1;ATP7A
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.4194581303051006,0.830454925213885,0.6392496392496393,1.0,1.0,3/13,7.30%,ELOF1;ARID1A;CHEK1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.4205874262445082,0.830421956143569,0.6388140161725068,1.0,1.0,5/13,26.55%,NEDD4;NIBAN2;PTPN1;DAB2IP;HGS
prerank,phosphate ion transmembrane transport (GO:0035435),0.43194677455714575,0.8301107478638707,0.6612426035502958,1.0,1.0,4/12,21.86%,SLC20A2;SLC25A30;SLC37A2;SLC37A3
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.40529511903991877,0.830068176229504,0.6531942633637549,1.0,1.0,7/20,20.13%,GSS;PTDSS2;PLOD2;GCLM;MTHFS;GCLC;HAGH
prerank,regulation of interleukin-2 production (GO:0032663),0.36421767447235937,0.8295799229494326,0.6659142212189616,1.0,1.0,13/43,21.58%,PRNP;STOML2;CD80;ANXA1;EZR;HOMER2;PRKD2;RUNX1;HAVCR2;PDE4B;TRAF6;TRAF2;PNP
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.40902079938071534,0.8295756192069095,0.636237897648686,1.0,1.0,9/14,29.21%,ZNHIT3;DDX18;WDR12;NOL9;URB1;RPL7;RPF2;PES1;FTSJ3
prerank,regulation of plasminogen activation (GO:0010755),-0.33077955926205904,-0.8285786696438503,0.6864686468646864,0.8648765702177499,1.0,6/12,26.06%,CTSZ;THBS1;PLGRKT;ENO1;CLEC3B;SERPINE2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.37478914592557255,0.828367632157055,0.655952380952381,1.0,1.0,6/31,12.64%,BMPR1A;FGFR2;TGFBR3;TGFBR1;RBPJ;SMAD4
prerank,regulation of amyloid-beta formation (GO:1902003),0.3801075607641023,0.8278854295617786,0.6690307328605201,1.0,1.0,7/34,9.53%,ROCK2;RTN3;PRNP;EFNA1;EPHA4;ROCK1;PICALM
prerank,peptidyl-glutamic acid modification (GO:0018200),0.390865369208955,0.8272537046689062,0.6700379266750948,1.0,1.0,6/24,16.99%,VKORC1L1;GGCX;TTLL4;TTLL11;TTLL3;AGTPBP1
prerank,reticulophagy (GO:0061709),0.4207924298641399,0.8267189884765302,0.6457399103139013,1.0,1.0,4/12,14.48%,DDRGK1;RB1CC1;ULK2;ATG2A
prerank,positive regulation of macroautophagy (GO:0016239),-0.21841880708424588,-0.8265588382712851,0.75,0.8677698916462948,1.0,18/48,25.06%,PIP4K2A;SESN3;EPM2A;PIP4K2B;RALB;BNIP3L;BNIP3;IRGM;PINK1;RAB3GAP2;SLC25A4;TBK1;HSPB8;PIP4K2C;VPS13D;PAFAH1B2;BAG3;SMCR8
prerank,rRNA methylation (GO:0031167),0.3750325224642058,0.8265512939214912,0.6619718309859155,1.0,1.0,7/22,17.60%,MRM1;MRM3;METTL15;METTL5;MRM2;TFB1M;NSUN3
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.2900940809677003,-0.8264244072225232,0.6929133858267716,0.8671903914038627,1.0,7/15,24.36%,SIK1;SLC27A1;GPLD1;NR1H3;NR1H2;MFSD2A;CTDNEP1
prerank,regulation of immune response (GO:0050776),0.3491783548545944,0.8261737790185439,0.7664307381193124,1.0,1.0,14/135,14.15%,ULBP1;FGL1;COLEC12;ITGB7;RAET1E;LAG3;SPPL2B;IRF1;AHR;APPL2;CASP8;IL4I1;XIAP;ITGB1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4180186972937129,0.8260323870678905,0.6582466567607727,1.0,1.0,3/11,10.05%,LEPROT;PICALM;SNX33
prerank,phospholipid dephosphorylation (GO:0046839),0.3684011945185035,0.8259987367550886,0.6549707602339181,1.0,1.0,10/37,16.13%,OCRL;INPP5B;MTMR1;MTMR2;MTMR9;PIP4P2;PLPP1;PLPP5;MTMR3;PTEN
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.35519375173948353,0.8258203619352247,0.7145855194123819,1.0,1.0,4/78,4.03%,PLK1;CDC20;GSK3B;DDRGK1
prerank,embryonic hemopoiesis (GO:0035162),0.4165774765142739,0.8258155721532837,0.638109305760709,1.0,1.0,3/12,10.75%,KIT;KMT2A;TAL1
prerank,negative regulation of TOR signaling (GO:0032007),0.37144249781575184,0.8257121216620962,0.6409356725146199,1.0,1.0,9/36,16.29%,FNIP1;TNFAIP8L1;DEPDC5;TBC1D7;SESN1;NPRL3;ITFG2;STK11;SESN2
prerank,snRNA 3'-end processing (GO:0034472),0.39262195446821463,0.825696184045532,0.6405405405405405,1.0,1.0,4/19,11.88%,INTS7;TUT1;INTS8;EXOSC7
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.26472642421322123,-0.8254458319051438,0.755,0.8682017568551305,1.0,7/23,18.26%,HSP90AB1;NR1H3;IFNGR2;IRGM;IFNGR1;NR1H2;NLRC5
prerank,sulfation (GO:0051923),0.4267779800389179,0.8253706021349072,0.6475770925110133,1.0,1.0,11/11,57.35%,UST;SULT4A1;SULT2A1;CHST4;SULT1C2;SULT1C4;SULT6B1;SULT1A1;SULT2B1;HS3ST5;CHST5
prerank,regulation of cellular localization (GO:0060341),0.35844493062302035,0.8244013817108293,0.6610169491525424,1.0,1.0,7/46,13.49%,SPAG5;NUMA1;STXBP2;LRRK2;MAD1L1;LRP5;GOSR1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.27026515362011433,-0.8239736517840329,0.7364016736401674,0.8699853272645842,1.0,2/20,1.54%,CAMK2D;HECW1
prerank,sulfur amino acid metabolic process (GO:0000096),0.3947172313382431,0.8239293484118775,0.6637390213299874,1.0,1.0,3/24,9.63%,AHCY;MTHFR;NOX4
prerank,response to molecule of bacterial origin (GO:0002237),-0.20132664181437646,-0.8225123745548573,0.8571428571428571,0.8718185545680099,1.0,15/69,17.81%,CYRIB;IFNAR1;TAB2;NOS3;TLR4;LIAS;GGT5;PTPN22;LBP;TNFRSF11A;GCH1;C4B;ERBIN;PRDX3;LGALS9
prerank,regulation of axon extension (GO:0030516),0.3655489194936268,0.8219392031474114,0.6628571428571428,1.0,1.0,7/37,11.40%,MACF1;GSK3B;RTN4R;NTN1;MAPT;DNM2;PTPRS
prerank,protein localization to cell surface (GO:0034394),0.3773403067610837,0.821320233330143,0.6474201474201474,1.0,1.0,8/26,17.05%,FBLN5;SMURF1;ANGPT1;PIGU;MESD;PTPRU;UNC50;PTPRK
prerank,acute-phase response (GO:0006953),-0.30845576254169627,-0.8207308902862882,0.6801242236024845,0.8742534369560316,1.0,3/12,21.28%,LBP;CEBPB;IL22
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.35758647570430513,0.8207070921612275,0.7218200620475698,1.0,1.0,18/75,19.56%,PLK1;RB1;PKIG;SLC8A1;AGT;PIK3CB;IPO7;LRP5;SMPD1;CDKN1B;IPO5;PTEN;PRKAR2B;PRKAR2A;TFAP4;DUSP7;PTPN1;PRKCD
prerank,lipoprotein transport (GO:0042953),0.4255092817523973,0.820654161226793,0.6532137518684604,1.0,1.0,4/10,19.54%,PRKCB;MIA3;UNC119;UNC119B
prerank,positive regulation of cilium assembly (GO:0045724),0.40227654772620475,0.8205460947244894,0.6572958500669344,1.0,1.0,3/18,10.89%,TAPT1;ARHGAP35;CEP120
prerank,regulation of translation (GO:0006417),0.34464804296731544,0.82046018318686,0.805,1.0,1.0,43/173,19.63%,TYMS;ILF3;SYNCRIP;LARP4B;CTIF;HNRNPD;CNOT1;DHX9;PRKDC;EIF4E;UPF3B;EIF4ENIF1;EIF4H;SAMD4A;CAPRIN1;FMR1;FOXO3;LARP1;PLXNB2;METTL5;EIF2AK3;MRPL13;EIF3C;RBM4;LARP4;DHFR;EIF4A2;MTRF1;EPRS1;CNOT7;PASK;FXR1;DDX1;METTL3;PYM1;EIF3H;NSUN3;PAIP2B;METAP1;PUS7;OGFOD1;ETF1;DAPK1
prerank,regulation of protein transport (GO:0051223),0.38753161492118693,0.8204136731191076,0.678391959798995,1.0,1.0,7/27,14.81%,ARFIP1;DNAJC1;STXBP5;LLGL2;SCFD1;P3H1;LCP1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3467607861043901,0.8200943058142495,0.7084233261339092,1.0,1.0,24/65,23.69%,AQP1;ANGPT4;MDM4;FAM162A;HP1BP3;CPEB2;NDRG1;RORA;TWIST1;NPEPPS;SFRP1;TP53;SUV39H2;PTGIS;BAD;TBL2;TERT;FMN2;EGLN1;SIRT2;ZFP36L1;EGLN3;KCND2;NOP53
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3638846571885522,0.8198837787595946,0.6997816593886463,1.0,1.0,14/51,17.51%,ROCK2;RHOA;LPAR1;SORBS3;TGFBR1;RAC1;SYNPO2;ARHGEF10L;SFRP1;NF2;RHOC;FHOD1;CCN2;CD47
prerank,neuromuscular synaptic transmission (GO:0007274),0.39732942096977697,0.8196130898482321,0.6580310880829016,1.0,1.0,4/18,13.17%,CHAT;ERC1;CHRNB1;ERC2
prerank,negative regulation of developmental process (GO:0051093),0.3511354049178652,0.8192467819051356,0.7190775681341719,1.0,1.0,15/69,15.25%,SFMBT1;LOXL2;ROCK2;SUZ12;ANP32B;MAPT;NFIB;ROCK1;PTPRS;BMP2;SOX9;HEY2;RC3H1;FOXM1;SFRP1
prerank,response to calcium ion (GO:0051592),0.33986928158322793,0.819206052321962,0.7469512195121951,1.0,1.0,18/102,16.20%,ECT2;ADGRV1;NEDD4;PPP3CA;KCNMB2;KCNMB3;CARF;TRPM2;CALM2;ITPR3;DMTN;CLIC4;ADAM9;SMPD1;KCNMB4;PKD2;ADD1;STIM1
prerank,peptidyl-proline modification (GO:0018208),0.3902230563279885,0.8188040107163035,0.662007623888183,1.0,1.0,6/25,15.73%,PPIL1;FKBP5;PPIG;PPID;PIN1;PPWD1
prerank,phosphate ion transport (GO:0006817),0.40554258848958935,0.8184049243639182,0.6414073071718539,1.0,1.0,4/16,21.86%,SLC20A2;SLC25A30;SLC37A2;SLC37A3
prerank,epidermis development (GO:0008544),0.3580500711112505,0.8180721136856813,0.7086956521739131,1.0,1.0,9/56,17.09%,FGFR2;SVEP1;GRHL2;ATP2A2;FLOT2;HDAC1;HDAC2;EMP1;CCN2
prerank,response to chemokine (GO:1990868),0.40963428138446445,0.8180377031862825,0.6671408250355618,1.0,1.0,5/13,18.35%,RHOA;WNK1;RIPOR2;STK39;OXSR1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3451132528310492,0.81803177269334,0.694591728525981,1.0,1.0,8/70,12.36%,PON1;CHAT;LPCAT1;LPIN2;ENPP2;CSNK2A2;TMEM86B;ACHE
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.22309698645337797,-0.8176482329281007,0.8208955223880597,0.8788353854912249,1.0,14/37,23.44%,NACC2;CAV1;FIS1;BECN1;RPS7;SIAH1;BCL2;BCAP31;NUPR1;DDIT3;UBB;BCL2L1;RACK1;RPS3
prerank,regulation of viral genome replication (GO:0045069),0.3553254882787647,0.8175975932462825,0.6713665943600867,1.0,1.0,13/56,18.12%,ILF3;FAM111A;ZC3HAV1;LARP1;TMEM39A;SRPK1;TRIM6;PPID;PABPC1;CNOT7;MAVS;SRPK2;PKN2
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.2942842583658655,-0.8175702071725021,0.708029197080292,0.8781409929932587,1.0,5/15,11.18%,SMAD7;RPL23;RPS7;LIMK1;ABL1
prerank,histone H2B ubiquitination (GO:0033523),-0.3386816316345633,-0.8171684186733849,0.6814159292035398,0.878001791241967,1.0,2/10,3.31%,CDC73;UBE2E1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.2775986854753869,-0.8162693365875645,0.7240143369175627,0.878905077459373,1.0,1/17,0.18%,PLA2G4A
prerank,cellular polysaccharide catabolic process (GO:0044247),0.4074487938208403,0.8157780147621335,0.6565517241379311,1.0,1.0,3/16,7.60%,AGL;PYGB;PHKA2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.3796485473203585,0.8147692287257223,0.6587795765877957,1.0,1.0,9/26,23.38%,IRF1;FLOT2;APPL2;LGR4;SMPDL3B;APPL1;BIRC2;GPR108;NFKBIL1
prerank,gliogenesis (GO:0042063),0.3998812333903461,0.8144377744929009,0.6777188328912467,1.0,1.0,4/15,16.45%,MMP24;NFIB;ANXA1;METTL3
prerank,protein glycosylation (GO:0006486),0.3418813067599227,0.8143874978010704,0.782258064516129,1.0,1.0,23/125,15.59%,POMT1;TRAK1;LARGE1;B4GALT1;FUT10;GALNT1;ST8SIA2;B3GNT8;ST3GAL3;B4GALT7;MAGT1;RPN2;ST3GAL5;SLC39A8;POFUT1;STT3A;MAN1C1;STT3B;ALG8;ST3GAL4;ST3GAL1;ST3GAL2;PLOD2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.4005909990318032,0.8142708014711244,0.6666666666666666,1.0,1.0,1/13,2.16%,FADD
prerank,eye development (GO:0001654),0.35467163773834776,0.8140688471844028,0.6875675675675675,1.0,1.0,12/54,19.48%,PBX4;PBX3;FBN1;COL5A2;NIPBL;CACNA1C;MAB21L2;EFEMP1;SH3PXD2B;SHROOM2;HIPK1;SKI
prerank,membrane depolarization during action potential (GO:0086010),-0.24907389966575777,-0.8133766263420508,0.8,0.8832223435891426,1.0,12/26,33.26%,SCN1A;SCN9A;ATP1A2;SCN3A;SCN8A;SCN1B;SCN4B;CACNA1H;CACNA1I;YWHAH;SCN3B;CACNA1D
prerank,negative regulation of protein modification process (GO:0031400),0.3482770259166061,0.8131471624197164,0.7272727272727273,1.0,1.0,26/79,20.55%,ATP2B4;GSK3B;PRKDC;PRNP;MAPT;XDH;WWTR1;LRRK2;PPP1R8;TPPP;SNTA1;CRKL;P3H1;ENSA;PPP1R15B;PTPN13;PTPA;PTEN;TINF2;SIRPA;TERF2IP;IGFBP3;DNAJC10;FBLN1;XRCC1;PNKP
prerank,peptide metabolic process (GO:0006518),0.35002991578246506,0.8130397110825174,0.7243186582809225,1.0,1.0,8/75,10.53%,RHD;DNPEP;LVRN;NLN;CPXM1;HPGDS;CPQ;TRHDE
prerank,Ras protein signal transduction (GO:0007265),0.34158108437493284,0.8129572358016167,0.7848484848484848,1.0,1.0,35/137,18.50%,GPSM2;KSR1;RB1;BRAP;RASSF1;ROCK2;RHOA;CCNA2;NTN1;PDPN;RAP2A;G3BP1;CDC42EP2;GNA13;CDK2;TRIM28;ROCK1;EPS8L1;ARHGAP6;MYO9B;USP28;CRKL;RAC1;RRAS;PLK2;PRKD1;TP53;NCKAP1;RRAS2;ABI2;PLEKHG5;NRAS;KRAS;ARHGAP29;MAPK14
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.39539057172659203,0.8129033474981767,0.6516220028208745,1.0,1.0,3/14,11.89%,UPB1;DPYD;ERH
prerank,acylglycerol catabolic process (GO:0046464),-0.24239783442126392,-0.8126327332283715,0.7530120481927711,0.8837149858010037,1.0,4/30,9.52%,ABHD6;ABHD12;ABHD16A;ABHD2
prerank,glycoprotein metabolic process (GO:0009100),0.35058976014970866,0.8123972868679571,0.6997816593886463,1.0,1.0,12/53,15.40%,HPSE;LARGE1;ST8SIA2;B4GALT7;ADAMTS9;GANAB;MAN1C1;STT3B;FBXO27;ST3GAL4;FBXO17;ST3GAL2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.29584022715352554,-0.8118840678480154,0.72,0.8841885652445899,1.0,3/15,18.89%,SAT1;MOXD1;DDC
prerank,cellular response to unfolded protein (GO:0034620),-0.24737718509487253,-0.8116979910747408,0.7796610169491526,0.8836493424705691,1.0,6/26,18.08%,PRKN;HSPD1;HSPA5;PACRG;TM7SF3;HSPB8
prerank,negative regulation of receptor internalization (GO:0002091),0.41682579740862863,0.8116706453199979,0.6819484240687679,1.0,1.0,6/12,26.58%,WDR54;MTMR2;ANKRD13D;RIN3;LRPAP1;ATXN2
prerank,ethanol metabolic process (GO:0006067),0.40905810468051373,0.8116620117982335,0.6531204644412192,1.0,1.0,2/12,9.63%,ALDH1A1;ACSS1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.39290822422203203,0.8116062430667701,0.6705426356589147,1.0,1.0,7/17,22.54%,ROCK2;ROCK1;S1PR2;ADD1;ZDHHC21;IKBKB;VCL
prerank,muscle cell migration (GO:0014812),0.42960493979178976,0.811470254990497,0.6578125,1.0,1.0,4/10,18.00%,ROCK1;CCN3;AAMP;PLAT
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.39360500810574384,0.8111488969420829,0.6666666666666666,1.0,1.0,3/16,20.28%,RHOA;ST3GAL4;TRAF6
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.3803428935813089,0.8103783297479452,0.6645885286783042,1.0,1.0,6/25,12.64%,BMPR1A;NUMA1;SULF1;CCN1;RBPJ;SMAD4
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.34074241877857425,0.80983944067063,0.903,1.0,1.0,60/348,16.04%,BRCA1;E2F1;MED26;MOV10;TICAM1;ROCK2;FGFR4;CTCF;GSK3B;AGO2;ANXA2;DDRGK1;MPHOSPH8;SETDB2;MUSK;BMP6;AFDN;ARRB1;FMR1;SCRIB;RAB29;ZBTB7B;UBR5;ATF7IP;TRIM28;YAP1;ROBO1;ANGPT1;ROCK1;SLC24A3;WNT6;PIK3CB;TGFBR1;LIMS1;EIF2AK3;RBMS3;CNTF;BMP2;NKX2-1;TERF2;EZR;STOX1;FUBP1;RBPJ;GJA1;C1QTNF1;ITCH;SOX9;CTSH;TWIST1;ADAM19;HEY2;MED1;SMAD3;RAMP3;PRKAG1;ITGB8;TNRC6C;TP53;MSN
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3698970770787569,0.8097984930501816,0.6732558139534883,1.0,1.0,5/33,10.09%,ATP2B4;ANGPT4;RHOA;HMGB1;MEOX2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.32117148403818857,-0.8092042395381077,0.7147058823529412,0.8873060734365531,1.0,7/11,32.35%,TOMM70;TIMM9;TIMM13;TIMM8B;NDUFA13;ROMO1;TIMM29
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.273439170478043,-0.8087358772545848,0.7142857142857143,0.8873183198925896,1.0,8/18,25.94%,PRKN;TRAP1;SOD2;PINK1;PARK7;HSPB1;MAPK7;HIF1A
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.3805817388846536,0.8084969735435706,0.6484076433121019,1.0,1.0,7/23,17.44%,TGFBR3L;TGFBR3;DKK3;SMURF2;SMAD4;SMAD3;SMAD2
prerank,regulation of neuroinflammatory response (GO:0150077),-0.2737335365240091,-0.8083202835388976,0.7191489361702128,0.8871763235636793,1.0,4/19,13.34%,IGF1;TNFRSF1B;PTGS2;NUPR1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.24105613255593678,-0.8082738648781252,0.7788944723618091,0.8864084767229844,1.0,4/26,6.28%,RYR3;RYR2;FGF2;HTR2C
prerank,cochlea morphogenesis (GO:0090103),0.4264305827576148,0.8080988964985836,0.6942392909896603,1.0,1.0,2/10,12.75%,TBX18;SOX9
prerank,superoxide anion generation (GO:0042554),0.4034641636006445,0.8080629792710151,0.6845070422535211,1.0,1.0,2/13,9.67%,NOX4;CYBB
prerank,hepaticobiliary system development (GO:0061008),0.38623257832043334,0.8078185915821068,0.6662387676508345,1.0,1.0,7/20,19.08%,TGFBR3;NIPBL;PHF2;GFER;PKD2;COBL;WNT4
prerank,polyol biosynthetic process (GO:0046173),-0.2876237985246667,-0.807817410348913,0.7378277153558053,0.8862889081043853,1.0,5/16,13.18%,IPPK;PPIP5K2;FGF2;ACER3;ITPKB
prerank,endothelial cell development (GO:0001885),0.37011155344052704,0.807615907343662,0.6573511543134872,1.0,1.0,4/25,11.81%,COL22A1;COL18A1;COL15A1;EZR
prerank,cation transmembrane transport (GO:0098655),0.3621245365110701,0.8073638279288711,0.7223451327433629,1.0,1.0,11/44,19.42%,RHAG;SLC6A5;TRPM2;TRPM4;PKD2;SLC36A4;SLC7A1;SLC25A19;SLC6A9;SLC25A29;TRPM6
prerank,regulation of phagocytosis (GO:0050764),-0.20146743765791597,-0.8072774408101256,0.8571428571428571,0.8863609720516779,1.0,22/53,37.47%,MERTK;GAS6;SNX3;TGM2;SYT7;SYT11;GATA2;RAB27A;RACK1;SPHK1;IL15;SYK;FCER1G;TUB;PTPRC;ABCA7;CALR;LYAR;HCK;PYCARD;SLC11A1;LMAN2
prerank,iron ion transmembrane transport (GO:0034755),0.42172236638355975,0.8063828860298249,0.6666666666666666,1.0,1.0,4/10,22.24%,SLC25A37;SLC39A8;SLC25A28;SLC11A2
prerank,zymogen activation (GO:0031638),0.3579116510467846,0.8063665683304265,0.702176403207331,1.0,1.0,8/39,19.30%,FADD;MMP14;PLAU;CASP8;CTSH;PLAT;BAD;TBC1D10A
prerank,snRNA processing (GO:0016180),0.39372618521907554,0.8062329455864852,0.6768377253814147,1.0,1.0,3/16,10.64%,INTS7;TUT1;INTS8
prerank,positive regulation of gene expression (GO:0010628),0.33908664843500413,0.8061502397797521,0.917,1.0,1.0,78/442,16.04%,BRCA1;E2F1;MED26;DYRK1A;BAZ1B;SETX;MOV10;DEK;TICAM1;ROCK2;FGFR4;LARP4B;CTCF;GSK3B;AGO2;POLR1A;HNRNPD;DDRGK1;PRKDC;UPF3B;MYO1C;MUSK;BMP6;POLR1B;AFDN;SAMD4A;TENT4A;FMR1;POLR2A;ZBTB7B;PHF2;UBR5;AGPAT2;YAP1;ROBO1;ANGPT1;ROCK1;SLC24A3;WNT6;AGT;TAF1D;PIK3CB;TGFBR1;LIMS1;PLXNB2;METTL5;EIF2AK3;RBMS3;CNTF;BMP2;NKX2-1;TERF2;EZR;STOX1;FUBP1;EIF3C;RBPJ;GJA1;C1QTNF1;SOX9;CTSH;POLR1G;TWIST1;ADAM19;DDX21;HEY2;MED1;LARP4;SMAD3;RAMP3;AGPAT1;PRKAG1;ITGB8;TNRC6C;PASK;FXR1;TP53;MSN
prerank,protein kinase A signaling (GO:0010737),0.4025200510077688,0.8059982159173508,0.6858789625360231,1.0,1.0,5/12,26.19%,EZR;LCP1;RAB13;PRKACA;RDX
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.3840881204564423,0.8054854528125519,0.658311345646438,1.0,1.0,7/21,19.57%,HPSE;SULF2;SULF1;HS2ST1;UGDH;XYLT1;GLCE
prerank,T cell receptor signaling pathway (GO:0050852),0.3370323240744399,0.8053837551064189,0.7848484848484848,1.0,1.0,45/138,25.03%,ERMAP;THEMIS;PSMC2;PSMD5;KHDRBS1;EIF2B1;WNK1;UBE2N;STOML2;RC3H2;RNF31;PSMB1;PSMD14;NCK1;PSMD1;IKBKG;PIK3CB;PSMB9;FBXW11;PDPK1;BTRC;RC3H1;PSMC6;PRKD2;NFKB1;PSMB2;PSME4;PSMB7;PSMD11;PDE4B;TRAF6;PSME3;EIF2B5;IKBKB;PSMD13;PSMB8;PSMD4;FYN;PSMF1;BCL10;RIPK2;PSMA5;RELA;SPPL3;PSMC3
prerank,regulation of bone mineralization (GO:0030500),0.3551884176836523,0.805162682894716,0.7207792207792207,1.0,1.0,12/55,13.22%,ADGRV1;BMPR1A;BCOR;BMP6;CCN1;SLC8A1;DDR2;ATP2B1;ENPP1;BMP2;TRPM4;TWIST1
prerank,cGMP biosynthetic process (GO:0006182),-0.3302837226603246,-0.8046760885581197,0.7543859649122807,0.89011351192809,1.0,2/10,9.77%,GUCY1A1;NPR1
prerank,microvillus organization (GO:0032528),0.40314002839272994,0.8042741836287015,0.6629055007052186,1.0,1.0,3/13,11.81%,MAP4K4;RAP2A;EZR
prerank,protein O-linked glycosylation (GO:0006493),0.34166768399565917,0.8027439450927402,0.770746887966805,1.0,1.0,16/96,15.59%,POMT1;TRAK1;LARGE1;CRPPA;GALNT1;B3GNT8;FKRP;ST3GAL3;C1GALT1;POFUT1;RXYLT1;TMTC4;ST3GAL4;ST3GAL1;ST3GAL2;PLOD2
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.28402598978344357,-0.8024462861120072,0.7142857142857143,0.8932057765822149,1.0,7/15,30.81%,SYN3;CNTNAP4;ADRA1A;NLGN1;DRD2;BAIAP3;CLN3
prerank,prostaglandin metabolic process (GO:0006693),0.37217779596001443,0.8023094464200321,0.6826568265682657,1.0,1.0,7/26,18.52%,PTGR1;PTGR2;HPGDS;PTGS1;DAGLB;PTGIS;PLAA
prerank,membrane raft organization (GO:0031579),0.3977729941399211,0.802126064848464,0.6671408250355618,1.0,1.0,5/15,25.05%,ANXA2;FLOT2;FA2H;S100A10;MYADM
prerank,positive regulation of mRNA processing (GO:0050685),0.3763196804162608,0.8020739677549089,0.6609947643979057,1.0,1.0,7/21,21.16%,TRA2B;THRAP3;LEO1;DAZAP1;NUP98;TRA2A;RBMX
prerank,regulation of lamellipodium assembly (GO:0010591),0.3549690723059806,0.8019544668023704,0.6755813953488372,1.0,1.0,11/34,22.14%,ACTR3;AUTS2;TWF1;RAC1;DMTN;WASF2;NCKAP1;ABI2;PLXNB3;FER;ARPC2
prerank,spliceosomal complex assembly (GO:0000245),0.35055988095270857,0.8018131656128091,0.6972067039106146,1.0,1.0,11/46,17.84%,SETX;SRSF10;DDX39B;PRPF19;CELF2;SF3A2;SRPK1;LUC7L3;DDX1;LUC7L2;SRPK2
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.29899619173460623,-0.8017680445665668,0.7275862068965517,0.8934488615127848,1.0,2/14,4.17%,CARD16;GAS6
prerank,positive regulation of cell aging (GO:0090343),-0.31902618682861894,-0.8015037195051706,0.7361563517915309,0.8930510064669329,1.0,4/11,29.81%,B2M;HMGA2;ABI3;EEF1E1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3489657726237786,0.8011695704650205,0.698781838316722,1.0,1.0,23/47,28.05%,TRIOBP;ACTN4;PDPN;LIMS1;CRKL;RAC1;DMTN;DOCK1;RCC2;DOCK5;FBLN1;RREB1;FERMT2;FLNA;S100A10;CRK;MYADM;P4HB;CDC42;CORO1C;KANK1;CARMIL1;MYOC
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.3947508474124781,0.8008293417747933,0.677891654465593,1.0,1.0,3/14,11.23%,IL18;CD80;ANXA1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.38139580802112655,0.8006260197392518,0.6626826029216467,1.0,1.0,8/18,23.95%,FAF1;EZR;MSN;AMER1;RIC1;VGLL4;DAB2IP;HSP90AA1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.38112565242433594,0.8006209876304431,0.6736020806241872,1.0,1.0,6/20,19.32%,ZC3H7A;AGO2;PUM2;ZC3H7B;SPOUT1;TERT
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.33941779512239106,0.8005424885340509,0.7975708502024291,1.0,1.0,41/124,24.50%,VANGL1;MOV10;RHOA;AGO2;PSMC2;PSMD5;NLK;DAAM1;SFRP2;TCF7L2;PPP3CA;SMURF1;PSMB1;PSMD14;PSMD1;SMURF2;PSMB9;RAC1;PSMC6;SFRP1;TNRC6C;PPP3R1;PSMB2;FRZB;PSME4;PSMB7;WNT4;TNRC6B;PSMD11;ARHGEF19;PSME3;PSMD13;GNB1;PSMB8;PSMD4;CELSR1;GNAO1;PSMF1;AP2B1;PPP3CB;PSMA5
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.3894685352508251,0.7999808953260259,0.6745152354570637,1.0,1.0,5/16,18.00%,LEPROT;STAM;VTA1;CHMP4A;CHMP4B
prerank,macrophage migration (GO:1905517),0.39674710098682775,0.799835151451775,0.6574585635359116,1.0,1.0,1/13,5.09%,CKLF
prerank,regulation of protein targeting to membrane (GO:0090313),0.3715652080111216,0.7997098426387207,0.6836363636363636,1.0,1.0,6/28,12.63%,MIEF2;PRNP;PDZK1;MYO1C;MIEF1;DMTN
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.37399742636916966,0.7987033794621805,0.6623544631306598,1.0,1.0,4/21,15.25%,TXNDC15;TUBD1;TEDC1;SFRP1
prerank,microvillus assembly (GO:0030033),0.3935473467335247,0.7986568368932582,0.6639118457300276,1.0,1.0,3/14,11.81%,MAP4K4;RAP2A;EZR
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.3617529637757819,0.7985616979573211,0.7144508670520231,1.0,1.0,10/39,18.30%,GLI2;SFRP2;NPNT;BMP2;NKX2-1;LRP5;PKD2;GDNF;SALL1;COL4A1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3343260081004254,0.7983304005793225,0.8173562058526741,1.0,1.0,32/166,17.16%,ATAD5;GLI2;FGFR4;LARP4B;GCK;HNRNPD;STN1;DNA2;DHX9;PRKDC;UPF3B;FAF1;PTPN2;SAMD4A;SLC25A37;NMD3;FMR1;ABCB10;PLXNB2;METTL5;PCNA;EIF3C;LARP4;ARNT;SMAD3;PRKD2;PKD2;PASK;FXR1;METTL3;LDLR;PYM1
prerank,cellular response to hypoxia (GO:0071456),0.3325702330883014,0.7983185324281974,0.794949494949495,1.0,1.0,45/126,23.69%,AQP1;ANGPT4;PSMC2;PSMD5;MDM4;FAM162A;HP1BP3;ELOC;PSMB1;PSMD14;LIMD1;CPEB2;VHL;PSMD1;NDRG1;PSMB9;RORA;STOX1;TWIST1;ARNT;PSMC6;NPEPPS;SFRP1;TP53;SUV39H2;PSMB2;PTGIS;BAD;TBL2;PSME4;PSMB7;TERT;FMN2;PSMD11;EGLN1;PSME3;SIRT2;PSMD13;PSMB8;ZFP36L1;EGLN3;PSMD4;KCND2;PSMF1;NOP53
prerank,apical protein localization (GO:0045176),0.4148381215506522,0.7975377635258429,0.6769706336939721,1.0,1.0,1/10,1.71%,SHROOM3
prerank,cellular response to chemical stress (GO:0062197),0.33991480848881034,0.7975130764078858,0.7645228215767634,1.0,1.0,31/96,21.93%,SETX;VKORC1L1;SRXN1;VRK2;ATG7;PYCR1;FOXO3;LRRK2;SOD3;HTRA2;STX2;CPEB2;LONP1;NOX4;CYBB;STOX1;PRKD1;GPX8;PKD2;RAD52;PNPT1;SESN2;CCS;TRPV4;FANCC;ADNP2;PYROXD1;TXNRD1;SNCA;SIRT2;SOD1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.39762577229185514,0.7974072061830042,0.6817538896746818,1.0,1.0,4/14,14.06%,RAB1A;SCAP;SEC24D;MIA3
prerank,calcium ion transport into cytosol (GO:0060402),0.3710261270005486,0.7972439402466757,0.6662198391420912,1.0,1.0,8/21,18.17%,ATP2B4;SLC8A1;CACNA1C;TRPM2;ITPR3;GRIN2D;TRPV4;JPH1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.40720422730984307,0.7969243114874969,0.6881405563689604,1.0,1.0,1/12,6.49%,IL18
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.2106217804458238,-0.7968724147562416,0.8761904761904762,0.9002493057291454,1.0,12/41,25.22%,PLA2G4A;SCP2;PNPLA8;GPX4;DEGS1;GPX1;DECR2;ACSL1;SCD;ELOVL1;GSTM2;FADS1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.2815254245006145,-0.796684074886293,0.7158671586715867,0.899731890040729,1.0,5/18,10.34%,CTSC;APOE;DACT1;VPS11;CD81
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3367762271145172,0.7966155881233455,0.7675840978593272,1.0,1.0,28/108,20.93%,FADD;SENP1;DAP;CASP8AP2;ANP32B;FAM162A;MAPT;XDH;HTRA2;ROBO1;TNFRSF10B;HMGB1;APAF1;BOK;EIF2AK3;UACA;CASP8;SMAD3;BCL2L13;NGF;TNFSF10;BAD;RIPK1;DAPK1;COL4A3;SNCA;PRR7;TRAF2
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3531519530614174,0.7963098090756288,0.6860189573459715,1.0,1.0,13/35,23.64%,HMGB2;PRKDC;FOXO3;ABCB10;TAL1;MED1;ARNT;MAPK14;ZFPM1;LDB1;ZFP36L1;STAT5B;ANKRD54
prerank,antibacterial humoral response (GO:0019731),0.3923684313771399,0.7955278890259732,0.7034574468085106,1.0,1.0,1/16,4.59%,RNASE6
prerank,zinc ion transport (GO:0006829),0.38091123952872996,0.7951094936644024,0.6861219195849546,1.0,1.0,6/21,15.09%,SLC39A11;TRPM2;SLC39A8;SLC30A9;SLC39A6;SLC30A10
prerank,cellular response to retinoic acid (GO:0071300),0.3491180449025872,0.7944500707047741,0.6937853107344633,1.0,1.0,6/42,12.75%,AQP1;SETX;HTRA2;WNT6;WNT9A;SOX9
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.25273994376056697,-0.7941577194594476,0.8144329896907216,0.9032684056040895,1.0,11/24,24.89%,NUB1;CTSC;APOE;PINK1;RHBDF1;GPX1;UBB;PSME2;PTK2B;PSME1;UBE3A
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.38095953994660303,0.7940267193976627,0.6801040312093628,1.0,1.0,5/19,15.46%,ADGRL1;PRNP;TRPM2;DMTN;STIMATE
prerank,dermatan sulfate metabolic process (GO:0030205),0.3981533645487108,0.7938008236278404,0.6700581395348837,1.0,1.0,3/13,13.34%,UST;DSE;BGN
prerank,glycine transport (GO:0015816),0.41212088738204083,0.793776697814758,0.6744868035190615,1.0,1.0,3/10,18.29%,SLC6A5;SLC6A17;SLC6A9
prerank,cellular response to growth factor stimulus (GO:0071363),0.33323419937141224,0.7933805540928606,0.8150753768844221,1.0,1.0,33/151,15.27%,KNSTRN;SETX;BMPR1A;HYAL1;WWOX;GAREM1;ACAP2;MAPT;BMP6;SOX6;HTRA2;CORO1B;EMD;GAS1;HAS1;TGFBR1;NR3C1;LIMS1;ANXA1;CRKL;BMP2;APPL2;PDPK1;NR4A1;SMAD4;SOX9;EHD1;MED1;PRKD1;SMAD3;CD44;SFRP1;PRKD2
prerank,mRNA metabolic process (GO:0016071),0.33442270019286346,0.7933276646397419,0.75,1.0,1.0,24/90,19.95%,SRSF4;CSTF3;LSM3;SLBP;LSM11;SRSF7;PRPF3;NONO;SF3A2;PCF11;LSM2;YTHDF2;SFPQ;DXO;KIN;HNRNPA2B1;TP53;PNPT1;HIPK3;METTL3;PRPF18;HNRNPR;SNRPB;SF3A3
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.2430004457577964,-0.7930584510733303,0.7614213197969543,0.9043288166932553,1.0,10/27,22.11%,TAB2;TLR4;TAB3;HSPD1;IRAK4;UBB;TIRAP;TNIP1;UBC;RPS27A
prerank,protein transport (GO:0015031),0.3339199576985064,0.7927376333464111,0.906,1.0,1.0,36/332,11.47%,CENPF;NEURL1B;NDC1;USP6NL;STX11;ZG16;MACF1;STEAP3;AP4M1;ARFIP1;RAB10;EVI5L;TBC1D25;SNX1;TBC1D13;WDR11;VPS26C;TBC1D2B;SLC10A7;RAB22A;RAB29;STXBP2;STX2;DNM2;SVBP;RAB1A;COPB2;SNX27;SNX33;VIPAS39;COPZ1;HERC2;ABCA1;AP3B1;ARRDC1;PRKCB
prerank,protein localization to cell junction (GO:1902414),0.37302621869094227,0.7927239289144757,0.6817010309278351,1.0,1.0,5/22,16.35%,CGNL1;MPP4;ARHGEF18;TJP2;NLGN2
prerank,amino sugar metabolic process (GO:0006040),-0.3256933064573276,-0.7925175055623658,0.743801652892562,0.9044399701461814,1.0,2/10,3.86%,CSGALNACT1;ST6GAL1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.33873331425375275,0.7924677615945666,0.7267015706806282,1.0,1.0,16/79,13.64%,ATP2B4;BMPR1A;NEDD4;CASK;SULF2;SULF1;LEMD3;CRIM1;SMURF1;SMAD6;AGT;RBPMS2;SMURF2;BMP2;SMAD4;HTRA3
prerank,regulation of primary metabolic process (GO:0080090),0.3323918326593516,0.7924000662878229,0.7921291624621595,1.0,1.0,31/126,19.80%,ZFP69;ROCK2;FGFR4;PSMC2;PSMD5;PMVK;TBL1XR1;PSMB1;PSMD14;NQO1;NFYA;PSMD1;PSMB9;NCOA2;TM7SF2;ACACA;PLPP1;ADIPOR1;MVK;MED1;PSMC6;AZIN1;DHCR7;LDLR;SREBF1;PSMB2;PSME4;PSMB7;TGS1;PSMD11;PRKAB1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.33126301730146607,0.791940279186285,0.82744702320888,1.0,1.0,26/149,15.53%,TRIML2;TRIM37;TICAM1;DDRGK1;RAB7B;DHX9;TAB1;RTKN2;IL18;UBE2N;RNF31;AGT;EDA;ERC1;IKBKG;FLOT2;PRKCB;ROR1;TRIM6;BTK;SLCO3A1;PRKCI;PRKD1;TRIM5;PRKD2;NFKB1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.3928995022178415,0.7918821009259791,0.6838235294117647,1.0,1.0,3/13,16.08%,ADGRV1;GNAI3;GABBR2
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.332179073608996,-0.7915575449584172,0.7703081232492998,0.9051974819516438,1.0,6/10,36.04%,GIPC1;ATP7A;CTNS;OPN3;CDH3;MFSD12
prerank,negative regulation of cyclase activity (GO:0031280),0.3889803676521356,0.7915561814809197,0.6710144927536232,1.0,1.0,3/14,16.08%,ADGRV1;GNAI3;GABBR2
prerank,defense response to Gram-positive bacterium (GO:0050830),0.3585706197601648,0.7914314652890962,0.7180067950169875,1.0,1.0,2/40,4.59%,HMGB2;RNASE6
prerank,regulation of signal transduction (GO:0009966),0.33236250810706314,0.7914285331176784,0.8535606820461384,1.0,1.0,45/190,19.65%,RGS12;CBFB;NCAM1;BRAP;FGFR2;TCF7L1;PRNP;GIT2;PTPN2;WDR11;ELF1;SULF1;NUCKS1;WWTR1;NCLN;LRRK2;CD80;GRK5;NCK1;RGS3;RIC8B;LLGL2;GAS1;FBXL17;POFUT1;RORA;NCK2;GRK3;RSPO3;SIK2;PRKD1;FOXL1;TRIM5;SRC;GDNF;RUNX1;ZDHHC3;TMEM237;VEPH1;IGFBP3;ZIC1;SP100;USP20;PTPN1;UGCG
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.2833192427774621,-0.791031508877586,0.7722007722007722,0.9052315149316306,1.0,5/16,20.44%,MEF2C;BOC;BTG1;LRRC8A;HIF1AN
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.3829597793983499,0.7909925748901135,0.6782246879334258,1.0,1.0,1/16,2.16%,FADD
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.29951021808719114,-0.790767746409486,0.7579617834394905,0.903924265667389,1.0,2/12,3.33%,IGF1;AKAP6
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.29951021808719114,-0.790767746409486,0.7579617834394905,0.903924265667389,1.0,2/12,3.33%,IGF1;AKAP6
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.2594058381967937,-0.7906314696673341,0.7699530516431925,0.9032571509280973,1.0,5/21,18.32%,GRIN2B;DELE1;GRIN1;SOX2;BIRC3
prerank,lysosome organization (GO:0007040),-0.21871150535854794,-0.7905408137204372,0.7857142857142857,0.9025816142423562,1.0,16/36,26.62%,ZKSCAN3;CLVS1;TPP1;TMEM106B;ACP2;GRN;MTOR;HOOK1;HPS4;TFEB;CLN5;MBTPS1;ATP10B;VPS33A;GNPTAB;AKTIP
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.329842604139435,0.7903758831867201,0.8241206030150754,1.0,1.0,43/173,20.67%,SPTA1;F5;RANGRF;ACTR1A;SPTB;GBF1;COG1;ZW10;ATL2;ANK1;ATL3;DCTN5;RAB29;CUL3;TRAPPC6B;RAB1A;COPB2;COPZ1;CAPZA1;F8;SCFD1;SEC24D;VTI1A;GOSR1;ARF4;MIA3;NRBP1;VAPA;BET1;BCAP29;TMED3;USO1;COG4;COG8;TMED10;PROS1;BET1L;CNIH4;COG5;TRAPPC8;WHAMM;ANK3;DYNC1I1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.3760523072848734,0.7902521388120383,0.6863237139272271,1.0,1.0,3/21,13.32%,FGL1;SAMSN1;IL4I1
prerank,renal filtration (GO:0097205),0.40177928295132004,0.7898888770369266,0.6823529411764706,1.0,1.0,2/10,7.21%,SULF2;SULF1
prerank,regulation of smooth muscle contraction (GO:0006940),0.3773349551795662,0.7898425862691244,0.6890322580645162,1.0,1.0,6/20,16.84%,SRF;SETD3;ATP2B1;ADRB2;KCNB2;ZDHHC21
prerank,secondary alcohol biosynthetic process (GO:1902653),0.35600756852053467,0.7896777731778927,0.682033096926714,1.0,1.0,7/30,17.83%,LBR;PMVK;TM7SF2;ACAT2;MVK;DHCR7;INSIG2
prerank,cellular response to estradiol stimulus (GO:0071392),0.3778128109485857,0.7893252166709135,0.6728971962616822,1.0,1.0,4/18,15.25%,LCOR;RUVBL2;RAMP3;SFRP1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.36477159874407905,0.7891998935425675,0.6943396226415094,1.0,1.0,4/25,10.61%,HAS3;B3GNT8;HAS1;HS2ST1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.3411555875580361,0.7888298547494956,0.7534102833158447,1.0,1.0,29/72,25.03%,MAP3K14;PSMC2;PSMD5;PSMB1;PSMD14;TNFRSF10B;PSMD1;PSMB9;FBXW11;BTRC;PSMC6;ZFP91;PSMB2;PSME4;PSMB7;RELB;PSMD11;TRAF6;PSME3;TRAF2;PSMD13;BIRC2;PSMB8;PSMD4;REL;PSMF1;PSMA5;RELA;PSMC3
prerank,global genome nucleotide-excision repair (GO:0070911),0.36164445355203756,0.7885747852551847,0.7036569987389659,1.0,1.0,11/26,22.91%,CHD1L;ERCC4;ERCC3;CUL4B;XPA;RAD23B;ERCC2;RNF111;GTF2H1;DDB1;DDB2
prerank,myotube differentiation (GO:0014902),0.37698829261703387,0.7880545712173849,0.6834437086092715,1.0,1.0,3/17,7.27%,MYEF2;ADAM12;ADAMTS5
prerank,regulation of innate immune response (GO:0045088),0.34341859645197614,0.787957941445221,0.7367853290183387,1.0,1.0,20/57,24.21%,USP18;DHX9;NMI;IRF1;RIOK3;POLR3D;PARP9;APPL2;AKIRIN2;CASP8;XIAP;SLC15A4;IFNAR2;PTPN1;APPL1;POLR3C;BIRC2;POLR3G;ABCE1;FGR
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.3834792989034728,0.7875677319199085,0.7046703296703297,1.0,1.0,1/17,1.65%,ATOH8
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.3553671453295151,0.7874454788443852,0.704,1.0,1.0,6/39,12.05%,TRAK1;ACTN4;MYO1C;NDE1;RAB1A;FBXW11
prerank,mitochondrial translational termination (GO:0070126),0.33273975967435115,0.787170969550177,0.7670807453416149,1.0,1.0,23/88,22.26%,MRPL36;MRPL18;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;MTRF1;GFM2;MRPS10;MRPS24;MRPL45;MRPL42;MRPL37;MRPL2;MRPL20;MRPS23;MRPS22;MRPL50;MRPL43;PTCD3
prerank,cellular response to oxidative stress (GO:0034599),0.3304304612163775,0.786979013656208,0.7937310414560161,1.0,1.0,37/118,21.93%,SETX;VKORC1L1;SRXN1;MAPT;VRK2;PDGFRA;PYCR1;FOXO3;LRRK2;AGAP3;SOD3;HTRA2;STX2;CPEB2;LONP1;NOX4;CYBB;PRKD1;ARNT;GPX8;PKD2;TP53;RAD52;PNPT1;SESN2;PTPRK;CCS;FANCC;ADNP2;PYROXD1;PRKCD;DAPK1;TXNRD1;SNCA;FER;SIRT2;SOD1
prerank,membrane assembly (GO:0071709),0.35305719203096797,0.7863213303746991,0.7127906976744186,1.0,1.0,12/34,20.51%,ANXA2;NLGN3;STX2;PICALM;FLOT2;GAK;PTEN;NLGN2;UBXN2B;CHMP4B;UGCG;ANK3
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.35764934780350915,0.7858532486265887,0.6892052194543298,1.0,1.0,5/36,7.61%,MOV10;AGO2;NLK;TCF7L2;PPP3CA
prerank,regulation of neuron apoptotic process (GO:0043523),0.33240588006182037,0.78562462267511,0.7715163934426229,1.0,1.0,1/96,0.13%,KIF14
prerank,sterol homeostasis (GO:0055092),0.33811755436966207,0.7853348223032672,0.7510460251046025,1.0,1.0,12/65,17.14%,CYP39A1;FGFR4;SOAT1;IL18;ABCA1;RORA;SOAT2;EHD1;LRP5;LPL;RALY;LDLR
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3721054507769248,0.785135372802985,0.7087126137841352,1.0,1.0,7/20,20.62%,LHPP;HPRT1;ADSL;PFAS;GART;PPAT;ADSS2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3818295278585019,0.7849037858181529,0.68,1.0,1.0,6/17,19.89%,ARFIP1;CORO1B;WASF2;NCKAP1;ABI2;ARF1
prerank,adherens junction organization (GO:0034332),0.3413847500445961,0.7844096198264094,0.735658042744657,1.0,1.0,6/48,6.12%,CDH15;CDH18;CDH24;CDH4;AFDN;CTNNA1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.39150127466030177,0.7843684609586559,0.6908809891808346,1.0,1.0,2/11,12.64%,ATP2B4;SMAD4
prerank,cGMP metabolic process (GO:0046068),-0.3057103092637272,-0.7842053383497815,0.784375,0.9124664214239949,1.0,3/12,18.00%,GUCY1A1;NPR1;PDE2A
prerank,regulation of focal adhesion assembly (GO:0051893),0.3410530880522773,0.7839806066049908,0.7239130434782609,1.0,1.0,16/54,17.91%,MAP4K4;MACF1;ROCK2;RHOA;ROCK1;ARHGAP6;LIMS1;RAC1;DMTN;PTPRA;SFRP1;SRC;PTEN;RCC2;EPHA3;CLASP1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.2950198133494174,-0.783863265816009,0.7625,0.9121972302415114,1.0,2/12,12.91%,TLR4;STRAP
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.40417836745610614,0.7834965292056787,0.6896046852122987,1.0,1.0,1/11,2.67%,BMPR1A
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3575951092567631,0.7830687049241397,0.6940024479804161,1.0,1.0,10/28,24.41%,FADD;CASP8AP2;TNFRSF10B;CASP8;ZDHHC3;NGF;DAXX;DAB2IP;BID;BAX
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.24629173241359803,-0.7830080665462196,0.7989949748743719,0.9127696908755247,1.0,9/23,30.86%,MAP3K5;PAK1;ARHGEF5;TNFRSF11A;MAP3K11;RPS3;EDN1;DVL2;DUSP19
prerank,protein O-linked glycosylation via serine (GO:0018242),0.4042857521792789,0.7829136214386585,0.6856702619414484,1.0,1.0,1/10,4.82%,GALNT1
prerank,cholesterol homeostasis (GO:0042632),0.3385201920738464,0.7828440284606462,0.750788643533123,1.0,1.0,12/64,17.14%,CYP39A1;FGFR4;SOAT1;IL18;ABCA1;RORA;SOAT2;EHD1;LRP5;LPL;RALY;LDLR
prerank,positive regulation of bone mineralization (GO:0030501),0.3573614756945632,0.7822617065522871,0.7132784958871915,1.0,1.0,7/35,11.48%,ADGRV1;BMPR1A;BMP6;CCN1;SLC8A1;ATP2B1;BMP2
prerank,regulation of cellular amine metabolic process (GO:0033238),0.3411701976833831,0.7821382979716013,0.7337733773377337,1.0,1.0,20/50,25.03%,PSMC2;PSMD5;PSMB1;PSMD14;NQO1;PSMD1;PSMB9;PSMC6;AZIN1;PSMB2;PSME4;PSMB7;PSMD11;PSME3;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,glutathione derivative metabolic process (GO:1901685),0.3779062513577829,0.7816185275873949,0.6895640686922061,1.0,1.0,6/20,22.35%,GSTO2;HPGDS;GSTT1;MGST3;GSTM5;GSTZ1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3779062513577829,0.7816185275873949,0.6895640686922061,1.0,1.0,6/20,22.35%,GSTO2;HPGDS;GSTT1;MGST3;GSTM5;GSTZ1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.30058222320392464,-0.7816091925377855,0.7111111111111111,0.9141830437237005,1.0,2/12,3.27%,RYR2;ANXA6
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3661197056677708,0.7815805369219779,0.7069825436408977,1.0,1.0,3/26,6.64%,FBN1;PTPN2;HOXA7
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.2501359719493873,-0.7814947554027281,0.7873303167420814,0.9134988341267927,1.0,4/24,7.37%,PECAM1;F11R;VCAM1;SEMA4D
prerank,regulation of chondrocyte differentiation (GO:0032330),0.36462820877113794,0.781461161458487,0.6934865900383141,1.0,1.0,6/24,15.24%,LOXL2;SOX6;TGFBR1;WNT9A;SOX9;EFEMP1
prerank,hippo signaling (GO:0035329),0.35590618685963005,0.7813119546254192,0.7038895859473023,1.0,1.0,11/26,22.86%,TEAD1;STK3;WWTR1;YAP1;TEAD3;TJP2;TEAD4;AMOTL1;LATS1;STK4;DCHS1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.35988824860793794,0.78123920853633,0.6931540342298288,1.0,1.0,8/28,16.13%,PSMC2;DDRGK1;FBXW7;FMR1;SMURF1;ATP5IF1;PSMC6;PTEN
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.39602169951035004,0.7810966869493837,0.7048022598870056,1.0,1.0,2/12,10.63%,RNF168;HNRNPU
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.35328098158942656,0.7801602308753784,0.6920289855072463,1.0,1.0,2/27,2.28%,ATP2B4;RANGRF
prerank,cholesterol biosynthetic process (GO:0006695),0.3531170365007367,0.7799762005136391,0.7021276595744681,1.0,1.0,7/31,17.83%,LBR;PMVK;TM7SF2;ACAT2;MVK;DHCR7;INSIG2
prerank,neuromuscular junction development (GO:0007528),0.36880618208319776,0.779816045361392,0.7114427860696517,1.0,1.0,4/24,8.10%,PDZRN3;NEDD4;MUSK;LRRK2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.36176485082473747,0.7795106955121898,0.7104591836734694,1.0,1.0,7/23,18.77%,MMP14;MYLK3;PIEZO1;MAML1;EFNB2;MAPK14;NIBAN2
prerank,pinocytosis (GO:0006907),0.4058166481811591,0.7794549236563525,0.686838124054463,1.0,1.0,3/10,20.66%,SNX33;MAPKAPK3;MAPKAPK2
prerank,regulation of gastrulation (GO:0010470),-0.2859062029462964,-0.7793404840662495,0.7366548042704626,0.9162368051523347,1.0,4/14,27.81%,PHLDB2;TENM4;RACK1;DAG1
prerank,protein localization to phagophore assembly site (GO:0034497),-0.30614840591740367,-0.779315007359053,0.7341040462427746,0.9154317826356427,1.0,2/11,4.54%,WDR45B;PACS2
prerank,regulation of execution phase of apoptosis (GO:1900117),0.39611972619370894,0.7791991404266903,0.6948640483383686,1.0,1.0,4/11,21.76%,BOK;TP53;PTGIS;SIRT2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.32878833533611446,0.7790759280018147,0.8085106382978723,1.0,1.0,25/124,15.51%,MNS1;STMN1;RB1;GSK3B;LAMB1;FAM161A;NEDD4;MAPT;WDPCP;CORO1B;ODF2;MAP4;ROCK1;HMGB1;SAMD14;RAC1;FRYL;EHD1;BLOC1S5;PLEKHA1;DOCK7;VAPA;PKD2;GDNF;HDGFL3
prerank,positive regulation of growth (GO:0045927),0.33177679290798784,0.7788206129321692,0.7435897435897436,1.0,1.0,13/64,15.25%,HYAL1;CEP43;MMP14;FXN;SFRP2;DERL2;KLHL22;TGFBR1;ADAM17;USP47;RPTOR;INO80;SFRP1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.3637544357485177,0.7783618381140286,0.6822085889570552,1.0,1.0,7/25,18.08%,WDR54;MTMR2;PICALM;RAC1;ITGAV;UNC119;ANKRD13D
prerank,positive regulation of cation channel activity (GO:2001259),-0.21431762121727543,-0.7782711474917663,0.8373983739837398,0.9162834934858645,1.0,5/40,5.38%,TMSB4X;SHANK3;CALM1;AKAP6;EPHB2
prerank,regulation of MAP kinase activity (GO:0043405),0.3313376479155695,0.7777874962023892,0.7681307456588355,1.0,1.0,7/92,10.24%,EZH2;KSR1;KIT;LRRK2;ROBO1;AGT;PIK3CB
prerank,calcium-mediated signaling (GO:0019722),0.33089690412451844,0.7777863241955788,0.8059244126659857,1.0,1.0,19/93,16.20%,ADGRL1;PRNP;CXCR4;PPP3CA;LRRK2;MCU;ATP2A2;SLC8A1;SAMD14;CACNA1C;TRPM2;EIF2AK3;PDPK1;TRPM4;DMTN;BTK;NUDT4;STIMATE;TPCN2
prerank,mitochondrial translational elongation (GO:0070125),0.3283707750300525,0.7776310050827602,0.7763975155279503,1.0,1.0,22/88,22.26%,MRPL36;MRPL18;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;GFM2;MRPS10;MRPS24;MRPL45;MRPL42;MRPL37;MRPL2;MRPL20;MRPS23;MRPS22;MRPL50;MRPL43;PTCD3
prerank,regulation of protein localization to centrosome (GO:1904779),0.4083460898920076,0.7775208218856979,0.7073529411764706,1.0,1.0,3/10,18.06%,GSK3B;UBXN2B;CEP250
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.2459208270305772,-0.7774230552428605,0.8133971291866029,0.9167881644763188,1.0,9/22,20.28%,CALM1;TAOK2;ACE;RAP2C;PDGFD;NBN;VEGFA;TNKS1BP1;CALM3
prerank,regulation of necroptotic process (GO:0060544),-0.24946091457646294,-0.7770376723459789,0.8110599078341014,0.9165073656776686,1.0,7/23,18.32%,OGT;CYLD;ARHGEF2;STUB1;SDCBP;SLC25A4;BIRC3
prerank,regulation of inclusion body assembly (GO:0090083),0.4069389510014391,0.776887751086475,0.7165932452276065,1.0,1.0,5/11,24.64%,BAG5;DNAJB2;DNAJB6;SACS;SNCAIP
prerank,sodium ion import across plasma membrane (GO:0098719),0.3774151637140204,0.7768245691168674,0.6985391766268261,1.0,1.0,3/17,12.45%,SLC9A5;SLC8A1;TRPM4
prerank,production of siRNA involved in RNA interference (GO:0030422),0.4061319326133986,0.7764237020717742,0.7088414634146342,1.0,1.0,1/10,3.53%,AGO2
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.3992028100373314,0.7759495140262693,0.7177650429799427,1.0,1.0,1/11,2.84%,TICAM1
prerank,protein localization to cell-cell junction (GO:0150105),0.378934687871993,0.7759338679281595,0.6903137789904502,1.0,1.0,4/15,13.07%,CGNL1;SCRIB;ARHGEF18;TJP2
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.3095867476127249,-0.7757288126463501,0.7552870090634441,0.9168579925596704,1.0,3/10,14.36%,CDC42EP4;CDC42EP5;APC
prerank,regulation of pseudopodium assembly (GO:0031272),-0.3095867476127249,-0.7757288126463501,0.7552870090634441,0.9168579925596704,1.0,3/10,14.36%,CDC42EP4;CDC42EP5;APC
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.2529886683734077,-0.7754010337499375,0.8278688524590164,0.9165046170132439,1.0,4/18,19.35%,ESR1;DDX5;MAP2K1;ZC3H12A
prerank,tRNA aminoacylation (GO:0043039),0.3476686611476912,0.7748667393993803,0.7317919075144509,1.0,1.0,10/37,16.38%,SARS2;VARS1;DARS2;IARS2;DARS1;PPA1;RARS2;EPRS1;QARS1;LARS1
prerank,defense response to tumor cell (GO:0002357),-0.30963889879819806,-0.7746824332674059,0.7567567567567568,0.916785467776217,1.0,5/10,27.28%,KLF4;PRDX2;ABI3;PLK5;LAPTM5
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.32871064560448887,0.7742749652833151,0.7542372881355932,1.0,1.0,20/80,18.03%,ROCK2;LARP4B;HNRNPD;PRKDC;UPF3B;SAMD4A;FMR1;EFNA1;EPHA4;PICALM;PLXNB2;METTL5;EIF3C;LARP4;PASK;FXR1;SMPD3;METTL3;PYM1;SMPD2
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.37336106074440883,0.7741982458804438,0.6936339522546419,1.0,1.0,5/19,10.26%,RTN3;PRNP;ROCK1;PICALM;FLOT2
prerank,ameboidal-type cell migration (GO:0001667),-0.20014710533909127,-0.7740520814074638,0.9270833333333334,0.9169369744371354,1.0,14/51,18.98%,SEMA6A;ANXA6;SEMA6D;SEMA7A;SEMA4D;ERBB4;SEMA3A;AMOT;MEGF8;TBX1;SEMA3B;SEMA3C;PDLIM1;SEMA5B
prerank,phospholipid translocation (GO:0045332),0.3575665153339011,0.774027116060562,0.7024390243902439,1.0,1.0,4/28,10.71%,PLSCR2;ABCA4;ABCB4;ABCA1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.34430654868447014,0.7736956896447343,0.7075688073394495,1.0,1.0,5/36,12.09%,MACF1;RAB10;AFDN;RILPL1;GORASP2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.2749282070309545,-0.7735069559778492,0.7697841726618705,0.9169626744861054,1.0,6/15,21.17%,APOE;FURIN;GPLD1;TNFRSF1B;ADRA2A;PACSIN3
prerank,positive regulation of axonogenesis (GO:0050772),0.33583324306718965,0.7733945989081831,0.7245575221238938,1.0,1.0,15/43,20.56%,MACF1;RHOA;NTN1;MAPT;ROBO1;PLXNB2;PLXNB1;PLXND1;MAP6;DBN1;NGF;AMIGO1;PLXNA2;PLXNB3;GOLGA4
prerank,organic cation transport (GO:0015695),0.3634145653445145,0.7732212453456472,0.6831432192648923,1.0,1.0,9/20,26.97%,PDZK1;SLC22A18;SLC25A42;SLC25A19;SLC25A29;SEC14L1;SLC22A4;SLC47A1;RALBP1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.3180535638810216,-0.7731700678503002,0.7640117994100295,0.9166390851396082,1.0,4/10,21.95%,CALM1;GNB5;CALM3;DRD2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.3651753582432161,0.7724913385110338,0.6906290115532734,1.0,1.0,6/21,17.35%,KCNN4;RAB29;IKBKG;PRKCB;PRKD2;FOXP1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.36535245955143125,0.7723807444746988,0.6980891719745222,1.0,1.0,3/23,7.96%,FGFR2;TGFBR3;ADAMTS9
prerank,regulation of mRNA metabolic process (GO:1903311),0.40340917171412183,0.7721035939973476,0.7051094890510949,1.0,1.0,4/11,17.84%,DHX9;SRPK1;IWS1;SRPK2
prerank,skeletal muscle contraction (GO:0003009),-0.25710218952479413,-0.771508762893604,0.8163265306122449,0.9184175368287524,1.0,9/19,47.84%,RCSD1;STAC;MYH14;STAC3;TNNI1;STAC2;TNNC1;CCDC78;TCAP
prerank,positive regulation of type 2 immune response (GO:0002830),-0.294408975100206,-0.7713578336311802,0.7188612099644128,0.9178064013639091,1.0,8/14,34.00%,CD81;DENND1B;PRKCZ;CD86;CD74;RSAD2;RARA;NOD2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.3831655201932701,0.771288525038301,0.6959654178674352,1.0,1.0,2/14,7.21%,SULF2;SULF1
prerank,regulation of RNA splicing (GO:0043484),0.3325198851131441,0.771110334773879,0.7762312633832976,1.0,1.0,22/69,19.69%,DYRK1A;SETX;TRA2B;KHDRBS1;SRSF10;MBNL3;HNRNPH1;FUS;POLR2A;SRSF3;HNRNPL;SRPK1;HNRNPH2;METTL4;PTBP2;HNRNPLL;SRPK2;CWC22;SLC38A2;CLK3;LARP7;KHDRBS3
prerank,endothelial tube morphogenesis (GO:0061154),0.4087304603495133,0.7703612506542918,0.7045813586097947,1.0,1.0,3/10,15.27%,RHOA;RBPJ;PRKD2
prerank,carbohydrate derivative catabolic process (GO:1901136),0.37605442659426147,0.7701443170349627,0.7119341563786008,1.0,1.0,5/18,20.77%,ADAMTS9;STT3B;FBXO27;FBXO17;NAGA
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.403137514616928,0.7697794439815732,0.7089783281733746,1.0,1.0,1/10,4.65%,KIT
prerank,negative regulation of receptor binding (GO:1900121),-0.31324740240260784,-0.769428762259377,0.7747747747747747,0.9199810064228181,1.0,4/10,25.89%,ADAM15;B2M;ATP2A3;PTPRF
prerank,negative regulation of phosphorylation (GO:0042326),0.3280828921507571,0.7693257547877259,0.764033264033264,1.0,1.0,22/85,19.81%,CDKN2D;CDKN2C;PFKFB1;PRKDC;PRNP;MAPT;XDH;WWTR1;LRRK2;ROCK1;HNRNPU;CRKL;CDKN1B;PPP1R15B;PTPN13;PTEN;ANKLE2;SIRPA;TERF2IP;IGFBP3;DNAJC10;FBLN1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.38208281466106786,0.7692131506069938,0.7055555555555556,1.0,1.0,2/13,10.63%,RNF168;HNRNPU
prerank,regulation of receptor internalization (GO:0002090),0.34373960459503466,0.7690170716035569,0.714614499424626,1.0,1.0,6/35,12.90%,WDR54;ARRB1;FMR1;ANGPT1;MTMR2;MKLN1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.397486981157908,0.7687032074261235,0.7155824508320726,1.0,1.0,1/10,5.19%,PRNP
prerank,carbohydrate catabolic process (GO:0016052),0.34557894832019875,0.7686191486379161,0.7215909090909091,1.0,1.0,4/38,8.41%,PFKFB1;GCK;GPI;PGM1
prerank,negative regulation of kinase activity (GO:0033673),0.32982549642731385,0.768599993359058,0.7478448275862069,1.0,1.0,13/62,14.80%,RB1;CEP43;TAB1;MAPT;WWTR1;GNAQ;CEP85;HNRNPU;PYDC1;PDPK1;SPRED1;CDKN1B;QARS1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.292930405893658,-0.7685398627001359,0.7605177993527508,0.9205004037339038,1.0,3/12,8.41%,ATP1B1;WNK2;ATP1B3
prerank,membrane lipid metabolic process (GO:0006643),-0.25382671580505056,-0.7681430174533066,0.7733333333333333,0.9202540523647713,1.0,10/22,32.23%,ST3GAL6;SERINC1;ARV1;B4GALT4;GAL3ST1;ST6GALNAC4;SPHK1;TECR;SPHK2;CERKL
prerank,positive regulation of superoxide anion generation (GO:0032930),0.3876663132467509,0.7681254009643455,0.7244755244755244,1.0,1.0,4/13,24.72%,MAPT;PRKCD;SOD1;TGFB1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3819848971456309,0.7680107052634423,0.6948424068767909,1.0,1.0,4/13,19.30%,FADD;CASP8;BAD;TBC1D10A
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.3467579416041269,0.7679840032743528,0.731042654028436,1.0,1.0,7/27,16.43%,SGF29;MSL3;RUVBL2;TRRAP;KAT6A;BRD8;PHF20
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.3725438018159027,0.7678264202092164,0.6977058029689609,1.0,1.0,5/17,12.58%,SLC8A1;GJD3;GJC1;CACNA1C;GJA1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.34374040427070374,0.7675582673623175,0.705607476635514,1.0,1.0,2/29,5.62%,FADD;RAET1E
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.39011482047691015,0.7675493583190381,0.6898148148148148,1.0,1.0,4/12,20.32%,SETX;ADRB2;UVRAG;FYCO1
prerank,cell-cell junction organization (GO:0045216),0.3279690288843204,0.7674190437883733,0.7814776274713839,1.0,1.0,14/79,14.18%,CDH15;SDK1;CDH18;CDH24;CDH4;AFDN;CTNNA1;GJC1;TLN1;LIMS1;TJP2;PRKCI;TLN2;SMAD3
prerank,negative regulation of cell death (GO:0060548),0.32351900632101244,0.7668043472733548,0.7712486883525709,1.0,1.0,23/88,21.00%,RAD18;TXNDC12;GSK3B;SPEF1;CCN1;LRRK2;HTRA2;NCK1;KANK2;IKBKG;SRGAP2;CCN3;NENF;PRKD1;BTBD10;CCN2;CHMP4A;CHMP4B;ADNP2;SNCA;TRAF2;FERMT2;INPP5A
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.3381329008024764,0.7666603773259502,0.7244546498277842,1.0,1.0,7/38,16.13%,PHLPP2;XDH;PPP2R5C;PIK3CB;PLEKHA1;PPP2R5B;PTEN
prerank,cellular response to interferon-gamma (GO:0071346),-0.18283031207017414,-0.7663377683278572,0.9354838709677419,0.922235689414477,1.0,19/88,17.81%,CAMK2D;TLR4;TRIM25;VCAM1;MID1;TRIM8;B2M;IRF2;CAMK2G;IFNGR2;IRF3;IRF9;CX3CL1;IFNGR1;GBP3;GBP4;MT2A;RPL13A;LGALS9
prerank,endodermal cell differentiation (GO:0035987),0.34621411326053786,0.765727687867518,0.726044226044226,1.0,1.0,7/31,15.01%,MMP14;LAMB1;SETD2;LEO1;COL12A1;ITGA5;ITGAV
prerank,regulation of cell junction assembly (GO:1901888),0.35853923250669756,0.7657254147985232,0.7290400972053463,1.0,1.0,6/27,15.47%,CBFB;ROCK2;MYO1C;ROCK1;PDLIM5;RUNX1
prerank,negative regulation of protein metabolic process (GO:0051248),0.3365381140695302,0.7656374670304722,0.7378318584070797,1.0,1.0,12/48,17.14%,IAPP;MDM4;PRNP;ROCK1;FLOT2;SF3B3;PFDN4;ITGAV;PIN1;AZIN1;NFKB1;LDLR
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.36466497059664454,0.7654778747895736,0.7040951122853368,1.0,1.0,5/17,14.26%,SRF;ROBO1;NR4A1;MIA3;EFNB2
prerank,mitochondrial translation (GO:0032543),0.3216004305822961,0.7653902189185335,0.7993827160493827,1.0,1.0,21/104,18.34%,MRPL36;MRPL18;IARS2;RARS2;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;MTRF1;GFM2;MRPS10;MRPS24;MRPL45;MTIF3;MRPL42;MRPL37;MRPL2;MRPL20
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.28003059382868817,-0.7652248379375102,0.7796052631578947,0.9230102463627026,1.0,4/14,17.81%,TGFBR2;PTPN22;CD81;LGALS9
prerank,canonical Wnt signaling pathway (GO:0060070),0.3301018659879343,0.7651859965197173,0.7773109243697479,1.0,1.0,17/68,19.08%,GSK3B;WNT2B;TCF7L1;SFRP2;TCF7L2;PORCN;LRRK2;WNT6;NR4A2;WNT9A;LRP5;SFRP1;PTEN;AMER1;CSNK1A1;FRZB;WNT4
prerank,cholesterol efflux (GO:0033344),0.36130200496819537,0.7651587041416468,0.6936339522546419,1.0,1.0,4/20,16.00%,SOAT1;ABCA1;SOAT2;STX12
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.26923809642307867,-0.7650902286065142,0.7803030303030303,0.9223620167147666,1.0,7/16,22.88%,DDX17;SLU7;DDX5;PUF60;SRSF6;SRSF9;SCNM1
prerank,modified amino acid transport (GO:0072337),0.3739532530452951,0.7649396637439014,0.7212885154061625,1.0,1.0,2/15,6.13%,PDPN;SLC19A1
prerank,ncRNA transcription (GO:0098781),-0.2866703512641934,-0.7648036600189715,0.7633333333333333,0.9219338112778627,1.0,8/13,36.44%,SNAPC3;SPIN1;GTF3C1;NIFK;RPAP2;GTF3A;SIRT7;ANG
prerank,lipid droplet organization (GO:0034389),0.3606010271609947,0.7644940962368444,0.7121588089330024,1.0,1.0,4/22,15.02%,TSPO2;ZFYVE1;PPID;FAF2
prerank,lipid catabolic process (GO:0016042),-0.2647394798332511,-0.7643254617014031,0.8061674008810573,0.9218886059623715,1.0,2/18,5.19%,PLAAT3;PLA1A
prerank,regulation of axonogenesis (GO:0050770),0.33902597240886817,0.7642104279841508,0.7636761487964989,1.0,1.0,18/51,19.83%,RHOA;GSK3B;RTN4R;EPHA4;ROBO1;MARK2;ARHGAP35;PLXNB2;PLXNB1;PLXND1;MAP6;PTEN;SIPA1L1;NGF;AMIGO1;PLXNA2;KIF13B;PLXNB3
prerank,regulation of histone deacetylation (GO:0031063),0.3881643843751717,0.7640926538018515,0.7057142857142857,1.0,1.0,3/13,7.78%,CTBP1;NIPBL;ZBTB7B
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.3527852177519441,0.763668174716325,0.6911957950065704,1.0,1.0,4/23,11.54%,MCU;RIPOR2;CAMK1D;RAC1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.30058327749225494,-0.7636585812480403,0.7951388888888888,0.9220556302326848,1.0,4/12,20.30%,ATF6;PIK3R1;XBP1;TMEM33
prerank,regulation of Rac protein signal transduction (GO:0035020),0.3693323087600039,0.7634405611570316,0.7246575342465753,1.0,1.0,3/16,10.24%,AUTS2;ARHGAP24;PIK3CB
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3425189082931577,0.7633183909433316,0.7161366313309776,1.0,1.0,6/33,7.99%,ADA;PDE3B;SFRP2;EFNA1;PLAU;SERPINE1
prerank,neuron projection regeneration (GO:0031102),-0.3092579812672507,-0.7628779279679035,0.7781065088757396,0.9224091807509784,1.0,5/10,28.11%,GAP43;RTN4RL1;NREP;MTR;OMG
prerank,positive regulation of cytokine production (GO:0001819),0.3195664239163227,0.7626882285596431,0.924924924924925,1.0,1.0,38/292,15.56%,BRCA1;HPSE;FADD;TICAM1;ROCK2;RAB7B;DHX9;PRKDC;SULF2;MRE11;G3BP1;IL18;STOML2;SULF1;SCRIB;ZBTB7B;SERPINE1;CD80;IRF1;AGPAT2;AGT;HMGB1;RAB1A;POLR3D;EIF2AK3;ANXA1;RORA;ADAM17;TRIM6;TWIST1;POU2F2;ARNT;AGPAT1;LPL;PRKD2;RUNX1;NFKB1;SETD4
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.34377835588270567,0.7620942864583168,0.720098643649815,1.0,1.0,6/25,20.28%,RB1;TRIM6;TWIST1;HEY2;NIBAN2;TRAF6
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3209430499318145,0.7620558025294362,0.923923923923924,1.0,1.0,47/308,15.48%,EZH2;BMP1;FBXO5;LOXL2;PAXIP1;MFAP2;BMPR1A;AGO2;NUMA1;PDPN;LEPR;CXCR4;SOX6;IL18;RIF1;ZBTB7B;WWTR1;SERPINE1;MFN2;AGPAT2;AXIN2;ALMS1;ROCK1;AGT;TAPT1;TGFBR1;ABCA1;SMURF2;BMP2;APPL2;ACHE;TRPM4;GJA1;SMAD4;KMT5C;SOX9;ADIPOR1;TWIST1;ADRB2;MED1;CPT2;SMAD3;ACADL;AGPAT1;GDNF;SHLD2;RBM19
prerank,negative regulation of innate immune response (GO:0045824),0.341691387823372,0.76196992039908,0.7414578587699316,1.0,1.0,9/34,22.50%,USP18;NMI;PTPN2;YTHDF2;CNOT7;METTL3;SUSD4;ISG15;FAM3A
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.3761631211370536,0.7618791727765043,0.7203994293865906,1.0,1.0,4/15,11.87%,ROCK2;ROCK1;AGT;PRKCA
prerank,negative regulation of viral process (GO:0048525),0.32954805928602243,0.7617070025589127,0.7669584245076586,1.0,1.0,13/57,21.14%,ILF3;FAM111A;ZC3HAV1;PML;TRIM28;SRPK1;TRIM6;TRIM5;MAVS;SRPK2;LARP7;ISG15;EIF2AK2
prerank,neuron development (GO:0048666),0.32164829119639426,0.7615954040182379,0.8292929292929293,1.0,1.0,31/141,17.45%,PBX4;GLI2;STMN1;PBX3;RB1;GSK3B;LAMB1;NEDD4;TDP2;SRF;MAPT;WNK1;POU3F2;MAP4;ROCK1;HMGB1;SAMD14;FRYL;EHD1;ACTL6B;BLOC1S5;DOCK7;VAPA;GDNF;RUNX1;HDGFL3;TBCD;UNK;UGDH;STMN2;RAB13
prerank,intermediate filament organization (GO:0045109),-0.260620232864452,-0.7613002825809895,0.7529411764705882,0.9239306776732142,1.0,8/17,36.44%,NEFL;GFAP;KLHL24;PKP2;BFSP1;DSP;TCHH;BFSP2
prerank,membrane organization (GO:0061024),0.31807467767975217,0.7611164038370816,0.8758758758758759,1.0,1.0,41/227,18.00%,CEP55;KIF20A;NEMP1;NUP155;STX11;ACTR3;PACSIN2;OCRL;STON2;ARRB1;MYOF;LEMD3;SH3GLB1;STAM;MFN2;DNM2;PICALM;EMD;FNBP1;STX18;GAK;CHRNB1;AAK1;MITD1;PRKCI;ADRB2;PIP5K1C;TOR1B;VAPA;TMCC1;SNAP23;SYP;SUN2;EPS15L1;DYSF;UBXN2B;LDLR;EPS15;USO1;CHMP4A;CHMP4B
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.32537510454866764,0.7610827643625235,0.8,1.0,1.0,11/86,12.64%,TTK;BMPR1A;NUMA1;BMP6;SULF1;CCN1;TGFBR1;BMP2;RBPJ;ADAM17;SMAD4
prerank,cellular response to cAMP (GO:0071320),0.34380822500142943,0.76098451775262,0.7342233009708737,1.0,1.0,6/30,15.27%,AQP1;AHR;AKAP9;EZR;DMTN;PKD2
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3572889048288821,0.7607015532163923,0.7249022164276402,1.0,1.0,5/22,16.20%,ADGRV1;CACNA1C;GNAI3;GABBR2;STIM1
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.3571733905443912,0.7606348684101428,0.72544080604534,1.0,1.0,3/24,6.12%,CDH15;SPAG9;CTNNA1
prerank,oligodendrocyte differentiation (GO:0048709),0.3663178386477518,0.7604997190241941,0.7154150197628458,1.0,1.0,7/19,21.74%,SOX6;EIF2B1;TPPP;SOX9;PRDM8;CDK5;EIF2B5
prerank,glial cell development (GO:0021782),-0.23857616199268264,-0.7595928971650545,0.8489583333333334,0.9256719280615842,1.0,12/25,30.80%,CDK6;NF1;APP;SOX4;NRROS;PICK1;CSPG5;EIF2B2;NSUN5;SOX11;SOX10;MT3
prerank,negative regulation of TORC1 signaling (GO:1904262),0.38505073825855063,0.7592886942569602,0.7307692307692307,1.0,1.0,5/13,16.29%,DEPDC5;SESN1;ITFG2;STK11;SESN2
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.37174965698255086,0.7590682892066938,0.7144846796657381,1.0,1.0,6/16,20.62%,LHPP;ADSL;PFAS;GART;PPAT;ADSS2
prerank,icosanoid secretion (GO:0032309),-0.29048220354553606,-0.758467012082779,0.799373040752351,0.926437688028775,1.0,3/12,10.55%,ABCC4;PNPLA8;ACE
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.34224283698212865,0.7582351841826144,0.7285223367697594,1.0,1.0,9/35,18.59%,AQP1;KSR1;AHR;PDE7B;SOX9;NUDT4;IRAG1;ADCY2;PDE7A
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.23687515131342385,-0.7569699161784493,0.8449197860962567,0.927721394273424,1.0,4/23,17.81%,LAMP1;NECTIN2;PIK3R6;LGALS9
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.286827389519448,-0.7567985280946379,0.7898305084745763,0.9271523313591952,1.0,8/13,36.27%,IGF1;RAMP1;SLC2A10;ABCA2;PLCB1;GOLGA2;CCL19;CHP1
prerank,epithelial structure maintenance (GO:0010669),-0.29051879498518773,-0.756766453992189,0.7728613569321534,0.9263532120528704,1.0,6/11,49.15%,STRAP;RBP4;NOD2;MUC13;PIWIL4;MUC6
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.3461727574622614,0.7567381482946008,0.7403846153846154,1.0,1.0,10/29,15.58%,TCF7L1;TCF7L2;SMARCA4;AXIN2;LEO1;HDAC1;KMT2D;TLE4;TLE3;TRRAP
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.3530582357467371,0.7567376067216208,0.7347994825355757,1.0,1.0,9/22,22.91%,CHD1L;ERCC3;CUL4B;XPA;RAD23B;ERCC2;GTF2H1;DDB1;DDB2
prerank,sulfur compound biosynthetic process (GO:0044272),0.31692969864589426,0.756407101078626,0.8173469387755102,1.0,1.0,27/104,20.13%,CHST15;GSTO2;B4GALT1;GSS;CHSY1;MAT2B;PAPSS2;HPGDS;SLC10A7;ST3GAL3;SLC35D2;CHST3;ANGPT1;UST;DSE;BGN;ST3GAL4;ST3GAL1;ST3GAL2;UGDH;GSTT1;MGST3;GCLM;GSTM5;GCLC;GLCE;HAGH
prerank,positive regulation of fat cell differentiation (GO:0045600),0.33291802976591944,0.7557782812694621,0.7527233115468409,1.0,1.0,16/47,20.15%,SFRP2;ZBTB7B;TMEM64;PIM1;HNRNPU;BMP2;TRPM4;LRP5;WDFY2;MEDAG;LPL;SFRP1;AAMDC;FRZB;SYAP1;RREB1
prerank,coenzyme A metabolic process (GO:0015936),0.3751486950868479,0.7551975428192511,0.7186629526462396,1.0,1.0,7/14,24.04%,ACAT1;PPCDC;PANK4;PANK2;COASY;SLC25A16;DCAKD
prerank,snRNA metabolic process (GO:0016073),0.36755630418398294,0.7549362356982036,0.7276422764227642,1.0,1.0,5/17,19.91%,INTS7;TUT1;INTS8;ZCCHC8;INTS4
prerank,cellular amino acid catabolic process (GO:0009063),0.3200246240050029,0.7547850438726866,0.8146240988671473,1.0,1.0,8/87,13.32%,ACMSD;SLC25A21;AMT;ACAT1;KMO;ABAT;HOGA1;IL4I1
prerank,cellular copper ion homeostasis (GO:0006878),-0.2751108806991154,-0.754637257168728,0.7758007117437722,0.9286646628453089,1.0,6/14,22.32%,APP;COX19;SLC31A2;MT2A;ATOX1;ATP7A
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.23770908082241052,-0.7545726381227551,0.784688995215311,0.9279326414269556,1.0,10/23,22.11%,RBX1;XPC;PARP1;COPS8;COPS7A;UBB;COPS2;COPS4;UBC;RPS27A
prerank,transcription by RNA polymerase III (GO:0006383),-0.2309732275608805,-0.7542344965388719,0.8288770053475936,0.9275367443419793,1.0,9/27,23.59%,RO60;SNAPC3;ICE1;POLR3K;GTF3C3;POLR3H;POLR2K;TBP;GTF3C1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.35559571795926426,0.7542219157242166,0.747141041931385,1.0,1.0,4/22,11.48%,XDH;MAP3K4;RELL1;BMP2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.21413496113659186,-0.7540326062474177,0.8609271523178808,0.9270279944727504,1.0,16/33,34.63%,ARAP1;TGFA;BCAR3;HIP1;ADRA2A;AFAP1L2;CBL;DGKD;HBEGF;GPER1;SHKBP1;EGF;NEU3;AKT1;PDE6H;DOK1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.3577065777782505,0.753949319179882,0.7320987654320987,1.0,1.0,3/22,11.81%,PRNP;PTPN2;EZR
prerank,regulation of tissue remodeling (GO:0034103),0.36088373329561757,0.7538696456181372,0.7092105263157895,1.0,1.0,4/18,15.47%,LEPR;IL18;DDR2;RUNX1
prerank,protein processing (GO:0016485),0.31530291543826994,0.7535732147357724,0.798974358974359,1.0,1.0,7/102,8.37%,KEL;FAM111A;MMP14;FXN;CPXM1;STOML2;HTRA2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.22834088829867402,-0.7531082017938252,0.8903225806451613,0.927563143060556,1.0,4/30,7.70%,CACNA2D1;RYR2;SCN1A;ATP1A1
prerank,T cell migration (GO:0072678),-0.2872574962518921,-0.7527333443720222,0.785234899328859,0.9272866808771324,1.0,9/13,48.71%,S1PR1;SLC12A2;PIK3CD;CXCL16;GPR183;PIK3CG;CXCL10;MYO1G;ZAP70
prerank,BMP signaling pathway (GO:0030509),0.32627523440294465,0.7526671986485528,0.7759914255091104,1.0,1.0,12/62,14.18%,BMPR1A;HIVEP1;RGMA;BMP6;TGFBR3;SMURF1;SMAD6;ZFYVE16;BMP2;SMAD4;USP9X;SMAD3
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.32132897156839013,0.7526151710186848,0.7987616099071208,1.0,1.0,12/85,11.54%,VANGL1;RHOA;PSMC2;PSMD5;DAAM1;SMURF1;PSMB1;PSMD14;PSMD1;SMURF2;PSMB9;RAC1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.33573994422534337,0.7523047275859244,0.7525655644241733,1.0,1.0,2/42,6.80%,RBM15;WNK1
prerank,visual system development (GO:0150063),0.34109229382517153,0.7518539458519596,0.7427240977881258,1.0,1.0,2/37,2.53%,PBX4;PBX3
prerank,energy reserve metabolic process (GO:0006112),0.3528714950367672,0.7515034990843211,0.7196765498652291,1.0,1.0,2/19,5.79%,GSK3B;LEPR
prerank,regulation of sprouting angiogenesis (GO:1903670),0.3417434813416695,0.7512389327662756,0.7384066587395958,1.0,1.0,5/33,14.01%,E2F2;ADAMTS9;PIK3CB;PDPK1;ITGA5
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.3201573842045591,0.7510385958425473,0.7635782747603834,1.0,1.0,19/61,22.56%,FGFR4;PSMC2;PSMD5;PSMB1;PSMD14;NQO1;PSMD1;PSMB9;PANK2;PSMC6;AZIN1;PSMB2;PSME4;PSMB7;PSMD11;PSME3;PSMD13;PSMB8;PSMD4
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.32245790395324975,0.7509719002300993,0.7861635220125787,1.0,1.0,20/80,19.63%,AQP1;CDKN2D;FNIP1;SIAH2;HTRA2;ARL6IP1;SH3RF1;HMGB1;UACA;USP47;XIAP;CD44;SRC;NGF;TNFSF10;LAMTOR5;DPEP1;BAD;DNAJB6;DAPK1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.30460286466400693,-0.7509480561159331,0.7838616714697406,0.9290153181807238,1.0,7/10,32.70%,PDE3A;UBE2B;PDE2A;PDE4D;PDE11A;APLNR;MGRN1
prerank,response to UV-B (GO:0010224),0.3864490466524493,0.7508243522818577,0.7130044843049327,1.0,1.0,2/12,14.61%,HYAL1;STK11
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3679591700641599,0.7506750568064732,0.745578231292517,1.0,1.0,3/13,20.28%,RHOA;ZDHHC21;TRAF6
prerank,amyloid precursor protein catabolic process (GO:0042987),0.3724426673688659,0.7500717069568682,0.7323741007194244,1.0,1.0,3/14,13.34%,DYRK1A;ADAM17;ADAM19
prerank,regulation of astrocyte differentiation (GO:0048710),0.3828068632796846,0.7500208384631359,0.7266081871345029,1.0,1.0,2/12,11.48%,EPHA4;BMP2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.3069997937158692,-0.7499892577959985,0.7846607669616519,0.9294821122664004,1.0,5/10,20.10%,EMC2;EMC3;EMC1;EMC9;MMGT1
prerank,Golgi to lysosome transport (GO:0090160),0.38535864181299195,0.7498948862914038,0.7357954545454546,1.0,1.0,2/11,11.87%,AP4M1;GAK
prerank,positive regulation of protein depolymerization (GO:1901881),0.3902653459028682,0.7495983863999582,0.727802037845706,1.0,1.0,5/11,23.22%,NES;STMN2;TRPV4;SEMA5A;CFL2
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.2198712174965924,-0.749488010975879,0.8520710059171598,0.9293548939980438,1.0,14/31,37.53%,SCP2;LIAS;MOCS2;CYP51A1;MOCS1;GCH1;DHRS11;PRLR;NOXRED1;PYCR2;STAR;SRD5A1;MOCS3;PYCR3
prerank,amino acid transport (GO:0006865),0.3271864002070357,0.7492053023945705,0.7775330396475771,1.0,1.0,14/49,20.46%,SLC38A7;PDPN;SLC38A4;SLC25A47;SLC16A10;SLC38A9;SLC1A5;SLC36A4;SLC6A17;SLC7A1;SLC25A29;SLC38A2;SLC7A11;SLC25A44
prerank,cellular response to pH (GO:0071467),0.3609493411456646,0.7488966334095877,0.7244201909959073,1.0,1.0,1/17,3.31%,HYAL1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.32934147990099244,0.7488424370362292,0.7679738562091504,1.0,1.0,10/47,16.78%,MAP4K4;ULK4;RAP2A;TGFBR3;MAPK8IP3;FOXM1;TAOK1;QARS1;PER1;KLHDC10
prerank,regulation of chemotaxis (GO:0050920),0.33915118511612397,0.7486499704346482,0.7315598548972189,1.0,1.0,5/30,6.49%,MYCBP2;ADGRA2;CXCR4;PTPN2;PDGFRA
prerank,MAPK cascade (GO:0000165),0.3142644399491336,0.7486444911823341,0.934,1.0,1.0,47/295,15.53%,CDK1;SPTA1;ARTN;MAP4K4;KSR1;SETX;NCAM1;BRAP;FGFR4;FGFR2;SPTB;PSMC2;PSMD5;RASA3;KIT;FRS2;NRK;PDGFRA;IL18;MAP3K20;LRRK2;PSMB1;CUL3;PSMD14;ANGPT1;MAP3K3;PSMD1;IKBKG;PIK3CB;PSMB9;FBXW11;PPP1CC;SOX9;IL31RA;CTSH;SPRED1;DLG1;PLVAP;BTRC;PSMC6;TAOK1;RGL3;PTPRA;ITGAV;GDNF;RASAL3;NFKB1
prerank,diterpenoid metabolic process (GO:0016101),0.32012537380328054,0.747986932302222,0.7668845315904139,1.0,1.0,8/55,15.55%,ABCA4;RDH11;RDH12;GPC6;ALDH1A1;SDC1;LPL;HSPG2
prerank,protein localization to membrane (GO:0072657),0.31557237765658425,0.7478858282773625,0.8846539618856569,1.0,1.0,40/187,18.08%,NDC1;SYNE3;NUP155;TSPAN33;ROCK2;AP4M1;RAB10;ITGB7;PDZK1;DENND4C;RAP2A;ANK1;SCRIB;RAB29;SH3GLB1;SMURF1;ROCK1;FLOT2;P2RY1;EPB41L3;KCNIP3;EZR;GAK;ZDHHC15;EHD1;TSPAN5;DLG1;RAMP3;TM9SF2;TTC7B;KCNB2;ZDHHC3;STXBP1;NLGN2;SH3PXD2B;DPP6;RAB13;TM9SF4;WNK3;ARL5A
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.38086711226371395,0.7475682928412863,0.7255747126436781,1.0,1.0,3/12,13.00%,ERFE;ZBTB7B;GKAP1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.31839583337573496,0.7473518187850492,0.8020512820512821,1.0,1.0,7/85,12.43%,BIRC5;ADGRV1;NIPBL;RIPOR2;ROR1;LHFPL5;HOMER2
prerank,hexose biosynthetic process (GO:0019319),0.3306185913613722,0.7469697081801805,0.7406568516421291,1.0,1.0,5/42,8.41%,PFKFB1;CHST15;GPI;SORD;PGM1
prerank,mitochondrial genome maintenance (GO:0000002),0.37710123820027397,0.7468903503299389,0.7357142857142858,1.0,1.0,2/11,9.53%,MGME1;LONP1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3126646494278529,0.7458985352924566,0.8714859437751004,1.0,1.0,28/163,15.53%,ERMAP;THEMIS;PSMC2;PSMD5;KHDRBS1;EIF2B1;WNK1;UBE2N;STOML2;RC3H2;RNF31;PSMB1;PSMD14;NCK1;PSMD1;IKBKG;PIK3CB;PSMB9;PRKCB;FBXW11;PDPK1;BTK;BTRC;RC3H1;PSMC6;PLEKHA1;PRKD2;NFKB1
prerank,cAMP biosynthetic process (GO:0006171),-0.3015409074914872,-0.7456801485777977,0.804093567251462,0.9337817456824223,1.0,3/10,14.63%,ADCY3;ADCY8;ADCY4
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.36779057449294494,0.7452254087187876,0.7510668563300142,1.0,1.0,3/14,11.45%,FIP1L1;TUT1;CPSF4
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.3530425314428243,0.7448348721614202,0.748062015503876,1.0,1.0,4/21,13.83%,BMPR1A;MFN2;GJA1;ADAMTS1
prerank,negative regulation of T cell activation (GO:0050868),0.3398726499011016,0.7448001482805728,0.7578215527230591,1.0,1.0,7/35,20.66%,FGL1;CD80;RIPOR2;IL4I1;HAVCR2;SDC4;CEACAM1
prerank,regulation of protein sumoylation (GO:0033233),0.36022370747390475,0.7443774359010621,0.7349081364829396,1.0,1.0,1/17,1.87%,SAE1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.35381964869849974,0.7441530235731248,0.7326478149100257,1.0,1.0,3/20,13.29%,TICAM1;IL18;PRKCE
prerank,action potential (GO:0001508),-0.2044266966329286,-0.7435942733522419,0.9532710280373832,0.935822941088264,1.0,18/44,32.32%,KCNB1;AKAP6;SCN1A;SCN9A;GNA14;KCNA2;SCN3A;SCN8A;SRI;KCNQ1;GPER1;CACNA1H;MYH14;CLN3;CACNA1I;KCNE4;YWHAH;SCN3B
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.23858726895524296,-0.7431655393327942,0.8349514563106796,0.9355312646854875,1.0,5/22,11.67%,TIMP3;APOE;FURIN;GPLD1;TNFRSF1B
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.26053489182537526,-0.7430791275780649,0.8346456692913385,0.9348033967804376,1.0,9/17,29.94%,PODXL;TGFB2;FOXC2;NCKAP1L;RET;SYK;SKAP1;P2RY12;CIB1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.2962322338861507,-0.7428435257662342,0.7837837837837838,0.9342695605351901,1.0,6/11,22.86%,FAS;GSN;ST18;LGALS9;PARK7;PIH1D1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3210751406644799,0.7427567067162534,0.7712707182320442,1.0,1.0,11/52,14.50%,ATP2B4;RANGRF;GPSM2;NUMA1;EPB41L2;PDPK1;PRKCE;PRKCI;DLG1;ITGB1;RAMP3
prerank,translational termination (GO:0006415),0.3139049015473666,0.7426934335716538,0.8195876288659794,1.0,1.0,24/95,22.26%,MRPL36;MRPL18;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;MTRF1;GFM2;MRPS10;MRPS24;MRPL45;MRPL42;MRPL37;MRPL2;MRPL20;ETF1;MRPS23;MRPS22;MRPL50;MRPL43;PTCD3
prerank,positive regulation of lipid transport (GO:0032370),-0.29049147357374294,-0.7426837285414553,0.7697368421052632,0.9336226943261647,1.0,5/12,25.20%,APOE;LRP1;DBI;ABCA3;PRELID1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.31261699622841504,0.7425397061939255,0.8708375378405651,1.0,1.0,24/151,15.40%,RHD;SLC25A15;CERS6;CERS5;GSTO2;LARGE1;PAM;CHAT;LPCAT1;LPIN2;SLC25A2;HPGDS;CSNK2A2;PLPP1;ACHE;CSNK1G2;PRKD1;ELOVL4;TYW1;ST3GAL4;SPTLC2;VAPA;PRKD2;ST3GAL2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.35451111408386476,0.7421127838837785,0.7305151915455746,1.0,1.0,5/19,18.79%,MMP14;PRKDC;BTK;AXL;ZBTB1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.26682329321210796,-0.7416827823040336,0.8566308243727598,0.9341112415595904,1.0,7/15,29.25%,NTRK2;GRB2;DDIT4;BCAR1;BDNF;ZFYVE27;SOS1
prerank,cellular response to purine-containing compound (GO:0071415),0.37594280345521036,0.7415286935531696,0.7457627118644068,1.0,1.0,3/10,10.76%,SLC8A1;P2RY1;TRPM2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3380846829258256,0.7414068981444084,0.7158671586715867,1.0,1.0,10/30,19.56%,SFRP2;PTPN2;SAMSN1;DMTN;SFRP1;NF2;MVP;SH3BP5;PARP14;PRKCD
prerank,gene expression (GO:0010467),0.3106568783458926,0.7412851633524622,0.951,1.0,1.0,59/348,13.96%,MRPL36;E2F1;NDC1;NUP155;SYNCRIP;SETX;PABPC4;NUP205;TSPAN33;NUP160;AGO2;SRSF4;HNRNPD;FIP1L1;SRBD1;EIF4E;UPF3B;MRPL18;SLBP;NUP85;TPR;DDX39B;HNRNPH1;TASP1;RBMS2;SRSF7;POLR2A;DHX8;CELF2;HNRNPUL1;DARS1;WDR33;NOX4;EPC1;SRSF3;NR4A2;MMS19;HNRNPU;DRG1;HNRNPL;MRPL13;SRRM1;RBM15B;CPSF4;ASMT;ATXN1;MRPL55;NUP214;RNGTT;RPS17;RANBP2;MRPS33;MCM3AP;RBMS1;TSPAN5;MRPS18B;RBM4;SMG6;NXT1
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.3715064026159731,0.7407661691939794,0.7366906474820144,1.0,1.0,4/13,13.69%,SFRP2;RBPJ;SMAD4;HEY2
prerank,microtubule-based transport (GO:0099111),-0.2805319710888363,-0.7403856667392766,0.8122977346278317,0.9350494386719003,1.0,9/12,49.67%,DYNC1I2;CABYR;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.311405599920184,0.7394806257993422,0.8340206185567011,1.0,1.0,41/102,24.66%,GCK;RAB10;PRKDC;PDE3B;DENND4C;LPIN2;RHOQ;CPEB2;NR4A2;ENPP1;PDPK1;NR4A1;PRKCI;EPRS1;SLC30A10;ADCY6;SRC;NFKB1;PCK2;CYSLTR2;PRKAR2B;RAB13;ADCY2;PRKAR2A;INSIG2;SLC2A4;SYAP1;PRKCD;CEACAM1;RAB8B;INSIG1;FER;VAMP2;ZFP36L1;PRKAR1A;SLC25A33;RAB8A;LPIN3;RPS6KB1;PRKACA;RELA
prerank,amyloid-beta metabolic process (GO:0050435),0.3540496059053797,0.7394222224847047,0.7459893048128342,1.0,1.0,1/16,2.23%,DYRK1A
prerank,response to metal ion (GO:0010038),0.3193027434449076,0.738355880454582,0.7985153764581124,1.0,1.0,10/67,13.73%,LOXL2;FXN;PAM;NEDD4;MAPT;PPP3CA;CALM2;NDRG1;ITPR3;ADAM9
prerank,protein hydroxylation (GO:0018126),0.3659413020058541,0.7383009379073665,0.7292517006802721,1.0,1.0,7/15,22.46%,VIPAS39;P3H1;P3H4;PLOD2;OGFOD1;PLOD1;EGLN3
prerank,cellular response to BMP stimulus (GO:0071773),0.31817294237563265,0.7378559416011821,0.7949260042283298,1.0,1.0,14/66,15.25%,BMPR1A;HIVEP1;RGMA;BMP6;TGFBR3;SMURF1;SMAD6;ZFYVE16;BMP2;SMAD4;SOX9;USP9X;SMAD3;SFRP1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.3690933889293091,0.7374028899265297,0.7646198830409356,1.0,1.0,3/13,11.45%,FIP1L1;TUT1;CPSF4
prerank,cytoplasmic translational initiation (GO:0002183),0.3663699154233653,0.7370793696509335,0.7543391188251002,1.0,1.0,9/17,23.54%,EIF4H;RBM4;EIF4A2;MCTS1;DENR;EIF3I;EIF2D;EIF5;EIF4B
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3457250921609867,0.7363454763647324,0.7320261437908496,1.0,1.0,4/23,15.67%,KIT;OCIAD2;CRLF3;OCIAD1
prerank,mesenchyme morphogenesis (GO:0072132),0.3528954512677764,0.735860688122438,0.7560321715817694,1.0,1.0,4/17,12.75%,BMPR1A;MDM4;BMP2;SOX9
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3091410455318092,0.7352603921202652,0.8617558022199798,1.0,1.0,35/118,21.89%,VASH2;PHIP;GSK3B;FGFR2;NEDD4;MAPT;ADGRA2;RAP2A;PDZD8;EPHA4;LRRK2;SH3D19;MARK2;ARHGAP35;LZTS3;PDLIM5;ZDHHC15;PLXND1;LARP4;RC3H1;SFRP1;GDNF;SIPA1L1;ABI2;CLASP1;SP100;TANC2;FMNL2;KIF13B;HECW2;EGLN1;CEACAM1;FERMT2;CDK5;ZRANB1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.3509704425194488,0.735196377516764,0.76657824933687,1.0,1.0,4/19,16.52%,UAP1;SLC35D1;GNPDA2;UGDH
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3149047169769439,0.734954704444418,0.7997858672376874,1.0,1.0,15/77,15.30%,RB1;PHIP;FXN;SIAH2;TCF7L2;RTKN2;SH3RF1;CSNK2A2;TGFBR1;NR4A2;PLAUR;BIRC6;QARS1;ITGAV;SRC
prerank,detection of calcium ion (GO:0005513),0.3622983658968353,0.734817321424894,0.7496443812233285,1.0,1.0,5/13,16.20%,KCNMB2;KCNMB3;CALM2;KCNMB4;STIM1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.33690580393680086,0.7347631715702062,0.7515299877600979,1.0,1.0,6/26,19.32%,EYA4;HTRA2;EYA2;GDNF;PPP2R1B;TERT
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.2155801440561198,-0.7347310087705164,0.89937106918239,0.9407656650486457,1.0,15/31,30.51%,CCNH;GTF2H5;CMTR1;POLR2K;POLR2H;NCBP1;POLR2F;GTF2H2;POLR2C;RAMAC;POLR2E;CDK7;POLR2J;GTF2H4;POLR2D
prerank,7-methylguanosine RNA capping (GO:0009452),-0.2155801440561198,-0.7347310087705164,0.89937106918239,0.9407656650486457,1.0,15/31,30.51%,CCNH;GTF2H5;CMTR1;POLR2K;POLR2H;NCBP1;POLR2F;GTF2H2;POLR2C;RAMAC;POLR2E;CDK7;POLR2J;GTF2H4;POLR2D
prerank,ruffle organization (GO:0031529),-0.26076841053952365,-0.73439091755844,0.8188405797101449,0.9404118479988708,1.0,9/16,31.63%,PLEK;TPM1;INPP5K;PIP5K1A;CYFIP1;ARFIP2;AIF1L;ARF6;CSF1R
prerank,proteoglycan metabolic process (GO:0006029),0.3415482047764661,0.7339838614549358,0.7365792759051186,1.0,1.0,4/26,7.94%,HPSE;SULF2;SULF1;B4GALT7
prerank,regulation of keratinocyte migration (GO:0051547),0.37294636341210463,0.7338912856365509,0.7206946454413893,1.0,1.0,3/12,16.13%,MAP4K4;ADAM9;PTEN
prerank,regulation of vesicle-mediated transport (GO:0060627),0.311306553156195,0.7335052699524717,0.8213552361396304,1.0,1.0,10/91,9.80%,RAB33B;STON1;RAB10;PACSIN2;STON2;STXBP5;LRRK2;ZFYVE16;PICALM;GAS1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.37563503876509735,0.7332711295036632,0.7567567567567568,1.0,1.0,3/11,13.07%,AFDN;RAB1A;TJP2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.3558126851076985,0.7330538033314256,0.7383798140770252,1.0,1.0,4/16,20.90%,PHIP;BMP2;IGFBP3;BMP5
prerank,ventricular septum development (GO:0003281),0.3273417627203305,0.7324648117002778,0.7627314814814815,1.0,1.0,12/37,19.67%,BMPR1A;MDM4;TGFBR3;MATR3;ROBO1;TGFBR1;SMAD4;HEY2;HECTD1;SALL1;ZFPM2;ZFPM1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.3613493113581375,0.7324076937838183,0.7554945054945055,1.0,1.0,3/16,11.17%,SRF;ROCK1;HDAC1
prerank,regulation of lipid metabolic process (GO:0019216),0.30952353488296747,0.7320274885384505,0.8310740354535975,1.0,1.0,14/88,13.71%,ZFP69;FGFR4;PMVK;TBL1XR1;NFYA;NCOA2;TM7SF2;ACACA;RORA;PLPP1;ADIPOR1;MVK;PANK2;MED1
prerank,negative regulation of lipid storage (GO:0010888),0.3538269407415813,0.7318023663316554,0.7606516290726817,1.0,1.0,4/19,15.01%,PTPN2;OSBPL8;ABCA1;ITGAV
prerank,cellular response to fatty acid (GO:0071398),-0.28094825744359886,-0.7316591928293835,0.7811550151975684,0.9431168060280107,1.0,8/12,44.56%,IRS1;ZC3H12A;DGAT2;PDK4;NR1H4;PDK3;KCNK4;PID1
prerank,striated muscle cell differentiation (GO:0051146),0.3515339560347031,0.7314116715669202,0.7489768076398363,1.0,1.0,3/16,11.48%,MYEF2;SDC1;BMP2
prerank,necroptotic process (GO:0070266),0.3650920800072446,0.7313965084071902,0.7580213903743316,1.0,1.0,2/16,7.46%,TICAM1;IPMK
prerank,transport along microtubule (GO:0010970),0.36589091931170176,0.7308883154621342,0.7503586800573888,1.0,1.0,1/13,1.66%,ARHGAP21
prerank,sterol biosynthetic process (GO:0016126),0.3296440856901175,0.7305297304552336,0.7497062279670975,1.0,1.0,7/33,17.83%,LBR;PMVK;TM7SF2;ACAT2;MVK;DHCR7;INSIG2
prerank,renal water homeostasis (GO:0003091),0.34309367987949146,0.730498477266227,0.7405541561712846,1.0,1.0,9/23,24.57%,AQP1;ADCY6;PRKAR2B;ADCY2;PRKAR2A;PRKAR1A;AQP4;MYO5B;PRKACA
prerank,PERK-mediated unfolded protein response (GO:0036499),0.38755817770970247,0.7303569035739382,0.7819548872180451,1.0,1.0,2/10,11.42%,EIF2AK3;QRICH1
prerank,heart trabecula morphogenesis (GO:0061384),0.3534315158197209,0.730256065869488,0.7526315789473684,1.0,1.0,4/18,12.27%,BMPR1A;TGFBR3;TGFBR1;RBPJ
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.3541632126671914,0.7301145728987292,0.7429340511440108,1.0,1.0,4/15,15.53%,IL18;AGT;LPL;NFKB1
prerank,nervous system development (GO:0007399),0.3071842942391654,0.7297860375552799,0.982,1.0,1.0,67/429,17.08%,ECT2;STIL;WDR62;NAV2;CDK5RAP2;ARTN;SDK1;DYRK1A;ADGRV1;TRAK1;TEAD1;LPAR1;OBSL1;ALDH1A2;RBFOX2;FUT10;NINJ2;ST8SIA2;GSS;BTD;ADGRA2;CXCR4;SOX6;NLGN3;GRHL2;CRIM1;RAB29;DPYSL4;POU3F2;WWTR1;WDPCP;YAP1;ROBO1;FARP1;DSCAML1;ZIC5;FBXL17;APAF1;TGFBR1;DSCAM;PRPS1;ATXN1;MPZ;ZIC4;ACHE;DAGLB;NOTCH2;SH3GL3;PLXND1;LY6H;NES;ACTL6B;SMPD1;MAB21L2;CAPG;UNC119;PKD2;GDNF;PTEN;ANKLE2;SHANK2;NLGN2;NCKAP1;ARNT2;JRKL;AXL;NGF
prerank,lamellipodium assembly (GO:0030032),0.3393753473277607,0.729372332643577,0.7673521850899743,1.0,1.0,6/26,14.15%,KIT;SPEF1;SRGAP2;RAC1;DMTN;ITGB1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.25331051608903987,-0.7293008422297079,0.8530465949820788,0.9452750420296621,1.0,5/16,24.02%,PRKN;PDK1;BCKDK;PDK2;SCARB2
prerank,small GTPase mediated signal transduction (GO:0007264),0.3089129530683321,0.7291435118145279,0.8271221532091098,1.0,1.0,25/103,18.50%,KSR1;RB1;BRAP;RASSF1;RRAD;CCNA2;ARHGAP18;SIAH2;NTN1;G3BP1;CDK2;TRIM28;USP28;ARHGEF18;CRKL;RAC1;RRAS;PLK2;PRKD1;TP53;TNK2;RRAS2;NRAS;KRAS;MAPK14
prerank,negative regulation of phagocytosis (GO:0050765),0.35579409239408444,0.729136351479657,0.7452574525745257,1.0,1.0,5/17,17.51%,HMGB1;PIP4P2;DYSF;SIRPA;CD47
prerank,regulation of protein secretion (GO:0050708),0.30720258260198974,0.7291199511963246,0.8571428571428571,1.0,1.0,20/119,13.73%,GCK;ARFIP1;ITPR1;FRMD4A;DNAJC1;STXBP5;MYH10;BMP6;LLGL2;CACNA1C;RAPGEF4;SYTL4;EZR;PRKCA;P3H1;ITPR3;ACHE;PPID;ENSA;ADAM9
prerank,negative regulation of neuron differentiation (GO:0045665),0.34066452902907524,0.729107237369154,0.7290076335877863,1.0,1.0,3/22,13.71%,GSK3B;SOX9;MED1
prerank,peptidyl-tyrosine modification (GO:0018212),0.31852649160690866,0.7285803245671904,0.7895902547065338,1.0,1.0,13/56,17.55%,DYRK1A;FGFR4;FGFR2;KIT;PDGFRA;EPHA4;ABI1;DDR2;BTK;EFEMP1;SRC;EPHA3;ABI2
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.35411594326195867,0.7284856729491054,0.7437908496732026,1.0,1.0,4/18,16.42%,FXN;AGT;GDNF;RFK
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.3310124619476119,0.7281148168542676,0.7736777367773677,1.0,1.0,9/29,17.53%,PATL1;LSM3;CNOT6;LSM2;EXOSC7;LSM7;CNOT7;LSM4;EDC3
prerank,defense response to bacterium (GO:0042742),0.30876347914470204,0.7276384460916202,0.847870182555781,1.0,1.0,7/105,9.83%,HMGB2;AQP1;COLEC12;RNASE6;ANXA3;SERPINE1;RAB1A
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.36068677605209476,0.727603374076715,0.7435897435897436,1.0,1.0,5/14,18.81%,TSEN34;CPSF4;TSEN2;DDX1;ZBTB8OS
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3275405536050807,0.7275795179481527,0.7647727272727273,1.0,1.0,10/41,15.30%,PRNP;FBXW7;EFNA1;EPHA4;NOX4;AGT;DOCK3;ADAM17;UNC119;SRC
prerank,negative regulation of autophagosome assembly (GO:1902902),0.35699343751780943,0.7271463485932537,0.7521246458923513,1.0,1.0,6/13,21.63%,LRRK2;TMEM39A;SCFD1;CHMP4A;CHMP4B;SEC22B
prerank,cytokine-mediated signaling pathway (GO:0019221),0.30614492545461097,0.7270862119709863,0.982,1.0,1.0,58/532,14.40%,TNFSF13B;LMNB1;BIRC5;IL1RL1;MAP3K14;NCAM1;PLP2;ZEB1;ANXA2;PSMC2;PSMD5;ACTN4;KIT;TAB1;LEPR;CNN2;IL18;PML;UBE2N;POU2F1;FOXO3;CD80;IRF1;PSMB1;PSMD14;SMARCA4;YAP1;MAP3K3;PIM1;PSMD1;EDA;IKBKG;PIK3CB;SDC1;LIMS1;IP6K2;PSMB9;CAPZA1;ANXA1;PYDC1;CRKL;CNTF;RORA;APPL2;FBXW11;ADAM17;SMAD4;IL31RA;ADIPOR1;TWIST1;IL1RL2;PLVAP;BTRC;CDKN1B;ITGB1;PSMC6;TRIM5;CD44
prerank,myoblast fusion (GO:0007520),0.36902247406628963,0.7269505674132027,0.7403560830860534,1.0,1.0,2/12,7.27%,ADAM12;ADAMTS5
prerank,endosome organization (GO:0007032),-0.20326064916642744,-0.7268596732175694,0.9009009009009009,0.9475823676868965,1.0,18/41,27.46%,SNX3;SQSTM1;LAPTM4B;DNM1;USP8;VPS11;CHMP2B;ARFGEF2;HOOK1;VPS33B;RAB27A;ALS2CL;PLEKHF1;TMEM9;SNX10;PI4K2A;AKTIP;PHETA1
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.3768946416443223,0.7267281877769574,0.7702503681885126,1.0,1.0,3/11,18.77%,BMPR1A;HEY2;ZFPM2
prerank,adipose tissue development (GO:0060612),0.3778395256841936,0.7265966411037664,0.7533432392273403,1.0,1.0,4/11,16.74%,PGRMC2;LRP5;SPTLC2;SH3PXD2B
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.32928212417656083,0.7263520323229486,0.770414201183432,1.0,1.0,7/33,22.39%,FADD;PRKCA;CASP8;RUNX1;RIPK1;TRAF6;ZFP36L1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.3136719936753738,0.7261737628860505,0.8233438485804416,1.0,1.0,13/75,15.27%,HMGB2;VASH2;JCAD;HMGB1;TGFBR1;BMP2;PRKCA;PDPK1;ADAM17;NR4A1;PRKD1;ARNT;PRKD2
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.3589759858689977,0.7261433601288281,0.7475177304964539,1.0,1.0,5/15,18.81%,TSEN34;CPSF4;TSEN2;DDX1;ZBTB8OS
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.30515647135356305,0.7260622220042071,0.9127382146439318,1.0,1.0,35/190,16.30%,CIT;ATP2B4;FNIP1;TNFAIP8L1;CGNL1;DEPDC5;ITPR1;AJUBA;PHLPP2;PDE3B;XDH;NMI;RTKN2;TRIM59;TBC1D7;RIOK3;LIMD1;NPRL3;PPP2R5C;PIK3CB;UACA;CCN3;RORA;CASP8;ADIPOR1;PLAUR;TWIST1;SPRED1;PLEKHA1;PER1;OTUD7B;SRC;PPP2R5B;PTEN;SHANK2
prerank,serine family amino acid catabolic process (GO:0009071),0.3661567475508554,0.7251306316177184,0.7694656488549618,1.0,1.0,1/10,6.15%,AMT
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.3381915032261779,0.7250035410670898,0.7551020408163265,1.0,1.0,8/23,24.41%,BMF;AGK;MAIP1;BAD;HSPA4;TIMM10B;HSP90AA1;BAX
prerank,negative regulation of protein polymerization (GO:0032272),0.3352854176511834,0.7249890910778933,0.7736318407960199,1.0,1.0,3/27,5.69%,STMN1;DYRK1A;SSH2
prerank,cell projection assembly (GO:0030031),0.33695758324628866,0.7248565728354645,0.7713920817369093,1.0,1.0,5/22,16.51%,PARVA;RHOQ;RAC1;CAPG;NCKAP1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.3422478906096604,0.7246260606339281,0.7595092024539877,1.0,1.0,7/24,19.49%,NEDD4;PRKCB;ITGA5;ARNT;PRKD2;NIBAN2;PTPN1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.3138593884494383,0.7242438351330249,0.8,1.0,1.0,20/53,25.03%,PSMC2;PSMD5;PSMB1;PSMD14;NQO1;PSMD1;PSMB9;PSMC6;AZIN1;PSMB2;PSME4;PSMB7;PSMD11;PSME3;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,purine ribonucleotide transport (GO:0015868),-0.25368336140149034,-0.7242056234910075,0.8339483394833949,0.9501361788603356,1.0,6/16,19.50%,ABCC4;SLC25A24;LRRC8D;ABCC5;SLC25A4;LRRC8A
prerank,lamellipodium organization (GO:0097581),0.33345306489587817,0.7233633406995297,0.7691326530612245,1.0,1.0,6/29,14.15%,KIT;SPEF1;SNX1;RAC1;DMTN;ITGB1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3045178811868945,-0.7232444980091697,0.8259668508287292,0.9504809183378549,1.0,6/10,44.12%,LGALS9;PTPRC;ARRB2;CX3CR1;FCGR2B;LILRB1
prerank,regulation of histone modification (GO:0031056),0.363236521982088,0.722615844972688,0.7590529247910863,1.0,1.0,2/13,6.93%,MTHFR;UBE2N
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.3686644431413661,0.7225579319765169,0.7618364418938307,1.0,1.0,5/13,24.44%,FBN1;BMP2;LTBP1;DAND5;FSTL1
prerank,cardiac cell development (GO:0055006),-0.2920036587997529,-0.7224535336216896,0.8254437869822485,0.9505931957492341,1.0,3/11,16.80%,JAG1;VEGFA;MYH11
prerank,positive regulation of lymphocyte migration (GO:2000403),0.37117115077812357,0.7223896391109653,0.7831669044222539,1.0,1.0,1/12,3.24%,RHOA
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.32529946425884226,0.7222993505746744,0.772782503037667,1.0,1.0,9/31,17.53%,PATL1;LSM3;CNOT6;LSM2;EXOSC7;LSM7;CNOT7;LSM4;EDC3
prerank,negative regulation of neurogenesis (GO:0050768),0.33597138658507747,0.7222307952492257,0.778169014084507,1.0,1.0,3/34,4.43%,RHOA;RTN4R;PCM1
prerank,skin development (GO:0043588),0.3134315397792084,0.7222045851411181,0.8045112781954887,1.0,1.0,8/65,13.73%,TGM1;STMN1;COL5A2;ERRFI1;ANXA1;CLIC4;MED1;ADAM9
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.30343251453533426,0.7213273247166067,0.8857431749241659,1.0,1.0,17/142,12.68%,LPAR3;ATP2B4;LPAR1;IAPP;CXCR4;PDGFRA;BDKRB2;SLC8A1;HMGB1;CACNA1C;P2RY1;ATP2B1;TRPC7;CALB1;ITPR3;TRPM4;C1QTNF1
prerank,regulation of protein localization to cell surface (GO:2000008),0.32045295424253,0.721070130442004,0.7523584905660378,1.0,1.0,5/33,10.05%,RANGRF;GBF1;LEPROT;PICALM;SNX33
prerank,pancreas development (GO:0031016),0.36199805829597076,0.7207619148846691,0.7406876790830945,1.0,1.0,2/12,8.91%,TCF7L2;NPHP3
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.3326710454110988,0.7204224903278511,0.7579462102689487,1.0,1.0,5/25,9.52%,PML;EFNA1;EPHA4;CSNK2A2;PSME3IP1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.3792331361179871,0.7203216809301859,0.7603053435114504,1.0,1.0,1/10,2.17%,MAP4K4
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.3712425195269661,0.7200683285262055,0.7801857585139319,1.0,1.0,4/10,22.00%,SMPD3;SMPD2;PRKCD;SIRT3
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.3712425195269661,0.7200683285262055,0.7801857585139319,1.0,1.0,4/10,22.00%,SMPD3;SMPD2;PRKCD;SIRT3
prerank,regulation of ossification (GO:0030278),0.3242057934018928,0.7199716950082692,0.7768878718535469,1.0,1.0,10/36,16.24%,CHSY1;SMAD6;DDR2;ENPP1;BMP2;RBPJ;SOX9;TWIST1;SFRP1;NOTUM
prerank,hematopoietic stem cell differentiation (GO:0060218),0.3797294073379468,0.7198012253313314,0.7425149700598802,1.0,1.0,4/10,17.30%,LMBR1L;SFRP1;TP53;MLLT3
prerank,macrophage activation involved in immune response (GO:0002281),-0.26821198092769566,-0.7197663103983036,0.8213166144200627,0.9531527601102363,1.0,4/13,15.37%,IFI35;LBP;GRN;SBNO2
prerank,regulation of epithelial cell migration (GO:0010632),0.31353581552602755,0.7195216338940621,0.7969432314410481,1.0,1.0,20/51,24.19%,MACF1;HYAL1;MCC;ENPP2;SOX9;ADIPOR1;CTSH;PRKCE;DOCK1;INSL3;SRC;ARSB;CLASP1;DOCK5;RREB1;CEACAM1;DAB2IP;PTPN23;SASH1;DUSP10
prerank,sensory perception of pain (GO:0019233),-0.23660342664530157,-0.7192929672156197,0.8652173913043478,0.9528696316473274,1.0,14/21,45.38%,SCN9A;OPRM1;KCNA2;NIPSNAP1;P2RX4;P2RX7;OPRK1;CHRNA4;CCR2;CCL2;KCNK4;OPRL1;CHRNB2;ALOXE3
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3528385146898845,0.7192863612576578,0.76221928665786,1.0,1.0,3/17,11.51%,HTRA2;SFPQ;BAG5
prerank,regulation of TORC1 signaling (GO:1903432),0.32454162115045815,0.719062881394098,0.7702227432590856,1.0,1.0,10/33,17.52%,DEPDC5;DYRK3;KLHL22;SESN1;ITFG2;STK11;CLEC16A;SESN2;LARS1;LAMTOR5
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.36564535499910417,0.7187774266714615,0.7572674418604651,1.0,1.0,2/12,7.44%,RAB10;SCRIB
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.32398052126246973,0.7187753760085593,0.782707622298066,1.0,1.0,7/36,13.79%,ATP2B4;NOSIP;DNM2;NPR3;PIK3CB;TERF2;DHFR
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3076706842452417,0.7180101471665239,0.8211297071129707,1.0,1.0,21/73,21.65%,ATP2B4;FNIP1;SH2D3C;SFRP2;TXN;AKAP9;STOX1;TRIM6;PRKD1;CD44;RAMP3;DOCK7;RPTOR;PRKD2;NGF;TERF2IP;BRAF;CAPRIN2;SNCA;LATS1;STK4
prerank,negative regulation of catalytic activity (GO:0043086),0.3340459136653134,0.7179021935038663,0.77375,1.0,1.0,6/24,19.43%,NOSIP;PARP9;ATP5IF1;NES;TP53;CAND1
prerank,nucleotide catabolic process (GO:0009166),0.35048157553863785,0.7178960100589102,0.7620320855614974,1.0,1.0,6/16,25.86%,XDH;ITPA;PNP;NT5E;GDA;DERA
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.3184611181102963,0.7176994916755587,0.7734104046242775,1.0,1.0,7/42,15.25%,MAP4K4;GSK3B;ROCK1;LIMS1;RAC1;RRAS;SFRP1
prerank,negative regulation of defense response to virus (GO:0050687),0.37416854492490015,0.7174295463310719,0.7560975609756098,1.0,1.0,2/10,12.73%,ILRUN;ITCH
prerank,heterotypic cell-cell adhesion (GO:0034113),0.3348807239093326,0.7172437912222934,0.7720403022670025,1.0,1.0,5/25,15.01%,PARVA;ITGB7;ITGA5;ITGB1;ITGAV
prerank,mesenchymal cell development (GO:0014031),-0.24623468270955903,-0.7169825996051816,0.8616600790513834,0.9547639283594214,1.0,8/18,33.47%,CDH2;FOXC1;HEYL;NOLC1;KLHL12;SOX11;SOX8;KBTBD8
prerank,muscle contraction (GO:0006936),0.30554919376772116,0.7164217144440639,0.8806875631951466,1.0,1.0,20/126,16.68%,ROCK2;TPM4;MYOF;SORBS3;ROCK1;BDKRB2;SLC8A1;EMD;GJC1;MYH2;TLN1;SNTA1;SMTN;CLCN1;CHRNB1;DES;TMOD3;DYSF;TPCN2;TNNT3
prerank,negative regulation of lyase activity (GO:0051350),0.3488953644946048,0.7163926411395606,0.7686980609418282,1.0,1.0,3/16,16.08%,ADGRV1;GNAI3;GABBR2
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3108289529227439,0.7163518898636543,0.7843137254901961,1.0,1.0,5/50,6.35%,TRIP6;RHOA;ACTN4;NMI;RTKN2
prerank,regulation of interleukin-6 production (GO:0032675),-0.16914073119632977,-0.715978751646283,1.0,0.9551364751665629,1.0,21/96,20.54%,STAT3;GAS6;TLR4;PTPN22;HSPD1;LBP;SELENOS;APP;ARHGEF2;SYT11;CX3CL1;PTPN11;IL17D;C1QTNF3;IFIH1;XBP1;AFAP1L2;LGALS9;NCKAP1L;ZC3H12A;TIRAP
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.3787743422028972,0.7157329216099187,0.7480438184663537,1.0,1.0,3/10,19.53%,PTPN2;NF2;PARP14
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.33512321795696576,0.7157115592305138,0.7509025270758123,1.0,1.0,5/26,11.51%,TXN;PYCR1;LRRK2;HTRA2;BAG5
prerank,regulation of interleukin-17 production (GO:0032660),0.3252432574849842,0.7156398793465408,0.7750611246943765,1.0,1.0,3/31,7.78%,PRNP;IL18;ZBTB7B
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.22723156910830788,-0.7152409852608108,0.8972972972972973,0.9551196094033332,1.0,8/23,37.61%,ATP6V0A4;SLC12A9;SLC12A2;PDK2;PDK4;SLC9A1;SLC12A5;KCNH2
prerank,arachidonic acid secretion (GO:0050482),0.3693721689807983,0.7152159234735159,0.7639097744360902,1.0,1.0,2/10,11.23%,BDKRB2;ANXA1
prerank,arachidonate transport (GO:1903963),0.3693721689807983,0.7152159234735159,0.7639097744360902,1.0,1.0,2/10,11.23%,BDKRB2;ANXA1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.31908209319032615,0.7150312752089902,0.7795823665893271,1.0,1.0,5/36,9.77%,ATP2B4;ANGPT4;ADAMTS9;SVBP;HMGB1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.3772373784660812,0.7150028527854279,0.7586206896551724,1.0,1.0,2/10,12.47%,FBXW7;ADAM17
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.342630919140088,0.7145338126302726,0.7690253671562083,1.0,1.0,3/17,14.00%,CASK;SULF1;XIAP
prerank,regulation of receptor recycling (GO:0001919),0.3497666384988016,0.7143672971915015,0.7724230254350736,1.0,1.0,3/16,7.72%,ANXA2;SCRIB;RAB29
prerank,regulation of cytoplasmic transport (GO:1903649),-0.2797615403443303,-0.7142106848271546,0.8463855421686747,0.9555078715048927,1.0,6/11,26.70%,MAPK3;MAPK1;MAP2K1;ATP9A;CHMP3;DENND10
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.29628019013857465,0.7140413540532639,0.8651115618661258,1.0,1.0,26/112,17.76%,TGFBR3L;BMPR1A;RHOA;WWOX;NLK;SOX6;TGFBR3;SMURF1;SMAD6;TGFBR1;NR3C1;LIMS1;ARHGEF18;CRKL;APPL2;SMAD4;SOX9;USP9X;ADAM9;ITGB1;SMAD3;SFRP1;SRC;PTPRK;SMAD2;ZFYVE9
prerank,intracellular sterol transport (GO:0032366),0.35502682408831227,0.7140380231026043,0.7411598302687411,1.0,1.0,3/13,15.63%,TSPO2;ABCA1;RELCH
prerank,response to interleukin-6 (GO:0070741),-0.29326310284019386,-0.7134208430565567,0.8445121951219512,0.9556119775506088,1.0,3/10,19.16%,ST3GAL6;SBNO2;PTPRT
prerank,positive regulation of ossification (GO:0045778),0.3195070578876601,0.7131609503552183,0.7913340935005702,1.0,1.0,7/39,11.48%,ADGRV1;BMPR1A;BMP6;CCN1;SLC8A1;ATP2B1;BMP2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.2992647443999655,0.7130314723965983,0.9094567404426559,1.0,1.0,20/159,12.14%,CDH15;SDK1;MMP24;PCDHGB4;CDH18;CDH24;ALCAM;OBSL1;ADGRL1;GPC6;CDH4;PCDHGC3;ROBO1;DSCAML1;FGFRL1;PLXNB2;DSCAM;PTPRS;EMB;MPZ
prerank,endocardial cushion morphogenesis (GO:0003203),0.33459709008854477,0.712354243346167,0.773936170212766,1.0,1.0,4/18,12.75%,BMPR1A;MDM4;BMP2;SOX9
prerank,termination of RNA polymerase I transcription (GO:0006363),0.32256533022135053,0.7121184810371297,0.7931034482758621,1.0,1.0,6/30,13.17%,POLR1A;POLR1B;ERCC3;TAF1D;TTF1;POLR1G
prerank,TOR signaling (GO:0031929),0.3280309952875596,0.711975878466244,0.7858017135862914,1.0,1.0,5/26,14.65%,FNIP1;LARP1;MAPKAP1;NPRL3;RPTOR
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.3528268886322467,0.7118787303279592,0.7673130193905817,1.0,1.0,4/15,18.50%,RIPOR2;EHD1;ADAM9;MAPK14
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.35077228239415953,0.7115785935420514,0.7542706964520368,1.0,1.0,5/16,19.32%,NPR3;PIK3CB;TERF2;DHFR;TERT
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.36973202553123646,0.7113448662708001,0.7851851851851852,1.0,1.0,3/11,14.16%,RC3H2;ANXA1;RC3H1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.3563033207003994,0.711303197491923,0.7853185595567868,1.0,1.0,4/15,15.25%,SPEF1;NPHP3;RSPO3;SFRP1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.34527392974512394,0.7112849093472902,0.785904255319149,1.0,1.0,4/19,15.13%,BMP6;AFDN;ADAM19;PTPRU
prerank,cGMP-mediated signaling (GO:0019934),0.3578305019283553,0.7111469759683033,0.7733142037302726,1.0,1.0,1/13,1.84%,AQP1
prerank,atrioventricular valve development (GO:0003171),0.35457031391676197,0.7106359941236664,0.7848101265822784,1.0,1.0,3/14,11.48%,BMPR1A;MDM4;BMP2
prerank,mesoderm formation (GO:0001707),-0.24503648086795787,-0.710473576221805,0.8699186991869918,0.958193687795822,1.0,7/17,31.49%,BMPR2;ITGB4;ITGB3;HMGA2;KDM6B;SNAI1;ITGA2
prerank,microglial cell activation (GO:0001774),-0.22335630244813848,-0.7102450284913873,0.8416289592760181,0.9575870602178391,1.0,13/21,43.29%,GRN;APP;CX3CL1;IFNGR1;JAK2;C1QA;TYROBP;ITGB2;CX3CR1;ITGAM;AGER;AIF1;TREM2
prerank,defense response to symbiont (GO:0140546),0.30299499488399545,0.7102187882306794,0.8526970954356846,1.0,1.0,11/92,11.54%,FADD;MAP3K14;MOV10;RNASE6;G3BP1;ATG7;TTC4;SETD2;IRF1;SKP2;RNASE1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.2457252552633232,-0.7098397403190254,0.8421052631578947,0.9571931642284214,1.0,5/17,15.74%,BIN1;PTPRZ1;TNFRSF1B;TENM4;DICER1
prerank,protein maturation (GO:0051604),0.29742096304678917,0.7096386291765114,0.845360824742268,1.0,1.0,10/95,13.51%,KEL;TSPAN33;MMP14;CPXM1;NDUFAB1;TASP1;MMS19;ADAM17;ADAM19;TSPAN5
prerank,inner ear morphogenesis (GO:0042472),0.33360873238985544,0.7093418358064285,0.7878787878787878,1.0,1.0,4/22,12.75%,FGFR2;TTC39C;TBX18;SOX9
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3236550962663115,0.7092648906598484,0.7751552795031056,1.0,1.0,6/27,18.30%,CHST15;CHSY1;CHST3;BGN;UGDH;XYLT1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.34785731747676085,0.7086862720553551,0.7581329561527581,1.0,1.0,2/14,8.10%,TXNDC12;LRRK2
prerank,positive regulation of endopeptidase activity (GO:0010950),0.33686353389642065,0.7085553088356421,0.7830303030303031,1.0,1.0,4/26,9.53%,ROCK2;EFNA1;EPHA4;PICALM
prerank,translational elongation (GO:0006414),0.2991192453729838,0.7082872256801096,0.8641975308641975,1.0,1.0,24/101,22.26%,MRPL36;MRPL18;EEFSEC;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;GFM2;MRPS10;MRPS24;MRPL45;MRPL42;MRPL37;MRPL2;MRPL20;LTN1;MRPS23;MRPS22;MRPL50;MRPL43;PTCD3
prerank,negative regulation of blood coagulation (GO:0030195),0.3140519820558267,0.7081471757038715,0.7983682983682984,1.0,1.0,6/38,13.02%,PDGFRA;PLAU;SERPINE1;F8;C1QTNF1;PLAUR
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.33168301230705055,0.7080138431036502,0.776595744680851,1.0,1.0,6/22,15.82%,ROCK2;ROCK1;AGT;PRKCA;SMAD4;LMCD1
prerank,glycine metabolic process (GO:0006544),0.3499555722956205,0.7079582359658122,0.7860326894502229,1.0,1.0,1/12,6.15%,AMT
prerank,striated muscle cell development (GO:0055002),0.3498366870506191,0.7069922485312001,0.7828571428571428,1.0,1.0,5/14,22.31%,SDC1;TMOD3;TMOD1;LMOD1;TMOD2
prerank,COPII-coated vesicle budding (GO:0090114),0.30287671009944706,0.7068572169005006,0.8199152542372882,1.0,1.0,16/68,18.46%,F5;CUL3;TRAPPC6B;RAB1A;SCAP;F8;SCFD1;SEC24D;TRAPPC10;MIA3;VAPA;ANKRD28;BET1;TRAPPC9;USO1;TMED10
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.32631280021364795,0.706754656766242,0.791970802919708,1.0,1.0,5/26,12.47%,GPRC5A;FBXW7;ERRFI1;NCK2;ADAM17
prerank,response to glucagon (GO:0033762),-0.23772145621361224,-0.7066720901005551,0.8719211822660099,0.9601050177940132,1.0,5/19,14.63%,PRKACB;PRKAR1B;ADCY3;ADCY8;ADCY4
prerank,ERBB2 signaling pathway (GO:0038128),0.3199036884108914,0.7066545031859901,0.7772455089820359,1.0,1.0,5/31,15.30%,MATK;CUL5;GAB1;PRKCA;SRC
prerank,presynapse organization (GO:0099172),-0.28170273780257404,-0.7060266968272783,0.8357348703170029,0.9599918205804392,1.0,4/10,19.94%,LRRTM3;DVL1;NLGN1;FZD1
prerank,pre-miRNA processing (GO:0031054),0.3572475381617957,0.7058364688941635,0.7682584269662921,1.0,1.0,3/14,13.59%,AGO2;TUT7;TUT4
prerank,cell-cell junction assembly (GO:0007043),0.30227378126003956,0.7055712996245881,0.8108395324123273,1.0,1.0,17/63,18.12%,CDH18;CDH24;RHOA;CTNNA1;GJD3;GJC1;EPB41L3;TLN1;PRKCA;GJA1;TLN2;PIP5K1C;RHOC;TBCD;CDH11;TRPV4;PKN2
prerank,ATP transport (GO:0015867),0.36760400776590746,0.7054219985050084,0.7975270479134466,1.0,1.0,4/10,19.47%,SLC25A42;CD47;SLC25A17;SLC25A5
prerank,regulation of transferase activity (GO:0051338),-0.2384239490877474,-0.7048409498352122,0.8565217391304348,0.9604834824326826,1.0,8/17,30.07%,PINX1;ATM;NABP2;FEM1A;NLRC5;SPTSSB;HMBOX1;JMJD8
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.23884278799984365,-0.70482276154177,0.8513011152416357,0.9596635772250494,1.0,5/17,22.25%,LARP6;RGCC;TGFB3;CREB3L1;SUCO
prerank,positive regulation of lyase activity (GO:0051349),0.3460576684696141,0.7047124069920876,0.7846153846153846,1.0,1.0,3/14,16.20%,FXN;CACNA1C;STIM1
prerank,regulation of cell aging (GO:0090342),-0.2737759598514416,-0.7046808236622627,0.8567073170731707,0.958971551236188,1.0,2/11,10.57%,NEK6;RSL1D1
prerank,regulation of membrane depolarization (GO:0003254),0.33877067333253796,0.7046670282814528,0.7837116154873164,1.0,1.0,2/18,8.10%,RANGRF;LRRK2
prerank,prostaglandin biosynthetic process (GO:0001516),0.3439546435226757,0.70465353955726,0.7726027397260274,1.0,1.0,4/18,12.59%,PTGES2;HPGDS;PTGS1;DAGLB
prerank,glycerol metabolic process (GO:0006071),-0.2954431393768956,-0.7042961914724388,0.8328840970350404,0.958589041302237,1.0,6/10,34.27%,COQ3;GOT1;TPI1;PGP;ANGPTL3;TKFC
prerank,regulation of fibrinolysis (GO:0051917),-0.2609826158391429,-0.7040828405517896,0.89198606271777,0.9579577712454583,1.0,4/13,24.80%,THBD;THBS1;USF1;FAP
prerank,positive regulation of MAPK cascade (GO:0043410),0.2967598539163405,0.7039666209779636,0.9497991967871486,1.0,1.0,32/245,15.27%,EZH2;KSR1;ROCK2;FGFR4;FGFR2;LPAR1;IAPP;GAREM1;KIT;PDGFRA;ARRB1;FBXW7;JCAD;NPNT;LRRK2;ROBO1;ANGPT1;ROCK1;HMGB1;P2RY1;CRKL;BMP2;ROR1;PRKCA;NOTCH2;ADRB2;TRIM5;CD44;RAMP3;TAOK1;SLC30A10;PRKD2
prerank,neuron fate commitment (GO:0048663),0.348232015610937,0.7035813447714424,0.7779310344827586,1.0,1.0,2/14,10.37%,POU3F2;TGFBR1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.3692687237508876,0.703520075265215,0.7733918128654971,1.0,1.0,2/10,9.01%,FTO;MGMT
prerank,DNA dealkylation (GO:0035510),0.3692687237508876,0.703520075265215,0.7733918128654971,1.0,1.0,2/10,9.01%,FTO;MGMT
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.22734633884820155,-0.7033754275962295,0.8636363636363636,0.9579341231526013,1.0,7/21,21.91%,SMAD7;CAV1;INPP5K;PPM1F;DDIT4;PDE4D;RACK1
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.2716518725933601,-0.7030091040485084,0.8825301204819277,0.9574725267189941,1.0,1/12,0.39%,DOCK10
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.21998791801312068,-0.7028398722308317,0.8952380952380953,0.956836394796794,1.0,12/25,34.63%,ARAP1;BCAR3;HIP1;AFAP1L2;CBL;DGKD;GPER1;SHKBP1;NEU3;AKT1;PDE6H;DOK1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.3098358258301454,0.7024422835534191,0.8067796610169492,1.0,1.0,3/39,5.36%,RANGRF;NEDD4;PDZK1
prerank,vesicle transport along actin filament (GO:0030050),0.3379195217752184,0.7022372379063987,0.7989690721649485,1.0,1.0,2/19,5.87%,ACTN4;MYO1C
prerank,endoderm formation (GO:0001706),0.3150689064743452,0.7018578617715862,0.7900355871886121,1.0,1.0,6/35,15.01%,MMP14;LAMB1;SETD2;COL12A1;ITGA5;ITGAV
prerank,intracellular cholesterol transport (GO:0032367),0.34540441595419263,0.7018411409389506,0.7754820936639119,1.0,1.0,4/15,17.14%,TSPO2;ABCA1;RELCH;LDLR
prerank,negative regulation of autophagy (GO:0010507),0.307326822484994,0.701825228087202,0.8080697928026173,1.0,1.0,9/54,9.51%,BMF;DAP;EIF4E;LEPR;ATG7;QSOX1;LRRK2;KLHL22;MTMR9
prerank,cellular response to metal ion (GO:0071248),0.2949422752037569,0.7007562852417225,0.8947368421052632,1.0,1.0,15/123,15.75%,ECT2;AQP1;ADGRV1;PRNP;BMP6;LRRK2;CARF;TRPM2;DMTN;CLIC4;SMPD1;CDKN1B;GLRA2;PKD2;ADD1
prerank,negative regulation of cartilage development (GO:0061037),0.35152481694620497,0.700513644002326,0.7799442896935933,1.0,1.0,5/13,20.44%,TGFBR1;WNT9A;SOX9;EFEMP1;CHADL
prerank,negative regulation of nervous system development (GO:0051961),0.33776700252414726,0.6999184397488654,0.7759784075573549,1.0,1.0,2/17,11.99%,PCM1;APPL2
prerank,positive regulation of protein localization to membrane (GO:1905477),0.29562423710604807,0.6998316110513553,0.8561151079136691,1.0,1.0,22/98,18.50%,E2F1;ATP2B4;RANGRF;MIEF2;TFDP1;PRNP;PDZK1;MYO1C;MIEF1;PDPK1;CASP8;PRKCE;PRKCI;DLG1;ITGB1;RAMP3;TP53;PPP3R1;EPHA3;WNK3;YWHAQ;BAD
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.3398944894597734,0.6998015880155067,0.7746288798920378,1.0,1.0,3/16,9.85%,LARGE1;ST8SIA2;ST3GAL5
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.2625341665979197,-0.6994958440936402,0.8815331010452961,0.9595224847170178,1.0,6/13,30.81%,SHISA6;GRIK2;SHISA9;SHISA7;RAB3GAP1;CLN3
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.2625300717295391,-0.6993436927694354,0.8787878787878788,0.9588198484985221,1.0,5/12,24.73%,AR;SELENOS;AP2A1;TAF7;EDN1
prerank,aromatic amino acid family metabolic process (GO:0009072),0.3594561699228521,0.6993281341744281,0.779320987654321,1.0,1.0,3/10,17.39%,ASRGL1;IL4I1;THAP4
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.24257050134041971,-0.6988205575297539,0.8700361010830325,0.9585175313978314,1.0,5/16,22.25%,LARP6;RGCC;TGFB3;CREB3L1;SUCO
prerank,pharyngeal system development (GO:0060037),0.3408095402401248,0.698719959598456,0.7786666666666666,1.0,1.0,2/15,10.37%,BMPR1A;TGFBR1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.32447808028262404,0.6982371259581207,0.7791411042944786,1.0,1.0,9/29,22.34%,FADD;TICAM1;IKBKG;CASP8;RIPK1;UBE2D3;TANK;IKBKB;BIRC2
prerank,UV protection (GO:0009650),0.3661606084130478,0.6981457339138684,0.7936267071320182,1.0,1.0,4/10,24.33%,XPA;SDF4;ERCC2;ERCC5
prerank,regulation of cellular protein localization (GO:1903827),0.30300927050468485,0.6974434316260958,0.8031496062992126,1.0,1.0,15/45,24.23%,GBF1;GPC6;MAPT;SPIDR;SETD2;LCP1;PIN1;PTPN1;CSNK1E;GPC4;CCDC66;PRKAA2;HSP90AA1;GPC3;KDM1A
prerank,regulation of endothelial cell proliferation (GO:0001936),0.3036178147697426,0.6973887950425844,0.8670157068062827,1.0,1.0,14/88,15.27%,HMGB2;VASH2;ATOH8;XDH;SULF1;ANGPT1;TGFBR1;BMP2;PRKCA;NR4A1;ATP5IF1;PRKD1;ARNT;PRKD2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.32485754401762706,0.6969729542136732,0.8002560819462228,1.0,1.0,3/24,7.03%,LEPR;COX10;COQ10B
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.29185625918212565,0.6966222201582699,0.991,1.0,1.0,72/509,15.30%,ECT2;TRIML2;HPSE;FADD;KSR1;ADGRV1;MAP3K14;TICAM1;FNIP1;TRIP6;ROCK2;MIER1;FGFR4;RHOA;FGFR2;LPAR1;BMF;IAPP;ACTN4;NEDD4;KIT;FRS2;NMI;TCF7L2;RTKN2;PDGFRA;IL18;JCAD;UBE2N;TXN;RNF31;CD80;BCLAF1;TNFRSF10B;ANGPT1;MAP3K3;ROCK1;PUM2;AGT;HMGB1;OSBPL8;IKBKG;PIK3CB;CXXC5;TGFBR1;LIMS1;BOK;PLXNB1;GAB1;PRKCB;BMP2;RAC1;ROR1;PDPK1;TRIM6;GJA1;CASP8;BRD4;SOX9;SLC38A9;DDX21;ADRB2;PLK2;PRKD1;ITGB1;TRIM5;RAMP3;RPTOR;ITGAV;VAPA;PRKD2;SRC
prerank,negative regulation of cellular component movement (GO:0051271),-0.24815794938983057,-0.6965148758718832,0.88,0.9601930447459889,1.0,4/15,17.95%,FRMD5;SPOCK3;CCDC125;ACTN1
prerank,positive regulation of exosomal secretion (GO:1903543),0.3453199275870667,0.6963205327266316,0.7903682719546742,1.0,1.0,5/15,21.80%,STAM;SDC1;SMPD3;SDC4;PDCD6IP
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.2171812530052864,-0.6959774848858741,0.9095238095238095,0.9599437755036813,1.0,4/24,12.57%,TRAF3IP2;PTPN22;ZDHHC1;TOMM70
prerank,copper ion transport (GO:0006825),0.3641247801108902,0.6959211766798833,0.7761627906976745,1.0,1.0,1/11,3.01%,STEAP3
prerank,cellular response to leucine starvation (GO:1990253),-0.28239268741580414,-0.6956937218575701,0.8779761904761905,0.9594116812042013,1.0,3/10,10.84%,SESN3;GCN1;MTOR
prerank,ear morphogenesis (GO:0042471),0.33117484904733546,0.6953121733997527,0.794344473007712,1.0,1.0,5/20,18.69%,FGFR2;NIPBL;TWIST1;OSR1;ZIC1
prerank,early endosome to Golgi transport (GO:0034498),-0.27651587260309035,-0.6951436113608669,0.8487654320987654,0.959127775009511,1.0,6/11,25.79%,STX5;SURF4;SNX2;SNX8;RBSN;RAB6A
prerank,fat cell differentiation (GO:0045444),0.302888352558257,0.6949568351673904,0.8417582417582418,1.0,1.0,10/57,13.71%,BBS9;CTBP1;MKKS;TCF7L2;SMAD6;OSBPL8;NR4A2;NR4A1;ATF5;MED1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.30390461652234296,0.6945362567594875,0.810989010989011,1.0,1.0,11/51,13.64%,BMPR1A;FBN1;LEMD3;CRIM1;SMURF1;SMAD6;RBPMS2;SMURF2;BMP2;SMAD4;HTRA3
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.3615657682159077,0.6944122068748945,0.7746268656716417,1.0,1.0,3/10,17.37%,ERRFI1;ENPP1;MVP
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.23983487497534706,-0.6939775592870966,0.8863636363636364,0.959563184679443,1.0,1/17,0.30%,CACNA2D1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.3642155685614259,0.6938999984400098,0.78125,1.0,1.0,2/10,10.24%,XDH;PIK3CB
prerank,programmed necrotic cell death (GO:0097300),0.3432181970833611,0.6938531264144879,0.8069948186528497,1.0,1.0,2/18,7.46%,TICAM1;IPMK
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.32120931072901904,0.6935130692815231,0.7779126213592233,1.0,1.0,9/30,22.34%,FADD;TICAM1;IKBKG;CASP8;RIPK1;UBE2D3;TANK;IKBKB;BIRC2
prerank,regulation of sequestering of triglyceride (GO:0010889),0.338677280689427,0.6933298300803776,0.7896879240162822,1.0,1.0,3/15,14.80%,OSBPL8;PLIN2;LPL
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.29528295122690434,0.6925256312893576,0.8247535596933188,1.0,1.0,8/55,10.91%,FADD;WWOX;BMF;PML;BCLAF1;AGT;TGFBR1;BOK
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.3382318214616388,0.6924260275832964,0.7815468113975577,1.0,1.0,6/15,23.31%,PIK3CB;AAK1;UNC119;TNK2;SNAP91;SCYL2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2912817668004225,0.6921691049724439,0.949,1.0,1.0,35/234,14.31%,TRIML2;TRIM37;TICAM1;TFDP1;DDRGK1;RAB7B;KIT;DHX9;SRF;TAB1;STK3;ANXA3;RTKN2;IL18;UBE2N;TAF12;RNF31;SMARCA4;AGT;EDA;DDR2;ERC1;IKBKG;FLOT2;CAMK1D;PRKCB;ROR1;TRIM6;BTK;PPRC1;SLCO3A1;PRKCI;PRKD1;SMAD3;TRIM5
prerank,negative regulation of response to stimulus (GO:0048585),0.299165124480371,0.6919844546996844,0.8349514563106796,1.0,1.0,9/60,15.09%,RBL1;FBXO5;BRAP;CASK;MAP3K3;TERF2;APPL2;TWIST1;SLC30A10
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.3476051012506318,0.6918349312032753,0.7949438202247191,1.0,1.0,3/12,15.37%,AGT;SOX9;GDNF
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.2976350779473795,0.6915124670711453,0.8473684210526315,1.0,1.0,21/67,22.56%,PSMC2;PSMD5;PSMB1;PSMD14;PSMD1;CYBB;IKBKG;PSMB9;PSMC6;ITGAV;SNAP23;PSMB2;PSME4;PSMB7;PSMD11;PSME3;SEC22B;IKBKB;PSMD13;PSMB8;PSMD4
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.32166574619581234,0.691181212609694,0.7893432465923172,1.0,1.0,1/23,1.25%,GLI3
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.3415891361951451,0.6910329906385512,0.7985714285714286,1.0,1.0,3/13,12.58%,GJC1;CACNA1C;GJA1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3343736211599666,0.6907448094623327,0.7829036635006784,1.0,1.0,5/16,19.20%,TBC1D25;MTRF1;CLEC16A;OGFOD1;ETF1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.29537023609299895,0.6906751390100332,0.8676470588235294,1.0,1.0,7/85,8.10%,PLK1;GSK3B;PSMC2;DDRGK1;FBXW7;FMR1;LRRK2
prerank,histone H3-K4 methylation (GO:0051568),0.3215523659236114,0.6901201320749456,0.805952380952381,1.0,1.0,4/26,15.56%,PAXIP1;KMT2A;KMT2D;SETD4
prerank,positive regulation of receptor internalization (GO:0002092),0.32656178681962855,0.6901062420400751,0.7961538461538461,1.0,1.0,3/22,9.20%,ARRB1;FMR1;ANGPT1
prerank,positive regulation of protein secretion (GO:0050714),0.2964070446074896,0.6900664678968877,0.8688699360341151,1.0,1.0,16/69,19.56%,GCK;FRMD4A;MYH10;BMP6;TCF7L2;MCU;SYTL4;EZR;ACHE;PPID;ADAM9;AACS;NLGN2;TMED10;BAD;DNM1L
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.2621125453611374,-0.6900264956718009,0.8861209964412812,0.9627858807578853,1.0,4/12,20.56%,ABCA5;NR1H3;NR1H2;ITGB3
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.2290045071470272,-0.6890988075200645,0.9079497907949791,0.962857834460057,1.0,7/19,25.94%,TLR4;LBP;RAB11FIP2;LGALS9;TIRAP;PIK3AP1;TRIL
prerank,regulation of protein phosphorylation (GO:0001932),0.2876932624771862,0.6889185308806121,0.9639278557114228,1.0,1.0,49/256,18.70%,ECT2;PHIP;FNIP1;ROCK2;PRKDC;PRNP;RAP2A;LEPR;XDH;MUSK;ARRB1;PML;FMR1;EFNA1;CCN1;WWTR1;LRRK2;AXIN2;ANGPT1;RB1CC1;PPP2R5C;P2RY1;PLXNB2;EIF2AK3;TWF1;CRKL;BMP2;RAC1;ADAM17;BRD4;SOX9;PLAUR;SLCO3A1;PPP1R15B;PTPN13;WDFY2;PIN1;FXR1;PPIL4;PPP2R5B;PTEN;SESN2;SIRPA;MAVS;TERF2IP;KRAS;LIMK2;IGFBP3;RIPK1
prerank,positive regulation of axon extension (GO:0045773),0.3236374525040417,0.6884027122065165,0.7883870967741935,1.0,1.0,7/22,20.56%,MACF1;NTN1;MAPT;DSCAM;DBN1;SEMA5A;GOLGA4
prerank,regulation of viral release from host cell (GO:1902186),0.3206825313224574,0.6883342326608425,0.803594351732991,1.0,1.0,3/21,8.31%,VPS37B;PML;TRIM28
prerank,protein stabilization (GO:0050821),0.29022682753787316,0.6877431553321833,0.9395770392749244,1.0,1.0,28/168,16.37%,GTSE1;MCM8;PARVA;NLK;CHEK2;MDM4;WIZ;TSPAN1;STK3;FBXW7;EFNA1;EPHA4;NCLN;ATF7IP;GNAQ;VHL;MTMR9;FLOT2;BAG5;SUGT1;P3H1;AAK1;USP9X;MORC3;PIN1;STX12;PTEN;CDC37L1
prerank,negative regulation of cell migration (GO:0030336),0.28924633913734843,0.6874690090706507,0.907258064516129,1.0,1.0,33/137,18.63%,BMPR1A;ARID2;MCC;RAP2A;STK24;SFRP2;AFDN;HOXA7;SULF1;EPHA4;SERPINE1;FOXO3;TMEFF2;ROBO1;SRGAP2;SRGAP3;HAS1;RAC1;NKX2-1;DPYSL3;GJA1;CLIC4;ADIPOR1;MIA3;PTPRU;SFRP1;NF2;PTEN;PTPRK;SLURP1;CLASP1;DPEP1;IGFBP3
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.29053604884286577,0.6874299844655308,0.8732106339468303,1.0,1.0,23/93,19.09%,ATP2B4;FNIP1;SH2D3C;SFRP2;TXN;NCK1;AKAP9;STOX1;NCK2;TRIM6;DMTN;PRKD1;CD44;RAMP3;DOCK7;RPTOR;PRKD2;CNKSR3;PTEN;NGF;TERF2IP;BRAF;CAPRIN2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.3088582233751006,0.6874185282002849,0.8067632850241546,1.0,1.0,5/32,12.36%,CHAT;LPCAT1;LPIN2;CSNK2A2;ACHE
prerank,positive regulation of interleukin-13 production (GO:0032736),0.3628769705292343,0.6871004165320803,0.8015267175572519,1.0,1.0,1/10,6.49%,IL18
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.28777854870736264,0.6864508031976809,0.985,1.0,1.0,60/390,15.30%,SHCBP1;CEP57;STMN1;STYK1;SETX;PHIP;ROCK2;ACTR3;FGFR4;RHOA;COL4A6;GSK3B;FGFR2;RBFOX2;KIT;SULF2;HNRNPA1;FRS2;MUSK;PTPN2;PDGFRA;VAV2;EFNA1;HNRNPH1;SULF1;POLR2A;EPHA4;NCK1;RHOQ;FGFRL1;ANGPT1;ABI1;ROCK1;BDKRB2;CYBB;DDR2;PIK3CB;SH2D2A;EIF2AK3;CLNK;GAB1;EFNB1;RAC1;ANKS1B;ROR1;NCK2;WASF2;IL31RA;MAPKAPK3;POLR1G;DOCK1;SPRED1;ADRB2;PRKD1;EFNB2;ITGAV;AAMP;ARPC1B;PRKD2;SRC
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.2500225894549376,-0.6857293449781163,0.8581818181818182,0.9655139704420775,1.0,3/15,11.50%,PRKCH;FOXC1;SFRP4
prerank,negative regulation of protein phosphorylation (GO:0001933),0.28568562049913254,0.684595894874324,0.9256281407035176,1.0,1.0,45/150,21.76%,RB1;CEP43;PRKDC;PRNP;TAB1;XDH;SFRP2;PMEPA1;WWTR1;LRRK2;SMAD6;GNAQ;NCK1;ERRFI1;CEP85;ENPP1;CALM2;SAMSN1;PYDC1;CRKL;NCK2;PDPK1;DMTN;TWIST1;SPRED1;PPP1R15B;PTPN13;QARS1;SFRP1;SPRED2;CNKSR3;PTEN;SIRPA;MVP;TERF2IP;IGFBP3;PRKCD;TRIB1;DNAJC10;FBLN1;CEACAM1;SNCA;UBASH3B;FKBP8;SIRT2
prerank,negative regulation of interleukin-2 production (GO:0032703),0.33412013844159166,0.684521734606201,0.8057851239669421,1.0,1.0,3/18,12.43%,PRNP;EZR;HOMER2
prerank,regulation of acute inflammatory response (GO:0002673),-0.23568198944988694,-0.6844602789081459,0.8933823529411765,0.9658978562133194,1.0,18/18,76.46%,OSMR;ADAM8;KLKB1;NLRP3;IL4;GSTP1;IL6;CREB3L3;OSM;FFAR2;DNASE1;PLA2G2D;C2CD4B;F12;DNASE1L3;C2CD4A;PTGES;IL6ST
prerank,negative regulation of DNA binding (GO:0043392),0.3125874178965523,0.6839449789983282,0.7962732919254658,1.0,1.0,5/28,18.81%,E2F1;ILRUN;HEY2;TFAP4;SP100
prerank,SNARE complex assembly (GO:0035493),-0.2813615625874225,-0.6839039595052775,0.86,0.9656157435373806,1.0,4/10,20.41%,STXBP6;VAMP8;VAMP3;VAMP1
prerank,lipid translocation (GO:0034204),0.3243863786990658,0.6834929923777306,0.8119325551232166,1.0,1.0,3/21,10.71%,ABCA4;ABCB4;ABCA1
prerank,vesicle coating (GO:0006901),0.29392770499715165,0.6832017336536824,0.8413719185423365,1.0,1.0,13/61,18.46%,F5;CUL3;TRAPPC6B;RAB1A;F8;SCFD1;SEC24D;TRAPPC10;ANKRD28;BET1;TRAPPC9;USO1;TMED10
prerank,COPII vesicle coating (GO:0048208),0.29392770499715165,0.6832017336536824,0.8413719185423365,1.0,1.0,13/61,18.46%,F5;CUL3;TRAPPC6B;RAB1A;F8;SCFD1;SEC24D;TRAPPC10;ANKRD28;BET1;TRAPPC9;USO1;TMED10
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.29392770499715165,0.6832017336536824,0.8413719185423365,1.0,1.0,13/61,18.46%,F5;CUL3;TRAPPC6B;RAB1A;F8;SCFD1;SEC24D;TRAPPC10;ANKRD28;BET1;TRAPPC9;USO1;TMED10
prerank,positive regulation of cell growth (GO:0030307),0.28580537144259227,0.6831348298931249,0.8739669421487604,1.0,1.0,18/96,15.51%,MACF1;HYAL1;CEP43;MMP14;FXN;NTN1;MAPT;SFRP2;DERL2;SMURF1;KLHL22;TGFBR1;ADAM17;USP47;RPTOR;INO80;SFRP1;DBN1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.3560632764324169,0.6829485604080674,0.7981220657276995,1.0,1.0,3/10,11.99%,ENPP1;PRKCB;APPL2
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.17635082010532196,-0.6828812957579194,1.0,0.9657531095636726,1.0,13/51,26.91%,STAT3;MALT1;TLR4;APP;S100A13;PANX1;LGALS9;TRIM16;EGR1;HSPB1;JAK2;P2RX7;TMEM106A
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.2890667077656004,0.6828371940962085,0.8638253638253638,1.0,1.0,18/86,16.57%,ANGPT4;PRNP;SFRP2;BMP6;ENPP2;EFNA1;CD80;ANGPT1;AGT;SAMSN1;DMTN;ITGA5;CD44;SFRP1;SRC;CNOT7;TP53;TNK2
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.2755707132077226,-0.6822392787446703,0.8757961783439491,0.9655322581665307,1.0,5/10,36.37%,ANO6;NCKAP1L;CD300A;RAB31;C3
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.2905121381847432,0.6819762038674015,0.8559670781893004,1.0,1.0,28/74,25.03%,PSMC2;PSMD5;ELOC;PSMB1;PSMD14;LIMD1;VHL;PSMD1;PSMB9;STOX1;RBPJ;ARNT;PSMC6;PSMB2;PSME4;PSMB7;PSMD11;EGLN1;PSME3;SIRT2;PSMD13;PSMB8;EGLN3;PSMD4;PSMF1;PSMA5;HIF3A;PSMC3
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.3206122563598017,0.6817875311033454,0.7914438502673797,1.0,1.0,5/20,13.69%,TGFBR3;TGFBR1;BMP2;RBPJ;HEY2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.24727467170161307,-0.6817825531140282,0.8793103448275862,0.9651699012227668,1.0,9/16,41.56%,GSK3A;GPER1;MRAP2;CHGA;PDE6H;C3;ACP3;GRP;NECAB2
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.25494669154400773,-0.6815862902798291,0.8704318936877077,0.9645335005224923,1.0,3/12,14.64%,NBL1;SLIT2;DUSP1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.22685231106847525,-0.6814753089524598,0.8857142857142857,0.9638185214869406,1.0,6/20,23.34%,NUMB;DAB2;AP2M1;PKDCC;BCL2L1;ABI3
prerank,regulation of mitochondrial depolarization (GO:0051900),0.3456686126714912,0.6805177112872387,0.7987987987987988,1.0,1.0,2/10,15.30%,LRRK2;SRC
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3114816302908649,0.6804417617187677,0.8146811070998796,1.0,1.0,7/30,14.18%,TGFBR3L;TGFBR3;DKK3;SMURF2;SMAD4;XIAP;SMAD3
prerank,regulation of actin filament-based movement (GO:1903115),0.3544699101772013,0.6798682242480807,0.8032305433186491,1.0,1.0,1/10,5.71%,PDPN
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.29088168666746317,0.6797733783825521,0.847457627118644,1.0,1.0,10/67,15.25%,TRIOBP;GSK3B;NPNT;RSU1;LIMS1;CRKL;RAC1;DMTN;DOCK1;SFRP1
prerank,negative regulation of cell junction assembly (GO:1901889),0.3197269066347663,0.679262536002876,0.8157560355781448,1.0,1.0,7/25,16.28%,ROCK2;ROCK1;ARHGAP6;DMTN;SRC;PTEN;RCC2
prerank,regulation of fibroblast migration (GO:0010762),0.32114742230788407,0.6791064014013367,0.8068331143232589,1.0,1.0,7/20,14.15%,DDR2;HAS1;RAC1;APPL2;DMTN;PRKCE;ITGB1
prerank,negative regulation by host of viral transcription (GO:0043922),-0.2635268479284712,-0.6788964985084843,0.8543689320388349,0.9655710584746742,1.0,4/12,20.95%,INPP5K;JUN;HMGA2;TARDBP
prerank,ceramide biosynthetic process (GO:0046513),0.3013835510850232,0.6787901607029603,0.8171557562076749,1.0,1.0,9/40,18.62%,CERS6;CERS5;ST8SIA2;ST3GAL5;AGK;SMPD1;SPTLC2;SMPD2;FA2H
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2941979588116031,0.6786898811706754,0.8378378378378378,1.0,1.0,9/54,12.60%,FADD;UBE2K;PTPN2;RNF31;SPPL2B;IKBKG;PYDC1;ADAM17;CASP8
prerank,dephosphorylation (GO:0016311),0.28414122169136025,0.6784875181883078,0.9152371342078708,1.0,1.0,35/147,20.55%,PPM1G;PPM1D;LHPP;TAB1;PPP2R3A;SSH2;PPP3CA;DUSP12;MTMR2;PPP2R5C;PTPN21;PTPRS;FBXW11;PLPP1;PLPP5;PPP1CC;BTRC;PTPN13;STK11;PTPRA;MTMR3;PTPRU;DAPP1;PPP2R5B;PTEN;PPP2R1B;UBLCP1;PTPRK;PTPRE;DUSP7;PPM1A;PTPN1;PTPN5;PPP4R1;PNKP
prerank,negative regulation of endocytosis (GO:0045806),0.31911144896799326,0.678299858534063,0.815043156596794,1.0,1.0,7/24,17.12%,MTMR2;PICALM;SNX33;RAC1;PRKD1;UNC119;EPHA3
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.31160033822882816,0.678157154306598,0.8279569892473119,1.0,1.0,2/30,4.01%,MACF1;RAB10
prerank,regulation of osteoclast differentiation (GO:0045670),-0.19534865316383337,-0.6780735217614376,0.9477124183006536,0.9655501541355701,1.0,5/33,13.64%,TLR4;CAMK4;MTOR;CEBPB;PRXL2A
prerank,cellular response to gamma radiation (GO:0071480),0.3306040069299728,0.6780711500286005,0.8018741633199464,1.0,1.0,4/17,16.96%,MAP3K20;YAP1;TP53;ATR
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.35080107729104126,0.6774630072149874,0.7981790591805766,1.0,1.0,2/10,9.31%,NCK1;VHL
prerank,inositol phosphate biosynthetic process (GO:0032958),0.348469332310072,0.6772853129120252,0.8308823529411765,1.0,1.0,3/11,11.05%,IPMK;PPIP5K1;IP6K2
prerank,pentose-phosphate shunt (GO:0006098),-0.26758406521473,-0.6772851209552122,0.8798798798798799,0.9654189127378773,1.0,4/11,20.81%,PGD;RPE;RPIA;SHPK
prerank,response to UV-A (GO:0070141),-0.2477670101450358,-0.6766928189761944,0.8866666666666667,0.9651570328875546,1.0,6/14,33.62%,MMP2;CERS1;CCND1;MMP1;OPN3;AKT1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.34277097318423594,0.6765497674150213,0.8024523160762943,1.0,1.0,3/13,10.63%,ZBTB7B;PIM1;HNRNPU
prerank,urogenital system development (GO:0001655),0.34826140216452584,0.676321813858751,0.8038067349926794,1.0,1.0,3/11,18.35%,ANXA1;SOX9;OSR1
prerank,nucleic acid-templated transcription (GO:0097659),0.29966559827832673,0.6762198600423734,0.8348519362186788,1.0,1.0,6/42,10.88%,E2F1;POLR2A;EPC1;NR4A2;MMS19;DRG1
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.20136841319816323,-0.6761085410533858,0.9308176100628931,0.9648427136270967,1.0,10/30,27.12%,SELENOF;ST13;HSPA5;CCT2;DNAJC18;DNAJB12;SDF2;CHCHD4;ENTPD5;HSPA9
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.2951839535817989,0.6759790468160474,0.839344262295082,1.0,1.0,15/59,20.89%,SDK1;OBSL1;CDH4;ROBO1;DSCAML1;PLXNB2;DSCAM;EMB;ITGB1;AMIGO1;PLXNB3;DSG2;KIRREL3;CEACAM1;MPZL2
prerank,regulation of autophagy (GO:0010506),0.28441847117172503,0.6758824610854667,0.9608826479438315,1.0,1.0,43/216,16.79%,TRIML2;TICAM1;GSK3B;BMF;DAP;DEPDC5;ITPR1;EXOC4;NEDD4;EIF4E;MAPT;LEPR;TPCN1;FBXW7;SH3GLB1;FOXO3;LRRK2;HTRA2;KLHL22;ROCK1;CSNK2A2;MTMR9;HMGB1;RB1CC1;PIK3CB;BOK;DCAF12;TRIM6;SLC38A9;EXOC8;PLK2;PRKD1;FOXK2;SNX32;TRIM5;STK11;RPTOR;MTMR3;PRKAG1;TPCN2;CISD2;VPS26A;LAMTOR3
prerank,regulation of gluconeogenesis (GO:0006111),0.31285839213507216,0.6757315062887244,0.8088779284833539,1.0,1.0,3/27,6.18%,GCK;ERFE;PTPN2
prerank,androgen receptor signaling pathway (GO:0030521),0.33720663004553114,0.6754334278986047,0.7962154294032023,1.0,1.0,3/11,12.33%,PMEPA1;ARID1A;PLPP1
prerank,regulation of interferon-beta production (GO:0032648),0.29860454358323574,0.6754017407859516,0.8436482084690554,1.0,1.0,17/46,23.95%,DHX9;IRF1;RIOK3;POLR3D;PTPRS;YY1;SIRPA;MAVS;RELB;ISG15;POLR3C;RNF216;TLR7;POLR3G;REL;RIPK2;HSP90AA1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.27915094222846487,-0.675312054426673,0.8688046647230321,0.9647491114919721,1.0,4/10,22.18%,CSGALNACT1;B3GAT2;XYLT2;B3GAT1
prerank,homeostasis of number of cells (GO:0048872),0.32705653745658864,0.675173018000442,0.8003072196620584,1.0,1.0,3/12,15.67%,OCIAD2;CCN3;OCIAD1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.31000449506867084,0.6749492872797481,0.804726368159204,1.0,1.0,6/26,15.64%,NEDD4;AKAP9;DLG1;CAB39;ITGB1;STK39
prerank,regulation of myeloid cell differentiation (GO:0045637),0.2966018525038415,0.674846795173419,0.8621420996818664,1.0,1.0,12/62,15.66%,RBM15;CBFB;MOV10;NFE2;LEO1;KMT2A;HDAC1;PRKCB;KMT2D;RUNX1;TNRC6C;CNOT4
prerank,mitochondrial RNA metabolic process (GO:0000959),0.33750858045558374,0.6745682726772959,0.8079658605974396,1.0,1.0,4/14,16.12%,FOXO3;FASTKD5;TFB1M;PNPT1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.24702027883825955,-0.674399177077922,0.883495145631068,0.9647553985509368,1.0,4/13,18.16%,ISCA1;GLRX3;CIAO1;LTO1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.32463632536958886,0.6740267021456464,0.8110539845758354,1.0,1.0,3/19,6.46%,OBSL1;CUX1;CAPRIN1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.33005475807224216,0.6740175763320216,0.8078484438430311,1.0,1.0,3/15,15.37%,AGT;SOX9;GDNF
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3491691778404784,0.6735986699041928,0.8220946915351507,1.0,1.0,3/11,15.63%,AGO2;RBM4;TNRC6C
prerank,miRNA mediated inhibition of translation (GO:0035278),0.3491691778404784,0.6735986699041928,0.8220946915351507,1.0,1.0,3/11,15.63%,AGO2;RBM4;TNRC6C
prerank,positive regulation of endothelial cell migration (GO:0010595),0.28941000479923734,0.6733718444337333,0.8797071129707112,1.0,1.0,17/84,15.27%,ATOH8;ROCK2;ANGPT4;GPI;ANXA3;ANGPT1;AGT;HMGB1;PIK3CB;RAC1;PRKCA;RRAS;PDPK1;ADAM17;PRKD1;AAMP;PRKD2
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.17130233437791714,-0.6733670917693382,1.0,0.9648803682307312,1.0,11/57,14.42%,GRIN2A;FIS1;GRIN2B;MALT1;MAP3K5;LGMN;NOD1;CTSD;BCAP31;PPM1F;GRIN1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.3022812631896976,0.673132896816301,0.8451977401129943,1.0,1.0,8/42,12.63%,RHOA;PDPN;NPNT;RSU1;PIK3CB;LIMS1;RAC1;DMTN
prerank,water-soluble vitamin metabolic process (GO:0006767),0.2906571944192916,0.6726083623809072,0.8598524762908325,1.0,1.0,14/68,17.86%,MTHFD1L;GSTO2;MTHFR;BTD;PDXK;SLC19A1;ENPP1;PANK2;DHFR;SLC19A2;RFK;CYB5A;MMAB;SLC25A19
prerank,regulation of cell death (GO:0010941),0.28554229134861353,0.6718072197984493,0.8860103626943006,1.0,1.0,15/94,14.50%,RAD18;TXNDC12;SPEF1;FAF1;RILPL1;CCN1;RAB29;LRRK2;NCK1;AXIN2;SRGAP2;CCN3;PRKD1;CDKN1B;RAMP3
prerank,negative regulation of viral release from host cell (GO:1902187),0.33968979977324293,0.6716621649576668,0.8159420289855073,1.0,1.0,3/13,14.31%,PML;TRIM28;TRIM5
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.3409740328461416,0.6712505367057253,0.8089080459770115,1.0,1.0,3/12,17.14%,IAPP;PFDN4;LDLR
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.28746264269143323,0.6712248774888552,0.8639667705088265,1.0,1.0,8/75,9.38%,ATP2B4;THBS2;ROCK2;ANGPT4;PDE3B;PML;SULF1;ROCK1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.24700026868880304,-0.6711369010199624,0.8927335640138409,0.9661031986107661,1.0,2/14,4.81%,TMSB4X;SUFU
prerank,lipoprotein biosynthetic process (GO:0042158),0.3451991802236475,0.6707694599640943,0.7961595273264401,1.0,1.0,2/11,8.05%,ATG7;PORCN
prerank,endocardial cushion development (GO:0003197),0.3108181560180556,0.6699933413204248,0.8125819134993447,1.0,1.0,4/21,12.75%,BMPR1A;MDM4;BMP2;SOX9
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.33402547064650917,0.6696060478985814,0.8212765957446808,1.0,1.0,3/13,12.47%,HMGB1;PDPK1;ADAM17
prerank,positive regulation of cell death (GO:0010942),0.2936720976534871,0.6693767327125437,0.8582333696837514,1.0,1.0,10/59,14.50%,GSK3B;PRNP;MAPT;FAF1;LRRK2;AXIN2;PICALM;CDKN1B;EFNB2;RAMP3
prerank,presynaptic endocytosis (GO:0140238),0.3106016673059573,0.6693127035773113,0.8229548229548229,1.0,1.0,8/24,21.85%,STON1;STON2;NLGN3;PIP5K1C;NLGN2;SNCA;CDK5;VAMP2
prerank,response to interleukin-1 (GO:0070555),0.2862366753771873,0.6691752098809844,0.8799582463465553,1.0,1.0,20/73,23.30%,HYAL1;MYLK3;ANXA1;PRKCA;SOX9;SMPD1;RC3H1;SFRP1;SRC;NFKB1;SIRPA;CD47;PTGIS;TRAF6;SNCA;TANK;RBMX;HDAC4;DAB2IP;CCL14
prerank,cellular lipid catabolic process (GO:0044242),0.30581763750213936,0.6691655015400385,0.8108108108108109,1.0,1.0,7/27,24.03%,LPIN2;ENPP2;ACADL;ACOT8;SMPDL3B;SIRT2;LPIN3
prerank,muscle tissue morphogenesis (GO:0060415),0.32376212121229553,0.6689472827226501,0.8044692737430168,1.0,1.0,4/16,19.67%,TGFBR3;BMP2;HEY2;ZFPM1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.19625847229741153,-0.6683053004090477,0.9673202614379085,0.9678725108584717,1.0,9/31,27.17%,LYN;TNFRSF21;ATM;CEBPB;CD274;DLG5;CD300A;CD86;SOX11
prerank,positive regulation of signaling receptor activity (GO:2000273),0.3027937757153077,0.6681611640087284,0.8210161662817552,1.0,1.0,7/36,14.15%,NLGN3;FBXW7;HDAC1;ADAM17;HDAC2;ADRB2;ITGB1
prerank,cellular response to interleukin-6 (GO:0071354),-0.20774712425004843,-0.668136389413424,0.9259259259259259,0.9672213158034649,1.0,7/26,19.16%,STAT3;ST3GAL6;PTPN11;ST18;SBNO2;CBL;PTPRT
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.3434663921376434,0.6680236052509769,0.8155619596541787,1.0,1.0,2/12,8.53%,STX11;STX2
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2887368916589051,0.6677928574606813,0.8549946294307197,1.0,1.0,12/67,12.63%,USP6NL;IFT140;TBC1D13;FMR1;TBC1D2B;SDCCAG8;TRPM2;TBC1D19;TWF1;RAC1;ATG3;DMTN
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.35008629330404084,0.6675515195494717,0.8073394495412844,1.0,1.0,4/10,15.27%,PRKCB;ITGA5;ARNT;PRKD2
prerank,positive regulation of immune response (GO:0050778),0.2888906084671185,0.6672949142578064,0.8603174603174604,1.0,1.0,7/64,15.17%,FADD;DHX9;NMI;RIOK3;POLR3D;AKIRIN2;SLC15A4
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.3103917630413174,0.6672196853705225,0.8215130023640662,1.0,1.0,10/30,22.74%,MAGT1;RPN2;STT3A;STT3B;UBE2J1;ALG8;OSTC;FUT8;DPM3;MCFD2
prerank,protein localization to plasma membrane (GO:0072659),0.2826546957215442,0.6671575888814947,0.9161616161616162,1.0,1.0,40/129,23.57%,TSPAN33;ROCK2;RAB10;PDZK1;DENND4C;RAP2A;AFDN;ANK1;SMURF1;ROCK1;FLOT2;P2RY1;EPB41L3;KCNIP3;EZR;GAK;GORASP2;EHD1;TSPAN5;DLG1;RAMP3;TTC7B;KCNB2;ZDHHC3;STXBP1;DPP6;RAB13;WNK3;ASB3;RAB3A;MAP7;ANK3;RAB8B;IKBKB;FLNA;PACS1;RAPGEF6;ZDHHC2;RAB8A;S100A10
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.2980838516933227,0.6666852876957597,0.847651775486827,1.0,1.0,9/43,13.00%,ERFE;PTPN2;NUCKS1;ZBTB7B;NCK1;ENPP1;PRKCB;SIK2;GKAP1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.34144771804982565,0.6664788905983539,0.8328651685393258,1.0,1.0,2/12,14.06%,WNK1;MIA3
prerank,phagosome-lysosome fusion (GO:0090385),0.34538168741119174,0.666141042050506,0.8107692307692308,1.0,1.0,1/10,4.60%,RAB7B
prerank,plasma membrane repair (GO:0001778),0.33808788426467123,0.666046836066371,0.8310055865921788,1.0,1.0,6/13,22.27%,MYOF;SYTL4;SMPD1;DYSF;RAB3A;MYH9
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.2551234363190769,-0.6658726128635799,0.8813056379821959,0.9683660095338668,1.0,2/11,13.19%,DDX5;MAP2K1
prerank,monocyte differentiation (GO:0030224),-0.27954040797105995,-0.6656915293046994,0.8816568047337278,0.9677330122733655,1.0,6/10,34.71%,PIR;VEGFA;MT1G;PDE1B;CSF1R;PPARG
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.2825482626730028,0.6651616441591687,0.8868312757201646,1.0,1.0,27/95,19.48%,TGFBR3L;PEG10;TGFBR3;PMEPA1;LEMD3;ADAMTSL2;SMURF1;SMAD6;TGFBR1;DKK3;SMURF2;NKX2-1;PDPK1;ADAM17;SMAD4;SPRED1;HTRA3;SMAD3;STK11;PIN1;SPRED2;VEPH1;SMAD2;SKIL;ZEB2;PPM1A;SKI
prerank,inositol phosphate dephosphorylation (GO:0046855),0.342821357662044,0.6650050889368984,0.8184568835098336,1.0,1.0,4/11,21.00%,OCRL;INPP5B;PTEN;INPP5A
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.342821357662044,0.6650050889368984,0.8184568835098336,1.0,1.0,4/11,21.00%,OCRL;INPP5B;PTEN;INPP5A
prerank,regulation of calcium ion import (GO:0090279),-0.21715663377554453,-0.664602543571533,0.9276018099547512,0.9678125340238949,1.0,6/21,18.40%,PDGFRB;CTNNB1;TRIM27;SLC30A1;PLPP4;PSEN2
prerank,response to cAMP (GO:0051591),0.2948858392467652,0.6645306885790851,0.8495887191539365,1.0,1.0,6/37,15.27%,AQP1;AHR;AKAP9;EZR;DMTN;PKD2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.1678239153511236,-0.6644844663518141,1.0,0.9670995110399613,1.0,11/69,14.09%,STAT3;PSEN1;TLR4;EPHB2;LBP;APP;ARHGEF2;THBS1;ARFGEF2;PTPN11;IFNGR1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.33825765449562667,0.6643808019541577,0.833578792341679,1.0,1.0,4/11,22.34%,YBX3;CASP8;RIPK1;BIRC2
prerank,intestinal absorption (GO:0050892),-0.24282196809898204,-0.6640434242273408,0.9,0.966624928621991,1.0,3/13,19.13%,F11R;ADRA2A;KCNQ1
prerank,defense response to virus (GO:0051607),0.28127608496526635,0.6638847979775628,0.9031925849639547,1.0,1.0,15/100,16.25%,FADD;MAP3K14;MOV10;RNASE6;G3BP1;ATG7;TTC4;SETD2;IRF1;SKP2;RNASE1;TRIM5;CNOT7;IFNAR2;AKAP1
prerank,neuron projection fasciculation (GO:0106030),0.3508038696819795,0.66375801344432,0.8169642857142857,1.0,1.0,4/10,20.27%,EPHA4;ARHGAP35;AMIGO1;SEMA5A
prerank,axonal fasciculation (GO:0007413),0.34192384726856334,0.6635598651796918,0.8241134751773049,1.0,1.0,5/12,20.27%,EPHA4;ARHGAP35;EPHA3;AMIGO1;SEMA5A
prerank,cellular response to cytokine stimulus (GO:0071345),0.28024607682413716,0.6633418988988062,0.993,1.0,1.0,52/416,16.19%,BRCA1;BIRC5;SYNCRIP;RHOA;HYAL1;PLP2;ZEB1;GSK3B;UBE2K;MYLK3;KIT;DHX9;LEPR;CXCR4;PTPN2;IL18;TPR;WNK1;NPNT;YBX3;POU2F1;FOXO3;CD80;IRF1;HTRA2;RIPOR2;PIM1;PIK3CB;SDC1;HNRNPU;ANXA1;CRKL;CNTF;RORA;DPYSL3;TRIM6;SOX9;IL31RA;TWIST1;IL1RL2;CDKN1B;ITGB1;RC3H1;SMAD3;PTPN13;EPRS1;SFRP1;NFKB1;STK39;TP53;PNPT1;IFNAR2
prerank,synaptic membrane adhesion (GO:0099560),-0.24079515225393128,-0.6632504690751694,0.9131944444444444,0.9665408673068877,1.0,4/14,15.46%,PTPRD;SLITRK1;NTNG1;LRRC4B
prerank,mitochondrial protein processing (GO:0034982),0.3368523043354929,0.6629762051860122,0.8103448275862069,1.0,1.0,5/11,20.39%,STOML2;PMPCA;ATP23;MIPEP;SPG7
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.2665999582066118,-0.6628477986059426,0.884393063583815,0.9660094454128192,1.0,2/10,6.09%,ST6GAL1;RENBP
prerank,cell differentiation in spinal cord (GO:0021515),-0.27298944519222557,-0.662778353414565,0.890282131661442,0.9652393926834697,1.0,4/10,22.19%,MDGA2;SOX4;SOX13;ZC4H2
prerank,cellular protein localization (GO:0034613),0.27904728942049567,0.662737611810948,0.976,1.0,1.0,65/285,18.08%,USP6NL;CNTLN;STX11;AP4M1;ARFIP1;EVI5L;TBC1D25;SNX1;RAP2A;TBC1D13;WDR11;BICD2;VPS26C;TBC1D2B;PRPF19;NIPBL;RAB22A;RAB29;STXBP2;FBLN5;LRRK2;MFN2;SMURF1;STX2;AXIN2;CORO1B;ANGPT1;RAB1A;COPB2;SNX27;VIPAS39;COPZ1;HERC2;EPB41L3;NPHP1;PIGU;AP3B1;SCFD1;ZDHHC15;GJA1;EHD1;IFT27;HEY2;ARF4;MESD;ARL4A;PTPRU;TM9SF2;CSRP3;STX12;ARF3;STXBP1;TBC1D9;VPS26A;SH3PXD2B;LAMTOR3;TMED3;UNC50;PTPRK;TM9SF4;USO1;RIC1;ACD;CEP250;ARL5A
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.2526861804663206,-0.6626874571267116,0.8906752411575563,0.9644996523912106,1.0,6/13,28.51%,SUFU;GOPC;GET4;MDFI;YWHAB;KEAP1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.27861580555172716,0.662361756734131,0.958,1.0,1.0,35/214,17.09%,FAM83D;FGFR4;FGFR2;GAREM1;PTPN2;PDGFRA;TGFBR3;ARRB1;FBXW7;NPNT;CCN1;ANGPT1;HMGB1;APIP;P2RY1;CRKL;BMP2;EZR;ROR1;PRKCA;RRAS;SMAD4;NOTCH2;SPRED1;DLG1;CD44;RAMP3;PIN1;SLC30A10;PRKD2;SPRED2;CNKSR3;PTEN;SIRPA;CCN2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.2833081832589962,0.6619347024792779,0.8685047720042418,1.0,1.0,6/76,8.32%,PLK1;GSK3B;DDRGK1;FBXW7;LRRK2;SMURF1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2835862121206713,0.6615120167430993,0.8825995807127882,1.0,1.0,12/76,13.65%,TRIP6;RHOA;ACTN4;NMI;RTKN2;LIMS1;UACA;CCN3;EZR;TRIM6;ADIPOR1;DLG1
prerank,Wnt signaling pathway (GO:0016055),0.27946351059705327,0.6609541004719788,0.8870636550308009,1.0,1.0,27/92,22.84%,GSK3B;WNT2B;TCF7L1;SFRP2;TCF7L2;PORCN;LRRK2;WNT6;NR4A2;WNT9A;CSNK1G2;LRP5;BTRC;SFRP1;PTEN;VPS26A;AMER1;CSNK1A1;CSNK1G1;FRZB;WNT4;FERMT2;CSNK1E;NXN;ZRANB1;GPC4;TCF7
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.15739523774802433,-0.6601597851257276,1.0,0.9658046016517374,1.0,11/73,14.09%,STAT3;PSEN1;TLR4;EPHB2;LBP;APP;ARHGEF2;THBS1;ARFGEF2;PTPN11;IFNGR1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.21540297841532274,-0.6600227839355375,0.9078947368421053,0.96511197029859,1.0,1/21,0.30%,CACNA2D1
prerank,defense response to fungus (GO:0050832),-0.22518053375196231,-0.6600214622136097,0.9310344827586207,0.9642989766188099,1.0,17/17,77.51%,GAPDH;CX3CR1;HRG;S100A9;CARD9;CLEC4D;S100A8;CLEC6A;LTF;CLEC4E;RARRES2;DEFB119;NLRP10;RNASE7;PLCG2;BCL10;FAM3A
prerank,cholesterol metabolic process (GO:0008203),0.28249933939888494,0.6595315503558183,0.8645502645502645,1.0,1.0,12/68,17.83%,LBR;PMVK;SOAT1;ABCA1;SCAP;TM7SF2;SOAT2;ACAT2;MVK;STARD3;DHCR7;INSIG2
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.25893868280452337,-0.6591567011053107,0.8686868686868687,0.9641407567994702,1.0,9/12,34.10%,GRN;PPT1;ATP6AP2;TMEM9;CLN5;VPS33A;TMEM199;CLN3;CLN6
prerank,regulation of protein autophosphorylation (GO:0031952),0.29686774399936905,0.6583766340944546,0.8506944444444444,1.0,1.0,10/36,20.49%,MRE11;RAP2A;ERRFI1;PPP2R5C;ENPP1;CALM2;PPP2R5B;MVP;RAD50;TOM1L1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.31419893882370203,0.656789088447825,0.8388324873096447,1.0,1.0,7/21,20.46%,PDZD8;MCU;MCUB;MICU1;MAIP1;RAP1GDS1;MICU2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.28892316344730873,0.6554499407209243,0.8584070796460177,1.0,1.0,11/48,15.27%,ANGPT4;JCAD;ANGPT1;MAP3K3;HMGB1;ANXA1;PRKCA;PDPK1;ADAM17;PRKD1;PRKD2
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.3319085543934056,0.654891139559265,0.8192090395480226,1.0,1.0,4/13,17.14%,ABCA1;ITGB1;LPL;LDLR
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.28637906985136513,0.6537330543285796,0.8590163934426229,1.0,1.0,7/53,9.52%,XPO1;PSMC2;DDRGK1;FBXW7;FMR1;PSMD14;PSME3IP1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.27954369409252067,0.6536385834888564,0.8776150627615062,1.0,1.0,14/75,19.24%,RGS12;ROCK2;GIT2;GRK5;RGS3;ROCK1;RIC8B;NMT2;RAMP3;SYP;ZDHHC3;METAP1;FNTB;USP20
prerank,aminoglycan biosynthetic process (GO:0006023),0.2853724580233285,0.6533195142423712,0.8535242290748899,1.0,1.0,15/49,23.06%,B3GNT8;GPC6;SLC35D2;B4GALT7;SDC1;HAS1;HS2ST1;HSPG2;UGDH;B3GALT2;XYLT1;SDC4;GPC4;GCNT2;EXT1
prerank,aminoglycan catabolic process (GO:0006026),0.2987640146781608,0.6530121587168783,0.8460575719649562,1.0,1.0,3/28,10.24%,HPSE;GPC6;SDC1
prerank,cellular response to lipid (GO:0071396),0.27289032033987637,0.6524199178133273,0.955955955955956,1.0,1.0,39/191,21.07%,HMGB2;AQP1;SETX;TICAM1;ROCK2;RHOA;ABCB4;LCOR;SERPINE1;CD80;HTRA2;WNT6;HMGB1;NR3C1;AHR;RORA;WNT9A;SOX9;MED1;ADAM9;RUVBL2;RAMP3;LPL;ADCY6;SFRP1;NFKB1;MSN;AXL;SIRPA;EPHA3;ADCY2;MAPK14;PLAA;ADNP2;CD68;PDE4B;TRAF6;INSIG1;UBE2L3
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.33500735858874,0.6524093111612189,0.823021582733813,1.0,1.0,2/11,12.08%,UAP1;GNPDA2
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.3262477167142871,0.652378973959213,0.8323943661971831,1.0,1.0,7/13,28.25%,UAP1;GNPDA2;SLC35A3;AMDHD2;GFPT1;GFPT2;PGM3
prerank,cholesterol transport (GO:0030301),0.2873331791372232,0.6522999678146827,0.8497757847533632,1.0,1.0,8/45,17.14%,TSPO2;SOAT1;ABCA1;SOAT2;STARD3;RELCH;STX12;LDLR
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.31934749086784286,0.6521949115399659,0.8146067415730337,1.0,1.0,3/15,13.34%,UST;DSE;BGN
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.32458405659437317,0.6519786316204225,0.8203342618384402,1.0,1.0,1/15,2.84%,TICAM1
prerank,myelin assembly (GO:0032288),0.3450132700169582,0.6515451046249802,0.8264094955489614,1.0,1.0,2/10,10.52%,TPPP;EPB41L3
prerank,regulation of BMP signaling pathway (GO:0030510),0.2820700633589341,0.6515333853540541,0.8796198521647307,1.0,1.0,15/73,14.00%,BMPR1A;NUMA1;SULF1;CCN1;LEMD3;CRIM1;SMURF1;SMAD6;RBPMS2;SMURF2;BMP2;RBPJ;SMAD4;HTRA3;XIAP
prerank,positive regulation of cell adhesion (GO:0045785),0.27994551139529417,0.6510210679735721,0.8747390396659708,1.0,1.0,13/74,15.27%,HYAL1;SFRP2;AFDN;NPNT;PPP3CA;EPHA4;RSU1;LIMS1;RAC1;PRKCA;ADAM9;ITGAV;PRKD2
prerank,protein localization to cell periphery (GO:1990778),0.2766141686066464,0.6509505457442846,0.9362348178137652,1.0,1.0,28/133,17.79%,TSPAN33;ROCK2;AP4M1;RAB10;PDZK1;DENND4C;RAP2A;ANK1;RAB29;SMURF1;ROCK1;FLOT2;P2RY1;EPB41L3;KCNIP3;EZR;GAK;EHD1;TSPAN5;DLG1;RAMP3;TTC7B;KCNB2;ZDHHC3;STXBP1;DPP6;RAB13;WNK3
prerank,magnesium ion transport (GO:0015693),-0.24798098889738296,-0.6507507848471218,0.8970099667774086,0.9699249159933261,1.0,2/12,5.23%,NIPA1;NIPA2
prerank,body fluid secretion (GO:0007589),-0.23196287437843138,-0.6503181210423417,0.9315589353612167,0.9694461774980744,1.0,3/15,14.73%,ERBB4;NPR1;VEGFA
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.26926335880803653,-0.6498008029835709,0.8929663608562691,0.9690489925970205,1.0,1/10,5.28%,PLEK
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3294019044018418,0.6497809407243849,0.8511821974965229,1.0,1.0,2/14,10.09%,RHOA;MEOX2
prerank,iron ion homeostasis (GO:0055072),0.2801247943118036,0.6488503391149673,0.8783351120597652,1.0,1.0,17/58,22.24%,FXN;ERFE;CYB561A3;BMP6;PICALM;SMAD4;CCDC115;ACO1;ALAS2;BDH2;CAND1;NUBP1;FRRS1;ATP6V0A2;SOD1;NEDD8;SLC11A2
prerank,positive regulation of signal transduction (GO:0009967),0.27384382219824194,0.6487132557327896,0.973,1.0,1.0,48/238,16.45%,LOXL3;MACF1;PHIP;DEPDC1B;FGFR2;ERFE;SULF2;ASXL1;MYO1C;TXNDC15;BMP6;NLGN3;JCAD;SULF1;ZBTB7B;TUBD1;LRRK2;CD80;AGPAT2;SMARCA4;YAP1;ROBO1;TGFBR1;LIMS1;TEDC1;CCN3;PRKCB;BMP2;PRKCA;RBPJ;AAK1;DMTN;RSPO3;GKAP1;MAML1;TSPAN5;PRKCI;ITGA5;ARNT;AGPAT1;ITGAV;SFRP1;PRKD2;PKD2;SRC;PTEN;NLGN2;SALL1
prerank,respiratory chain complex IV assembly (GO:0008535),-0.21336829785770278,-0.6485388534357873,0.954337899543379,0.9691163878743191,1.0,9/21,24.14%,COX16;OXA1L;COX19;PET100;COX20;SMIM20;COX17;COX14;COA8
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.27975793061637844,0.648167853853762,0.8775510204081632,1.0,1.0,13/67,17.55%,DYRK1A;FGFR4;FGFR2;KIT;PDGFRA;EPHA4;ABI1;DDR2;BTK;EFEMP1;SRC;EPHA3;ABI2
prerank,postsynaptic membrane organization (GO:0001941),0.31850516594671546,0.6477627443389087,0.8398950131233596,1.0,1.0,5/17,20.08%,MUSK;NLGN3;CHRNB1;NLGN2;GPHN
prerank,calcium ion transmembrane transport (GO:0070588),0.27405646876896705,0.6474254712596935,0.9025906735751296,1.0,1.0,24/86,20.46%,ATP2B4;TRPA1;STOML2;MCU;ATP2A2;SLC24A3;SLC8A1;MCUB;CACNA1C;ATP2B1;TRPM2;TRPC7;MICU1;TRPM4;PMPCA;MAIP1;ITGAV;PKD2;GRIN2D;TRPV4;TRPM6;CACNA1G;SPG7;MICU2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.2933102902275593,0.6471062681651626,0.8501170960187353,1.0,1.0,12/34,27.17%,TICAM1;RAB7B;PTPRS;LGR4;SMPDL3B;GPR108;DAB2IP;NFKBIL1;ACOD1;LY96;NLRP2B;TLR3
prerank,cell junction assembly (GO:0034329),0.2739819949465191,0.6465823181642841,0.9164118246687054,1.0,1.0,22/100,17.85%,SDK1;CDH18;CDH24;RHOA;OBSL1;NLGN3;GRHL2;RAB29;FARP1;GJC1;TLN1;LIMS1;CAPZA1;DSCAM;ACHE;PLXND1;TLN2;PTEN;SHANK2;NLGN2;CDH11;TRPV4
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.29640553724290497,0.646175701595014,0.8527980535279805,1.0,1.0,7/27,16.00%,PML;FBXL8;FBXL17;PPP1CC;RBM4;PER1;TP53
prerank,heterocycle biosynthetic process (GO:0018130),-0.24357692038002618,-0.6460362427092866,0.8873720136518771,0.9702474699454343,1.0,4/14,15.50%,LIAS;MOCS2;MOCS1;GCH1
prerank,regulation of endocytic recycling (GO:2001135),-0.25467268604151805,-0.6460150595924693,0.9012345679012346,0.9694493253039955,1.0,5/11,30.71%,ATP9A;ARHGAP1;SORL1;EIPR1;PLA2G4E
prerank,response to insulin (GO:0032868),0.2728287380850127,0.6458683746060108,0.890738813735692,1.0,1.0,28/80,24.14%,GCK;RAB10;PRKDC;PDE3B;DENND4C;LPIN2;ZBTB7B;RHOQ;CPEB2;ENPP1;PDPK1;PRKCI;EPRS1;PCK2;RAB13;INSIG2;SLC2A4;SYAP1;CEACAM1;RAB8B;INSIG1;FER;VAMP2;ZFP36L1;SLC25A33;RAB8A;LPIN3;RPS6KB1
prerank,mRNA catabolic process (GO:0006402),0.2864049521080032,0.6454943547842448,0.8512110726643599,1.0,1.0,12/44,18.84%,THRAP3;TUT7;MRTO4;LSM2;YTHDF2;DXO;TUT4;RC3H1;PNPT1;METTL3;EXOSC10;XRN2
prerank,potassium ion transport (GO:0006813),0.26716715964478954,0.6453871128067536,0.9244126659856997,1.0,1.0,16/120,15.72%,AQP1;CCDC51;KCNN4;KCNK2;KCNH4;KCNH8;SLC9A5;KCNJ13;SLC24A3;KCNMB2;KCNMB3;KCNK12;KCNK6;KCNMB4;PKD2;KCNB2
prerank,regulation of monocyte differentiation (GO:0045655),-0.23508704780402423,-0.6453755558756364,0.931899641577061,0.969090834070616,1.0,2/14,5.35%,CDK6;ACIN1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.21721062298401533,-0.6453414318686959,0.9233870967741935,0.9682964309575833,1.0,4/18,20.15%,BNIP3;BCL2;SLC25A4;BCL2L1
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.22151746959158589,-0.6443619299630835,0.8968253968253969,0.9681862719044397,1.0,7/18,25.44%,RPS13;ESR1;KAT2B;ZC3H12A;PTBP1;RPS26;PTBP3
prerank,cell junction maintenance (GO:0034331),-0.24442936908482293,-0.6441854281502528,0.9328358208955224,0.9674914311927552,1.0,9/14,46.29%,DCTN1;CLDN1;CHCHD10;CSF1R;CBLN2;F2R;CBLN1;PRTN3;PARD6A
prerank,regulation of mRNA processing (GO:0050684),0.2934201322537137,0.6439386318585258,0.8642857142857143,1.0,1.0,11/32,19.69%,KHDRBS1;DHX9;SRSF10;SRSF3;SRPK1;CPSF4;IWS1;SRPK2;CWC22;LARP7;KHDRBS3
prerank,dicarboxylic acid metabolic process (GO:0043648),0.27853626509145546,0.6439129104481605,0.8793859649122807,1.0,1.0,17/52,23.70%,MTHFD1L;MTHFR;SLC19A1;HOGA1;DGLUCY;DHFR;GCLM;MTHFS;GCLC;ME3;L2HGDH;ACOT8;ME2;ALDH18A1;IDH2;SLC25A32;SDHA
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.3025365503473678,0.6430622579205216,0.8438320209973753,1.0,1.0,2/18,10.91%,GSK3B;BOK
prerank,transcription by RNA polymerase I (GO:0006360),0.28693994847311094,0.6428559899219782,0.8392434988179669,1.0,1.0,6/34,13.17%,POLR1A;POLR1B;ERCC3;TAF1D;TTF1;POLR1G
prerank,negative regulation of B cell activation (GO:0050869),-0.20452482603115044,-0.6428306909901134,0.9388888888888889,0.9676771819376486,1.0,13/21,42.44%,LYN;TNFRSF21;ATM;INHBA;CD300A;LAPTM5;TNFAIP3;TYROBP;INHA;FCGR2B;ID2;BANK1;FOXJ1
prerank,histone lysine demethylation (GO:0070076),0.30303912249022613,0.6426750023830388,0.8613496932515338,1.0,1.0,9/25,25.29%,PHF2;KDM2B;KDM5C;JMJD1C;KDM4B;KDM2A;HR;KDM1A;KDM5A
prerank,regulation of pH (GO:0006885),-0.2510684244001518,-0.6425326306802673,0.8971061093247589,0.967119880832397,1.0,5/11,36.46%,ATP6V0A4;PDK2;ATP6AP1;PDK4;SLC9A1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.2424466914952425,-0.6423374440614736,0.9084967320261438,0.9664491166925171,1.0,9/12,47.47%,BCL2;TAF9B;CD74;MIF;RPL26;TAF9;TRIAP1;MUC1;SIRT1
prerank,Notch signaling involved in heart development (GO:0061314),0.33151687432085664,0.6419196632926872,0.8474320241691843,1.0,1.0,3/11,13.69%,RBPJ;NOTCH2;HEY2
prerank,cellular response to glucose starvation (GO:0042149),0.28806336255576015,0.6417529941061726,0.8747152619589977,1.0,1.0,11/41,16.29%,HNRNPA1;SH3GLB1;FOXO3;SESN1;EIF2AK3;SIK2;ITFG2;MTMR3;PRKAG1;TP53;SESN2
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.2847955167426325,0.6416668004724949,0.8526682134570766,1.0,1.0,5/36,10.45%,RB1;BCL2L12;CSNK2A2;TGFBR1;NR4A2
prerank,regulation of secretion by cell (GO:1903530),0.2819203148130868,0.6411183542031121,0.8856209150326797,1.0,1.0,16/54,23.39%,ARFIP1;RAB10;DNAJC1;STXBP5;FMR1;LLGL2;ANXA1;P3H1;KCNMB4;RAB13;RIC1;RAB3A;RAB8B;VAMP2;CPLANE2;RAB8A
prerank,methylguanosine-cap decapping (GO:0110156),0.33230069833847375,0.6410717075191292,0.8325652841781874,1.0,1.0,1/10,4.27%,PATL1
prerank,canonical glycolysis (GO:0061621),0.2985579011099915,0.6400208548289151,0.8658227848101265,1.0,1.0,2/24,4.04%,GCK;GPI
prerank,glucose catabolic process to pyruvate (GO:0061718),0.2985579011099915,0.6400208548289151,0.8658227848101265,1.0,1.0,2/24,4.04%,GCK;GPI
prerank,protein secretion (GO:0009306),0.27859328664976385,0.6396589289069953,0.888402625820569,1.0,1.0,16/56,23.51%,STEAP3;RAB10;PORCN;SVBP;ABCA1;ANXA1;NAGPA;MIA3;SNX19;RAB13;TMEM167A;RAB3A;RAB8B;PPY;RAB8A;WLS
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.22347343111296947,-0.6393865114983753,0.9390681003584229,0.9678011042921674,1.0,4/17,23.62%,ADRA1A;ADRA2A;DRD2;ADRA1B
prerank,positive regulation of interleukin-17 production (GO:0032740),0.297136001850826,0.6386758862999833,0.8567741935483871,1.0,1.0,2/22,7.78%,IL18;ZBTB7B
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.2565797501665806,-0.6383264496581541,0.8994082840236687,0.9677133209071098,1.0,4/10,27.17%,LRP6;BMP7;ARHGAP12;SOX11
prerank,regulation of vacuole organization (GO:0044088),0.3071852221252309,0.638135975626267,0.8416988416988417,1.0,1.0,5/20,18.89%,ANXA2;NPRL3;MTMR3;PIKFYVE;TBC1D12
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.2812321820452034,0.6381189344069101,0.856655290102389,1.0,1.0,3/44,4.86%,LBR;CYP39A1;PMVK
prerank,positive regulation of monooxygenase activity (GO:0032770),0.2964756916049909,0.6380477815430345,0.8494623655913979,1.0,1.0,6/26,19.32%,NPR3;PIK3CB;TERF2;DHFR;GDNF;TERT
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.2989032202980215,0.6380038225742979,0.8562577447335812,1.0,1.0,3/24,8.07%,PRNP;FBXW7;FOXO3
prerank,positive regulation of phospholipase C activity (GO:0010863),0.2819531596276528,0.63734643337562,0.8704128440366973,1.0,1.0,5/40,10.32%,LPAR1;KIT;PDGFRA;GNAQ;ARHGAP6
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.29686950091730135,0.6373326655548804,0.8697850821744627,1.0,1.0,2/25,4.04%,GCK;GPI
prerank,I-kappaB phosphorylation (GO:0007252),0.33535781106536866,0.6373246279418034,0.8527245949926362,1.0,1.0,4/10,23.27%,ERC1;PRDX4;TLR7;DAB2IP
prerank,activation of adenylate cyclase activity (GO:0007190),-0.1801280164201794,-0.6369890295545971,0.9671052631578947,0.9678567505401452,1.0,5/35,14.63%,CAP1;LGR5;ADCY3;ADCY8;ADCY4
prerank,myeloid cell activation involved in immune response (GO:0002275),0.30969047872589406,0.6368091141057549,0.8344459279038718,1.0,1.0,2/18,7.68%,NMI;ENPP3
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.26835984882935754,0.636645442169701,0.9182194616977226,1.0,1.0,30/88,23.45%,AP4M1;GBF1;RAB10;EXOC4;ACBD3;ARRB1;VPS13A;SH3D19;DNM2;CLVS2;SCFD1;TXNDC5;EXOC8;CLINT1;AP1B1;SNAP23;AP1M1;EPS15;MON2;ARF1;CLTA;SCAMP2;DNAJC6;MYO1B;EXOC2;VAMP2;SCAMP3;NAPA;HSPA8;GOLGB1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.2910327358150542,0.6361295308364091,0.8672456575682382,1.0,1.0,8/25,20.51%,PDZK1;WNK1;AKAP9;STK39;GLRX;WNK3;SLC6A9;ANK3
prerank,regulation of lipase activity (GO:0060191),0.3192975774807493,0.6359598319085312,0.8541076487252125,1.0,1.0,4/13,20.73%,RHOA;LPL;RHOC;SNCA
prerank,cellular iron ion homeostasis (GO:0006879),0.2752650110191736,0.635753911850094,0.8858057630736392,1.0,1.0,15/55,22.24%,FXN;ERFE;CYB561A3;BMP6;SMAD4;CCDC115;ACO1;ALAS2;CAND1;NUBP1;FRRS1;ATP6V0A2;SOD1;NEDD8;SLC11A2
prerank,glycolipid biosynthetic process (GO:0009247),0.2852517389111331,0.6354230416969178,0.8656036446469249,1.0,1.0,12/38,22.17%,LARGE1;PIGN;PIGA;ST3GAL5;PIGU;ST3GAL4;ST3GAL2;PIGM;DPM3;PIGG;A4GALT;PIGH
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.3198248005652778,0.6350968754733257,0.8679775280898876,1.0,1.0,2/13,10.20%,GPRC5A;ERRFI1
prerank,peptidyl-asparagine modification (GO:0018196),0.2938869336927838,0.6349329744724203,0.8576429404900817,1.0,1.0,10/31,22.74%,MAGT1;RPN2;STT3A;STT3B;UBE2J1;ALG8;OSTC;FUT8;DPM3;MCFD2
prerank,tRNA metabolic process (GO:0006399),0.309604072605144,0.6349222406674805,0.8552631578947368,1.0,1.0,7/17,24.90%,DARS2;POP1;RPP30;FARS2;RPP21;DTD1;SSB
prerank,synaptic vesicle endocytosis (GO:0048488),0.2880555078225243,0.6339634735393938,0.8755868544600939,1.0,1.0,13/33,21.85%,STON1;STON2;NLGN3;DNM2;PICALM;GAK;PIP5K1C;NLGN2;DNAJC6;SNCA;SNAP91;CDK5;VAMP2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.20684929133887975,-0.6338371607657154,0.9448818897637795,0.9692170228789355,1.0,5/19,22.25%,LARP6;RGCC;TGFB3;CREB3L1;SUCO
prerank,regulation of lymphocyte differentiation (GO:0045619),0.3050432527813732,0.6334688506109872,0.859395532194481,1.0,1.0,3/18,16.45%,PRKDC;IL4I1;METTL3
prerank,protein localization to lysosome (GO:0061462),0.29480579325484624,0.6334576455112064,0.8720787207872078,1.0,1.0,4/28,12.29%,AP4M1;NEDD4;ZFYVE16;NAGPA
prerank,regulation of T cell migration (GO:2000404),0.3047164944323564,0.6333896712391508,0.8619354838709677,1.0,1.0,2/18,8.87%,RHOA;RIPOR2
prerank,regulation of cholesterol esterification (GO:0010872),-0.25982242961138763,-0.632520056671288,0.8881789137380192,0.9693689331241602,1.0,2/10,12.06%,APOE;AGTR1
prerank,amino sugar biosynthetic process (GO:0046349),0.31954226949287856,0.6324075963609113,0.8356741573033708,1.0,1.0,2/12,12.08%,UAP1;GNPDA2
prerank,regulation of cytokine production (GO:0001817),0.26849645145912004,0.632110862160963,0.9431472081218274,1.0,1.0,19/126,21.14%,POLA1;ERMAP;MAST2;AGPAT2;AGT;ATP2B1;ANXA1;CASP8;AGPAT1;PER1;SIRPA;FOXP1;CD47;MAPK14;LGR4;NLRP4;MAPKAPK2;ISG15;EIF2AK2
prerank,cellular glucan metabolic process (GO:0006073),0.3197885121968599,0.6315795245771498,0.8450074515648286,1.0,1.0,1/11,3.51%,GSK3B
prerank,actin filament network formation (GO:0051639),-0.24793921219105713,-0.6312697393576697,0.9030303030303031,0.9694209960634688,1.0,1/11,0.93%,PLS3
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.29301251316975546,0.6311658838289225,0.8670588235294118,1.0,1.0,6/27,15.53%,IL18;AGT;ABCA1;LPL;ITGAV;NFKB1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.2941647635727153,0.630947015073197,0.870843989769821,1.0,1.0,5/24,15.25%,MAP4K4;ROCK1;LIMS1;RAC1;SFRP1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.2514357523505346,-0.6308745681070871,0.9131832797427653,0.9688616810406706,1.0,3/11,19.94%,CTNNB1;LRP6;FZD1
prerank,toll-like receptor signaling pathway (GO:0002224),0.2668078721434531,0.6307001541422185,0.8986415882967607,1.0,1.0,11/84,13.25%,FADD;TICAM1;COLEC12;TAB1;NMI;MAP3K1;HMGB1;IKBKG;CASP8;MAPKAPK3;BTK
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.21314723773352307,-0.6306232267487452,0.9173553719008265,0.9682081239517452,1.0,4/18,17.25%,ATXN3;PIK3R1;DDIT3;XBP1
prerank,C-terminal protein amino acid modification (GO:0018410),0.3299506630313288,0.6305758204980215,0.8641221374045801,1.0,1.0,7/11,27.57%,ATG7;AGTPBP1;ICMT;ATG5;TTL;FOLH1;LCMT1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.2713815548755905,0.6301725996877986,0.9121338912133892,1.0,1.0,21/70,22.56%,PSMC2;PSMD5;PSMB1;PSMD14;PSMD1;CYBB;IKBKG;PSMB9;PSMC6;ITGAV;SNAP23;PSMB2;PSME4;PSMB7;PSMD11;PSME3;SEC22B;IKBKB;PSMD13;PSMB8;PSMD4
prerank,oligosaccharide metabolic process (GO:0009311),0.2769492721760108,0.6300807672077825,0.8773690078037905,1.0,1.0,10/46,20.97%,B4GALT1;ST8SIA2;MPDU1;ST3GAL3;ST3GAL4;ST3GAL2;B3GALT2;MAN1B1;NAGA;FUT8
prerank,epithelial cell development (GO:0002064),0.3013499829588171,0.6297194326713383,0.8652849740932642,1.0,1.0,2/20,7.29%,GRHL2;RILPL1
prerank,myeloid leukocyte differentiation (GO:0002573),0.27187367578175015,0.6295562070110474,0.8888888888888888,1.0,1.0,7/65,12.88%,E2F1;DEK;KIT;PML;CDK2;CASP8;IL31RA
prerank,negative regulation of cellular catabolic process (GO:0031330),0.2762895138468979,0.629075333884187,0.8816631130063965,1.0,1.0,9/63,9.51%,BMF;DAP;EIF4E;LEPR;NRDE2;KLHL22;MTMR2;ROCK1;MTMR9
prerank,platelet aggregation (GO:0070527),0.288112427698122,0.6287884070665342,0.8649592549476135,1.0,1.0,11/33,22.54%,PDGFRA;PIK3CB;TLN1;CLIC1;STXBP1;FERMT3;METAP1;UBASH3B;FLNA;MYH9;VCL
prerank,ERBB signaling pathway (GO:0038127),0.26839218911307255,0.627567396181139,0.9026455026455027,1.0,1.0,13/64,15.30%,MATK;GAREM1;CUL5;GAB1;PRKCA;NCK2;PDPK1;ADAM17;SOX9;SLC30A10;AAMP;EFEMP1;SRC
prerank,inflammatory response (GO:0006954),0.264313731772632,0.6267908794601782,0.9608826479438315,1.0,1.0,16/195,11.54%,LOXL3;SCUBE1;MMP25;HYAL1;KIT;CXCR4;IL18;BDKRB2;NOX4;CYBB;HMGB1;PXK;IKBKG;ANXA1;BMP2;RAC1
prerank,positive regulation of actin nucleation (GO:0051127),0.3233016223293252,0.6266787011544785,0.8449275362318841,1.0,1.0,5/11,23.48%,WASF2;NCKAP1;ABI2;WHAMM;WASF1
prerank,androgen metabolic process (GO:0008209),0.3015415383361817,0.6262381253656926,0.8743315508021391,1.0,1.0,2/18,13.71%,SRD5A3;MED1
prerank,regulation of protein polymerization (GO:0032271),0.2808090266899505,0.6259164907606972,0.8752941176470588,1.0,1.0,4/35,9.14%,ARHGAP28;ARHGAP18;MAPT;TPPP
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2664766685995021,0.6255592300890547,0.9207003089598352,1.0,1.0,25/86,22.56%,PSMC2;PSMD5;ELOC;CHEK1;PSMB1;PSMD14;LIMD1;VHL;PSMD1;PSMB9;STOX1;ARNT;PSMC6;INO80;TP53;PSMB2;PSME4;PSMB7;PSMD11;EGLN1;PSME3;PSMD13;PSMB8;EGLN3;PSMD4
prerank,axon extension (GO:0048675),0.2961547416321006,0.6254480564023646,0.8668373879641486,1.0,1.0,5/23,13.23%,ALCAM;AUTS2;NLGN3;ULK2;USP9X
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.23504000496662514,-0.6251736304554875,0.926829268292683,0.9709874069387576,1.0,7/13,35.75%,PTPRT;JAK2;EGF;PTPRC;MGAT5;CRLF2;JAK3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.24481833339631293,-0.6249970786327349,0.9230769230769231,0.9703076472961644,1.0,4/11,26.91%,XBP1;TAF7;JAK2;TMEM106A
prerank,sensory organ development (GO:0007423),0.274061392920226,0.6246468399110139,0.8773480662983425,1.0,1.0,2/51,2.53%,PBX4;PBX3
prerank,positive regulation of wound healing (GO:0090303),0.2799392746395027,0.6246328542042807,0.8643867924528302,1.0,1.0,8/36,14.41%,HPSE;SERPINE1;ANXA1;DMTN;PRKCE;INSL3;ITGB1;ST3GAL4
prerank,cation transport (GO:0006812),0.26270379190271986,0.6245131737647404,0.9658291457286432,1.0,1.0,25/167,18.66%,RHAG;SLC18A2;AQP1;KCNN4;SLC38A7;KCNH4;KCNJ13;SLC8A1;KCNMB2;KCNMB3;TRPM2;PIEZO1;CHRNB1;TRPM4;KCNK6;KCNMB4;SLC22A18;KCNB2;KCNA1;SLC36A4;SLC6A17;SLC7A1;SLC6A9;SLC25A29;KCNQ4
prerank,blood vessel endothelial cell migration (GO:0043534),0.2894204488361063,0.6244714365704593,0.8693467336683417,1.0,1.0,5/22,14.26%,SRF;ROBO1;NR4A1;MIA3;EFNB2
prerank,regulation of lipid catabolic process (GO:0050994),0.2976206354519918,0.6243094069481949,0.848314606741573,1.0,1.0,1/19,5.00%,PDE3B
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.286394133525029,0.6241359720499005,0.8817966903073287,1.0,1.0,5/35,13.16%,IQGAP2;PDGFRA;TRPM2;NOTCH2;BAIAP2L1
prerank,negative regulation of leukocyte migration (GO:0002686),0.318655934539296,0.624010592476539,0.8734939759036144,1.0,1.0,1/10,6.64%,HOXA7
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.2616816057206525,0.6238495713715779,0.947261663286004,1.0,1.0,21/128,14.18%,TGFBR3L;BMPR1A;RHOA;NLK;HIVEP1;RGMA;BMP6;TGFBR3;SMURF1;SMAD6;ZFYVE16;TGFBR1;SMURF2;ARHGEF18;BMP2;APPL2;SMAD4;USP9X;ADAM9;ITGB1;SMAD3
prerank,positive regulation of embryonic development (GO:0040019),-0.20887882369359606,-0.6236439078595661,0.9565217391304348,0.970406894204846,1.0,6/19,29.26%,B4GALT5;NR2C2;TENM4;RACK1;PLCB1;ZBED3
prerank,plasma membrane organization (GO:0007009),0.27117330394182676,0.6234454979907891,0.9019607843137255,1.0,1.0,19/61,22.27%,PLSCR2;PACSIN2;CXCR4;MYOF;STX2;SNX33;EPB41L3;SYTL4;SMPD1;DYSF;CHMP4A;FA2H;UGCG;RAB3A;WHAMM;ANK3;A4GALT;SNX9;MYH9
prerank,regulation of smooth muscle cell migration (GO:0014910),0.2941886468195426,0.623416761499337,0.8781456953642384,1.0,1.0,3/20,7.99%,BMPR1A;PLAU;SERPINE1
prerank,focal adhesion assembly (GO:0048041),0.2944473269807154,0.6230950352330011,0.871261378413524,1.0,1.0,7/21,20.95%,TRIP6;SRC;RCC2;PTPRK;TESK2;WHAMM;FERMT2
prerank,detection of mechanical stimulus (GO:0050982),0.29487503398658405,0.6230669948235745,0.8526315789473684,1.0,1.0,7/19,22.54%,PKD2L2;PIEZO1;LHFPL5;PKD2;CSRP3;PIEZO2;PKD1L2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.28764392558346075,0.6230522370472031,0.8815461346633416,1.0,1.0,4/25,12.65%,RNF168;LEO1;HNRNPU;BRD4
prerank,photoperiodism (GO:0009648),0.2850866508605944,0.6218661642395705,0.8774271844660194,1.0,1.0,7/28,16.00%,PML;FBXL8;FBXL17;PPP1CC;RBM4;PER1;TP53
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.3194047473404095,0.6218483174564382,0.8738872403560831,1.0,1.0,2/10,13.41%,ACTN4;RARB
prerank,acyl-CoA biosynthetic process (GO:0071616),0.3019353919927298,0.6216400007420768,0.8436657681940701,1.0,1.0,3/16,11.82%,ACAT1;ACSS1;ACACA
prerank,autophagosome assembly (GO:0000045),0.2733288738406498,0.6214058253430651,0.8897464167585446,1.0,1.0,16/52,22.64%,ATG7;MFN2;SMURF1;ATP2A2;RAB1A;RB1CC1;ULK2;ATG3;ATG2A;STX12;UBXN2B;TRAPPC8;TP53INP2;AMBRA1;ATG13;ATG5
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.2944454897170947,0.6212387308379348,0.866580310880829,1.0,1.0,4/21,19.32%,EYA4;EYA2;GDNF;TERT
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.2944454897170947,0.6212387308379348,0.866580310880829,1.0,1.0,4/21,19.32%,EYA4;EYA2;GDNF;TERT
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.2606642790883261,0.6210402234611301,0.9197916666666667,1.0,1.0,19/87,17.76%,TGFBR3L;BMPR1A;RHOA;NLK;TGFBR3;SMURF1;SMAD6;TGFBR1;ARHGEF18;APPL2;SMAD4;USP9X;ADAM9;ITGB1;SMAD3;SRC;PTPRK;SMAD2;ZFYVE9
prerank,regulation of response to stress (GO:0080134),0.3287663600914861,0.6209699624255335,0.8714918759231906,1.0,1.0,3/10,18.95%,DYRK3;STOX1;SLC38A2
prerank,negative regulation of cell motility (GO:2000146),0.26373714385025177,0.6203696281516323,0.932446264073695,1.0,1.0,25/108,18.03%,ARID2;RAP2A;STK24;SFRP2;AFDN;SULF1;EPHA4;SERPINE1;FOXO3;TMEFF2;ROBO1;SRGAP2;SRGAP3;NKX2-1;DPYSL3;CLIC4;MIA3;PIN1;PTPRU;SFRP1;NF2;PTEN;PTPRK;SLURP1;DPEP1
prerank,peripheral nervous system development (GO:0007422),0.2973505728233837,0.6203585238358489,0.8690176322418136,1.0,1.0,1/23,1.74%,ARTN
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.2789508180183482,0.6197317916809297,0.8805104408352669,1.0,1.0,2/32,6.37%,RNASE6;HMGN2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.29336310162542245,0.6194869029924173,0.8610778443113772,1.0,1.0,6/26,16.01%,ROCK2;ALMS1;ROCK1;RAC1;SYNPO2;FHOD1
prerank,protein insertion into membrane (GO:0051205),0.28226374098105034,0.6189037722504703,0.8726190476190476,1.0,1.0,9/32,21.85%,PRNP;TRAM2;EMD;MAIP1;VAPA;CYB5A;TRAM1;CCDC47;VAMP2
prerank,embryonic appendage morphogenesis (GO:0035113),0.3195596169462688,0.6186367775552469,0.8492957746478873,1.0,1.0,1/12,3.25%,CYP26B1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2857106475437584,0.6185564352032601,0.8657635467980296,1.0,1.0,4/25,9.94%,KLHL15;CUL3;LONP1;FBXL17
prerank,positive regulation of metabolic process (GO:0009893),0.2630716824446764,0.6184797414987173,0.9296636085626911,1.0,1.0,18/103,14.53%,MFAP2;LEPR;CXCR4;PIGA;IL18;ZBTB7B;MFN2;ALMS1;CAMK1D;ACACA;APPL2;ACHE;GJA1;ADIPOR1;ADRB2;CPT2;ACADL;AGPAT1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.26326487910081586,0.618147139153111,0.9155509783728115,1.0,1.0,28/104,19.87%,BMPR1A;PEG10;PMEPA1;LEMD3;CRIM1;ADAMTSL2;SMURF1;SMAD6;TGFBR1;RBPMS2;SMURF2;CCN3;BMP2;NKX2-1;PDPK1;ADAM17;SMAD4;SPRED1;HTRA3;SMAD3;PIN1;SPRED2;VEPH1;SMAD2;SKIL;PPM1A;SKI;UBE2D3
prerank,negative regulation of response to external stimulus (GO:0032102),0.26270080679037333,0.6178321953217711,0.9274028629856851,1.0,1.0,14/105,13.44%,RB1;RTN4R;CASK;NMI;PTPN2;ENPP3;EPHA4;SERPINE1;PTPRS;CCN3;ILRUN;RORA;ITCH;MVK
prerank,Fc receptor signaling pathway (GO:0038093),0.2609337810233359,0.6173106344610256,0.932994923857868,1.0,1.0,39/110,24.66%,PSMC2;PSMD5;KIT;TAB1;MAP3K1;VAV2;PPP3CA;PSMB1;PSMD14;PSMD1;IKBKG;PIK3CB;PSMB9;RAC1;FBXW11;PDPK1;BTK;BTRC;PSMC6;NFKB1;PPP3R1;PSMB2;PSME4;PSMB7;NFATC3;PSMD11;TRAF6;PSME3;FER;IKBKB;PSMD13;GAB2;PSMB8;PSMD4;PSMF1;BCL10;PPP3CB;PSMA5;RELA
prerank,lipid droplet formation (GO:0140042),-0.2585300271165465,-0.6169304954062104,0.9034267912772586,0.9736814794668651,1.0,3/10,17.98%,CDS2;CDS1;AUP1
prerank,modulation by host of symbiont process (GO:0051851),0.279116091380328,0.6169000428134448,0.8952496954933008,1.0,1.0,6/31,17.61%,AQP1;NUCKS1;SMARCA4;HDAC1;CHD1;TFAP4
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.25919515606208865,0.6167535223587861,0.9524772497472194,1.0,1.0,18/150,12.28%,HPSE;FGFR4;FGFR2;IAPP;KIT;FRS2;TCF7L2;PDGFRA;IL18;TXN;CD80;ANGPT1;OSBPL8;PIK3CB;TGFBR1;GAB1;RAC1;PDPK1
prerank,regulation of myoblast differentiation (GO:0045661),-0.17788319013420126,-0.6165416929819738,0.9808917197452229,0.973120003509227,1.0,7/32,20.44%,MEF2C;BOC;TBX3;BTG1;SRA1;LRRC8A;HIF1AN
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.21150911087097635,-0.6156003459141497,0.9698275862068966,0.972863335301075,1.0,10/18,40.60%,HEATR1;WDR75;ERBB2;POLR2K;MAF1;LYAR;SIRT7;WDR43;POLR2L;RASL11A
prerank,extracellular transport (GO:0006858),-0.23894061240042808,-0.6155225025284118,0.926984126984127,0.9721170425459718,1.0,10/12,49.67%,TSG101;WWP2;CABYR;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,response to glucose (GO:0009749),0.2663348004760965,0.6146699394684962,0.882750845546787,1.0,1.0,5/46,9.40%,GCK;TRA2B;TCF7L2;EIF2B1;ZBTB20
prerank,regulation of endothelial cell migration (GO:0010594),0.25971751565160905,0.6141116464751507,0.9164926931106472,1.0,1.0,16/85,15.27%,ATOH8;ROCK2;ANGPT4;GPI;ANXA3;ADAMTS9;ANGPT1;AGT;SVBP;PIK3CB;RAC1;PRKCA;RRAS;PRKD1;AAMP;PRKD2
prerank,O-glycan processing (GO:0016266),0.26713752046941475,0.613750320650974,0.9002169197396963,1.0,1.0,8/54,15.40%,GALNT1;B3GNT8;ST3GAL3;C1GALT1;POFUT1;ST3GAL4;ST3GAL1;ST3GAL2
prerank,zinc ion transmembrane transport (GO:0071577),0.2942729657723895,0.6137349721406155,0.8780487804878049,1.0,1.0,5/22,15.09%,SLC39A11;TRPM2;SLC39A8;SLC39A6;SLC30A10
prerank,positive regulation of filopodium assembly (GO:0051491),0.28485985135120384,0.6135091580549588,0.8602015113350125,1.0,1.0,5/24,12.71%,FMR1;RHOQ;RIPOR2;DPYSL3;DOCK11
prerank,secondary alcohol metabolic process (GO:1902652),0.27288816650264824,0.6132034317886796,0.8980526918671249,1.0,1.0,6/42,15.58%,IDH3A;SOAT1;ABCA1;SCAP;SOAT2;STARD3
prerank,regulation of Notch signaling pathway (GO:0008593),0.2607636926494486,0.6128918958251746,0.9312896405919662,1.0,1.0,17/76,16.45%,MMP14;DLK1;ARRB1;FBXW7;YAP1;LLGL2;YTHDF2;POFUT1;ARRDC1;CCN3;RBPJ;AAK1;MAML1;TSPAN5;PRKCI;SRC;METTL3
prerank,synaptic vesicle membrane organization (GO:0048499),0.2983801523396744,0.6127493385296738,0.8641160949868074,1.0,1.0,4/17,15.74%,STX11;STX2;SNAP23;SYP
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.29089245513025375,0.612652729639597,0.8701986754966887,1.0,1.0,2/20,7.21%,SULF2;SULF1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.27454723055670377,0.6124194002468205,0.8713942307692307,1.0,1.0,4/32,8.18%,GSK3B;FMR1;LRRK2;VPS18
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.2776341416047356,0.6121857036475697,0.9005714285714286,1.0,1.0,8/38,18.40%,ATP2B4;ROCK2;RAC1;SMAD3;PKD2;SIRPA;CD47;PTGIS
prerank,modulation by host of viral genome replication (GO:0044827),0.3042495267661684,0.6121495590034293,0.8757062146892656,1.0,1.0,3/13,15.17%,FMR1;NUCKS1;VAPA
prerank,ubiquinone metabolic process (GO:0006743),0.30265429113432896,0.6119561729842156,0.8849315068493151,1.0,1.0,2/15,7.03%,AIFM2;COQ10B
prerank,substantia nigra development (GO:0021762),0.27666557557365495,0.6117548773992197,0.8855491329479769,1.0,1.0,5/37,10.79%,RHOA;RAD1;CCDC14;MAPKAP1;CALM2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.29867067029977834,0.6113969005078811,0.8890356671070013,1.0,1.0,1/16,5.62%,RAET1E
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.21495909010532885,-0.6109738583454172,0.9523809523809523,0.9739471955899685,1.0,7/17,31.41%,FIS1;SOD2;BCL2;BCL2L1;GGCT;BAK1;BBC3
prerank,cellular response to estrogen stimulus (GO:0071391),-0.2266163178872026,-0.6107296272562602,0.9115646258503401,0.9732886538466142,1.0,5/14,20.67%,AR;SFR1;SERPINB9;SRA1;WBP2
prerank,homotypic cell-cell adhesion (GO:0034109),0.27370349325688226,0.6101138645165106,0.8922902494331065,1.0,1.0,12/39,22.54%,PDGFRA;PIK3CB;TLN1;TJP2;CLIC1;STXBP1;FERMT3;METAP1;UBASH3B;FLNA;MYH9;VCL
prerank,phagolysosome assembly (GO:0001845),0.30822288060498315,0.6097556020023774,0.865979381443299,1.0,1.0,1/12,4.60%,RAB7B
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.2834236015321134,0.6097367259760618,0.8764186633039092,1.0,1.0,6/24,15.14%,TAB1;UBE2N;IKBKG;CASP8;ITCH;AAMP
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.31093801301032964,0.6096337292839347,0.8807471264367817,1.0,1.0,3/13,14.19%,DDRGK1;NCK1;PPP1R15B
prerank,regulation of programmed cell death (GO:0043067),0.25569359287542215,0.6096149153159992,0.9676113360323887,1.0,1.0,18/161,12.75%,BIRC5;STEAP3;ACTN4;ANP32B;AIFM2;RBM25;TMEM219;LRRK2;TNFRSF10B;KANK2;AGT;SKP2;GAS1;APAF1;NDRG1;ANP32E;CHM;SOX9
prerank,muscle cell development (GO:0055001),0.27583073626269883,0.6091240598939724,0.8820638820638821,1.0,1.0,6/30,16.11%,MYOF;SLC8A1;SDC1;CHRNB1;HEY2;DYSF
prerank,regulation of response to external stimulus (GO:0032101),0.253448625240263,0.6089753567498061,0.944331983805668,1.0,1.0,24/121,18.36%,SETD6;USP18;ADGRA2;STK24;CXCR4;PDGFRA;AKNA;IRF1;NMT2;NLRP6;ANXA1;APPL2;DAGLB;CASP8;BRD4;IL1RL2;XIAP;EFNB2;TRIM5;LACC1;FOXP1;USP14;METAP1;FNTB
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.28977490725581717,0.6075662014909897,0.857516339869281,1.0,1.0,1/21,2.15%,NAP1L1
prerank,heart process (GO:0003015),0.3054802948279761,0.6074243518710652,0.8691322901849218,1.0,1.0,4/14,22.93%,NOX4;RAMP3;SOD1;FYN
prerank,positive regulation of defense response (GO:0031349),0.25718956386577535,0.6072296838217949,0.9247648902821317,1.0,1.0,20/89,23.02%,DHX9;NMI;IL18;SERPINE1;RIOK3;AGT;POLR3D;AKIRIN2;LPL;SLC15A4;SETD4;CD47;RIPK1;IL16;SNCA;POLR3C;OPTN;GPRC5B;TLR7;POLR3G
prerank,regulation of RNA metabolic process (GO:0051252),0.2629261020845569,0.6072272586864826,0.9163916391639164,1.0,1.0,12/59,14.16%,TRA2B;MBNL3;HNRNPH1;FUS;RC3H2;YTHDF2;HNRNPL;HNRNPH2;METTL4;PTBP2;MED1;RC3H1
prerank,mitochondrial membrane organization (GO:0007006),0.2767735098836056,0.6071261023002057,0.8827085852478839,1.0,1.0,11/32,22.12%,TMEM11;MFN2;CHCHD3;APOO;MAIP1;MFN1;MICOS10;BAD;SLC25A5;SPG7;IMMT
prerank,plasma membrane tubulation (GO:0097320),0.3069045868403512,0.6066149713010449,0.8760932944606414,1.0,1.0,6/13,24.16%,PACSIN2;SNX33;CHMP4A;WHAMM;SNX9;EHD2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2599058646710417,0.6064662113187401,0.9183040330920372,1.0,1.0,5/76,6.67%,SETD6;TRIM37;DAP;FAF1;ARRB1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.25872176204698794,0.6064401765162872,0.9478527607361963,1.0,1.0,35/104,25.03%,PSMC2;PSMD5;TAB1;PSMB1;PSMD14;PSMD1;IKBKG;PSMB9;FBXW11;PDPK1;BTRC;PSMC6;SRC;NFKB1;PSMB2;NRAS;KRAS;PSME4;PSMB7;RELB;PRKCD;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;PSMB8;PSMD4;FYN;PSMF1;BCL10;PSMA5;PRKACA;RELA;PSMC3
prerank,cellular response to lectin (GO:1990858),0.25872176204698794,0.6064401765162872,0.9478527607361963,1.0,1.0,35/104,25.03%,PSMC2;PSMD5;TAB1;PSMB1;PSMD14;PSMD1;IKBKG;PSMB9;FBXW11;PDPK1;BTRC;PSMC6;SRC;NFKB1;PSMB2;NRAS;KRAS;PSME4;PSMB7;RELB;PRKCD;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;PSMB8;PSMD4;FYN;PSMF1;BCL10;PSMA5;PRKACA;RELA;PSMC3
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.25823768762789545,0.6064064109899073,0.9113924050632911,1.0,1.0,22/70,25.12%,FADD;GSK3B;CASP8AP2;TNFRSF10B;BOK;PDPK1;CASP8;SMAD3;ITGAV;NGF;BAD;RIPK1;HIPK1;TRAF2;APPL1;DAXX;IL6R;DAB2IP;BID;BAX;TGFB1;MCL1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.2685459464197231,0.606060272679013,0.9029768467475193,1.0,1.0,14/48,24.04%,ACAT1;PAPSS2;PPCDC;ADSL;GUCY2C;PANK4;PANK2;ADCY6;ADCY2;COASY;ADSS2;GUCY2D;SLC25A16;DCAKD
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.22958699795636692,-0.6058749791846618,0.9548387096774194,0.9751232890937053,1.0,1/12,8.01%,PRKCQ
prerank,steroid biosynthetic process (GO:0006694),0.2635175143585127,0.605239465245206,0.9050218340611353,1.0,1.0,3/56,4.86%,LBR;CYP39A1;PMVK
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2700129617085056,0.6046027796046238,0.8894009216589862,1.0,1.0,10/39,21.57%,STEAP3;RAB10;SVBP;ABCA1;MIA3;RAB13;TMEM167A;RAB3A;RAB8B;PPY
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.25797881485345237,0.6045499711410399,0.9478527607361963,1.0,1.0,35/105,25.03%,PSMC2;PSMD5;TAB1;PSMB1;PSMD14;PSMD1;IKBKG;PSMB9;FBXW11;PDPK1;BTRC;PSMC6;SRC;NFKB1;PSMB2;NRAS;KRAS;PSME4;PSMB7;RELB;PRKCD;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;PSMB8;PSMD4;FYN;PSMF1;BCL10;PSMA5;PRKACA;RELA;PSMC3
prerank,peptide catabolic process (GO:0043171),0.2878491512423375,0.6044519817640569,0.8775252525252525,1.0,1.0,6/23,18.03%,LVRN;CPQ;TRHDE;CTSH;NPEPPS;DPEP1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.29283313375096814,0.6043629512134249,0.9014454664914586,1.0,1.0,1/17,5.62%,RAET1E
prerank,positive regulation of phospholipid transport (GO:2001140),0.31504048291679787,0.6039632580661898,0.8573596358118362,1.0,1.0,1/10,4.62%,ABCB4
prerank,positive regulation of calcium ion import (GO:0090280),-0.22820540249406965,-0.6032333867559834,0.9246987951807228,0.9757387433043639,1.0,1/12,4.47%,PDGFRB
prerank,glycosaminoglycan metabolic process (GO:0030203),0.26192486822575467,0.6031660940680159,0.8981380065717415,1.0,1.0,7/54,10.61%,HPSE;GPC6;SLC35D2;B4GALT7;SDC1;HAS1;HS2ST1
prerank,regulation of cardiac conduction (GO:1903779),0.25739664845590515,0.6028655207121614,0.9001074113856069,1.0,1.0,9/54,16.20%,ATP2B4;ITPR1;ATP2A2;SLC8A1;AGT;ATP2B1;ITPR3;TMEM65;STIM1
prerank,chondroitin sulfate catabolic process (GO:0030207),0.3036607086382655,0.6022810890105584,0.8914956011730205,1.0,1.0,3/13,17.28%,HYAL1;BGN;ARSB
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.257579562457041,0.6019760722253878,0.9246861924686193,1.0,1.0,17/80,19.62%,GBF1;RAB7B;SPAG9;SNX1;DENND2A;RAB29;DENND5A;ERC1;VTI1A;GOSR1;TRAPPC10;SNX32;VPS26A;RIC1;PIKFYVE;TBC1D10A;BET1L
prerank,glycoprotein catabolic process (GO:0006516),0.2906690316245651,0.6017883703840587,0.8820301783264746,1.0,1.0,4/17,15.08%,ADAMTS9;STT3B;FBXO27;FBXO17
prerank,T-helper cell differentiation (GO:0042093),0.30104948503733114,0.6017256642395293,0.8803301237964236,1.0,1.0,4/14,19.67%,HMGB1;TMEM98;FOXP1;ZFPM1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.288150659299312,0.6015052587701779,0.8758344459279038,1.0,1.0,3/20,16.84%,LMBRD2;ADRB2;ZDHHC21
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.17696977691787885,-0.6013932143525996,0.9634146341463414,0.9758623374950433,1.0,10/31,35.13%,TLR4;HSPD1;LGALS9;TIRAP;SYK;LAPTM5;PLCB1;CD40;CCL19;IRF5
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.26305542647886787,0.6011759445539809,0.9014557670772676,1.0,1.0,6/46,10.83%,PRKDC;TCF7L2;IL18;MFN2;ELN;RBPMS2
prerank,B cell differentiation (GO:0030183),0.26389853638215577,0.6009944829359778,0.8980044345898004,1.0,1.0,6/46,15.54%,FNIP1;KIT;PTPN2;ADAM17;ITGB1;DCAF1
prerank,calcineurin-mediated signaling (GO:0097720),0.3147607097366021,0.6001200423560347,0.8888888888888888,1.0,1.0,4/10,24.34%,PPP3CA;PPP3R1;NFATC3;PPP3CB
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.3147607097366021,0.6001200423560347,0.8888888888888888,1.0,1.0,4/10,24.34%,PPP3CA;PPP3R1;NFATC3;PPP3CB
prerank,regulation of cholesterol storage (GO:0010885),0.29887523000951,0.5997790888824209,0.8797297297297297,1.0,1.0,3/15,14.80%,ABCA1;EHD1;LPL
prerank,negative regulation of stem cell differentiation (GO:2000737),0.3081621223653443,0.59974462672927,0.87518573551263,1.0,1.0,2/12,10.63%,YTHDF2;HNRNPU
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.2726229360732892,0.5996993637539354,0.8926014319809069,1.0,1.0,3/28,10.36%,ARHGAP28;ARHGAP18;ARHGAP35
prerank,regulation of protein kinase B signaling (GO:0051896),0.2501743751407209,0.5996373829301619,0.968937875751503,1.0,1.0,28/193,16.13%,HPSE;FGFR4;FGFR2;IAPP;KIT;PHLPP2;FRS2;XDH;TCF7L2;PDGFRA;IL18;TXN;CD80;ANGPT1;OSBPL8;PPP2R5C;PIK3CB;TGFBR1;GAB1;RAC1;RRAS;PDPK1;ITGB1;RAMP3;PLEKHA1;SRC;PPP2R5B;PTEN
prerank,acylglycerol homeostasis (GO:0055090),0.28163298277120546,0.5988515802239002,0.8983481575603558,1.0,1.0,3/20,14.80%,IL18;RORA;LPL
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.26466277306657904,0.5985215025515074,0.9163802978235968,1.0,1.0,6/43,13.83%,BMPR1A;IL18;MFN2;RBPMS2;GJA1;ADAMTS1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.28495117116168495,0.5984319838946416,0.9025710419485792,1.0,1.0,5/18,18.29%,SMAD4;SMAD3;ITGAV;ITGB8;LTBP1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.2742166427280017,0.5980360060979246,0.896797153024911,1.0,1.0,3/33,5.53%,FXN;IAPP;MAPT
prerank,protein localization to synapse (GO:0035418),0.3043954657975265,0.5975516949255791,0.8848396501457726,1.0,1.0,3/12,16.35%,MPP4;ZDHHC15;NLGN2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.2958542454779322,0.5971389239862275,0.8947368421052632,1.0,1.0,2/16,6.10%,PIGN;PIGA
prerank,activation of phospholipase C activity (GO:0007202),0.27260783098282027,0.5968178695706514,0.8993939393939394,1.0,1.0,3/29,10.32%,LPAR1;GNAQ;ARHGAP6
prerank,histone H3-K4 trimethylation (GO:0080182),0.3121137353600205,0.596241484970726,0.8916544655929722,1.0,1.0,2/11,12.39%,KMT2A;KMT2D
prerank,pigment granule transport (GO:0051904),0.2831897211188174,0.5946733104311633,0.8822733423545331,1.0,1.0,3/18,14.02%,MLPH;MKKS;BLOC1S5
prerank,melanosome transport (GO:0032402),0.2831897211188174,0.5946733104311633,0.8822733423545331,1.0,1.0,3/18,14.02%,MLPH;MKKS;BLOC1S5
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.2510021328543724,0.5940705506454256,0.9634888438133874,1.0,1.0,21/121,16.57%,ANGPT4;KIT;PRNP;BMP6;IL18;ENPP2;EFNA1;EPHA4;CD80;ANGPT1;NOX4;AGT;PARP9;CNTF;IL31RA;ITGA5;CD44;UNC119;SRC;TP53;TNK2
prerank,circulatory system development (GO:0072359),0.25114662979730773,0.5935961080933114,0.9522842639593908,1.0,1.0,23/118,16.74%,GLI2;FBN1;BCOR;SRF;PDLIM4;MKKS;WDR11;FBXW7;CACNA1C;TGFBR1;BMP2;PDLIM5;CASP8;SOX9;HEY2;FOXL1;CDKN1B;STK11;PKD2;HSPG2;PTEN;SALL1;SH3PXD2B
prerank,regulation of lymphocyte activation (GO:0051249),0.3011299435028248,0.5935678048980401,0.883551673944687,1.0,1.0,12/12,69.91%,KAT2A;SIT1;CD4;CD19;LCK;CRTAM;CCL5;THEMIS2;IKZF3;LAT;DCAF15;PAG1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.2719247777116527,0.593533447628318,0.8780788177339901,1.0,1.0,6/26,15.14%,TAB1;UBE2N;IKBKG;CASP8;ITCH;AAMP
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.289599490505107,0.5933279808265252,0.8972222222222223,1.0,1.0,1/16,2.73%,MOV10
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.2517237314744478,0.5930804511379599,0.9616161616161616,1.0,1.0,14/136,13.80%,SETD6;TRIM37;PAXIP1;RB1;DAP;TAF3;PRNP;TCF7L2;ARRB1;PIM1;PYDC1;ITCH;HDAC2;BTRC
prerank,receptor clustering (GO:0043113),0.27107526970054274,0.5930696561043707,0.900990099009901,1.0,1.0,3/27,7.44%,ITGB7;MUSK;SCRIB
prerank,inorganic cation transmembrane transport (GO:0098662),0.24818820484511536,0.5927825000817439,0.99,1.0,1.0,21/268,10.98%,RHD;RHAG;ATP2B4;CCDC51;KCNN4;KCNK2;SLC6A2;SLC6A5;TRPA1;SLC39A11;KCNH4;KCNH8;SLC9A5;ATP2A2;SLC24A3;SLC8A1;CACNA1C;KCNK12;TRPM2;TRPC7;SLC39A8
prerank,establishment of melanosome localization (GO:0032401),0.2794636554946279,0.5922987541725746,0.8803191489361702,1.0,1.0,4/19,17.62%,MLPH;MKKS;BLOC1S5;SHROOM2
prerank,myeloid cell differentiation (GO:0030099),0.2583148416923582,0.5922771736231038,0.8932893289328933,1.0,1.0,11/47,19.67%,KIT;DYRK3;IKZF1;PTPN2;TAL1;ATP5IF1;RUNX1;KAT6A;ALAS2;SLC25A5;ZFPM1
prerank,positive regulation of immune system process (GO:0002684),0.2871686931948828,0.5917047008093438,0.8782722513089005,1.0,1.0,3/16,14.06%,PIK3CB;ANXA1;MIA3
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.19653692222218488,-0.5913323479892995,0.9649122807017544,0.9802732837649829,1.0,13/20,38.05%,HSP90AB1;HSPD1;CCT2;PSMG2;PSMG1;NDUFAF1;BBS12;HOPX;TMEM35A;PFDN6;HSPA1A;PTGES3L;PTGES3
prerank,regulation of response to biotic stimulus (GO:0002831),0.2688452414418709,0.5913221513807205,0.9007263922518159,1.0,1.0,10/28,24.21%,IRF1;APPL2;CASP8;XIAP;TRIM5;FOXP1;APPL1;BIRC2;ELMOD2;FGR
prerank,inositol phosphate catabolic process (GO:0071545),0.30271927828776957,0.5910316743508529,0.8877400295420975,1.0,1.0,2/12,7.85%,OCRL;INPP5B
prerank,positive regulation of neuron death (GO:1901216),0.26494386165418826,0.5909949253605148,0.9008908685968819,1.0,1.0,5/46,9.53%,GSK3B;PRNP;MAPT;FOXO3;PICALM
prerank,aerobic respiration (GO:0009060),0.28821916055316626,0.590994730610703,0.8901808785529716,1.0,1.0,1/20,2.48%,MTFR2
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.2687588446957389,0.5904149961362217,0.8879813302217037,1.0,1.0,6/33,13.18%,TCF7L2;SERPINE1;YAP1;ANGPT1;PDPK1;CAST
prerank,NAD biosynthetic process (GO:0009435),0.2778728603441667,0.5897079520284592,0.8919631093544137,1.0,1.0,6/20,20.20%,NADSYN1;PARP9;NAPRT;NMNAT1;PTGIS;NMNAT2
prerank,positive regulation of exocytosis (GO:0045921),0.26478831015913046,0.5895980361817449,0.9098360655737705,1.0,1.0,10/35,21.80%,STXBP5;STAM;SDC1;SYTL4;SMPD3;CLASP1;RAB3A;SDC4;SNCA;PDCD6IP
prerank,monocarboxylic acid metabolic process (GO:0032787),0.24845329437279512,0.5895477926151721,0.9483282674772037,1.0,1.0,14/117,14.80%,ALDH8A1;ECHDC3;PTGR1;CYP26B1;MTHFD1L;ALDH1A2;BTD;SCPEP1;AGXT;ABAT;HOGA1;PANK2;ACOT2;LPL
prerank,mononuclear cell differentiation (GO:1903131),0.27765354350880517,0.5894974671848819,0.8907035175879398,1.0,1.0,8/24,23.52%,IKZF1;TRPM2;IL31RA;AXL;RELB;MYH9;THOC5;IRF8
prerank,regulation of protein modification process (GO:0031399),0.2594663741368524,0.5889112090140919,0.9218061674008811,1.0,1.0,9/50,16.29%,PHIP;FNIP1;PML;ATG7;PLXNB2;SPRED1;PIN1;SPRED2;SESN2
prerank,Golgi ribbon formation (GO:0090161),-0.22501328364521817,-0.5884939017518338,0.954225352112676,0.9808001634604152,1.0,2/13,9.73%,STX6;MYO18A
prerank,nitric oxide biosynthetic process (GO:0006809),0.2918562710554747,0.5884675443860956,0.9264497878359265,1.0,1.0,2/13,10.17%,NQO1;CYB5B
prerank,multivesicular body assembly (GO:0036258),0.26310213672906424,0.5877686417547981,0.9148418491484185,1.0,1.0,4/30,10.87%,VPS37B;VPS37A;STAM;VTA1
prerank,manganese ion transport (GO:0006828),0.2932289748742383,0.5876937126718511,0.9078212290502793,1.0,1.0,5/14,22.88%,TRPC7;SLC39A8;SLC30A10;SLC11A2;TMEM165
prerank,phospholipid homeostasis (GO:0055091),-0.22860212877619374,-0.5875851693107027,0.9221183800623053,0.9804114281621176,1.0,6/11,41.14%,TLCD2;RCN3;TLCD1;ANGPTL3;ABCG1;FABP3
prerank,positive regulation of vascular permeability (GO:0043117),0.29736626848495196,0.5866424812653254,0.9012875536480687,1.0,1.0,4/12,17.85%,BMP6;ANGPT1;TJP2;TRPV4
prerank,cellular response to interleukin-1 (GO:0071347),0.24726404155548704,0.5861017517649362,0.9717741935483871,1.0,1.0,39/143,23.79%,HYAL1;PSMC2;PSMD5;MYLK3;TAB1;UBE2N;PSMB1;PSMD14;MAP3K3;PSMD1;IKBKG;PSMB9;FBXW11;SOX9;BTRC;RC3H1;PSMC6;SFRP1;NFKB1;SIRPA;CD47;PSMB2;MAP3K8;PTGIS;PSME4;PSMB7;PSMD11;TRAF6;PSME3;TANK;RBMX;IKBKB;PSMD13;PSMB8;PSMD4;DAB2IP;CCL14;PSMF1;RIPK2
prerank,gonad development (GO:0008406),0.2627134998080039,0.5851494014379786,0.9140271493212669,1.0,1.0,3/41,6.20%,KIT;WNT2B;MKKS
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.25717517980989,0.5836066208938061,0.90744920993228,1.0,1.0,9/46,15.46%,RB1;ADAMTS5;ALDH1A1;NPR3;RBPJ;ADAM17;DOCK7;STK11;TLE3
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.3027240773286467,0.5835887502821485,0.8892355694227769,1.0,1.0,10/10,69.75%,CEP250;TULP1;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;CACNA2D4
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.3027240773286467,0.5835887502821485,0.8892355694227769,1.0,1.0,10/10,69.75%,CEP250;TULP1;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;CACNA2D4
prerank,negative regulation of ATP metabolic process (GO:1903579),0.28705822636909206,0.5832551073917368,0.9014647137150466,1.0,1.0,1/17,3.00%,PFKFB1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.22441774253766822,-0.5831157266635645,0.9536423841059603,0.9816648922493697,1.0,4/12,34.71%,ESR1;ZC3H12A;ZC3H10;PPARG
prerank,protein targeting to membrane (GO:0006612),0.24723036132273243,0.583001229908803,0.9374348279457768,1.0,1.0,25/83,23.07%,VPS37B;MYO1C;VPS37A;ARL6IP1;SRPRA;ZDHHC18;CHM;ZDHHC15;ATG3;PRKCI;ZDHHC3;ZDHHC21;SLC25A17;PIKFYVE;CHMP4A;CHMP4B;TRAM1;PEX12;ZDHHC24;ICMT;RAB8B;PEX13;VPS37C;ZDHHC2;ZDHHC14
prerank,positive regulation of stem cell differentiation (GO:2000738),0.2819960905529968,0.582925702829975,0.8974358974358975,1.0,1.0,2/16,12.75%,SOX6;SOX9
prerank,axon guidance (GO:0007411),0.24398652188832307,0.5828392022272725,0.9839357429718876,1.0,1.0,35/201,15.76%,SPTA1;GLI2;ARTN;NCAM1;ALCAM;SPTB;NTN1;NFIB;FRS2;CXCR4;NTN3;EFNA1;EPHA4;ROBO1;DOK2;DSCAML1;PIK3CB;ARHGAP35;PLXNB2;PLXNB1;GAB1;DSCAM;EFNB1;RAC1;EZR;PRKCA;EMB;NOTCH2;PLXND1;EFNB2;PTPRA;SRC;GDNF;SEMA3D;NTN4
prerank,regulation of endocytosis (GO:0030100),0.2541301673246741,0.5827794686052049,0.9247311827956989,1.0,1.0,11/61,15.30%,STON1;PACSIN2;STON2;ZFYVE16;MTMR2;ROCK1;PICALM;SNX33;PRKD1;SMPD1;SRC
prerank,brain morphogenesis (GO:0048854),0.29819065275141454,0.5826034563752842,0.8797564687975646,1.0,1.0,3/12,16.13%,MKKS;FBXW11;PTEN
prerank,regulation of ATP biosynthetic process (GO:2001169),0.2891825117149887,0.5825612118749854,0.8857938718662952,1.0,1.0,1/16,2.88%,ATPSCKMT
prerank,nitric oxide metabolic process (GO:0046209),0.28808703408214476,0.582343761183751,0.9075862068965517,1.0,1.0,2/14,10.17%,NQO1;CYB5B
prerank,response to lipid (GO:0033993),0.2451550391016197,0.5822610069343945,0.9518935516888434,1.0,1.0,12/105,12.97%,HMGB2;CDKN2D;FGFR4;ASXL1;FOXO3;SMAD6;ANXA1;ADAM17;TRIM6;SOX9;MAPKAPK3;CTSH
prerank,carbohydrate homeostasis (GO:0033500),0.2500699965369915,0.5822410655717685,0.9320594479830149,1.0,1.0,13/67,19.44%,FGFR4;GCK;LEPR;PTPN2;TCF7L2;MCU;APPL2;ADIPOR1;STK11;BAD;HECTD4;SLC2A4;PYGL
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.2872809168537943,0.5818002437761398,0.891583452211127,1.0,1.0,4/14,20.66%,YBX3;ANGEL2;MAPK14;MAPKAPK2
prerank,negative regulation of catabolic process (GO:0009895),0.2509681756508672,0.5813712890215593,0.9167591564927858,1.0,1.0,10/47,22.20%,PFKFB1;MDM4;PDE3B;SF3B3;PIN1;AZIN1;FMN2;HDAC4;SIRT2;FLNA
prerank,positive regulation of interferon-beta production (GO:0032728),0.2590414848076014,0.580804463364078,0.9140893470790378,1.0,1.0,11/33,23.95%,DHX9;IRF1;RIOK3;POLR3D;MAVS;ISG15;POLR3C;TLR7;POLR3G;RIPK2;HSP90AA1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.2742508890879848,0.5807892041629135,0.8970013037809648,1.0,1.0,4/22,12.65%,DDX39B;LEO1;SCAF8;BRD4
prerank,regulation of cellular amide metabolic process (GO:0034248),0.2693632759614234,0.5807675911728735,0.9144196951934349,1.0,1.0,7/32,19.56%,EIF4E;FOXO3;ROCK1;PICALM;METAP1;TMED10;PRKCD
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.26228616067466154,0.5806523920639712,0.9235225955967555,1.0,1.0,10/38,19.49%,PRNP;EFNA1;EPHA4;NOX4;AGT;NCK2;UNC119;MVP;SH3BP5;PTPN1
prerank,response to interferon-gamma (GO:0034341),-0.1444928071237679,-0.5801465860192556,1.0,0.9821277127315896,1.0,13/67,20.43%,NUB1;TLR4;IFITM3;CX3CL1;GBP3;GBP4;GCH1;BST2;IFITM2;RPL13A;LGALS9;GBP6;GAPDH
prerank,negative regulation of ion transport (GO:0043271),0.2714597210244423,0.5800231421189864,0.9071246819338422,1.0,1.0,3/24,9.87%,NEDD4;WNK1;PXK
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.2000210999354513,-0.5795273482400598,0.9653846153846154,0.9815988898257096,1.0,7/16,41.44%,PTPN22;TNFRSF1B;FGF10;SOX11;TNFSF8;IL27;LST1
prerank,cAMP-mediated signaling (GO:0019933),0.27161910228786645,0.5794140416686331,0.9077306733167082,1.0,1.0,6/24,18.59%,KSR1;AHR;PDE7B;SOX9;ADCY2;PDE7A
prerank,positive regulation of insulin secretion (GO:0032024),0.2599764108388575,0.579121335085687,0.9159859976662778,1.0,1.0,8/36,18.50%,GCK;TCF7L2;MCU;TRPM4;AACS;C2CD2L;NLGN2;BAD
prerank,regulation of interferon-alpha production (GO:0032647),0.27412899957451986,0.5791170267152518,0.9051186017478152,1.0,1.0,7/23,23.79%,DHX9;SETD2;PTPRS;MAVS;HAVCR2;TLR7;RIPK2
prerank,response to peptide hormone (GO:0043434),0.2590696574286614,0.5786642862963596,0.9180509413067552,1.0,1.0,6/43,11.23%,ROCK2;EIF2B1;TGFBR3;ZBTB7B;ROCK1;ANXA1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.24563357527851537,0.5786507088902249,0.9607032057911065,1.0,1.0,4/100,4.03%,PLK1;XPO1;GSK3B;DDRGK1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.26597913024223935,0.5780880323026317,0.9023199023199023,1.0,1.0,3/29,11.48%,FGFR2;TGFBR3;BMP2
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.2440594749180291,0.5778642815806992,0.950354609929078,1.0,1.0,39/109,25.03%,PSMC2;PSMD5;TAB1;MAP3K1;VAV2;PPP3CA;PSMB1;PSMD14;PSMD1;IKBKG;PIK3CB;PSMB9;RAC1;FBXW11;PDPK1;BTK;BTRC;PSMC6;NFKB1;PPP3R1;PSMB2;PSME4;PSMB7;NFATC3;PSMD11;TRAF6;PSME3;FER;IKBKB;PSMD13;GAB2;PSMB8;PSMD4;PSMF1;BCL10;PPP3CB;PSMA5;RELA;PSMC3
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.2509061450806655,0.5772142559366472,0.928416485900217,1.0,1.0,8/57,15.36%,KIT;PTPN2;IL18;PARP9;CNTF;IL31RA;NF2;CNOT7
prerank,negative regulation of ATPase activity (GO:0032780),0.2867851358553584,0.576389115817838,0.9041835357624831,1.0,1.0,3/16,16.00%,PXK;ATP5IF1;TP53
prerank,regulation of vasculogenesis (GO:2001212),0.28825016964197486,0.5763177829581331,0.8932584269662921,1.0,1.0,3/14,13.69%,XDH;RRAS;HEY2
prerank,regulation of macroautophagy (GO:0016241),0.2423758026388882,0.5762948283255719,0.963265306122449,1.0,1.0,21/105,17.52%,EXOC4;NEDD4;TBC1D25;QSOX1;SH3GLB1;LRRK2;LARP1;SESN1;IKBKG;RB1CC1;SLC38A9;GNAI3;EXOC8;SNX32;RPTOR;PRKAG1;CLEC16A;SESN2;VPS26A;LAMTOR3;LAMTOR5
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.249538852291057,0.5761187109506128,0.9182027649769585,1.0,1.0,6/40,12.90%,MAPT;STOML2;PYCR1;LRRK2;STOX1;ATP5IF1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.25496652035637263,0.5754685862790455,0.9243119266055045,1.0,1.0,8/40,19.56%,FXN;BMF;FAM162A;PLAUR;TP53;TNFSF10;BAD;DNM1L
prerank,lymphocyte differentiation (GO:0030098),0.2460711041603064,0.5753976066159288,0.9305555555555556,1.0,1.0,12/68,19.47%,KIT;NFIL3;LEPR;IKZF1;PTPN2;LMBR1L;ADAM17;ITGB1;DCAF1;AXL;RELB;SLC25A5
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.24883447565530423,0.5750520166418555,0.9263736263736264,1.0,1.0,12/54,18.28%,KCNN4;NEDD4;KCNMB2;KCNMB3;KCNIP3;DLG1;CAB39;KCNMB4;STK39;GABBR2;DPP6;AMIGO1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.24933508876604935,0.5749700461533412,0.937641723356009,1.0,1.0,10/41,22.20%,KCNN4;PDZK1;KCNMB2;KCNMB3;KCNMB4;GABBR2;AMIGO1;ANK3;GNB1;FLNA
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.2574858172472155,0.5748082944635902,0.8892900120336944,1.0,1.0,5/32,13.17%,POLR1A;POLR1B;ERCC3;TAF1D;POLR1G
prerank,regulation of axon guidance (GO:1902667),0.299630909933367,0.5747658166160362,0.8998505231689088,1.0,1.0,1/10,4.45%,MYCBP2
prerank,negative regulation of macroautophagy (GO:0016242),0.2668740184142052,0.5743793070565053,0.91625,1.0,1.0,7/26,18.00%,QSOX1;LRRK2;TMEM39A;SCFD1;CLEC16A;CHMP4A;CHMP4B
prerank,steroid hormone biosynthetic process (GO:0120178),0.26137609546367957,0.5742697843598594,0.9149453219927096,1.0,1.0,5/29,16.10%,SRD5A3;MED1;FDXR;STARD3;DHCR7
prerank,cellular amide metabolic process (GO:0043603),0.242320467583734,0.5740594062727481,0.9620901639344263,1.0,1.0,15/102,16.07%,MTHFD1L;DNPEP;NLN;MTHFR;BTD;CPXM1;SLC19A1;PLPP1;PANK2;DHFR;ACOT2;SMPD1;ST3GAL1;ABHD4;SMPD3
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.2778149897601705,0.5739368477129254,0.9109874826147427,1.0,1.0,6/15,25.01%,SMPD3;SMPD2;PRKCD;ORMDL2;SIRT3;ORMDL3
prerank,regulation of neutrophil migration (GO:1902622),0.2959240795147139,0.5735085530854037,0.9214175654853621,1.0,1.0,2/10,23.18%,RAC1;RHOH
prerank,regulation of fatty acid oxidation (GO:0046320),0.2811103934353788,0.5732326399951431,0.8838174273858921,1.0,1.0,3/16,14.38%,APPL2;SOX9;ACADL
prerank,positive regulation of dendrite development (GO:1900006),0.29733658176142674,0.5723736990625102,0.9094955489614244,1.0,1.0,4/10,23.27%,ZDHHC15;COBL;BMP5;DAB2IP
prerank,negative regulation of developmental growth (GO:0048640),0.260387154891044,0.5720985615621705,0.9131985731272295,1.0,1.0,11/30,26.01%,RTN4R;PTPRS;ULK2;CDKN1B;NKD1;PTEN;DIP2B;WWC2;DUSP10;SLC6A4;RTN4
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.29324629676123526,0.571776630856837,0.9056047197640118,1.0,1.0,10/10,70.69%,GNB1;CNGA1;GRK1;GNAT1;RHO;PDE6B;PDE6G;CNGB1;PDE6A;SAG
prerank,protein insertion into ER membrane (GO:0045048),0.25815473047497484,0.5707180175405634,0.9287356321839081,1.0,1.0,11/37,21.85%,PRNP;EMC7;TRAM2;EMD;VAPA;CYB5A;EMC8;TRAM1;CCDC47;EMC4;VAMP2
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.2809622357569806,0.570415069375516,0.9096774193548387,1.0,1.0,8/18,23.27%,B4GALT7;EMD;MORC3;SFRP1;TP53;SKI;MED25;DAB2IP
prerank,regulation of actin filament polymerization (GO:0030833),0.24400103057275385,0.5703432203989158,0.946751863684771,1.0,1.0,17/69,22.26%,ARHGAP28;ARHGAP18;SSH2;CDC42EP2;NCK1;TWF1;NCK2;BAIAP2L1;PRKCE;DBN1;NCKAP1;PRKCD;FER;LATS1;VASP;LMOD1;SNX9
prerank,oxoacid metabolic process (GO:0043436),0.26259630820057783,0.5698940157369767,0.9170731707317074,1.0,1.0,6/27,21.15%,PPA1;AGXT;ENPP1;THAP4;BPNT1;DDO
prerank,cellular response to oxygen-containing compound (GO:1901701),0.23789409033706838,0.5693890353478647,0.999,1.0,1.0,55/291,19.63%,HMGB2;AQP1;ATP2B4;SETX;TICAM1;ROCK2;RHOA;ABCB4;MAPT;LCOR;PDGFRA;SERPINE1;CDK2;CD80;AGAP3;HTRA2;WNT6;HMGB1;P2RY1;IP6K2;AHR;AKAP9;EZR;RORA;WNT9A;DMTN;SOX9;SLC38A9;ADAM9;PRKD1;GLRA2;RUVBL2;RAMP3;RPTOR;LPL;ADCY6;SFRP1;PKD2;NFKB1;IPO5;SESN2;LARS1;LAMTOR3;AXL;PTPRK;SIRPA;EPHA3;LAMTOR5;DPEP1;MAPK14;PLAA;ADNP2;CD68;PRKCD;DAPK1
prerank,negative regulation of cell adhesion (GO:0007162),0.24096561775509895,0.5691716203853955,0.9422268907563025,1.0,1.0,18/72,20.27%,RHOA;PDE3B;SERPINE1;RIPOR2;ANGPT1;PLXNB2;PLXNB1;DSCAM;DMTN;PLXND1;MIA3;NF2;TBCD;SIPA1;PLXNA2;FBLN1;PLXNB3;SEMA5A
prerank,smooth muscle cell differentiation (GO:0051145),0.28175469627846855,0.5691425303242076,0.9045454545454545,1.0,1.0,3/12,13.69%,TBX18;MRTFA;HEY2
prerank,actin-myosin filament sliding (GO:0033275),0.25625864129943143,0.569114101166237,0.9129438717067583,1.0,1.0,4/38,16.68%,TPM4;MYH2;DES;TNNT3
prerank,muscle filament sliding (GO:0030049),0.25625864129943143,0.569114101166237,0.9129438717067583,1.0,1.0,4/38,16.68%,TPM4;MYH2;DES;TNNT3
prerank,protein kinase B signaling (GO:0043491),0.2647067229207777,0.5688242153587538,0.9245049504950495,1.0,1.0,1/23,2.61%,SETX
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.24203395652840057,0.5687287094500724,0.9588900308324769,1.0,1.0,14/90,14.38%,MFAP2;LEPR;CXCR4;IL18;ZBTB7B;MFN2;ALMS1;APPL2;ACHE;GJA1;ADIPOR1;ADRB2;CPT2;ACADL
prerank,positive regulation of cell projection organization (GO:0031346),0.2429813199112191,0.5681358654908959,0.971252566735113,1.0,1.0,27/115,19.09%,SETX;RHOA;OBSL1;CUX1;CAPRIN1;ROBO1;MARK2;ARHGAP35;CAMK1D;PLXNB2;PLXNB1;GRIP1;TWF1;ROR1;P3H1;DPYSL3;PLXND1;PRKCI;PRKD1;MAP6;STMN2;NGF;EPHA3;ARSB;AMIGO1;PLXNA2;CAPRIN2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.28252350527402503,0.5678857689803195,0.9099099099099099,1.0,1.0,4/12,16.02%,KLF9;CTSH;MED1;BRD8
prerank,JNK cascade (GO:0007254),0.24803484195444944,0.5674271094715788,0.9365798414496036,1.0,1.0,6/40,11.44%,MAP4K2;SH2D3C;TAB1;UBE2N;IKBKG;CRKL
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.2739871762576449,0.5671068155481248,0.912258064516129,1.0,1.0,5/21,18.52%,CGNL1;MFN2;MAPKAP1;RASAL3;LZTR1
prerank,multivesicular body organization (GO:0036257),0.25272059218694376,0.5668752035224092,0.9293413173652695,1.0,1.0,4/31,10.87%,VPS37B;VPS37A;STAM;VTA1
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.1900667927359515,-0.5663603442256362,0.9778761061946902,0.9860926465616044,1.0,2/20,9.23%,AKR1B1;FDX1
prerank,Rap protein signal transduction (GO:0032486),0.2948690141483072,0.5655914187410722,0.9162929745889388,1.0,1.0,2/10,13.82%,RAP2A;PLK2
prerank,organophosphate biosynthetic process (GO:0090407),0.2523857698476357,0.5655727677705755,0.9038461538461539,1.0,1.0,10/37,20.54%,LPCAT1;IPMK;PPIP5K1;TKT;IP6K2;AGPAT3;GK5;GK;GPHN;MOCOS
prerank,negative regulation of dephosphorylation (GO:0035305),-0.19722242413854507,-0.5654879386529252,0.9673469387755103,0.9856438936131571,1.0,6/18,24.87%,PPP1R16B;INPP5K;SH3RF2;URI1;YWHAB;MFHAS1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.26623382874226215,0.5654811363839128,0.9133663366336634,1.0,1.0,3/22,14.40%,WNK1;FLOT2;CD44
prerank,metanephric mesenchyme development (GO:0072075),0.30178001784917285,0.5652882074732235,0.8942457231726283,1.0,1.0,3/10,19.08%,PKD2;OSR1;WNT4
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.2929798346319015,0.5648498067849644,0.893353941267388,1.0,1.0,3/11,20.66%,AHR;IL4I1;CEACAM1
prerank,mitochondrion morphogenesis (GO:0070584),-0.22544835240133587,-0.5647739983525241,0.9671641791044776,0.9851260645392546,1.0,2/11,12.45%,FIS1;SUPV3L1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.26146379506161604,0.5644662063086088,0.92625,1.0,1.0,7/28,17.14%,TAB1;UBE2N;IKBKG;CASP8;ITCH;AAMP;LACC1
prerank,positive regulation of leukocyte migration (GO:0002687),0.25649671684069375,0.5643581280008214,0.9257907542579076,1.0,1.0,3/27,14.06%,ADAM17;PLVAP;MIA3
prerank,protein polyglutamylation (GO:0018095),0.29086043482744006,0.5642105545243431,0.9086826347305389,1.0,1.0,2/11,12.29%,TTLL4;TTLL11
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.2520255977683472,0.5639409640603252,0.9357798165137615,1.0,1.0,6/39,18.50%,GCK;TCF7L2;MCU;AACS;NLGN2;BAD
prerank,histone H3-K36 demethylation (GO:0070544),0.2952767920040196,0.5635368457081674,0.8905325443786982,1.0,1.0,3/10,21.51%,KDM2B;KDM4B;KDM2A
prerank,dendrite self-avoidance (GO:0070593),0.2738604570278276,0.5633757628292565,0.908,1.0,1.0,3/16,11.93%,DSCAML1;DSCAM;EMB
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.21284540591451706,-0.5628575685691851,0.9470404984423676,0.9850415293493839,1.0,2/12,9.23%,AKR1B1;FDX1
prerank,regulation of neuron projection development (GO:0010975),0.2378703506199249,0.5628515149732691,0.9789156626506024,1.0,1.0,37/163,17.85%,SETX;ULK4;GSK3B;LPAR1;RTN4R;RAB29;EPHA4;LRRK2;DENND5A;MARK2;ARHGAP35;CAMK1D;PLXNB2;LZTS3;TWF1;PTPRS;BAG5;ROR1;GAK;P3H1;DPYSL3;PDLIM5;ZDHHC15;HDAC2;PRKCI;PRKD1;EFNB2;ADCY6;DBN1;PTEN;STMN2;SIPA1L1;EPHA3;ARSB;ABI2;TRPV4;MYLIP
prerank,lipid biosynthetic process (GO:0008610),0.2407209130686936,0.5624876076946,0.9434554973821989,1.0,1.0,10/77,15.09%,PAM;LPCAT1;NDUFAB1;AGPS;ACACA;AGPAT3;MVK;ELOVL4;LPL;FDXR
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.272102581805657,0.5624657320882945,0.9089673913043478,1.0,1.0,2/17,9.77%,SERPINE1;HMGB1
prerank,regulation of histone methylation (GO:0031060),0.2839656811677197,0.5621636990337558,0.896551724137931,1.0,1.0,1/13,5.54%,MTHFR
prerank,transcription preinitiation complex assembly (GO:0070897),0.28124485025216805,0.5618598229225916,0.9194729136163983,1.0,1.0,4/12,21.67%,TAF12;DR1;GTF2B;GTF2A2
prerank,positive regulation of chemokine production (GO:0032722),0.2505182637779829,0.5616290294146673,0.9349775784753364,1.0,1.0,12/44,26.03%,IL18;HMGB1;ADAM17;TWIST1;LPL;MAVS;EIF2AK2;IL6R;TLR7;MBP;IL33;WNT5A
prerank,metal ion export (GO:0070839),0.25538891728477203,0.5615098121773692,0.9252669039145908,1.0,1.0,1/31,2.13%,ATP2B4
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.22209878078877066,-0.5605447165345973,0.9772727272727273,0.9851034879360071,1.0,8/11,47.47%,BCL2;TAF9B;CD74;MIF;TAF9;TRIAP1;MUC1;SIRT1
prerank,fatty acid metabolic process (GO:0006631),0.2381990885316164,0.5604789641773755,0.9663265306122449,1.0,1.0,11/115,15.31%,PON1;ECHDC3;LPIN2;NDUFAB1;ACACA;ADIPOR1;ACOT2;CPT2;ELOVL4;LPL;PON2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.2454198944548244,0.5604244993580715,0.9294245385450597,1.0,1.0,9/54,15.27%,ATP2B4;ANGPT4;ANGPT1;HMGB1;PRKCA;PDPK1;ADAM17;PRKD1;PRKD2
prerank,regulation of autophagosome assembly (GO:2000785),0.252626737619367,0.5599160994543484,0.9303944315545244,1.0,1.0,10/33,18.89%,SH3GLB1;LRRK2;NPRL3;TMEM39A;SCFD1;MTMR3;PIKFYVE;CHMP4A;CHMP4B;TBC1D12
prerank,positive regulation of interleukin-8 production (GO:0032757),0.24690454574838605,0.5597319269305872,0.9351230425055929,1.0,1.0,8/49,18.70%,FADD;SERPINE1;HMGB1;RAB1A;PRKD2;MAVS;LAMTOR5;RIPK1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.26011371717145954,0.5579786794494689,0.9307411907654921,1.0,1.0,10/28,26.76%,ITPR1;TNFRSF10B;QRICH1;TMEM117;DNAJC10;TRAF2;DAB2IP;BAX;TRIB3;BAG6
prerank,regulation of defense response (GO:0031347),0.23371626845179178,0.5575253824518109,0.9563409563409564,1.0,1.0,12/76,14.00%,SETD6;USP18;AKNA;IRF1;NLRP6;ANXA1;APPL2;DAGLB;CASP8;BRD4;IL1RL2;XIAP
prerank,regulation of cell communication (GO:0010646),0.252587450710212,0.5571016959070981,0.9352601156069364,1.0,1.0,10/35,20.76%,NCLN;GRK5;SLC8A1;ANXA1;TBX18;GRK3;VEPH1;PTPN1;UGCG;CDC42SE2
prerank,purine ribonucleotide metabolic process (GO:0009150),0.24018107294418187,0.5570974643840728,0.9475374732334048,1.0,1.0,14/68,20.81%,HPRT1;ACAT1;EFL1;LRRK2;RHOQ;HINT1;ENPP1;GNAI3;ACOT2;MFN1;BPNT1;BAD;ADSS2;ACOT8
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.26671667623955975,0.5563520010436576,0.9311639549436797,1.0,1.0,4/22,17.14%,TRPM4;TRIM6;BTK;LACC1
prerank,positive regulation of neurogenesis (GO:0050769),0.24123528874936903,0.55635018786161,0.9471458773784355,1.0,1.0,15/68,19.83%,NAP1L1;RHOA;OBSL1;CUX1;CAPRIN1;ROBO1;PLXNB2;PLXNB1;PLXND1;MAP6;NGF;AMIGO1;PLXNA2;CAPRIN2;PLXNB3
prerank,positive regulation of lipid storage (GO:0010884),0.26580312546438145,0.5557005782810364,0.9264516129032258,1.0,1.0,4/21,15.53%,PLIN2;EHD1;LPL;NFKB1
prerank,neutrophil degranulation (GO:0043312),0.2337889815092357,0.5551476149224734,0.997,1.0,1.0,77/425,19.72%,IQGAP2;HPSE;DSN1;MMP25;RHOA;ANXA2;PSMC2;PTGES2;B4GALT1;STK10;RAB10;GPI;DIAPH1;UBR4;LPCAT1;ANXA3;PDXK;CNN2;AGL;ATG7;PYGB;PLAU;QSOX1;STXBP2;PSMB1;PGM1;AGPAT2;MAGT1;PSMD14;CDA;ROCK1;PSMD1;CYBB;HMGB1;ARMC8;APAF1;TRPM2;RAC1;PLEKHO2;GYG1;TXNDC5;ILF2;CTSH;PLAUR;NAPRT;TOM1;CAB39;PRDX4;GSDMD;CD44;CYSTM1;ITGAV;FAF2;VAPA;SLC15A4;CKAP4;NFKB1;SNAP23;COMMD3;GGH;LAMTOR3;SIRPA;AP1M1;ARSB;MVP;CD47;DNAJC5;CFP;NRAS;MAPK14;PSMB7;CD68;CAND1;PYGL;PRKCD;RAB3A;PSMD11
prerank,regulation of mast cell degranulation (GO:0043304),-0.20764239201151918,-0.5550678911841652,0.9784172661870504,0.9863046050651063,1.0,7/14,31.74%,LYN;LGALS9;CD84;CD300A;SYK;FES;SPHK2
prerank,cellular response to lipopolysaccharide (GO:0071222),0.23610910988112294,0.5546562037125815,0.9671457905544147,1.0,1.0,17/101,20.28%,HMGB2;TICAM1;RHOA;IL18;SERPINE1;CD80;HMGB1;PRKCE;ADAM9;NFKB1;AXL;SIRPA;MAPK14;PLAA;CD68;PDE4B;TRAF6
prerank,regulation of cellular biosynthetic process (GO:0031326),0.25819660674214795,0.5545596512020358,0.9251269035532995,1.0,1.0,6/28,17.51%,FGFR4;RAC1;ADIPOR1;MED1;SIRPA;CD47
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.2775468168674974,0.5543211965272679,0.921595598349381,1.0,1.0,2/15,9.57%,RAB10;SRPRA
prerank,oligodendrocyte development (GO:0014003),0.27358854480069955,0.5541822877271453,0.9175824175824175,1.0,1.0,3/15,15.34%,EIF2B1;TPPP;PRDM8
prerank,integrated stress response signaling (GO:0140467),0.2776179293307147,0.5539060650651211,0.9265927977839336,1.0,1.0,2/14,11.42%,EIF2AK3;QRICH1
prerank,positive regulation of phosphorylation (GO:0042327),0.2315767810643561,0.5535616116505975,0.9879759519038076,1.0,1.0,46/240,18.83%,FNIP1;PFKFB1;ROCK2;FGFR4;FGFR2;KIT;MRE11;RAP2A;LEPR;MUSK;PDGFRA;ARRB1;FMR1;EFNA1;CCN1;EPHA4;LRRK2;AXIN2;ANGPT1;ZBTB20;DDR2;RB1CC1;P2RY1;DSCAM;CRKL;BMP2;RAC1;ROR1;KCTD20;ADAM17;SOX9;PLAUR;SLCO3A1;ARNT;WDFY2;BTBD10;PIN1;FXR1;LMO4;AXL;EPHA3;MAVS;KRAS;LIMK2;RIPK1;RAD50
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.2494479369581966,0.5534924501929177,0.9471264367816092,1.0,1.0,11/38,23.27%,TRIM59;RIOK3;RORA;CASP8;PER1;OTUD7B;RIPK1;PPM1A;TANK;RHOH;DAB2IP
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.27258994416744003,0.5530727948471248,0.9122807017543859,1.0,1.0,8/17,26.54%,BMP6;PRKCA;TRIM5;TRIB1;NFKBIL1;SASH1;LY96;CD55
prerank,amino acid transmembrane transport (GO:0003333),0.24242103429974388,0.5530664718328161,0.9386160714285714,1.0,1.0,11/45,21.75%,SLC38A7;TSPO2;SLC38A4;SLC16A2;SLC38A9;SLC25A22;SLC36A4;SLC7A1;SLC38A2;SLC7A11;SLC6A13
prerank,neutrophil activation involved in immune response (GO:0002283),0.2328925331201366,0.5529149303024768,0.998,1.0,1.0,77/428,19.72%,IQGAP2;HPSE;DSN1;MMP25;RHOA;ANXA2;PSMC2;PTGES2;B4GALT1;STK10;RAB10;GPI;DIAPH1;UBR4;LPCAT1;ANXA3;PDXK;CNN2;AGL;ATG7;PYGB;PLAU;QSOX1;STXBP2;PSMB1;PGM1;AGPAT2;MAGT1;PSMD14;CDA;ROCK1;PSMD1;CYBB;HMGB1;ARMC8;APAF1;TRPM2;RAC1;PLEKHO2;GYG1;TXNDC5;ILF2;CTSH;PLAUR;NAPRT;TOM1;CAB39;PRDX4;GSDMD;CD44;CYSTM1;ITGAV;FAF2;VAPA;SLC15A4;CKAP4;NFKB1;SNAP23;COMMD3;GGH;LAMTOR3;SIRPA;AP1M1;ARSB;MVP;CD47;DNAJC5;CFP;NRAS;MAPK14;PSMB7;CD68;CAND1;PYGL;PRKCD;RAB3A;PSMD11
prerank,regulation of cellular pH (GO:0030641),0.2581190026540111,0.5527064949201148,0.936969696969697,1.0,1.0,5/29,17.47%,SLC4A2;SLC9A5;CA2;LACC1;TM9SF4
prerank,positive regulation of interferon-gamma production (GO:0032729),0.2417483869553109,0.5521374255710693,0.9473106476399561,1.0,1.0,3/48,7.44%,FADD;IL18;SCRIB
prerank,cranial nerve development (GO:0021545),0.28497897181595633,0.5521086481879283,0.9292786421499293,1.0,1.0,11/11,71.52%,SALL1;PAX2;ATOH7;ISL1;TIFAB;POU4F1;TFAP2A;CHRNB2;TMEM126A;CHD7;ERBB3
prerank,sphingolipid catabolic process (GO:0030149),0.2770834257391994,0.5516157599527471,0.9306518723994452,1.0,1.0,5/15,21.05%,ENPP2;SMPDL3A;SMPD1;SMPD2;PDXDC1
prerank,response to thyroid hormone (GO:0097066),0.27311381288436704,0.5511973877025178,0.9239766081871345,1.0,1.0,4/13,16.02%,KLF9;CTSH;MED1;BRD8
prerank,positive regulation of sodium ion transport (GO:0010765),-0.2145667292014106,-0.5511616793649166,0.9773462783171522,0.9867690038605414,1.0,6/12,32.32%,SCN1B;NOS1;SCN4B;PKP2;GPD1L;SCN3B
prerank,AMP metabolic process (GO:0046033),0.27656427146811724,0.5506237185955172,0.9118881118881119,1.0,1.0,2/13,11.46%,XDH;ADSL
prerank,protein lipidation (GO:0006497),0.24028394055194088,0.5505423633126753,0.9437229437229437,1.0,1.0,18/59,23.07%,PIGN;PIGA;ATG7;PORCN;ZDHHC18;PIGU;ZDHHC15;HHAT;PIGM;ZDHHC3;ZDHHC21;UGCG;DPM3;PIGG;PIGH;ATG5;ZDHHC2;ZDHHC14
prerank,positive regulation of actin filament polymerization (GO:0030838),0.24116884785326642,0.5498331058997042,0.9429530201342282,1.0,1.0,12/44,23.90%,CDC42EP2;NCK1;NCK2;BAIAP2L1;PRKCE;NCKAP1;WHAMM;FER;VASP;LMOD1;SNX9;CDC42EP1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.26357112241689507,0.5493653247384647,0.9325551232166018,1.0,1.0,2/19,7.46%,DHX9;SETD2
prerank,innate immune response (GO:0045087),0.23135874795668138,0.548946951273808,0.993,1.0,1.0,29/217,18.98%,TRIML2;STYK1;COLEC12;RNASE6;TRIM59;PML;TTC4;SETD2;TRIM28;CYBB;SKP2;HMGB1;IKBKG;CAPZA1;SRPK1;PYDC1;TRIM6;BTK;SMPD1;TRIM5;SRC;AKAP1;TNK2;MAVS;SRPK2;CFP;ANKRD17;SP100;RELB
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.2591417776135779,0.5488353472224993,0.9414012738853503,1.0,1.0,5/22,17.08%,ACAP2;MAPT;EHD1;STMN2;NGF
prerank,neutrophil mediated immunity (GO:0002446),0.23103617438132698,0.5484407539177601,0.998,1.0,1.0,78/432,19.72%,IQGAP2;HPSE;DSN1;MMP25;RHOA;ANXA2;PSMC2;PTGES2;B4GALT1;STK10;RAB10;GPI;DIAPH1;UBR4;LPCAT1;ANXA3;PDXK;CNN2;AGL;ATG7;PYGB;PLAU;QSOX1;STXBP2;PSMB1;PGM1;AGPAT2;MAGT1;PSMD14;CDA;ROCK1;PSMD1;CYBB;HMGB1;ARMC8;APAF1;TRPM2;RAC1;PLEKHO2;ADAM17;GYG1;TXNDC5;ILF2;CTSH;PLAUR;NAPRT;TOM1;CAB39;PRDX4;GSDMD;CD44;CYSTM1;ITGAV;FAF2;VAPA;SLC15A4;CKAP4;NFKB1;SNAP23;COMMD3;GGH;LAMTOR3;SIRPA;AP1M1;ARSB;MVP;CD47;DNAJC5;CFP;NRAS;MAPK14;PSMB7;CD68;CAND1;PYGL;PRKCD;RAB3A;PSMD11
prerank,triglyceride metabolic process (GO:0006641),0.2458499913174041,0.5482310416072358,0.9471947194719472,1.0,1.0,6/48,17.63%,FABP12;LPIN2;AGMO;LPL;GK5;GK
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.24018384398639286,0.5482128643872641,0.9549945115257958,1.0,1.0,4/52,10.57%,DDX11;HDGF;SRPRA;TLN1
prerank,regulation of cell differentiation (GO:0045595),0.2319972290156817,0.54759914920727,0.9858442871587462,1.0,1.0,19/148,17.12%,CDK5RAP2;TCFL5;CBFB;SUZ12;FGFR2;ANP32B;SRF;VHL;ROCK1;FLOT2;TGFBR1;PRKCB;HEY2;GDNF;RUNX1;OCIAD1;NGF;CCN2;EPHA3
prerank,regulation of response to interferon-gamma (GO:0060330),0.273425541715213,0.5462759768707032,0.9177304964539007,1.0,1.0,2/14,10.56%,PTPN2;PARP9
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.27062852539949167,0.5456594947854027,0.9329608938547486,1.0,1.0,4/14,20.93%,TNFRSF10B;ZFP91;TRAF6;TRAF2
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.16929393136063334,-0.545475327679186,0.9946524064171123,0.9878166502644435,1.0,2/23,8.51%,CALM1;NMT1
prerank,regulation of urine volume (GO:0035809),0.28649000491167537,0.5450995581557485,0.9319213313161876,1.0,1.0,2/10,15.22%,NPR3;ADCY6
prerank,vitamin transport (GO:0051180),0.24718028516394103,0.5448784849562762,0.9376498800959233,1.0,1.0,2/29,6.13%,PDPN;SLC19A1
prerank,cell part morphogenesis (GO:0032990),0.2738823464373819,0.5442090547851697,0.9313304721030042,1.0,1.0,4/13,23.48%,PACSIN2;PNPT1;DNM1L;WASF1
prerank,positive regulation of nervous system process (GO:0031646),0.262710979403281,0.5441830614099089,0.9501965923984272,1.0,1.0,4/18,18.74%,ATPSCKMT;TPPP;NLGN2;EGR2
prerank,aminoglycan metabolic process (GO:0006022),-0.2264784896882827,-0.5441115940551,0.9588235294117647,0.9874051689697027,1.0,7/10,35.99%,CHST9;B3GAT2;XYLT2;B3GAT1;B3GAT3;CLN6;B3GALT6
prerank,negative regulation of axonogenesis (GO:0050771),0.257999711763475,0.5438244888816222,0.9441747572815534,1.0,1.0,5/27,16.13%,RHOA;RTN4R;PTPRS;ULK2;PTEN
prerank,adenine nucleotide transport (GO:0051503),0.2645010720030624,0.5437395352814053,0.934156378600823,1.0,1.0,5/17,19.47%,SLC19A1;SLC25A42;LRRC8C;SLC25A17;SLC25A5
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.22308366151650777,-0.5436759538450127,0.9554317548746518,0.9867250380954634,1.0,3/10,19.58%,GAP43;PICK1;DGKD
prerank,neuronal action potential (GO:0019228),0.25272295457783434,0.5436146403325122,0.9299123904881101,1.0,1.0,6/22,20.51%,KCNMB2;KCNMB3;KCNMB4;KCNA1;CACNA1G;ANK3
prerank,camera-type eye morphogenesis (GO:0048593),0.2825982226806349,0.5428868383570026,0.9214501510574018,1.0,1.0,3/10,19.48%,KDM2B;SHROOM2;SKI
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.27640775488135044,0.5423379428164404,0.9202363367799113,1.0,1.0,1/12,5.22%,B3GNT8
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2287920730228993,0.5421779637533907,0.9778225806451613,1.0,1.0,13/140,12.68%,LPAR3;LPAR1;IAPP;CXCR4;PDGFRA;BDKRB2;SLC8A1;HMGB1;CACNA1C;P2RY1;ITPR3;TRPM4;C1QTNF1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.27827288622397806,0.5421610233143398,0.9367469879518072,1.0,1.0,2/10,13.71%,NUMA1;MED1
prerank,pyruvate metabolic process (GO:0006090),0.23793315999397074,0.5418508204384423,0.9508733624454149,1.0,1.0,5/52,11.92%,PFKFB1;GCK;GPI;PGM1;HOGA1
prerank,sphingolipid biosynthetic process (GO:0030148),0.23265066658005065,0.5415189861765559,0.9581545064377682,1.0,1.0,13/71,15.27%,CERS6;CERS5;LARGE1;ST3GAL5;PLPP1;CSNK1G2;AGK;PRKD1;ELOVL4;SMPD1;SPTLC2;VAPA;PRKD2
prerank,integrin-mediated signaling pathway (GO:0007229),0.2293416925051016,0.54093659141377,0.9620253164556962,1.0,1.0,22/73,22.27%,ITGB7;CUL3;DOCK1;ADAM9;ADAMTS1;PRKD1;ITGA5;ITGB1;PTPRA;ITGAV;SRC;ITGB8;RCC2;FERMT3;CD47;FBLN1;CEACAM1;ITGBL1;FERMT2;ISG15;ITGA11;MYH9
prerank,Golgi to plasma membrane transport (GO:0006893),0.2369756182079887,0.5407978377422025,0.9462129527991219,1.0,1.0,3/47,4.25%,MACF1;RAB10;EXOC4
prerank,ovarian follicle development (GO:0001541),0.27171538876712603,0.5407072634499864,0.9370529327610873,1.0,1.0,1/13,4.65%,KIT
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.22854297898792844,0.5407013093616994,0.9723643807574207,1.0,1.0,30/94,25.03%,PSMC2;PSMD5;TAB1;UBE2N;PSMB1;PSMD14;MAP3K3;PSMD1;IKBKG;PSMB9;FBXW11;BTRC;PSMC6;NFKB1;PSMB2;MAP3K8;PSME4;PSMB7;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;PSMB8;PSMD4;PSMF1;RIPK2;PSMA5;RELA;PSMC3
prerank,peptidyl-amino acid modification (GO:0018193),0.2805516664048375,0.5403920686893611,0.9327217125382263,1.0,1.0,2/10,17.78%,TTLL4;METAP1
prerank,cellular response to heat (GO:0034605),0.24012199969874143,0.5395165415557228,0.9601406799531067,1.0,1.0,4/35,8.37%,MAPT;TPR;RBBP7;HTRA2
prerank,cellular response to catecholamine stimulus (GO:0071870),0.25147293651056574,0.5392201060912645,0.9442282749675746,1.0,1.0,7/23,21.97%,ATP2B4;LRRK2;ADCY6;PDE4B;SNCA;SIRT2;GNB1
prerank,GPI anchor biosynthetic process (GO:0006506),0.24624633471489082,0.5391969246743741,0.950354609929078,1.0,1.0,9/30,22.17%,PIGN;PIGA;PIGU;PIGT;PIGM;DPM3;PIGG;GPAA1;PIGH
prerank,osteoclast differentiation (GO:0030316),0.25133063635627995,0.5391863237413705,0.9398976982097187,1.0,1.0,5/22,22.12%,ANXA2;SRC;FOXP1;MAPK14;GAB2
prerank,cellular protein metabolic process (GO:0044267),0.2262068218154642,0.5388988102516847,0.999,1.0,1.0,50/396,16.24%,MRPL36;TGM1;MATN3;F5;UBE2S;LOXL2;LOX;PABPC4;AGO2;GGCX;FBN1;LAMB1;CHEK2;PRKDC;SRBD1;ST8SIA2;SIAH2;MRPL18;STOML2;PHKA2;CCN1;QSOX1;B4GALT7;HTRA2;DARS1;DUSP12;RPN2;MRPL13;ASMT;TTF1;MRPL55;APLP2;NAGPA;SEPHS1;ADAM17;ATG3;RPS17;CTSH;MRPS33;MRPS18B;MIA3;ST3GAL1;UBL5;FDXR;CKAP4;PLOD2;PRSS23;LMCD1;ATP23;NOTUM
prerank,negative regulation of reproductive process (GO:2000242),0.2600398328349246,0.5388768956943767,0.9391891891891891,1.0,1.0,2/17,12.58%,SULF1;GJA1
prerank,peptide hormone secretion (GO:0030072),0.24954859585749878,0.5381247799837158,0.9381188118811881,1.0,1.0,3/26,14.71%,RAB1A;ANXA1;SNX19
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.2313490096763398,0.5377944131339333,0.9600886917960089,1.0,1.0,10/52,17.79%,ATP2B4;RANGRF;PDPK1;PRKCE;PRKCI;DLG1;ITGB1;RAMP3;EPHA3;WNK3
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.25473396547813976,0.5369906458151495,0.9246913580246914,1.0,1.0,4/23,12.96%,NMI;UACA;CCN3;ADIPOR1
prerank,positive regulation of signaling (GO:0023056),0.24344184632389432,0.5366796005617744,0.9502314814814815,1.0,1.0,4/37,8.13%,ANXA2;SCRIB;RAB29;CD80
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.27428468991833205,0.5366405839160867,0.9301994301994302,1.0,1.0,6/13,23.44%,PLXNB2;PLXNB1;PLXND1;PLXNA2;PLXNB3;PLXNA1
prerank,negative regulation of defense response (GO:0031348),0.23012970732529567,0.5364338626956316,0.9728033472803347,1.0,1.0,9/77,13.44%,RB1;NMI;PTPN2;ENPP3;CCN3;ILRUN;RORA;ITCH;MVK
prerank,cellular response to amino acid stimulus (GO:0071230),0.24161625419071567,0.5359855584048514,0.9588235294117647,1.0,1.0,10/33,17.52%,KLHL22;SESN1;SLC38A9;GLRA2;RPTOR;IPO5;SESN2;LARS1;LAMTOR3;LAMTOR5
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.2249609893393091,0.5355805849254176,0.9673802242609582,1.0,1.0,14/110,17.46%,LPAR3;LPAR1;IAPP;ADGRL1;GNA13;GNAQ;S1PR2;ABCA1;ADGRG2;ADRB2;RAMP3;ADCY6;ADGRD1;ADCY2
prerank,alcohol catabolic process (GO:0046164),0.2830840613540683,0.5344398141787853,0.937888198757764,1.0,1.0,1/10,6.72%,SRD5A3
prerank,hexose metabolic process (GO:0019318),0.24095225255045571,0.5344335365049158,0.9502314814814815,1.0,1.0,3/39,8.41%,CHST15;SORD;PGM1
prerank,negative regulation of cholesterol transport (GO:0032375),-0.22177024327775938,-0.5338981188041618,0.9614325068870524,0.9887688916620847,1.0,2/10,23.28%,SREBF2;ABCA2
prerank,T cell activation involved in immune response (GO:0002286),0.27143753923414926,0.5337359594788448,0.9464788732394366,1.0,1.0,12/12,72.88%,LCP1;TNFSF18;IFNK;F2RL1;ITGAL;ICAM1;MDK;LILRB1;EIF2AK4;SLC11A1;FCER1G;CD74
prerank,ribonucleoprotein complex assembly (GO:0022618),0.22451745437829476,0.5334634939757835,0.9828456104944501,1.0,1.0,24/132,18.34%,COIL;SETX;DHX9;PRKDC;SRSF10;EIF4H;DDX39B;RRS1;PRPF19;CELF2;SF3A2;SRPK1;PPAN;LUC7L3;DDX1;LSM4;MCTS1;DENR;PRPF18;GEMIN7;LUC7L2;SRPK2;ABT1;MRPL20
prerank,positive chemotaxis (GO:0050918),0.2603777026087104,0.5334314409113325,0.9450402144772118,1.0,1.0,4/17,20.27%,SCRIB;ANGPT1;PLXNB3;SEMA5A
prerank,response to hexose (GO:0009746),0.24563648582409786,0.5328037133524354,0.9360902255639098,1.0,1.0,2/25,6.59%,TCF7L2;EIF2B1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.24788765495110532,0.5321073323038199,0.9360100376411543,1.0,1.0,4/23,15.37%,AGT;GJA1;SOX9;GDNF
prerank,cellular response to glucagon stimulus (GO:0071377),0.25811830511342715,0.5318369046141798,0.9341935483870968,1.0,1.0,7/17,24.57%,ADCY6;CYSLTR2;PRKAR2B;ADCY2;PRKAR2A;PRKAR1A;PRKACA
prerank,regulation of ion transmembrane transport (GO:0034765),0.2423033170012235,0.5317581111533575,0.9543817527010804,1.0,1.0,4/33,11.55%,NEDD4;WNK1;KCNJ13;AKAP9
prerank,amyloid fibril formation (GO:1990000),0.23181893843042395,0.5317070973108035,0.9597765363128492,1.0,1.0,8/51,15.55%,TSPAN33;IAPP;SIAH2;MAPT;CALB1;USP9X;TSPAN5;HSPG2
prerank,macrophage differentiation (GO:0030225),0.26884673531949327,0.5317065333160965,0.9237536656891495,1.0,1.0,2/13,12.88%,CASP8;IL31RA
prerank,macroautophagy (GO:0016236),0.2234612053282642,0.5314185872257098,0.9795501022494888,1.0,1.0,35/118,23.18%,VPS37B;MTMR14;ATG7;VPS37A;STAM;MFN2;LIX1L;ZFYVE1;CSNK2A2;VIPAS39;RB1CC1;VTA1;ILRUN;ATG3;MTMR3;UVRAG;SRC;PRKAG1;MFN1;VPS16;CHMP4A;CHMP4B;PLAA;VPS39;PRKAB1;TOMM40;AMBRA1;LIX1;PGAM5;VPS37C;ATG13;ATG5;TOMM20;ATG4B;PRKAG3
prerank,positive regulation of viral transcription (GO:0050434),0.24162071221900566,0.5312631338701109,0.943558282208589,1.0,1.0,2/25,7.55%,DHX9;POLR2A
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.26600514724231367,0.530633754788255,0.9405797101449276,1.0,1.0,1/13,5.22%,B3GNT8
prerank,regulation of type I interferon production (GO:0032479),0.2259002348163856,0.530555181639676,0.9701030927835051,1.0,1.0,11/84,15.53%,POLA1;DHX9;PRKDC;MRE11;G3BP1;IRF1;POLR3D;ILRUN;ITCH;PIN1;NFKB1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.2568932979313563,0.529754743443062,0.9336941813261164,1.0,1.0,4/16,17.65%,PSIP1;WBP4;PRPF39;SFSWAP
prerank,regulation of superoxide anion generation (GO:0032928),0.2636296053428016,0.5286793403765827,0.9129834254143646,1.0,1.0,4/14,24.72%,MAPT;PRKCD;SOD1;TGFB1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.23583061928132668,0.5284614193493846,0.9516853932584269,1.0,1.0,7/48,16.45%,USP18;PTPN2;ROBO1;YTHDF2;PYDC1;CNOT7;METTL3
prerank,acute inflammatory response (GO:0002526),0.2464088626795939,0.5281562523297326,0.9482323232323232,1.0,1.0,1/23,4.28%,MYLK3
prerank,male gonad development (GO:0008584),0.24338884496651084,0.5267762380367433,0.9568764568764568,1.0,1.0,2/34,4.67%,KIT;WNT2B
prerank,membrane protein proteolysis (GO:0033619),0.23565283190872235,0.5263959144565178,0.9585253456221198,1.0,1.0,13/37,24.85%,SPPL2B;ADAM17;CTSH;ADAM19;ADAM9;NFKB1;TRAF6;RBMX;MYH9;NAPSA;RELA;TGFB1;SPPL3
prerank,protein catabolic process (GO:0030163),0.22721135727963468,0.5260786269753382,0.9546925566343042,1.0,1.0,9/59,15.08%,CHEK2;SIAH2;PRPF19;ADAMTS9;HTRA2;CUL4B;STT3B;FBXO27;FBXO17
prerank,negative regulation of lipid catabolic process (GO:0050995),0.2552867747457333,0.5259492953027887,0.9418282548476454,1.0,1.0,1/17,5.00%,PDE3B
prerank,muscle organ development (GO:0007517),0.2307531912308198,0.5247836418296336,0.9635584137191854,1.0,1.0,6/54,11.22%,LARGE1;SOX6;SGCE;EMD;SMTN;CHD2
prerank,protein K63-linked deubiquitination (GO:0070536),0.24014755319463008,0.5246577248134571,0.9562575941676792,1.0,1.0,11/31,24.74%,UIMC1;PSMD14;USP16;BRCC3;OTUD1;OTUD7B;USP20;ZRANB1;USP25;BABAM2;USP13
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.2324528237365839,0.5244612083351805,0.9487179487179487,1.0,1.0,11/41,23.60%,AFDN;PIEZO1;PLAUR;ADAM19;CD44;PTPRU;CD47;ANK3;DENND6A;GCNT2;PTPN23
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.2606013524064272,0.5243998233445086,0.9483240223463687,1.0,1.0,1/14,5.80%,NUDT5
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.24789629171142363,0.5239815920573813,0.9520807061790668,1.0,1.0,5/25,20.93%,KIT;TRIM6;LACC1;TRAF6;TRAF2
prerank,regulation of inflammatory response (GO:0050727),0.21722609679336516,0.5234383249033246,0.992992992992993,1.0,1.0,31/190,19.56%,SETD6;RB1;USP18;DHX9;NMI;PTPN2;IL18;AKNA;ENPP3;SERPINE1;AGT;NLRP6;ANXA1;CCN3;RORA;DAGLB;BRD4;MVK;IL1RL2;XIAP;LPL;SETD4;SIRPA;LACC1;FOXP1;CD47;PTGIS;RIPK1;DAGLA;IL16;PRKCD
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.22116885566151692,0.5232563242826785,0.9735169491525424,1.0,1.0,16/69,21.67%,INTS7;PHAX;POU2F1;POLR2A;INTS8;GTF2A1;RPRD1A;POU2F2;ZC3H8;RPRD1B;POLR2B;INTS4;ELL2;GTF2B;INTS13;GTF2A2
prerank,regulation of ERBB signaling pathway (GO:1901184),0.2551049077470534,0.522475767533139,0.9417613636363636,1.0,1.0,4/15,21.19%,WDR54;RBPJ;CEACAM1;FER
prerank,lysosome localization (GO:0032418),0.23454859657655158,0.5224449540407904,0.9564719358533792,1.0,1.0,7/37,19.68%,KIT;SPAG9;BORCS6;SYTL4;MAP6;KLC2;RAB3A
prerank,snRNA transcription (GO:0009301),0.22000911365612633,0.5201676530414798,0.9725158562367865,1.0,1.0,16/70,21.67%,INTS7;PHAX;POU2F1;POLR2A;INTS8;GTF2A1;RPRD1A;POU2F2;ZC3H8;RPRD1B;POLR2B;INTS4;ELL2;GTF2B;INTS13;GTF2A2
prerank,central nervous system development (GO:0007417),0.21780176594218767,0.5198590374035462,0.994,1.0,1.0,43/250,18.74%,PBX4;LOXL3;CDK5RAP2;PBX3;NFIB;BTD;ADGRA2;CXCR4;SOX6;GRHL2;NIPBL;UTP3;TPPP;DSCAML1;ZIC5;NR4A2;PLXNB2;DHX37;ATXN1;NKX2-1;ZIC4;SOX9;SH3GL3;TMX2;NES;CAPG;QARS1;PKD2;HSPG2;PTEN;ANKLE2;NCKAP1;ARNT2;JRKL;SLC6A17;WWP1;GRIN2D;SHROOM2;MAST1;AMIGO1;COL4A1;ZIC1;EGR2
prerank,melanosome organization (GO:0032438),0.23788126913894997,0.5196613173133737,0.9690210656753407,1.0,1.0,6/26,17.77%,RAB29;AP3B1;BLOC1S5;AP1M1;SHROOM2;PIKFYVE
prerank,glycoprotein biosynthetic process (GO:0009101),0.22169457920886493,0.5188662336452666,0.9728317659352143,1.0,1.0,14/79,18.87%,LARGE1;FUT10;ST8SIA2;B3GNT8;ST3GAL3;B4GALT7;ST3GAL5;FOXL1;ST3GAL4;ST3GAL2;B3GALT2;CHST10;XYLT1;GCNT1
prerank,regulation of biosynthetic process (GO:0009889),0.2666995586578471,0.5176527108845576,0.9426470588235294,1.0,1.0,3/11,23.26%,PIKFYVE;SNCA;SLC25A33
prerank,regulation of hormone secretion (GO:0046883),-0.18783262888791358,-0.5172963083838765,0.9900662251655629,0.992164931111719,1.0,6/15,34.02%,VAMP3;SCG5;EDN1;SOX11;EDN3;SNX6
prerank,arachidonic acid metabolic process (GO:0019369),0.23173401281781547,0.5168843975556371,0.9588719153936546,1.0,1.0,4/35,12.59%,PTGES2;HPGDS;PTGS1;DAGLB
prerank,positive regulation of neuron projection development (GO:0010976),0.22034461163021402,0.5155397645754511,0.9844398340248963,1.0,1.0,18/85,17.28%,SETX;CAPRIN1;MARK2;ARHGAP35;CAMK1D;PLXNB2;TWF1;ROR1;P3H1;DPYSL3;ZDHHC15;PRKCI;PRKD1;DBN1;STMN2;COBL;EPHA3;ARSB
prerank,melanosome localization (GO:0032400),0.24170945796721544,0.5153480538295981,0.9431524547803618,1.0,1.0,4/21,17.62%,MLPH;MKKS;BLOC1S5;SHROOM2
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.24260550897779315,0.5152061561969545,0.9525641025641025,1.0,1.0,5/20,16.29%,CARF;BMP2;RBPJ;SMAD4;SESN2
prerank,positive regulation of potassium ion transport (GO:0043268),0.22416699135734833,0.5151448661611361,0.9670828603859251,1.0,1.0,7/38,18.28%,KCNN4;KCNMB2;KCNMB3;DLG1;KCNMB4;GABBR2;AMIGO1
prerank,cellular response to chemokine (GO:1990869),0.2279824731583639,0.5145130327618869,0.9698660714285714,1.0,1.0,3/46,8.87%,RHOA;WNK1;RIPOR2
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.25880627054751715,0.5144724742227502,0.9462686567164179,1.0,1.0,1/11,9.66%,AGT
prerank,negative regulation of GTPase activity (GO:0034260),0.2460705965830996,0.5144696092550064,0.963302752293578,1.0,1.0,3/22,9.19%,WNK1;LRRK2;CPEB2
prerank,GPI anchor metabolic process (GO:0006505),0.24070711802357034,0.5144104965810263,0.9605425400739828,1.0,1.0,7/26,22.17%,PIGN;PIGA;PIGU;PIGM;DPM3;PIGG;PIGH
prerank,positive regulation of secretion by cell (GO:1903532),0.2202084528055592,0.5142346789415714,0.9658848614072495,1.0,1.0,10/70,13.73%,FRMD4A;STXBP5;MYH10;BMP6;BMP2;SYTL4;EZR;ACHE;PPID;ADAM9
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.2676193877282137,0.5125808076761375,0.9502262443438914,1.0,1.0,2/10,14.36%,ZNHIT3;RUVBL2
prerank,glutathione metabolic process (GO:0006749),0.2282963903027998,0.5121877242167483,0.9517241379310345,1.0,1.0,10/38,22.35%,GSS;HPGDS;GSTT1;DPEP1;GCLM;GSTM5;GCLC;HAGH;SOD1;GSTZ1
prerank,regulation of interferon-gamma production (GO:0032649),0.22025775194921632,0.5114371263173618,0.9799154334038055,1.0,1.0,12/71,21.10%,FADD;PRNP;IL18;SCRIB;HMGB1;AXL;SIRPA;CD47;HAVCR2;ZFPM1;PDE4B;ISG15
prerank,maturation of LSU-rRNA (GO:0000470),0.2332641737011434,0.5103715317805337,0.9503105590062112,1.0,1.0,5/26,15.83%,ZNHIT3;DDX18;MRPL1;MAK16;WDR12
prerank,regulation of interleukin-8 production (GO:0032677),0.22007867235016457,0.5078732616102983,0.9776833156216791,1.0,1.0,11/69,18.70%,FADD;ARRB1;SERPINE1;HMGB1;RAB1A;ANXA1;OTUD7B;PRKD2;MAVS;LAMTOR5;RIPK1
prerank,regulation of defense response to virus by host (GO:0050691),0.22977103132524995,0.5068001526919331,0.9647058823529412,1.0,1.0,4/30,17.44%,DHX9;PARP9;TRIM6;MAVS
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.2182347640436468,0.5056779224076409,0.9732739420935412,1.0,1.0,10/49,19.56%,BMF;RTKN2;BCLAF1;BOK;EIF2AK3;PLAUR;SRC;TP53;BAD;DNM1L
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.21437187457190568,0.5052793981814209,0.9888324873096447,1.0,1.0,23/138,17.12%,STYK1;FGFR4;FGFR2;KIT;FRS2;MUSK;PDGFRA;EPHA4;ABI1;BDKRB2;DDR2;PIK3CB;CLNK;ROR1;GUCY2C;IL31RA;POLR1G;PTPRU;SRC;TNK2;AXL;NGF;EPHA3
prerank,positive regulation of type I interferon production (GO:0032481),0.2165794435505177,0.5046701569901493,0.9736008447729673,1.0,1.0,8/73,10.02%,DHX9;PRKDC;MRE11;G3BP1;SETD2;IRF1;RIOK3;POLR3D
prerank,ceramide metabolic process (GO:0006672),0.2212883924303804,0.5042271240062599,0.9689922480620154,1.0,1.0,8/49,18.62%,CERS6;CERS5;PLPP1;AGK;SMPD1;SPTLC2;SMPD2;FA2H
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.2121972094545181,0.5033900539229631,0.9909365558912386,1.0,1.0,19/151,15.27%,FGFR4;FGFR2;GAREM1;PDGFRA;ARRB1;FBXW7;NPNT;ANGPT1;HMGB1;P2RY1;CRKL;BMP2;ROR1;PRKCA;NOTCH2;CD44;RAMP3;SLC30A10;PRKD2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.23769317307789156,0.5012799963327035,0.9447300771208226,1.0,1.0,3/20,15.01%,GSK3B;BOK;ITGAV
prerank,phosphate-containing compound metabolic process (GO:0006796),0.20999559300866663,0.5011687277082946,0.995995995995996,1.0,1.0,32/198,16.73%,PFKFB1;GCK;GPI;LHPP;OCRL;NUDT5;IPMK;PPP3CA;ENPP3;INPP5B;LRRK2;AGPAT2;LIMD1;PPA1;DUSP12;PPIP5K1;PIK3CB;ACYP2;ENPP1;IP6K2;PLPP1;AGK;NUDT4;PANK2;AGPAT1;TAOK1;LPL;PLCB4;PTEN;GK5;TNK2;GDE1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.25163234555499747,0.500893694717836,0.9411764705882353,1.0,1.0,14/14,74.86%,TRAF6;IFNG;POU4F2;IL23R;IL12B;TNFSF11;TNF;IL23A;OCSTAMP;CCR1;POU4F1;CSF1;TYROBP;ATP6AP1
prerank,glial cell differentiation (GO:0010001),0.2336156224442065,0.5008385855323788,0.963855421686747,1.0,1.0,4/28,12.75%,MMP24;NFIB;TPPP;SOX9
prerank,development of primary male sexual characteristics (GO:0046546),0.23034023014621116,0.500379584447195,0.9613583138173302,1.0,1.0,2/34,4.67%,KIT;WNT2B
prerank,cytosolic transport (GO:0016482),0.21349490575621033,0.49930460462898063,0.9856410256410256,1.0,1.0,21/108,19.85%,AP4M1;GBF1;SPAG9;SNX1;DENND2A;RAB29;ANKRD27;VPS13A;DENND5A;ERC1;GAK;VTI1A;GOSR1;SNX32;VPS26A;EPS15;RIC1;PIKFYVE;TBC1D10A;BET1L;MON2
prerank,cellular respiration (GO:0045333),0.224355581206382,0.49901304623248044,0.9674157303370786,1.0,1.0,3/41,7.03%,MTFR2;COX10;COQ10B
prerank,regulation of interleukin-12 production (GO:0032655),0.21898226529576584,0.498720365841731,0.9688542825361512,1.0,1.0,6/47,19.53%,MAST2;HMGB1;FOXP1;CD47;MAPK14;IL16
prerank,response to fatty acid (GO:0070542),0.23764372918766574,0.4986653006606112,0.9642857142857143,1.0,1.0,3/17,14.80%,FOXO3;SOX9;LPL
prerank,negative regulation of hormone secretion (GO:0046888),0.25830573587951955,0.4985826178317279,0.9509954058192955,1.0,1.0,1/10,12.58%,GJA1
prerank,acylglycerol biosynthetic process (GO:0046463),0.23376841737305248,0.4980869279245188,0.973384030418251,1.0,1.0,2/23,7.28%,LPIN2;AGMO
prerank,regulation of B cell activation (GO:0050864),0.2314614510321159,0.49784221149589475,0.9652605459057072,1.0,1.0,3/25,13.32%,SAMSN1;AHR;IL4I1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.23654725018838757,0.49780118155524533,0.9551681195516812,1.0,1.0,8/20,26.47%,SPPL2B;ADAM17;ADAM9;NFKB1;TRAF6;RELA;TGFB1;RHBDD1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.24233733620670006,0.49746740528297145,0.9689922480620154,1.0,1.0,3/20,13.45%,LYPD1;GNAQ;LY6H
prerank,negative regulation of protein localization to membrane (GO:1905476),0.2310654597173889,0.4970820984794327,0.9634760705289672,1.0,1.0,4/24,15.26%,RHOQ;PICALM;DMTN;LZTFL1
prerank,cellular response to starvation (GO:0009267),0.21066585039985217,0.49677349173863317,0.9919517102615694,1.0,1.0,28/147,17.96%,FNIP1;DAP;DEPDC5;HNRNPA1;STK24;ATG7;SH3GLB1;FOXO3;LRRK2;ZFYVE1;SESN1;NPRL3;EIF2AK3;SLC38A9;SIK2;PRKD1;ITFG2;RPTOR;MTMR3;SFRP1;PRKAG1;CLEC16A;TP53;SESN2;LARS1;LAMTOR3;LAMTOR5;SREBF1
prerank,second-messenger-mediated signaling (GO:0019932),0.21130918922970235,0.4953313940764321,0.9824198552223371,1.0,1.0,10/82,13.46%,CXCR4;LRRK2;MCU;AGT;SAMD14;EIF2AK3;PDPK1;TRPM4;BTK;NUDT4
prerank,maturation of SSU-rRNA (GO:0030490),0.22333024312628008,0.4925939227512302,0.9730679156908665,1.0,1.0,6/34,15.70%,UTP3;RIOK3;NOL11;DHX37;TSR1;HELB
prerank,stress-activated MAPK cascade (GO:0051403),0.21069411988078568,0.4923243149637114,0.9795479009687836,1.0,1.0,14/61,20.28%,MAP4K2;SH2D3C;TAB1;MAP3K20;UBE2N;IKBKG;CRKL;FBXW11;BTRC;NFKB1;MAP3K8;MAPK14;TRIB1;TRAF6
prerank,negative regulation of bone remodeling (GO:0046851),0.2557278262507063,0.49069816879939,0.9527896995708155,1.0,1.0,11/11,74.44%,SFRP1;UBASH3B;GPR137B;IL6;TMEM119;CARTPT;CALCA;GREM1;TNFAIP3;GPR137;P2RX7
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.23669166188481802,0.49052480380710645,0.9620915032679739,1.0,1.0,3/17,12.45%,SLC8A1;CACNA1C;TRPM4
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.22071764436206404,0.4902746146799307,0.9729411764705882,1.0,1.0,4/35,14.11%,PAM;ACAT1;ACACA;AACS
prerank,negative regulation of complement activation (GO:0045916),0.2534521717298519,0.4900294814863191,0.9739663093415007,1.0,1.0,10/10,74.67%,SUSD4;CD55;VSIG4;C4BPA;C4BPB;CD46;A2M;SERPING1;CR2;CR1L
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2050016202591839,0.48961984457811,0.992964824120603,1.0,1.0,17/152,15.22%,LPAR3;LPAR1;IAPP;ADGRL1;GNA13;GRK5;GNAQ;S1PR2;ABCA1;GLP2R;WASF2;GNAI3;ADGRG2;ADRB2;INSL3;RAMP3;ADCY6
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.22387243952742442,0.4896019190440422,0.9682539682539683,1.0,1.0,3/25,11.76%,DDX39B;SCAF8;HTATSF1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.2575216779038305,0.48951523773352235,0.9580209895052474,1.0,1.0,4/10,21.99%,TUT7;TUT4;ISG15;NEDD8
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.22872910692779053,0.4891585317133677,0.9644218551461246,1.0,1.0,4/21,13.73%,SPPL2B;ADAM17;ADAM19;ADAM9
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.228916021553541,0.48895528235296826,0.9629629629629629,1.0,1.0,7/26,23.38%,NMI;ILRUN;ITCH;TRIB1;SIRT2;PCBP2;NFKBIL1
prerank,positive regulation of response to external stimulus (GO:0032103),0.20544513683131396,0.48856703022923925,0.9898580121703854,1.0,1.0,25/128,23.02%,DHX9;NMI;BMP6;IL18;SERPINE1;RIOK3;PUM2;AGT;POLR3D;CNTF;PRKCA;AKIRIN2;LPL;SLC15A4;SETD4;CD47;ANKRD17;RIPK1;IL16;SNCA;POLR3C;OPTN;GPRC5B;TLR7;POLR3G
prerank,mammary gland epithelium development (GO:0061180),-0.1746344214125463,-0.48816138134035164,0.9895104895104895,0.997120378839954,1.0,2/14,8.53%,AKT2;ERBB4
prerank,response to cytokine (GO:0034097),0.2044465488675235,0.4878092781954089,0.9919436052366566,1.0,1.0,30/141,21.55%,RHOA;ALDH1A2;SRF;AFF3;CXCR4;PTPN2;PML;SETD2;ANXA1;PRKCA;DPYSL3;CASP8;MAPKAPK3;IL1RL2;ADAM9;SMPD1;SMAD3;PTPN13;SRC;IFNAR2;RIPK1;SP100;RELB;PTPN5;TRAF6;MAPKAPK2;SNCA;ISG15;EIF2AK2;HDAC4
prerank,metanephros development (GO:0001656),0.23212898285027325,0.48770080912550223,0.9697732997481109,1.0,1.0,5/26,18.35%,NIPBL;CTSH;PKD2;GDNF;OSR1
prerank,negative regulation of protein kinase activity (GO:0006469),0.20715881419692128,0.48720254467937535,0.9823284823284824,1.0,1.0,20/88,21.03%,RB1;CEP43;TAB1;WWTR1;GNAQ;SLC8A1;CEP85;PYDC1;PDPK1;LRP5;SPRED1;CDKN1B;QARS1;MVP;SH3BP5;PTPN1;TRIB1;CEACAM1;SNCA;UBASH3B
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.19050907036595316,-0.4867288372123565,0.9793103448275862,0.996510708498708,1.0,11/11,80.97%,P3H2;P4HA1;EGLN2;P4HA3;P4HTM;P4HA2;CRTAP;P4HB;EGLN3;EGLN1;OGFOD1
prerank,lytic vacuole organization (GO:0080171),0.21862492703190833,0.48603197699921324,0.9738717339667459,1.0,1.0,7/32,17.28%,LRRK2;VPS18;ABCA1;CLVS2;NAGPA;TPCN2;ARSB
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.23280639537895245,0.48594860922924543,0.9666666666666667,1.0,1.0,7/22,24.50%,PSMB1;PSMB9;PSMB2;PSME4;PSMB7;PSMB8;PSMA5
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.24323202329469368,0.48416647331147594,0.967741935483871,1.0,1.0,1/14,4.03%,DDRGK1
prerank,carnitine shuttle (GO:0006853),0.24657184195374376,0.48394524057661353,0.95,1.0,1.0,2/11,13.86%,ACACA;CPT2
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.22594646422946324,0.4836453588077356,0.9669211195928753,1.0,1.0,7/22,23.07%,ZDHHC18;ZDHHC15;ZDHHC3;ZDHHC21;ZDHHC24;ZDHHC2;ZDHHC14
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.22594646422946324,0.4836453588077356,0.9669211195928753,1.0,1.0,7/22,23.07%,ZDHHC18;ZDHHC15;ZDHHC3;ZDHHC21;ZDHHC24;ZDHHC2;ZDHHC14
prerank,positive regulation of TORC1 signaling (GO:1904263),0.23992346220316915,0.4835729813367741,0.9629629629629629,1.0,1.0,4/16,17.52%,KLHL22;CLEC16A;LARS1;LAMTOR5
prerank,ion transport (GO:0006811),0.20350607045712724,0.4831536792485687,0.9928861788617886,0.9998547681798443,1.0,11/111,12.23%,KCNN4;PLP2;SLC20A2;TRPA1;WNK1;SLC4A2;SLC9A5;SLC24A3;SLC8A1;PIEZO1;CHRNB1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.24337849847665854,0.48228251805786465,0.9648876404494382,0.9997906124493303,1.0,1/12,4.76%,IDH3A
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.25006639453432394,0.4815414407316324,0.9613601236476044,0.9996852848700166,1.0,3/11,20.51%,PRKCA;PLAUR;ANK3
prerank,negative regulation of signaling receptor activity (GO:2000272),0.22317266327522797,0.48153658588779735,0.9651022864019254,0.9992787566182144,1.0,4/25,18.29%,GPRC5A;ERRFI1;RAMP3;SLC6A9
prerank,autophagosome organization (GO:1905037),0.210357302398796,0.48057468317932606,0.9822419533851277,0.99927973828245,1.0,13/50,22.64%,ATG7;ATP2A2;RAB1A;RB1CC1;ULK2;ATG3;ATG2A;STX12;UBXN2B;TP53INP2;AMBRA1;ATG13;ATG5
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.20483482271831385,0.48026590291959914,0.986639260020555,0.999002964737708,1.0,15/95,20.28%,HMGB2;TICAM1;RHOA;SERPINE1;CD80;HMGB1;ADAM9;NFKB1;AXL;SIRPA;MAPK14;PLAA;CD68;PDE4B;TRAF6
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.2358362798671993,0.47928867129404135,0.9679218967921897,0.9989726839882818,1.0,5/16,22.43%,PDGFRA;PLAT;PTPN1;FER;PDGFA
prerank,superoxide metabolic process (GO:0006801),0.2187904000333227,0.477684053958809,0.9742331288343559,0.9991845487228423,1.0,5/29,17.26%,SOD3;NOX4;CYBB;SH3PXD2B;CCS
prerank,positive regulation of TOR signaling (GO:0032008),0.210374647704178,0.4776399694656127,0.9798657718120806,0.9987921963645218,1.0,8/40,17.52%,FNIP1;KLHL22;SLC38A9;RPTOR;CLEC16A;LARS1;LAMTOR3;LAMTOR5
prerank,inositol phosphate-mediated signaling (GO:0048016),0.23028433184015024,0.47746047938321684,0.9696569920844327,0.998452388814655,1.0,6/19,24.34%,PPP3CA;PPP3R1;NFATC3;INPP5A;HRH1;PPP3CB
prerank,female gonad development (GO:0008585),0.2275905816365702,0.47678921969073135,0.9628154050464808,0.998296415907184,1.0,1/19,4.65%,KIT
prerank,protein targeting (GO:0006605),0.20261514971407857,0.476662170219156,0.9939086294416244,0.9979362121608096,1.0,30/118,23.96%,TRAK1;VPS37B;AP4M1;FUT10;MYO1C;VPS37A;MFN2;SRPRA;ZDHHC18;CHM;ZDHHC15;ATG3;PRKCI;ZDHHC3;ZDHHC21;PIKFYVE;KIF13B;PEX12;ZDHHC24;TSPO;ICMT;TIMM23;TOMM40;VPS37C;SPCS3;TOMM20;ZDHHC2;ZDHHC14;TIMM10B;PITRM1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.2374534687650919,0.47140009356206897,0.972972972972973,0.9994420308198555,1.0,3/13,16.96%,SPRED1;SPRED2;ATR
prerank,ncRNA catabolic process (GO:0034661),0.2158020558806597,0.47007923386629574,0.9878787878787879,0.9995068576876924,1.0,7/28,21.39%,POP1;EXOSC7;TUT4;ZCCHC8;EXOSC10;DIS3;TRIR
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.2024396290116357,0.4683612984576049,0.9893955461293743,0.9997155505973238,1.0,8/62,12.86%,ERCC3;ELOF1;ELOC;SETD2;POLR2A;LEO1;ADRM1;SSRP1
prerank,mitochondrial transcription (GO:0006390),0.24292284403600872,0.46781397555481063,0.9602446483180428,0.9995059383629274,1.0,2/10,15.10%,FOXO3;TFB1M
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.2380414312617701,0.4677553530623329,0.9674681753889675,0.999123127237556,1.0,12/12,76.21%,CD44;GCNT2;FLOT1;FGG;IL10;IL1B;TNF;LCK;AGER;THY1;SKAP1;BMP7
prerank,negative regulation of immune response (GO:0050777),0.19712837045821816,0.46699266010697243,0.998995983935743,0.9989797513190655,1.0,31/154,23.21%,IAPP;NMI;ENPP3;SAMSN1;ILRUN;GLP2R;ADAM17;ITCH;ADRB2;PLK2;INSL3;RC3H1;RAMP3;ADCY6;SRC;CYSLTR2;PRKAR2B;ADCY2;PRKAR2A;DPEP1;MAPK14;HAVCR2;YES1;FER;HTR7;SIRT2;GNB1;MYH9;FYN;PRKAR1A;PCBP2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.20253942114570392,0.4610242919173915,0.9878183831672204,1.0,1.0,5/49,12.88%,KIT;IL18;PARP9;CNTF;IL31RA
prerank,protein localization to mitochondrion (GO:0070585),0.24153287560046957,0.46101636982361915,0.9824304538799414,1.0,1.0,5/11,27.30%,LRRK2;MAIP1;ISG15;RALA;COX18
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.23301227261659688,0.4608735070325097,0.9691444600280504,0.999779380123817,1.0,7/14,26.26%,AK7;NMNAT1;NMNAT2;PNP;NMNAT3;ME1;AK8
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.19780932416805577,0.4592574188249689,0.989440337909187,0.9998783974528601,1.0,8/64,12.86%,ERCC3;ELOF1;ELOC;SETD2;POLR2A;LEO1;ADRM1;SSRP1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.20092360285202635,0.45865619718712225,0.9805194805194806,0.9996555704616049,1.0,3/53,11.23%,LPAR3;AGT;ANXA1
prerank,negative chemotaxis (GO:0050919),0.20445298474422666,0.45733159831295117,0.9892857142857143,0.9996517018420704,1.0,5/33,15.45%,RHOA;NTN1;ROBO1;ITGAV;SEMA3D
prerank,neutrophil chemotaxis (GO:0030593),0.19998338608876745,0.4547409024349178,0.9891186071817193,1.0,1.0,2/53,5.09%,GBF1;CKLF
prerank,regulation of T cell proliferation (GO:0042129),0.19587198082524745,0.45367109837316,0.9935483870967742,0.9998846701373935,1.0,8/61,21.58%,CD80;NCK1;ANXA1;NCK2;IL4I1;SLC7A1;SDC4;PNP
prerank,steroid metabolic process (GO:0008202),0.19254927043314726,0.45353239800486894,0.9894847528916929,0.9995186439972811,1.0,2/72,3.25%,CYP39A1;CYP26B1
prerank,response to lipopolysaccharide (GO:0032496),0.19142124456613044,0.4534469802101378,0.9949238578680203,0.999136857393914,1.0,24/138,21.19%,HMGB2;TICAM1;RHOA;SERPINE1;CD80;SMAD6;HMGB1;ADAM17;TRIM6;MAPKAPK3;ADAM9;NFKB1;AXL;SIRPA;FOXP1;MAPK14;PLAA;CD68;TRIB1;PDE4B;TRAF6;MAPKAPK2;SNCA;FER
prerank,positive regulation of integrin activation (GO:0033625),0.23769317111828397,0.4505465616285831,0.9894736842105263,0.9995354410781732,1.0,3/11,20.95%,PIEZO1;SRC;FERMT2
prerank,regulation of chemokine production (GO:0032642),0.20042026452457282,0.44949398703683824,0.9839080459770115,0.9994220042857511,1.0,10/36,27.17%,IL18;ADAM17;LPL;FOXP1;EIF2AK2;IL6R;TLR7;IL33;WNT5A;TLR3
prerank,histone H3-K9 demethylation (GO:0033169),-0.17584433237568906,-0.449279841346777,0.9931972789115646,1.0,1.0,3/11,20.14%,KDM4C;KDM4D;KDM4A
prerank,B cell activation (GO:0042113),0.19525020006079447,0.44849361512537594,0.9935622317596566,0.9993069884469336,1.0,9/68,15.54%,KIT;PTPN2;CTPS1;PRKCB;ADAM17;CASP8;BTK;ITGB1;DCAF1
prerank,regulation of intracellular pH (GO:0051453),0.20352561070863495,0.4483251094633186,0.9870892018779343,0.9989539544505613,1.0,5/34,17.47%,LRRK2;SLC4A2;SLC9A5;CA2;TM9SF4
prerank,negative regulation of type I interferon production (GO:0032480),0.2010174750574453,0.4459860305327009,0.994413407821229,0.9991620253221731,1.0,15/40,24.32%,PTPRS;ILRUN;ITCH;YY1;PIN1;SIRPA;MAVS;RELB;HAVCR2;ISG15;TAX1BP1;RNF216;PCBP2;REL;GPATCH3
prerank,positive regulation of peptidase activity (GO:0010952),0.2136456956135029,0.4444292554345679,0.969735182849937,0.9991396843822624,1.0,4/20,20.93%,DDRGK1;CTSH;PSME3;TANK
prerank,cellular response to UV-A (GO:0071492),-0.1762124474019254,-0.43898401422079436,1.0,1.0,1.0,4/11,33.61%,MMP2;CERS1;MMP1;OPN3
prerank,lymphocyte migration (GO:0072676),0.19903412644393226,0.4387818446296446,0.9892729439809297,1.0,1.0,1/32,5.09%,CKLF
prerank,negative regulation of inclusion body assembly (GO:0090084),0.229860102471383,0.43745807810342574,0.9849397590361446,1.0,1.0,3/10,20.12%,DNAJB2;DNAJB6;SACS
prerank,regulation of actin filament depolymerization (GO:0030834),-0.1721524694511135,-0.43730143871568944,0.9900990099009901,0.9994858666913949,1.0,2/12,17.97%,PLEK;PIK3CA
prerank,regulation of phosphatase activity (GO:0010921),0.1983674972887208,0.4350257769366434,0.9899244332493703,1.0,1.0,4/24,17.50%,MTMR9;BMP2;PTPA;PPP6R2
prerank,DNA catabolic process (GO:0006308),0.22628836858954254,0.4337296216394226,0.9807407407407407,1.0,1.0,11/11,77.39%,XRN2;DFFB;DNASE1L1;DNASE1L3;DNASE1;ISG20;FBH1;DNASE1L2;SETMAR;MUS81;REXO4
prerank,negative regulation of interferon-gamma production (GO:0032689),0.20319590401754767,0.4325094147072663,0.9936061381074168,0.9999303930108322,1.0,4/23,19.37%,PRNP;HMGB1;AXL;HAVCR2
prerank,RNA methylation (GO:0001510),0.1840101219948158,0.43169542834226526,0.989247311827957,0.999694418960563,1.0,10/60,19.59%,RBM15;METTL5;RBM15B;MRM2;METTL8;TFB1M;METTL3;NSUN3;VIRMA;TGS1
prerank,granulocyte chemotaxis (GO:0071621),0.1884409210487319,0.4310805279994088,0.9891774891774892,0.9994283540328713,1.0,8/55,23.30%,GBF1;CKLF;ANXA1;PIP5K1C;PIKFYVE;PDE4B;CXADR;CCL14
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.16007564011736589,-0.43100909220696565,0.996551724137931,0.9990748732599051,1.0,9/13,51.17%,TBX3;SRA1;SOX8;DLL1;EID2B;SOSTDC1;ANKRD2;PRICKLE1;NOTCH1
prerank,positive regulation of myelination (GO:0031643),0.22296392537529236,0.4285801162616449,0.9748520710059172,0.9995373615370587,1.0,3/11,22.73%,TPPP;EGR2;RNF10
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.19777855183543788,0.4269484548194901,0.986682808716707,0.9994717278934785,1.0,1/27,3.86%,LPAR1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.19718644376643213,0.4250857101122309,0.9940758293838863,0.9994204379137205,1.0,5/30,17.30%,KIT;LMBR1L;SFRP1;TP53;MLLT3
prerank,peptidyl-methionine modification (GO:0018206),0.21176082351179346,0.42422033102790535,0.9898255813953488,0.9991781643222043,1.0,3/12,18.25%,NAA20;METAP1;NAA60
prerank,triglyceride homeostasis (GO:0070328),0.1905560538677728,0.4203487044923123,0.980722891566265,0.999496974387633,1.0,3/26,14.80%,IL18;RORA;LPL
prerank,rRNA modification (GO:0000154),0.19493362929831715,0.41993735529992776,0.9933862433862434,0.9991791793259172,1.0,4/21,17.60%,METTL5;MRM2;TFB1M;NSUN3
prerank,mesenchymal to epithelial transition (GO:0060231),0.21767511925684163,0.4116313091035885,0.9799072642967542,1.0,1.0,10/10,78.25%,SALL1;BMP4;FZD7;SIX2;PAX2;CITED1;WT1;GATA3;PAX8;BASP1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.1752975101814063,0.40754383060231847,0.9978260869565218,1.0,1.0,14/68,24.82%,RAB7B;DHX9;HMGB1;TWIST1;POU2F2;LPL;SETD4;MAVS;IL16;IL6R;TLR7;BCL10;MBP;IL33
prerank,rRNA transcription (GO:0009303),0.19632503410894425,0.40647226941586245,0.9877216916780355,1.0,1.0,5/17,24.87%,GTF3C4;POLR1G;GTF3C5;BRF1;CAVIN1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.1778834444629459,0.40613286057026227,0.9977827050997783,0.9997827321334907,1.0,8/47,19.56%,MAPT;XDH;AGT;TP53;DHRS4;MAPK14;RIPK1;PRKCD
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.14336597996737283,-0.4060585725775416,1.0,0.9993150430062032,1.0,1/15,4.42%,TLR4
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.19463406567912114,0.4021011488614364,0.9920424403183024,0.9999252851916802,1.0,6/18,23.55%,YAP1;SMAD4;SRC;FER;IL6R;IL6ST
prerank,N-terminal protein amino acid modification (GO:0031365),0.19711542532262982,0.3977861680545475,0.9886845827439887,1.0,1.0,4/14,22.76%,METAP1;NAA60;NAA40;NAA50
prerank,monosaccharide transmembrane transport (GO:0015749),0.1865502951149064,0.393397055379438,0.9920634920634921,1.0,1.0,16/16,81.36%,SLC50A1;SLC2A8;SLC2A7;SLC2A12;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A6;SLC23A1;SLC23A2;SLC2A2;SLC5A3;SLC2A9;SLC45A3;SLC2A10
prerank,neutrophil migration (GO:1990266),0.1715651726514374,0.39294116463875,0.9989189189189189,0.9998407039543615,1.0,2/58,5.09%,GBF1;CKLF
prerank,negative regulation of hydrolase activity (GO:0051346),0.1680344302590214,0.3921927147943089,0.9988814317673378,0.9995361507434045,1.0,8/49,20.42%,WNK1;LRRK2;CPEB2;TERF2;ATP5IF1;RCC2;PLXNB3;EGLN1
prerank,rRNA catabolic process (GO:0016075),0.1894919610353633,0.38828320415573525,0.9958904109589041,0.9995389931889083,1.0,5/16,24.58%,EXOSC7;EXOSC10;DIS3;TRIR;EXOSC8
prerank,positive regulation of T cell activation (GO:0050870),0.1642501545391046,0.3871310973104279,1.0,0.9992503362890423,1.0,9/62,18.79%,CD80;NCK1;FLOT2;ANXA1;NCK2;SIRPA;SLC7A1;CD47;ZBTB1
prerank,potassium ion export across plasma membrane (GO:0097623),0.19134911168309382,0.3819954801526744,0.9941605839416059,0.9993424885885036,1.0,13/13,80.88%,KCNT2;KCNK5;KCND3;KCNA5;KCNE1;KCNK18;KCNE3;KCNE2;KCNE5;KCNH2;KCNIP2;KCNE4;KCNQ1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.19191889817991886,0.37168556281734666,0.9984779299847792,0.9998060788455619,1.0,1/10,9.08%,RIOK3
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.15847740887802741,0.3372964677032426,1.0,1.0,1.0,5/25,23.37%,DNAJB5;GAK;HSPA14;BAG1;HSPA8
prerank,insulin secretion (GO:0030073),0.1554965086148711,0.3335069735918845,0.9986754966887417,1.0,1.0,2/19,14.71%,ANXA1;SNX19
prerank,cell-cell junction maintenance (GO:0045217),0.1716031511951056,0.33327973964577284,0.9984984984984985,1.0,1.0,3/11,25.05%,NLGN2;FERMT2;MYADM
prerank,negative regulation of inflammatory response (GO:0050728),0.1393673405779774,0.3319979518921388,1.0,1.0,1.0,25/182,19.56%,RB1;IAPP;PTPN2;ENPP3;CCN3;GLP2R;RORA;ADAM17;MVK;ADRB2;PLK2;INSL3;RAMP3;ADCY6;SRC;CYSLTR2;PRKAR2B;SIRPA;ADCY2;PRKAR2A;DPEP1;PTGIS;MAPK14;YES1;PRKCD
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.13911350324964925,0.32958065678899195,1.0,0.9997808194858967,1.0,21/116,23.00%,IAPP;GLP2R;ADAM17;ADRB2;PLK2;INSL3;RAMP3;ADCY6;SRC;CYSLTR2;PRKAR2B;ADCY2;PRKAR2A;DPEP1;MAPK14;YES1;HTR7;GNB1;MYH9;FYN;PRKAR1A
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.13647359878563856,0.3221890176225255,1.0,0.9995559079886157,1.0,21/117,23.00%,IAPP;GLP2R;ADAM17;ADRB2;PLK2;INSL3;RAMP3;ADCY6;SRC;CYSLTR2;PRKAR2B;ADCY2;PRKAR2A;DPEP1;MAPK14;YES1;HTR7;GNB1;MYH9;FYN;PRKAR1A
